data_1dvd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dvd _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.634 ' CD2' ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 122.067 0.937 . . . . 0.0 111.47 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 3.8 m -102.78 -179.1 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.871 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -51.75 -177.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.23 110.71 22.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.098 -1.001 . . . . 0.0 110.74 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -76.93 138.25 65.71 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 175.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' ALA . 26.5 Cg_endo -64.44 131.84 31.31 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 109.152 -1.134 . . . . 0.0 109.152 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.571 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -41.67 167.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.511 1.148 . . . . 0.0 111.493 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.619 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -147.28 -167.43 0.15 Allowed Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.6 Cg_endo -73.13 -20.73 21.26 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 N-CA-C 108.471 -1.396 . . . . 0.0 108.471 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -39.93 22.95 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.219 -0.926 . . . . 0.0 108.688 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.603 HG13 ' CD1' ' A' ' 50' ' ' TYR . 4.7 mm -62.28 -54.83 29.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 23.5 tp60 -59.69 -19.44 49.76 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -76.2 -43.78 40.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.725 -1.234 . . . . 0.0 108.801 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.622 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 5.5 mt -55.48 -52.5 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 26' ' ' ASP . 12.3 p -67.51 -39.98 83.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 122.028 0.918 . . . . 0.0 109.717 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.574 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 25.6 t70 -70.71 -10.74 60.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -100.25 -18.07 17.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.542 ' CG2' HD22 ' A' ' 97' ' ' LEU . 19.8 m -116.28 1.48 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.514 -0.741 . . . . 0.0 110.397 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.641 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.56 -39.84 79.79 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.736 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 29' ' ' LYS . 33.7 Cg_endo -77.55 -35.37 1.58 Allowed 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 108.172 -1.511 . . . . 0.0 108.172 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 26.8 mt-30 -66.78 -15.32 63.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 97' ' ' LEU . 4.6 mt -89.92 -34.27 16.11 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.555 0.693 . . . . 0.0 109.535 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -55.14 -55.19 33.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 110.41 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.18 -8.52 50.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 31' ' ' GLN . 3.3 tttp -91.23 5.38 49.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.778 -1.201 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.629 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 9.7 p -131.61 -56.8 1.0 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 36' ' ' THR . 45.8 p30 134.15 20.54 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -149.65 -177.82 6.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.87 -1.144 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.538 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -117.72 118.68 32.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.466 ' OH ' HG22 ' A' ' 115' ' ' VAL . 74.0 m-85 -90.88 178.99 5.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 108.936 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -130.5 -168.04 12.16 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -37.47 127.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.926 . . . . 0.0 109.283 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 59.2 mt -102.97 79.99 1.82 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.059 -1.026 . . . . 0.0 108.704 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 1.3 mt-10 -61.8 85.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.145 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.571 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -43.64 145.9 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.235 1.017 . . . . 0.0 109.998 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.78 -44.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HG2' ' HB3' ' A' ' 63' ' ' LYS . 2.4 pt20 -151.57 169.53 21.89 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.603 ' CD1' HG13 ' A' ' 21' ' ' ILE . 14.1 p90 -163.12 133.56 4.54 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.055 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' CB ' ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -99.01 126.53 44.73 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.51 145.07 45.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.272 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.47 177.73 8.45 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.07 158.93 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 111.563 -178.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.97 -102.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.49 28.46 5.04 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.1 -110.34 0.44 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.522 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 86.5 m -165.67 109.59 0.83 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.367 -1.078 . . . . 0.0 110.76 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.524 ' OD1' ' CD2' ' A' ' 100' ' ' PHE . 70.2 m-80 -69.57 -176.44 1.01 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CD2' HD12 ' A' ' 24' ' ' ILE . 78.6 m-85 -149.54 151.61 34.17 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.472 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.613 ' CD2' ' O ' ' A' ' 124' ' ' GLY . 8.3 m-85 -138.04 132.55 32.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.572 HG13 ' C ' ' A' ' 61' ' ' TYR . 13.6 mt -150.77 115.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 116.847 -1.941 . . . . 0.0 111.683 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.559 ' N ' HD12 ' A' ' 122' ' ' LEU . 1.4 ttmp? -81.02 103.11 10.62 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.556 HG11 ' N ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -109.39 138.5 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.942 -176.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -68.11 127.18 31.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.08 46.07 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.044 0.926 . . . . 0.0 109.125 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 78.55 -93.84 1.26 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 22.6 p-10 -56.01 -163.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.187 -1.184 . . . . 0.0 109.563 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.45 -10.84 59.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.05 159.42 33.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 109.045 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.579 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 30.3 m-85 -129.35 176.21 8.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.455 ' HE2' HD12 ' A' ' 32' ' ' LEU . 2.7 ttp -155.76 113.22 3.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 109.561 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.843 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -69.83 151.72 45.4 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.557 ' CD2' ' HA ' ' A' ' 25' ' ' VAL . 11.0 tp -132.8 142.66 49.1 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 111.025 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -132.41 102.77 5.87 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.622 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.3 t -110.35 161.41 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.346 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.688 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 6.7 t80 -123.77 135.92 54.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.2 . . . . 0.0 108.28 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.562 ' O ' ' CE1' ' A' ' 100' ' ' PHE . 1.9 tmtt? . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.495 HD13 ' HD3' ' A' ' 101' ' ' LYS . 8.0 mp . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 122.698 1.237 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.688 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 14.7 p -156.91 163.39 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.71 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.557 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 10.3 tp -98.9 83.37 2.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.543 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 17.2 p -69.49 -11.77 61.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.965 . . . . 0.0 111.249 -176.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.485 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . 173.81 -165.96 37.98 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.83 -1.652 . . . . 0.0 110.929 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.6 p90 167.76 135.57 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.657 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.6 mm-40 -96.19 96.67 8.97 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.466 HG22 ' OH ' ' A' ' 40' ' ' TYR . 8.5 p -67.72 157.03 6.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.836 -1.165 . . . . 0.0 110.19 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 1.5 t0 51.56 21.15 1.21 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.1 OUTLIER -83.11 131.18 35.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.672 -1.268 . . . . 0.0 108.044 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.36 178.59 7.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.297 -0.877 . . . . 0.0 111.45 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 119' ' ' ASP . 10.2 tmtt? -61.51 -50.01 74.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.188 0.518 . . . . 0.0 110.197 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 118' ' ' LYS . 41.6 t0 -43.29 -26.43 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.179 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.436 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -69.45 93.3 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.358 -0.839 . . . . 0.0 110.321 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.543 ' O ' ' CG2' ' A' ' 123' ' ' THR . 2.3 tt0 -68.15 141.99 55.87 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.843 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -64.17 -35.65 81.48 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.364 -1.46 . . . . 0.0 110.27 -178.064 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.715 ' O ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER 49.48 -149.73 0.22 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.715 ' O ' ' O ' ' A' ' 123' ' ' THR . . . -48.82 -99.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 104.41 -3.476 . . . . 0.0 104.41 175.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.657 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 23.5 t80 . . . . . 0 C--N 1.29 -1.979 0 O-C-N 119.237 -2.331 . . . . 0.0 108.138 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.658 ' CD1' ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 122.206 1.003 . . . . 0.0 111.504 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -102.28 179.25 4.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.675 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.323 -0.861 . . . . 0.0 109.031 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . . . -91.47 101.02 13.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.789 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.596 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -70.93 141.07 86.51 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 103.236 -2.876 . . . . 0.0 103.236 175.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -68.02 126.63 14.76 Favored 'Trans proline' 0 C--N 1.29 -2.535 0 N-CA-C 109.531 -0.988 . . . . 0.0 109.531 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.545 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . . . -42.59 147.86 0.26 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.42 1.105 . . . . 0.0 111.994 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.613 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -122.3 -168.44 0.13 Allowed Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.613 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -71.56 -20.01 27.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 109.202 -1.115 . . . . 0.0 109.202 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -82.5 -43.97 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -0.999 . . . . 0.0 108.663 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.595 HG13 ' CD1' ' A' ' 50' ' ' TYR . 7.6 mm -58.81 -52.09 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.558 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -64.46 -18.22 64.56 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.381 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 28.8 tp10 -76.47 -31.24 57.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.597 -1.315 . . . . 0.0 108.525 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.606 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 5.4 mt -69.36 -50.66 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.569 HG23 ' CD1' ' A' ' 45' ' ' LEU . 7.3 p -62.48 -43.44 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-O 122.089 0.947 . . . . 0.0 109.358 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.555 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 21.4 t70 -74.4 -18.92 60.59 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.21 -12.76 56.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.505 HG13 ' CG2' ' A' ' 99' ' ' VAL . 27.7 m -116.59 -8.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.476 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.9 ttpp -42.25 -49.99 11.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 110.389 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.25 -34.75 7.54 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.535 1.49 . . . . 0.0 110.006 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.429 ' O ' HD22 ' A' ' 110' ' ' LEU . 29.6 mt-30 -78.84 0.07 28.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.206 -0.934 . . . . 0.0 108.592 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.574 HD22 ' CD2' ' A' ' 113' ' ' TYR . 3.2 mt -100.26 -41.23 7.16 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.444 -0.785 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 48.5 mt-10 -59.37 -44.38 92.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.5 -46.62 89.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.474 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB3' ' OH ' ' A' ' 113' ' ' TYR . 1.2 mmtp -71.11 -66.1 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 110.019 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.547 HG22 ' CZ ' ' A' ' 40' ' ' TYR . 9.4 t -70.12 -0.68 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.392 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 2.7 p-10 40.91 48.2 2.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.158 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -119.19 172.22 7.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.283 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' TYR . 5.9 t -80.91 -29.78 35.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 0.0 109.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.623 ' CE2' ' CE ' ' A' ' 95' ' ' MET . 4.9 m-30 40.31 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.529 0.681 . . . . 0.0 110.256 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 168.6 -163.39 37.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.1 118.26 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.488 -1.007 . . . . 0.0 109.443 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.569 ' CD1' HG23 ' A' ' 25' ' ' VAL . 36.5 mt -100.47 86.04 3.08 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.142 . . . . 0.0 108.073 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' C ' HG11 ' A' ' 64' ' ' VAL . 63.4 mt-10 -69.83 83.74 0.47 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -0.763 . . . . 0.0 110.063 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.558 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -41.11 145.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.148 0.975 . . . . 0.0 110.25 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -122.02 -44.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 42.2 mt-30 -149.45 170.08 19.4 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 17.5 p90 -164.45 138.19 5.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.196 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 35.3 mttt -108.93 125.32 51.9 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.2 p -76.4 175.74 8.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 109.785 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.602 ' HG2' ' CE2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -150.6 154.53 37.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.358 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.482 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -128.31 141.72 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.025 -1.047 . . . . 0.0 110.303 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.49 -101.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.73 30.17 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 157.9 -110.91 0.46 Allowed Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 29.6 m -165.17 108.22 0.84 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.364 -1.08 . . . . 0.0 110.913 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.618 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 76.0 m-20 -71.37 -170.44 0.5 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.618 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 19.6 m-85 -143.55 154.95 44.13 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.468 -0.77 . . . . 0.0 109.586 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.63 ' CE2' ' O ' ' A' ' 124' ' ' GLY . 21.2 m-85 -137.21 133.5 35.22 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.587 ' CG2' ' CG2' ' A' ' 64' ' ' VAL . 12.9 mt -149.11 114.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 117.004 -1.878 . . . . 0.0 111.442 -177.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 96' ' ' HIS . 19.2 ttpt -81.09 99.23 8.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.587 ' CG2' ' CG2' ' A' ' 62' ' ' ILE . 38.2 t -109.13 144.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.37 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.552 ' HD2' ' CZ ' ' A' ' 94' ' ' TYR . 1.4 mmm180 -69.71 132.93 46.9 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.13 44.9 1.17 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.976 0.893 . . . . 0.0 108.951 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 84.67 -92.79 1.76 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' GLY . 10.5 p-10 -60.68 -140.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.258 -1.142 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.64 -7.98 57.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.958 -1.089 . . . . 0.0 109.994 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.485 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -69.45 178.36 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 108.692 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.552 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 25.6 m-85 -142.78 179.06 7.22 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.06 -1.025 . . . . 0.0 109.285 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.623 ' CE ' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -164.76 114.02 1.11 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.462 -179.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.696 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.3 m170 -71.65 140.94 49.9 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -124.84 133.99 52.9 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.511 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -121.71 113.9 20.36 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.135 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.606 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.1 t -119.89 159.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.777 -1.202 . . . . 0.0 109.684 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.687 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 4.2 t80 -121.67 130.77 53.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.592 -1.318 . . . . 0.0 108.173 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.505 ' CE ' ' HB ' ' A' ' 58' ' ' THR . 2.5 pttt . . . . . 0 C--N 1.303 -1.425 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.533 ' N ' HD11 ' A' ' 108' ' ' LEU . 7.3 mp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 122.086 0.945 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.687 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.1 p -147.65 161.23 7.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.808 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 18.1 tp -97.81 87.94 4.16 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.488 ' OG1' ' HG3' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -75.57 -8.76 57.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 111.87 -176.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . 174.01 -168.27 41.03 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.625 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.606 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 31.4 p90 165.84 138.0 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.717 -0.872 . . . . 0.0 109.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.62 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.1 mm-40 -97.34 97.87 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.529 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 7.4 p -69.35 159.06 5.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.845 -1.16 . . . . 0.0 110.282 -178.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 56.4 t0 52.24 22.25 1.92 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.78 -0.575 . . . . 0.0 110.562 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 3.2 mptp? -90.56 106.31 18.42 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.755 -1.216 . . . . 0.0 108.951 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.455 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 4.5 m120 -69.51 -172.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 110.127 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -16.46 62.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.88 -20.05 63.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.586 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.7 OUTLIER -90.82 110.02 21.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 110.072 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.529 ' C ' HG21 ' A' ' 123' ' ' THR . 2.1 tt0 -92.62 150.6 20.61 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.696 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 2.0 mp -68.87 -44.27 73.65 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.515 -1.366 . . . . 0.0 107.734 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.538 ' CG2' ' C ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER 39.2 18.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.624 -0.672 . . . . 0.0 112.485 175.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.658 ' HA2' ' CD1' ' A' ' 11' ' ' LEU . . . 154.94 -65.63 0.32 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.2 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.62 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.269 0 O-C-N 121.286 -1.126 . . . . 0.0 109.251 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 123' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.827 0.822 . . . . 0.0 111.096 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 m -101.25 163.91 12.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.384 0.612 . . . . 0.0 109.458 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 5.7 tt0 -48.14 176.94 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.398 -0.814 . . . . 0.0 109.308 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.421 ' HB2' ' CD ' ' A' ' 49' ' ' GLN . . . -84.89 96.7 9.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.109 . . . . 0.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.649 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 20.0 mmtt -72.27 133.19 83.52 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 176.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 17' ' ' ALA . 27.5 Cg_endo -65.98 126.08 15.25 Favored 'Trans proline' 0 C--N 1.291 -2.452 0 N-CA-C 109.257 -1.093 . . . . 0.0 109.257 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -39.37 153.52 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.536 1.16 . . . . 0.0 111.815 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.599 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -136.27 -170.12 0.23 Allowed Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.3 Cg_endo -68.97 -16.53 40.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 N-CA-C 109.244 -1.099 . . . . 0.0 109.244 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.56 -46.45 14.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.068 -1.02 . . . . 0.0 108.41 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.624 HG13 ' CD1' ' A' ' 50' ' ' TYR . 10.2 mm -58.88 -53.67 44.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.498 ' O ' HG11 ' A' ' 25' ' ' VAL . 22.9 tp60 -61.47 -19.17 61.73 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -76.13 -37.06 58.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.711 -1.243 . . . . 0.0 108.776 179.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.595 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.9 mt -63.22 -50.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.596 HG23 ' CD1' ' A' ' 45' ' ' LEU . 11.4 p -66.21 -41.62 89.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 122.183 0.992 . . . . 0.0 109.251 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.566 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 8.8 t70 -69.39 -16.58 63.54 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -85.9 -20.16 29.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.57 ' C ' ' HD2' ' A' ' 30' ' ' PRO . 13.1 m -118.4 6.58 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.613 -0.68 . . . . 0.0 110.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.619 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -53.14 -36.85 42.16 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.687 -1.258 . . . . 0.0 110.646 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.619 ' HD3' ' CG ' ' A' ' 29' ' ' LYS . 35.9 Cg_endo -79.3 -37.04 0.57 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 108.361 -1.438 . . . . 0.0 108.361 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -74.17 -3.24 28.57 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.497 HD23 ' CE ' ' A' ' 95' ' ' MET . 10.0 mt -92.43 -41.12 10.49 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.417 -0.802 . . . . 0.0 109.624 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 23.6 mt-10 -65.32 -46.27 80.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.511 -0.743 . . . . 0.0 110.972 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.7 -37.26 62.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.807 -1.183 . . . . 0.0 111.136 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -58.08 -42.65 86.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.771 -1.205 . . . . 0.0 110.063 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.622 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 1.3 p -86.5 -57.48 2.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.933 -1.104 . . . . 0.0 109.663 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 36' ' ' THR . 52.6 p-10 131.26 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 C-N-CA 122.937 0.495 . . . . 0.0 109.714 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 5.0 pt-20 -133.93 171.75 13.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 109.148 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.435 HG23 ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -107.14 117.76 34.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.009 -1.057 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.458 ' OH ' ' CG2' ' A' ' 36' ' ' THR . 58.8 m-85 -93.05 178.77 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 108.594 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -126.31 -157.57 9.6 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 43' ' ' GLY . 4.2 tttt -41.68 125.11 2.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.451 -1.029 . . . . 0.0 109.151 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.596 ' CD1' HG23 ' A' ' 25' ' ' VAL . 28.4 mt -97.43 77.41 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.055 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.53 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.872 -177.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.566 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -45.69 144.27 1.72 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.127 -0.983 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.5 t -125.6 -42.14 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.421 ' CD ' ' HB2' ' A' ' 14' ' ' ALA . 8.8 mt-30 -150.28 166.96 28.39 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 2.5 p90 -163.54 138.06 6.07 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.458 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 23.8 mttt -113.38 131.89 55.81 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.878 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -81.08 -173.72 4.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.196 -0.94 . . . . 0.0 110.86 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.58 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.9 OUTLIER -164.32 156.01 16.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -125.43 141.43 45.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.949 -1.094 . . . . 0.0 110.746 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -170.2 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.29 28.93 5.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.464 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 160.23 -104.04 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 9.1 m -168.75 112.31 0.56 Allowed 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.7 -0.883 . . . . 0.0 109.766 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.58 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 32.6 m-80 -71.36 -166.63 0.19 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.598 ' CD1' HG13 ' A' ' 99' ' ' VAL . 28.5 m-85 -150.44 154.34 37.53 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.597 ' C ' HG13 ' A' ' 62' ' ' ILE . 22.6 m-85 -138.99 133.76 32.15 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 177.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.597 HG13 ' C ' ' A' ' 61' ' ' TYR . 11.1 mt -151.81 118.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 C-N-CA 116.719 -1.992 . . . . 0.0 111.589 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -78.44 98.7 6.13 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 175.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.566 HG11 ' N ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -108.81 132.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.353 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 5.7 ttp180 -66.36 139.14 58.0 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.55 43.96 1.07 Allowed 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.922 0.868 . . . . 0.0 109.405 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 72.9 -80.63 0.68 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.0 OUTLIER -53.67 -112.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.41 -1.053 . . . . 0.0 110.394 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.402 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 5.0 m-20 -125.44 -21.4 4.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.687 -1.258 . . . . 0.0 109.876 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -68.46 177.07 2.54 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 20.0 m-85 -135.72 176.08 9.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.007 -1.058 . . . . 0.0 109.204 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.497 ' CE ' HD23 ' A' ' 32' ' ' LEU . 4.6 ttp -156.66 117.42 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.393 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.698 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.6 m170 -69.19 148.35 50.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.584 ' CD2' ' HA ' ' A' ' 25' ' ' VAL . 13.9 tp -129.04 128.58 43.88 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.725 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 41.6 tttt -114.52 107.79 15.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.598 HG13 ' CD1' ' A' ' 60' ' ' TYR . 1.8 t -111.38 160.66 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.215 . . . . 0.0 109.164 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.708 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 34.7 t80 -122.94 133.11 54.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.792 -1.192 . . . . 0.0 109.003 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 tttp . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.232 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.514 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 122.116 0.96 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.708 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.3 p -152.31 166.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.089 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.54 ' HB2' ' CG1' ' A' ' 28' ' ' VAL . 12.4 tp -98.52 85.29 3.34 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.527 HG22 ' CB ' ' A' ' 100' ' ' PHE . 3.4 p -81.18 -1.55 45.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.1 -1.0 . . . . 0.0 111.947 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.579 ' O ' ' CB ' ' A' ' 113' ' ' TYR . . . 177.67 -160.19 26.6 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.193 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.667 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER 150.3 133.47 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.383 0.611 . . . . 0.0 109.959 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.641 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.07 95.08 7.94 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' HD3' ' A' ' 116' ' ' LYS . 9.4 p -67.98 161.4 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.185 . . . . 0.0 111.088 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 49.6 t0 50.11 20.76 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.912 -0.492 . . . . 0.0 110.815 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.571 ' CG ' ' OD2' ' A' ' 120' ' ' ASP . 1.6 mptt -93.61 129.44 39.88 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.64 -1.288 . . . . 0.0 108.546 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 2.9 m-80 -104.4 -156.86 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 0.0 112.285 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.535 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 3.4 tttm -54.2 -56.7 15.73 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.937 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.42 -20.98 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 0.0 111.089 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.571 ' OD2' ' CG ' ' A' ' 116' ' ' LYS . 63.2 t0 -83.9 123.02 29.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.665 -1.272 . . . . 0.0 111.724 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.558 ' O ' ' CG2' ' A' ' 123' ' ' THR . 5.1 tt0 -100.3 139.88 35.34 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 176.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.698 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.2 mp -59.55 -49.54 77.36 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.541 -1.35 . . . . 0.0 109.411 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.3 OUTLIER 43.7 -168.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.89 178.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.575 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -55.38 91.77 0.01 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 109.488 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 122.331 1.062 . . . . 0.0 110.945 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.5 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 79.1 p -101.52 -176.72 3.22 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.114 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -51.02 179.77 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.976 -1.078 . . . . 0.0 108.574 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.94 95.79 4.87 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.289 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mmtt -70.75 126.36 92.17 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.96 127.36 18.37 Favored 'Trans proline' 0 C--N 1.293 -2.345 0 N-CA-C 109.514 -0.995 . . . . 0.0 109.514 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -42.34 165.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.346 1.07 . . . . 0.0 111.431 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.619 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.46 -167.88 0.17 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -71.93 -18.03 28.23 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 N-CA-C 108.939 -1.216 . . . . 0.0 108.939 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.479 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.5 mt-10 -83.93 -45.32 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.601 HG13 ' CD1' ' A' ' 50' ' ' TYR . 4.6 mm -57.74 -54.43 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.501 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 13.6 tp60 -61.76 -20.29 63.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 7.0 tt0 -75.74 -34.81 60.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.471 -1.393 . . . . 0.0 108.643 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.635 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.7 mt -66.04 -49.67 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.004 0.907 . . . . 0.0 108.815 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.575 HG23 ' HB2' ' A' ' 45' ' ' LEU . 12.5 p -69.34 -41.38 80.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-O 121.966 0.889 . . . . 0.0 109.861 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.568 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 7.2 t70 -72.12 -17.0 62.01 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 14.4 tppt? -89.83 -13.47 36.49 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.612 ' CG2' ' CD2' ' A' ' 97' ' ' LEU . 31.3 m -126.58 4.18 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.883 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.594 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 6.3 ttpt -54.66 -43.66 98.48 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 111.07 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.68 -18.75 24.99 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.383 1.389 . . . . 0.0 109.615 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -91.92 -10.89 37.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD23 ' CB ' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -92.06 -33.27 14.86 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -82.68 -20.1 36.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 109.952 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.71 -45.85 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.017 -1.052 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -67.27 -40.16 86.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.587 ' OG1' ' CE1' ' A' ' 113' ' ' TYR . 2.7 m -82.67 -32.44 28.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.917 . . . . 0.0 109.388 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 88.71 26.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.254 0.55 . . . . 0.0 109.725 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -107.24 -178.84 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.518 ' O ' ' O ' ' A' ' 40' ' ' TYR . 29.9 m -97.03 -25.7 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.147 -0.971 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.641 ' CD2' ' CE ' ' A' ' 95' ' ' MET . 14.5 m-30 37.79 -165.29 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.705 0.764 . . . . 0.0 110.976 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 176.1 -165.63 36.29 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' O ' HD22 ' A' ' 45' ' ' LEU . 14.0 mttt -42.46 134.51 3.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.629 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 34.5 mt -111.85 81.66 1.49 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.2 tt0 -64.01 86.89 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.583 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -44.71 132.83 6.29 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.291 1.043 . . . . 0.0 110.371 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.459 HG22 ' HG2' ' A' ' 65' ' ' ARG . 1.3 t -110.83 -45.32 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.506 ' OE1' ' CD1' ' A' ' 122' ' ' LEU . 1.3 pt20 -149.05 173.21 13.63 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.803 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.601 ' CD1' HG13 ' A' ' 21' ' ' ILE . 26.7 p90 -165.31 141.12 5.33 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.69 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 12' ' ' SER . 9.0 mttt -117.7 135.96 53.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.366 0.603 . . . . 0.0 109.378 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.4 p -76.93 -175.59 3.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.266 -0.896 . . . . 0.0 110.064 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.606 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.6 OUTLIER -158.94 149.15 19.46 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.509 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -123.84 141.04 45.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.798 -1.189 . . . . 0.0 110.51 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.66 -103.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 30.24 4.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.406 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 158.94 -111.37 0.48 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 106.734 -2.547 . . . . 0.0 106.734 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 16.4 m -165.26 107.31 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.345 -1.091 . . . . 0.0 110.697 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.607 ' OD1' ' CD2' ' A' ' 100' ' ' PHE . 82.0 m-20 -71.89 -171.52 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 101' ' ' LYS . 22.8 m-85 -139.38 160.2 40.39 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.606 ' CE1' ' OXT' ' A' ' 125' ' ' PHE . 11.0 m-85 -141.8 136.57 30.79 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.588 HG13 ' C ' ' A' ' 61' ' ' TYR . 14.1 mt -151.15 119.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.675 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 26.4 ttpp -86.36 94.61 9.41 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.583 HG11 ' N ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -100.09 137.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.843 -0.536 . . . . 0.0 110.86 -176.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -67.76 123.46 20.6 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . . . -82.02 39.33 0.56 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.605 0.717 . . . . 0.0 111.007 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.04 -127.99 9.06 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.24 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -68.39 80.02 0.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.691 -0.888 . . . . 0.0 112.261 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 10.8 m120 71.22 -8.64 0.98 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.114 -0.991 . . . . 0.0 111.712 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -69.48 -179.76 1.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.649 -1.282 . . . . 0.0 108.367 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 7.3 m-85 -150.74 155.98 40.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.972 -1.08 . . . . 0.0 109.391 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.641 ' CE ' ' CD2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -150.79 111.21 4.19 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.652 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.11 135.25 44.74 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.612 ' CD2' ' CG2' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -120.25 157.35 29.32 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.868 -1.145 . . . . 0.0 111.274 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.2 tttt -141.77 107.49 5.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.635 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.1 t -115.31 160.27 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.755 -1.216 . . . . 0.0 110.308 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.607 ' CD2' ' OD1' ' A' ' 59' ' ' ASN . 0.2 OUTLIER -121.1 122.46 40.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 60' ' ' TYR . 1.8 tttt . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 122.487 1.137 . . . . 0.0 107.998 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.542 ' CD1' ' HG2' ' A' ' 101' ' ' LYS . 5.7 mp . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 122.353 1.073 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.588 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 14.3 p -153.86 161.42 2.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.099 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 8.1 tp -96.69 82.05 3.26 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.589 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -70.37 -9.48 56.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 111.918 -176.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.494 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . 168.78 -168.7 41.28 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.382 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.596 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 22.4 p90 167.79 135.38 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.593 -0.945 . . . . 0.0 109.139 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.652 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -90.53 103.9 16.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 36' ' ' THR . 8.1 p -68.25 161.69 3.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.552 -177.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' A ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 115' ' ' VAL . 0.9 OUTLIER 42.2 43.31 2.83 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.11 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.513 ' HG2' ' HB2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.959 -1.088 . . . . 0.0 108.404 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.97 -171.41 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 110.306 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 14.5 tttt -66.94 -40.5 87.57 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.425 0.631 . . . . 0.0 109.627 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.19 -18.56 0.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.341 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.586 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.4 OUTLIER -88.19 105.58 17.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.828 -1.17 . . . . 0.0 110.251 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.98 162.77 20.31 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.652 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 3.0 mp -85.07 13.91 5.62 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.406 -1.434 . . . . 0.0 109.484 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.543 ' C ' ' O ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER 2.77 -76.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.439 0.696 . . . . 0.0 112.236 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.538 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -139.71 15.02 3.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.652 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.602 0 O-C-N 121.603 -0.94 . . . . 0.0 108.545 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.591 HD22 ' CE2' ' A' ' 61' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 122.383 1.087 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.5 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -101.93 178.68 4.54 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.966 179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.474 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -51.96 163.83 0.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.161 -0.962 . . . . 0.0 109.182 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . . . -72.54 107.68 5.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.942 . . . . 0.0 110.865 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.03 139.5 79.71 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 175.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.93 127.39 17.65 Favored 'Trans proline' 0 C--N 1.292 -2.435 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.548 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -44.61 131.43 6.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.06 0.933 . . . . 0.0 112.266 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.583 ' OG1' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -102.52 -173.42 0.29 Allowed Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 176.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.583 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 28.5 Cg_endo -68.42 -20.82 41.55 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 109.643 -0.945 . . . . 0.0 109.643 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.6 mt-10 -81.72 -41.54 21.13 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.035 -1.041 . . . . 0.0 108.929 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.629 HG13 ' CG ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -62.36 -47.48 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -67.6 -16.1 64.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.2 tt0 -77.18 -29.99 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.814 -1.179 . . . . 0.0 108.315 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.597 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.0 mt -70.62 -50.41 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.574 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 7.7 p -61.42 -44.33 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.984 0.897 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.542 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 8.6 t0 -72.11 -20.26 61.67 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -80.34 -12.86 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.591 HG22 ' CD1' ' A' ' 97' ' ' LEU . 35.2 m -116.17 -10.85 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.556 -0.715 . . . . 0.0 110.203 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.2 ttmt -39.77 -49.91 5.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.05 -1.031 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 28.9 Cg_endo -69.69 -35.52 12.71 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.587 1.525 . . . . 0.0 109.8 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 27.6 mt-30 -73.76 -4.8 36.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.609 HD21 ' CE2' ' A' ' 40' ' ' TYR . 7.0 mt -96.89 -43.15 7.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.62 0.724 . . . . 0.0 110.03 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.7 -27.19 69.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.752 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.04 -46.79 5.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.963 -1.085 . . . . 0.0 110.916 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 70.7 mttt -67.76 -33.89 75.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.071 . . . . 0.0 110.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 2.8 m -92.98 -35.5 13.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.886 -1.134 . . . . 0.0 109.532 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 36' ' ' THR . 1.0 OUTLIER 91.3 28.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.218 0.532 . . . . 0.0 110.019 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -115.38 -175.99 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 40' ' ' TYR . 43.2 m -98.78 -20.75 16.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.609 ' CE2' HD21 ' A' ' 32' ' ' LEU . 4.1 m-85 39.22 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.974 0.892 . . . . 0.0 111.051 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.9 -152.29 11.12 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 129.77 42.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.673 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.574 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . 35.5 mt -111.05 81.94 1.51 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.974 -1.079 . . . . 0.0 109.028 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -65.23 85.69 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.481 0.658 . . . . 0.0 110.137 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.556 ' HA ' ' CG1' ' A' ' 64' ' ' VAL . . . -43.96 125.99 4.61 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.105 0.955 . . . . 0.0 109.891 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.9 t -103.4 -44.87 9.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 3.4 mt-30 -142.78 172.79 12.21 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.629 ' CG ' HG13 ' A' ' 21' ' ' ILE . 31.7 p90 -169.75 139.82 2.03 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.877 -1.139 . . . . 0.0 110.593 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 12' ' ' SER . 7.5 mtmt -122.23 128.99 51.82 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.92 139.6 37.32 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.171 -0.956 . . . . 0.0 110.062 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.514 ' CD ' ' N ' ' A' ' 53' ' ' GLN . 1.3 pm0 -133.23 158.52 42.68 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.487 ' O ' HG11 ' A' ' 55' ' ' VAL . 4.7 p -97.36 155.85 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 111.772 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.504 HG22 ' ND2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -162.28 -101.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 27.91 5.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.406 ' O ' HG21 ' A' ' 54' ' ' VAL . . . 156.55 -103.37 0.23 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 106.373 -2.691 . . . . 0.0 106.373 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -160.89 122.64 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.584 -0.951 . . . . 0.0 109.891 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.574 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 9.7 m-20 -85.12 -164.96 1.07 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 7.9 m-85 -149.52 131.05 14.84 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.619 ' C ' HG13 ' A' ' 62' ' ' ILE . 8.9 m-30 -115.88 134.53 54.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.619 HG13 ' C ' ' A' ' 61' ' ' TYR . 17.8 mt -150.47 128.13 2.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 116.812 -1.955 . . . . 0.0 111.371 -176.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.572 ' HG3' ' NZ ' ' A' ' 116' ' ' LYS . 19.4 ttmt -95.34 90.99 6.02 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.556 ' CG1' ' HA ' ' A' ' 47' ' ' ALA . 31.4 m -99.6 142.06 15.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.773 -0.579 . . . . 0.0 110.956 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.33 123.15 19.97 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB1' ' N ' ' A' ' 94' ' ' TYR . . . -86.06 46.75 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.139 0.971 . . . . 0.0 109.141 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 -152.05 19.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 92' ' ' ASN . 2.0 p-10 -59.15 126.84 29.32 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.426 -1.044 . . . . 0.0 111.044 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 68' ' ' ASP . 7.8 p-10 31.62 44.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.217 0.532 . . . . 0.0 111.304 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.489 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -127.76 171.41 11.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.495 ' N ' ' HB1' ' A' ' 66' ' ' ALA . 25.8 m-85 -156.94 156.36 32.92 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.754 -1.216 . . . . 0.0 110.495 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.51 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 9.2 tmm? -153.97 116.52 4.39 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.296 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.687 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.1 m170 -76.29 143.22 41.01 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.591 ' CD1' HG22 ' A' ' 28' ' ' VAL . 1.4 tp -133.55 131.92 40.3 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.795 -1.562 . . . . 0.0 112.437 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.2 ttpt -111.7 83.38 1.77 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.598 HG11 ' CD1' ' A' ' 60' ' ' TYR . 1.6 t -84.47 159.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.665 -1.272 . . . . 0.0 109.206 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.701 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 58.4 t80 -125.4 131.43 52.94 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.635 -1.291 . . . . 0.0 108.35 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.475 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 122.307 1.051 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.701 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.5 p -163.39 164.94 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.089 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.541 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 4.4 tp -97.49 83.52 3.27 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.533 HG22 ' CB ' ' A' ' 100' ' ' PHE . 1.4 p -85.89 -3.61 58.96 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.016 -1.052 . . . . 0.0 112.81 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 113' ' ' TYR . . . -171.31 -172.34 37.36 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.633 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER 155.38 132.61 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.736 -0.861 . . . . 0.0 111.3 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.636 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 6.2 mm-40 -95.37 95.95 8.8 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.451 HG21 ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -65.84 160.1 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.99 -176.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' A ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 115' ' ' VAL . 2.7 t70 42.85 37.19 1.01 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.441 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.572 ' NZ ' ' HG3' ' A' ' 63' ' ' LYS . 8.1 ptmm? -69.61 -163.83 0.06 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.074 -1.016 . . . . 0.0 108.935 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.452 ' O ' ' NZ ' ' A' ' 116' ' ' LYS . 14.2 m-80 -157.35 178.5 10.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.84 -1.163 . . . . 0.0 109.922 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -68.92 -9.27 50.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.814 . . . . 0.0 109.756 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.32 5.09 46.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -100.68 119.65 38.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.035 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.551 ' O ' ' CG2' ' A' ' 123' ' ' THR . 0.9 OUTLIER -96.9 138.43 34.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.687 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.6 mp -58.57 -55.93 28.65 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.715 -1.241 . . . . 0.0 109.196 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.3 OUTLIER 44.69 -169.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.182 177.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.558 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -49.51 91.93 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.539 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.594 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.532 HD21 ' N ' ' A' ' 11' ' ' LEU . 1.3 pt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 t -101.33 -177.22 3.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 110.731 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -49.98 -175.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.555 -0.716 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . . . -90.17 107.88 19.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.928 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 9.6 mmpt? -73.26 141.11 80.32 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 175.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HA ' ' HG3' ' A' ' 49' ' ' GLN . 28.2 Cg_endo -66.47 131.29 25.87 Favored 'Trans proline' 0 C--N 1.291 -2.499 0 N-CA-C 109.45 -1.019 . . . . 0.0 109.45 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.557 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -48.17 165.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.399 1.095 . . . . 0.0 111.813 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.628 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -145.92 -166.07 0.12 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.628 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.5 Cg_endo -71.85 -18.35 28.26 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 N-CA-C 108.755 -1.287 . . . . 0.0 108.755 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.42 -45.93 15.34 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.6 HG13 ' CD1' ' A' ' 50' ' ' TYR . 4.4 mm -59.85 -53.03 54.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.501 ' NE2' HG12 ' A' ' 25' ' ' VAL . 26.9 tp60 -60.45 -19.48 56.61 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 tt0 -75.17 -43.12 54.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 108.737 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.613 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.3 mt -57.29 -52.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.584 ' CG2' ' CD1' ' A' ' 45' ' ' LEU . 11.4 p -66.42 -39.76 84.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 122.024 0.916 . . . . 0.0 109.095 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.575 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 23.3 t70 -68.44 -13.45 62.31 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -94.76 -19.96 19.91 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.257 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.576 HG22 ' CD1' ' A' ' 97' ' ' LEU . 27.4 m -111.66 -6.03 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.885 . . . . 0.0 111.23 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.578 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 ttpm? -44.46 -48.25 26.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -29.96 12.62 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.625 1.55 . . . . 0.0 110.112 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' HD22 ' A' ' 110' ' ' LEU . 26.3 mt-30 -83.77 -0.72 52.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -100.27 -37.6 8.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 1.5 tm-20 -72.08 -30.6 65.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -19.44 29.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.0 . . . . 0.0 109.886 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 7.6 44.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 109.855 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.572 HG23 ' CE2' ' A' ' 40' ' ' TYR . 14.4 t -135.56 -32.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.939 -1.1 . . . . 0.0 110.281 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER 92.62 18.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.919 -0.488 . . . . 0.0 110.116 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -115.5 157.76 23.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.916 -1.115 . . . . 0.0 109.057 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.524 ' O ' ' O ' ' A' ' 40' ' ' TYR . 8.9 m -81.22 -15.43 55.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.588 ' CD2' ' HE2' ' A' ' 95' ' ' MET . 12.0 m-30 39.0 -165.76 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.521 0.677 . . . . 0.0 110.14 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -176.65 -169.44 38.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' O ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -42.04 134.44 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.464 -1.021 . . . . 0.0 108.875 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.611 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 34.0 mt -112.55 83.73 1.86 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.085 -1.01 . . . . 0.0 109.859 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 3.7 mt-10 -65.33 85.5 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.481 0.658 . . . . 0.0 109.667 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.592 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -47.89 116.88 1.64 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.3 1.048 . . . . 0.0 110.579 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.55 HG22 ' CD ' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -90.67 -46.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 63' ' ' LYS . 2.6 mt-30 -148.73 168.78 21.98 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.696 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.6 ' CD1' HG13 ' A' ' 21' ' ' ILE . 7.0 p90 -161.75 136.23 6.98 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.821 -1.152 . . . . 0.0 110.983 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 11' ' ' LEU . 11.5 mttt -105.41 137.0 43.94 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 p -86.97 178.63 6.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.858 . . . . 0.0 110.049 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.624 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -157.32 161.25 39.1 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.02 140.08 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.068 -1.02 . . . . 0.0 110.374 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.15 -103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.63 29.35 4.13 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.464 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 158.65 -99.74 0.18 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 18.7 m -167.38 120.4 0.94 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.644 -0.916 . . . . 0.0 110.236 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.624 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 17.5 m-20 -77.92 -164.25 0.5 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.598 ' CD2' HD12 ' A' ' 24' ' ' ILE . 75.9 m-85 -151.58 152.61 33.13 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.704 0.764 . . . . 0.0 109.023 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CE1' ' HB2' ' A' ' 125' ' ' PHE . 19.7 m-85 -138.58 132.78 31.6 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.559 HG13 ' C ' ' A' ' 61' ' ' TYR . 14.4 mt -149.11 119.0 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 C-N-CA 116.917 -1.913 . . . . 0.0 111.378 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 14.2 ptpt -85.99 98.71 10.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.592 HG11 ' N ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -102.26 141.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.217 0.532 . . . . 0.0 110.746 -175.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.62 ' NH1' ' CE2' ' A' ' 94' ' ' TYR . 0.9 OUTLIER -68.93 125.0 25.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 93' ' ' LYS . . . -83.11 38.95 0.62 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.619 0.723 . . . . 0.0 110.839 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.87 -74.09 0.8 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.612 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 54.0 p30 -78.21 44.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.982 -1.305 . . . . 0.0 113.485 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 3.4 t-20 79.94 -41.28 0.22 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.849 -1.157 . . . . 0.0 111.246 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 33.6 mtmt -67.21 144.3 56.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.723 -1.236 . . . . 0.0 107.826 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.62 ' CE2' ' NH1' ' A' ' 65' ' ' ARG . 18.8 m-30 -104.82 172.16 6.94 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.416 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.588 ' HE2' ' CD2' ' A' ' 40' ' ' TYR . 2.4 mtp -144.01 115.68 8.19 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.721 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -69.63 148.45 49.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.576 ' CD1' HG22 ' A' ' 28' ' ' VAL . 12.9 tp -133.27 132.76 41.79 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.296 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 30.0 tttt -122.61 103.34 8.62 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.613 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.4 t -108.8 163.64 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.32 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.671 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.2 t80 -127.05 133.13 50.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.975 -1.078 . . . . 0.0 108.809 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 5.9 tttt . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.6 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 6.9 mp . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 122.422 1.106 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.671 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 8.4 p -146.07 164.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.927 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.569 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 11.1 tp -98.01 83.85 3.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -72.69 -10.15 59.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 111.157 -177.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . 174.35 -165.96 37.7 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 37.6 p90 164.98 137.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.657 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 1.5 mm-40 -103.09 107.99 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.546 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -66.6 162.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.634 -1.291 . . . . 0.0 111.626 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' A ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 115' ' ' VAL . 22.6 t0 39.49 30.69 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.635 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -77.8 158.39 29.55 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.695 -1.253 . . . . 0.0 108.254 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.34 179.4 4.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.039 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -65.03 -50.07 67.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 0.0 109.271 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' LYS . 13.9 t70 -44.5 -27.16 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.493 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -76.19 88.39 3.06 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.507 -0.746 . . . . 0.0 109.385 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.08 164.82 3.74 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.721 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -90.35 50.84 1.9 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.373 -1.454 . . . . 0.0 109.674 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -48.84 -177.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.083 178.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.464 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -42.41 94.11 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.657 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.363 -1.081 . . . . 0.0 109.646 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.569 ' CD1' ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.871 0.843 . . . . 0.0 111.082 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' GLU . 2.0 t -101.4 167.95 9.84 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.52 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.652 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.14 98.62 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.39 127.3 90.33 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 176.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.72 124.39 13.12 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -45.47 128.77 8.3 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.952 0.882 . . . . 0.0 111.667 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.578 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -101.07 -171.89 0.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 177.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.4 Cg_endo -69.06 -18.29 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 N-CA-C 109.369 -1.05 . . . . 0.0 109.369 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -43.3 22.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.143 -0.973 . . . . 0.0 108.504 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.622 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -63.33 -47.46 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.622 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -58.31 -23.03 55.24 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.4 tt0 -76.88 -40.61 46.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.22 -0.925 . . . . 0.0 110.286 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.639 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.0 mt -61.28 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 14.7 p -64.14 -41.65 93.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.017 0.913 . . . . 0.0 109.021 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.568 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 8.9 t70 -72.51 -12.56 61.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mttt -96.71 -10.12 27.57 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.593 HG22 ' CD1' ' A' ' 97' ' ' LEU . 4.3 m -120.76 -6.03 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 110.473 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -48.37 -45.28 67.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 0.0 110.379 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.4 Cg_endo -72.23 -28.94 14.85 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.287 1.324 . . . . 0.0 109.517 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.417 ' O ' HD22 ' A' ' 110' ' ' LEU . 39.1 mt-30 -81.79 -7.49 59.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.557 ' CD1' HD12 ' A' ' 97' ' ' LEU . 11.1 mt -88.1 -48.77 7.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -63.29 -25.25 68.23 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.149 0.5 . . . . 0.0 110.027 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -88.58 -28.14 20.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 110.178 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 13.8 mmtt -99.87 2.85 44.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 110.094 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.599 HG23 ' CE2' ' A' ' 40' ' ' TYR . 6.1 t -128.2 -4.48 5.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.121 -0.987 . . . . 0.0 109.874 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 40.14 45.3 1.67 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 109.834 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -138.14 161.25 37.28 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.408 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -88.16 119.11 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 110.309 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.599 ' CE2' HG23 ' A' ' 36' ' ' THR . 14.8 m-30 -114.29 -169.8 1.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -153.89 -171.84 21.35 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 43' ' ' GLY . 3.8 mttt -44.36 135.66 4.48 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.622 ' O ' ' NE2' ' A' ' 22' ' ' GLN . 31.0 mt -107.66 69.77 0.75 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.897 -1.127 . . . . 0.0 109.028 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -58.15 86.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.271 -178.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -41.01 142.68 0.46 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 109.963 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 2.1 t -125.26 -40.31 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -140.43 171.32 14.3 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.645 ' CE2' ' CB ' ' A' ' 15' ' ' LYS . 4.3 p90 -170.18 141.45 2.09 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.73 -1.231 . . . . 0.0 110.944 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 4.7 mttp -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.1 p -82.83 -174.31 5.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.153 -0.967 . . . . 0.0 110.739 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.606 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.9 OUTLIER -165.11 148.74 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.458 ' O ' HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.21 134.62 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 120.844 -1.16 . . . . 0.0 110.936 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -160.35 -102.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.03 29.06 4.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 159.66 -105.54 0.27 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 57' ' ' GLY . 23.3 m -168.26 118.78 0.78 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.682 -0.893 . . . . 0.0 110.327 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.606 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 43.3 m-20 -79.07 -165.64 0.79 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.568 ' CD1' HG11 ' A' ' 99' ' ' VAL . 32.2 m-85 -148.36 157.62 43.59 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.236 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.613 ' C ' HG13 ' A' ' 62' ' ' ILE . 18.9 m-85 -139.65 137.56 35.36 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.613 HG13 ' C ' ' A' ' 61' ' ' TYR . 10.9 mt -155.9 126.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 116.935 -1.906 . . . . 0.0 112.067 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.629 ' HD2' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.45 94.54 7.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 176.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.549 HG12 ' CG2' ' A' ' 25' ' ' VAL . 5.3 m -102.51 143.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.519 -0.738 . . . . 0.0 111.338 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.01 125.34 26.0 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.91 46.24 1.16 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.147 0.975 . . . . 0.0 109.358 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 94.2 -105.79 3.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 67' ' ' GLY . 5.6 p-10 -58.29 -144.73 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.497 -1.002 . . . . 0.0 109.93 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -77.53 -2.11 33.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.823 -1.173 . . . . 0.0 110.252 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -69.82 168.9 14.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.629 ' CD1' ' HD2' ' A' ' 63' ' ' LYS . 35.6 m-85 -142.13 165.3 27.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.546 ' SD ' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.7 116.5 4.8 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.725 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.676 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -73.99 143.61 45.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.593 ' CD1' HG22 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -146.29 130.19 17.22 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.845 -1.159 . . . . 0.0 110.786 -178.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.3 pttm -115.26 130.7 56.98 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.487 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.639 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 1.6 t -117.15 167.11 10.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.689 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.9 t80 -132.23 123.57 27.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.467 -1.396 . . . . 0.0 108.445 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.454 ' HG2' HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.454 HD13 ' HG2' ' A' ' 101' ' ' LYS . 11.0 mp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 122.408 1.099 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.689 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.0 p -148.78 160.93 5.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.774 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 1.9 tp -96.84 86.25 3.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.536 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -68.7 -20.71 64.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.97 -1.081 . . . . 0.0 111.087 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.494 ' HA3' ' HE2' ' A' ' 98' ' ' LYS . . . 178.32 -163.35 31.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.777 -1.677 . . . . 0.0 110.84 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.2 p90 167.81 135.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.687 -0.89 . . . . 0.0 108.896 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.666 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -94.55 103.36 15.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.436 ' HA ' ' HG2' ' A' ' 95' ' ' MET . 3.6 p -67.06 159.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.679 -1.263 . . . . 0.0 110.536 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.76 32.93 1.35 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.487 ' HG2' ' HB2' ' A' ' 114' ' ' GLN . 5.0 tptt -90.53 127.06 36.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.519 -1.363 . . . . 0.0 109.248 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.517 ' O ' ' CE ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -68.9 170.57 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.51 -0.744 . . . . 0.0 110.191 -178.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -62.99 -61.13 2.6 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.428 -0.795 . . . . 0.0 109.551 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 12.7 t0 -40.28 -31.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.457 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 1.1 t70 -50.77 121.54 6.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 110.031 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.553 ' O ' ' CG2' ' A' ' 123' ' ' THR . 0.7 OUTLIER -88.66 134.93 33.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.676 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 2.5 mp -65.22 -40.95 94.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.834 -1.166 . . . . 0.0 108.442 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 54.83 -161.91 0.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.027 0.918 . . . . 0.0 111.248 176.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.569 ' HA2' ' CD1' ' A' ' 11' ' ' LEU . . . -47.84 -17.97 0.64 Allowed Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.666 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 O-C-N 121.17 -1.194 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.411 HD21 ' CG ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 122.176 0.988 . . . . 0.0 110.586 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.512 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -102.07 -178.63 3.76 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.357 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.533 ' O ' ' CE ' ' A' ' 15' ' ' LYS . 2.8 mm-40 -59.01 135.0 57.49 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.05 -1.031 . . . . 0.0 108.797 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' HA ' ' NZ ' ' A' ' 51' ' ' LYS . . . -39.4 109.34 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.226 -0.921 . . . . 0.0 110.936 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.603 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -79.59 129.85 70.01 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 175.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.95 128.92 20.71 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.57 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -43.29 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.627 1.203 . . . . 0.0 112.285 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.624 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.59 -167.69 0.16 Allowed Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.624 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.7 Cg_endo -71.83 -18.02 28.58 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 109.263 -1.091 . . . . 0.0 109.263 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -83.28 -44.91 14.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 108.569 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.612 HG13 ' CD1' ' A' ' 50' ' ' TYR . 4.1 mm -57.82 -54.57 29.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.512 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 9.7 tp60 -60.45 -20.86 61.35 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 tm-20 -73.67 -36.84 65.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.683 -1.26 . . . . 0.0 109.091 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.582 HD12 ' CE2' ' A' ' 60' ' ' TYR . 4.5 mt -65.95 -50.76 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.084 0.945 . . . . 0.0 108.967 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 45' ' ' LEU . 8.7 p -65.0 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 122.074 0.94 . . . . 0.0 109.708 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.566 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 31.6 t70 -70.26 -18.15 63.13 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.91 -17.68 27.54 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.591 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' A' ' 97' ' ' LEU . 30.9 m -107.54 -9.32 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -47.07 -46.13 53.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.912 -1.117 . . . . 0.0 109.947 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.3 Cg_endo -73.73 -29.89 10.11 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.442 1.428 . . . . 0.0 109.097 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' HD22 ' A' ' 110' ' ' LEU . 2.5 mt-30 -81.57 -2.22 49.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.595 HD22 ' CG ' ' A' ' 113' ' ' TYR . 4.6 mt -95.08 -41.39 9.14 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.542 -0.723 . . . . 0.0 109.503 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 10.5 mt-10 -75.29 -23.64 57.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.537 -0.727 . . . . 0.0 109.441 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -23.57 21.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.994 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.33 -6.43 34.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.703 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.591 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 1.4 t -127.58 -30.57 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.8 OUTLIER 91.98 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.403 0.621 . . . . 0.0 109.939 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 36' ' ' THR . 1.2 mm-40 -110.04 -176.56 3.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 0.0 109.363 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' TYR . 7.3 m -108.89 -24.45 11.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 95' ' ' MET . 20.5 m-85 34.31 -162.91 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.784 0.802 . . . . 0.0 111.088 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' A' ' 45' ' ' LEU . . . 175.26 -160.27 28.87 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -42.6 125.78 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -1.095 . . . . 0.0 109.275 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 68.1 mt -108.62 82.58 1.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.079 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 25.5 mt-10 -64.16 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.35 -0.844 . . . . 0.0 110.094 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.58 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -42.05 149.42 0.15 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.397 1.094 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.91 -44.46 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -152.69 168.89 24.17 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.612 ' CD1' HG13 ' A' ' 21' ' ' ILE . 17.5 p90 -166.0 144.53 5.84 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 111.284 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.553 ' CE ' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -109.14 165.7 11.4 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.62 141.71 29.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.501 ' HG3' ' OH ' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -117.55 162.87 17.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -117.59 135.17 58.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.162 -0.961 . . . . 0.0 110.035 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -158.74 -101.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.01 30.17 4.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.77 -115.24 0.65 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 106.411 -2.676 . . . . 0.0 106.411 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.488 ' CB ' ' HE3' ' A' ' 101' ' ' LYS . 10.3 m -160.55 125.95 3.89 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.275 -1.132 . . . . 0.0 110.343 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.544 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 61.8 m-80 -78.0 -172.37 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.582 ' CE2' HD12 ' A' ' 24' ' ' ILE . 18.7 m-85 -150.4 154.37 37.63 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.439 1.114 . . . . 0.0 110.004 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 17.2 m-85 -152.73 130.83 11.88 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.577 HG13 ' C ' ' A' ' 61' ' ' TYR . 4.3 mt -146.39 118.53 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 117.133 -1.827 . . . . 0.0 112.073 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.596 ' HE3' ' CG ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -77.31 102.29 6.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 175.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.58 HG11 ' N ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -111.65 137.85 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.739 . . . . 0.0 110.807 -175.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.2 127.41 32.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 93' ' ' LYS . . . -80.45 36.71 0.38 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.557 0.694 . . . . 0.0 110.884 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.96 -75.78 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.596 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -79.85 47.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 113.165 -176.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 1.2 t-20 79.31 -38.75 0.2 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.93 -1.106 . . . . 0.0 111.739 177.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 2.8 mtmp? -66.99 144.57 56.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.581 -1.324 . . . . 0.0 107.469 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.596 ' CG ' ' HE3' ' A' ' 63' ' ' LYS . 15.3 m-30 -108.51 170.89 7.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.298 -0.877 . . . . 0.0 109.898 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -155.82 127.94 7.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.496 -0.752 . . . . 0.0 109.069 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.775 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -77.5 139.92 39.69 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.608 ' CD1' ' CD1' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -123.05 127.78 49.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 111.097 -179.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 4.4 ttmt -113.01 126.84 55.93 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.581 ' CG2' HG22 ' A' ' 24' ' ' ILE . 2.1 t -133.49 166.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.087 -1.008 . . . . 0.0 109.515 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.649 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 48.3 t80 -130.79 132.68 45.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.582 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.277 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 5.6 mp . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 122.217 1.008 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.649 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 7.4 p -137.6 162.44 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.084 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.608 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 16.3 tp -102.28 89.07 3.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.2 p -68.5 -21.22 64.61 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.314 -0.866 . . . . 0.0 110.707 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . -179.7 -161.26 26.69 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.623 -1.751 . . . . 0.0 111.029 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.595 ' CG ' HD22 ' A' ' 32' ' ' LEU . 29.1 p90 170.08 133.48 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.745 -0.856 . . . . 0.0 108.968 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.18 107.84 20.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.544 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -66.75 158.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.582 -1.324 . . . . 0.0 111.239 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.9 t70 41.84 37.87 0.88 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.714 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.507 ' CE ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -81.06 -169.77 2.4 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.543 -1.348 . . . . 0.0 107.953 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 62.6 m-80 -148.07 -176.42 5.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.648 -1.283 . . . . 0.0 110.686 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 119' ' ' ASP . 1.3 ttmm -74.74 -46.22 38.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.63 -0.669 . . . . 0.0 109.464 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.5 t70 -47.61 -24.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.142 -0.974 . . . . 0.0 108.441 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 21.6 t0 -83.22 66.12 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.672 -0.643 . . . . 0.0 109.395 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.554 ' O ' ' C ' ' A' ' 122' ' ' LEU . 1.8 tt0 -61.35 103.27 0.29 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.786 -1.196 . . . . 0.0 108.052 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.775 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 3.4 mp -26.39 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.585 1.184 . . . . 0.0 110.256 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER -108.0 -7.91 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.066 -177.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.15 107.43 0.2 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.662 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.661 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.93 0.871 . . . . 0.0 110.935 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -101.51 171.22 7.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' SER . 12.7 tm-20 -43.53 166.97 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.281 -0.887 . . . . 0.0 109.347 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' N ' ' CD ' ' A' ' 13' ' ' GLU . . . -71.25 103.05 2.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -73.28 132.65 81.72 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 175.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.39 127.67 18.69 Favored 'Trans proline' 0 C--N 1.293 -2.352 0 N-CA-C 109.378 -1.047 . . . . 0.0 109.378 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.563 ' CB ' ' CB ' ' A' ' 47' ' ' ALA . . . -47.29 132.35 12.87 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.044 0.926 . . . . 0.0 111.909 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.588 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -102.56 -172.63 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.588 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.0 Cg_endo -68.08 -17.59 45.77 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 N-CA-C 109.545 -0.983 . . . . 0.0 109.545 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -81.79 -36.62 28.23 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.09 -1.006 . . . . 0.0 108.494 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.64 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 0.7 OUTLIER -68.84 -45.31 80.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.525 ' O ' HG11 ' A' ' 25' ' ' VAL . 11.0 tp60 -66.82 -18.92 65.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.73 -30.29 59.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.835 -1.166 . . . . 0.0 108.774 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.649 ' CD1' ' CD2' ' A' ' 60' ' ' TYR . 46.0 mt -71.61 -51.98 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.57 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 8.4 p -60.1 -42.89 91.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.879 0.847 . . . . 0.0 109.074 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.556 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 1.4 t70 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' GLU . 7.3 mttt -81.45 -6.85 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.626 ' CG2' ' CD2' ' A' ' 97' ' ' LEU . 6.4 m -127.05 -8.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.577 -0.702 . . . . 0.0 110.501 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 15.5 ttpp -41.66 -47.9 9.74 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.024 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.0 Cg_endo -72.87 -34.88 6.17 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.33 1.354 . . . . 0.0 109.655 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 43.1 mt-30 -74.6 -5.35 42.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.922 . . . . 0.0 108.513 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.563 ' HG ' ' CD2' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -100.84 -37.47 8.67 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.863 0.839 . . . . 0.0 109.048 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.1 mt-10 -54.07 -54.88 33.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.654 -0.654 . . . . 0.0 110.55 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.71 -35.78 57.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 110.491 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 1.3 mptp? -53.46 -56.73 14.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.222 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 38' ' ' GLU . 10.0 t -95.37 20.67 9.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER 41.32 39.83 1.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.328 -0.858 . . . . 0.0 110.001 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.6 tt0 -136.77 160.12 39.81 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.433 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -102.92 135.8 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.698 -1.251 . . . . 0.0 110.422 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.552 ' CE1' ' HG3' ' A' ' 95' ' ' MET . 98.5 m-85 -117.52 169.1 9.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.834 . . . . 0.0 109.296 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -125.88 -164.69 11.86 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.1 123.82 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -1.206 . . . . 0.0 108.595 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 39.1 mt -100.32 76.72 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.919 -1.113 . . . . 0.0 109.063 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -57.2 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.461 0.648 . . . . 0.0 109.777 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.563 ' CB ' ' CB ' ' A' ' 17' ' ' ALA . . . -42.82 133.67 3.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.117 0.96 . . . . 0.0 110.006 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.2 t -113.36 -41.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.428 ' CD ' ' HB2' ' A' ' 14' ' ' ALA . 16.6 mt-30 -146.55 171.26 15.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.006 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.609 ' CG ' HG13 ' A' ' 21' ' ' ILE . 1.9 p90 -167.6 141.43 3.53 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.38 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 1.1 mppp? -121.14 128.91 52.98 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.956 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.5 p -73.01 -172.07 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.967 -1.083 . . . . 0.0 109.703 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.637 ' CG ' ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -167.33 127.27 1.43 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 4.6 p -107.84 115.58 49.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -136.85 -104.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.65 29.55 4.05 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.57 -116.73 0.73 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 11.5 m -158.61 113.49 2.55 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.218 -1.166 . . . . 0.0 110.113 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.583 ' OD1' ' CD1' ' A' ' 100' ' ' PHE . 54.8 m-20 -82.37 -173.13 4.39 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.836 0.827 . . . . 0.0 109.099 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.649 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 93.2 m-85 -137.49 152.0 49.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.637 ' CE1' ' CG ' ' A' ' 53' ' ' GLN . 4.5 m-85 -133.29 138.25 46.35 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.565 ' N ' HD23 ' A' ' 122' ' ' LEU . 13.0 mt -156.2 125.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 116.747 -1.981 . . . . 0.0 112.466 -175.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.56 ' HD2' ' NE2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -103.12 90.64 3.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.541 ' CG2' ' HB3' ' A' ' 45' ' ' LEU . 5.1 m -97.47 159.69 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.355 -0.84 . . . . 0.0 110.973 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -82.38 128.93 34.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.1 45.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.005 0.907 . . . . 0.0 109.377 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 86.23 -96.82 2.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 9.8 p-10 -58.83 -146.74 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.479 -1.012 . . . . 0.0 109.759 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.72 0.84 28.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.079 -1.013 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.58 175.72 6.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.265 -0.897 . . . . 0.0 109.238 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 21.7 m-85 -150.22 169.12 22.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 108.899 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.552 ' HG3' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -151.86 112.75 4.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.7 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -72.28 152.44 42.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.626 ' CD2' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -146.85 158.06 43.82 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.279 -1.368 . . . . 0.0 111.615 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 6.5 mtpt -141.3 114.03 8.37 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.627 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.3 t -118.8 168.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.746 -1.221 . . . . 0.0 110.358 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.608 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 1.2 t80 -130.59 122.66 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 108.708 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 4.9 tttt . . . . . 0 N--CA 1.504 2.266 0 CA-C-O 122.935 1.35 . . . . 0.0 108.299 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.585 HD22 ' CE1' ' A' ' 60' ' ' TYR . 6.2 mp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 122.314 1.054 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.608 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 7.1 p -143.9 163.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.798 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.563 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 6.4 tp -101.7 84.38 2.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.566 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 41.4 p -67.02 -19.82 65.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -176.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.464 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . 178.36 -170.24 42.24 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.442 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.3 p90 172.53 134.53 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.452 -1.029 . . . . 0.0 109.501 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.0 mm100 -96.85 103.25 15.15 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.476 HG22 ' OH ' ' A' ' 40' ' ' TYR . 2.2 p -66.79 154.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 122.254 1.026 . . . . 0.0 111.057 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 12.7 t0 47.29 33.01 2.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.952 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.499 ' HG2' ' ND1' ' A' ' 96' ' ' HIS . 5.6 tptt -77.84 162.62 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.446 -1.409 . . . . 0.0 108.461 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.433 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -107.88 160.76 15.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.93 -1.106 . . . . 0.0 109.911 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.504 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 3.0 ttpm? -55.47 -48.95 73.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.48 -38.44 9.22 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.335 -0.853 . . . . 0.0 109.126 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.613 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -66.27 96.31 0.34 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.325 -0.859 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.31 170.74 15.78 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.7 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 3.4 mp -93.16 25.4 3.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.411 -1.43 . . . . 0.0 109.202 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.532 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -17.14 -59.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.596 177.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.09 41.06 0.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CG ' ' OXT' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.57 0 CA-C-O 117.827 -1.083 . . . . 0.0 109.054 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 123' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.969 0.89 . . . . 0.0 112.867 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.493 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 23.0 t -102.2 169.56 8.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 12' ' ' SER . 42.4 tt0 -46.87 172.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.109 -0.995 . . . . 0.0 109.267 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . . . -81.65 107.25 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.956 -1.09 . . . . 0.0 110.228 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.649 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 1.1 mmtt -77.37 139.95 64.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.22 129.23 22.3 Favored 'Trans proline' 0 C--N 1.291 -2.476 0 N-CA-C 109.584 -0.968 . . . . 0.0 109.584 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -51.63 133.7 30.45 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.373 1.083 . . . . 0.0 111.788 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.619 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -109.33 -165.19 0.07 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -72.11 -16.52 28.62 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' HD13 ' A' ' 24' ' ' ILE . 7.5 pt-20 -81.53 -39.1 25.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.924 -1.11 . . . . 0.0 108.539 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.639 HG13 ' CD1' ' A' ' 50' ' ' TYR . 25.7 mm -67.39 -50.32 63.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.545 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -65.13 -15.04 61.97 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -77.37 -37.35 52.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.594 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 4.6 mt -63.9 -50.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.583 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 14.3 p -66.75 -40.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.099 0.952 . . . . 0.0 109.253 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.568 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 18.5 t0 -72.37 -15.08 61.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -92.91 -13.56 28.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 97' ' ' LEU . 31.6 m -116.86 -6.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.487 -0.758 . . . . 0.0 109.676 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -46.03 -48.55 41.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.894 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.8 Cg_endo -73.58 -29.19 11.13 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.575 1.517 . . . . 0.0 109.101 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' HD22 ' A' ' 110' ' ' LEU . 15.9 mt-30 -79.66 -4.77 53.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.543 ' O ' ' CG2' ' A' ' 36' ' ' THR . 2.3 mt -98.2 -41.34 7.94 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.657 0.741 . . . . 0.0 109.016 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -65.83 -22.58 66.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 110.453 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -36.45 12.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.955 -1.091 . . . . 0.0 110.206 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -53.68 10.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.043 . . . . 0.0 110.045 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 32' ' ' LEU . 10.0 t -78.76 6.6 8.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.737 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 3.5 p-10 42.93 42.95 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.715 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.552 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 7.9 tt0 -139.22 159.67 41.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.162 -0.962 . . . . 0.0 108.961 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.521 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -94.32 133.51 37.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 110.203 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.643 ' CD2' ' CE ' ' A' ' 95' ' ' MET . 21.1 m-85 -122.77 -168.51 1.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -144.25 -171.1 14.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.99 136.05 3.9 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.162 -1.199 . . . . 0.0 108.978 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 29.9 mt -107.89 85.18 2.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.044 -1.035 . . . . 0.0 108.901 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -68.64 84.47 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.697 -0.627 . . . . 0.0 109.534 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -43.6 129.5 5.33 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.211 1.005 . . . . 0.0 109.953 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.5 t -105.0 -46.26 9.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 1.8 mt-30 -146.92 167.23 24.47 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 3.8 p90 -161.1 137.51 8.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.565 -1.335 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 1.9 mttt -103.73 122.92 46.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 p -70.43 -173.67 0.75 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.688 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.6 OUTLIER -162.18 145.84 11.95 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.525 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -127.67 139.45 51.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.741 -1.224 . . . . 0.0 110.283 179.246 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.38 -100.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.22 29.6 5.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 157.72 -115.68 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 106.449 -2.66 . . . . 0.0 106.449 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 27.4 m -162.32 111.66 1.45 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.188 -1.184 . . . . 0.0 110.831 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.688 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 77.8 m-20 -77.92 -169.49 1.57 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.597 ' O ' ' CD1' ' A' ' 61' ' ' TYR . 25.2 m-85 -149.97 159.09 44.66 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.279 -0.888 . . . . 0.0 109.891 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.602 ' CE1' ' O ' ' A' ' 125' ' ' PHE . 22.9 m-85 -140.11 136.53 33.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.561 HG13 ' C ' ' A' ' 61' ' ' TYR . 14.4 mt -151.29 121.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 116.775 -1.97 . . . . 0.0 111.312 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.465 ' NZ ' HG12 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -86.92 94.77 9.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.553 HG11 ' CG2' ' A' ' 62' ' ' ILE . 6.6 m -102.01 141.66 17.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.566 -0.709 . . . . 0.0 110.943 -176.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -68.88 129.41 39.85 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.59 47.25 1.4 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.033 0.92 . . . . 0.0 108.744 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.56 -94.96 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.69 -164.74 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.333 -1.098 . . . . 0.0 109.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -64.0 -9.04 13.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 110.121 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -68.53 163.52 23.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 6.5 m-85 -133.32 176.6 8.38 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 108.707 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.643 ' CE ' ' CD2' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -157.32 108.76 2.34 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.176 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.757 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -69.58 144.49 53.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.579 HD21 ' HA ' ' A' ' 25' ' ' VAL . 46.3 tp -130.59 153.32 49.02 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.994 -1.066 . . . . 0.0 111.063 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.499 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 4.3 ttmt -139.01 111.09 7.31 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.594 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 1.9 t -117.44 161.14 16.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.688 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 3.2 t80 -127.36 127.92 45.03 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.702 -1.249 . . . . 0.0 107.815 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.487 ' HB3' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.266 -0.896 . . . . 0.0 108.721 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 7.3 mp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 122.42 1.105 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.688 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.9 p -158.57 164.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.055 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 4.9 tp -97.47 83.13 3.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.481 ' OG1' ' HG2' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -71.94 -11.57 60.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 112.082 -176.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.511 ' O ' HD13 ' A' ' 110' ' ' LEU . . . 175.28 -171.91 45.0 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.575 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.578 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 20.8 p90 168.39 134.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.217 -1.167 . . . . 0.0 109.137 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -94.61 102.2 14.1 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.498 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 2.3 p -68.41 164.08 2.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.868 -1.145 . . . . 0.0 110.73 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.88 25.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.86 -0.525 . . . . 0.0 110.711 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.576 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.54 161.72 13.52 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 120.66 -1.275 . . . . 0.0 108.366 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 25.0 p-10 -140.4 -155.79 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.613 -1.305 . . . . 0.0 111.389 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -65.31 -48.46 73.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.27 0.557 . . . . 0.0 110.031 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 118' ' ' LYS . 2.9 t70 -41.05 -26.59 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 109.915 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.576 ' CB ' ' CD ' ' A' ' 116' ' ' LYS . 3.1 t70 -98.26 115.0 27.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 111.376 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.556 ' O ' ' CG2' ' A' ' 123' ' ' THR . 3.0 tt0 -75.07 146.89 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.757 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -66.59 -12.3 57.23 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.336 -1.477 . . . . 0.0 109.417 -178.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.609 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER 37.25 -156.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.44 177.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -83.93 49.58 4.26 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.267 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.569 ' CD2' ' O ' ' A' ' 123' ' ' THR . 1.1 mp . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.955 0.883 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -101.59 171.44 7.56 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.67 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.99 -179.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.384 -0.823 . . . . 0.0 109.526 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.538 ' CB ' ' OE1' ' A' ' 49' ' ' GLN . . . -82.89 107.76 15.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.005 . . . . 0.0 110.003 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.669 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -83.4 128.78 62.99 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 175.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.87 130.78 23.9 Favored 'Trans proline' 0 C--N 1.294 -2.29 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -46.53 162.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.392 1.092 . . . . 0.0 111.552 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.61 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -143.31 -166.95 0.14 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.73 -18.28 28.74 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 N-CA-C 108.992 -1.195 . . . . 0.0 108.992 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.45 -45.57 14.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 0.0 108.567 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.637 HG13 ' CD1' ' A' ' 50' ' ' TYR . 3.6 mm -58.48 -53.16 50.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.37 -19.84 62.32 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 tm-20 -73.87 -35.73 64.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.428 -1.42 . . . . 0.0 108.505 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 5.1 mt -65.46 -51.22 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.75 0.786 . . . . 0.0 108.934 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.588 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 8.8 p -62.34 -41.99 93.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 122.054 0.931 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.562 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 6.3 t70 -69.95 -19.86 63.35 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.0 tttt -79.35 -20.7 47.13 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.571 HG22 ' CD1' ' A' ' 97' ' ' LEU . 17.6 m -117.83 3.1 7.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.732 -0.605 . . . . 0.0 109.938 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.578 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 14.7 tttp -47.91 -46.85 64.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.695 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.7 Cg_endo -75.34 -27.34 9.57 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.555 1.503 . . . . 0.0 109.028 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.524 ' O ' ' CD2' ' A' ' 110' ' ' LEU . 1.2 mt-30 -83.01 -1.03 51.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.597 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 2.5 mt -100.47 -33.48 10.33 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.676 0.75 . . . . 0.0 109.269 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 38' ' ' GLU . 2.4 mm-40 -73.89 -32.1 63.42 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.572 -0.705 . . . . 0.0 110.838 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -101.44 -4.43 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.355 -1.466 . . . . 0.0 112.009 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -99.95 -11.39 20.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.488 -1.383 . . . . 0.0 110.355 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.576 ' HB ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -140.11 -28.22 0.74 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.998 -1.064 . . . . 0.0 110.889 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.7 p30 149.11 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' GLU . 26.9 tt0 -66.38 105.09 1.36 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.234 1.016 . . . . 0.0 109.904 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 39' ' ' THR . 46.9 m -158.76 14.39 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.66 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.38 -175.53 2.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.048 -1.032 . . . . 0.0 109.171 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -145.72 -108.47 0.57 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -77.76 134.66 38.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -1.183 . . . . 0.0 108.811 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.588 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . 14.5 mt -108.16 83.47 1.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 108.511 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 3.7 mt-10 -71.87 85.5 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.708 -0.62 . . . . 0.0 109.961 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.547 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -40.47 155.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 110.05 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.79 -41.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.538 ' OE1' ' CB ' ' A' ' 14' ' ' ALA . 25.1 tt0 -142.41 168.97 18.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.669 ' CE1' ' CB ' ' A' ' 15' ' ' LYS . 9.2 p90 -167.8 137.03 2.58 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.607 -1.308 . . . . 0.0 110.727 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 30.1 mttt -112.41 135.16 53.44 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.451 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 p -87.78 175.46 7.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.088 -1.008 . . . . 0.0 109.754 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.6 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -150.31 158.96 44.73 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -129.49 137.03 57.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.935 -1.103 . . . . 0.0 110.495 179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -164.46 -96.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.03 28.76 7.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.474 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 161.44 -107.05 0.3 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 3.3 m -168.59 109.65 0.52 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.592 -0.946 . . . . 0.0 110.729 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.6 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 41.5 m-80 -70.26 -165.98 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CD2' HD12 ' A' ' 24' ' ' ILE . 64.6 m-85 -147.7 159.54 43.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.039 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.627 ' C ' HG13 ' A' ' 62' ' ' ILE . 47.6 m-85 -140.41 138.18 34.55 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.627 HG13 ' C ' ' A' ' 61' ' ' TYR . 24.9 mt -155.95 116.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 C-N-CA 116.873 -1.931 . . . . 0.0 111.495 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HE3' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -81.66 101.79 10.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.547 HG11 ' N ' ' A' ' 47' ' ' ALA . 11.5 t -113.7 139.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 112.319 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -69.36 121.29 16.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.457 ' HA ' HD21 ' A' ' 45' ' ' LEU . . . -82.64 43.0 0.8 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 111.83 -129.73 9.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 67' ' ' GLY . 34.9 t70 -51.4 -107.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.518 -0.989 . . . . 0.0 110.365 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.03 3.99 36.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.71 -1.244 . . . . 0.0 109.706 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 94' ' ' TYR . 13.1 tptt -68.53 157.37 36.14 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' CD ' ' A' ' 65' ' ' ARG . 2.3 m-85 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.975 -1.078 . . . . 0.0 109.595 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.526 ' CB ' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -163.46 133.66 4.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.572 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.633 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 5.7 m170 -69.98 161.14 30.61 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.597 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 2.8 tp -142.04 129.88 21.76 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.576 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.595 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ttmt -117.54 122.43 43.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.636 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.1 t -123.83 168.19 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.971 -1.081 . . . . 0.0 109.009 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.666 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 14.8 t80 -131.84 127.42 36.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.85 -1.156 . . . . 0.0 108.954 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.532 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.514 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 7.5 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 122.21 1.005 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.666 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 7.3 p -136.73 164.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.52 -177.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.561 ' HB2' ' CG1' ' A' ' 28' ' ' VAL . 7.1 tp -100.09 83.66 2.73 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 98' ' ' LYS . 1.2 p -67.72 -17.29 64.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 111.197 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . 176.32 -164.78 34.81 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.063 -1.541 . . . . 0.0 110.355 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.9 p90 165.99 137.17 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.686 -0.891 . . . . 0.0 109.099 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.61 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 8.6 mm-40 -99.0 94.51 6.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.526 ' HA ' ' CB ' ' A' ' 95' ' ' MET . 1.0 OUTLIER -67.64 157.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.029 -1.669 . . . . 0.0 110.241 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 7.8 t0 53.93 18.6 1.69 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.743 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -87.07 116.15 24.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.687 -1.258 . . . . 0.0 108.364 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.484 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 1.3 m120 -71.72 177.92 3.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.371 -0.831 . . . . 0.0 110.554 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -64.7 -24.22 67.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.62 -0.675 . . . . 0.0 110.066 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.64 -8.78 15.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.168 -0.957 . . . . 0.0 109.605 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.537 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -95.18 116.01 28.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.234 -0.916 . . . . 0.0 110.228 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.533 ' O ' ' CG2' ' A' ' 123' ' ' THR . 8.1 tt0 -86.95 139.31 30.73 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.633 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 3.1 mp -62.88 -46.97 85.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.775 -1.203 . . . . 0.0 109.256 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.569 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER 54.78 -157.55 0.21 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 107.331 178.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.54 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -77.98 66.45 3.11 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.631 ' CD1' ' O ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.72 -0.871 . . . . 0.0 109.934 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.634 ' CD1' ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.83 0.824 . . . . 0.0 110.617 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -100.97 170.96 7.93 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.457 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 1.0 OUTLIER -49.04 -179.38 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 0.0 109.836 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HB2' ' NE2' ' A' ' 49' ' ' GLN . . . -81.2 99.04 8.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 110.25 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.608 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 2.2 mmpt? -70.42 128.42 91.25 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.61 126.3 14.57 Favored 'Trans proline' 0 C--N 1.292 -2.414 0 N-CA-C 108.813 -1.264 . . . . 0.0 108.813 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 21' ' ' ILE . . . -37.41 162.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.495 1.14 . . . . 0.0 111.794 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.627 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -145.6 -166.17 0.12 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -72.9 -21.09 21.51 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.503 -1.384 . . . . 0.0 108.503 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -81.3 -44.92 16.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -0.969 . . . . 0.0 108.811 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 50' ' ' TYR . 4.4 mm -58.7 -56.18 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.482 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 15.2 tp60 -57.5 -20.09 29.01 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.3 tt0 -75.13 -39.17 60.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.339 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.616 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 2.2 mt -63.76 -49.63 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.043 0.925 . . . . 0.0 108.77 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.586 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 12.4 p -66.82 -40.57 86.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 122.307 1.051 . . . . 0.0 109.401 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 19.3 t0 -75.46 -13.35 60.38 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -95.43 -10.1 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.925 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.558 HG22 ' CD1' ' A' ' 97' ' ' LEU . 27.0 m -114.59 -15.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 110.981 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 ttpt -37.95 -51.07 3.08 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.035 -1.041 . . . . 0.0 110.911 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.5 Cg_endo -70.5 -35.9 9.72 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.421 1.414 . . . . 0.0 109.413 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.434 ' O ' HD22 ' A' ' 110' ' ' LEU . 28.6 mt-30 -71.76 -6.44 41.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 40' ' ' TYR . 2.6 mt -96.79 -41.97 8.21 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 13.9 mt-10 -66.84 -8.99 32.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -0.808 . . . . 0.0 109.182 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.34 -56.4 2.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -48.56 20.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 109.958 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -79.39 -14.56 58.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.06 -1.025 . . . . 0.0 108.973 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 1.4 p-10 44.97 64.84 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.417 0.627 . . . . 0.0 109.907 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.574 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 9.1 mt-10 -130.77 -177.74 4.49 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.3 m -98.8 -26.69 14.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.574 ' CE1' ' OE1' ' A' ' 38' ' ' GLU . 19.6 m-85 35.45 -161.84 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.809 0.814 . . . . 0.0 110.529 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' O ' HD22 ' A' ' 45' ' ' LEU . . . 179.26 -169.83 41.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.65 129.7 3.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -1.093 . . . . 0.0 108.793 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 44.2 mt -109.48 82.98 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.846 -1.158 . . . . 0.0 109.301 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -63.74 84.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.522 -0.737 . . . . 0.0 109.932 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.551 ' HA ' ' CG1' ' A' ' 64' ' ' VAL . . . -43.68 123.29 3.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.145 0.974 . . . . 0.0 109.966 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.2 t -99.51 -47.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.524 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 4.7 mm100 -145.18 172.58 12.91 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.618 ' CD1' HG13 ' A' ' 21' ' ' ILE . 17.2 p90 -166.89 137.08 3.08 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.061 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.527 ' CD ' ' HB2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.13 133.75 54.88 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.915 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.6 p -76.73 -176.87 4.02 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.273 -0.892 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.601 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 1.3 mm-40 -160.32 149.22 17.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.581 -0.699 . . . . 0.0 109.323 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.486 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -120.48 141.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 110.576 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.25 -103.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.1 30.58 3.71 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.07 -118.19 0.85 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 106.178 -2.769 . . . . 0.0 106.178 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 11.4 m -154.38 116.66 4.29 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.332 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.601 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 64.8 m-20 -77.72 -166.03 0.71 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.64 ' CE1' ' HB2' ' A' ' 101' ' ' LYS . 85.1 m-85 -147.34 153.14 39.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.617 ' CE1' ' OXT' ' A' ' 125' ' ' PHE . 16.0 m-30 -136.94 132.32 34.25 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.555 HG13 ' C ' ' A' ' 61' ' ' TYR . 13.6 mt -148.97 124.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 117.06 -1.856 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.524 ' CG ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -95.78 94.66 7.8 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 176.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.551 ' CG1' ' HA ' ' A' ' 47' ' ' ALA . 15.7 m -99.4 144.88 11.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.274 0.559 . . . . 0.0 110.642 -176.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.1 mmm-85 -69.24 125.41 26.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 93' ' ' LYS . . . -86.26 46.59 1.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.072 0.939 . . . . 0.0 108.904 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 -85.23 1.39 Allowed Glycine 0 C--N 1.287 -2.167 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.39 -168.67 1.2 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.203 -1.175 . . . . 0.0 109.87 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.13 7.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -69.21 127.02 31.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 108.798 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.583 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 5.6 m-30 -97.39 -179.12 4.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.096 -1.003 . . . . 0.0 110.324 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.567 ' SD ' ' CD1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -148.0 99.93 3.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.514 -0.741 . . . . 0.0 109.569 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.727 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -71.71 146.96 47.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' CD1' HG22 ' A' ' 28' ' ' VAL . 4.7 tp -138.21 139.26 39.2 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.371 -1.331 . . . . 0.0 111.531 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 9.6 ttpp -122.92 94.28 4.22 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.616 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.3 t -97.25 164.58 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.708 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 7.1 t80 -119.25 138.5 52.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.661 -1.274 . . . . 0.0 108.298 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.64 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.778 0.799 . . . . 0.0 109.064 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 3.0 mp . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 122.373 1.082 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.708 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 11.8 p -147.89 162.19 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.627 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 8.0 tp -98.05 89.23 4.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.493 HG22 ' HB2' ' A' ' 100' ' ' PHE . 4.4 p -82.12 -11.98 58.45 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.901 -1.124 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.534 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . -175.01 -168.98 36.35 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 27.0 p90 164.84 139.29 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.578 -0.954 . . . . 0.0 109.26 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.604 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.4 mm100 -102.31 97.82 8.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.467 HG22 ' OE2' ' A' ' 38' ' ' GLU . 2.0 p -66.85 164.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 110.354 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' A ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 115' ' ' VAL . 35.1 t0 43.46 24.75 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.115 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.613 ' HE3' ' CD2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -69.45 155.35 40.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.702 -1.249 . . . . 0.0 108.284 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.518 ' N ' ' HG2' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -107.9 -174.91 2.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -70.21 -38.78 75.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.813 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.96 -8.07 20.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.984 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.531 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 5.3 t0 -75.19 91.41 2.62 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.042 -1.036 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -64.4 155.1 33.56 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.727 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -90.13 55.65 3.16 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.667 1.222 . . . . 0.0 109.575 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -46.85 -172.09 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.291 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.634 ' HA2' ' CD1' ' A' ' 11' ' ' LEU . . . -45.09 -16.08 0.07 OUTLIER Glycine 0 N--CA 1.503 3.142 0 O-C-N 121.025 -1.047 . . . . 0.0 110.548 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.617 ' OXT' ' CE1' ' A' ' 61' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.685 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.798 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.561 ' CD2' ' HA2' ' A' ' 124' ' ' GLY . 1.2 pt? . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' GLU . 42.4 m -100.52 179.8 4.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 110.829 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tt0 -49.87 -176.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.674 -0.641 . . . . 0.0 109.992 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 49' ' ' GLN . . . -91.38 100.55 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -68.06 146.58 98.22 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 175.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.12 129.63 20.99 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 N-CA-C 108.885 -1.237 . . . . 0.0 108.885 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -37.36 159.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.282 1.039 . . . . 0.0 111.346 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.607 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -139.41 -166.52 0.12 Allowed Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 18' ' ' THR . 30.3 Cg_endo -73.65 -17.62 23.1 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 108.693 -1.311 . . . . 0.0 108.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 24' ' ' ILE . 15.6 mt-10 -85.68 -39.95 16.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.607 HG13 ' CD1' ' A' ' 50' ' ' TYR . 6.2 mm -65.17 -53.72 37.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.545 ' NE2' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -57.95 -26.0 61.69 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.297 178.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 60.6 tt0 -76.91 -41.12 44.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 109.54 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.611 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 5.8 mt -56.48 -53.65 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 122.319 1.057 . . . . 0.0 108.271 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.568 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . 11.7 p -66.05 -40.69 87.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.615 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.565 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 1.8 t70 -70.39 -10.53 59.33 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -99.26 -20.2 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.557 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.537 HG22 ' CD1' ' A' ' 97' ' ' LEU . 16.1 m -110.41 -4.94 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -44.72 -47.6 28.26 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.003 -1.06 . . . . 0.0 110.133 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -32.4 9.75 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.36 1.374 . . . . 0.0 109.421 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 21.0 mt-30 -79.77 -1.39 38.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.493 ' CD1' ' HE2' ' A' ' 95' ' ' MET . 4.2 mt -95.85 -38.48 10.27 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.572 -0.705 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 3.3 mt-10 -66.11 -43.78 86.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.424 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -84.34 -11.29 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -0.967 . . . . 0.0 110.976 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -91.84 -12.21 34.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.76 -1.213 . . . . 0.0 110.451 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.618 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 6.2 t -122.82 -31.36 3.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.847 -1.158 . . . . 0.0 110.075 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER 101.83 8.82 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.349 0.595 . . . . 0.0 109.724 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.587 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 2.0 tt0 -117.03 152.92 33.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.468 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -102.29 121.26 41.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 0.0 110.689 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.587 ' CE1' ' HG2' ' A' ' 38' ' ' GLU . 11.0 m-85 -110.93 -175.97 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.513 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -139.56 -156.43 6.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -38.35 132.17 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.529 -0.983 . . . . 0.0 109.763 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 65.8 mt -112.89 91.49 3.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.085 -1.009 . . . . 0.0 109.064 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.31 90.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -47.65 125.05 7.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.219 1.009 . . . . 0.0 110.142 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.4 t -97.63 -45.72 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.529 ' CG ' ' HB3' ' A' ' 63' ' ' LYS . 12.8 pt20 -150.91 171.33 17.43 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.607 ' CD1' HG13 ' A' ' 21' ' ' ILE . 8.9 p90 -165.42 139.73 4.8 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.858 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 61.8 mttt -109.39 123.43 49.32 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 p -73.19 -175.97 2.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.601 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 1.1 tm0? -161.85 152.36 17.42 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.495 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.36 140.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 110.084 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.33 -102.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.59 30.53 3.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.477 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 157.08 -108.84 0.38 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.749 -2.54 . . . . 0.0 106.749 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 26.8 m -167.82 109.2 0.59 Allowed 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.619 -0.93 . . . . 0.0 110.61 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.611 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 65.6 m-20 -69.93 -172.96 0.58 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 20.4 m-85 -144.72 145.79 31.87 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.615 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 1.4 m-85 -128.68 133.67 48.27 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.585 HG13 ' C ' ' A' ' 61' ' ' TYR . 32.0 mt -150.99 121.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 116.423 -2.111 . . . . 0.0 112.021 -176.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.13 96.97 10.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 176.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.531 ' CG1' HG23 ' A' ' 62' ' ' ILE . 6.3 m -105.98 140.3 24.5 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 O-C-N 121.174 -0.954 . . . . 0.0 111.561 -175.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.579 ' HA ' ' CD1' ' A' ' 94' ' ' TYR . 1.2 mtm-85 -68.51 133.87 49.22 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 93' ' ' LYS . . . -85.12 42.81 0.96 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.793 0.806 . . . . 0.0 109.175 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 73.35 -81.33 0.71 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 7.0 m-20 -55.13 -113.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -1.033 . . . . 0.0 110.496 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.05 -30.91 4.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.747 -1.22 . . . . 0.0 109.293 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 29.7 mtmt -68.73 144.58 54.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.579 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 15.7 m-30 -109.81 176.99 4.86 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.116 -0.99 . . . . 0.0 109.023 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.559 ' CA ' ' HD2' ' A' ' 116' ' ' LYS . 20.2 ttp -144.65 119.92 10.2 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.007 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.779 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -69.17 151.13 46.72 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.568 ' CD2' ' HA ' ' A' ' 25' ' ' VAL . 13.3 tp -130.71 142.04 50.41 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.118 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.615 ' HE2' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -131.0 95.79 3.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.611 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.2 t -105.42 161.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.197 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.676 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.0 t80 -126.54 129.71 49.14 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.636 -1.29 . . . . 0.0 108.483 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.554 ' HG2' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.554 ' CD1' ' HG2' ' A' ' 101' ' ' LYS . 10.4 mp . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 122.72 1.247 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.676 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.9 p -152.37 163.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.742 -177.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 9.0 tp -100.43 83.41 2.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' LYS . 0.9 OUTLIER -69.26 -10.51 58.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 111.735 -176.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.532 ' CA ' ' HB3' ' A' ' 98' ' ' LYS . . . 171.35 -165.4 38.42 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.612 -1.756 . . . . 0.0 111.157 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 30.2 p90 165.73 143.47 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.627 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.9 mm100 -105.26 103.6 13.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.629 -1.294 . . . . 0.0 107.662 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.441 HG22 ' OH ' ' A' ' 40' ' ' TYR . 1.3 p -68.61 162.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.71 -1.244 . . . . 0.0 111.162 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.1 t0 51.78 20.34 1.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.603 ' HG3' ' OD2' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -74.32 161.67 29.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.81 -1.181 . . . . 0.0 108.293 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 1.1 m120 -152.68 -167.73 2.83 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.199 -1.563 . . . . 0.0 112.752 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -36.7 -38.34 0.17 Allowed 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.196 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.43 53.27 2.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.718 ' CG ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -92.91 108.59 20.12 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.85 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.562 ' O ' ' CG2' ' A' ' 123' ' ' THR . 1.9 tt0 -102.29 105.49 16.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.779 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.8 OUTLIER -69.07 -28.86 66.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.364 -1.46 . . . . 0.0 107.841 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER 39.9 -160.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.758 0.789 . . . . 0.0 110.55 176.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.566 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -69.71 -0.35 24.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.627 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.33 -1.1 . . . . 0.0 109.01 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.506 HD13 ' NE2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 122.654 1.216 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -103.28 -176.37 3.07 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.558 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' SER . 7.5 tt0 -50.3 -179.85 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.125 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' CB ' ' NE2' ' A' ' 49' ' ' GLN . . . -81.1 104.92 11.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.59 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -74.83 133.44 76.22 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.47 130.2 21.8 Favored 'Trans proline' 0 C--N 1.292 -2.397 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.557 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -40.94 167.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.422 1.106 . . . . 0.0 111.786 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.607 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -149.88 -165.53 0.11 Allowed Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 18' ' ' THR . 30.1 Cg_endo -73.37 -19.05 22.58 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 108.581 -1.354 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.23 -45.87 13.35 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.153 -0.967 . . . . 0.0 108.572 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 50' ' ' TYR . 3.2 mm -58.03 -54.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.507 ' NE2' HG12 ' A' ' 25' ' ' VAL . 34.1 tp60 -58.97 -21.66 58.96 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.7 tt0 -75.14 -41.33 58.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 109.061 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.614 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.6 mt -60.5 -50.03 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.989 0.9 . . . . 0.0 108.791 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.682 ' HA ' HD23 ' A' ' 97' ' ' LEU . 11.1 p -65.03 -40.84 90.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 122.134 0.969 . . . . 0.0 108.893 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.56 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 43.8 t0 -71.45 -13.24 61.76 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.7 mmtt -96.03 -11.26 26.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.594 HG22 ' CD1' ' A' ' 97' ' ' LEU . 16.9 m -121.88 -4.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 0.0 110.995 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.564 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 13.3 ttpt -47.95 -45.59 62.72 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.927 -1.108 . . . . 0.0 111.035 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.83 -36.89 4.19 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.473 1.449 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.1 mt-30 -71.52 -7.32 46.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.542 HD23 ' CG ' ' A' ' 113' ' ' TYR . 8.8 mt -100.89 -34.86 9.62 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.612 -0.68 . . . . 0.0 109.867 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 20.2 mt-10 -52.6 -48.83 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.139 -0.976 . . . . 0.0 109.814 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' OE1' ' CA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -86.71 -44.75 11.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.322 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 5.3 mmtt -42.81 -27.0 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 67.5 p -104.48 -72.57 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.953 . . . . 0.0 110.003 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.0 p30 149.55 38.3 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -164.23 -177.99 5.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.327 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.471 HG21 ' OE2' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -114.96 125.23 53.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 110.296 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 10.8 m-85 -103.12 169.5 8.52 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.468 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -129.25 -150.99 7.23 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.811 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.99 119.81 1.62 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.486 -1.008 . . . . 0.0 109.022 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 62.8 mt -99.54 86.45 3.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.964 -1.085 . . . . 0.0 108.497 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.206 0.526 . . . . 0.0 110.332 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.557 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -47.28 115.28 1.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.054 -1.029 . . . . 0.0 109.493 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 49' ' ' GLN . 1.5 t -94.08 -46.34 13.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.587 ' NE2' ' CB ' ' A' ' 14' ' ' ALA . 5.8 mt-30 -146.26 173.55 12.14 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.169 -1.013 . . . . 0.0 108.964 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.618 ' CD1' HG13 ' A' ' 21' ' ' ILE . 18.1 p90 -168.34 138.15 2.48 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.946 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -106.08 130.44 53.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 p -83.27 -174.01 5.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.38 -0.825 . . . . 0.0 110.786 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 59' ' ' ASN . 0.1 OUTLIER -164.69 152.1 11.51 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -125.77 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.941 -1.099 . . . . 0.0 110.594 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -165.46 -102.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.11 30.42 5.6 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 160.71 -109.27 0.39 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.53 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 8.4 m -167.28 112.21 0.72 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.418 -1.048 . . . . 0.0 110.856 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 53' ' ' GLN . 45.6 m-80 -72.38 -165.95 0.23 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CD1' HG11 ' A' ' 99' ' ' VAL . 44.7 m-85 -156.02 160.23 39.84 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.672 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.619 ' CE1' ' CB ' ' A' ' 125' ' ' PHE . 26.7 m-85 -144.45 134.85 24.49 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.563 HG13 ' C ' ' A' ' 61' ' ' TYR . 15.3 mt -151.41 125.26 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 116.828 -1.949 . . . . 0.0 111.405 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.543 ' CD ' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -94.6 91.25 6.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.535 HG11 ' CG2' ' A' ' 62' ' ' ILE . 34.4 m -98.77 140.43 18.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 O-C-N 121.857 -0.527 . . . . 0.0 110.317 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.598 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 ttp180 -68.12 138.3 55.61 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.702 -1.249 . . . . 0.0 107.943 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.2 46.63 1.4 Allowed 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 122.269 1.033 . . . . 0.0 108.412 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.54 -77.93 1.69 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.46 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 3.8 t0 -61.1 -155.77 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.274 -1.133 . . . . 0.0 109.236 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -83.22 -3.67 57.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 109.366 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.575 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -75.31 178.48 5.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.21 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.598 ' CD2' ' HA ' ' A' ' 65' ' ' ARG . 33.7 m-85 -150.76 165.89 32.11 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.038 -1.039 . . . . 0.0 109.55 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.467 ' HG2' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -146.41 126.07 13.38 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 108.703 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.701 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.7 m170 -74.76 151.3 39.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 25' ' ' VAL . 15.6 tp -138.48 133.75 33.1 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.852 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.532 ' CD ' ' OG1' ' A' ' 111' ' ' THR . 0.1 OUTLIER -115.6 124.17 50.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.614 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.2 t -129.42 166.53 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.612 -1.305 . . . . 0.0 108.698 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.8 t80 -131.06 136.0 48.06 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.844 -1.16 . . . . 0.0 109.195 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HG3' ' OH ' ' A' ' 60' ' ' TYR . 6.1 tttt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.446 ' CD1' ' HG2' ' A' ' 101' ' ' LYS . 10.6 mp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 122.36 1.076 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 8.3 p -145.45 164.56 11.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.499 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 9.1 tp -102.35 86.88 2.9 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.532 ' OG1' ' CD ' ' A' ' 98' ' ' LYS . 2.2 p -70.38 -29.82 66.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 0.0 111.625 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . -165.88 -162.85 18.14 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.865 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 19.1 p90 165.77 134.68 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.357 -1.084 . . . . 0.0 109.168 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.628 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 2.9 mm-40 -97.51 102.14 13.83 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.467 ' HA ' ' HG2' ' A' ' 95' ' ' MET . 0.6 OUTLIER -68.17 159.3 5.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.683 -1.26 . . . . 0.0 111.349 -177.236 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.7 t0 48.73 31.44 3.07 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.525 ' HD3' ' CB ' ' A' ' 114' ' ' GLN . 2.5 mptt -93.95 114.34 26.53 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 13.0 m-80 -69.11 -169.18 0.17 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.867 . . . . 0.0 110.062 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -44.45 40.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.454 -0.779 . . . . 0.0 109.442 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -50.9 -21.09 1.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.437 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -73.12 127.3 32.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.146 -0.971 . . . . 0.0 110.05 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.54 ' O ' ' CG2' ' A' ' 123' ' ' THR . 22.4 tt0 -93.63 136.12 34.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.701 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.5 mp -64.2 -32.12 73.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 108.664 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.553 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER 43.81 -160.31 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.136 178.083 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.553 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -62.36 89.2 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.628 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.586 HD23 ' CE2' ' A' ' 61' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.949 0.88 . . . . 0.0 111.28 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.9 m -101.73 167.81 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.0 tt0 -49.28 179.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.319 -0.863 . . . . 0.0 109.458 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.527 ' CB ' ' OE1' ' A' ' 49' ' ' GLN . . . -73.3 96.21 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 0.0 110.297 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.588 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 3.1 mmpt? -69.66 131.82 89.46 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.93 124.89 13.31 Favored 'Trans proline' 0 C--N 1.291 -2.466 0 N-CA-C 109.164 -1.129 . . . . 0.0 109.164 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -47.59 123.29 5.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.902 0.858 . . . . 0.0 111.763 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.599 ' OG1' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -95.69 -172.75 0.3 Allowed Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.373 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 27.8 Cg_endo -67.82 -20.06 46.12 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 N-CA-C 109.786 -0.89 . . . . 0.0 109.786 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -81.58 -34.76 30.83 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.981 -1.074 . . . . 0.0 108.777 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.652 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -69.28 -46.8 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -69.57 -13.44 62.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.2 tt0 -76.56 -40.16 50.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.629 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 5.3 mt -60.76 -51.5 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 26' ' ' ASP . 12.4 p -64.38 -42.06 94.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.981 0.895 . . . . 0.0 108.81 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.568 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 43.3 t0 -68.84 -14.92 63.33 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -93.37 -15.16 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.198 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.558 HG22 ' CD1' ' A' ' 97' ' ' LEU . 31.6 m -119.85 -0.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.872 . . . . 0.0 110.557 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 7.7 ttpp -50.82 -44.62 85.84 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.847 -1.158 . . . . 0.0 110.361 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 29' ' ' LYS . 32.3 Cg_endo -73.86 -34.23 5.5 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.155 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.8 mt-30 -74.52 -5.52 43.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.61 HD22 ' CG ' ' A' ' 113' ' ' TYR . 0.3 OUTLIER -100.43 -35.84 9.43 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.519 -0.738 . . . . 0.0 109.488 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -72.37 -29.33 63.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.462 -0.774 . . . . 0.0 110.881 -179.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.43 -17.73 17.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.889 -1.132 . . . . 0.0 110.464 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 22.8 ttmt -78.34 -61.74 1.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.995 -1.066 . . . . 0.0 109.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -72.98 -19.33 61.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.846 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.5 OUTLIER 85.75 11.83 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.65 -0.657 . . . . 0.0 109.517 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.522 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 7.9 tt0 -109.17 138.86 44.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.401 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -76.44 125.63 29.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.124 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.522 ' CE1' ' HG2' ' A' ' 38' ' ' GLU . 31.9 m-85 -112.77 179.76 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 108.948 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.456 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -144.68 -164.43 10.56 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.05 123.78 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -1.111 . . . . 0.0 108.836 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 46.3 mt -102.49 91.37 4.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.849 -1.157 . . . . 0.0 108.372 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -72.01 82.85 0.96 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -40.17 134.68 1.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.116 0.96 . . . . 0.0 110.005 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 2.0 t -118.45 -42.14 2.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.527 ' OE1' ' CB ' ' A' ' 14' ' ' ALA . 2.4 mt-30 -142.72 171.71 13.69 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.602 ' CD1' HG12 ' A' ' 21' ' ' ILE . 18.4 p90 -170.82 136.48 1.17 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 3.8 mttt -109.11 157.41 18.76 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.353 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.93 140.2 38.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.373 -0.829 . . . . 0.0 109.162 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.567 ' HG2' ' CE1' ' A' ' 61' ' ' TYR . 0.9 OUTLIER -138.29 174.31 10.69 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.561 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.459 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -113.4 158.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.718 -1.239 . . . . 0.0 110.933 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.67 -101.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.476 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 27.26 6.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.69 -119.94 0.99 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 106.202 -2.759 . . . . 0.0 106.202 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.482 HG21 ' O ' ' A' ' 53' ' ' GLN . 19.1 m -151.68 109.31 3.63 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.038 -1.272 . . . . 0.0 110.542 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.611 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 64.4 m-80 -72.85 -171.09 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.2 m-85 -144.44 158.63 43.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.918 0.866 . . . . 0.0 108.988 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' CE2' ' O ' ' A' ' 125' ' ' PHE . 2.1 m-85 -138.73 139.99 38.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.596 ' N ' HD23 ' A' ' 122' ' ' LEU . 13.2 mt -154.7 123.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 116.72 -1.992 . . . . 0.0 112.06 -176.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HE3' ' CA ' ' A' ' 118' ' ' LYS . 15.9 tttt -93.06 92.44 7.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 47' ' ' ALA . 6.1 m -98.91 143.27 13.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.587 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 3.9 mtm180 -67.67 131.28 45.3 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.35 44.65 1.11 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.986 0.898 . . . . 0.0 109.445 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 96.69 -113.12 4.6 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.5 p30 -49.84 -104.43 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -1.031 . . . . 0.0 110.655 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -119.66 -1.9 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.945 -1.097 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -68.47 -177.93 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 8.2 m-85 -146.12 166.82 25.02 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.879 -1.138 . . . . 0.0 109.727 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.478 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 49.0 ttp -151.73 111.31 3.98 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.485 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.734 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -69.6 147.6 50.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.125 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' CD1' HG22 ' A' ' 28' ' ' VAL . 13.2 tp -128.52 153.02 47.61 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.246 -0.909 . . . . 0.0 110.71 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 2.6 tttm -143.09 102.32 3.98 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.629 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.1 t -112.95 160.39 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.762 -1.211 . . . . 0.0 109.404 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.689 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.3 t80 -120.37 137.9 54.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.47 -1.394 . . . . 0.0 108.408 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HB2' ' OH ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 122.015 0.912 . . . . 0.0 109.317 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.556 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 122.259 1.028 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.689 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.2 p -153.7 163.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.79 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 6.7 tp -99.6 84.1 2.89 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 16.8 p -69.02 -15.75 63.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 111.504 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.476 ' O ' HD13 ' A' ' 110' ' ' LEU . . . 174.68 -167.52 39.8 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.61 ' CG ' HD22 ' A' ' 32' ' ' LEU . 30.1 p90 170.99 137.54 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -98.04 102.66 14.47 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.498 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 9.9 p -67.99 158.47 5.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.131 -0.98 . . . . 0.0 111.195 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.5 t70 45.92 27.99 0.55 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.504 ' CE ' ' OD1' ' A' ' 120' ' ' ASP . 7.6 mmtm -101.01 129.76 46.9 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 120.676 -1.265 . . . . 0.0 108.48 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.484 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 2.4 m120 -105.65 -156.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 111.054 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.513 ' CA ' ' HE3' ' A' ' 63' ' ' LYS . 1.5 ttpm? -58.73 -45.41 89.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.699 -0.626 . . . . 0.0 109.981 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.21 -22.88 0.44 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.504 ' OD1' ' CE ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -89.0 122.52 32.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 110.993 -179.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 123' ' ' THR . 0.3 OUTLIER -94.99 132.79 39.45 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.734 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 2.2 mp -60.76 -55.92 27.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.782 -1.199 . . . . 0.0 109.344 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.582 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 56.7 -163.79 0.16 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.802 -1.186 . . . . 0.0 110.031 177.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.582 ' N ' HD12 ' A' ' 11' ' ' LEU . . . -50.52 -14.98 1.08 Allowed Glycine 0 N--CA 1.501 3.022 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 120.859 -1.377 . . . . 0.0 109.113 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' A' ' 51' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 121.916 0.865 . . . . 0.0 112.534 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -101.06 160.41 14.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 41.5 tt0 -46.76 173.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 49' ' ' GLN . . . -59.85 95.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.875 -1.14 . . . . 0.0 109.871 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.608 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -69.68 130.31 90.5 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.1 Cg_endo -67.64 126.14 14.32 Favored 'Trans proline' 0 C--N 1.288 -2.608 0 N-CA-C 108.772 -1.28 . . . . 0.0 108.772 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -40.66 156.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.289 1.042 . . . . 0.0 111.468 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.615 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -135.05 -168.38 0.18 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.615 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.35 -18.11 30.22 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 N-CA-C 109.177 -1.124 . . . . 0.0 109.177 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' HD13 ' A' ' 24' ' ' ILE . 13.9 mt-10 -82.96 -47.37 11.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.046 -1.034 . . . . 0.0 108.435 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.612 HG13 ' CD1' ' A' ' 50' ' ' TYR . 6.7 mm -56.8 -54.72 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.573 ' NE2' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -53.97 -26.95 28.45 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.81 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 4.2 tp10 -76.77 -35.2 57.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.083 . . . . 0.0 110.155 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.612 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.5 mt -66.19 -49.95 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.578 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 12.8 p -66.18 -41.3 89.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 122.279 1.038 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.563 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 12.5 t70 -74.98 -14.17 60.59 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 30.8 ttmt -93.36 -10.96 33.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG12 ' CG2' ' A' ' 99' ' ' VAL . 15.5 m -117.78 -5.31 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 110.653 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 4.5 ttpm? -42.72 -48.65 13.51 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.891 -1.131 . . . . 0.0 110.661 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 29.3 Cg_endo -69.65 -33.89 16.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.294 1.329 . . . . 0.0 109.799 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.409 ' O ' HD22 ' A' ' 110' ' ' LEU . 25.4 mt-30 -74.92 -5.01 41.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.492 ' CD1' HD12 ' A' ' 97' ' ' LEU . 5.4 mt -97.67 -38.07 9.66 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.593 -0.692 . . . . 0.0 109.705 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.472 ' OE1' ' HA ' ' A' ' 39' ' ' THR . 35.5 mt-10 -65.34 -26.46 68.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.503 -0.748 . . . . 0.0 109.645 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.39 -40.74 11.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG2' ' OH ' ' A' ' 113' ' ' TYR . 12.0 tttt -75.19 -8.07 55.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.608 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 9.9 p -123.03 -48.31 2.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.608 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER 104.48 32.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.189 0.519 . . . . 0.0 109.724 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 5.1 mt-10 -130.42 145.08 51.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.265 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.6 m -75.17 -10.36 59.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.107 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CG ' ' HE2' ' A' ' 95' ' ' MET . 25.7 m-85 36.71 -163.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.76 0.79 . . . . 0.0 110.61 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -162.97 -167.71 23.8 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.73 126.22 3.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -1.108 . . . . 0.0 108.787 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 41.4 mt -100.17 71.62 1.61 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 108.082 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 19.1 mt-10 -53.31 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.883 -0.51 . . . . 0.0 109.962 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.563 ' HA ' ' CG1' ' A' ' 64' ' ' VAL . . . -44.28 143.06 1.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.104 0.955 . . . . 0.0 109.589 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.9 -41.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.521 ' HB2' ' CD ' ' A' ' 63' ' ' LYS . 12.5 mt-30 -147.9 171.89 15.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.612 ' CD1' HG13 ' A' ' 21' ' ' ILE . 14.5 p90 -171.18 137.09 1.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.88 -1.138 . . . . 0.0 110.648 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -108.64 119.41 39.45 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 p -71.7 176.46 4.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.34 -0.85 . . . . 0.0 109.853 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.594 ' HG2' ' CE2' ' A' ' 61' ' ' TYR . 2.4 mm100 -152.34 148.25 27.28 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.451 ' O ' HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -129.73 137.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.942 -1.099 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -165.67 -102.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.67 28.49 5.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.48 -121.7 1.04 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 106.856 -2.498 . . . . 0.0 106.856 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 23.1 m -159.52 104.91 1.63 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.087 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.593 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 48.3 m-80 -70.04 -178.45 1.61 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.1 m-85 -141.44 153.68 45.13 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.098 -1.001 . . . . 0.0 109.256 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 23.3 m-30 -133.76 135.53 43.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.574 HG13 ' C ' ' A' ' 61' ' ' TYR . 30.5 mt -153.91 129.99 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 116.774 -1.97 . . . . 0.0 112.408 -176.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.539 ' HB3' ' NE2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -100.22 102.79 14.17 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.563 ' CG1' ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -109.7 139.99 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.46 -0.775 . . . . 0.0 110.825 -176.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -67.32 126.87 30.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.99 45.06 1.05 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.91 0.862 . . . . 0.0 109.646 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 85.36 -98.07 2.22 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -56.69 -157.39 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.378 -1.072 . . . . 0.0 109.612 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -71.83 -6.62 42.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 109.476 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -69.85 164.31 23.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 109.085 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.478 ' OH ' ' HD2' ' A' ' 65' ' ' ARG . 11.7 m-85 -136.77 169.87 17.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.733 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.573 ' HE2' ' CG ' ' A' ' 40' ' ' TYR . 20.8 ttm -154.93 113.31 3.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.038 -1.038 . . . . 0.0 109.659 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.709 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.3 m170 -74.31 156.9 36.65 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.544 ' CD1' HG22 ' A' ' 28' ' ' VAL . 1.4 tp -148.96 139.85 22.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.698 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.1 tttt -121.63 107.25 12.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.612 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.2 t -107.24 162.08 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.729 -1.232 . . . . 0.0 109.712 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.683 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 10.5 t80 -124.15 133.03 53.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.536 -1.352 . . . . 0.0 108.681 177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.341 0 CA-C-O 121.838 0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 122.087 0.946 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.683 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.6 p -151.98 164.76 2.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.737 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.563 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 4.6 tp -101.67 83.76 2.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.485 ' OG1' ' HG2' ' A' ' 98' ' ' LYS . 1.2 p -72.84 -12.79 61.12 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.023 -1.048 . . . . 0.0 112.054 -176.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.545 ' O ' ' CD1' ' A' ' 110' ' ' LEU . . . -176.34 -167.48 35.13 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.066 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 30.2 p90 164.66 137.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.613 -0.933 . . . . 0.0 108.975 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.648 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.8 mm-40 -100.14 97.19 8.04 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.531 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 5.3 p -67.56 163.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.987 -1.071 . . . . 0.0 111.034 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' A ASP . . . . . . . . . . . . . 3.9 t0 48.92 26.64 1.38 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.045 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.541 ' HG2' ' CA ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -67.73 -166.27 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.779 -1.201 . . . . 0.0 108.463 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.53 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -149.51 -177.62 5.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.749 -1.22 . . . . 0.0 110.099 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -71.69 -34.09 69.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.419 -0.801 . . . . 0.0 109.267 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.03 -14.22 59.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.516 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 3.2 t0 -72.31 103.54 3.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.824 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.502 ' C ' HG21 ' A' ' 123' ' ' THR . 0.1 OUTLIER -87.92 146.24 25.65 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.709 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.9 mp -66.98 -40.0 87.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.553 -1.342 . . . . 0.0 108.302 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.544 ' CG2' ' C ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER 40.04 22.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.007 0.908 . . . . 0.0 110.905 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 121.73 116.99 2.45 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.648 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.505 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.596 ' CD1' ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.92 0.866 . . . . 0.0 110.759 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLU . 33.6 m -101.32 171.6 7.5 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tp10 -47.8 174.79 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.912 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.23 99.62 3.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.099 -1.0 . . . . 0.0 110.006 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 9.8 mmpt? -69.16 131.19 90.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -68.11 125.35 12.91 Favored 'Trans proline' 0 C--N 1.291 -2.494 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.21 148.66 1.75 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.441 1.115 . . . . 0.0 111.466 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.607 ' OG1' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -128.96 -169.33 0.19 Allowed Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.607 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 27.9 Cg_endo -69.09 -17.67 40.49 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 N-CA-C 109.796 -0.886 . . . . 0.0 109.796 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 15.3 pt-20 -82.03 -41.79 20.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.787 -1.196 . . . . 0.0 108.758 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.608 HG13 ' CD1' ' A' ' 50' ' ' TYR . 13.0 mm -63.54 -51.58 68.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.47 -19.23 61.79 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.8 tp10 -75.71 -35.18 60.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.847 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.588 HG21 ' CG2' ' A' ' 99' ' ' VAL . 5.4 mt -64.99 -52.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 7.1 p -61.41 -42.57 94.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.554 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 32.5 t70 -72.75 -16.44 61.65 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 11.9 tptt -89.75 -11.6 41.78 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.562 ' CG2' ' HG ' ' A' ' 97' ' ' LEU . 18.3 m -116.08 -8.72 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.447 -0.783 . . . . 0.0 109.802 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 11.3 ttpp -51.95 -44.13 90.9 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.837 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.77 -29.05 13.06 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.451 1.434 . . . . 0.0 110.016 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -80.69 -11.87 59.56 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.558 ' HG ' ' CD2' ' A' ' 110' ' ' LEU . 6.4 mt -93.65 -35.25 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.503 0.668 . . . . 0.0 109.762 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 30.3 mt-10 -58.74 -46.05 88.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.77 -51.12 6.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 109.961 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -49.77 -58.32 5.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 108.497 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.618 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 1.4 m -68.97 -60.52 2.31 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.539 -0.726 . . . . 0.0 109.512 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER 119.48 41.6 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 73.0 mm-40 -130.4 -166.73 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.888 . . . . 0.0 110.017 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.552 ' CG2' ' O ' ' A' ' 39' ' ' THR . 94.5 m -129.05 26.15 5.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.813 -0.554 . . . . 0.0 109.516 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 38' ' ' GLU . 11.5 m-85 -29.06 147.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.72 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -117.38 -135.52 5.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -54.65 126.29 23.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.336 -1.097 . . . . 0.0 110.078 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 28.8 mt -107.56 74.47 0.96 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -54.83 85.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.313 0.577 . . . . 0.0 110.495 -178.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HA ' ' CG1' ' A' ' 64' ' ' VAL . . . -46.22 124.73 5.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.26 1.028 . . . . 0.0 109.754 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG13 ' HG2' ' A' ' 49' ' ' GLN . 1.9 t -101.56 -44.68 10.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.529 ' CG ' ' HB3' ' A' ' 63' ' ' LYS . 9.2 pt20 -147.23 171.34 15.53 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 15' ' ' LYS . 12.1 p90 -168.17 138.79 2.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 12' ' ' SER . 1.4 mttp -109.88 124.01 50.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 p -76.51 -178.14 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.307 -0.871 . . . . 0.0 110.148 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.599 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 2.3 mm100 -159.53 150.8 19.86 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.495 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.06 146.97 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 120.915 -1.116 . . . . 0.0 111.126 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -171.04 -103.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.57 29.14 6.79 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 164.54 -114.02 0.58 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 106.294 -2.722 . . . . 0.0 106.294 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 28.8 m -166.92 113.72 0.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -1.157 . . . . 0.0 111.005 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.599 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 70.0 m-20 -73.51 -166.55 0.36 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 101' ' ' LYS . 86.6 m-85 -154.44 153.75 32.06 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.632 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.57 ' CE2' ' HG2' ' A' ' 53' ' ' GLN . 22.8 m-85 -138.04 130.41 29.14 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.593 ' N ' ' CD2' ' A' ' 122' ' ' LEU . 11.7 mt -149.34 122.68 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 119.583 -1.948 . . . . 0.0 112.098 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 21.8 ttpt -92.16 95.53 9.8 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.549 ' CG1' ' HA ' ' A' ' 47' ' ' ALA . 14.6 m -101.9 140.06 21.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.64 127.0 31.47 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.98 45.11 1.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.928 0.871 . . . . 0.0 109.615 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 99.37 -122.88 7.72 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' GLY . 16.8 t70 -43.26 -101.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.939 . . . . 0.0 111.37 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.3 m120 -120.02 -4.27 10.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.6 mttt -69.47 179.17 2.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 108.624 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 30.3 m-85 -146.52 168.25 21.69 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.026 -1.046 . . . . 0.0 109.94 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.552 ' HE3' ' CD2' ' A' ' 40' ' ' TYR . 18.9 mtp -154.87 115.43 3.9 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.675 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -73.69 137.58 44.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -125.17 123.26 39.25 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.497 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -108.68 121.65 45.47 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.588 ' CG2' HG21 ' A' ' 24' ' ' ILE . 2.5 t -125.27 166.26 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.59 -1.319 . . . . 0.0 109.445 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.669 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 10.0 t80 -125.08 136.45 53.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.987 -1.071 . . . . 0.0 108.201 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.929 0.871 . . . . 0.0 109.872 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.483 ' N ' HD11 ' A' ' 108' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 122.251 1.025 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.669 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 8.7 p -139.27 162.36 27.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.715 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 18.6 tp -99.31 88.09 3.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 14.7 p -71.53 -29.71 65.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 111.85 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . -168.94 -163.31 22.75 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.337 -1.411 . . . . 0.0 109.85 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 20.5 p90 166.48 135.64 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.41 -1.053 . . . . 0.0 109.854 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.629 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.4 mm-40 -95.48 95.4 8.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.465 HG22 ' OH ' ' A' ' 40' ' ' TYR . 6.3 p -67.51 160.15 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.092 -1.005 . . . . 0.0 110.57 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' A ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 115' ' ' VAL . 21.2 t0 43.2 28.37 0.16 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.304 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.562 ' HG3' ' CB ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -82.26 160.96 22.83 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.701 -1.249 . . . . 0.0 107.807 179.207 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.87 -170.91 1.91 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.756 -1.215 . . . . 0.0 110.888 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.49 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 18.9 mttt -68.47 -69.64 0.31 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.713 -0.617 . . . . 0.0 110.657 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -40.8 -26.91 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.347 -0.846 . . . . 0.0 110.292 -179.128 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 96' ' ' HIS . 14.8 t70 -47.43 109.88 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.027 . . . . 0.0 110.733 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.553 ' O ' ' CG2' ' A' ' 123' ' ' THR . 74.8 tt0 -84.3 136.91 33.72 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.675 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 2.6 mp -67.27 -32.38 73.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.904 -1.122 . . . . 0.0 108.741 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 45.36 -167.02 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.038 0.923 . . . . 0.0 110.499 177.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.596 ' HA2' ' CD1' ' A' ' 11' ' ' LEU . . . -43.35 -21.57 0.16 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.629 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.676 0 O-C-N 121.213 -1.169 . . . . 0.0 109.079 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 34.5 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -154.21 77.78 5.43 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.226 -0.922 . . . . 0.0 109.598 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.85 101.17 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.573 2.182 . . . . 0.0 110.596 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.42 172.07 28.59 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 85.53 135.98 3.77 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.634 ' CD2' ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -37.91 108.06 0.07 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.521 -0.988 . . . . 0.0 111.47 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 3.8 m -102.78 -179.1 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.871 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -51.75 -177.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.23 110.71 22.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.098 -1.001 . . . . 0.0 110.74 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -76.93 138.25 65.71 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 175.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' ALA . 26.5 Cg_endo -64.44 131.84 31.31 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 109.152 -1.134 . . . . 0.0 109.152 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.571 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -41.67 167.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.511 1.148 . . . . 0.0 111.493 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.619 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -147.28 -167.43 0.15 Allowed Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.6 Cg_endo -73.13 -20.73 21.26 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 N-CA-C 108.471 -1.396 . . . . 0.0 108.471 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -39.93 22.95 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.219 -0.926 . . . . 0.0 108.688 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.603 HG13 ' CD1' ' A' ' 50' ' ' TYR . 4.7 mm -62.28 -54.83 29.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 23.5 tp60 -59.69 -19.44 49.76 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -76.2 -43.78 40.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.725 -1.234 . . . . 0.0 108.801 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.622 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 5.5 mt -55.48 -52.5 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 26' ' ' ASP . 12.3 p -67.51 -39.98 83.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 122.028 0.918 . . . . 0.0 109.717 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.574 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 25.6 t70 -70.71 -10.74 60.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -100.25 -18.07 17.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.542 ' CG2' HD22 ' A' ' 97' ' ' LEU . 19.8 m -116.28 1.48 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.514 -0.741 . . . . 0.0 110.397 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.641 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.56 -39.84 79.79 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.736 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 29' ' ' LYS . 33.7 Cg_endo -77.55 -35.37 1.58 Allowed 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 108.172 -1.511 . . . . 0.0 108.172 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 26.8 mt-30 -66.78 -15.32 63.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 97' ' ' LEU . 4.6 mt -89.92 -34.27 16.11 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.555 0.693 . . . . 0.0 109.535 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -55.14 -55.19 33.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 110.41 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.18 -8.52 50.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 31' ' ' GLN . 3.3 tttp -91.23 5.38 49.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.778 -1.201 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.629 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 9.7 p -131.61 -56.8 1.0 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 36' ' ' THR . 45.8 p30 134.15 20.54 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -149.65 -177.82 6.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.87 -1.144 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.538 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -117.72 118.68 32.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.466 ' OH ' HG22 ' A' ' 115' ' ' VAL . 74.0 m-85 -90.88 178.99 5.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 108.936 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -130.5 -168.04 12.16 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -37.47 127.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.926 . . . . 0.0 109.283 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 59.2 mt -102.97 79.99 1.82 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.059 -1.026 . . . . 0.0 108.704 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 1.3 mt-10 -61.8 85.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.145 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.571 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -43.64 145.9 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.235 1.017 . . . . 0.0 109.998 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.78 -44.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HG2' ' HB3' ' A' ' 63' ' ' LYS . 2.4 pt20 -151.57 169.53 21.89 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.603 ' CD1' HG13 ' A' ' 21' ' ' ILE . 14.1 p90 -163.12 133.56 4.54 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.055 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' CB ' ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -99.01 126.53 44.73 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.51 145.07 45.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.272 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.47 177.73 8.45 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.07 158.93 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 111.563 -178.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.97 -102.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.49 28.46 5.04 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.1 -110.34 0.44 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.522 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 86.5 m -165.67 109.59 0.83 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.367 -1.078 . . . . 0.0 110.76 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.524 ' OD1' ' CD2' ' A' ' 100' ' ' PHE . 70.2 m-80 -69.57 -176.44 1.01 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CD2' HD12 ' A' ' 24' ' ' ILE . 78.6 m-85 -149.54 151.61 34.17 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.472 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.613 ' CD2' ' O ' ' A' ' 124' ' ' GLY . 8.3 m-85 -138.04 132.55 32.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.572 HG13 ' C ' ' A' ' 61' ' ' TYR . 13.6 mt -150.77 115.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 116.847 -1.941 . . . . 0.0 111.683 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.559 ' N ' HD12 ' A' ' 122' ' ' LEU . 1.4 ttmp? -81.02 103.11 10.62 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.556 HG11 ' N ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -109.39 138.5 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.942 -176.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -68.11 127.18 31.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.08 46.07 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.044 0.926 . . . . 0.0 109.125 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 78.55 -93.84 1.26 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 22.6 p-10 -56.01 -163.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.187 -1.184 . . . . 0.0 109.563 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.45 -10.84 59.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.05 159.42 33.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 109.045 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.579 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 30.3 m-85 -129.35 176.21 8.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.455 ' HE2' HD12 ' A' ' 32' ' ' LEU . 2.7 ttp -155.76 113.22 3.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 109.561 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.843 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -69.83 151.72 45.4 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.557 ' CD2' ' HA ' ' A' ' 25' ' ' VAL . 11.0 tp -132.8 142.66 49.1 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 111.025 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -132.41 102.77 5.87 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.622 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.3 t -110.35 161.41 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.346 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.688 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 6.7 t80 -123.77 135.92 54.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.2 . . . . 0.0 108.28 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.562 ' O ' ' CE1' ' A' ' 100' ' ' PHE . 1.9 tmtt? -96.77 122.71 40.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.529 ' O ' ' O ' ' A' ' 102' A LEU . 74.2 m -102.27 46.19 0.94 Allowed 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.616 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 102' ' ' SER . 0.6 OUTLIER 51.95 166.31 0.04 OUTLIER Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 121.115 -0.991 . . . . 0.0 110.559 178.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 102' A LEU . 35.0 Cg_endo -76.46 117.05 4.46 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.257 1.971 . . . . 0.0 110.378 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.28 34.03 0.77 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 105' A ASN . 25.4 mt-30 50.99 -149.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -1.181 . . . . 0.0 109.623 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' A ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 105' ' ' GLN . 7.0 m120 39.64 -153.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 110.134 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -58.66 159.62 6.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.865 . . . . 0.0 109.551 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -145.7 147.36 31.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.935 . . . . 0.0 109.874 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.495 HD13 ' HD3' ' A' ' 101' ' ' LYS . 8.0 mp 49.82 170.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.698 1.237 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.688 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 14.7 p -156.91 163.39 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.71 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.557 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 10.3 tp -98.9 83.37 2.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.543 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 17.2 p -69.49 -11.77 61.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.965 . . . . 0.0 111.249 -176.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.485 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . 173.81 -165.96 37.98 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.83 -1.652 . . . . 0.0 110.929 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.6 p90 167.76 135.57 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.657 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.6 mm-40 -96.19 96.67 8.97 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.466 HG22 ' OH ' ' A' ' 40' ' ' TYR . 8.5 p -67.72 157.03 6.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.836 -1.165 . . . . 0.0 110.19 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 1.5 t0 51.56 21.15 1.21 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.1 OUTLIER -83.11 131.18 35.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.672 -1.268 . . . . 0.0 108.044 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.36 178.59 7.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.297 -0.877 . . . . 0.0 111.45 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 119' ' ' ASP . 10.2 tmtt? -61.51 -50.01 74.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.188 0.518 . . . . 0.0 110.197 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 118' ' ' LYS . 41.6 t0 -43.29 -26.43 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.179 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.436 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -69.45 93.3 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.358 -0.839 . . . . 0.0 110.321 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.543 ' O ' ' CG2' ' A' ' 123' ' ' THR . 2.3 tt0 -68.15 141.99 55.87 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.843 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -64.17 -35.65 81.48 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.364 -1.46 . . . . 0.0 110.27 -178.064 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.715 ' O ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER 49.48 -149.73 0.22 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.715 ' O ' ' O ' ' A' ' 123' ' ' THR . . . -48.82 -99.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 104.41 -3.476 . . . . 0.0 104.41 175.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.657 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 23.5 t80 . . . . . 0 C--N 1.29 -1.979 0 O-C-N 119.237 -2.331 . . . . 0.0 108.138 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.342 0.592 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 mt -48.94 119.19 8.17 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.526 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' GLY . 36.4 Cg_endo -77.48 160.06 32.15 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.358 2.039 . . . . 0.0 110.462 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . 51.03 -179.39 0.04 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -85.72 1.29 88.14 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.13 -1.217 . . . . 0.0 110.16 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.658 ' CD1' ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -35.1 108.0 0.06 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 122.206 1.003 . . . . 0.0 111.504 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -102.28 179.25 4.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.675 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.323 -0.861 . . . . 0.0 109.031 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . . . -91.47 101.02 13.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.789 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.596 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -70.93 141.07 86.51 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 103.236 -2.876 . . . . 0.0 103.236 175.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -68.02 126.63 14.76 Favored 'Trans proline' 0 C--N 1.29 -2.535 0 N-CA-C 109.531 -0.988 . . . . 0.0 109.531 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.545 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . . . -42.59 147.86 0.26 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.42 1.105 . . . . 0.0 111.994 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.613 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -122.3 -168.44 0.13 Allowed Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.613 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -71.56 -20.01 27.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 109.202 -1.115 . . . . 0.0 109.202 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -82.5 -43.97 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -0.999 . . . . 0.0 108.663 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.595 HG13 ' CD1' ' A' ' 50' ' ' TYR . 7.6 mm -58.81 -52.09 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.558 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -64.46 -18.22 64.56 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.381 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 28.8 tp10 -76.47 -31.24 57.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.597 -1.315 . . . . 0.0 108.525 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.606 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 5.4 mt -69.36 -50.66 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.569 HG23 ' CD1' ' A' ' 45' ' ' LEU . 7.3 p -62.48 -43.44 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-O 122.089 0.947 . . . . 0.0 109.358 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.555 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 21.4 t70 -74.4 -18.92 60.59 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.21 -12.76 56.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.505 HG13 ' CG2' ' A' ' 99' ' ' VAL . 27.7 m -116.59 -8.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.476 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.9 ttpp -42.25 -49.99 11.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 110.389 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.25 -34.75 7.54 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.535 1.49 . . . . 0.0 110.006 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.429 ' O ' HD22 ' A' ' 110' ' ' LEU . 29.6 mt-30 -78.84 0.07 28.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.206 -0.934 . . . . 0.0 108.592 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.574 HD22 ' CD2' ' A' ' 113' ' ' TYR . 3.2 mt -100.26 -41.23 7.16 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.444 -0.785 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 48.5 mt-10 -59.37 -44.38 92.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.5 -46.62 89.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.474 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB3' ' OH ' ' A' ' 113' ' ' TYR . 1.2 mmtp -71.11 -66.1 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 110.019 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.547 HG22 ' CZ ' ' A' ' 40' ' ' TYR . 9.4 t -70.12 -0.68 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.392 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 2.7 p-10 40.91 48.2 2.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.158 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -119.19 172.22 7.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.283 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' TYR . 5.9 t -80.91 -29.78 35.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 0.0 109.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.623 ' CE2' ' CE ' ' A' ' 95' ' ' MET . 4.9 m-30 40.31 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.529 0.681 . . . . 0.0 110.256 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 168.6 -163.39 37.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.1 118.26 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.488 -1.007 . . . . 0.0 109.443 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.569 ' CD1' HG23 ' A' ' 25' ' ' VAL . 36.5 mt -100.47 86.04 3.08 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.142 . . . . 0.0 108.073 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' C ' HG11 ' A' ' 64' ' ' VAL . 63.4 mt-10 -69.83 83.74 0.47 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -0.763 . . . . 0.0 110.063 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -41.11 145.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.148 0.975 . . . . 0.0 110.25 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -122.02 -44.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 48' ' ' VAL . 42.2 mt-30 -149.45 170.08 19.4 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 17.5 p90 -164.45 138.19 5.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.196 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 35.3 mttt -108.93 125.32 51.9 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.2 p -76.4 175.74 8.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 109.785 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.602 ' HG2' ' CE2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -150.6 154.53 37.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.358 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.482 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -128.31 141.72 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.025 -1.047 . . . . 0.0 110.303 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.49 -101.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.73 30.17 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 157.9 -110.91 0.46 Allowed Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 29.6 m -165.17 108.22 0.84 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.364 -1.08 . . . . 0.0 110.913 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.618 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 76.0 m-20 -71.37 -170.44 0.5 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.618 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 19.6 m-85 -143.55 154.95 44.13 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.468 -0.77 . . . . 0.0 109.586 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.63 ' CE2' ' O ' ' A' ' 124' ' ' GLY . 21.2 m-85 -137.21 133.5 35.22 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.587 ' CG2' ' CG2' ' A' ' 64' ' ' VAL . 12.9 mt -149.11 114.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 117.004 -1.878 . . . . 0.0 111.442 -177.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 96' ' ' HIS . 19.2 ttpt -81.09 99.23 8.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.587 ' CG2' ' CG2' ' A' ' 62' ' ' ILE . 38.2 t -109.13 144.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.37 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.552 ' HD2' ' CZ ' ' A' ' 94' ' ' TYR . 1.4 mmm180 -69.71 132.93 46.9 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.13 44.9 1.17 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.976 0.893 . . . . 0.0 108.951 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 84.67 -92.79 1.76 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' GLY . 10.5 p-10 -60.68 -140.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.258 -1.142 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.64 -7.98 57.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.958 -1.089 . . . . 0.0 109.994 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.485 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -69.45 178.36 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 108.692 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.552 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 25.6 m-85 -142.78 179.06 7.22 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.06 -1.025 . . . . 0.0 109.285 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.623 ' CE ' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -164.76 114.02 1.11 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.462 -179.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.696 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.3 m170 -71.65 140.94 49.9 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -124.84 133.99 52.9 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.511 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -121.71 113.9 20.36 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.135 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.606 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.1 t -119.89 159.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.777 -1.202 . . . . 0.0 109.684 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.687 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 4.2 t80 -121.67 130.77 53.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.592 -1.318 . . . . 0.0 108.173 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.505 ' CE ' ' HB ' ' A' ' 58' ' ' THR . 2.5 pttt -107.08 160.59 15.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 102' A LEU . 12.1 t -100.81 89.77 3.99 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.109 -0.994 . . . . 0.0 110.289 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.512 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 1.3 mt 52.66 167.05 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.787 -0.571 . . . . 0.0 110.576 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 102' A LEU . 33.9 Cg_endo -76.29 169.47 21.92 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.339 2.026 . . . . 0.0 110.446 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.5 -72.97 0.45 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -155.81 -179.63 8.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -1.074 . . . . 0.0 109.212 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' A ASN . . . . . . . . . . . . . 2.4 m-80 -80.68 102.29 9.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.934 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.507 ' O ' HD12 ' A' ' 108' ' ' LEU . 2.2 pp20? -98.59 -166.73 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.438 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -71.49 83.44 0.82 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.381 -0.824 . . . . 0.0 110.456 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.533 ' N ' HD11 ' A' ' 108' ' ' LEU . 7.3 mp -63.53 -174.5 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.086 0.945 . . . . 0.0 109.467 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.687 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.1 p -147.65 161.23 7.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.808 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 18.1 tp -97.81 87.94 4.16 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.488 ' OG1' ' HG3' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -75.57 -8.76 57.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 111.87 -176.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . 174.01 -168.27 41.03 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.625 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.606 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 31.4 p90 165.84 138.0 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.717 -0.872 . . . . 0.0 109.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.62 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.1 mm-40 -97.34 97.87 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.529 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 7.4 p -69.35 159.06 5.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.845 -1.16 . . . . 0.0 110.282 -178.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 56.4 t0 52.24 22.25 1.92 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.78 -0.575 . . . . 0.0 110.562 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 3.2 mptp? -90.56 106.31 18.42 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.755 -1.216 . . . . 0.0 108.951 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.455 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 4.5 m120 -69.51 -172.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 110.127 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -16.46 62.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.88 -20.05 63.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.586 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.7 OUTLIER -90.82 110.02 21.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 110.072 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.529 ' C ' HG21 ' A' ' 123' ' ' THR . 2.1 tt0 -92.62 150.6 20.61 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.696 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 2.0 mp -68.87 -44.27 73.65 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.515 -1.366 . . . . 0.0 107.734 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.538 ' CG2' ' C ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER 39.2 18.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.624 -0.672 . . . . 0.0 112.485 175.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.658 ' HA2' ' CD1' ' A' ' 11' ' ' LEU . . . 154.94 -65.63 0.32 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.2 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.62 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.269 0 O-C-N 121.286 -1.126 . . . . 0.0 109.251 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.3 pt -109.62 154.54 42.35 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.204 -0.935 . . . . 0.0 109.151 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.14 88.32 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.592 2.194 . . . . 0.0 110.376 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.29 136.73 3.51 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 116.09 140.95 7.08 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -35.88 128.45 0.67 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.724 -0.868 . . . . 0.0 111.096 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 m -101.25 163.91 12.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.384 0.612 . . . . 0.0 109.458 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 5.7 tt0 -48.14 176.94 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.398 -0.814 . . . . 0.0 109.308 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' HB2' ' CD ' ' A' ' 49' ' ' GLN . . . -84.89 96.7 9.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.109 . . . . 0.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.649 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 20.0 mmtt -72.27 133.19 83.52 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 176.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 17' ' ' ALA . 27.5 Cg_endo -65.98 126.08 15.25 Favored 'Trans proline' 0 C--N 1.291 -2.452 0 N-CA-C 109.257 -1.093 . . . . 0.0 109.257 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -39.37 153.52 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.536 1.16 . . . . 0.0 111.815 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.599 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -136.27 -170.12 0.23 Allowed Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.3 Cg_endo -68.97 -16.53 40.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 N-CA-C 109.244 -1.099 . . . . 0.0 109.244 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.56 -46.45 14.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.068 -1.02 . . . . 0.0 108.41 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.624 HG13 ' CD1' ' A' ' 50' ' ' TYR . 10.2 mm -58.88 -53.67 44.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.498 ' O ' HG11 ' A' ' 25' ' ' VAL . 22.9 tp60 -61.47 -19.17 61.73 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -76.13 -37.06 58.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.711 -1.243 . . . . 0.0 108.776 179.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.595 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.9 mt -63.22 -50.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.596 HG23 ' CD1' ' A' ' 45' ' ' LEU . 11.4 p -66.21 -41.62 89.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 122.183 0.992 . . . . 0.0 109.251 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.566 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 8.8 t70 -69.39 -16.58 63.54 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -85.9 -20.16 29.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' C ' ' HD2' ' A' ' 30' ' ' PRO . 13.1 m -118.4 6.58 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.613 -0.68 . . . . 0.0 110.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.619 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -53.14 -36.85 42.16 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.687 -1.258 . . . . 0.0 110.646 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.619 ' HD3' ' CG ' ' A' ' 29' ' ' LYS . 35.9 Cg_endo -79.3 -37.04 0.57 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 108.361 -1.438 . . . . 0.0 108.361 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -74.17 -3.24 28.57 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.497 HD23 ' CE ' ' A' ' 95' ' ' MET . 10.0 mt -92.43 -41.12 10.49 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.417 -0.802 . . . . 0.0 109.624 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 23.6 mt-10 -65.32 -46.27 80.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.511 -0.743 . . . . 0.0 110.972 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.7 -37.26 62.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.807 -1.183 . . . . 0.0 111.136 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -58.08 -42.65 86.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.771 -1.205 . . . . 0.0 110.063 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.622 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 1.3 p -86.5 -57.48 2.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.933 -1.104 . . . . 0.0 109.663 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 36' ' ' THR . 52.6 p-10 131.26 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 C-N-CA 122.937 0.495 . . . . 0.0 109.714 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 5.0 pt-20 -133.93 171.75 13.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 109.148 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.435 HG23 ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -107.14 117.76 34.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.009 -1.057 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.458 ' OH ' ' CG2' ' A' ' 36' ' ' THR . 58.8 m-85 -93.05 178.77 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 108.594 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -126.31 -157.57 9.6 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 43' ' ' GLY . 4.2 tttt -41.68 125.11 2.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.451 -1.029 . . . . 0.0 109.151 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.596 ' CD1' HG23 ' A' ' 25' ' ' VAL . 28.4 mt -97.43 77.41 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.055 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.53 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.872 -177.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.566 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -45.69 144.27 1.72 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.127 -0.983 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.5 t -125.6 -42.14 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.421 ' CD ' ' HB2' ' A' ' 14' ' ' ALA . 8.8 mt-30 -150.28 166.96 28.39 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 2.5 p90 -163.54 138.06 6.07 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.458 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 23.8 mttt -113.38 131.89 55.81 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.878 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -81.08 -173.72 4.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.196 -0.94 . . . . 0.0 110.86 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.58 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.9 OUTLIER -164.32 156.01 16.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -125.43 141.43 45.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.949 -1.094 . . . . 0.0 110.746 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -170.2 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.29 28.93 5.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.464 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 160.23 -104.04 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 9.1 m -168.75 112.31 0.56 Allowed 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.7 -0.883 . . . . 0.0 109.766 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.58 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 32.6 m-80 -71.36 -166.63 0.19 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.598 ' CD1' HG13 ' A' ' 99' ' ' VAL . 28.5 m-85 -150.44 154.34 37.53 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.597 ' C ' HG13 ' A' ' 62' ' ' ILE . 22.6 m-85 -138.99 133.76 32.15 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 177.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.597 HG13 ' C ' ' A' ' 61' ' ' TYR . 11.1 mt -151.81 118.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 C-N-CA 116.719 -1.992 . . . . 0.0 111.589 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -78.44 98.7 6.13 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 175.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.566 HG11 ' N ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -108.81 132.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.353 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 5.7 ttp180 -66.36 139.14 58.0 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.55 43.96 1.07 Allowed 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.922 0.868 . . . . 0.0 109.405 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 72.9 -80.63 0.68 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.0 OUTLIER -53.67 -112.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.41 -1.053 . . . . 0.0 110.394 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.402 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 5.0 m-20 -125.44 -21.4 4.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.687 -1.258 . . . . 0.0 109.876 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -68.46 177.07 2.54 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 20.0 m-85 -135.72 176.08 9.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.007 -1.058 . . . . 0.0 109.204 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.497 ' CE ' HD23 ' A' ' 32' ' ' LEU . 4.6 ttp -156.66 117.42 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.393 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.698 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.6 m170 -69.19 148.35 50.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.584 ' CD2' ' HA ' ' A' ' 25' ' ' VAL . 13.9 tp -129.04 128.58 43.88 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.725 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 41.6 tttt -114.52 107.79 15.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.598 HG13 ' CD1' ' A' ' 60' ' ' TYR . 1.8 t -111.38 160.66 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.215 . . . . 0.0 109.164 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.708 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 34.7 t80 -122.94 133.11 54.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.792 -1.192 . . . . 0.0 109.003 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -106.25 137.16 44.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.539 ' O ' ' CD2' ' A' ' 102' A LEU . 1.1 t -102.06 -149.72 0.39 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.914 0.864 . . . . 0.0 109.416 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.57 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -160.94 -59.62 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.917 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.641 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 102' A LEU . 36.5 Cg_endo -76.8 -167.81 0.51 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.148 1.899 . . . . 0.0 110.778 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.61 62.8 4.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 47.41 -155.48 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.256 -1.144 . . . . 0.0 109.31 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' A ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.91 70.3 9.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.307 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.564 ' HG2' ' N ' ' A' ' 107' ' ' ASP . 26.7 tt0 -61.31 156.19 19.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.151 -0.968 . . . . 0.0 109.461 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.564 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 0.7 OUTLIER -105.61 148.93 26.78 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.446 -0.784 . . . . 0.0 109.311 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.514 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 8.1 mp -53.02 -173.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.116 0.96 . . . . 0.0 109.784 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.708 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.3 p -152.31 166.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.089 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.54 ' HB2' ' CG1' ' A' ' 28' ' ' VAL . 12.4 tp -98.52 85.29 3.34 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.527 HG22 ' CB ' ' A' ' 100' ' ' PHE . 3.4 p -81.18 -1.55 45.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.1 -1.0 . . . . 0.0 111.947 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.579 ' O ' ' CB ' ' A' ' 113' ' ' TYR . . . 177.67 -160.19 26.6 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.193 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.667 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER 150.3 133.47 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.383 0.611 . . . . 0.0 109.959 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.641 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.07 95.08 7.94 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' HD3' ' A' ' 116' ' ' LYS . 9.4 p -67.98 161.4 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.185 . . . . 0.0 111.088 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 49.6 t0 50.11 20.76 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.912 -0.492 . . . . 0.0 110.815 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.571 ' CG ' ' OD2' ' A' ' 120' ' ' ASP . 1.6 mptt -93.61 129.44 39.88 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.64 -1.288 . . . . 0.0 108.546 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 2.9 m-80 -104.4 -156.86 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 0.0 112.285 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.535 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 3.4 tttm -54.2 -56.7 15.73 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.937 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.42 -20.98 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 0.0 111.089 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.571 ' OD2' ' CG ' ' A' ' 116' ' ' LYS . 63.2 t0 -83.9 123.02 29.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.665 -1.272 . . . . 0.0 111.724 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.558 ' O ' ' CG2' ' A' ' 123' ' ' THR . 5.1 tt0 -100.3 139.88 35.34 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 176.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.698 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.2 mp -59.55 -49.54 77.36 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.541 -1.35 . . . . 0.0 109.411 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.3 OUTLIER 43.7 -168.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.89 178.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.575 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -55.38 91.77 0.01 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 109.488 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.5 mtp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.451 HG21 ' HD2' ' A' ' 8' ' ' PRO . 39.9 mt -65.23 130.21 94.69 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 0.0 109.532 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD2' HG21 ' A' ' 7' ' ' ILE . 35.9 Cg_endo -78.76 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.412 2.075 . . . . 0.0 110.157 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . 144.44 -77.3 0.28 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 9' ' ' GLY . . . -60.32 -131.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER 38.92 94.48 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.331 1.062 . . . . 0.0 110.945 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.5 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 79.1 p -101.52 -176.72 3.22 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.114 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -51.02 179.77 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.976 -1.078 . . . . 0.0 108.574 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.94 95.79 4.87 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.289 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mmtt -70.75 126.36 92.17 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.96 127.36 18.37 Favored 'Trans proline' 0 C--N 1.293 -2.345 0 N-CA-C 109.514 -0.995 . . . . 0.0 109.514 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -42.34 165.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.346 1.07 . . . . 0.0 111.431 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.619 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.46 -167.88 0.17 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -71.93 -18.03 28.23 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 N-CA-C 108.939 -1.216 . . . . 0.0 108.939 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.479 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.5 mt-10 -83.93 -45.32 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.601 HG13 ' CD1' ' A' ' 50' ' ' TYR . 4.6 mm -57.74 -54.43 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.501 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 13.6 tp60 -61.76 -20.29 63.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 7.0 tt0 -75.74 -34.81 60.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.471 -1.393 . . . . 0.0 108.643 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.635 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.7 mt -66.04 -49.67 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.004 0.907 . . . . 0.0 108.815 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.575 HG23 ' HB2' ' A' ' 45' ' ' LEU . 12.5 p -69.34 -41.38 80.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-O 121.966 0.889 . . . . 0.0 109.861 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.568 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 7.2 t70 -72.12 -17.0 62.01 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 14.4 tppt? -89.83 -13.47 36.49 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.612 ' CG2' ' CD2' ' A' ' 97' ' ' LEU . 31.3 m -126.58 4.18 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.883 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.594 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 6.3 ttpt -54.66 -43.66 98.48 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 111.07 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.68 -18.75 24.99 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.383 1.389 . . . . 0.0 109.615 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -91.92 -10.89 37.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD23 ' CB ' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -92.06 -33.27 14.86 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -82.68 -20.1 36.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 109.952 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.71 -45.85 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.017 -1.052 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -67.27 -40.16 86.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.587 ' OG1' ' CE1' ' A' ' 113' ' ' TYR . 2.7 m -82.67 -32.44 28.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.917 . . . . 0.0 109.388 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 88.71 26.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.254 0.55 . . . . 0.0 109.725 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -107.24 -178.84 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.518 ' O ' ' O ' ' A' ' 40' ' ' TYR . 29.9 m -97.03 -25.7 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.147 -0.971 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.641 ' CD2' ' CE ' ' A' ' 95' ' ' MET . 14.5 m-30 37.79 -165.29 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.705 0.764 . . . . 0.0 110.976 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 176.1 -165.63 36.29 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' O ' HD22 ' A' ' 45' ' ' LEU . 14.0 mttt -42.46 134.51 3.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.629 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 34.5 mt -111.85 81.66 1.49 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.2 tt0 -64.01 86.89 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.583 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -44.71 132.83 6.29 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.291 1.043 . . . . 0.0 110.371 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 HG22 ' HG2' ' A' ' 65' ' ' ARG . 1.3 t -110.83 -45.32 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.506 ' OE1' ' CD1' ' A' ' 122' ' ' LEU . 1.3 pt20 -149.05 173.21 13.63 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.803 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.601 ' CD1' HG13 ' A' ' 21' ' ' ILE . 26.7 p90 -165.31 141.12 5.33 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.69 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 12' ' ' SER . 9.0 mttt -117.7 135.96 53.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.366 0.603 . . . . 0.0 109.378 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.4 p -76.93 -175.59 3.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.266 -0.896 . . . . 0.0 110.064 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.606 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.6 OUTLIER -158.94 149.15 19.46 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.509 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -123.84 141.04 45.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.798 -1.189 . . . . 0.0 110.51 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.66 -103.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 30.24 4.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.406 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 158.94 -111.37 0.48 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 106.734 -2.547 . . . . 0.0 106.734 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 16.4 m -165.26 107.31 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.345 -1.091 . . . . 0.0 110.697 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.607 ' OD1' ' CD2' ' A' ' 100' ' ' PHE . 82.0 m-20 -71.89 -171.52 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 101' ' ' LYS . 22.8 m-85 -139.38 160.2 40.39 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.606 ' CE1' ' OXT' ' A' ' 125' ' ' PHE . 11.0 m-85 -141.8 136.57 30.79 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.588 HG13 ' C ' ' A' ' 61' ' ' TYR . 14.1 mt -151.15 119.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.675 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 26.4 ttpp -86.36 94.61 9.41 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.583 HG11 ' N ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -100.09 137.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.843 -0.536 . . . . 0.0 110.86 -176.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -67.76 123.46 20.6 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . . . -82.02 39.33 0.56 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.605 0.717 . . . . 0.0 111.007 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.04 -127.99 9.06 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.24 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -68.39 80.02 0.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.691 -0.888 . . . . 0.0 112.261 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 10.8 m120 71.22 -8.64 0.98 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.114 -0.991 . . . . 0.0 111.712 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -69.48 -179.76 1.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.649 -1.282 . . . . 0.0 108.367 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 7.3 m-85 -150.74 155.98 40.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.972 -1.08 . . . . 0.0 109.391 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.641 ' CE ' ' CD2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -150.79 111.21 4.19 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.652 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.11 135.25 44.74 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.612 ' CD2' ' CG2' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -120.25 157.35 29.32 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.868 -1.145 . . . . 0.0 111.274 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.2 tttt -141.77 107.49 5.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.635 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.1 t -115.31 160.27 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.755 -1.216 . . . . 0.0 110.308 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.607 ' CD2' ' OD1' ' A' ' 59' ' ' ASN . 0.2 OUTLIER -121.1 122.46 40.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 60' ' ' TYR . 1.8 tttt -89.9 44.4 1.2 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.487 1.137 . . . . 0.0 107.998 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 102' A LEU . 0.2 OUTLIER -34.73 90.17 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.304 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.559 ' CG ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -28.74 -57.73 0.25 Allowed Pre-proline 0 N--CA 1.499 2.012 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.559 ' HD3' ' CG ' ' A' ' 102' A LEU . 37.4 Cg_endo -75.5 -104.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.351 2.034 . . . . 0.0 110.299 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.26 167.07 0.28 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 105' A ASN . 0.3 OUTLIER -132.35 -164.21 1.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -1.199 . . . . 0.0 109.289 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' A ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 105' ' ' GLN . 10.1 p-10 35.15 -147.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.787 -0.571 . . . . 0.0 109.804 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 105' A ASN . 73.7 mm-40 -43.24 160.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 109.14 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.61 162.63 12.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 110.092 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.542 ' CD1' ' HG2' ' A' ' 101' ' ' LYS . 5.7 mp 58.45 172.54 0.06 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.353 1.073 . . . . 0.0 110.77 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.588 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 14.3 p -153.86 161.42 2.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.099 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 8.1 tp -96.69 82.05 3.26 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.589 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -70.37 -9.48 56.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 111.918 -176.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.494 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . 168.78 -168.7 41.28 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.382 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.596 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 22.4 p90 167.79 135.38 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.593 -0.945 . . . . 0.0 109.139 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.652 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -90.53 103.9 16.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 36' ' ' THR . 8.1 p -68.25 161.69 3.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.552 -177.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' A ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 115' ' ' VAL . 0.9 OUTLIER 42.2 43.31 2.83 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.11 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.513 ' HG2' ' HB2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.959 -1.088 . . . . 0.0 108.404 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.97 -171.41 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 110.306 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 14.5 tttt -66.94 -40.5 87.57 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.425 0.631 . . . . 0.0 109.627 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.19 -18.56 0.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.341 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.586 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.4 OUTLIER -88.19 105.58 17.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.828 -1.17 . . . . 0.0 110.251 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.98 162.77 20.31 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.652 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 3.0 mp -85.07 13.91 5.62 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.406 -1.434 . . . . 0.0 109.484 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.543 ' C ' ' O ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER 2.77 -76.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.439 0.696 . . . . 0.0 112.236 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.538 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -139.71 15.02 3.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.652 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.602 0 O-C-N 121.603 -0.94 . . . . 0.0 108.545 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.402 ' O ' ' C ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.496 ' HB ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 pp -42.9 161.13 0.19 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.844 . . . . 0.0 109.43 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 7' ' ' ILE . 33.1 Cg_endo -75.56 167.03 27.36 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.444 2.096 . . . . 0.0 110.611 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . -105.36 -82.03 1.52 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 12' ' ' SER . . . 60.53 112.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.591 HD22 ' CE2' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -44.98 94.7 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 122.383 1.087 . . . . 0.0 110.917 -178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.5 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -101.93 178.68 4.54 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.966 179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -51.96 163.83 0.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.161 -0.962 . . . . 0.0 109.182 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . . . -72.54 107.68 5.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.942 . . . . 0.0 110.865 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.03 139.5 79.71 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 175.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.93 127.39 17.65 Favored 'Trans proline' 0 C--N 1.292 -2.435 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.548 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -44.61 131.43 6.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.06 0.933 . . . . 0.0 112.266 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.583 ' OG1' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -102.52 -173.42 0.29 Allowed Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 176.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.583 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 28.5 Cg_endo -68.42 -20.82 41.55 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 109.643 -0.945 . . . . 0.0 109.643 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.6 mt-10 -81.72 -41.54 21.13 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.035 -1.041 . . . . 0.0 108.929 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.629 HG13 ' CG ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -62.36 -47.48 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -67.6 -16.1 64.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.2 tt0 -77.18 -29.99 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.814 -1.179 . . . . 0.0 108.315 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.597 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.0 mt -70.62 -50.41 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.574 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 7.7 p -61.42 -44.33 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.984 0.897 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.542 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 8.6 t0 -72.11 -20.26 61.67 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -80.34 -12.86 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.591 HG22 ' CD1' ' A' ' 97' ' ' LEU . 35.2 m -116.17 -10.85 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.556 -0.715 . . . . 0.0 110.203 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.2 ttmt -39.77 -49.91 5.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.05 -1.031 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 28.9 Cg_endo -69.69 -35.52 12.71 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.587 1.525 . . . . 0.0 109.8 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 27.6 mt-30 -73.76 -4.8 36.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.609 HD21 ' CE2' ' A' ' 40' ' ' TYR . 7.0 mt -96.89 -43.15 7.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.62 0.724 . . . . 0.0 110.03 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.7 -27.19 69.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.752 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.04 -46.79 5.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.963 -1.085 . . . . 0.0 110.916 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 70.7 mttt -67.76 -33.89 75.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.071 . . . . 0.0 110.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 2.8 m -92.98 -35.5 13.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.886 -1.134 . . . . 0.0 109.532 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 36' ' ' THR . 1.0 OUTLIER 91.3 28.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.218 0.532 . . . . 0.0 110.019 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -115.38 -175.99 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 40' ' ' TYR . 43.2 m -98.78 -20.75 16.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.609 ' CE2' HD21 ' A' ' 32' ' ' LEU . 4.1 m-85 39.22 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.974 0.892 . . . . 0.0 111.051 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.9 -152.29 11.12 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 129.77 42.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.673 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.574 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . 35.5 mt -111.05 81.94 1.51 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.974 -1.079 . . . . 0.0 109.028 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -65.23 85.69 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.481 0.658 . . . . 0.0 110.137 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.556 ' HA ' ' CG1' ' A' ' 64' ' ' VAL . . . -43.96 125.99 4.61 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.105 0.955 . . . . 0.0 109.891 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.9 t -103.4 -44.87 9.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 3.4 mt-30 -142.78 172.79 12.21 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.629 ' CG ' HG13 ' A' ' 21' ' ' ILE . 31.7 p90 -169.75 139.82 2.03 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.877 -1.139 . . . . 0.0 110.593 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 12' ' ' SER . 7.5 mtmt -122.23 128.99 51.82 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.92 139.6 37.32 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.171 -0.956 . . . . 0.0 110.062 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.514 ' CD ' ' N ' ' A' ' 53' ' ' GLN . 1.3 pm0 -133.23 158.52 42.68 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.487 ' O ' HG11 ' A' ' 55' ' ' VAL . 4.7 p -97.36 155.85 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 111.772 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG22 ' ND2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -162.28 -101.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 27.91 5.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.406 ' O ' HG21 ' A' ' 54' ' ' VAL . . . 156.55 -103.37 0.23 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 106.373 -2.691 . . . . 0.0 106.373 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -160.89 122.64 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.584 -0.951 . . . . 0.0 109.891 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.574 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 9.7 m-20 -85.12 -164.96 1.07 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 7.9 m-85 -149.52 131.05 14.84 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.619 ' C ' HG13 ' A' ' 62' ' ' ILE . 8.9 m-30 -115.88 134.53 54.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.619 HG13 ' C ' ' A' ' 61' ' ' TYR . 17.8 mt -150.47 128.13 2.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 116.812 -1.955 . . . . 0.0 111.371 -176.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.572 ' HG3' ' NZ ' ' A' ' 116' ' ' LYS . 19.4 ttmt -95.34 90.99 6.02 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.556 ' CG1' ' HA ' ' A' ' 47' ' ' ALA . 31.4 m -99.6 142.06 15.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.773 -0.579 . . . . 0.0 110.956 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.33 123.15 19.97 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB1' ' N ' ' A' ' 94' ' ' TYR . . . -86.06 46.75 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.139 0.971 . . . . 0.0 109.141 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 -152.05 19.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 92' ' ' ASN . 2.0 p-10 -59.15 126.84 29.32 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.426 -1.044 . . . . 0.0 111.044 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 68' ' ' ASP . 7.8 p-10 31.62 44.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.217 0.532 . . . . 0.0 111.304 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.489 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -127.76 171.41 11.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.495 ' N ' ' HB1' ' A' ' 66' ' ' ALA . 25.8 m-85 -156.94 156.36 32.92 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.754 -1.216 . . . . 0.0 110.495 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.51 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 9.2 tmm? -153.97 116.52 4.39 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.296 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.687 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.1 m170 -76.29 143.22 41.01 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.591 ' CD1' HG22 ' A' ' 28' ' ' VAL . 1.4 tp -133.55 131.92 40.3 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.795 -1.562 . . . . 0.0 112.437 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.2 ttpt -111.7 83.38 1.77 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.598 HG11 ' CD1' ' A' ' 60' ' ' TYR . 1.6 t -84.47 159.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.665 -1.272 . . . . 0.0 109.206 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.701 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 58.4 t80 -125.4 131.43 52.94 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.635 -1.291 . . . . 0.0 108.35 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.552 ' HG2' ' N ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -107.55 145.34 33.31 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.552 ' N ' ' HG2' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -98.37 73.24 2.13 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.932 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 102' ' ' SER . 74.1 mt 54.7 157.29 0.06 OUTLIER Pre-proline 0 C--N 1.307 -1.25 0 O-C-N 121.567 -0.708 . . . . 0.0 110.396 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.35 179.96 5.94 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.545 2.163 . . . . 0.0 110.037 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 139.31 -111.42 0.77 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 105' A ASN . 14.0 mt-30 -141.66 145.71 35.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -1.17 . . . . 0.0 109.691 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' A ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER 41.0 65.86 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.515 -0.741 . . . . 0.0 109.836 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -76.56 -178.91 4.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.0 109.287 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.92 77.51 1.55 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.093 -1.004 . . . . 0.0 110.084 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 10.6 mp -60.97 -174.35 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.307 1.051 . . . . 0.0 109.453 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.701 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.5 p -163.39 164.94 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.089 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.541 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 4.4 tp -97.49 83.52 3.27 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.533 HG22 ' CB ' ' A' ' 100' ' ' PHE . 1.4 p -85.89 -3.61 58.96 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.016 -1.052 . . . . 0.0 112.81 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 113' ' ' TYR . . . -171.31 -172.34 37.36 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.633 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER 155.38 132.61 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.736 -0.861 . . . . 0.0 111.3 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.636 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 6.2 mm-40 -95.37 95.95 8.8 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.451 HG21 ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -65.84 160.1 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.99 -176.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' A ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 115' ' ' VAL . 2.7 t70 42.85 37.19 1.01 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.441 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.572 ' NZ ' ' HG3' ' A' ' 63' ' ' LYS . 8.1 ptmm? -69.61 -163.83 0.06 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.074 -1.016 . . . . 0.0 108.935 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.452 ' O ' ' NZ ' ' A' ' 116' ' ' LYS . 14.2 m-80 -157.35 178.5 10.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.84 -1.163 . . . . 0.0 109.922 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -68.92 -9.27 50.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.814 . . . . 0.0 109.756 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.32 5.09 46.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -100.68 119.65 38.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.035 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.551 ' O ' ' CG2' ' A' ' 123' ' ' THR . 0.9 OUTLIER -96.9 138.43 34.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.687 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.6 mp -58.57 -55.93 28.65 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.715 -1.241 . . . . 0.0 109.196 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.3 OUTLIER 44.69 -169.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.182 177.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.558 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -49.51 91.93 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.539 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.594 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.414 ' C ' HD12 ' A' ' 7' ' ' ILE . 15.8 mtm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.356 0.598 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.438 ' CD1' ' N ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -127.93 131.96 24.08 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.06 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.04 -24.04 7.23 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.378 2.052 . . . . 0.0 110.493 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.12 109.11 2.09 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' OE1' ' A' ' 53' ' ' GLN . . . 176.77 -167.89 39.54 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.532 HD21 ' N ' ' A' ' 11' ' ' LEU . 1.3 pt? -132.88 155.94 48.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -1.144 . . . . 0.0 109.524 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 t -101.33 -177.22 3.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 110.731 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -49.98 -175.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.555 -0.716 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . . . -90.17 107.88 19.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.928 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 9.6 mmpt? -73.26 141.11 80.32 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 175.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HA ' ' HG3' ' A' ' 49' ' ' GLN . 28.2 Cg_endo -66.47 131.29 25.87 Favored 'Trans proline' 0 C--N 1.291 -2.499 0 N-CA-C 109.45 -1.019 . . . . 0.0 109.45 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.557 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -48.17 165.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.399 1.095 . . . . 0.0 111.813 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.628 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -145.92 -166.07 0.12 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.628 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.5 Cg_endo -71.85 -18.35 28.26 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 N-CA-C 108.755 -1.287 . . . . 0.0 108.755 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.42 -45.93 15.34 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.6 HG13 ' CD1' ' A' ' 50' ' ' TYR . 4.4 mm -59.85 -53.03 54.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.501 ' NE2' HG12 ' A' ' 25' ' ' VAL . 26.9 tp60 -60.45 -19.48 56.61 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 tt0 -75.17 -43.12 54.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 108.737 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.613 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.3 mt -57.29 -52.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.584 ' CG2' ' CD1' ' A' ' 45' ' ' LEU . 11.4 p -66.42 -39.76 84.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 122.024 0.916 . . . . 0.0 109.095 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.575 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 23.3 t70 -68.44 -13.45 62.31 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -94.76 -19.96 19.91 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.257 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.576 HG22 ' CD1' ' A' ' 97' ' ' LEU . 27.4 m -111.66 -6.03 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.885 . . . . 0.0 111.23 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.578 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 ttpm? -44.46 -48.25 26.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -29.96 12.62 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.625 1.55 . . . . 0.0 110.112 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' HD22 ' A' ' 110' ' ' LEU . 26.3 mt-30 -83.77 -0.72 52.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -100.27 -37.6 8.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 1.5 tm-20 -72.08 -30.6 65.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -19.44 29.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.0 . . . . 0.0 109.886 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 7.6 44.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 109.855 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.572 HG23 ' CE2' ' A' ' 40' ' ' TYR . 14.4 t -135.56 -32.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.939 -1.1 . . . . 0.0 110.281 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER 92.62 18.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.919 -0.488 . . . . 0.0 110.116 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -115.5 157.76 23.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.916 -1.115 . . . . 0.0 109.057 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.524 ' O ' ' O ' ' A' ' 40' ' ' TYR . 8.9 m -81.22 -15.43 55.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.588 ' CD2' ' HE2' ' A' ' 95' ' ' MET . 12.0 m-30 39.0 -165.76 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.521 0.677 . . . . 0.0 110.14 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -176.65 -169.44 38.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' O ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -42.04 134.44 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.464 -1.021 . . . . 0.0 108.875 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.611 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 34.0 mt -112.55 83.73 1.86 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.085 -1.01 . . . . 0.0 109.859 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 3.7 mt-10 -65.33 85.5 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.481 0.658 . . . . 0.0 109.667 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.592 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -47.89 116.88 1.64 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.3 1.048 . . . . 0.0 110.579 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.55 HG22 ' CD ' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -90.67 -46.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 63' ' ' LYS . 2.6 mt-30 -148.73 168.78 21.98 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.696 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.6 ' CD1' HG13 ' A' ' 21' ' ' ILE . 7.0 p90 -161.75 136.23 6.98 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.821 -1.152 . . . . 0.0 110.983 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 11' ' ' LEU . 11.5 mttt -105.41 137.0 43.94 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 p -86.97 178.63 6.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.858 . . . . 0.0 110.049 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.624 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -157.32 161.25 39.1 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.02 140.08 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.068 -1.02 . . . . 0.0 110.374 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.15 -103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.63 29.35 4.13 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.464 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 158.65 -99.74 0.18 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 18.7 m -167.38 120.4 0.94 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.644 -0.916 . . . . 0.0 110.236 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.624 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 17.5 m-20 -77.92 -164.25 0.5 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.598 ' CD2' HD12 ' A' ' 24' ' ' ILE . 75.9 m-85 -151.58 152.61 33.13 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.704 0.764 . . . . 0.0 109.023 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CE1' ' HB2' ' A' ' 125' ' ' PHE . 19.7 m-85 -138.58 132.78 31.6 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.559 HG13 ' C ' ' A' ' 61' ' ' TYR . 14.4 mt -149.11 119.0 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 C-N-CA 116.917 -1.913 . . . . 0.0 111.378 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 14.2 ptpt -85.99 98.71 10.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.592 HG11 ' N ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -102.26 141.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.217 0.532 . . . . 0.0 110.746 -175.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.62 ' NH1' ' CE2' ' A' ' 94' ' ' TYR . 0.9 OUTLIER -68.93 125.0 25.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 93' ' ' LYS . . . -83.11 38.95 0.62 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.619 0.723 . . . . 0.0 110.839 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.87 -74.09 0.8 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.612 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 54.0 p30 -78.21 44.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.982 -1.305 . . . . 0.0 113.485 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 3.4 t-20 79.94 -41.28 0.22 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.849 -1.157 . . . . 0.0 111.246 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 33.6 mtmt -67.21 144.3 56.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.723 -1.236 . . . . 0.0 107.826 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.62 ' CE2' ' NH1' ' A' ' 65' ' ' ARG . 18.8 m-30 -104.82 172.16 6.94 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.416 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.588 ' HE2' ' CD2' ' A' ' 40' ' ' TYR . 2.4 mtp -144.01 115.68 8.19 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.721 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -69.63 148.45 49.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.576 ' CD1' HG22 ' A' ' 28' ' ' VAL . 12.9 tp -133.27 132.76 41.79 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.296 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 30.0 tttt -122.61 103.34 8.62 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.613 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.4 t -108.8 163.64 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.32 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.671 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.2 t80 -127.05 133.13 50.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.975 -1.078 . . . . 0.0 108.809 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 5.9 tttt -99.61 129.46 45.76 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 102' A LEU . 7.4 m -102.03 14.27 32.41 Favored 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.143 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.561 ' C ' ' O ' ' A' ' 102' ' ' SER . 0.7 OUTLIER 18.55 64.19 0.23 Allowed Pre-proline 0 N--CA 1.499 1.995 0 CA-C-O 120.825 0.345 . . . . 0.0 111.533 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 102' A LEU . 37.5 Cg_endo -79.12 19.49 0.91 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.014 2.476 . . . . 0.0 111.317 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.2 47.08 50.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -154.64 -154.84 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.155 . . . . 0.0 109.393 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' A ASN . . . . . . . . . . . . . 10.8 t-20 -62.3 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 0.0 109.299 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.98 139.54 30.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 109.318 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -155.25 49.97 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 109.598 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.6 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 6.9 mp -79.24 -174.74 4.29 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.422 1.106 . . . . 0.0 110.107 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.671 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 8.4 p -146.07 164.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.927 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.569 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 11.1 tp -98.01 83.85 3.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -72.69 -10.15 59.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 111.157 -177.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . 174.35 -165.96 37.7 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 37.6 p90 164.98 137.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.657 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 1.5 mm-40 -103.09 107.99 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.546 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -66.6 162.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.634 -1.291 . . . . 0.0 111.626 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' A ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 115' ' ' VAL . 22.6 t0 39.49 30.69 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.635 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -77.8 158.39 29.55 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.695 -1.253 . . . . 0.0 108.254 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.34 179.4 4.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.039 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -65.03 -50.07 67.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 0.0 109.271 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' LYS . 13.9 t70 -44.5 -27.16 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.493 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -76.19 88.39 3.06 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.507 -0.746 . . . . 0.0 109.385 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.08 164.82 3.74 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.721 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -90.35 50.84 1.9 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.373 -1.454 . . . . 0.0 109.674 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -48.84 -177.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.083 178.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.464 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -42.41 94.11 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.657 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.363 -1.081 . . . . 0.0 109.646 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.497 ' HG3' HD11 ' A' ' 7' ' ' ILE . 1.6 ptt? . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.256 0.55 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.497 HD11 ' HG3' ' A' ' 6' ' ' MET . 3.0 mp 52.42 92.27 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.878 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.46 -31.92 2.47 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.721 2.281 . . . . 0.0 110.237 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.13 99.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 136.29 126.54 2.56 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.569 ' CD1' ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -41.41 128.7 3.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.598 -0.942 . . . . 0.0 111.082 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' GLU . 2.0 t -101.4 167.95 9.84 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.52 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.652 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.14 98.62 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.39 127.3 90.33 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 176.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.72 124.39 13.12 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -45.47 128.77 8.3 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.952 0.882 . . . . 0.0 111.667 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.578 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -101.07 -171.89 0.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 177.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.4 Cg_endo -69.06 -18.29 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 N-CA-C 109.369 -1.05 . . . . 0.0 109.369 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -43.3 22.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.143 -0.973 . . . . 0.0 108.504 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.622 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -63.33 -47.46 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.622 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -58.31 -23.03 55.24 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.4 tt0 -76.88 -40.61 46.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.22 -0.925 . . . . 0.0 110.286 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.639 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.0 mt -61.28 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 14.7 p -64.14 -41.65 93.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.017 0.913 . . . . 0.0 109.021 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.568 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 8.9 t70 -72.51 -12.56 61.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mttt -96.71 -10.12 27.57 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.593 HG22 ' CD1' ' A' ' 97' ' ' LEU . 4.3 m -120.76 -6.03 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 110.473 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -48.37 -45.28 67.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 0.0 110.379 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.4 Cg_endo -72.23 -28.94 14.85 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.287 1.324 . . . . 0.0 109.517 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.417 ' O ' HD22 ' A' ' 110' ' ' LEU . 39.1 mt-30 -81.79 -7.49 59.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.557 ' CD1' HD12 ' A' ' 97' ' ' LEU . 11.1 mt -88.1 -48.77 7.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -63.29 -25.25 68.23 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.149 0.5 . . . . 0.0 110.027 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -88.58 -28.14 20.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 110.178 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 13.8 mmtt -99.87 2.85 44.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 110.094 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.599 HG23 ' CE2' ' A' ' 40' ' ' TYR . 6.1 t -128.2 -4.48 5.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.121 -0.987 . . . . 0.0 109.874 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 40.14 45.3 1.67 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 109.834 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -138.14 161.25 37.28 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.408 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -88.16 119.11 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 110.309 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.599 ' CE2' HG23 ' A' ' 36' ' ' THR . 14.8 m-30 -114.29 -169.8 1.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -153.89 -171.84 21.35 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 43' ' ' GLY . 3.8 mttt -44.36 135.66 4.48 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.622 ' O ' ' NE2' ' A' ' 22' ' ' GLN . 31.0 mt -107.66 69.77 0.75 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.897 -1.127 . . . . 0.0 109.028 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -58.15 86.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.271 -178.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -41.01 142.68 0.46 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 109.963 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 2.1 t -125.26 -40.31 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -140.43 171.32 14.3 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.645 ' CE2' ' CB ' ' A' ' 15' ' ' LYS . 4.3 p90 -170.18 141.45 2.09 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.73 -1.231 . . . . 0.0 110.944 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 4.7 mttp -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.1 p -82.83 -174.31 5.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.153 -0.967 . . . . 0.0 110.739 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.606 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.9 OUTLIER -165.11 148.74 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.458 ' O ' HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.21 134.62 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 120.844 -1.16 . . . . 0.0 110.936 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -160.35 -102.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.03 29.06 4.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 159.66 -105.54 0.27 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 57' ' ' GLY . 23.3 m -168.26 118.78 0.78 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.682 -0.893 . . . . 0.0 110.327 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.606 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 43.3 m-20 -79.07 -165.64 0.79 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.568 ' CD1' HG11 ' A' ' 99' ' ' VAL . 32.2 m-85 -148.36 157.62 43.59 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.236 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.613 ' C ' HG13 ' A' ' 62' ' ' ILE . 18.9 m-85 -139.65 137.56 35.36 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.613 HG13 ' C ' ' A' ' 61' ' ' TYR . 10.9 mt -155.9 126.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 116.935 -1.906 . . . . 0.0 112.067 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.629 ' HD2' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.45 94.54 7.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 176.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.549 HG12 ' CG2' ' A' ' 25' ' ' VAL . 5.3 m -102.51 143.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.519 -0.738 . . . . 0.0 111.338 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.01 125.34 26.0 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.91 46.24 1.16 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.147 0.975 . . . . 0.0 109.358 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 94.2 -105.79 3.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 67' ' ' GLY . 5.6 p-10 -58.29 -144.73 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.497 -1.002 . . . . 0.0 109.93 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -77.53 -2.11 33.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.823 -1.173 . . . . 0.0 110.252 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -69.82 168.9 14.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.629 ' CD1' ' HD2' ' A' ' 63' ' ' LYS . 35.6 m-85 -142.13 165.3 27.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.546 ' SD ' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.7 116.5 4.8 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.725 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.676 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -73.99 143.61 45.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.593 ' CD1' HG22 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -146.29 130.19 17.22 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.845 -1.159 . . . . 0.0 110.786 -178.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.3 pttm -115.26 130.7 56.98 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.487 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.639 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 1.6 t -117.15 167.11 10.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.689 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.9 t80 -132.23 123.57 27.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.467 -1.396 . . . . 0.0 108.445 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.454 ' HG2' HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -96.22 126.38 41.4 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 102' A LEU . 13.1 p -101.16 44.3 1.02 Allowed 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.678 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 1.0 OUTLIER 54.44 164.56 0.05 OUTLIER Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.476 -0.765 . . . . 0.0 109.785 179.021 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 102' A LEU . 34.7 Cg_endo -77.67 90.42 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.512 2.141 . . . . 0.0 110.528 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.61 -76.05 0.23 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.448 ' O ' ' CB ' ' A' ' 105' A ASN . 1.5 pp0? -168.05 -174.34 2.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.618 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' A ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 10.7 t-20 73.06 -170.84 0.13 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.301 -0.875 . . . . 0.0 109.942 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -54.74 179.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.725 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 108' ' ' LEU . 1.3 t70 -111.44 124.87 53.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.489 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.454 HD13 ' HG2' ' A' ' 101' ' ' LYS . 11.0 mp 49.7 177.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.408 1.099 . . . . 0.0 109.928 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.689 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.0 p -148.78 160.93 5.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.774 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 1.9 tp -96.84 86.25 3.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.536 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -68.7 -20.71 64.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.97 -1.081 . . . . 0.0 111.087 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.494 ' HA3' ' HE2' ' A' ' 98' ' ' LYS . . . 178.32 -163.35 31.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.777 -1.677 . . . . 0.0 110.84 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.2 p90 167.81 135.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.687 -0.89 . . . . 0.0 108.896 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.666 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -94.55 103.36 15.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.436 ' HA ' ' HG2' ' A' ' 95' ' ' MET . 3.6 p -67.06 159.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.679 -1.263 . . . . 0.0 110.536 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.76 32.93 1.35 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.487 ' HG2' ' HB2' ' A' ' 114' ' ' GLN . 5.0 tptt -90.53 127.06 36.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.519 -1.363 . . . . 0.0 109.248 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.517 ' O ' ' CE ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -68.9 170.57 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.51 -0.744 . . . . 0.0 110.191 -178.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -62.99 -61.13 2.6 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.428 -0.795 . . . . 0.0 109.551 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 12.7 t0 -40.28 -31.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.457 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 1.1 t70 -50.77 121.54 6.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 110.031 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.553 ' O ' ' CG2' ' A' ' 123' ' ' THR . 0.7 OUTLIER -88.66 134.93 33.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.676 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 2.5 mp -65.22 -40.95 94.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.834 -1.166 . . . . 0.0 108.442 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 54.83 -161.91 0.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.027 0.918 . . . . 0.0 111.248 176.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.569 ' HA2' ' CD1' ' A' ' 11' ' ' LEU . . . -47.84 -17.97 0.64 Allowed Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.666 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 O-C-N 121.17 -1.194 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.403 ' O ' HG21 ' A' ' 7' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.318 0.58 . . . . 0.0 109.586 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.403 HG21 ' O ' ' A' ' 6' ' ' MET . 0.5 OUTLIER -151.86 81.08 5.9 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 109.347 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.17 126.64 7.9 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.713 2.276 . . . . 0.0 110.568 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.17 -166.01 34.37 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 73.74 135.46 0.3 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -41.58 122.3 1.92 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.2 -1.176 . . . . 0.0 110.586 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.512 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -102.07 -178.63 3.76 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.357 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.533 ' O ' ' CE ' ' A' ' 15' ' ' LYS . 2.8 mm-40 -59.01 135.0 57.49 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.05 -1.031 . . . . 0.0 108.797 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' HA ' ' NZ ' ' A' ' 51' ' ' LYS . . . -39.4 109.34 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.226 -0.921 . . . . 0.0 110.936 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.603 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -79.59 129.85 70.01 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 175.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.95 128.92 20.71 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.57 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -43.29 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.627 1.203 . . . . 0.0 112.285 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.624 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.59 -167.69 0.16 Allowed Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.624 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.7 Cg_endo -71.83 -18.02 28.58 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 109.263 -1.091 . . . . 0.0 109.263 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -83.28 -44.91 14.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 108.569 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.612 HG13 ' CD1' ' A' ' 50' ' ' TYR . 4.1 mm -57.82 -54.57 29.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.512 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 9.7 tp60 -60.45 -20.86 61.35 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 tm-20 -73.67 -36.84 65.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.683 -1.26 . . . . 0.0 109.091 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.582 HD12 ' CE2' ' A' ' 60' ' ' TYR . 4.5 mt -65.95 -50.76 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.084 0.945 . . . . 0.0 108.967 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 45' ' ' LEU . 8.7 p -65.0 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 122.074 0.94 . . . . 0.0 109.708 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.566 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 31.6 t70 -70.26 -18.15 63.13 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.91 -17.68 27.54 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.591 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' A' ' 97' ' ' LEU . 30.9 m -107.54 -9.32 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -47.07 -46.13 53.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.912 -1.117 . . . . 0.0 109.947 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.3 Cg_endo -73.73 -29.89 10.11 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.442 1.428 . . . . 0.0 109.097 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' HD22 ' A' ' 110' ' ' LEU . 2.5 mt-30 -81.57 -2.22 49.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.595 HD22 ' CG ' ' A' ' 113' ' ' TYR . 4.6 mt -95.08 -41.39 9.14 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.542 -0.723 . . . . 0.0 109.503 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 10.5 mt-10 -75.29 -23.64 57.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.537 -0.727 . . . . 0.0 109.441 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -23.57 21.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.994 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.33 -6.43 34.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.703 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.591 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 1.4 t -127.58 -30.57 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.8 OUTLIER 91.98 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.403 0.621 . . . . 0.0 109.939 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 36' ' ' THR . 1.2 mm-40 -110.04 -176.56 3.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 0.0 109.363 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' TYR . 7.3 m -108.89 -24.45 11.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 95' ' ' MET . 20.5 m-85 34.31 -162.91 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.784 0.802 . . . . 0.0 111.088 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' A' ' 45' ' ' LEU . . . 175.26 -160.27 28.87 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -42.6 125.78 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -1.095 . . . . 0.0 109.275 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 68.1 mt -108.62 82.58 1.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.079 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 25.5 mt-10 -64.16 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.35 -0.844 . . . . 0.0 110.094 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.58 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -42.05 149.42 0.15 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.397 1.094 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.91 -44.46 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -152.69 168.89 24.17 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.612 ' CD1' HG13 ' A' ' 21' ' ' ILE . 17.5 p90 -166.0 144.53 5.84 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 111.284 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.553 ' CE ' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -109.14 165.7 11.4 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.62 141.71 29.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.501 ' HG3' ' OH ' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -117.55 162.87 17.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -117.59 135.17 58.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.162 -0.961 . . . . 0.0 110.035 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -158.74 -101.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.01 30.17 4.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.526 ' HA2' ' CD2' ' A' ' 102' A LEU . . . 156.77 -115.24 0.65 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 106.411 -2.676 . . . . 0.0 106.411 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.488 ' CB ' ' HE3' ' A' ' 101' ' ' LYS . 10.3 m -160.55 125.95 3.89 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.275 -1.132 . . . . 0.0 110.343 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.544 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 61.8 m-80 -78.0 -172.37 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.582 ' CE2' HD12 ' A' ' 24' ' ' ILE . 18.7 m-85 -150.4 154.37 37.63 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.439 1.114 . . . . 0.0 110.004 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 17.2 m-85 -152.73 130.83 11.88 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.577 HG13 ' C ' ' A' ' 61' ' ' TYR . 4.3 mt -146.39 118.53 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 117.133 -1.827 . . . . 0.0 112.073 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.596 ' HE3' ' CG ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -77.31 102.29 6.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 175.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.58 HG11 ' N ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -111.65 137.85 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.739 . . . . 0.0 110.807 -175.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.2 127.41 32.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 93' ' ' LYS . . . -80.45 36.71 0.38 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.557 0.694 . . . . 0.0 110.884 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.96 -75.78 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.596 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -79.85 47.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 113.165 -176.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 1.2 t-20 79.31 -38.75 0.2 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.93 -1.106 . . . . 0.0 111.739 177.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 2.8 mtmp? -66.99 144.57 56.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.581 -1.324 . . . . 0.0 107.469 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.596 ' CG ' ' HE3' ' A' ' 63' ' ' LYS . 15.3 m-30 -108.51 170.89 7.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.298 -0.877 . . . . 0.0 109.898 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -155.82 127.94 7.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.496 -0.752 . . . . 0.0 109.069 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.775 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -77.5 139.92 39.69 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.608 ' CD1' ' CD1' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -123.05 127.78 49.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 111.097 -179.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 4.4 ttmt -113.01 126.84 55.93 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.581 ' CG2' HG22 ' A' ' 24' ' ' ILE . 2.1 t -133.49 166.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.087 -1.008 . . . . 0.0 109.515 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.649 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 48.3 t80 -130.79 132.68 45.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.582 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -110.44 145.78 37.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.277 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.546 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -102.33 108.93 20.45 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.926 0.869 . . . . 0.0 108.782 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.694 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 1.3 pp -73.22 -21.99 0.48 Allowed Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 102' A LEU . 36.2 Cg_endo -81.72 113.29 2.51 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 120.929 1.086 . . . . 0.0 110.302 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.05 -130.85 9.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -129.95 -163.18 1.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.292 -1.122 . . . . 0.0 109.241 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' A ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.91 87.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.235 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -85.08 -179.0 6.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.244 -0.91 . . . . 0.0 109.246 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 108' ' ' LEU . 47.6 m-20 -79.43 100.54 7.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.356 -0.84 . . . . 0.0 110.234 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 5.6 mp -51.1 -177.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.217 1.008 . . . . 0.0 109.186 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.649 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 7.4 p -137.6 162.44 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.084 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.608 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 16.3 tp -102.28 89.07 3.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.2 p -68.5 -21.22 64.61 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.314 -0.866 . . . . 0.0 110.707 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . -179.7 -161.26 26.69 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.623 -1.751 . . . . 0.0 111.029 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.595 ' CG ' HD22 ' A' ' 32' ' ' LEU . 29.1 p90 170.08 133.48 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.745 -0.856 . . . . 0.0 108.968 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.18 107.84 20.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.544 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -66.75 158.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.582 -1.324 . . . . 0.0 111.239 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.9 t70 41.84 37.87 0.88 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.714 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.507 ' CE ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -81.06 -169.77 2.4 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.543 -1.348 . . . . 0.0 107.953 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 62.6 m-80 -148.07 -176.42 5.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.648 -1.283 . . . . 0.0 110.686 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 119' ' ' ASP . 1.3 ttmm -74.74 -46.22 38.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.63 -0.669 . . . . 0.0 109.464 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.5 t70 -47.61 -24.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.142 -0.974 . . . . 0.0 108.441 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 21.6 t0 -83.22 66.12 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.672 -0.643 . . . . 0.0 109.395 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.554 ' O ' ' C ' ' A' ' 122' ' ' LEU . 1.8 tt0 -61.35 103.27 0.29 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.786 -1.196 . . . . 0.0 108.052 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.775 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 3.4 mp -26.39 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.585 1.184 . . . . 0.0 110.256 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER -108.0 -7.91 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.066 -177.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.15 107.43 0.2 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.662 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.661 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 pt -146.38 85.97 7.12 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.958 . . . . 0.0 109.74 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.5 -65.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.687 2.258 . . . . 0.0 110.468 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.64 137.08 3.79 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 91.04 133.5 5.71 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER -40.37 115.55 0.57 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.608 -0.936 . . . . 0.0 110.935 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -101.51 171.22 7.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' SER . 12.7 tm-20 -43.53 166.97 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.281 -0.887 . . . . 0.0 109.347 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' N ' ' CD ' ' A' ' 13' ' ' GLU . . . -71.25 103.05 2.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -73.28 132.65 81.72 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 175.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.39 127.67 18.69 Favored 'Trans proline' 0 C--N 1.293 -2.352 0 N-CA-C 109.378 -1.047 . . . . 0.0 109.378 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.563 ' CB ' ' CB ' ' A' ' 47' ' ' ALA . . . -47.29 132.35 12.87 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.044 0.926 . . . . 0.0 111.909 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.588 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -102.56 -172.63 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.588 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.0 Cg_endo -68.08 -17.59 45.77 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 N-CA-C 109.545 -0.983 . . . . 0.0 109.545 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -81.79 -36.62 28.23 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.09 -1.006 . . . . 0.0 108.494 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.64 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 0.7 OUTLIER -68.84 -45.31 80.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.525 ' O ' HG11 ' A' ' 25' ' ' VAL . 11.0 tp60 -66.82 -18.92 65.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.73 -30.29 59.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.835 -1.166 . . . . 0.0 108.774 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.649 ' CD1' ' CD2' ' A' ' 60' ' ' TYR . 46.0 mt -71.61 -51.98 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.57 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 8.4 p -60.1 -42.89 91.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.879 0.847 . . . . 0.0 109.074 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.556 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 1.4 t70 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' GLU . 7.3 mttt -81.45 -6.85 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.626 ' CG2' ' CD2' ' A' ' 97' ' ' LEU . 6.4 m -127.05 -8.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.577 -0.702 . . . . 0.0 110.501 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 15.5 ttpp -41.66 -47.9 9.74 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.024 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.0 Cg_endo -72.87 -34.88 6.17 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.33 1.354 . . . . 0.0 109.655 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 43.1 mt-30 -74.6 -5.35 42.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.922 . . . . 0.0 108.513 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.563 ' HG ' ' CD2' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -100.84 -37.47 8.67 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.863 0.839 . . . . 0.0 109.048 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.1 mt-10 -54.07 -54.88 33.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.654 -0.654 . . . . 0.0 110.55 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.71 -35.78 57.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 110.491 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 1.3 mptp? -53.46 -56.73 14.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.222 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 38' ' ' GLU . 10.0 t -95.37 20.67 9.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER 41.32 39.83 1.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.328 -0.858 . . . . 0.0 110.001 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.6 tt0 -136.77 160.12 39.81 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.433 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -102.92 135.8 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.698 -1.251 . . . . 0.0 110.422 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.552 ' CE1' ' HG3' ' A' ' 95' ' ' MET . 98.5 m-85 -117.52 169.1 9.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.834 . . . . 0.0 109.296 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -125.88 -164.69 11.86 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.1 123.82 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -1.206 . . . . 0.0 108.595 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 39.1 mt -100.32 76.72 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.919 -1.113 . . . . 0.0 109.063 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -57.2 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.461 0.648 . . . . 0.0 109.777 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.563 ' CB ' ' CB ' ' A' ' 17' ' ' ALA . . . -42.82 133.67 3.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.117 0.96 . . . . 0.0 110.006 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.2 t -113.36 -41.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' CD ' ' HB2' ' A' ' 14' ' ' ALA . 16.6 mt-30 -146.55 171.26 15.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.006 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.609 ' CG ' HG13 ' A' ' 21' ' ' ILE . 1.9 p90 -167.6 141.43 3.53 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.38 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 1.1 mppp? -121.14 128.91 52.98 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.956 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.5 p -73.01 -172.07 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.967 -1.083 . . . . 0.0 109.703 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.637 ' CG ' ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -167.33 127.27 1.43 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 4.6 p -107.84 115.58 49.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -136.85 -104.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.65 29.55 4.05 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' A' ' 102' ' ' SER . . . 162.57 -116.73 0.73 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 11.5 m -158.61 113.49 2.55 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.218 -1.166 . . . . 0.0 110.113 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.583 ' OD1' ' CD1' ' A' ' 100' ' ' PHE . 54.8 m-20 -82.37 -173.13 4.39 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.836 0.827 . . . . 0.0 109.099 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.649 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 93.2 m-85 -137.49 152.0 49.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.637 ' CE1' ' CG ' ' A' ' 53' ' ' GLN . 4.5 m-85 -133.29 138.25 46.35 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.565 ' N ' HD23 ' A' ' 122' ' ' LEU . 13.0 mt -156.2 125.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 116.747 -1.981 . . . . 0.0 112.466 -175.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.56 ' HD2' ' NE2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -103.12 90.64 3.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.541 ' CG2' ' HB3' ' A' ' 45' ' ' LEU . 5.1 m -97.47 159.69 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.355 -0.84 . . . . 0.0 110.973 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -82.38 128.93 34.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.1 45.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.005 0.907 . . . . 0.0 109.377 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 86.23 -96.82 2.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 9.8 p-10 -58.83 -146.74 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.479 -1.012 . . . . 0.0 109.759 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.72 0.84 28.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.079 -1.013 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.58 175.72 6.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.265 -0.897 . . . . 0.0 109.238 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 21.7 m-85 -150.22 169.12 22.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 108.899 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.552 ' HG3' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -151.86 112.75 4.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.7 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -72.28 152.44 42.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.626 ' CD2' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -146.85 158.06 43.82 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.279 -1.368 . . . . 0.0 111.615 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 6.5 mtpt -141.3 114.03 8.37 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.627 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.3 t -118.8 168.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.746 -1.221 . . . . 0.0 110.358 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.608 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 1.2 t80 -130.59 122.66 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 108.708 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 4.9 tttt -113.73 19.88 16.35 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 122.935 1.35 . . . . 0.0 108.299 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 100' ' ' PHE . 7.0 t -103.63 -92.37 0.35 Allowed 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.792 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.494 ' HG ' ' OG ' ' A' ' 102' ' ' SER . 6.1 mt -96.4 108.99 45.43 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.586 -0.696 . . . . 0.0 109.621 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 102' ' ' SER . 36.2 Cg_endo -78.84 135.3 12.56 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.621 2.214 . . . . 0.0 110.582 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.74 -46.7 6.64 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.532 ' O ' ' CB ' ' A' ' 105' A ASN . 1.1 pt20 -170.58 162.81 8.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -1.107 . . . . 0.0 108.982 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' A ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 20.9 t-20 78.61 7.21 2.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.328 -0.857 . . . . 0.0 109.568 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 105' A ASN . 4.8 mm-40 46.32 -177.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.552 -0.717 . . . . 0.0 110.56 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER 64.36 163.06 0.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.399 -0.813 . . . . 0.0 109.769 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.585 HD22 ' CE1' ' A' ' 60' ' ' TYR . 6.2 mp -52.08 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.314 1.054 . . . . 0.0 109.788 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.608 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 7.1 p -143.9 163.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.798 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.563 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 6.4 tp -101.7 84.38 2.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.566 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 41.4 p -67.02 -19.82 65.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -176.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.464 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . 178.36 -170.24 42.24 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.442 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.3 p90 172.53 134.53 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.452 -1.029 . . . . 0.0 109.501 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.0 mm100 -96.85 103.25 15.15 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.476 HG22 ' OH ' ' A' ' 40' ' ' TYR . 2.2 p -66.79 154.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 122.254 1.026 . . . . 0.0 111.057 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 12.7 t0 47.29 33.01 2.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.952 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.499 ' HG2' ' ND1' ' A' ' 96' ' ' HIS . 5.6 tptt -77.84 162.62 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.446 -1.409 . . . . 0.0 108.461 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.433 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -107.88 160.76 15.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.93 -1.106 . . . . 0.0 109.911 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.504 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 3.0 ttpm? -55.47 -48.95 73.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.48 -38.44 9.22 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.335 -0.853 . . . . 0.0 109.126 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.613 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -66.27 96.31 0.34 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.325 -0.859 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.31 170.74 15.78 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.7 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 3.4 mp -93.16 25.4 3.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.411 -1.43 . . . . 0.0 109.202 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.532 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -17.14 -59.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.596 177.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.09 41.06 0.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CG ' ' OXT' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.57 0 CA-C-O 117.827 -1.083 . . . . 0.0 109.054 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.1 ttp . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.306 0.574 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.48 89.8 37.5 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.242 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.42 68.87 7.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.522 2.148 . . . . 0.0 110.507 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.29 171.19 42.11 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.552 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -133.5 6.93 4.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 123' ' ' THR . 0.2 OUTLIER -6.74 100.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.969 0.89 . . . . 0.0 112.867 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.493 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 23.0 t -102.2 169.56 8.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 12' ' ' SER . 42.4 tt0 -46.87 172.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.109 -0.995 . . . . 0.0 109.267 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . . . -81.65 107.25 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.956 -1.09 . . . . 0.0 110.228 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.649 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 1.1 mmtt -77.37 139.95 64.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.22 129.23 22.3 Favored 'Trans proline' 0 C--N 1.291 -2.476 0 N-CA-C 109.584 -0.968 . . . . 0.0 109.584 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -51.63 133.7 30.45 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.373 1.083 . . . . 0.0 111.788 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.619 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -109.33 -165.19 0.07 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -72.11 -16.52 28.62 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' HD13 ' A' ' 24' ' ' ILE . 7.5 pt-20 -81.53 -39.1 25.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.924 -1.11 . . . . 0.0 108.539 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.639 HG13 ' CD1' ' A' ' 50' ' ' TYR . 25.7 mm -67.39 -50.32 63.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.545 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -65.13 -15.04 61.97 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -77.37 -37.35 52.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.594 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 4.6 mt -63.9 -50.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.583 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 14.3 p -66.75 -40.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.099 0.952 . . . . 0.0 109.253 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.568 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 18.5 t0 -72.37 -15.08 61.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -92.91 -13.56 28.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 97' ' ' LEU . 31.6 m -116.86 -6.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.487 -0.758 . . . . 0.0 109.676 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -46.03 -48.55 41.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.894 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.8 Cg_endo -73.58 -29.19 11.13 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.575 1.517 . . . . 0.0 109.101 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' HD22 ' A' ' 110' ' ' LEU . 15.9 mt-30 -79.66 -4.77 53.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.543 ' O ' ' CG2' ' A' ' 36' ' ' THR . 2.3 mt -98.2 -41.34 7.94 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.657 0.741 . . . . 0.0 109.016 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -65.83 -22.58 66.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 110.453 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -36.45 12.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.955 -1.091 . . . . 0.0 110.206 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -53.68 10.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.043 . . . . 0.0 110.045 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 32' ' ' LEU . 10.0 t -78.76 6.6 8.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.737 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 3.5 p-10 42.93 42.95 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.715 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.552 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 7.9 tt0 -139.22 159.67 41.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.162 -0.962 . . . . 0.0 108.961 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.521 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -94.32 133.51 37.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 110.203 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.643 ' CD2' ' CE ' ' A' ' 95' ' ' MET . 21.1 m-85 -122.77 -168.51 1.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -144.25 -171.1 14.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.99 136.05 3.9 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.162 -1.199 . . . . 0.0 108.978 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 29.9 mt -107.89 85.18 2.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.044 -1.035 . . . . 0.0 108.901 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -68.64 84.47 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.697 -0.627 . . . . 0.0 109.534 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -43.6 129.5 5.33 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.211 1.005 . . . . 0.0 109.953 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.5 t -105.0 -46.26 9.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 1.8 mt-30 -146.92 167.23 24.47 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 3.8 p90 -161.1 137.51 8.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.565 -1.335 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 1.9 mttt -103.73 122.92 46.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 p -70.43 -173.67 0.75 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.688 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.6 OUTLIER -162.18 145.84 11.95 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.525 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -127.67 139.45 51.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.741 -1.224 . . . . 0.0 110.283 179.246 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.38 -100.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.22 29.6 5.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 157.72 -115.68 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 106.449 -2.66 . . . . 0.0 106.449 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 27.4 m -162.32 111.66 1.45 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.188 -1.184 . . . . 0.0 110.831 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.688 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 77.8 m-20 -77.92 -169.49 1.57 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.597 ' O ' ' CD1' ' A' ' 61' ' ' TYR . 25.2 m-85 -149.97 159.09 44.66 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.279 -0.888 . . . . 0.0 109.891 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.602 ' CE1' ' O ' ' A' ' 125' ' ' PHE . 22.9 m-85 -140.11 136.53 33.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.561 HG13 ' C ' ' A' ' 61' ' ' TYR . 14.4 mt -151.29 121.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 116.775 -1.97 . . . . 0.0 111.312 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.465 ' NZ ' HG12 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -86.92 94.77 9.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.553 HG11 ' CG2' ' A' ' 62' ' ' ILE . 6.6 m -102.01 141.66 17.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.566 -0.709 . . . . 0.0 110.943 -176.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -68.88 129.41 39.85 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.59 47.25 1.4 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.033 0.92 . . . . 0.0 108.744 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.56 -94.96 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.69 -164.74 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.333 -1.098 . . . . 0.0 109.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -64.0 -9.04 13.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 110.121 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -68.53 163.52 23.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 6.5 m-85 -133.32 176.6 8.38 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 108.707 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.643 ' CE ' ' CD2' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -157.32 108.76 2.34 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.176 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.757 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -69.58 144.49 53.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.579 HD21 ' HA ' ' A' ' 25' ' ' VAL . 46.3 tp -130.59 153.32 49.02 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.994 -1.066 . . . . 0.0 111.063 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.499 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 4.3 ttmt -139.01 111.09 7.31 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.594 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 1.9 t -117.44 161.14 16.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.688 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 3.2 t80 -127.36 127.92 45.03 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.702 -1.249 . . . . 0.0 107.815 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.487 ' HB3' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -103.4 141.09 36.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.266 -0.896 . . . . 0.0 108.721 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 102' A LEU . 1.1 t -101.58 104.53 15.41 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.517 -0.739 . . . . 0.0 109.153 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.557 ' O ' ' O ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -36.73 164.85 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.939 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.075 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 102' A LEU . 29.7 Cg_endo -69.63 127.02 14.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.369 2.046 . . . . 0.0 111.083 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.35 -23.94 0.76 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 105' A ASN . 0.0 OUTLIER -131.47 6.33 4.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.576 -0.955 . . . . 0.0 109.128 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' A ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 105' A ASN . 5.6 p-10 41.75 95.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.383 0.611 . . . . 0.0 110.397 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.528 ' CB ' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -125.21 178.72 5.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.232 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -127.61 51.55 1.92 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 7.3 mp 44.41 -177.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.42 1.105 . . . . 0.0 110.658 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.688 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.9 p -158.57 164.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.055 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 4.9 tp -97.47 83.13 3.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.481 ' OG1' ' HG2' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -71.94 -11.57 60.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 112.082 -176.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.511 ' O ' HD13 ' A' ' 110' ' ' LEU . . . 175.28 -171.91 45.0 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.575 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.578 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 20.8 p90 168.39 134.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.217 -1.167 . . . . 0.0 109.137 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -94.61 102.2 14.1 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.498 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 2.3 p -68.41 164.08 2.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.868 -1.145 . . . . 0.0 110.73 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.88 25.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.86 -0.525 . . . . 0.0 110.711 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.576 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.54 161.72 13.52 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 120.66 -1.275 . . . . 0.0 108.366 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 25.0 p-10 -140.4 -155.79 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.613 -1.305 . . . . 0.0 111.389 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -65.31 -48.46 73.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.27 0.557 . . . . 0.0 110.031 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 118' ' ' LYS . 2.9 t70 -41.05 -26.59 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 109.915 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.576 ' CB ' ' CD ' ' A' ' 116' ' ' LYS . 3.1 t70 -98.26 115.0 27.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 111.376 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.556 ' O ' ' CG2' ' A' ' 123' ' ' THR . 3.0 tt0 -75.07 146.89 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.757 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -66.59 -12.3 57.23 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.336 -1.477 . . . . 0.0 109.417 -178.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.609 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER 37.25 -156.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.44 177.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -83.93 49.58 4.26 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.267 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -110.09 174.47 2.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.326 -0.859 . . . . 0.0 109.019 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 7' ' ' ILE . 36.6 Cg_endo -80.6 30.44 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.584 2.189 . . . . 0.0 110.815 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.486 ' HA2' HG11 ' A' ' 54' ' ' VAL . . . 132.69 66.83 0.08 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.82 126.06 1.37 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.109 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.569 ' CD2' ' O ' ' A' ' 123' ' ' THR . 1.1 mp -50.6 143.7 9.02 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.668 -0.901 . . . . 0.0 111.125 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -101.59 171.44 7.56 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.67 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.99 -179.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.384 -0.823 . . . . 0.0 109.526 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.538 ' CB ' ' OE1' ' A' ' 49' ' ' GLN . . . -82.89 107.76 15.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.005 . . . . 0.0 110.003 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.669 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -83.4 128.78 62.99 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 175.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.87 130.78 23.9 Favored 'Trans proline' 0 C--N 1.294 -2.29 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -46.53 162.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.392 1.092 . . . . 0.0 111.552 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.61 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -143.31 -166.95 0.14 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.73 -18.28 28.74 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 N-CA-C 108.992 -1.195 . . . . 0.0 108.992 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.45 -45.57 14.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 0.0 108.567 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.637 HG13 ' CD1' ' A' ' 50' ' ' TYR . 3.6 mm -58.48 -53.16 50.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.37 -19.84 62.32 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 tm-20 -73.87 -35.73 64.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.428 -1.42 . . . . 0.0 108.505 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 5.1 mt -65.46 -51.22 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.75 0.786 . . . . 0.0 108.934 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.588 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 8.8 p -62.34 -41.99 93.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 122.054 0.931 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.562 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 6.3 t70 -69.95 -19.86 63.35 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.0 tttt -79.35 -20.7 47.13 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.571 HG22 ' CD1' ' A' ' 97' ' ' LEU . 17.6 m -117.83 3.1 7.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.732 -0.605 . . . . 0.0 109.938 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.578 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 14.7 tttp -47.91 -46.85 64.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.695 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.7 Cg_endo -75.34 -27.34 9.57 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.555 1.503 . . . . 0.0 109.028 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.524 ' O ' ' CD2' ' A' ' 110' ' ' LEU . 1.2 mt-30 -83.01 -1.03 51.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.597 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 2.5 mt -100.47 -33.48 10.33 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.676 0.75 . . . . 0.0 109.269 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 38' ' ' GLU . 2.4 mm-40 -73.89 -32.1 63.42 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.572 -0.705 . . . . 0.0 110.838 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -101.44 -4.43 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.355 -1.466 . . . . 0.0 112.009 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -99.95 -11.39 20.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.488 -1.383 . . . . 0.0 110.355 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.576 ' HB ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -140.11 -28.22 0.74 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.998 -1.064 . . . . 0.0 110.889 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.7 p30 149.11 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' GLU . 26.9 tt0 -66.38 105.09 1.36 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.234 1.016 . . . . 0.0 109.904 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 39' ' ' THR . 46.9 m -158.76 14.39 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.66 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.38 -175.53 2.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.048 -1.032 . . . . 0.0 109.171 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -145.72 -108.47 0.57 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -77.76 134.66 38.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -1.183 . . . . 0.0 108.811 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.588 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . 14.5 mt -108.16 83.47 1.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 108.511 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 3.7 mt-10 -71.87 85.5 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.708 -0.62 . . . . 0.0 109.961 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.547 ' N ' HG11 ' A' ' 64' ' ' VAL . . . -40.47 155.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 110.05 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.79 -41.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.538 ' OE1' ' CB ' ' A' ' 14' ' ' ALA . 25.1 tt0 -142.41 168.97 18.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.669 ' CE1' ' CB ' ' A' ' 15' ' ' LYS . 9.2 p90 -167.8 137.03 2.58 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.607 -1.308 . . . . 0.0 110.727 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 30.1 mttt -112.41 135.16 53.44 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.451 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 p -87.78 175.46 7.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.088 -1.008 . . . . 0.0 109.754 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.6 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -150.31 158.96 44.73 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG11 ' HA2' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -129.49 137.03 57.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.935 -1.103 . . . . 0.0 110.495 179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -164.46 -96.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.03 28.76 7.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.503 ' HA2' ' CD2' ' A' ' 102' A LEU . . . 161.44 -107.05 0.3 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 3.3 m -168.59 109.65 0.52 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.592 -0.946 . . . . 0.0 110.729 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.6 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 41.5 m-80 -70.26 -165.98 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CD2' HD12 ' A' ' 24' ' ' ILE . 64.6 m-85 -147.7 159.54 43.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.039 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.627 ' C ' HG13 ' A' ' 62' ' ' ILE . 47.6 m-85 -140.41 138.18 34.55 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.627 HG13 ' C ' ' A' ' 61' ' ' TYR . 24.9 mt -155.95 116.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 C-N-CA 116.873 -1.931 . . . . 0.0 111.495 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HE3' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -81.66 101.79 10.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.547 HG11 ' N ' ' A' ' 47' ' ' ALA . 11.5 t -113.7 139.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 112.319 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -69.36 121.29 16.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.457 ' HA ' HD21 ' A' ' 45' ' ' LEU . . . -82.64 43.0 0.8 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 111.83 -129.73 9.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 67' ' ' GLY . 34.9 t70 -51.4 -107.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.518 -0.989 . . . . 0.0 110.365 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.03 3.99 36.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.71 -1.244 . . . . 0.0 109.706 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 94' ' ' TYR . 13.1 tptt -68.53 157.37 36.14 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' CD ' ' A' ' 65' ' ' ARG . 2.3 m-85 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.975 -1.078 . . . . 0.0 109.595 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.526 ' CB ' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -163.46 133.66 4.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.572 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.633 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 5.7 m170 -69.98 161.14 30.61 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.597 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 2.8 tp -142.04 129.88 21.76 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.576 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.595 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ttmt -117.54 122.43 43.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.636 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.1 t -123.83 168.19 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.971 -1.081 . . . . 0.0 109.009 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.666 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 14.8 t80 -131.84 127.42 36.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.85 -1.156 . . . . 0.0 108.954 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.532 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -113.47 152.97 29.43 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -89.59 -140.83 0.14 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.81 -1.181 . . . . 0.0 109.575 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.719 ' HB2' ' CD ' ' A' ' 103' ' ' PRO . 13.7 mt -119.8 -87.75 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 111.412 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.719 ' CD ' ' HB2' ' A' ' 102' A LEU . 37.1 Cg_endo -74.79 3.83 5.16 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 121.401 1.401 . . . . 0.0 110.729 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 106' ' ' GLU . . . -83.65 69.81 3.29 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 105' A ASN . 1.6 mm100 -70.45 166.11 21.12 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.046 -1.267 . . . . 0.0 108.7 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' A ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' GLN . 1.5 t-20 43.59 27.61 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.362 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 104' ' ' GLY . 2.8 pt-20 -85.62 -173.34 4.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.858 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 108' ' ' LEU . 58.5 m-20 -108.86 91.42 3.63 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.588 -0.695 . . . . 0.0 109.22 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.514 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 7.5 mp -52.77 -172.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.21 1.005 . . . . 0.0 109.238 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.666 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 7.3 p -136.73 164.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.52 -177.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.561 ' HB2' ' CG1' ' A' ' 28' ' ' VAL . 7.1 tp -100.09 83.66 2.73 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 98' ' ' LYS . 1.2 p -67.72 -17.29 64.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 111.197 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . 176.32 -164.78 34.81 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.063 -1.541 . . . . 0.0 110.355 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.9 p90 165.99 137.17 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.686 -0.891 . . . . 0.0 109.099 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.61 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 8.6 mm-40 -99.0 94.51 6.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.526 ' HA ' ' CB ' ' A' ' 95' ' ' MET . 1.0 OUTLIER -67.64 157.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.029 -1.669 . . . . 0.0 110.241 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 7.8 t0 53.93 18.6 1.69 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.743 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -87.07 116.15 24.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.687 -1.258 . . . . 0.0 108.364 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.484 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 1.3 m120 -71.72 177.92 3.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.371 -0.831 . . . . 0.0 110.554 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -64.7 -24.22 67.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.62 -0.675 . . . . 0.0 110.066 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.64 -8.78 15.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.168 -0.957 . . . . 0.0 109.605 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.537 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -95.18 116.01 28.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.234 -0.916 . . . . 0.0 110.228 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.533 ' O ' ' CG2' ' A' ' 123' ' ' THR . 8.1 tt0 -86.95 139.31 30.73 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.633 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 3.1 mp -62.88 -46.97 85.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.775 -1.203 . . . . 0.0 109.256 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.569 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER 54.78 -157.55 0.21 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 107.331 178.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.54 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -77.98 66.45 3.11 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.631 ' CD1' ' O ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.72 -0.871 . . . . 0.0 109.934 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.9 mtt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.353 0.597 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 7' ' ' ILE . 3.0 tt 173.41 92.7 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.043 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.45 -92.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.523 2.149 . . . . 0.0 110.651 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.68 145.76 2.45 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -123.1 46.19 1.12 Allowed Glycine 0 N--CA 1.491 2.314 0 O-C-N 121.09 -1.241 . . . . 0.0 110.254 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.634 ' CD1' ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -37.46 120.32 0.78 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.83 0.824 . . . . 0.0 110.617 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -100.97 170.96 7.93 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.457 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 1.0 OUTLIER -49.04 -179.38 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 0.0 109.836 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HB2' ' NE2' ' A' ' 49' ' ' GLN . . . -81.2 99.04 8.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 110.25 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.608 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 2.2 mmpt? -70.42 128.42 91.25 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.61 126.3 14.57 Favored 'Trans proline' 0 C--N 1.292 -2.414 0 N-CA-C 108.813 -1.264 . . . . 0.0 108.813 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 21' ' ' ILE . . . -37.41 162.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.495 1.14 . . . . 0.0 111.794 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.627 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -145.6 -166.17 0.12 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -72.9 -21.09 21.51 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.503 -1.384 . . . . 0.0 108.503 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -81.3 -44.92 16.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -0.969 . . . . 0.0 108.811 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 50' ' ' TYR . 4.4 mm -58.7 -56.18 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.482 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 15.2 tp60 -57.5 -20.09 29.01 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.3 tt0 -75.13 -39.17 60.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.339 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.616 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 2.2 mt -63.76 -49.63 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.043 0.925 . . . . 0.0 108.77 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.586 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 12.4 p -66.82 -40.57 86.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 122.307 1.051 . . . . 0.0 109.401 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 19.3 t0 -75.46 -13.35 60.38 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -95.43 -10.1 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.925 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.558 HG22 ' CD1' ' A' ' 97' ' ' LEU . 27.0 m -114.59 -15.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 110.981 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 ttpt -37.95 -51.07 3.08 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.035 -1.041 . . . . 0.0 110.911 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.5 Cg_endo -70.5 -35.9 9.72 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.421 1.414 . . . . 0.0 109.413 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.434 ' O ' HD22 ' A' ' 110' ' ' LEU . 28.6 mt-30 -71.76 -6.44 41.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 40' ' ' TYR . 2.6 mt -96.79 -41.97 8.21 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 13.9 mt-10 -66.84 -8.99 32.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -0.808 . . . . 0.0 109.182 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.34 -56.4 2.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -48.56 20.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 109.958 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -79.39 -14.56 58.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.06 -1.025 . . . . 0.0 108.973 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 1.4 p-10 44.97 64.84 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.417 0.627 . . . . 0.0 109.907 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.574 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 9.1 mt-10 -130.77 -177.74 4.49 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.3 m -98.8 -26.69 14.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.574 ' CE1' ' OE1' ' A' ' 38' ' ' GLU . 19.6 m-85 35.45 -161.84 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.809 0.814 . . . . 0.0 110.529 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' O ' HD22 ' A' ' 45' ' ' LEU . . . 179.26 -169.83 41.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.65 129.7 3.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -1.093 . . . . 0.0 108.793 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 44.2 mt -109.48 82.98 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.846 -1.158 . . . . 0.0 109.301 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -63.74 84.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.522 -0.737 . . . . 0.0 109.932 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.551 ' HA ' ' CG1' ' A' ' 64' ' ' VAL . . . -43.68 123.29 3.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.145 0.974 . . . . 0.0 109.966 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.2 t -99.51 -47.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.524 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 4.7 mm100 -145.18 172.58 12.91 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.618 ' CD1' HG13 ' A' ' 21' ' ' ILE . 17.2 p90 -166.89 137.08 3.08 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.061 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.527 ' CD ' ' HB2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.13 133.75 54.88 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.915 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.6 p -76.73 -176.87 4.02 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.273 -0.892 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.601 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 1.3 mm-40 -160.32 149.22 17.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.581 -0.699 . . . . 0.0 109.323 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.486 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -120.48 141.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 110.576 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.25 -103.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.1 30.58 3.71 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.481 ' HA2' ' CD2' ' A' ' 102' A LEU . . . 154.07 -118.19 0.85 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 106.178 -2.769 . . . . 0.0 106.178 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 11.4 m -154.38 116.66 4.29 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.332 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.601 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 64.8 m-20 -77.72 -166.03 0.71 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.64 ' CE1' ' HB2' ' A' ' 101' ' ' LYS . 85.1 m-85 -147.34 153.14 39.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.617 ' CE1' ' OXT' ' A' ' 125' ' ' PHE . 16.0 m-30 -136.94 132.32 34.25 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.555 HG13 ' C ' ' A' ' 61' ' ' TYR . 13.6 mt -148.97 124.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 117.06 -1.856 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.524 ' CG ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -95.78 94.66 7.8 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 176.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.551 ' CG1' ' HA ' ' A' ' 47' ' ' ALA . 15.7 m -99.4 144.88 11.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.274 0.559 . . . . 0.0 110.642 -176.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.1 mmm-85 -69.24 125.41 26.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 93' ' ' LYS . . . -86.26 46.59 1.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.072 0.939 . . . . 0.0 108.904 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 -85.23 1.39 Allowed Glycine 0 C--N 1.287 -2.167 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.39 -168.67 1.2 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.203 -1.175 . . . . 0.0 109.87 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.13 7.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -69.21 127.02 31.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 108.798 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.583 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 5.6 m-30 -97.39 -179.12 4.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.096 -1.003 . . . . 0.0 110.324 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.567 ' SD ' ' CD1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -148.0 99.93 3.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.514 -0.741 . . . . 0.0 109.569 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.727 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -71.71 146.96 47.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' CD1' HG22 ' A' ' 28' ' ' VAL . 4.7 tp -138.21 139.26 39.2 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.371 -1.331 . . . . 0.0 111.531 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 9.6 ttpp -122.92 94.28 4.22 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.616 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.3 t -97.25 164.58 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.708 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 7.1 t80 -119.25 138.5 52.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.661 -1.274 . . . . 0.0 108.298 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.64 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -100.65 135.76 41.59 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.778 0.799 . . . . 0.0 109.064 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.498 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -103.29 94.67 5.63 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.053 178.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -41.49 -49.27 9.48 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.688 -0.633 . . . . 0.0 110.537 -179.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 102' A LEU . 35.1 Cg_endo -77.62 106.09 2.14 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.954 1.769 . . . . 0.0 110.446 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.4 137.51 2.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 105' A ASN . 4.3 mm-40 -77.75 -111.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.38 -1.071 . . . . 0.0 109.349 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' A ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 105' ' ' GLN . 5.8 t-20 -39.38 150.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 109.769 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.34 145.1 2.54 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.711 0.767 . . . . 0.0 110.499 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -158.52 44.54 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 3.0 mp -68.54 -175.28 0.64 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 122.373 1.082 . . . . 0.0 110.381 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.708 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 11.8 p -147.89 162.19 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.627 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 8.0 tp -98.05 89.23 4.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.493 HG22 ' HB2' ' A' ' 100' ' ' PHE . 4.4 p -82.12 -11.98 58.45 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.901 -1.124 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.534 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . -175.01 -168.98 36.35 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 27.0 p90 164.84 139.29 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.578 -0.954 . . . . 0.0 109.26 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.604 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.4 mm100 -102.31 97.82 8.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.467 HG22 ' OE2' ' A' ' 38' ' ' GLU . 2.0 p -66.85 164.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 110.354 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' A ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 115' ' ' VAL . 35.1 t0 43.46 24.75 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.115 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.613 ' HE3' ' CD2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -69.45 155.35 40.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.702 -1.249 . . . . 0.0 108.284 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.518 ' N ' ' HG2' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -107.9 -174.91 2.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -70.21 -38.78 75.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.813 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.96 -8.07 20.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.984 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.531 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 5.3 t0 -75.19 91.41 2.62 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.042 -1.036 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -64.4 155.1 33.56 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.727 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -90.13 55.65 3.16 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.667 1.222 . . . . 0.0 109.575 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -46.85 -172.09 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.291 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.634 ' HA2' ' CD1' ' A' ' 11' ' ' LEU . . . -45.09 -16.08 0.07 OUTLIER Glycine 0 N--CA 1.503 3.142 0 O-C-N 121.025 -1.047 . . . . 0.0 110.548 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.617 ' OXT' ' CE1' ' A' ' 61' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.685 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.798 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.8 tpp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 mt 48.05 71.32 1.63 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.333 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.9 82.99 2.35 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.749 2.3 . . . . 0.0 111.107 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.512 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . 68.48 123.42 0.03 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' C ' ' NE2' ' A' ' 53' ' ' GLN . . . -176.76 157.01 21.94 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.561 ' CD2' ' HA2' ' A' ' 124' ' ' GLY . 1.2 pt? -107.04 149.45 27.56 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.128 -1.219 . . . . 0.0 109.027 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' GLU . 42.4 m -100.52 179.8 4.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 110.829 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tt0 -49.87 -176.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.674 -0.641 . . . . 0.0 109.992 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 49' ' ' GLN . . . -91.38 100.55 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -68.06 146.58 98.22 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 175.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.12 129.63 20.99 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 N-CA-C 108.885 -1.237 . . . . 0.0 108.885 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -37.36 159.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.282 1.039 . . . . 0.0 111.346 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.607 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -139.41 -166.52 0.12 Allowed Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 18' ' ' THR . 30.3 Cg_endo -73.65 -17.62 23.1 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 108.693 -1.311 . . . . 0.0 108.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 24' ' ' ILE . 15.6 mt-10 -85.68 -39.95 16.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.607 HG13 ' CD1' ' A' ' 50' ' ' TYR . 6.2 mm -65.17 -53.72 37.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.545 ' NE2' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -57.95 -26.0 61.69 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.297 178.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 60.6 tt0 -76.91 -41.12 44.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 109.54 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.611 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 5.8 mt -56.48 -53.65 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 122.319 1.057 . . . . 0.0 108.271 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.568 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . 11.7 p -66.05 -40.69 87.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.615 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.565 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 1.8 t70 -70.39 -10.53 59.33 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -99.26 -20.2 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.557 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.537 HG22 ' CD1' ' A' ' 97' ' ' LEU . 16.1 m -110.41 -4.94 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -44.72 -47.6 28.26 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.003 -1.06 . . . . 0.0 110.133 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -32.4 9.75 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.36 1.374 . . . . 0.0 109.421 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 21.0 mt-30 -79.77 -1.39 38.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.493 ' CD1' ' HE2' ' A' ' 95' ' ' MET . 4.2 mt -95.85 -38.48 10.27 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.572 -0.705 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 3.3 mt-10 -66.11 -43.78 86.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.424 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -84.34 -11.29 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -0.967 . . . . 0.0 110.976 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -91.84 -12.21 34.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.76 -1.213 . . . . 0.0 110.451 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.618 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 6.2 t -122.82 -31.36 3.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.847 -1.158 . . . . 0.0 110.075 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER 101.83 8.82 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.349 0.595 . . . . 0.0 109.724 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.587 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 2.0 tt0 -117.03 152.92 33.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.468 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -102.29 121.26 41.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 0.0 110.689 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.587 ' CE1' ' HG2' ' A' ' 38' ' ' GLU . 11.0 m-85 -110.93 -175.97 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.513 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -139.56 -156.43 6.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -38.35 132.17 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.529 -0.983 . . . . 0.0 109.763 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 65.8 mt -112.89 91.49 3.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.085 -1.009 . . . . 0.0 109.064 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.31 90.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -47.65 125.05 7.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.219 1.009 . . . . 0.0 110.142 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.4 t -97.63 -45.72 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.529 ' CG ' ' HB3' ' A' ' 63' ' ' LYS . 12.8 pt20 -150.91 171.33 17.43 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.607 ' CD1' HG13 ' A' ' 21' ' ' ILE . 8.9 p90 -165.42 139.73 4.8 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.858 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 61.8 mttt -109.39 123.43 49.32 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 p -73.19 -175.97 2.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.601 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 1.1 tm0? -161.85 152.36 17.42 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG13 ' HA2' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -126.36 140.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 110.084 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.33 -102.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.59 30.53 3.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.477 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 157.08 -108.84 0.38 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.749 -2.54 . . . . 0.0 106.749 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 26.8 m -167.82 109.2 0.59 Allowed 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.619 -0.93 . . . . 0.0 110.61 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.611 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 65.6 m-20 -69.93 -172.96 0.58 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 20.4 m-85 -144.72 145.79 31.87 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.615 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 1.4 m-85 -128.68 133.67 48.27 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.585 HG13 ' C ' ' A' ' 61' ' ' TYR . 32.0 mt -150.99 121.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 116.423 -2.111 . . . . 0.0 112.021 -176.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.13 96.97 10.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 176.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.531 ' CG1' HG23 ' A' ' 62' ' ' ILE . 6.3 m -105.98 140.3 24.5 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 O-C-N 121.174 -0.954 . . . . 0.0 111.561 -175.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.579 ' HA ' ' CD1' ' A' ' 94' ' ' TYR . 1.2 mtm-85 -68.51 133.87 49.22 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 93' ' ' LYS . . . -85.12 42.81 0.96 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.793 0.806 . . . . 0.0 109.175 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 73.35 -81.33 0.71 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 7.0 m-20 -55.13 -113.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -1.033 . . . . 0.0 110.496 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.05 -30.91 4.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.747 -1.22 . . . . 0.0 109.293 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 29.7 mtmt -68.73 144.58 54.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.579 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 15.7 m-30 -109.81 176.99 4.86 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.116 -0.99 . . . . 0.0 109.023 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.559 ' CA ' ' HD2' ' A' ' 116' ' ' LYS . 20.2 ttp -144.65 119.92 10.2 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.007 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.779 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -69.17 151.13 46.72 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.568 ' CD2' ' HA ' ' A' ' 25' ' ' VAL . 13.3 tp -130.71 142.04 50.41 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.118 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.615 ' HE2' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -131.0 95.79 3.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.611 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.2 t -105.42 161.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.197 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.676 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.0 t80 -126.54 129.71 49.14 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.636 -1.29 . . . . 0.0 108.483 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.554 ' HG2' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -98.97 115.71 29.54 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 102' A LEU . 28.8 m -102.11 47.62 0.89 Allowed 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.202 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.517 ' C ' ' O ' ' A' ' 102' ' ' SER . 0.5 OUTLIER 31.02 63.32 1.03 Allowed Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.767 -0.583 . . . . 0.0 110.287 179.31 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 102' A LEU . 36.5 Cg_endo -77.56 -167.55 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.794 2.329 . . . . 0.0 111.534 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.95 -35.24 0.06 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.2 -179.1 5.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.624 -0.927 . . . . 0.0 108.873 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' A ASN . . . . . . . . . . . . . 1.6 t-20 53.1 -146.03 0.55 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 109.737 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.458 ' O ' ' OD1' ' A' ' 107' ' ' ASP . 0.7 OUTLIER -71.88 -179.58 2.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.102 -0.999 . . . . 0.0 109.785 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -151.72 140.55 20.94 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.351 -0.843 . . . . 0.0 110.146 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.554 ' CD1' ' HG2' ' A' ' 101' ' ' LYS . 10.4 mp 55.6 175.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.72 1.247 . . . . 0.0 111.05 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.676 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.9 p -152.37 163.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.742 -177.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 9.0 tp -100.43 83.41 2.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' LYS . 0.9 OUTLIER -69.26 -10.51 58.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 111.735 -176.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.532 ' CA ' ' HB3' ' A' ' 98' ' ' LYS . . . 171.35 -165.4 38.42 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.612 -1.756 . . . . 0.0 111.157 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 30.2 p90 165.73 143.47 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.627 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.9 mm100 -105.26 103.6 13.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.629 -1.294 . . . . 0.0 107.662 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.441 HG22 ' OH ' ' A' ' 40' ' ' TYR . 1.3 p -68.61 162.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.71 -1.244 . . . . 0.0 111.162 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.1 t0 51.78 20.34 1.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.603 ' HG3' ' OD2' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -74.32 161.67 29.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.81 -1.181 . . . . 0.0 108.293 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 1.1 m120 -152.68 -167.73 2.83 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.199 -1.563 . . . . 0.0 112.752 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -36.7 -38.34 0.17 Allowed 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.196 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.43 53.27 2.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.718 ' CG ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -92.91 108.59 20.12 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.85 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.562 ' O ' ' CG2' ' A' ' 123' ' ' THR . 1.9 tt0 -102.29 105.49 16.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.779 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.8 OUTLIER -69.07 -28.86 66.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.364 -1.46 . . . . 0.0 107.841 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER 39.9 -160.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.758 0.789 . . . . 0.0 110.55 176.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.566 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -69.71 -0.35 24.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.627 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.33 -1.1 . . . . 0.0 109.01 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.6 ttm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.449 ' CG2' ' HD2' ' A' ' 8' ' ' PRO . 10.7 mm -67.96 138.83 92.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 109.485 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 36.2 Cg_endo -79.02 -85.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.375 2.05 . . . . 0.0 110.107 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.54 -5.54 62.48 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' HA3' ' NE2' ' A' ' 53' ' ' GLN . . . -77.73 -162.98 19.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.506 HD13 ' NE2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER 39.98 71.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.654 1.216 . . . . 0.0 110.647 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -103.28 -176.37 3.07 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.558 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' SER . 7.5 tt0 -50.3 -179.85 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.125 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' CB ' ' NE2' ' A' ' 49' ' ' GLN . . . -81.1 104.92 11.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.59 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -74.83 133.44 76.22 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.47 130.2 21.8 Favored 'Trans proline' 0 C--N 1.292 -2.397 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.557 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -40.94 167.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.422 1.106 . . . . 0.0 111.786 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.607 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -149.88 -165.53 0.11 Allowed Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 18' ' ' THR . 30.1 Cg_endo -73.37 -19.05 22.58 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 108.581 -1.354 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.23 -45.87 13.35 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.153 -0.967 . . . . 0.0 108.572 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 50' ' ' TYR . 3.2 mm -58.03 -54.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.507 ' NE2' HG12 ' A' ' 25' ' ' VAL . 34.1 tp60 -58.97 -21.66 58.96 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.7 tt0 -75.14 -41.33 58.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 109.061 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.614 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.6 mt -60.5 -50.03 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.989 0.9 . . . . 0.0 108.791 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.682 ' HA ' HD23 ' A' ' 97' ' ' LEU . 11.1 p -65.03 -40.84 90.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 122.134 0.969 . . . . 0.0 108.893 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.56 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 43.8 t0 -71.45 -13.24 61.76 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.7 mmtt -96.03 -11.26 26.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.594 HG22 ' CD1' ' A' ' 97' ' ' LEU . 16.9 m -121.88 -4.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 0.0 110.995 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.564 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 13.3 ttpt -47.95 -45.59 62.72 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.927 -1.108 . . . . 0.0 111.035 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.83 -36.89 4.19 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.473 1.449 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.1 mt-30 -71.52 -7.32 46.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.542 HD23 ' CG ' ' A' ' 113' ' ' TYR . 8.8 mt -100.89 -34.86 9.62 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.612 -0.68 . . . . 0.0 109.867 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 20.2 mt-10 -52.6 -48.83 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.139 -0.976 . . . . 0.0 109.814 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' OE1' ' CA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -86.71 -44.75 11.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.322 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 5.3 mmtt -42.81 -27.0 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 67.5 p -104.48 -72.57 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.953 . . . . 0.0 110.003 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.0 p30 149.55 38.3 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -164.23 -177.99 5.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.327 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.471 HG21 ' OE2' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -114.96 125.23 53.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 110.296 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 10.8 m-85 -103.12 169.5 8.52 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.468 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -129.25 -150.99 7.23 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.811 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.99 119.81 1.62 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.486 -1.008 . . . . 0.0 109.022 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 62.8 mt -99.54 86.45 3.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.964 -1.085 . . . . 0.0 108.497 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.206 0.526 . . . . 0.0 110.332 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.557 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -47.28 115.28 1.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.054 -1.029 . . . . 0.0 109.493 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 49' ' ' GLN . 1.5 t -94.08 -46.34 13.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.587 ' NE2' ' CB ' ' A' ' 14' ' ' ALA . 5.8 mt-30 -146.26 173.55 12.14 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.169 -1.013 . . . . 0.0 108.964 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.618 ' CD1' HG13 ' A' ' 21' ' ' ILE . 18.1 p90 -168.34 138.15 2.48 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.946 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -106.08 130.44 53.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 p -83.27 -174.01 5.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.38 -0.825 . . . . 0.0 110.786 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 59' ' ' ASN . 0.1 OUTLIER -164.69 152.1 11.51 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -125.77 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.941 -1.099 . . . . 0.0 110.594 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -165.46 -102.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.11 30.42 5.6 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 160.71 -109.27 0.39 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.53 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 8.4 m -167.28 112.21 0.72 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.418 -1.048 . . . . 0.0 110.856 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 53' ' ' GLN . 45.6 m-80 -72.38 -165.95 0.23 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CD1' HG11 ' A' ' 99' ' ' VAL . 44.7 m-85 -156.02 160.23 39.84 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.672 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.619 ' CE1' ' CB ' ' A' ' 125' ' ' PHE . 26.7 m-85 -144.45 134.85 24.49 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.563 HG13 ' C ' ' A' ' 61' ' ' TYR . 15.3 mt -151.41 125.26 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 116.828 -1.949 . . . . 0.0 111.405 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.543 ' CD ' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -94.6 91.25 6.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.535 HG11 ' CG2' ' A' ' 62' ' ' ILE . 34.4 m -98.77 140.43 18.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 O-C-N 121.857 -0.527 . . . . 0.0 110.317 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.598 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 ttp180 -68.12 138.3 55.61 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.702 -1.249 . . . . 0.0 107.943 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.2 46.63 1.4 Allowed 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 122.269 1.033 . . . . 0.0 108.412 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.54 -77.93 1.69 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.46 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 3.8 t0 -61.1 -155.77 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.274 -1.133 . . . . 0.0 109.236 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -83.22 -3.67 57.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 109.366 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.575 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -75.31 178.48 5.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.21 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.598 ' CD2' ' HA ' ' A' ' 65' ' ' ARG . 33.7 m-85 -150.76 165.89 32.11 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.038 -1.039 . . . . 0.0 109.55 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.467 ' HG2' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -146.41 126.07 13.38 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 108.703 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.701 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.7 m170 -74.76 151.3 39.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 25' ' ' VAL . 15.6 tp -138.48 133.75 33.1 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.852 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.532 ' CD ' ' OG1' ' A' ' 111' ' ' THR . 0.1 OUTLIER -115.6 124.17 50.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.614 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.2 t -129.42 166.53 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.612 -1.305 . . . . 0.0 108.698 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.8 t80 -131.06 136.0 48.06 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.844 -1.16 . . . . 0.0 109.195 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HG3' ' OH ' ' A' ' 60' ' ' TYR . 6.1 tttt -102.96 108.79 20.11 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.47 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 91.4 p -102.42 87.59 3.06 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 121.419 0.628 . . . . 0.0 109.478 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.579 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -45.03 -49.15 30.39 Favored Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.413 -0.804 . . . . 0.0 109.935 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' A LEU . 35.8 Cg_endo -78.41 164.84 26.02 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.356 2.037 . . . . 0.0 110.843 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 106' ' ' GLU . . . 108.83 46.84 0.93 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 55.08 -178.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -1.159 . . . . 0.0 109.515 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' A ASN . . . . . . . . . . . . . 1.2 m-20 -69.92 86.11 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 104' ' ' GLY . 6.7 mm-40 -120.41 -176.13 3.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -0.909 . . . . 0.0 109.573 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.01 176.49 6.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.296 -0.877 . . . . 0.0 110.086 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.446 ' CD1' ' HG2' ' A' ' 101' ' ' LYS . 10.6 mp -55.92 -172.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.36 1.076 . . . . 0.0 110.89 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 8.3 p -145.45 164.56 11.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.499 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 9.1 tp -102.35 86.88 2.9 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.532 ' OG1' ' CD ' ' A' ' 98' ' ' LYS . 2.2 p -70.38 -29.82 66.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 0.0 111.625 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . -165.88 -162.85 18.14 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.865 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 19.1 p90 165.77 134.68 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.357 -1.084 . . . . 0.0 109.168 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.628 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 2.9 mm-40 -97.51 102.14 13.83 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.467 ' HA ' ' HG2' ' A' ' 95' ' ' MET . 0.6 OUTLIER -68.17 159.3 5.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.683 -1.26 . . . . 0.0 111.349 -177.236 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.7 t0 48.73 31.44 3.07 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.525 ' HD3' ' CB ' ' A' ' 114' ' ' GLN . 2.5 mptt -93.95 114.34 26.53 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 13.0 m-80 -69.11 -169.18 0.17 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.867 . . . . 0.0 110.062 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -44.45 40.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.454 -0.779 . . . . 0.0 109.442 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -50.9 -21.09 1.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.437 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -73.12 127.3 32.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.146 -0.971 . . . . 0.0 110.05 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.54 ' O ' ' CG2' ' A' ' 123' ' ' THR . 22.4 tt0 -93.63 136.12 34.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.701 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.5 mp -64.2 -32.12 73.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 108.664 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.553 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER 43.81 -160.31 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.136 178.083 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.553 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -62.36 89.2 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.628 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.419 ' O ' HG22 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -164.52 83.11 1.24 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.431 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 54' ' ' VAL . 36.2 Cg_endo -78.39 -172.37 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.597 2.198 . . . . 0.0 110.289 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.532 ' CA ' HG11 ' A' ' 54' ' ' VAL . . . 137.52 133.25 3.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.45 114.61 0.77 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.586 HD23 ' CE2' ' A' ' 61' ' ' TYR . 0.9 OUTLIER -55.61 138.26 47.36 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.949 0.88 . . . . 0.0 111.28 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.9 m -101.73 167.81 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.0 tt0 -49.28 179.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.319 -0.863 . . . . 0.0 109.458 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.527 ' CB ' ' OE1' ' A' ' 49' ' ' GLN . . . -73.3 96.21 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 0.0 110.297 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.588 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 3.1 mmpt? -69.66 131.82 89.46 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.93 124.89 13.31 Favored 'Trans proline' 0 C--N 1.291 -2.466 0 N-CA-C 109.164 -1.129 . . . . 0.0 109.164 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -47.59 123.29 5.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.902 0.858 . . . . 0.0 111.763 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.599 ' OG1' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -95.69 -172.75 0.3 Allowed Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.373 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 27.8 Cg_endo -67.82 -20.06 46.12 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 N-CA-C 109.786 -0.89 . . . . 0.0 109.786 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -81.58 -34.76 30.83 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.981 -1.074 . . . . 0.0 108.777 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.652 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -69.28 -46.8 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -69.57 -13.44 62.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.2 tt0 -76.56 -40.16 50.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.629 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 5.3 mt -60.76 -51.5 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 26' ' ' ASP . 12.4 p -64.38 -42.06 94.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.981 0.895 . . . . 0.0 108.81 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.568 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 43.3 t0 -68.84 -14.92 63.33 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -93.37 -15.16 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.198 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.558 HG22 ' CD1' ' A' ' 97' ' ' LEU . 31.6 m -119.85 -0.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.872 . . . . 0.0 110.557 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 7.7 ttpp -50.82 -44.62 85.84 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.847 -1.158 . . . . 0.0 110.361 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 29' ' ' LYS . 32.3 Cg_endo -73.86 -34.23 5.5 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.155 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.8 mt-30 -74.52 -5.52 43.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.61 HD22 ' CG ' ' A' ' 113' ' ' TYR . 0.3 OUTLIER -100.43 -35.84 9.43 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.519 -0.738 . . . . 0.0 109.488 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -72.37 -29.33 63.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.462 -0.774 . . . . 0.0 110.881 -179.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.43 -17.73 17.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.889 -1.132 . . . . 0.0 110.464 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 22.8 ttmt -78.34 -61.74 1.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.995 -1.066 . . . . 0.0 109.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -72.98 -19.33 61.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.846 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.5 OUTLIER 85.75 11.83 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.65 -0.657 . . . . 0.0 109.517 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.522 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 7.9 tt0 -109.17 138.86 44.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.401 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -76.44 125.63 29.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.124 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.522 ' CE1' ' HG2' ' A' ' 38' ' ' GLU . 31.9 m-85 -112.77 179.76 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 108.948 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.456 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -144.68 -164.43 10.56 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.05 123.78 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -1.111 . . . . 0.0 108.836 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 46.3 mt -102.49 91.37 4.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.849 -1.157 . . . . 0.0 108.372 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -72.01 82.85 0.96 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 17' ' ' ALA . . . -40.17 134.68 1.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.116 0.96 . . . . 0.0 110.005 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 2.0 t -118.45 -42.14 2.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.527 ' OE1' ' CB ' ' A' ' 14' ' ' ALA . 2.4 mt-30 -142.72 171.71 13.69 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.602 ' CD1' HG12 ' A' ' 21' ' ' ILE . 18.4 p90 -170.82 136.48 1.17 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 3.8 mttt -109.11 157.41 18.76 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.353 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.93 140.2 38.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.373 -0.829 . . . . 0.0 109.162 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.567 ' HG2' ' CE1' ' A' ' 61' ' ' TYR . 0.9 OUTLIER -138.29 174.31 10.69 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.561 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.532 HG11 ' CA ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -113.4 158.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.718 -1.239 . . . . 0.0 110.933 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.67 -101.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.476 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 27.26 6.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.53 ' HA2' HD12 ' A' ' 102' A LEU . . . 153.69 -119.94 0.99 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 106.202 -2.759 . . . . 0.0 106.202 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.482 HG21 ' O ' ' A' ' 53' ' ' GLN . 19.1 m -151.68 109.31 3.63 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.038 -1.272 . . . . 0.0 110.542 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.611 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 64.4 m-80 -72.85 -171.09 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.2 m-85 -144.44 158.63 43.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.918 0.866 . . . . 0.0 108.988 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' CE2' ' O ' ' A' ' 125' ' ' PHE . 2.1 m-85 -138.73 139.99 38.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.596 ' N ' HD23 ' A' ' 122' ' ' LEU . 13.2 mt -154.7 123.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 116.72 -1.992 . . . . 0.0 112.06 -176.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HE3' ' CA ' ' A' ' 118' ' ' LYS . 15.9 tttt -93.06 92.44 7.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 47' ' ' ALA . 6.1 m -98.91 143.27 13.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.587 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 3.9 mtm180 -67.67 131.28 45.3 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.35 44.65 1.11 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.986 0.898 . . . . 0.0 109.445 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 96.69 -113.12 4.6 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.5 p30 -49.84 -104.43 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -1.031 . . . . 0.0 110.655 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -119.66 -1.9 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.945 -1.097 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -68.47 -177.93 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 8.2 m-85 -146.12 166.82 25.02 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.879 -1.138 . . . . 0.0 109.727 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.478 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 49.0 ttp -151.73 111.31 3.98 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.485 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.734 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -69.6 147.6 50.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.125 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' CD1' HG22 ' A' ' 28' ' ' VAL . 13.2 tp -128.52 153.02 47.61 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.246 -0.909 . . . . 0.0 110.71 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 2.6 tttm -143.09 102.32 3.98 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.629 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.1 t -112.95 160.39 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.762 -1.211 . . . . 0.0 109.404 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.689 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.3 t80 -120.37 137.9 54.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.47 -1.394 . . . . 0.0 108.408 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HB2' ' OH ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -110.91 138.5 47.23 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.015 0.912 . . . . 0.0 109.317 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 102' ' ' SER . 22.0 p -103.51 93.41 4.93 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.565 ' CD1' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -38.61 -52.7 3.45 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.757 -0.589 . . . . 0.0 110.53 -179.148 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.565 ' HD3' ' CD1' ' A' ' 102' A LEU . 36.6 Cg_endo -78.43 -173.06 1.69 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.427 2.085 . . . . 0.0 110.704 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 105' ' ' GLN . . . 87.58 125.39 2.13 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 105' A ASN . 11.6 tp60 -54.03 -104.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -1.058 . . . . 0.0 109.216 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' A ASN . . . . . 0.491 ' N ' ' HG3' ' A' ' 105' ' ' GLN . 0.9 OUTLIER -47.44 125.21 7.86 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.216 -0.928 . . . . 0.0 109.377 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -51.52 153.0 2.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 109.117 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.71 59.86 0.94 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.651 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.556 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 7.2 mp -60.5 -177.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.259 1.028 . . . . 0.0 109.54 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.689 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.2 p -153.7 163.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.79 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 6.7 tp -99.6 84.1 2.89 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 16.8 p -69.02 -15.75 63.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 111.504 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.476 ' O ' HD13 ' A' ' 110' ' ' LEU . . . 174.68 -167.52 39.8 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.61 ' CG ' HD22 ' A' ' 32' ' ' LEU . 30.1 p90 170.99 137.54 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -98.04 102.66 14.47 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.498 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 9.9 p -67.99 158.47 5.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.131 -0.98 . . . . 0.0 111.195 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.5 t70 45.92 27.99 0.55 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.504 ' CE ' ' OD1' ' A' ' 120' ' ' ASP . 7.6 mmtm -101.01 129.76 46.9 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 120.676 -1.265 . . . . 0.0 108.48 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.484 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 2.4 m120 -105.65 -156.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 111.054 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.513 ' CA ' ' HE3' ' A' ' 63' ' ' LYS . 1.5 ttpm? -58.73 -45.41 89.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.699 -0.626 . . . . 0.0 109.981 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.21 -22.88 0.44 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.504 ' OD1' ' CE ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -89.0 122.52 32.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 110.993 -179.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 123' ' ' THR . 0.3 OUTLIER -94.99 132.79 39.45 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.734 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 2.2 mp -60.76 -55.92 27.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.782 -1.199 . . . . 0.0 109.344 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.582 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 56.7 -163.79 0.16 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.802 -1.186 . . . . 0.0 110.031 177.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.582 ' N ' HD12 ' A' ' 11' ' ' LEU . . . -50.52 -14.98 1.08 Allowed Glycine 0 N--CA 1.501 3.022 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 120.859 -1.377 . . . . 0.0 109.113 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 57.0 mmm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.61 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.0 mm -71.37 -47.04 13.64 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.559 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 7' ' ' ILE . 36.1 Cg_endo -78.74 101.2 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.147 1.898 . . . . 0.0 110.661 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.7 -145.32 0.3 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -125.6 2.82 8.13 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 121.096 -1.238 . . . . 0.0 110.182 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.566 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER 1.47 113.89 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.916 0.865 . . . . 0.0 112.534 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -101.06 160.41 14.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 41.5 tt0 -46.76 173.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 49' ' ' GLN . . . -59.85 95.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.875 -1.14 . . . . 0.0 109.871 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.608 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -69.68 130.31 90.5 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.1 Cg_endo -67.64 126.14 14.32 Favored 'Trans proline' 0 C--N 1.288 -2.608 0 N-CA-C 108.772 -1.28 . . . . 0.0 108.772 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . . . -40.66 156.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.289 1.042 . . . . 0.0 111.468 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.615 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -135.05 -168.38 0.18 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.615 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.35 -18.11 30.22 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 N-CA-C 109.177 -1.124 . . . . 0.0 109.177 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' HD13 ' A' ' 24' ' ' ILE . 13.9 mt-10 -82.96 -47.37 11.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.046 -1.034 . . . . 0.0 108.435 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.612 HG13 ' CD1' ' A' ' 50' ' ' TYR . 6.7 mm -56.8 -54.72 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.573 ' NE2' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -53.97 -26.95 28.45 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.81 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 4.2 tp10 -76.77 -35.2 57.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.083 . . . . 0.0 110.155 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.612 ' CG2' ' CG2' ' A' ' 99' ' ' VAL . 3.5 mt -66.19 -49.95 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.578 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 12.8 p -66.18 -41.3 89.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 122.279 1.038 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.563 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 12.5 t70 -74.98 -14.17 60.59 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 30.8 ttmt -93.36 -10.96 33.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG12 ' CG2' ' A' ' 99' ' ' VAL . 15.5 m -117.78 -5.31 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 110.653 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 4.5 ttpm? -42.72 -48.65 13.51 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.891 -1.131 . . . . 0.0 110.661 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 29.3 Cg_endo -69.65 -33.89 16.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.294 1.329 . . . . 0.0 109.799 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.409 ' O ' HD22 ' A' ' 110' ' ' LEU . 25.4 mt-30 -74.92 -5.01 41.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.492 ' CD1' HD12 ' A' ' 97' ' ' LEU . 5.4 mt -97.67 -38.07 9.66 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.593 -0.692 . . . . 0.0 109.705 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.472 ' OE1' ' HA ' ' A' ' 39' ' ' THR . 35.5 mt-10 -65.34 -26.46 68.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.503 -0.748 . . . . 0.0 109.645 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.39 -40.74 11.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG2' ' OH ' ' A' ' 113' ' ' TYR . 12.0 tttt -75.19 -8.07 55.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.608 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 9.9 p -123.03 -48.31 2.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.608 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER 104.48 32.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.189 0.519 . . . . 0.0 109.724 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 5.1 mt-10 -130.42 145.08 51.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.265 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.6 m -75.17 -10.36 59.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.107 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CG ' ' HE2' ' A' ' 95' ' ' MET . 25.7 m-85 36.71 -163.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.76 0.79 . . . . 0.0 110.61 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -162.97 -167.71 23.8 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.73 126.22 3.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -1.108 . . . . 0.0 108.787 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 41.4 mt -100.17 71.62 1.61 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 108.082 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 19.1 mt-10 -53.31 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.883 -0.51 . . . . 0.0 109.962 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.563 ' HA ' ' CG1' ' A' ' 64' ' ' VAL . . . -44.28 143.06 1.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.104 0.955 . . . . 0.0 109.589 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.9 -41.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.521 ' HB2' ' CD ' ' A' ' 63' ' ' LYS . 12.5 mt-30 -147.9 171.89 15.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.612 ' CD1' HG13 ' A' ' 21' ' ' ILE . 14.5 p90 -171.18 137.09 1.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.88 -1.138 . . . . 0.0 110.648 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -108.64 119.41 39.45 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 p -71.7 176.46 4.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.34 -0.85 . . . . 0.0 109.853 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.594 ' HG2' ' CE2' ' A' ' 61' ' ' TYR . 2.4 mm100 -152.34 148.25 27.28 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.451 ' O ' HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -129.73 137.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.942 -1.099 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -165.67 -102.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.67 28.49 5.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.55 ' HA2' ' CD1' ' A' ' 102' A LEU . . . 162.48 -121.7 1.04 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 106.856 -2.498 . . . . 0.0 106.856 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 23.1 m -159.52 104.91 1.63 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.087 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.593 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 48.3 m-80 -70.04 -178.45 1.61 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.1 m-85 -141.44 153.68 45.13 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.098 -1.001 . . . . 0.0 109.256 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 23.3 m-30 -133.76 135.53 43.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.574 HG13 ' C ' ' A' ' 61' ' ' TYR . 30.5 mt -153.91 129.99 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 116.774 -1.97 . . . . 0.0 112.408 -176.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.539 ' HB3' ' NE2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -100.22 102.79 14.17 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.563 ' CG1' ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -109.7 139.99 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.46 -0.775 . . . . 0.0 110.825 -176.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -67.32 126.87 30.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.99 45.06 1.05 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.91 0.862 . . . . 0.0 109.646 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 85.36 -98.07 2.22 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -56.69 -157.39 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.378 -1.072 . . . . 0.0 109.612 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -71.83 -6.62 42.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 109.476 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -69.85 164.31 23.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 109.085 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.478 ' OH ' ' HD2' ' A' ' 65' ' ' ARG . 11.7 m-85 -136.77 169.87 17.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.733 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.573 ' HE2' ' CG ' ' A' ' 40' ' ' TYR . 20.8 ttm -154.93 113.31 3.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.038 -1.038 . . . . 0.0 109.659 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.709 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.3 m170 -74.31 156.9 36.65 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.544 ' CD1' HG22 ' A' ' 28' ' ' VAL . 1.4 tp -148.96 139.85 22.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.698 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.1 tttt -121.63 107.25 12.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.612 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 2.2 t -107.24 162.08 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.729 -1.232 . . . . 0.0 109.712 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.683 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 10.5 t80 -124.15 133.03 53.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.536 -1.352 . . . . 0.0 108.681 177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -107.02 128.01 53.97 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.838 0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.452 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -103.93 94.54 5.47 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.319 0.581 . . . . 0.0 109.865 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.3 OUTLIER -47.2 -48.43 54.88 Favored Pre-proline 0 C--N 1.295 -1.781 0 O-C-N 121.324 -0.86 . . . . 0.0 109.732 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' A LEU . 36.5 Cg_endo -79.3 168.14 20.54 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.275 1.983 . . . . 0.0 110.52 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.85 145.8 5.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -76.53 -0.68 24.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -1.166 . . . . 0.0 109.851 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' A ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 106' ' ' GLU . 4.0 t-20 -166.33 111.73 0.82 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.575 -0.703 . . . . 0.0 109.528 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 105' A ASN . 1.2 pt-20 -42.98 156.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.3 OUTLIER 172.57 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.884 . . . . 0.0 109.796 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 5.4 mp -52.18 -176.05 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.087 0.946 . . . . 0.0 109.386 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.683 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.6 p -151.98 164.76 2.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.737 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.563 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 4.6 tp -101.67 83.76 2.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.485 ' OG1' ' HG2' ' A' ' 98' ' ' LYS . 1.2 p -72.84 -12.79 61.12 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.023 -1.048 . . . . 0.0 112.054 -176.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.545 ' O ' ' CD1' ' A' ' 110' ' ' LEU . . . -176.34 -167.48 35.13 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.066 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 30.2 p90 164.66 137.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.613 -0.933 . . . . 0.0 108.975 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.648 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.8 mm-40 -100.14 97.19 8.04 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.531 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 5.3 p -67.56 163.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.987 -1.071 . . . . 0.0 111.034 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' A ASP . . . . . . . . . . . . . 3.9 t0 48.92 26.64 1.38 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.045 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.541 ' HG2' ' CA ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -67.73 -166.27 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.779 -1.201 . . . . 0.0 108.463 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.53 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -149.51 -177.62 5.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.749 -1.22 . . . . 0.0 110.099 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -71.69 -34.09 69.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.419 -0.801 . . . . 0.0 109.267 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.03 -14.22 59.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.516 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 3.2 t0 -72.31 103.54 3.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.824 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.502 ' C ' HG21 ' A' ' 123' ' ' THR . 0.1 OUTLIER -87.92 146.24 25.65 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.709 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.9 mp -66.98 -40.0 87.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.553 -1.342 . . . . 0.0 108.302 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.544 ' CG2' ' C ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER 40.04 22.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.007 0.908 . . . . 0.0 110.905 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 121.73 116.99 2.45 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.648 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.505 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.467 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.525 HD13 ' N ' ' A' ' 7' ' ' ILE . 1.9 mp 62.01 143.03 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.012 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HD2' HG22 ' A' ' 7' ' ' ILE . 34.5 Cg_endo -75.95 171.39 18.25 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.427 2.085 . . . . 0.0 110.624 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.522 ' HA3' ' CG1' ' A' ' 54' ' ' VAL . . . 80.45 -173.99 54.89 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 145.6 135.0 2.76 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.571 -1.299 . . . . 0.0 110.077 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.596 ' CD1' ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -40.55 125.42 2.18 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.408 -1.054 . . . . 0.0 110.759 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLU . 33.6 m -101.32 171.6 7.5 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tp10 -47.8 174.79 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.912 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.23 99.62 3.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.099 -1.0 . . . . 0.0 110.006 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 9.8 mmpt? -69.16 131.19 90.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -68.11 125.35 12.91 Favored 'Trans proline' 0 C--N 1.291 -2.494 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.21 148.66 1.75 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.441 1.115 . . . . 0.0 111.466 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.607 ' OG1' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -128.96 -169.33 0.19 Allowed Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.607 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 27.9 Cg_endo -69.09 -17.67 40.49 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 N-CA-C 109.796 -0.886 . . . . 0.0 109.796 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 15.3 pt-20 -82.03 -41.79 20.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.787 -1.196 . . . . 0.0 108.758 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.608 HG13 ' CD1' ' A' ' 50' ' ' TYR . 13.0 mm -63.54 -51.58 68.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.47 -19.23 61.79 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.8 tp10 -75.71 -35.18 60.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.847 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.588 HG21 ' CG2' ' A' ' 99' ' ' VAL . 5.4 mt -64.99 -52.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 45' ' ' LEU . 7.1 p -61.41 -42.57 94.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.554 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 32.5 t70 -72.75 -16.44 61.65 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 11.9 tptt -89.75 -11.6 41.78 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.562 ' CG2' ' HG ' ' A' ' 97' ' ' LEU . 18.3 m -116.08 -8.72 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.447 -0.783 . . . . 0.0 109.802 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 11.3 ttpp -51.95 -44.13 90.9 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.837 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.77 -29.05 13.06 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.451 1.434 . . . . 0.0 110.016 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -80.69 -11.87 59.56 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.558 ' HG ' ' CD2' ' A' ' 110' ' ' LEU . 6.4 mt -93.65 -35.25 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.503 0.668 . . . . 0.0 109.762 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 30.3 mt-10 -58.74 -46.05 88.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.77 -51.12 6.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 109.961 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -49.77 -58.32 5.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 108.497 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.618 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 1.4 m -68.97 -60.52 2.31 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.539 -0.726 . . . . 0.0 109.512 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER 119.48 41.6 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 73.0 mm-40 -130.4 -166.73 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.888 . . . . 0.0 110.017 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.552 ' CG2' ' O ' ' A' ' 39' ' ' THR . 94.5 m -129.05 26.15 5.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.813 -0.554 . . . . 0.0 109.516 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 38' ' ' GLU . 11.5 m-85 -29.06 147.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.72 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -117.38 -135.52 5.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -54.65 126.29 23.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.336 -1.097 . . . . 0.0 110.078 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 28.8 mt -107.56 74.47 0.96 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -54.83 85.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.313 0.577 . . . . 0.0 110.495 -178.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HA ' ' CG1' ' A' ' 64' ' ' VAL . . . -46.22 124.73 5.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.26 1.028 . . . . 0.0 109.754 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG13 ' HG2' ' A' ' 49' ' ' GLN . 1.9 t -101.56 -44.68 10.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.529 ' CG ' ' HB3' ' A' ' 63' ' ' LYS . 9.2 pt20 -147.23 171.34 15.53 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 15' ' ' LYS . 12.1 p90 -168.17 138.79 2.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 12' ' ' SER . 1.4 mttp -109.88 124.01 50.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 p -76.51 -178.14 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.307 -0.871 . . . . 0.0 110.148 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.599 ' CB ' ' HB2' ' A' ' 59' ' ' ASN . 2.3 mm100 -159.53 150.8 19.86 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.522 ' CG1' ' HA3' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -126.06 146.97 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 120.915 -1.116 . . . . 0.0 111.126 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -171.04 -103.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.57 29.14 6.79 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 164.54 -114.02 0.58 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 106.294 -2.722 . . . . 0.0 106.294 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' A' ' 53' ' ' GLN . 28.8 m -166.92 113.72 0.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -1.157 . . . . 0.0 111.005 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.599 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 70.0 m-20 -73.51 -166.55 0.36 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 101' ' ' LYS . 86.6 m-85 -154.44 153.75 32.06 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.632 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.57 ' CE2' ' HG2' ' A' ' 53' ' ' GLN . 22.8 m-85 -138.04 130.41 29.14 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.593 ' N ' ' CD2' ' A' ' 122' ' ' LEU . 11.7 mt -149.34 122.68 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 119.583 -1.948 . . . . 0.0 112.098 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 21.8 ttpt -92.16 95.53 9.8 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.549 ' CG1' ' HA ' ' A' ' 47' ' ' ALA . 14.6 m -101.9 140.06 21.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.64 127.0 31.47 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.98 45.11 1.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.928 0.871 . . . . 0.0 109.615 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 99.37 -122.88 7.72 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' GLY . 16.8 t70 -43.26 -101.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.939 . . . . 0.0 111.37 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.3 m120 -120.02 -4.27 10.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.6 mttt -69.47 179.17 2.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 108.624 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 30.3 m-85 -146.52 168.25 21.69 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.026 -1.046 . . . . 0.0 109.94 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.552 ' HE3' ' CD2' ' A' ' 40' ' ' TYR . 18.9 mtp -154.87 115.43 3.9 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.675 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -73.69 137.58 44.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -125.17 123.26 39.25 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.497 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -108.68 121.65 45.47 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.588 ' CG2' HG21 ' A' ' 24' ' ' ILE . 2.5 t -125.27 166.26 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.59 -1.319 . . . . 0.0 109.445 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.669 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 10.0 t80 -125.08 136.45 53.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.987 -1.071 . . . . 0.0 108.201 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -103.56 120.53 41.05 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.929 0.871 . . . . 0.0 109.872 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 103' ' ' PRO . 0.3 OUTLIER -102.93 80.16 1.84 Allowed 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' A LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 102' ' ' SER . 0.5 OUTLIER -30.23 91.77 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 122.032 -0.417 . . . . 0.0 110.883 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.528 ' N ' ' O ' ' A' ' 102' ' ' SER . 37.0 Cg_endo -80.81 -172.34 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.929 2.419 . . . . 0.0 110.546 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.19 -36.76 4.82 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.71 -96.93 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.508 -0.995 . . . . 0.0 108.941 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' A ASN . . . . . . . . . . . . . 23.0 t-20 -49.35 138.88 12.4 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.501 -0.749 . . . . 0.0 109.385 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.46 ' HA ' ' HG3' ' A' ' 103' ' ' PRO . 12.7 mp0 -99.82 158.24 15.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 108' ' ' LEU . 8.4 p30 -154.08 57.7 0.72 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.483 ' N ' HD11 ' A' ' 108' ' ' LEU . 8.6 mp -49.74 178.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.251 1.025 . . . . 0.0 109.379 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.669 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 8.7 p -139.27 162.36 27.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.715 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 18.6 tp -99.31 88.09 3.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 14.7 p -71.53 -29.71 65.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 111.85 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . -168.94 -163.31 22.75 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.337 -1.411 . . . . 0.0 109.85 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 20.5 p90 166.48 135.64 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.41 -1.053 . . . . 0.0 109.854 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.629 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.4 mm-40 -95.48 95.4 8.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.465 HG22 ' OH ' ' A' ' 40' ' ' TYR . 6.3 p -67.51 160.15 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.092 -1.005 . . . . 0.0 110.57 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' A ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 115' ' ' VAL . 21.2 t0 43.2 28.37 0.16 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.304 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.562 ' HG3' ' CB ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -82.26 160.96 22.83 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.701 -1.249 . . . . 0.0 107.807 179.207 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.87 -170.91 1.91 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.756 -1.215 . . . . 0.0 110.888 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.49 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 18.9 mttt -68.47 -69.64 0.31 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.713 -0.617 . . . . 0.0 110.657 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -40.8 -26.91 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.347 -0.846 . . . . 0.0 110.292 -179.128 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 96' ' ' HIS . 14.8 t70 -47.43 109.88 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.027 . . . . 0.0 110.733 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.553 ' O ' ' CG2' ' A' ' 123' ' ' THR . 74.8 tt0 -84.3 136.91 33.72 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.675 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 2.6 mp -67.27 -32.38 73.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.904 -1.122 . . . . 0.0 108.741 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 45.36 -167.02 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.038 0.923 . . . . 0.0 110.499 177.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.596 ' HA2' ' CD1' ' A' ' 11' ' ' LEU . . . -43.35 -21.57 0.16 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.629 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.676 0 O-C-N 121.213 -1.169 . . . . 0.0 109.079 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.821 HD22 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 122.067 0.937 . . . . 0.0 111.47 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 3.8 m -102.78 -179.1 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.871 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -51.75 -177.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -92.23 110.71 22.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.098 -1.001 . . . . 0.0 110.74 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -76.93 138.25 65.71 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 175.249 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' ALA . 26.5 Cg_endo -64.44 131.84 31.31 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 109.152 -1.134 . . . . 0.0 109.152 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.603 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -41.67 167.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.511 1.148 . . . . 0.0 111.493 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.654 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -147.28 -167.43 0.15 Allowed Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.654 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.6 Cg_endo -73.13 -20.73 21.26 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 N-CA-C 108.471 -1.396 . . . . 0.0 108.471 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -39.93 22.95 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.219 -0.926 . . . . 0.0 108.688 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.741 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.7 mm -62.28 -54.83 29.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 23.5 tp60 -59.69 -19.44 49.76 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -76.2 -43.78 40.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.725 -1.234 . . . . 0.0 108.801 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.011 HG23 HG21 ' A' ' 99' ' ' VAL . 5.5 mt -55.48 -52.5 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.803 HG22 HD12 ' A' ' 45' ' ' LEU . 12.3 p -67.51 -39.98 83.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 122.028 0.918 . . . . 0.0 109.717 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.717 ' N ' HG13 ' A' ' 25' ' ' VAL . 25.6 t70 -70.71 -10.74 60.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -100.25 -18.07 17.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 97' ' ' LEU . 19.8 m -116.28 1.48 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.514 -0.741 . . . . 0.0 110.397 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.641 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.56 -39.84 79.79 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.736 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 29' ' ' LYS . 33.7 Cg_endo -77.55 -35.37 1.58 Allowed 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 108.172 -1.511 . . . . 0.0 108.172 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 61.0 mt-30 -66.78 -15.32 63.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.72 HD11 HD11 ' A' ' 97' ' ' LEU . 4.6 mt -89.92 -34.27 16.11 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.555 0.693 . . . . 0.0 109.535 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.639 ' HG2' HG23 ' A' ' 39' ' ' THR . 0.7 OUTLIER -55.14 -55.19 33.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 110.41 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.18 -8.52 50.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 31' ' ' GLN . 3.3 tttp -91.23 5.38 49.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.778 -1.201 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 32' ' ' LEU . 9.7 p -131.61 -56.8 1.0 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 36' ' ' THR . 45.8 p30 134.15 20.54 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -149.65 -177.82 6.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.87 -1.144 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.639 HG23 ' HG2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -117.72 118.68 32.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' HE1' HG23 ' A' ' 115' ' ' VAL . 74.0 m-85 -90.88 178.99 5.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 108.936 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -130.5 -168.04 12.16 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -37.47 127.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.926 . . . . 0.0 109.283 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.803 HD12 HG22 ' A' ' 25' ' ' VAL . 59.2 mt -102.97 79.99 1.82 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.059 -1.026 . . . . 0.0 108.704 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 1.3 mt-10 -61.8 85.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.145 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.799 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -43.64 145.9 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.235 1.017 . . . . 0.0 109.998 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.78 -44.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HG2' ' HB3' ' A' ' 63' ' ' LYS . 2.4 pt20 -151.57 169.53 21.89 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.741 ' HB3' HG21 ' A' ' 21' ' ' ILE . 14.1 p90 -163.12 133.56 4.54 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.055 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HD2' ' HB2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -99.01 126.53 44.73 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.51 145.07 45.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.272 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.693 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -144.47 177.73 8.45 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.834 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.07 158.93 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 111.563 -178.257 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.97 -102.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.49 28.46 5.04 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.1 -110.34 0.44 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 53' ' ' GLN . 86.5 m -165.67 109.59 0.83 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.367 -1.078 . . . . 0.0 110.76 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.671 ' ND2' ' CD2' ' A' ' 100' ' ' PHE . 31.4 m120 -69.57 -176.44 1.01 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CD1' HG12 ' A' ' 99' ' ' VAL . 78.6 m-85 -149.54 151.61 34.17 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.472 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.64 ' HB3' HD22 ' A' ' 122' ' ' LEU . 8.3 m-85 -138.04 132.55 32.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.645 HG12 HG23 ' A' ' 21' ' ' ILE . 13.6 mt -150.77 115.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 116.847 -1.941 . . . . 0.0 111.683 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.628 ' HB2' HD11 ' A' ' 122' ' ' LEU . 1.4 ttmp? -81.02 103.11 10.62 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.799 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -109.39 138.5 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.942 -176.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -68.11 127.18 31.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.08 46.07 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.044 0.926 . . . . 0.0 109.125 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 78.55 -93.84 1.26 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 22.6 p-10 -56.01 -163.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.187 -1.184 . . . . 0.0 109.563 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.45 -10.84 59.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.05 159.42 33.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 109.045 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.607 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 30.3 m-85 -129.35 176.21 8.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.7 ttp -155.76 113.22 3.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 109.561 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 1.053 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER -69.83 151.72 45.4 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 28' ' ' VAL . 11.0 tp -132.8 142.66 49.1 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 111.025 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -132.41 102.77 5.87 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.011 HG21 HG23 ' A' ' 24' ' ' ILE . 2.3 t -110.35 161.41 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.346 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.81 ' HB2' HG21 ' A' ' 111' ' ' THR . 6.7 t80 -123.77 135.92 54.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.2 . . . . 0.0 108.28 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.634 ' HG2' HD11 ' A' ' 108' ' ' LEU . 1.9 tmtt? . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.634 HD11 ' HG2' ' A' ' 101' ' ' LYS . 8.0 mp . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 122.698 1.237 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.723 HG13 HG23 ' A' ' 111' ' ' THR . 14.7 p -156.91 163.39 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.71 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.64 HD11 ' O ' ' A' ' 112' ' ' GLY . 10.3 tp -98.9 83.37 2.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.81 HG21 ' HB2' ' A' ' 100' ' ' PHE . 17.2 p -69.49 -11.77 61.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.965 . . . . 0.0 111.249 -176.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.64 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 173.81 -165.96 37.98 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.83 -1.652 . . . . 0.0 110.929 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.6 p90 167.76 135.57 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.672 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -96.19 96.67 8.97 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 177.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.473 HG23 ' HE1' ' A' ' 40' ' ' TYR . 8.5 p -67.72 157.03 6.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.836 -1.165 . . . . 0.0 110.19 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' A ASP . . . . . . . . . . . . . 1.5 t0 51.56 21.15 1.21 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.1 OUTLIER -83.11 131.18 35.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.672 -1.268 . . . . 0.0 108.044 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.36 178.59 7.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.297 -0.877 . . . . 0.0 111.45 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 119' ' ' ASP . 10.2 tmtt? -61.51 -50.01 74.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.188 0.518 . . . . 0.0 110.197 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 118' ' ' LYS . 41.6 t0 -43.29 -26.43 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.179 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.459 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -69.45 93.3 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.358 -0.839 . . . . 0.0 110.321 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 123' ' ' THR . 2.3 tt0 -68.15 141.99 55.87 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.053 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -64.17 -35.65 81.48 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.364 -1.46 . . . . 0.0 110.27 -178.064 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.715 ' O ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER 49.48 -149.73 0.22 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.821 ' HA2' HD22 ' A' ' 11' ' ' LEU . . . -48.82 -99.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 104.41 -3.476 . . . . 0.0 104.41 175.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.672 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 23.5 t80 . . . . . 0 C--N 1.29 -1.979 0 O-C-N 119.237 -2.331 . . . . 0.0 108.138 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.802 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 122.206 1.003 . . . . 0.0 111.504 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -102.28 179.25 4.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.675 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.323 -0.861 . . . . 0.0 109.031 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -91.47 101.02 13.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.789 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -70.93 141.07 86.51 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 103.236 -2.876 . . . . 0.0 103.236 175.331 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -68.02 126.63 14.76 Favored 'Trans proline' 0 C--N 1.29 -2.535 0 N-CA-C 109.531 -0.988 . . . . 0.0 109.531 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.623 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -42.59 147.86 0.26 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.42 1.105 . . . . 0.0 111.994 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.646 HG23 HG12 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -122.3 -168.44 0.13 Allowed Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -71.56 -20.01 27.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 109.202 -1.115 . . . . 0.0 109.202 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -82.5 -43.97 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -0.999 . . . . 0.0 108.663 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.698 HG21 ' HB3' ' A' ' 50' ' ' TYR . 7.6 mm -58.81 -52.09 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.532 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -64.46 -18.22 64.56 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.381 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 28.8 tp10 -76.47 -31.24 57.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.597 -1.315 . . . . 0.0 108.525 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.015 HG23 HG21 ' A' ' 99' ' ' VAL . 5.4 mt -69.36 -50.66 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.754 HG21 HG11 ' A' ' 64' ' ' VAL . 7.3 p -62.48 -43.44 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-O 122.089 0.947 . . . . 0.0 109.358 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.733 ' N ' HG13 ' A' ' 25' ' ' VAL . 21.4 t70 -74.4 -18.92 60.59 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.21 -12.76 56.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.226 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.613 HG11 ' CG2' ' A' ' 99' ' ' VAL . 27.7 m -116.59 -8.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.476 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.9 ttpp -42.25 -49.99 11.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 110.389 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.25 -34.75 7.54 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.535 1.49 . . . . 0.0 110.006 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' HD23 ' A' ' 110' ' ' LEU . 91.0 mt-30 -78.84 0.07 28.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.206 -0.934 . . . . 0.0 108.592 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.067 ' O ' HG22 ' A' ' 36' ' ' THR . 3.2 mt -100.26 -41.23 7.16 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.444 -0.785 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 48.5 mt-10 -59.37 -44.38 92.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.5 -46.62 89.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.474 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB3' ' OH ' ' A' ' 113' ' ' TYR . 1.2 mmtp -71.11 -66.1 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 110.019 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 1.067 HG22 ' O ' ' A' ' 32' ' ' LEU . 9.4 t -70.12 -0.68 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.392 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 2.7 p-10 40.91 48.2 2.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.158 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.514 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -119.19 172.22 7.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.283 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' TYR . 5.9 t -80.91 -29.78 35.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 0.0 109.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.947 ' CZ ' HG21 ' A' ' 36' ' ' THR . 4.9 m-30 40.31 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.529 0.681 . . . . 0.0 110.256 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 168.6 -163.39 37.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.1 118.26 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.488 -1.007 . . . . 0.0 109.443 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.71 ' HB3' HG11 ' A' ' 64' ' ' VAL . 36.5 mt -100.47 86.04 3.08 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.142 . . . . 0.0 108.073 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 47' ' ' ALA . 63.4 mt-10 -69.83 83.74 0.47 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -0.763 . . . . 0.0 110.063 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.799 ' N ' HG13 ' A' ' 64' ' ' VAL . . . -41.11 145.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.148 0.975 . . . . 0.0 110.25 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -122.02 -44.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.863 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 42.2 mt-30 -149.45 170.08 19.4 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.698 ' HB3' HG21 ' A' ' 21' ' ' ILE . 17.5 p90 -164.45 138.19 5.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.196 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 35.3 mttt -108.93 125.32 51.9 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.2 p -76.4 175.74 8.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 109.785 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.902 ' O ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -150.6 154.53 37.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.358 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.84 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -128.31 141.72 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.025 -1.047 . . . . 0.0 110.303 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.49 -101.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.73 30.17 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 157.9 -110.91 0.46 Allowed Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.902 HG23 ' O ' ' A' ' 53' ' ' GLN . 29.6 m -165.17 108.22 0.84 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.364 -1.08 . . . . 0.0 110.913 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.618 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 76.0 m-20 -71.37 -170.44 0.5 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.618 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 19.6 m-85 -143.55 154.95 44.13 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.468 -0.77 . . . . 0.0 109.586 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.856 ' HB3' HD22 ' A' ' 122' ' ' LEU . 21.2 m-85 -137.21 133.5 35.22 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.774 HG22 ' CG2' ' A' ' 64' ' ' VAL . 12.9 mt -149.11 114.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 117.004 -1.878 . . . . 0.0 111.442 -177.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 19.2 ttpt -81.09 99.23 8.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.799 HG13 ' N ' ' A' ' 47' ' ' ALA . 38.2 t -109.13 144.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.37 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.4 mmm180 -69.71 132.93 46.9 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.13 44.9 1.17 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.976 0.893 . . . . 0.0 108.951 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 84.67 -92.79 1.76 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' GLY . 10.5 p-10 -60.68 -140.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.258 -1.142 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.64 -7.98 57.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.958 -1.089 . . . . 0.0 109.994 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.485 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -69.45 178.36 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 108.692 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.578 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 25.6 m-85 -142.78 179.06 7.22 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.06 -1.025 . . . . 0.0 109.285 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . 1.037 ' HE1' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.76 114.02 1.11 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.462 -179.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.907 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -71.65 140.94 49.9 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.056 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -124.84 133.99 52.9 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.511 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -121.71 113.9 20.36 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.135 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.015 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -119.89 159.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.777 -1.202 . . . . 0.0 109.684 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.717 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 4.2 t80 -121.67 130.77 53.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.592 -1.318 . . . . 0.0 108.173 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.531 ' HE2' ' HB ' ' A' ' 58' ' ' THR . 2.5 pttt . . . . . 0 C--N 1.303 -1.425 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.3 mp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 122.086 0.945 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.717 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.1 p -147.65 161.23 7.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.808 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.629 HD13 HD11 ' A' ' 97' ' ' LEU . 18.1 tp -97.81 87.94 4.16 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -75.57 -8.76 57.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 111.87 -176.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . 174.01 -168.27 41.03 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.625 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.606 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 31.4 p90 165.84 138.0 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.717 -0.872 . . . . 0.0 109.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.625 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.1 mm-40 -97.34 97.87 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.8 HG23 ' OH ' ' A' ' 40' ' ' TYR . 7.4 p -69.35 159.06 5.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.845 -1.16 . . . . 0.0 110.282 -178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' A ASP . . . . . 0.438 ' N ' HG22 ' A' ' 115' ' ' VAL . 56.4 t0 52.24 22.25 1.92 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.78 -0.575 . . . . 0.0 110.562 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 3.2 mptp? -90.56 106.31 18.42 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.755 -1.216 . . . . 0.0 108.951 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 4.5 m120 -69.51 -172.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 110.127 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -16.46 62.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.88 -20.05 63.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.539 ' CB ' ' HG3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -90.82 110.02 21.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 110.072 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.525 ' C ' HG22 ' A' ' 123' ' ' THR . 2.1 tt0 -92.62 150.6 20.61 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.907 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 2.0 mp -68.87 -44.27 73.65 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.515 -1.366 . . . . 0.0 107.734 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER 39.2 18.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.624 -0.672 . . . . 0.0 112.485 175.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.802 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . 154.94 -65.63 0.32 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.2 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.625 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.269 0 O-C-N 121.286 -1.126 . . . . 0.0 109.251 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.827 0.822 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 m -101.25 163.91 12.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.384 0.612 . . . . 0.0 109.458 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 5.7 tt0 -48.14 176.94 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.398 -0.814 . . . . 0.0 109.308 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HB1' ' CG ' ' A' ' 49' ' ' GLN . . . -84.89 96.7 9.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.109 . . . . 0.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.68 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 20.0 mmtt -72.27 133.19 83.52 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 176.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 17' ' ' ALA . 27.5 Cg_endo -65.98 126.08 15.25 Favored 'Trans proline' 0 C--N 1.291 -2.452 0 N-CA-C 109.257 -1.093 . . . . 0.0 109.257 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.623 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -39.37 153.52 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.536 1.16 . . . . 0.0 111.815 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.63 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -136.27 -170.12 0.23 Allowed Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.3 Cg_endo -68.97 -16.53 40.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 N-CA-C 109.244 -1.099 . . . . 0.0 109.244 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.56 -46.45 14.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.068 -1.02 . . . . 0.0 108.41 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.763 HG21 ' HB3' ' A' ' 50' ' ' TYR . 10.2 mm -58.88 -53.67 44.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 22.9 tp60 -61.47 -19.17 61.73 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -76.13 -37.06 58.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.711 -1.243 . . . . 0.0 108.776 179.061 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.912 HG23 HG21 ' A' ' 99' ' ' VAL . 3.9 mt -63.22 -50.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.862 HG22 HD12 ' A' ' 45' ' ' LEU . 11.4 p -66.21 -41.62 89.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 122.183 0.992 . . . . 0.0 109.251 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.709 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.8 t70 -69.39 -16.58 63.54 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -85.9 -20.16 29.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 24' ' ' ILE . 13.1 m -118.4 6.58 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.613 -0.68 . . . . 0.0 110.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.885 ' HA ' HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -53.14 -36.85 42.16 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.687 -1.258 . . . . 0.0 110.646 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HD3' ' CG ' ' A' ' 29' ' ' LYS . 35.9 Cg_endo -79.3 -37.04 0.57 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 108.361 -1.438 . . . . 0.0 108.361 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.659 ' O ' HD23 ' A' ' 110' ' ' LEU . 1.8 mt-30 -74.17 -3.24 28.57 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.889 HD22 ' SD ' ' A' ' 95' ' ' MET . 10.0 mt -92.43 -41.12 10.49 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.417 -0.802 . . . . 0.0 109.624 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.809 ' OE2' HG22 ' A' ' 39' ' ' THR . 23.6 mt-10 -65.32 -46.27 80.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.511 -0.743 . . . . 0.0 110.972 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.7 -37.26 62.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.807 -1.183 . . . . 0.0 111.136 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -58.08 -42.65 86.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.771 -1.205 . . . . 0.0 110.063 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.823 HG21 ' OH ' ' A' ' 40' ' ' TYR . 1.3 p -86.5 -57.48 2.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.933 -1.104 . . . . 0.0 109.663 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 36' ' ' THR . 52.6 p-10 131.26 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 C-N-CA 122.937 0.495 . . . . 0.0 109.714 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 5.0 pt-20 -133.93 171.75 13.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 109.148 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.809 HG22 ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -107.14 117.76 34.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.009 -1.057 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.823 ' OH ' HG21 ' A' ' 36' ' ' THR . 58.8 m-85 -93.05 178.77 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 108.594 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -126.31 -157.57 9.6 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 43' ' ' GLY . 4.2 tttt -41.68 125.11 2.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.451 -1.029 . . . . 0.0 109.151 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.862 HD12 HG22 ' A' ' 25' ' ' VAL . 28.4 mt -97.43 77.41 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.055 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.53 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.872 -177.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.816 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -45.69 144.27 1.72 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.127 -0.983 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.5 t -125.6 -42.14 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' CG ' ' HB1' ' A' ' 14' ' ' ALA . 8.8 mt-30 -150.28 166.96 28.39 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.763 ' HB3' HG21 ' A' ' 21' ' ' ILE . 2.5 p90 -163.54 138.06 6.07 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.458 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 23.8 mttt -113.38 131.89 55.81 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.878 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -81.08 -173.72 4.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.196 -0.94 . . . . 0.0 110.86 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -164.32 156.01 16.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.765 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -125.43 141.43 45.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.949 -1.094 . . . . 0.0 110.746 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -170.2 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.275 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.29 28.93 5.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.446 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 160.23 -104.04 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 53' ' ' GLN . 9.1 m -168.75 112.31 0.56 Allowed 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.7 -0.883 . . . . 0.0 109.766 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.606 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 32.6 m-80 -71.36 -166.63 0.19 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 28.5 m-85 -150.44 154.34 37.53 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.689 ' HB3' HD22 ' A' ' 122' ' ' LEU . 22.6 m-85 -138.99 133.76 32.15 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 177.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.813 HD12 HD23 ' A' ' 97' ' ' LEU . 11.1 mt -151.81 118.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 C-N-CA 116.719 -1.992 . . . . 0.0 111.589 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.555 ' CE ' ' HA ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -78.44 98.7 6.13 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 175.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.816 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -108.81 132.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.353 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 5.7 ttp180 -66.36 139.14 58.0 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.55 43.96 1.07 Allowed 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.922 0.868 . . . . 0.0 109.405 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 72.9 -80.63 0.68 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.0 OUTLIER -53.67 -112.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.41 -1.053 . . . . 0.0 110.394 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.402 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 5.0 m-20 -125.44 -21.4 4.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.687 -1.258 . . . . 0.0 109.876 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -68.46 177.07 2.54 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 20.0 m-85 -135.72 176.08 9.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.007 -1.058 . . . . 0.0 109.204 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.889 ' SD ' HD22 ' A' ' 32' ' ' LEU . 4.6 ttp -156.66 117.42 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.393 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.714 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.6 m170 -69.19 148.35 50.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.813 HD23 HD12 ' A' ' 62' ' ' ILE . 13.9 tp -129.04 128.58 43.88 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.725 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 41.6 tttt -114.52 107.79 15.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.912 HG21 HG23 ' A' ' 24' ' ' ILE . 1.8 t -111.38 160.66 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.215 . . . . 0.0 109.164 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.764 ' HB2' HG21 ' A' ' 111' ' ' THR . 34.7 t80 -122.94 133.11 54.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.792 -1.192 . . . . 0.0 109.003 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 tttp . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.232 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 108' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 122.116 0.96 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.776 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.3 p -152.31 166.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.089 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.695 HD11 ' O ' ' A' ' 112' ' ' GLY . 12.4 tp -98.52 85.29 3.34 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 100' ' ' PHE . 3.4 p -81.18 -1.55 45.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.1 -1.0 . . . . 0.0 111.947 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.695 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 177.67 -160.19 26.6 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.193 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.677 ' HD2' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER 150.3 133.47 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.383 0.611 . . . . 0.0 109.959 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.641 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.07 95.08 7.94 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.468 ' O ' ' HD3' ' A' ' 116' ' ' LYS . 9.4 p -67.98 161.4 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.185 . . . . 0.0 111.088 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' A ASP . . . . . 0.436 ' N ' HG22 ' A' ' 115' ' ' VAL . 49.6 t0 50.11 20.76 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.912 -0.492 . . . . 0.0 110.815 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.571 ' CG ' ' OD2' ' A' ' 120' ' ' ASP . 1.6 mptt -93.61 129.44 39.88 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.64 -1.288 . . . . 0.0 108.546 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 2.9 m-80 -104.4 -156.86 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 0.0 112.285 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.555 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 3.4 tttm -54.2 -56.7 15.73 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.937 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.42 -20.98 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 0.0 111.089 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.571 ' OD2' ' CG ' ' A' ' 116' ' ' LYS . 63.2 t0 -83.9 123.02 29.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.665 -1.272 . . . . 0.0 111.724 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.558 ' O ' ' CG2' ' A' ' 123' ' ' THR . 5.1 tt0 -100.3 139.88 35.34 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 176.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.714 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.2 mp -59.55 -49.54 77.36 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.541 -1.35 . . . . 0.0 109.411 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.3 OUTLIER 43.7 -168.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.89 178.407 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.575 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -55.38 91.77 0.01 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 109.488 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.037 HD22 ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 122.331 1.062 . . . . 0.0 110.945 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 79.1 p -101.52 -176.72 3.22 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.114 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -51.02 179.77 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.976 -1.078 . . . . 0.0 108.574 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -77.94 95.79 4.87 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.289 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mmtt -70.75 126.36 92.17 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.96 127.36 18.37 Favored 'Trans proline' 0 C--N 1.293 -2.345 0 N-CA-C 109.514 -0.995 . . . . 0.0 109.514 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.631 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -42.34 165.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.346 1.07 . . . . 0.0 111.431 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.653 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.46 -167.88 0.17 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -71.93 -18.03 28.23 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 N-CA-C 108.939 -1.216 . . . . 0.0 108.939 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' HD12 ' A' ' 24' ' ' ILE . 1.5 mt-10 -83.93 -45.32 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.752 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.6 mm -57.74 -54.43 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.504 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 2.0 tp-100 -61.76 -20.29 63.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 7.0 tt0 -75.74 -34.81 60.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.471 -1.393 . . . . 0.0 108.643 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.08 HG23 HG21 ' A' ' 99' ' ' VAL . 3.7 mt -66.04 -49.67 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.004 0.907 . . . . 0.0 108.815 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 HD12 ' A' ' 45' ' ' LEU . 12.5 p -69.34 -41.38 80.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-O 121.966 0.889 . . . . 0.0 109.861 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.723 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.2 t70 -72.12 -17.0 62.01 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 14.4 tppt? -89.83 -13.47 36.49 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.863 ' CG2' HD21 ' A' ' 97' ' ' LEU . 31.3 m -126.58 4.18 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.883 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 6.3 ttpt -54.66 -43.66 98.48 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 111.07 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.68 -18.75 24.99 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.383 1.389 . . . . 0.0 109.615 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -91.92 -10.89 37.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.809 HD13 HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -92.06 -33.27 14.86 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 40' ' ' TYR . 2.3 pt-20 -82.68 -20.1 36.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 109.952 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.71 -45.85 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.017 -1.052 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -67.27 -40.16 86.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.697 HG21 ' OH ' ' A' ' 40' ' ' TYR . 2.7 m -82.67 -32.44 28.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.917 . . . . 0.0 109.388 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 88.71 26.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.254 0.55 . . . . 0.0 109.725 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -107.24 -178.84 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.518 ' O ' ' O ' ' A' ' 40' ' ' TYR . 29.9 m -97.03 -25.7 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.147 -0.971 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.697 ' OH ' HG21 ' A' ' 36' ' ' THR . 14.5 m-30 37.79 -165.29 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.705 0.764 . . . . 0.0 110.976 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 176.1 -165.63 36.29 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.444 ' O ' HD23 ' A' ' 45' ' ' LEU . 14.0 mttt -42.46 134.51 3.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.796 HD12 HG22 ' A' ' 25' ' ' VAL . 34.5 mt -111.85 81.66 1.49 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.2 tt0 -64.01 86.89 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.853 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -44.71 132.83 6.29 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.291 1.043 . . . . 0.0 110.371 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.3 t -110.83 -45.32 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 63' ' ' LYS . 1.3 pt20 -149.05 173.21 13.63 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.803 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.752 ' HB3' HG21 ' A' ' 21' ' ' ILE . 26.7 p90 -165.31 141.12 5.33 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.69 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.545 ' HD3' HD23 ' A' ' 11' ' ' LEU . 9.0 mttt -117.7 135.96 53.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.366 0.603 . . . . 0.0 109.378 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.4 p -76.93 -175.59 3.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.266 -0.896 . . . . 0.0 110.064 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 58' ' ' THR . 0.5 OUTLIER -158.94 149.15 19.46 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.869 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -123.84 141.04 45.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.798 -1.189 . . . . 0.0 110.51 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.66 -103.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 30.24 4.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.94 -111.37 0.48 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 106.734 -2.547 . . . . 0.0 106.734 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 53' ' ' GLN . 16.4 m -165.26 107.31 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.345 -1.091 . . . . 0.0 110.697 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.749 ' ND2' ' CD2' ' A' ' 100' ' ' PHE . 21.4 m120 -71.89 -171.52 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 101' ' ' LYS . 22.8 m-85 -139.38 160.2 40.39 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.827 ' HB3' HD22 ' A' ' 122' ' ' LEU . 11.0 m-85 -141.8 136.57 30.79 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.611 HG13 ' C ' ' A' ' 61' ' ' TYR . 14.1 mt -151.15 119.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.675 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.507 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 26.4 ttpp -86.36 94.61 9.41 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.853 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -100.09 137.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.843 -0.536 . . . . 0.0 110.86 -176.432 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.666 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -67.76 123.46 20.6 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.32 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.8 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -82.02 39.33 0.56 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.605 0.717 . . . . 0.0 111.007 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.04 -127.99 9.06 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.24 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -68.39 80.02 0.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.691 -0.888 . . . . 0.0 112.261 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 10.8 m120 71.22 -8.64 0.98 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.114 -0.991 . . . . 0.0 111.712 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.8 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -69.48 -179.76 1.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.649 -1.282 . . . . 0.0 108.367 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 7.3 m-85 -150.74 155.98 40.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.972 -1.08 . . . . 0.0 109.391 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.641 ' CE ' ' CD2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -150.79 111.21 4.19 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.862 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.11 135.25 44.74 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.863 HD21 ' CG2' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -120.25 157.35 29.32 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.868 -1.145 . . . . 0.0 111.274 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.2 tttt -141.77 107.49 5.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.08 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -115.31 160.27 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.755 -1.216 . . . . 0.0 110.308 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.749 ' CD2' ' ND2' ' A' ' 59' ' ' ASN . 0.2 OUTLIER -121.1 122.46 40.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.819 ' HG2' HD11 ' A' ' 108' ' ' LEU . 1.8 tttt . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 122.487 1.137 . . . . 0.0 107.998 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.819 HD11 ' HG2' ' A' ' 101' ' ' LYS . 5.7 mp . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 122.353 1.073 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.668 ' O ' HG22 ' A' ' 99' ' ' VAL . 14.3 p -153.86 161.42 2.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.099 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.584 HD11 ' HD2' ' A' ' 113' ' ' TYR . 8.1 tp -96.69 82.05 3.26 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.61 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -70.37 -9.48 56.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 111.918 -176.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.501 ' CA ' ' HB3' ' A' ' 98' ' ' LYS . . . 168.78 -168.7 41.28 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.382 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.631 ' CB ' HD21 ' A' ' 32' ' ' LEU . 22.4 p90 167.79 135.38 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.593 -0.945 . . . . 0.0 109.139 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.691 ' HG3' ' CD2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -90.53 103.9 16.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.693 HG23 ' OH ' ' A' ' 40' ' ' TYR . 8.1 p -68.25 161.69 3.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.552 -177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' A ASP . . . . . 0.488 ' N ' HG22 ' A' ' 115' ' ' VAL . 0.9 OUTLIER 42.2 43.31 2.83 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.11 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.959 -1.088 . . . . 0.0 108.404 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.97 -171.41 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 110.306 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 14.5 tttt -66.94 -40.5 87.57 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.425 0.631 . . . . 0.0 109.627 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.19 -18.56 0.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.341 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.4 OUTLIER -88.19 105.58 17.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.828 -1.17 . . . . 0.0 110.251 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.98 162.77 20.31 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.862 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 3.0 mp -85.07 13.91 5.62 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.406 -1.434 . . . . 0.0 109.484 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.037 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.5 OUTLIER 2.77 -76.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.439 0.696 . . . . 0.0 112.236 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.706 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . -139.71 15.02 3.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.681 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.602 0 O-C-N 121.603 -0.94 . . . . 0.0 108.545 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.765 HD21 ' CE2' ' A' ' 61' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 122.383 1.087 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.51 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -101.93 178.68 4.54 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.966 179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.495 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -51.96 163.83 0.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.161 -0.962 . . . . 0.0 109.182 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -72.54 107.68 5.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.942 . . . . 0.0 110.865 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.03 139.5 79.71 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 175.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.93 127.39 17.65 Favored 'Trans proline' 0 C--N 1.292 -2.435 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.599 ' HB1' ' CB ' ' A' ' 47' ' ' ALA . . . -44.61 131.43 6.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.06 0.933 . . . . 0.0 112.266 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.607 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -102.52 -173.42 0.29 Allowed Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 176.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -68.42 -20.82 41.55 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 109.643 -0.945 . . . . 0.0 109.643 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 1.6 mt-10 -81.72 -41.54 21.13 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.035 -1.041 . . . . 0.0 108.929 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.82 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -62.36 -47.48 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -67.6 -16.1 64.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.2 tt0 -77.18 -29.99 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.814 -1.179 . . . . 0.0 108.315 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.935 HG23 HG21 ' A' ' 99' ' ' VAL . 3.0 mt -70.62 -50.41 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.719 HG13 ' N ' ' A' ' 26' ' ' ASP . 7.7 p -61.42 -44.33 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.984 0.897 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.719 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.6 t0 -72.11 -20.26 61.67 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -80.34 -12.86 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.814 HG21 ' CD2' ' A' ' 97' ' ' LEU . 35.2 m -116.17 -10.85 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.556 -0.715 . . . . 0.0 110.203 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.2 ttmt -39.77 -49.91 5.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.05 -1.031 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 28.9 Cg_endo -69.69 -35.52 12.71 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.587 1.525 . . . . 0.0 109.8 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 94.9 mt-30 -73.76 -4.8 36.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 40' ' ' TYR . 7.0 mt -96.89 -43.15 7.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.62 0.724 . . . . 0.0 110.03 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.7 -27.19 69.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.752 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.04 -46.79 5.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.963 -1.085 . . . . 0.0 110.916 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 70.7 mttt -67.76 -33.89 75.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.071 . . . . 0.0 110.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 2.8 m -92.98 -35.5 13.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.886 -1.134 . . . . 0.0 109.532 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 36' ' ' THR . 1.0 OUTLIER 91.3 28.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.218 0.532 . . . . 0.0 110.019 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -115.38 -175.99 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 40' ' ' TYR . 43.2 m -98.78 -20.75 16.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.913 ' OH ' HG23 ' A' ' 115' ' ' VAL . 4.1 m-85 39.22 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.974 0.892 . . . . 0.0 111.051 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.9 -152.29 11.12 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 129.77 42.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.673 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.655 ' HB2' HG22 ' A' ' 25' ' ' VAL . 35.5 mt -111.05 81.94 1.51 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.974 -1.079 . . . . 0.0 109.028 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -65.23 85.69 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.481 0.658 . . . . 0.0 110.137 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.931 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.96 125.99 4.61 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.105 0.955 . . . . 0.0 109.891 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.9 t -103.4 -44.87 9.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.642 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 3.4 mt-30 -142.78 172.79 12.21 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.82 ' HB3' HG21 ' A' ' 21' ' ' ILE . 31.7 p90 -169.75 139.82 2.03 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.877 -1.139 . . . . 0.0 110.593 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.614 ' HG3' HD13 ' A' ' 122' ' ' LEU . 7.5 mtmt -122.23 128.99 51.82 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.92 139.6 37.32 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.171 -0.956 . . . . 0.0 110.062 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.518 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 1.3 pm0 -133.23 158.52 42.68 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 55' ' ' VAL . 4.7 p -97.36 155.85 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 111.772 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.606 HG21 ' ND2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -162.28 -101.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 27.91 5.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.55 -103.37 0.23 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 106.373 -2.691 . . . . 0.0 106.373 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -160.89 122.64 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.584 -0.951 . . . . 0.0 109.891 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.606 ' ND2' HG21 ' A' ' 55' ' ' VAL . 9.7 m-20 -85.12 -164.96 1.07 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 7.9 m-85 -149.52 131.05 14.84 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.765 ' CE2' HD21 ' A' ' 11' ' ' LEU . 8.9 m-30 -115.88 134.53 54.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.759 HG22 HG13 ' A' ' 64' ' ' VAL . 17.8 mt -150.47 128.13 2.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 116.812 -1.955 . . . . 0.0 111.371 -176.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.598 ' HG3' ' NZ ' ' A' ' 116' ' ' LYS . 19.4 ttmt -95.34 90.99 6.02 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.931 HG12 ' HA ' ' A' ' 47' ' ' ALA . 31.4 m -99.6 142.06 15.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.773 -0.579 . . . . 0.0 110.956 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.33 123.15 19.97 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -86.06 46.75 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.139 0.971 . . . . 0.0 109.141 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 -152.05 19.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 92' ' ' ASN . 2.0 p-10 -59.15 126.84 29.32 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.426 -1.044 . . . . 0.0 111.044 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 68' ' ' ASP . 7.8 p-10 31.62 44.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.217 0.532 . . . . 0.0 111.304 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -127.76 171.41 11.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.489 ' CD2' ' O ' ' A' ' 93' ' ' LYS . 25.8 m-85 -156.94 156.36 32.92 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.754 -1.216 . . . . 0.0 110.495 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.741 ' O ' HG22 ' A' ' 64' ' ' VAL . 9.2 tmm? -153.97 116.52 4.39 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.296 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.905 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -76.29 143.22 41.01 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.814 ' CD2' HG21 ' A' ' 28' ' ' VAL . 1.4 tp -133.55 131.92 40.3 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.795 -1.562 . . . . 0.0 112.437 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.2 ttpt -111.7 83.38 1.77 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.935 HG21 HG23 ' A' ' 24' ' ' ILE . 1.6 t -84.47 159.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.665 -1.272 . . . . 0.0 109.206 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.724 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 58.4 t80 -125.4 131.43 52.94 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.635 -1.291 . . . . 0.0 108.35 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.617 HD12 ' N ' ' A' ' 108' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 122.307 1.051 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.75 ' CG1' HG23 ' A' ' 111' ' ' THR . 12.5 p -163.39 164.94 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.089 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.728 HD11 ' CD2' ' A' ' 113' ' ' TYR . 4.4 tp -97.49 83.52 3.27 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.75 HG23 ' CG1' ' A' ' 109' ' ' VAL . 1.4 p -85.89 -3.61 58.96 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.016 -1.052 . . . . 0.0 112.81 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 113' ' ' TYR . . . -171.31 -172.34 37.36 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.633 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.728 ' CD2' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER 155.38 132.61 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.736 -0.861 . . . . 0.0 111.3 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.636 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 6.2 mm-40 -95.37 95.95 8.8 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.913 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -65.84 160.1 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.99 -176.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' A ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 115' ' ' VAL . 2.7 t70 42.85 37.19 1.01 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.441 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.682 ' HE3' ' CE1' ' A' ' 96' ' ' HIS . 8.1 ptmm? -69.61 -163.83 0.06 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.074 -1.016 . . . . 0.0 108.935 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.452 ' O ' ' NZ ' ' A' ' 116' ' ' LYS . 14.2 m-80 -157.35 178.5 10.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.84 -1.163 . . . . 0.0 109.922 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -68.92 -9.27 50.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.814 . . . . 0.0 109.756 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.32 5.09 46.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -100.68 119.65 38.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.035 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.686 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.9 OUTLIER -96.9 138.43 34.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.905 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 1.6 mp -58.57 -55.93 28.65 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.715 -1.241 . . . . 0.0 109.196 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 121' ' ' GLU . 0.3 OUTLIER 44.69 -169.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.182 177.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.558 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -49.51 91.93 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.539 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.594 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.547 HD12 ' HD3' ' A' ' 51' ' ' LYS . 1.3 pt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 t -101.33 -177.22 3.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 110.731 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -49.98 -175.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.555 -0.716 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -90.17 107.88 19.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.928 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 9.6 mmpt? -73.26 141.11 80.32 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 175.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.47 131.29 25.87 Favored 'Trans proline' 0 C--N 1.291 -2.499 0 N-CA-C 109.45 -1.019 . . . . 0.0 109.45 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -48.17 165.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.399 1.095 . . . . 0.0 111.813 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.663 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -145.92 -166.07 0.12 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.663 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.5 Cg_endo -71.85 -18.35 28.26 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 N-CA-C 108.755 -1.287 . . . . 0.0 108.755 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.42 -45.93 15.34 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.4 mm -59.85 -53.03 54.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.474 ' OE1' ' O ' ' A' ' 45' ' ' LEU . 26.9 tp60 -60.45 -19.48 56.61 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 tt0 -75.17 -43.12 54.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 108.737 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HG21 ' A' ' 99' ' ' VAL . 3.3 mt -57.29 -52.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.84 HG22 HD12 ' A' ' 45' ' ' LEU . 11.4 p -66.42 -39.76 84.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 122.024 0.916 . . . . 0.0 109.095 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.705 ' N ' HG13 ' A' ' 25' ' ' VAL . 23.3 t70 -68.44 -13.45 62.31 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -94.76 -19.96 19.91 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.257 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.825 HG21 HD11 ' A' ' 97' ' ' LEU . 27.4 m -111.66 -6.03 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.885 . . . . 0.0 111.23 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.688 ' HG3' HD11 ' A' ' 45' ' ' LEU . 1.4 ttpm? -44.46 -48.25 26.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -29.96 12.62 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.625 1.55 . . . . 0.0 110.112 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' HD23 ' A' ' 110' ' ' LEU . 94.7 mt-30 -83.77 -0.72 52.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.951 HD11 ' CD1' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.27 -37.6 8.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 1.5 tm-20 -72.08 -30.6 65.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -19.44 29.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.0 . . . . 0.0 109.886 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 7.6 44.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 109.855 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.821 HG21 ' CZ ' ' A' ' 40' ' ' TYR . 14.4 t -135.56 -32.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.939 -1.1 . . . . 0.0 110.281 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.679 ' ND2' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER 92.62 18.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.919 -0.488 . . . . 0.0 110.116 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.706 ' H ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -115.5 157.76 23.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.916 -1.115 . . . . 0.0 109.057 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.524 ' O ' ' O ' ' A' ' 40' ' ' TYR . 8.9 m -81.22 -15.43 55.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.822 ' OH ' HG23 ' A' ' 115' ' ' VAL . 12.0 m-30 39.0 -165.76 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.521 0.677 . . . . 0.0 110.14 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -176.65 -169.44 38.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' O ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -42.04 134.44 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.464 -1.021 . . . . 0.0 108.875 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.84 HD12 HG22 ' A' ' 25' ' ' VAL . 34.0 mt -112.55 83.73 1.86 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.085 -1.01 . . . . 0.0 109.859 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 3.7 mt-10 -65.33 85.5 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.481 0.658 . . . . 0.0 109.667 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.838 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -47.89 116.88 1.64 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.3 1.048 . . . . 0.0 110.579 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.788 HG21 ' NH1' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -90.67 -46.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.636 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 2.4 mt-30 -148.73 168.78 21.98 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.696 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.729 ' HB3' HG21 ' A' ' 21' ' ' ILE . 7.0 p90 -161.75 136.23 6.98 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.821 -1.152 . . . . 0.0 110.983 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HD3' HD12 ' A' ' 11' ' ' LEU . 11.5 mttt -105.41 137.0 43.94 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 p -86.97 178.63 6.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.858 . . . . 0.0 110.049 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.823 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -157.32 161.25 39.1 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.685 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -127.02 140.08 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.068 -1.02 . . . . 0.0 110.374 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -165.15 -103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HB3' ' HZ ' ' A' ' 100' ' ' PHE . . . -99.63 29.35 4.13 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 158.65 -99.74 0.18 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 53' ' ' GLN . 18.7 m -167.38 120.4 0.94 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.644 -0.916 . . . . 0.0 110.236 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.659 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 17.5 m-20 -77.92 -164.25 0.5 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.662 ' CD1' HG12 ' A' ' 99' ' ' VAL . 75.9 m-85 -151.58 152.61 33.13 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.704 0.764 . . . . 0.0 109.023 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' A' ' 125' ' ' PHE . 19.7 m-85 -138.58 132.78 31.6 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.751 HD12 HD23 ' A' ' 97' ' ' LEU . 14.4 mt -149.11 119.0 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 C-N-CA 116.917 -1.913 . . . . 0.0 111.378 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HD2' ' HB2' ' A' ' 49' ' ' GLN . 14.2 ptpt -85.99 98.71 10.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -102.26 141.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.217 0.532 . . . . 0.0 110.746 -175.654 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.788 ' NH1' HG21 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -68.93 125.0 25.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -83.11 38.95 0.62 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.619 0.723 . . . . 0.0 110.839 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.87 -74.09 0.8 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.612 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 54.0 p30 -78.21 44.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.982 -1.305 . . . . 0.0 113.485 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 3.4 t-20 79.94 -41.28 0.22 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.849 -1.157 . . . . 0.0 111.246 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.872 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 33.6 mtmt -67.21 144.3 56.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.723 -1.236 . . . . 0.0 107.826 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.62 ' CE2' ' NH1' ' A' ' 65' ' ' ARG . 18.8 m-30 -104.82 172.16 6.94 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.416 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.574 ' HE1' ' CD2' ' A' ' 40' ' ' TYR . 2.4 mtp -144.01 115.68 8.19 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.723 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -69.63 148.45 49.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.951 ' CD1' HD11 ' A' ' 32' ' ' LEU . 12.9 tp -133.27 132.76 41.79 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.296 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 30.0 tttt -122.61 103.34 8.62 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.016 HG21 HG23 ' A' ' 24' ' ' ILE . 2.4 t -108.8 163.64 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.32 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.698 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.2 t80 -127.05 133.13 50.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.975 -1.078 . . . . 0.0 108.809 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.585 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 5.9 tttt . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 108' ' ' LEU . 6.9 mp . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 122.422 1.106 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.4 p -146.07 164.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.927 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.629 HD11 ' O ' ' A' ' 112' ' ' GLY . 11.1 tp -98.01 83.85 3.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.615 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -72.69 -10.15 59.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 111.157 -177.157 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.629 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 174.35 -165.96 37.7 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 37.6 p90 164.98 137.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.677 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 1.5 mm-40 -103.09 107.99 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.822 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -66.6 162.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.634 -1.291 . . . . 0.0 111.626 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' A ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 115' ' ' VAL . 22.6 t0 39.49 30.69 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.635 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -77.8 158.39 29.55 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.695 -1.253 . . . . 0.0 108.254 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -118.34 179.4 4.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.039 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -65.03 -50.07 67.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 0.0 109.271 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' LYS . 13.9 t70 -44.5 -27.16 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.493 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -76.19 88.39 3.06 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.507 -0.746 . . . . 0.0 109.385 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.08 164.82 3.74 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.723 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -90.35 50.84 1.9 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.373 -1.454 . . . . 0.0 109.674 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -48.84 -177.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.083 178.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.464 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -42.41 94.11 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.677 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.363 -1.081 . . . . 0.0 109.646 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.93 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.871 0.843 . . . . 0.0 111.082 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' GLU . 2.0 t -101.4 167.95 9.84 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.52 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.652 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.14 98.62 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.39 127.3 90.33 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 176.386 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.72 124.39 13.12 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -45.47 128.77 8.3 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.952 0.882 . . . . 0.0 111.667 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.611 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -101.07 -171.89 0.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 177.255 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.4 Cg_endo -69.06 -18.29 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 N-CA-C 109.369 -1.05 . . . . 0.0 109.369 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -43.3 22.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.143 -0.973 . . . . 0.0 108.504 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.827 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -63.33 -47.46 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.55 ' HG2' ' HB3' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -58.31 -23.03 55.24 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.4 tt0 -76.88 -40.61 46.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.22 -0.925 . . . . 0.0 110.286 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.01 HG23 HG21 ' A' ' 99' ' ' VAL . 3.0 mt -61.28 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.802 HG22 ' HB2' ' A' ' 45' ' ' LEU . 14.7 p -64.14 -41.65 93.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.017 0.913 . . . . 0.0 109.021 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.707 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.9 t70 -72.51 -12.56 61.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mttt -96.71 -10.12 27.57 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.039 HG21 HD21 ' A' ' 97' ' ' LEU . 4.3 m -120.76 -6.03 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 110.473 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.627 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -48.37 -45.28 67.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 0.0 110.379 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.4 Cg_endo -72.23 -28.94 14.85 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.287 1.324 . . . . 0.0 109.517 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' O ' HD23 ' A' ' 110' ' ' LEU . 74.9 mt-30 -81.79 -7.49 59.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.015 HD11 HD13 ' A' ' 97' ' ' LEU . 11.1 mt -88.1 -48.77 7.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -63.29 -25.25 68.23 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.149 0.5 . . . . 0.0 110.027 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -88.58 -28.14 20.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 110.178 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 13.8 mmtt -99.87 2.85 44.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 110.094 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.911 HG21 ' CE2' ' A' ' 40' ' ' TYR . 6.1 t -128.2 -4.48 5.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.121 -0.987 . . . . 0.0 109.874 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 40.14 45.3 1.67 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 109.834 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -138.14 161.25 37.28 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.408 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -88.16 119.11 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 110.309 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.911 ' CE2' HG21 ' A' ' 36' ' ' THR . 14.8 m-30 -114.29 -169.8 1.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -153.89 -171.84 21.35 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 43' ' ' GLY . 3.8 mttt -44.36 135.66 4.48 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.802 ' HB2' HG22 ' A' ' 25' ' ' VAL . 31.0 mt -107.66 69.77 0.75 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.897 -1.127 . . . . 0.0 109.028 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -58.15 86.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.271 -178.674 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.602 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -41.01 142.68 0.46 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 109.963 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 2.1 t -125.26 -40.31 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -140.43 171.32 14.3 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.827 ' HB3' HG21 ' A' ' 21' ' ' ILE . 4.3 p90 -170.18 141.45 2.09 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.73 -1.231 . . . . 0.0 110.944 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 4.7 mttp -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.1 p -82.83 -174.31 5.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.153 -0.967 . . . . 0.0 110.739 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.764 ' O ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -165.11 148.74 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.21 134.62 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 120.844 -1.16 . . . . 0.0 110.936 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -160.35 -102.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.03 29.06 4.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.433 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 159.66 -105.54 0.27 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 53' ' ' GLN . 23.3 m -168.26 118.78 0.78 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.682 -0.893 . . . . 0.0 110.327 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.632 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 43.3 m-20 -79.07 -165.64 0.79 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 32.2 m-85 -148.36 157.62 43.59 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.236 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.646 ' C ' HG13 ' A' ' 62' ' ' ILE . 18.9 m-85 -139.65 137.56 35.36 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.713 ' N ' HD22 ' A' ' 122' ' ' LEU . 10.9 mt -155.9 126.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 116.935 -1.906 . . . . 0.0 112.067 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.663 ' HZ1' ' HB3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -97.45 94.54 7.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 176.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 25' ' ' VAL . 5.3 m -102.51 143.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.519 -0.738 . . . . 0.0 111.338 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.01 125.34 26.0 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.91 46.24 1.16 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.147 0.975 . . . . 0.0 109.358 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 94.2 -105.79 3.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 67' ' ' GLY . 5.6 p-10 -58.29 -144.73 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.497 -1.002 . . . . 0.0 109.93 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -77.53 -2.11 33.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.823 -1.173 . . . . 0.0 110.252 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -69.82 168.9 14.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.651 ' CD1' ' HD2' ' A' ' 63' ' ' LYS . 35.6 m-85 -142.13 165.3 27.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.779 ' HE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -152.7 116.5 4.8 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.725 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.894 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -73.99 143.61 45.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.039 HD21 HG21 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -146.29 130.19 17.22 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.845 -1.159 . . . . 0.0 110.786 -178.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.3 pttm -115.26 130.7 56.98 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.487 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.01 HG21 HG23 ' A' ' 24' ' ' ILE . 1.6 t -117.15 167.11 10.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.717 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.9 t80 -132.23 123.57 27.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.467 -1.396 . . . . 0.0 108.445 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.942 ' HG3' HD11 ' A' ' 108' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.942 HD11 ' HG3' ' A' ' 101' ' ' LYS . 11.0 mp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 122.408 1.099 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.717 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.0 p -148.78 160.93 5.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.774 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.874 HD13 HD11 ' A' ' 97' ' ' LEU . 1.9 tp -96.84 86.25 3.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -68.7 -20.71 64.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.97 -1.081 . . . . 0.0 111.087 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.506 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 178.32 -163.35 31.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.777 -1.677 . . . . 0.0 110.84 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.755 ' HD2' HD11 ' A' ' 110' ' ' LEU . 29.2 p90 167.81 135.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.687 -0.89 . . . . 0.0 108.896 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.679 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -94.55 103.36 15.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.023 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.483 ' HA ' ' HG2' ' A' ' 95' ' ' MET . 3.6 p -67.06 159.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.679 -1.263 . . . . 0.0 110.536 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.76 32.93 1.35 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.663 ' HB3' ' HZ1' ' A' ' 63' ' ' LYS . 5.0 tptt -90.53 127.06 36.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.519 -1.363 . . . . 0.0 109.248 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.517 ' O ' ' CE ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -68.9 170.57 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.51 -0.744 . . . . 0.0 110.191 -178.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -62.99 -61.13 2.6 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.428 -0.795 . . . . 0.0 109.551 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 12.7 t0 -40.28 -31.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.48 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 1.1 t70 -50.77 121.54 6.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 110.031 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.7 OUTLIER -88.66 134.93 33.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.894 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 2.5 mp -65.22 -40.95 94.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.834 -1.166 . . . . 0.0 108.442 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 54.83 -161.91 0.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.027 0.918 . . . . 0.0 111.248 176.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.93 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -47.84 -17.97 0.64 Allowed Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.679 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 O-C-N 121.17 -1.194 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.417 HD23 ' CG ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 122.176 0.988 . . . . 0.0 110.586 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.516 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -102.07 -178.63 3.76 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.357 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.533 ' O ' ' CE ' ' A' ' 15' ' ' LYS . 2.8 mm-40 -59.01 135.0 57.49 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.05 -1.031 . . . . 0.0 108.797 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.586 ' HB2' ' CG ' ' A' ' 121' ' ' GLU . . . -39.4 109.34 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.226 -0.921 . . . . 0.0 110.936 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -79.59 129.85 70.01 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 175.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.95 128.92 20.71 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.635 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -43.29 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.627 1.203 . . . . 0.0 112.285 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.659 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.59 -167.69 0.16 Allowed Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.7 Cg_endo -71.83 -18.02 28.58 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 109.263 -1.091 . . . . 0.0 109.263 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -83.28 -44.91 14.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 108.569 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 21' ' ' ILE . 4.1 mm -57.82 -54.57 29.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.509 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 9.7 tp60 -60.45 -20.86 61.35 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.536 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 tm-20 -73.67 -36.84 65.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.683 -1.26 . . . . 0.0 109.091 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.889 HG23 HG21 ' A' ' 99' ' ' VAL . 4.5 mt -65.95 -50.76 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.084 0.945 . . . . 0.0 108.967 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 45' ' ' LEU . 8.7 p -65.0 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 122.074 0.94 . . . . 0.0 109.708 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.74 ' N ' HG13 ' A' ' 25' ' ' VAL . 31.6 t70 -70.26 -18.15 63.13 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.91 -17.68 27.54 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.591 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.695 HG11 ' CG2' ' A' ' 99' ' ' VAL . 30.9 m -107.54 -9.32 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -47.07 -46.13 53.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.912 -1.117 . . . . 0.0 109.947 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.3 Cg_endo -73.73 -29.89 10.11 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.442 1.428 . . . . 0.0 109.097 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 110' ' ' LEU . 7.4 mt-30 -81.57 -2.22 49.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.053 ' CD1' HD21 ' A' ' 97' ' ' LEU . 4.6 mt -95.08 -41.39 9.14 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.542 -0.723 . . . . 0.0 109.503 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 10.5 mt-10 -75.29 -23.64 57.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.537 -0.727 . . . . 0.0 109.441 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -23.57 21.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.994 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.33 -6.43 34.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.703 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 32' ' ' LEU . 1.4 t -127.58 -30.57 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.8 OUTLIER 91.98 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.403 0.621 . . . . 0.0 109.939 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.513 ' HB2' ' CG2' ' A' ' 36' ' ' THR . 1.2 mm-40 -110.04 -176.56 3.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 0.0 109.363 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' TYR . 7.3 m -108.89 -24.45 11.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.799 ' OH ' HG23 ' A' ' 115' ' ' VAL . 20.5 m-85 34.31 -162.91 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.784 0.802 . . . . 0.0 111.088 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' HG ' ' A' ' 45' ' ' LEU . . . 175.26 -160.27 28.87 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -42.6 125.78 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -1.095 . . . . 0.0 109.275 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 25' ' ' VAL . 68.1 mt -108.62 82.58 1.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.079 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 25.5 mt-10 -64.16 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.35 -0.844 . . . . 0.0 110.094 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.88 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -42.05 149.42 0.15 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.397 1.094 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.91 -44.46 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -152.69 168.89 24.17 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 17.5 p90 -166.0 144.53 5.84 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 111.284 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.578 ' CE ' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -109.14 165.7 11.4 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.62 141.71 29.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.511 ' HG3' ' OH ' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -117.55 162.87 17.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -117.59 135.17 58.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.162 -0.961 . . . . 0.0 110.035 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -158.74 -101.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -101.01 30.17 4.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.77 -115.24 0.65 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 106.411 -2.676 . . . . 0.0 106.411 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.512 ' CB ' ' HE3' ' A' ' 101' ' ' LYS . 10.3 m -160.55 125.95 3.89 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.275 -1.132 . . . . 0.0 110.343 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.544 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 61.8 m-80 -78.0 -172.37 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' A' ' 101' ' ' LYS . 18.7 m-85 -150.4 154.37 37.63 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.439 1.114 . . . . 0.0 110.004 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 17.2 m-85 -152.73 130.83 11.88 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.612 HG22 HG22 ' A' ' 64' ' ' VAL . 4.3 mt -146.39 118.53 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 117.133 -1.827 . . . . 0.0 112.073 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.692 ' N ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.31 102.29 6.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 175.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.88 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -111.65 137.85 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.739 . . . . 0.0 110.807 -175.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.2 127.41 32.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.846 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -80.45 36.71 0.38 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.557 0.694 . . . . 0.0 110.884 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.96 -75.78 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.596 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -79.85 47.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 113.165 -176.37 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 1.2 t-20 79.31 -38.75 0.2 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.93 -1.106 . . . . 0.0 111.739 177.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.846 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.8 mtmp? -66.99 144.57 56.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.581 -1.324 . . . . 0.0 107.469 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.608 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 15.3 m-30 -108.51 170.89 7.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.298 -0.877 . . . . 0.0 109.898 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -155.82 127.94 7.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.496 -0.752 . . . . 0.0 109.069 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.777 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -77.5 139.92 39.69 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.053 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -123.05 127.78 49.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 111.097 -179.043 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 4.4 ttmt -113.01 126.84 55.93 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.889 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -133.49 166.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.087 -1.008 . . . . 0.0 109.515 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.677 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 48.3 t80 -130.79 132.68 45.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.277 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 5.6 mp . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 122.217 1.008 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.828 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.4 p -137.6 162.44 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.084 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.663 HD11 ' O ' ' A' ' 112' ' ' GLY . 16.3 tp -102.28 89.07 3.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.449 HG21 ' HB2' ' A' ' 100' ' ' PHE . 11.2 p -68.5 -21.22 64.61 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.314 -0.866 . . . . 0.0 110.707 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.663 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -179.7 -161.26 26.69 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.623 -1.751 . . . . 0.0 111.029 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.674 ' CB ' HD21 ' A' ' 32' ' ' LEU . 29.1 p90 170.08 133.48 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.745 -0.856 . . . . 0.0 108.968 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.673 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.18 107.84 20.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.799 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -66.75 158.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.582 -1.324 . . . . 0.0 111.239 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.9 t70 41.84 37.87 0.88 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.714 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.529 ' CE ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -81.06 -169.77 2.4 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.543 -1.348 . . . . 0.0 107.953 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 62.6 m-80 -148.07 -176.42 5.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.648 -1.283 . . . . 0.0 110.686 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 119' ' ' ASP . 1.3 ttmm -74.74 -46.22 38.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.63 -0.669 . . . . 0.0 109.464 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.5 t70 -47.61 -24.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.142 -0.974 . . . . 0.0 108.441 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 21.6 t0 -83.22 66.12 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.672 -0.643 . . . . 0.0 109.395 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.586 ' CG ' ' HB2' ' A' ' 14' ' ' ALA . 1.8 tt0 -61.35 103.27 0.29 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.786 -1.196 . . . . 0.0 108.052 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.777 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 3.4 mp -26.39 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.585 1.184 . . . . 0.0 110.256 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER -108.0 -7.91 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.066 -177.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.15 107.43 0.2 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.673 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.661 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 123' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.93 0.871 . . . . 0.0 110.935 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -101.51 171.22 7.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' SER . 12.7 tm-20 -43.53 166.97 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.281 -0.887 . . . . 0.0 109.347 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' N ' ' CD ' ' A' ' 13' ' ' GLU . . . -71.25 103.05 2.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.609 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -73.28 132.65 81.72 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 175.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.39 127.67 18.69 Favored 'Trans proline' 0 C--N 1.293 -2.352 0 N-CA-C 109.378 -1.047 . . . . 0.0 109.378 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.729 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -47.29 132.35 12.87 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.044 0.926 . . . . 0.0 111.909 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.619 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -102.56 -172.63 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.273 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.0 Cg_endo -68.08 -17.59 45.77 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 N-CA-C 109.545 -0.983 . . . . 0.0 109.545 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -81.79 -36.62 28.23 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.09 -1.006 . . . . 0.0 108.494 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.822 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -68.84 -45.31 80.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.504 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 11.0 tp60 -66.82 -18.92 65.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.73 -30.29 59.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.835 -1.166 . . . . 0.0 108.774 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.922 ' O ' HG22 ' A' ' 28' ' ' VAL . 46.0 mt -71.61 -51.98 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.737 HG13 ' N ' ' A' ' 26' ' ' ASP . 8.4 p -60.1 -42.89 91.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.879 0.847 . . . . 0.0 109.074 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.737 ' N ' HG13 ' A' ' 25' ' ' VAL . 1.4 t70 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' GLU . 7.3 mttt -81.45 -6.85 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.041 HG21 ' CD2' ' A' ' 97' ' ' LEU . 6.4 m -127.05 -8.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.577 -0.702 . . . . 0.0 110.501 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 15.5 ttpp -41.66 -47.9 9.74 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.024 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.0 Cg_endo -72.87 -34.88 6.17 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.33 1.354 . . . . 0.0 109.655 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.502 ' O ' HD23 ' A' ' 110' ' ' LEU . 60.9 mt-30 -74.6 -5.35 42.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.922 . . . . 0.0 108.513 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.89 HD11 HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.84 -37.47 8.67 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.863 0.839 . . . . 0.0 109.048 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.1 mt-10 -54.07 -54.88 33.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.654 -0.654 . . . . 0.0 110.55 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.71 -35.78 57.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 110.491 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 1.3 mptp? -53.46 -56.73 14.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.222 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.974 HG21 ' OH ' ' A' ' 40' ' ' TYR . 10.0 t -95.37 20.67 9.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER 41.32 39.83 1.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.328 -0.858 . . . . 0.0 110.001 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.685 ' HB3' HG23 ' A' ' 36' ' ' THR . 1.6 tt0 -136.77 160.12 39.81 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -102.92 135.8 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.698 -1.251 . . . . 0.0 110.422 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.974 ' OH ' HG21 ' A' ' 36' ' ' THR . 98.5 m-85 -117.52 169.1 9.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.834 . . . . 0.0 109.296 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -125.88 -164.69 11.86 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.1 123.82 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -1.206 . . . . 0.0 108.595 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.716 ' HB3' HG21 ' A' ' 64' ' ' VAL . 39.1 mt -100.32 76.72 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.919 -1.113 . . . . 0.0 109.063 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -57.2 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.461 0.648 . . . . 0.0 109.777 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.729 ' HB1' ' CB ' ' A' ' 17' ' ' ALA . . . -42.82 133.67 3.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.117 0.96 . . . . 0.0 110.006 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.2 t -113.36 -41.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -146.55 171.26 15.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.006 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.822 ' HB3' HG21 ' A' ' 21' ' ' ILE . 1.9 p90 -167.6 141.43 3.53 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.38 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 1.1 mppp? -121.14 128.91 52.98 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.956 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.5 p -73.01 -172.07 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.967 -1.083 . . . . 0.0 109.703 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.637 ' CG ' ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -167.33 127.27 1.43 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.6 p -107.84 115.58 49.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.507 HG21 ' ND2' ' A' ' 59' ' ' ASN . 0.3 OUTLIER -136.85 -104.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.65 29.55 4.05 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.57 -116.73 0.73 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 11.5 m -158.61 113.49 2.55 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.218 -1.166 . . . . 0.0 110.113 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.594 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 54.8 m-20 -82.37 -173.13 4.39 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.836 0.827 . . . . 0.0 109.099 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.649 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 93.2 m-85 -137.49 152.0 49.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.637 ' CE1' ' CG ' ' A' ' 53' ' ' GLN . 4.5 m-85 -133.29 138.25 46.35 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.735 ' N ' HD22 ' A' ' 122' ' ' LEU . 13.0 mt -156.2 125.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 116.747 -1.981 . . . . 0.0 112.466 -175.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.569 ' HD2' ' NE2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -103.12 90.64 3.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 45' ' ' LEU . 5.1 m -97.47 159.69 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.355 -0.84 . . . . 0.0 110.973 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.681 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -82.38 128.93 34.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.455 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.1 45.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.005 0.907 . . . . 0.0 109.377 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 86.23 -96.82 2.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 9.8 p-10 -58.83 -146.74 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.479 -1.012 . . . . 0.0 109.759 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.72 0.84 28.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.079 -1.013 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.58 175.72 6.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.265 -0.897 . . . . 0.0 109.238 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 21.7 m-85 -150.22 169.12 22.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 108.899 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.75 ' SD ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -151.86 112.75 4.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.706 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -72.28 152.44 42.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.041 ' CD2' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -146.85 158.06 43.82 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.279 -1.368 . . . . 0.0 111.615 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 6.5 mtpt -141.3 114.03 8.37 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.965 HG11 HD23 ' A' ' 108' ' ' LEU . 2.3 t -118.8 168.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.746 -1.221 . . . . 0.0 110.358 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.633 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 1.2 t80 -130.59 122.66 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 108.708 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.835 ' CG ' HD11 ' A' ' 108' ' ' LEU . 4.9 tttt . . . . . 0 N--CA 1.504 2.266 0 CA-C-O 122.935 1.35 . . . . 0.0 108.299 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.965 HD23 HG11 ' A' ' 99' ' ' VAL . 6.2 mp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 122.314 1.054 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.1 p -143.9 163.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.798 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.67 HD22 ' HG ' ' A' ' 32' ' ' LEU . 6.4 tp -101.7 84.38 2.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.584 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 41.4 p -67.02 -19.82 65.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -176.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 178.36 -170.24 42.24 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.442 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.3 p90 172.53 134.53 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.452 -1.029 . . . . 0.0 109.501 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.626 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 2.0 mm100 -96.85 103.25 15.15 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.683 HG23 ' OH ' ' A' ' 40' ' ' TYR . 2.2 p -66.79 154.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 122.254 1.026 . . . . 0.0 111.057 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' A ASP . . . . . . . . . . . . . 12.7 t0 47.29 33.01 2.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.952 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.525 ' HG2' ' ND1' ' A' ' 96' ' ' HIS . 5.6 tptt -77.84 162.62 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.446 -1.409 . . . . 0.0 108.461 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.442 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -107.88 160.76 15.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.93 -1.106 . . . . 0.0 109.911 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 3.0 ttpm? -55.47 -48.95 73.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -46.48 -38.44 9.22 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.335 -0.853 . . . . 0.0 109.126 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.613 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -66.27 96.31 0.34 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.325 -0.859 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.31 170.74 15.78 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.735 HD22 ' N ' ' A' ' 62' ' ' ILE . 3.4 mp -93.16 25.4 3.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.411 -1.43 . . . . 0.0 109.202 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.922 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -17.14 -59.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.596 177.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.529 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . -150.09 41.06 0.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CG ' ' OXT' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.57 0 CA-C-O 117.827 -1.083 . . . . 0.0 109.054 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 123' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.969 0.89 . . . . 0.0 112.867 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.518 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 23.0 t -102.2 169.56 8.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 42.4 tt0 -46.87 172.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.109 -0.995 . . . . 0.0 109.267 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -81.65 107.25 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.956 -1.09 . . . . 0.0 110.228 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.665 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 1.1 mmtt -77.37 139.95 64.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.22 129.23 22.3 Favored 'Trans proline' 0 C--N 1.291 -2.476 0 N-CA-C 109.584 -0.968 . . . . 0.0 109.584 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.64 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -51.63 133.7 30.45 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.373 1.083 . . . . 0.0 111.788 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.656 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -109.33 -165.19 0.07 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.656 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -72.11 -16.52 28.62 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.428 ' CG ' ' N ' ' A' ' 21' ' ' ILE . 7.5 pt-20 -81.53 -39.1 25.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.924 -1.11 . . . . 0.0 108.539 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.797 HG21 ' HB3' ' A' ' 50' ' ' TYR . 25.7 mm -67.39 -50.32 63.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.559 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -65.13 -15.04 61.97 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -77.37 -37.35 52.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.174 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 99' ' ' VAL . 4.6 mt -63.9 -50.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 26' ' ' ASP . 14.3 p -66.75 -40.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.099 0.952 . . . . 0.0 109.253 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.698 ' N ' HG13 ' A' ' 25' ' ' VAL . 18.5 t0 -72.37 -15.08 61.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -92.91 -13.56 28.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' CG2' ' A' ' 99' ' ' VAL . 31.6 m -116.86 -6.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.487 -0.758 . . . . 0.0 109.676 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.614 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -46.03 -48.55 41.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.894 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.8 Cg_endo -73.58 -29.19 11.13 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.575 1.517 . . . . 0.0 109.101 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' HD23 ' A' ' 110' ' ' LEU . 54.0 mt-30 -79.66 -4.77 53.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.057 ' O ' HG22 ' A' ' 36' ' ' THR . 2.3 mt -98.2 -41.34 7.94 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.657 0.741 . . . . 0.0 109.016 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -65.83 -22.58 66.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 110.453 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -36.45 12.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.955 -1.091 . . . . 0.0 110.206 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -53.68 10.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.043 . . . . 0.0 110.045 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 1.057 HG22 ' O ' ' A' ' 32' ' ' LEU . 10.0 t -78.76 6.6 8.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.737 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 3.5 p-10 42.93 42.95 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.715 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.548 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 7.9 tt0 -139.22 159.67 41.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.162 -0.962 . . . . 0.0 108.961 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.561 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -94.32 133.51 37.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 110.203 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.845 ' OH ' HG21 ' A' ' 36' ' ' THR . 21.1 m-85 -122.77 -168.51 1.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -144.25 -171.1 14.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.99 136.05 3.9 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.162 -1.199 . . . . 0.0 108.978 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.645 ' HB2' HG22 ' A' ' 25' ' ' VAL . 29.9 mt -107.89 85.18 2.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.044 -1.035 . . . . 0.0 108.901 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -68.64 84.47 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.697 -0.627 . . . . 0.0 109.534 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.949 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.6 129.5 5.33 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.211 1.005 . . . . 0.0 109.953 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.536 HG11 ' NZ ' ' A' ' 63' ' ' LYS . 1.5 t -105.0 -46.26 9.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.646 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 1.8 mt-30 -146.92 167.23 24.47 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.797 ' HB3' HG21 ' A' ' 21' ' ' ILE . 3.8 p90 -161.1 137.51 8.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.565 -1.335 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 1.9 mttt -103.73 122.92 46.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.503 HG22 ' HE2' ' A' ' 50' ' ' TYR . 44.1 p -70.43 -173.67 0.75 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.882 ' O ' HG23 ' A' ' 58' ' ' THR . 0.6 OUTLIER -162.18 145.84 11.95 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.885 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -127.67 139.45 51.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.741 -1.224 . . . . 0.0 110.283 179.246 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.885 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.38 -100.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.22 29.6 5.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 157.72 -115.68 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 106.449 -2.66 . . . . 0.0 106.449 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.882 HG23 ' O ' ' A' ' 53' ' ' GLN . 27.4 m -162.32 111.66 1.45 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.188 -1.184 . . . . 0.0 110.831 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.702 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 77.8 m-20 -77.92 -169.49 1.57 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.633 ' CD1' HG12 ' A' ' 99' ' ' VAL . 25.2 m-85 -149.97 159.09 44.66 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.279 -0.888 . . . . 0.0 109.891 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.609 ' HB3' HD22 ' A' ' 122' ' ' LEU . 22.9 m-85 -140.11 136.53 33.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.829 HD12 HD23 ' A' ' 97' ' ' LEU . 14.4 mt -151.29 121.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 116.775 -1.97 . . . . 0.0 111.312 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' NZ ' HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -86.92 94.77 9.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.092 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.949 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.6 m -102.01 141.66 17.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.566 -0.709 . . . . 0.0 110.943 -176.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.614 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -68.88 129.41 39.85 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.59 47.25 1.4 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.033 0.92 . . . . 0.0 108.744 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.56 -94.96 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.69 -164.74 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.333 -1.098 . . . . 0.0 109.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -64.0 -9.04 13.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 110.121 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -68.53 163.52 23.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.614 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 6.5 m-85 -133.32 176.6 8.38 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 108.707 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.682 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -157.32 108.76 2.34 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.176 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.972 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -69.58 144.49 53.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.829 HD23 HD12 ' A' ' 62' ' ' ILE . 46.3 tp -130.59 153.32 49.02 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.994 -1.066 . . . . 0.0 111.063 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.3 ttmt -139.01 111.09 7.31 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 24' ' ' ILE . 1.9 t -117.44 161.14 16.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.713 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 3.2 t80 -127.36 127.92 45.03 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.702 -1.249 . . . . 0.0 107.815 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HB3' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.266 -0.896 . . . . 0.0 108.721 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.3 mp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 122.42 1.105 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.727 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.9 p -158.57 164.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.055 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.81 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.9 tp -97.47 83.13 3.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.6 OUTLIER -71.94 -11.57 60.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 112.082 -176.197 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.509 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . 175.28 -171.91 45.0 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.575 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.81 ' HD2' HD11 ' A' ' 110' ' ' LEU . 20.8 p90 168.39 134.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.217 -1.167 . . . . 0.0 109.137 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -94.61 102.2 14.1 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.498 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 2.3 p -68.41 164.08 2.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.868 -1.145 . . . . 0.0 110.73 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.88 25.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.86 -0.525 . . . . 0.0 110.711 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.576 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.54 161.72 13.52 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 120.66 -1.275 . . . . 0.0 108.366 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.55 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 25.0 p-10 -140.4 -155.79 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.613 -1.305 . . . . 0.0 111.389 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -65.31 -48.46 73.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.27 0.557 . . . . 0.0 110.031 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 118' ' ' LYS . 2.9 t70 -41.05 -26.59 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 109.915 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.576 ' CB ' ' CD ' ' A' ' 116' ' ' LYS . 3.1 t70 -98.26 115.0 27.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 111.376 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.7 ' O ' HG23 ' A' ' 123' ' ' THR . 3.0 tt0 -75.07 146.89 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.972 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -66.59 -12.3 57.23 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.336 -1.477 . . . . 0.0 109.417 -178.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 37.25 -156.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.44 177.486 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -83.93 49.58 4.26 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.655 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.267 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.614 HD22 ' C ' ' A' ' 123' ' ' THR . 1.1 mp . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.955 0.883 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -101.59 171.44 7.56 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.67 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.99 -179.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.384 -0.823 . . . . 0.0 109.526 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HB1' ' CD ' ' A' ' 49' ' ' GLN . . . -82.89 107.76 15.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.005 . . . . 0.0 110.003 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.669 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -83.4 128.78 62.99 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 175.692 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.87 130.78 23.9 Favored 'Trans proline' 0 C--N 1.294 -2.29 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.501 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -46.53 162.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.392 1.092 . . . . 0.0 111.552 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.642 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -143.31 -166.95 0.14 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.73 -18.28 28.74 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 N-CA-C 108.992 -1.195 . . . . 0.0 108.992 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.45 -45.57 14.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 0.0 108.567 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.816 HG21 ' HB3' ' A' ' 50' ' ' TYR . 3.6 mm -58.48 -53.16 50.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.536 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.37 -19.84 62.32 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 tm-20 -73.87 -35.73 64.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.428 -1.42 . . . . 0.0 108.505 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.94 HG23 HG21 ' A' ' 99' ' ' VAL . 5.1 mt -65.46 -51.22 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.75 0.786 . . . . 0.0 108.934 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.828 HG21 HG11 ' A' ' 64' ' ' VAL . 8.8 p -62.34 -41.99 93.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 122.054 0.931 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.714 ' N ' HG13 ' A' ' 25' ' ' VAL . 6.3 t70 -69.95 -19.86 63.35 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.0 tttt -79.35 -20.7 47.13 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.665 HG21 HD21 ' A' ' 97' ' ' LEU . 17.6 m -117.83 3.1 7.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.732 -0.605 . . . . 0.0 109.938 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 14.7 tttp -47.91 -46.85 64.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.695 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.7 Cg_endo -75.34 -27.34 9.57 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.555 1.503 . . . . 0.0 109.028 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.624 ' O ' HD23 ' A' ' 110' ' ' LEU . 2.4 mt-30 -83.01 -1.03 51.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.127 HD11 ' CD1' ' A' ' 97' ' ' LEU . 2.5 mt -100.47 -33.48 10.33 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.676 0.75 . . . . 0.0 109.269 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 38' ' ' GLU . 2.4 mm-40 -73.89 -32.1 63.42 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.572 -0.705 . . . . 0.0 110.838 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -101.44 -4.43 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.355 -1.466 . . . . 0.0 112.009 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -99.95 -11.39 20.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.488 -1.383 . . . . 0.0 110.355 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.586 ' HB ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -140.11 -28.22 0.74 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.998 -1.064 . . . . 0.0 110.889 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.7 p30 149.11 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' GLU . 26.9 tt0 -66.38 105.09 1.36 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.234 1.016 . . . . 0.0 109.904 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 39' ' ' THR . 46.9 m -158.76 14.39 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.66 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.38 -175.53 2.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.048 -1.032 . . . . 0.0 109.171 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -145.72 -108.47 0.57 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -77.76 134.66 38.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -1.183 . . . . 0.0 108.811 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 25' ' ' VAL . 14.5 mt -108.16 83.47 1.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 108.511 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 3.7 mt-10 -71.87 85.5 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.708 -0.62 . . . . 0.0 109.961 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.838 ' N ' HG13 ' A' ' 64' ' ' VAL . . . -40.47 155.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 110.05 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.4 t -134.79 -41.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.671 ' CD ' ' HB1' ' A' ' 14' ' ' ALA . 25.1 tt0 -142.41 168.97 18.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.816 ' HB3' HG21 ' A' ' 21' ' ' ILE . 9.2 p90 -167.8 137.03 2.58 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.607 -1.308 . . . . 0.0 110.727 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 30.1 mttt -112.41 135.16 53.44 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.451 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 p -87.78 175.46 7.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.088 -1.008 . . . . 0.0 109.754 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.791 ' O ' HG23 ' A' ' 58' ' ' THR . 0.8 OUTLIER -150.31 158.96 44.73 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.65 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -129.49 137.03 57.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.935 -1.103 . . . . 0.0 110.495 179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -164.46 -96.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -108.03 28.76 7.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 161.44 -107.05 0.3 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 53' ' ' GLN . 3.3 m -168.59 109.65 0.52 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.592 -0.946 . . . . 0.0 110.729 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.625 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 41.5 m-80 -70.26 -165.98 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.613 ' CD1' HG12 ' A' ' 99' ' ' VAL . 64.6 m-85 -147.7 159.54 43.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.039 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.763 ' HB3' HD22 ' A' ' 122' ' ' LEU . 47.6 m-85 -140.41 138.18 34.55 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.787 HD12 HD23 ' A' ' 97' ' ' LEU . 24.9 mt -155.95 116.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 C-N-CA 116.873 -1.931 . . . . 0.0 111.495 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.717 ' HD2' ' CE1' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -81.66 101.79 10.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.838 HG13 ' N ' ' A' ' 47' ' ' ALA . 11.5 t -113.7 139.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 112.319 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -69.36 121.29 16.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HG2' ' A' ' 95' ' ' MET . . . -82.64 43.0 0.8 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 111.83 -129.73 9.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 67' ' ' GLY . 34.9 t70 -51.4 -107.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.518 -0.989 . . . . 0.0 110.365 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.03 3.99 36.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.71 -1.244 . . . . 0.0 109.706 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 94' ' ' TYR . 13.1 tptt -68.53 157.37 36.14 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' CD ' ' A' ' 65' ' ' ARG . 2.3 m-85 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.975 -1.078 . . . . 0.0 109.595 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . 1.032 ' HE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -163.46 133.66 4.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.572 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.841 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 2.3 m-70 -69.98 161.14 30.61 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.127 ' CD1' HD11 ' A' ' 32' ' ' LEU . 2.8 tp -142.04 129.88 21.76 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.576 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ttmt -117.54 122.43 43.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.94 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -123.83 168.19 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.971 -1.081 . . . . 0.0 109.009 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.703 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 14.8 t80 -131.84 127.42 36.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.85 -1.156 . . . . 0.0 108.954 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.532 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.5 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 122.21 1.005 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.791 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.3 p -136.73 164.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.52 -177.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 31' ' ' GLN . 7.1 tp -100.09 83.66 2.73 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -67.72 -17.29 64.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 111.197 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.622 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 176.32 -164.78 34.81 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.063 -1.541 . . . . 0.0 110.355 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.9 p90 165.99 137.17 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.686 -0.891 . . . . 0.0 109.099 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.622 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 8.6 mm-40 -99.0 94.51 6.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.546 ' HA ' ' CB ' ' A' ' 95' ' ' MET . 1.0 OUTLIER -67.64 157.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.029 -1.669 . . . . 0.0 110.241 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' A ASP . . . . . . . . . . . . . 7.8 t0 53.93 18.6 1.69 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.743 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -87.07 116.15 24.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.687 -1.258 . . . . 0.0 108.364 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.488 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 1.3 m120 -71.72 177.92 3.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.371 -0.831 . . . . 0.0 110.554 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -64.7 -24.22 67.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.62 -0.675 . . . . 0.0 110.066 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.64 -8.78 15.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.168 -0.957 . . . . 0.0 109.605 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.449 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -95.18 116.01 28.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.234 -0.916 . . . . 0.0 110.228 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 123' ' ' THR . 8.1 tt0 -86.95 139.31 30.73 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.841 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 3.1 mp -62.88 -46.97 85.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.775 -1.203 . . . . 0.0 109.256 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.719 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 54.78 -157.55 0.21 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 107.331 178.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.541 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -77.98 66.45 3.11 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.631 ' CD1' ' O ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.72 -0.871 . . . . 0.0 109.934 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.112 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.83 0.824 . . . . 0.0 110.617 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -100.97 170.96 7.93 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.457 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 1.0 OUTLIER -49.04 -179.38 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 0.0 109.836 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.494 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . . . -81.2 99.04 8.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 110.25 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 2.2 mmpt? -70.42 128.42 91.25 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.61 126.3 14.57 Favored 'Trans proline' 0 C--N 1.292 -2.414 0 N-CA-C 108.813 -1.264 . . . . 0.0 108.813 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 21' ' ' ILE . . . -37.41 162.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.495 1.14 . . . . 0.0 111.794 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.662 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -145.6 -166.17 0.12 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -72.9 -21.09 21.51 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.503 -1.384 . . . . 0.0 108.503 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.504 ' O ' HD12 ' A' ' 24' ' ' ILE . 3.4 mt-10 -81.3 -44.92 16.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -0.969 . . . . 0.0 108.811 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.702 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.4 mm -58.7 -56.18 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.476 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 2.0 tp-100 -57.5 -20.09 29.01 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.3 tt0 -75.13 -39.17 60.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.339 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.088 HG23 HG21 ' A' ' 99' ' ' VAL . 2.2 mt -63.76 -49.63 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.043 0.925 . . . . 0.0 108.77 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.72 HG13 ' N ' ' A' ' 26' ' ' ASP . 12.4 p -66.82 -40.57 86.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 122.307 1.051 . . . . 0.0 109.401 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.72 ' N ' HG13 ' A' ' 25' ' ' VAL . 19.3 t0 -75.46 -13.35 60.38 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -95.43 -10.1 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.925 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.899 HG21 ' CD2' ' A' ' 97' ' ' LEU . 27.0 m -114.59 -15.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 110.981 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 ttpt -37.95 -51.07 3.08 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.035 -1.041 . . . . 0.0 110.911 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.5 Cg_endo -70.5 -35.9 9.72 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.421 1.414 . . . . 0.0 109.413 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' HD23 ' A' ' 110' ' ' LEU . 70.6 mt-30 -71.76 -6.44 41.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.9 HD13 ' CE ' ' A' ' 95' ' ' MET . 2.6 mt -96.79 -41.97 8.21 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 13.9 mt-10 -66.84 -8.99 32.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -0.808 . . . . 0.0 109.182 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.34 -56.4 2.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -48.56 20.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 109.958 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.607 HG22 ' CZ ' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -79.39 -14.56 58.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.06 -1.025 . . . . 0.0 108.973 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 1.4 p-10 44.97 64.84 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.417 0.627 . . . . 0.0 109.907 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.574 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 9.1 mt-10 -130.77 -177.74 4.49 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.3 m -98.8 -26.69 14.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.574 ' CE1' ' OE1' ' A' ' 38' ' ' GLU . 19.6 m-85 35.45 -161.84 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.809 0.814 . . . . 0.0 110.529 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . 179.26 -169.83 41.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.65 129.7 3.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -1.093 . . . . 0.0 108.793 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.705 HD12 HG22 ' A' ' 25' ' ' VAL . 44.2 mt -109.48 82.98 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.846 -1.158 . . . . 0.0 109.301 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -63.74 84.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.522 -0.737 . . . . 0.0 109.932 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.939 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.68 123.29 3.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.145 0.974 . . . . 0.0 109.966 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.2 t -99.51 -47.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.526 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 4.7 mm100 -145.18 172.58 12.91 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.702 ' HB3' HG21 ' A' ' 21' ' ' ILE . 17.2 p90 -166.89 137.08 3.08 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.061 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.541 ' CD ' ' HB2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.13 133.75 54.88 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.915 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.6 p -76.73 -176.87 4.02 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.273 -0.892 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.704 ' O ' HG23 ' A' ' 58' ' ' THR . 1.4 mm100 -160.32 149.22 17.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.581 -0.699 . . . . 0.0 109.323 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -120.48 141.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 110.576 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.25 -103.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.1 30.58 3.71 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.07 -118.19 0.85 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 106.178 -2.769 . . . . 0.0 106.178 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 53' ' ' GLN . 11.4 m -154.38 116.66 4.29 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.332 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.626 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 64.8 m-20 -77.72 -166.03 0.71 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.686 ' CD1' HG12 ' A' ' 99' ' ' VAL . 85.1 m-85 -147.34 153.14 39.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.617 ' CE1' ' OXT' ' A' ' 125' ' ' PHE . 16.0 m-30 -136.94 132.32 34.25 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.807 HG22 HG13 ' A' ' 64' ' ' VAL . 13.6 mt -148.97 124.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 117.06 -1.856 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HA ' ' HZ1' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -95.78 94.66 7.8 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 176.254 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 47' ' ' ALA . 15.7 m -99.4 144.88 11.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.274 0.559 . . . . 0.0 110.642 -176.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.658 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.1 mmm-85 -69.24 125.41 26.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.919 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -86.26 46.59 1.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.072 0.939 . . . . 0.0 108.904 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 -85.23 1.39 Allowed Glycine 0 C--N 1.287 -2.167 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.39 -168.67 1.2 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.203 -1.175 . . . . 0.0 109.87 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.13 7.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.919 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -69.21 127.02 31.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 108.798 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.599 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 5.6 m-30 -97.39 -179.12 4.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.096 -1.003 . . . . 0.0 110.324 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.9 ' CE ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.0 99.93 3.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.514 -0.741 . . . . 0.0 109.569 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.93 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -71.71 146.96 47.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.899 ' CD2' HG21 ' A' ' 28' ' ' VAL . 4.7 tp -138.21 139.26 39.2 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.371 -1.331 . . . . 0.0 111.531 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 9.6 ttpp -122.92 94.28 4.22 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.088 HG21 HG23 ' A' ' 24' ' ' ILE . 2.3 t -97.25 164.58 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.736 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 7.1 t80 -119.25 138.5 52.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.661 -1.274 . . . . 0.0 108.298 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.651 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.778 0.799 . . . . 0.0 109.064 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 3.0 mp . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 122.373 1.082 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.736 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 11.8 p -147.89 162.19 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.627 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.681 HD22 ' HG ' ' A' ' 32' ' ' LEU . 8.0 tp -98.05 89.23 4.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 100' ' ' PHE . 4.4 p -82.12 -11.98 58.45 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.901 -1.124 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.534 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . -175.01 -168.98 36.35 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.607 ' CZ ' HG22 ' A' ' 36' ' ' THR . 27.0 p90 164.84 139.29 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.578 -0.954 . . . . 0.0 109.26 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.628 ' HG2' ' CE2' ' A' ' 125' ' ' PHE . 3.4 mm100 -102.31 97.82 8.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.523 HG21 ' OE2' ' A' ' 38' ' ' GLU . 2.0 p -66.85 164.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 110.354 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' A ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 115' ' ' VAL . 35.1 t0 43.46 24.75 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.115 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.604 ' HE3' ' CE1' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -69.45 155.35 40.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.702 -1.249 . . . . 0.0 108.284 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.497 ' N ' ' HG2' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -107.9 -174.91 2.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -70.21 -38.78 75.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.813 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.96 -8.07 20.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.984 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.555 ' CB ' ' HG2' ' A' ' 116' ' ' LYS . 5.3 t0 -75.19 91.41 2.62 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.042 -1.036 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -64.4 155.1 33.56 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.93 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -90.13 55.65 3.16 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.667 1.222 . . . . 0.0 109.575 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -46.85 -172.09 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.291 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 1.112 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -45.09 -16.08 0.07 OUTLIER Glycine 0 N--CA 1.503 3.142 0 O-C-N 121.025 -1.047 . . . . 0.0 110.548 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.628 ' CE2' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.685 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.798 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.768 HD22 ' HA2' ' A' ' 124' ' ' GLY . 1.2 pt? . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' GLU . 42.4 m -100.52 179.8 4.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 110.829 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tt0 -49.87 -176.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.674 -0.641 . . . . 0.0 109.992 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.912 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -91.38 100.55 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -68.06 146.58 98.22 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 175.517 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.12 129.63 20.99 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 N-CA-C 108.885 -1.237 . . . . 0.0 108.885 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -37.36 159.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.282 1.039 . . . . 0.0 111.346 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.642 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -139.41 -166.52 0.12 Allowed Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 30.3 Cg_endo -73.65 -17.62 23.1 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 108.693 -1.311 . . . . 0.0 108.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -85.68 -39.95 16.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.713 HG21 ' HB3' ' A' ' 50' ' ' TYR . 6.2 mm -65.17 -53.72 37.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.55 HE22 ' HB2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -57.95 -26.0 61.69 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.297 178.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 60.6 tt0 -76.91 -41.12 44.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 109.54 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.072 HG23 HG21 ' A' ' 99' ' ' VAL . 5.8 mt -56.48 -53.65 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 122.319 1.057 . . . . 0.0 108.271 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.713 HG13 ' N ' ' A' ' 26' ' ' ASP . 11.7 p -66.05 -40.69 87.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.615 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.713 ' N ' HG13 ' A' ' 25' ' ' VAL . 1.8 t70 -70.39 -10.53 59.33 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -99.26 -20.2 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.557 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.749 HG21 HD21 ' A' ' 97' ' ' LEU . 16.1 m -110.41 -4.94 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -44.72 -47.6 28.26 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.003 -1.06 . . . . 0.0 110.133 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -32.4 9.75 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.36 1.374 . . . . 0.0 109.421 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' HD23 ' A' ' 110' ' ' LEU . 82.5 mt-30 -79.77 -1.39 38.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.884 HD11 ' CD1' ' A' ' 97' ' ' LEU . 4.2 mt -95.85 -38.48 10.27 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.572 -0.705 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 3.3 mt-10 -66.11 -43.78 86.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.424 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -84.34 -11.29 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -0.967 . . . . 0.0 110.976 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -91.84 -12.21 34.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.76 -1.213 . . . . 0.0 110.451 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 1.049 HG21 ' OH ' ' A' ' 40' ' ' TYR . 6.2 t -122.82 -31.36 3.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.847 -1.158 . . . . 0.0 110.075 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 2.3 p-10 101.83 8.82 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.349 0.595 . . . . 0.0 109.724 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.855 ' H ' HG23 ' A' ' 36' ' ' THR . 2.0 tt0 -117.03 152.92 33.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.486 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -102.29 121.26 41.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 0.0 110.689 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 1.049 ' OH ' HG21 ' A' ' 36' ' ' THR . 11.0 m-85 -110.93 -175.97 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -139.56 -156.43 6.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -38.35 132.17 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.529 -0.983 . . . . 0.0 109.763 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.706 ' HB2' HG22 ' A' ' 25' ' ' VAL . 65.8 mt -112.89 91.49 3.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.085 -1.009 . . . . 0.0 109.064 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.31 90.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.922 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -47.65 125.05 7.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.219 1.009 . . . . 0.0 110.142 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.4 t -97.63 -45.72 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.912 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 3.6 pt20 -150.91 171.33 17.43 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.713 ' HB3' HG21 ' A' ' 21' ' ' ILE . 8.9 p90 -165.42 139.73 4.8 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.858 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 61.8 mttt -109.39 123.43 49.32 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 p -73.19 -175.97 2.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.892 ' O ' HG23 ' A' ' 58' ' ' THR . 1.1 tm0? -161.85 152.36 17.42 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.848 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.36 140.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 110.084 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.33 -102.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.59 30.53 3.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.46 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 157.08 -108.84 0.38 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.749 -2.54 . . . . 0.0 106.749 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 53' ' ' GLN . 26.8 m -167.82 109.2 0.59 Allowed 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.619 -0.93 . . . . 0.0 110.61 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.622 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 65.6 m-20 -69.93 -172.96 0.58 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 20.4 m-85 -144.72 145.79 31.87 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.776 ' HB3' HD22 ' A' ' 122' ' ' LEU . 1.4 m-85 -128.68 133.67 48.27 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.919 HG22 HG13 ' A' ' 64' ' ' VAL . 32.0 mt -150.99 121.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 116.423 -2.111 . . . . 0.0 112.021 -176.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.13 96.97 10.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 176.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.922 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.3 m -105.98 140.3 24.5 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 O-C-N 121.174 -0.954 . . . . 0.0 111.561 -175.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.2 mtm-85 -68.51 133.87 49.22 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -85.12 42.81 0.96 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.793 0.806 . . . . 0.0 109.175 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 73.35 -81.33 0.71 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 7.0 m-20 -55.13 -113.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -1.033 . . . . 0.0 110.496 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.05 -30.91 4.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.747 -1.22 . . . . 0.0 109.293 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.776 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 29.7 mtmt -68.73 144.58 54.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.602 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 15.7 m-30 -109.81 176.99 4.86 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.116 -0.99 . . . . 0.0 109.023 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.658 ' O ' HG22 ' A' ' 64' ' ' VAL . 20.2 ttp -144.65 119.92 10.2 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.007 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.788 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -69.17 151.13 46.72 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.884 ' CD1' HD11 ' A' ' 32' ' ' LEU . 13.3 tp -130.71 142.04 50.41 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.118 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.629 ' HE2' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -131.0 95.79 3.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.072 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -105.42 161.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.197 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.705 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.0 t80 -126.54 129.71 49.14 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.636 -1.29 . . . . 0.0 108.483 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HG2' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 108' ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 122.72 1.247 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.705 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.9 p -152.37 163.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.742 -177.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 112' ' ' GLY . 9.0 tp -100.43 83.41 2.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.604 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.9 OUTLIER -69.26 -10.51 58.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 111.735 -176.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.598 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 171.35 -165.4 38.42 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.612 -1.756 . . . . 0.0 111.157 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 30.2 p90 165.73 143.47 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.639 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.9 mm100 -105.26 103.6 13.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.629 -1.294 . . . . 0.0 107.662 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -68.61 162.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.71 -1.244 . . . . 0.0 111.162 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.1 t0 51.78 20.34 1.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.654 ' HG3' ' OD2' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -74.32 161.67 29.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.81 -1.181 . . . . 0.0 108.293 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.506 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 1.1 m120 -152.68 -167.73 2.83 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.199 -1.563 . . . . 0.0 112.752 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -36.7 -38.34 0.17 Allowed 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.196 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.43 53.27 2.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.718 ' CG ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -92.91 108.59 20.12 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.85 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.674 ' O ' HG23 ' A' ' 123' ' ' THR . 1.9 tt0 -102.29 105.49 16.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.788 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.8 OUTLIER -69.07 -28.86 66.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.364 -1.46 . . . . 0.0 107.841 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 39.9 -160.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.758 0.789 . . . . 0.0 110.55 176.146 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.768 ' HA2' HD22 ' A' ' 11' ' ' LEU . . . -69.71 -0.35 24.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.639 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.33 -1.1 . . . . 0.0 109.01 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.543 HD12 ' OE1' ' A' ' 53' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 122.654 1.216 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -103.28 -176.37 3.07 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.558 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' SER . 7.5 tt0 -50.3 -179.85 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.125 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.521 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -81.1 104.92 11.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -74.83 133.44 76.22 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.47 130.2 21.8 Favored 'Trans proline' 0 C--N 1.292 -2.397 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -40.94 167.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.422 1.106 . . . . 0.0 111.786 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.639 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -149.88 -165.53 0.11 Allowed Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 30.1 Cg_endo -73.37 -19.05 22.58 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 108.581 -1.354 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.23 -45.87 13.35 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.153 -0.967 . . . . 0.0 108.572 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.688 HG21 ' HB3' ' A' ' 50' ' ' TYR . 3.2 mm -58.03 -54.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 5.0 tp-100 -58.97 -21.66 58.96 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.7 tt0 -75.14 -41.33 58.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 109.061 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.057 HG23 HG21 ' A' ' 99' ' ' VAL . 3.6 mt -60.5 -50.03 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.989 0.9 . . . . 0.0 108.791 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.733 HG22 HD12 ' A' ' 45' ' ' LEU . 11.1 p -65.03 -40.84 90.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 122.134 0.969 . . . . 0.0 108.893 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.712 ' N ' HG13 ' A' ' 25' ' ' VAL . 43.8 t0 -71.45 -13.24 61.76 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.7 mmtt -96.03 -11.26 26.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.045 HG21 HD21 ' A' ' 97' ' ' LEU . 16.9 m -121.88 -4.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 0.0 110.995 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 13.3 ttpt -47.95 -45.59 62.72 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.927 -1.108 . . . . 0.0 111.035 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.83 -36.89 4.19 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.473 1.449 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 2.8 mt-30 -71.52 -7.32 46.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.838 HD22 ' CE ' ' A' ' 95' ' ' MET . 8.8 mt -100.89 -34.86 9.62 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.612 -0.68 . . . . 0.0 109.867 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 20.2 mt-10 -52.6 -48.83 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.139 -0.976 . . . . 0.0 109.814 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' OE1' ' CA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -86.71 -44.75 11.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.322 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 5.3 mmtt -42.81 -27.0 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 67.5 p -104.48 -72.57 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.953 . . . . 0.0 110.003 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.0 p30 149.55 38.3 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -164.23 -177.99 5.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.327 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.96 125.23 53.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 110.296 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 10.8 m-85 -103.12 169.5 8.52 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -129.25 -150.99 7.23 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.811 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.99 119.81 1.62 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.486 -1.008 . . . . 0.0 109.022 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 25' ' ' VAL . 62.8 mt -99.54 86.45 3.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.964 -1.085 . . . . 0.0 108.497 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.206 0.526 . . . . 0.0 110.332 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.753 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -47.28 115.28 1.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.054 -1.029 . . . . 0.0 109.493 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.603 HG12 ' HG3' ' A' ' 49' ' ' GLN . 1.5 t -94.08 -46.34 13.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HG3' HG12 ' A' ' 48' ' ' VAL . 14.6 mt-30 -146.26 173.55 12.14 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.169 -1.013 . . . . 0.0 108.964 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.688 ' HB3' HG21 ' A' ' 21' ' ' ILE . 18.1 p90 -168.34 138.15 2.48 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.946 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -106.08 130.44 53.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.691 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 p -83.27 -174.01 5.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.38 -0.825 . . . . 0.0 110.786 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.787 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -164.69 152.1 11.51 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.675 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -125.77 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.941 -1.099 . . . . 0.0 110.594 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -165.46 -102.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.11 30.42 5.6 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 160.71 -109.27 0.39 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 53' ' ' GLN . 8.4 m -167.28 112.21 0.72 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.418 -1.048 . . . . 0.0 110.856 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.636 ' HB2' ' HB3' ' A' ' 53' ' ' GLN . 45.6 m-80 -72.38 -165.95 0.23 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CD1' HG12 ' A' ' 99' ' ' VAL . 44.7 m-85 -156.02 160.23 39.84 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.672 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 125' ' ' PHE . 26.7 m-85 -144.45 134.85 24.49 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.737 HG22 HG13 ' A' ' 64' ' ' VAL . 15.3 mt -151.41 125.26 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 116.828 -1.949 . . . . 0.0 111.405 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.701 ' CG ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -94.6 91.25 6.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.427 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 47' ' ' ALA . 34.4 m -98.77 140.43 18.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 O-C-N 121.857 -0.527 . . . . 0.0 110.317 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.649 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 ttp180 -68.12 138.3 55.61 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.702 -1.249 . . . . 0.0 107.943 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.2 46.63 1.4 Allowed 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 122.269 1.033 . . . . 0.0 108.412 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.54 -77.93 1.69 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' CD ' ' A' ' 65' ' ' ARG . 3.8 t0 -61.1 -155.77 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.274 -1.133 . . . . 0.0 109.236 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -83.22 -3.67 57.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 109.366 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.575 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -75.31 178.48 5.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.21 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.649 ' CD2' ' HA ' ' A' ' 65' ' ' ARG . 33.7 m-85 -150.76 165.89 32.11 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.038 -1.039 . . . . 0.0 109.55 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.838 ' CE ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -146.41 126.07 13.38 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 108.703 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.72 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.7 m170 -74.76 151.3 39.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.045 HD21 HG21 ' A' ' 28' ' ' VAL . 15.6 tp -138.48 133.75 33.1 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.852 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.532 ' CD ' ' OG1' ' A' ' 111' ' ' THR . 0.1 OUTLIER -115.6 124.17 50.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.174 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.057 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -129.42 166.53 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.612 -1.305 . . . . 0.0 108.698 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.691 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.8 t80 -131.06 136.0 48.06 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.844 -1.16 . . . . 0.0 109.195 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.621 ' CG ' HD11 ' A' ' 108' ' ' LEU . 6.1 tttt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.693 HD23 HG11 ' A' ' 99' ' ' VAL . 10.6 mp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 122.36 1.076 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.795 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.3 p -145.45 164.56 11.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.499 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 97' ' ' LEU . 9.1 tp -102.35 86.88 2.9 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.532 ' OG1' ' CD ' ' A' ' 98' ' ' LYS . 2.2 p -70.38 -29.82 66.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 0.0 111.625 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.599 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -165.88 -162.85 18.14 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.865 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.756 ' CG ' HD21 ' A' ' 32' ' ' LEU . 19.1 p90 165.77 134.68 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.357 -1.084 . . . . 0.0 109.168 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.632 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.9 mm-40 -97.51 102.14 13.83 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.626 HG23 ' HE3' ' A' ' 95' ' ' MET . 0.6 OUTLIER -68.17 159.3 5.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.683 -1.26 . . . . 0.0 111.349 -177.236 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.7 t0 48.73 31.44 3.07 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.523 ' HD3' ' CB ' ' A' ' 114' ' ' GLN . 2.5 mptt -93.95 114.34 26.53 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.504 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 13.0 m-80 -69.11 -169.18 0.17 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.867 . . . . 0.0 110.062 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -44.45 40.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.454 -0.779 . . . . 0.0 109.442 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -50.9 -21.09 1.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -73.12 127.3 32.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.146 -0.971 . . . . 0.0 110.05 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 123' ' ' THR . 22.4 tt0 -93.63 136.12 34.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.72 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.5 mp -64.2 -32.12 73.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 108.664 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 43.81 -160.31 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.136 178.083 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.553 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -62.36 89.2 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.634 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.89 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.949 0.88 . . . . 0.0 111.28 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.9 m -101.73 167.81 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.0 tt0 -49.28 179.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.319 -0.863 . . . . 0.0 109.458 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.527 ' CB ' ' OE1' ' A' ' 49' ' ' GLN . . . -73.3 96.21 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 0.0 110.297 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 3.1 mmpt? -69.66 131.82 89.46 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.93 124.89 13.31 Favored 'Trans proline' 0 C--N 1.291 -2.466 0 N-CA-C 109.164 -1.129 . . . . 0.0 109.164 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.721 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -47.59 123.29 5.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.902 0.858 . . . . 0.0 111.763 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.609 ' OG1' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -95.69 -172.75 0.3 Allowed Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.373 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 27.8 Cg_endo -67.82 -20.06 46.12 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 N-CA-C 109.786 -0.89 . . . . 0.0 109.786 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.58 -34.76 30.83 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.981 -1.074 . . . . 0.0 108.777 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.891 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -69.28 -46.8 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.529 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -69.57 -13.44 62.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.2 tt0 -76.56 -40.16 50.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.984 HG23 HG21 ' A' ' 99' ' ' VAL . 5.3 mt -60.76 -51.5 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.802 HG21 HG11 ' A' ' 64' ' ' VAL . 12.4 p -64.38 -42.06 94.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.981 0.895 . . . . 0.0 108.81 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.712 ' N ' HG13 ' A' ' 25' ' ' VAL . 43.3 t0 -68.84 -14.92 63.33 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -93.37 -15.16 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.198 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.747 ' O ' HD12 ' A' ' 32' ' ' LEU . 31.6 m -119.85 -0.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.872 . . . . 0.0 110.557 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 7.7 ttpp -50.82 -44.62 85.84 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.847 -1.158 . . . . 0.0 110.361 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.3 Cg_endo -73.86 -34.23 5.5 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.155 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 2.4 mt-30 -74.52 -5.52 43.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.857 HD11 HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.43 -35.84 9.43 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.519 -0.738 . . . . 0.0 109.488 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -72.37 -29.33 63.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.462 -0.774 . . . . 0.0 110.881 -179.035 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.43 -17.73 17.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.889 -1.132 . . . . 0.0 110.464 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 22.8 ttmt -78.34 -61.74 1.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.995 -1.066 . . . . 0.0 109.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.749 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -72.98 -19.33 61.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.846 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.5 OUTLIER 85.75 11.83 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.65 -0.657 . . . . 0.0 109.517 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' H ' HG23 ' A' ' 36' ' ' THR . 7.9 tt0 -109.17 138.86 44.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -76.44 125.63 29.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.124 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.659 ' OH ' HG21 ' A' ' 36' ' ' THR . 31.9 m-85 -112.77 179.76 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 108.948 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -144.68 -164.43 10.56 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.05 123.78 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -1.111 . . . . 0.0 108.836 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.65 HD12 HG22 ' A' ' 25' ' ' VAL . 46.3 mt -102.49 91.37 4.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.849 -1.157 . . . . 0.0 108.372 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -72.01 82.85 0.96 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.898 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -40.17 134.68 1.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.116 0.96 . . . . 0.0 110.005 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.683 HG12 ' HG3' ' A' ' 49' ' ' GLN . 2.0 t -118.45 -42.14 2.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.683 ' HG3' HG12 ' A' ' 48' ' ' VAL . 2.4 mt-30 -142.72 171.71 13.69 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.891 ' HB3' HG21 ' A' ' 21' ' ' ILE . 18.4 p90 -170.82 136.48 1.17 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 3.8 mttt -109.11 157.41 18.76 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.353 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.421 HG22 ' HD1' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -138.93 140.2 38.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.373 -0.829 . . . . 0.0 109.162 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.592 ' HG2' ' CE1' ' A' ' 61' ' ' TYR . 0.9 OUTLIER -138.29 174.31 10.69 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.561 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.824 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -113.4 158.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.718 -1.239 . . . . 0.0 110.933 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.67 -101.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.476 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 27.26 6.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.69 -119.94 0.99 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 106.202 -2.759 . . . . 0.0 106.202 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 53' ' ' GLN . 19.1 m -151.68 109.31 3.63 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.038 -1.272 . . . . 0.0 110.542 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.721 ' ND2' HG21 ' A' ' 55' ' ' VAL . 64.4 m-80 -72.85 -171.09 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.2 m-85 -144.44 158.63 43.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.918 0.866 . . . . 0.0 108.988 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.62 ' CE2' HD21 ' A' ' 11' ' ' LEU . 2.1 m-85 -138.73 139.99 38.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.948 HD12 HD23 ' A' ' 97' ' ' LEU . 13.2 mt -154.7 123.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 116.72 -1.992 . . . . 0.0 112.06 -176.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.505 ' HE3' ' CA ' ' A' ' 118' ' ' LYS . 15.9 tttt -93.06 92.44 7.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.898 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.1 m -98.91 143.27 13.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.587 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 3.9 mtm180 -67.67 131.28 45.3 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -85.35 44.65 1.11 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.986 0.898 . . . . 0.0 109.445 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 96.69 -113.12 4.6 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.5 p30 -49.84 -104.43 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -1.031 . . . . 0.0 110.655 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -119.66 -1.9 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.945 -1.097 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.1 mptp? -68.47 -177.93 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.53 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 8.2 m-85 -146.12 166.82 25.02 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.879 -1.138 . . . . 0.0 109.727 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.646 ' O ' HG22 ' A' ' 64' ' ' VAL . 49.0 ttp -151.73 111.31 3.98 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.485 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.951 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -69.6 147.6 50.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.125 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.948 HD23 HD12 ' A' ' 62' ' ' ILE . 13.2 tp -128.52 153.02 47.61 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.246 -0.909 . . . . 0.0 110.71 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.556 ' C ' ' HG1' ' A' ' 111' ' ' THR . 2.6 tttm -143.09 102.32 3.98 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.984 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -112.95 160.39 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.762 -1.211 . . . . 0.0 109.404 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.74 ' HB2' HG21 ' A' ' 111' ' ' THR . 9.3 t80 -120.37 137.9 54.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.47 -1.394 . . . . 0.0 108.408 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 108' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 122.015 0.912 . . . . 0.0 109.317 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 122.259 1.028 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.2 p -153.7 163.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.79 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 6.7 tp -99.6 84.1 2.89 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.74 HG21 ' HB2' ' A' ' 100' ' ' PHE . 16.8 p -69.02 -15.75 63.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 111.504 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 174.68 -167.52 39.8 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 30.1 p90 170.99 137.54 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.645 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -98.04 102.66 14.47 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.532 HG23 ' OH ' ' A' ' 40' ' ' TYR . 9.9 p -67.99 158.47 5.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.131 -0.98 . . . . 0.0 111.195 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.5 t70 45.92 27.99 0.55 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 7.6 mmtm -101.01 129.76 46.9 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 120.676 -1.265 . . . . 0.0 108.48 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 6.6 m-20 -105.65 -156.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 111.054 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' CA ' ' HE3' ' A' ' 63' ' ' LYS . 1.5 ttpm? -58.73 -45.41 89.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.699 -0.626 . . . . 0.0 109.981 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.21 -22.88 0.44 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.504 ' OD1' ' CE ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -89.0 122.52 32.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 110.993 -179.346 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.698 ' O ' HG23 ' A' ' 123' ' ' THR . 0.3 OUTLIER -94.99 132.79 39.45 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.951 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 2.2 mp -60.76 -55.92 27.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.782 -1.199 . . . . 0.0 109.344 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.743 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 56.7 -163.79 0.16 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.802 -1.186 . . . . 0.0 110.031 177.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.89 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -50.52 -14.98 1.08 Allowed Glycine 0 N--CA 1.501 3.022 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.645 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 120.859 -1.377 . . . . 0.0 109.113 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 121.916 0.865 . . . . 0.0 112.534 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -101.06 160.41 14.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 41.5 tt0 -46.76 173.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB1' ' CG ' ' A' ' 49' ' ' GLN . . . -59.85 95.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.875 -1.14 . . . . 0.0 109.871 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.608 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -69.68 130.31 90.5 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.437 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.1 Cg_endo -67.64 126.14 14.32 Favored 'Trans proline' 0 C--N 1.288 -2.608 0 N-CA-C 108.772 -1.28 . . . . 0.0 108.772 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.573 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -40.66 156.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.289 1.042 . . . . 0.0 111.468 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.648 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -135.05 -168.38 0.18 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.648 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.35 -18.11 30.22 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 N-CA-C 109.177 -1.124 . . . . 0.0 109.177 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -82.96 -47.37 11.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.046 -1.034 . . . . 0.0 108.435 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.809 HG21 ' HB3' ' A' ' 50' ' ' TYR . 6.7 mm -56.8 -54.72 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.627 HE22 ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -53.97 -26.95 28.45 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.81 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 4.2 tp10 -76.77 -35.2 57.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.083 . . . . 0.0 110.155 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.971 HG23 HG21 ' A' ' 99' ' ' VAL . 3.5 mt -66.19 -49.95 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.887 HG21 HG11 ' A' ' 64' ' ' VAL . 12.8 p -66.18 -41.3 89.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 122.279 1.038 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.702 ' N ' HG13 ' A' ' 25' ' ' VAL . 12.5 t70 -74.98 -14.17 60.59 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 30.8 ttmt -93.36 -10.96 33.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.994 HG21 HD21 ' A' ' 97' ' ' LEU . 15.5 m -117.78 -5.31 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 110.653 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 4.5 ttpm? -42.72 -48.65 13.51 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.891 -1.131 . . . . 0.0 110.661 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 29.3 Cg_endo -69.65 -33.89 16.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.294 1.329 . . . . 0.0 109.799 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' O ' HD23 ' A' ' 110' ' ' LEU . 60.1 mt-30 -74.92 -5.01 41.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.996 HD11 ' CD1' ' A' ' 97' ' ' LEU . 5.4 mt -97.67 -38.07 9.66 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.593 -0.692 . . . . 0.0 109.705 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 39' ' ' THR . 35.5 mt-10 -65.34 -26.46 68.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.503 -0.748 . . . . 0.0 109.645 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.39 -40.74 11.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HG2' ' OH ' ' A' ' 113' ' ' TYR . 12.0 tttt -75.19 -8.07 55.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 32' ' ' LEU . 9.9 p -123.03 -48.31 2.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.608 ' CB ' ' O ' ' A' ' 36' ' ' THR . 3.7 p-10 104.48 32.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.189 0.519 . . . . 0.0 109.724 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 5.1 mt-10 -130.42 145.08 51.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.265 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.6 m -75.17 -10.36 59.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.107 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.722 ' CD2' ' HE1' ' A' ' 95' ' ' MET . 25.7 m-85 36.71 -163.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.76 0.79 . . . . 0.0 110.61 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -162.97 -167.71 23.8 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.73 126.22 3.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -1.108 . . . . 0.0 108.787 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.671 ' HB2' HG22 ' A' ' 25' ' ' VAL . 41.4 mt -100.17 71.62 1.61 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 108.082 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 19.1 mt-10 -53.31 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.883 -0.51 . . . . 0.0 109.962 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -44.28 143.06 1.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.104 0.955 . . . . 0.0 109.589 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.9 -41.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.548 ' HB2' ' CD ' ' A' ' 63' ' ' LYS . 12.5 mt-30 -147.9 171.89 15.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.809 ' HB3' HG21 ' A' ' 21' ' ' ILE . 14.5 p90 -171.18 137.09 1.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.88 -1.138 . . . . 0.0 110.648 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.502 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -108.64 119.41 39.45 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 p -71.7 176.46 4.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.34 -0.85 . . . . 0.0 109.853 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.861 ' O ' HG23 ' A' ' 58' ' ' THR . 2.4 mm100 -152.34 148.25 27.28 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -129.73 137.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.942 -1.099 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -165.67 -102.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.67 28.49 5.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.48 -121.7 1.04 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 106.856 -2.498 . . . . 0.0 106.856 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.861 HG23 ' O ' ' A' ' 53' ' ' GLN . 23.1 m -159.52 104.91 1.63 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.087 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.711 ' ND2' ' CD1' ' A' ' 100' ' ' PHE . 28.5 m120 -70.04 -178.45 1.61 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.1 m-85 -141.44 153.68 45.13 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.098 -1.001 . . . . 0.0 109.256 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 23.3 m-30 -133.76 135.53 43.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.74 HG22 HG13 ' A' ' 64' ' ' VAL . 30.5 mt -153.91 129.99 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 116.774 -1.97 . . . . 0.0 112.408 -176.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.947 ' HG2' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.22 102.79 14.17 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.779 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -109.7 139.99 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.46 -0.775 . . . . 0.0 110.825 -176.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -67.32 126.87 30.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.99 45.06 1.05 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.91 0.862 . . . . 0.0 109.646 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 85.36 -98.07 2.22 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -56.69 -157.39 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.378 -1.072 . . . . 0.0 109.612 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -71.83 -6.62 42.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 109.476 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -69.85 164.31 23.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 109.085 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.507 ' OH ' ' HD2' ' A' ' 65' ' ' ARG . 11.7 m-85 -136.77 169.87 17.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.733 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.722 ' HE1' ' CD2' ' A' ' 40' ' ' TYR . 20.8 ttm -154.93 113.31 3.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.038 -1.038 . . . . 0.0 109.659 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.923 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 m-70 -74.31 156.9 36.65 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.996 ' CD1' HD11 ' A' ' 32' ' ' LEU . 1.4 tp -148.96 139.85 22.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.698 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.1 tttt -121.63 107.25 12.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.971 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -107.24 162.08 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.729 -1.232 . . . . 0.0 109.712 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.711 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 10.5 t80 -124.15 133.03 53.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.536 -1.352 . . . . 0.0 108.681 177.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.341 0 CA-C-O 121.838 0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 122.087 0.946 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 99' ' ' VAL . 13.6 p -151.98 164.76 2.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.737 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 97' ' ' LEU . 4.6 tp -101.67 83.76 2.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.577 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -72.84 -12.79 61.12 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.023 -1.048 . . . . 0.0 112.054 -176.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.688 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -176.34 -167.48 35.13 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.066 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 30.2 p90 164.66 137.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.613 -0.933 . . . . 0.0 108.975 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.663 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.8 mm-40 -100.14 97.19 8.04 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.531 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 5.3 p -67.56 163.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.987 -1.071 . . . . 0.0 111.034 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' A ASP . . . . . 0.435 ' N ' HG22 ' A' ' 115' ' ' VAL . 3.9 t0 48.92 26.64 1.38 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.045 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.555 ' HG2' ' N ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -67.73 -166.27 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.779 -1.201 . . . . 0.0 108.463 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.536 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -149.51 -177.62 5.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.749 -1.22 . . . . 0.0 110.099 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -71.69 -34.09 69.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.419 -0.801 . . . . 0.0 109.267 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.03 -14.22 59.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -72.31 103.54 3.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.824 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.1 OUTLIER -87.92 146.24 25.65 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.947 HD11 ' HG2' ' A' ' 63' ' ' LYS . 1.9 mp -66.98 -40.0 87.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.553 -1.342 . . . . 0.0 108.302 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER 40.04 22.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.007 0.908 . . . . 0.0 110.905 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 121.73 116.99 2.45 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.663 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.505 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.902 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.92 0.866 . . . . 0.0 110.759 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 33.6 m -101.32 171.6 7.5 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tp10 -47.8 174.79 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.912 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.23 99.62 3.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.099 -1.0 . . . . 0.0 110.006 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 9.8 mmpt? -69.16 131.19 90.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -68.11 125.35 12.91 Favored 'Trans proline' 0 C--N 1.291 -2.494 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.624 ' HB1' ' CB ' ' A' ' 47' ' ' ALA . . . -48.21 148.66 1.75 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.441 1.115 . . . . 0.0 111.466 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.629 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -128.96 -169.33 0.19 Allowed Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 27.9 Cg_endo -69.09 -17.67 40.49 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 N-CA-C 109.796 -0.886 . . . . 0.0 109.796 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.506 ' HG3' HD13 ' A' ' 21' ' ' ILE . 15.3 pt-20 -82.03 -41.79 20.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.787 -1.196 . . . . 0.0 108.758 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.667 HG21 ' HB3' ' A' ' 50' ' ' TYR . 13.0 mm -63.54 -51.58 68.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -61.47 -19.23 61.79 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.8 tp10 -75.71 -35.18 60.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.847 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.007 HG23 HG21 ' A' ' 99' ' ' VAL . 5.4 mt -64.99 -52.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.761 HG21 HG11 ' A' ' 64' ' ' VAL . 7.1 p -61.41 -42.57 94.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.722 ' N ' HG13 ' A' ' 25' ' ' VAL . 32.5 t70 -72.75 -16.44 61.65 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 11.9 tptt -89.75 -11.6 41.78 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 97' ' ' LEU . 18.3 m -116.08 -8.72 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.447 -0.783 . . . . 0.0 109.802 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 11.3 ttpp -51.95 -44.13 90.9 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.837 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.77 -29.05 13.06 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.451 1.434 . . . . 0.0 110.016 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -80.69 -11.87 59.56 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.986 HD11 HD11 ' A' ' 97' ' ' LEU . 6.4 mt -93.65 -35.25 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.503 0.668 . . . . 0.0 109.762 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 30.3 mt-10 -58.74 -46.05 88.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.77 -51.12 6.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 109.961 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -49.77 -58.32 5.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 108.497 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.749 HG21 ' OH ' ' A' ' 40' ' ' TYR . 1.4 m -68.97 -60.52 2.31 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.539 -0.726 . . . . 0.0 109.512 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 34.2 p-10 119.48 41.6 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 73.0 mm-40 -130.4 -166.73 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.888 . . . . 0.0 110.017 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 39' ' ' THR . 94.5 m -129.05 26.15 5.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.813 -0.554 . . . . 0.0 109.516 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.749 ' OH ' HG21 ' A' ' 36' ' ' THR . 11.5 m-85 -29.06 147.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.72 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -117.38 -135.52 5.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -54.65 126.29 23.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.336 -1.097 . . . . 0.0 110.078 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.633 HD12 HG22 ' A' ' 25' ' ' VAL . 28.8 mt -107.56 74.47 0.96 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -54.83 85.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.313 0.577 . . . . 0.0 110.495 -178.103 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.903 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -46.22 124.73 5.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.26 1.028 . . . . 0.0 109.754 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.486 HG12 ' HG2' ' A' ' 49' ' ' GLN . 1.9 t -101.56 -44.68 10.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.554 ' CG ' ' HB3' ' A' ' 63' ' ' LYS . 9.2 pt20 -147.23 171.34 15.53 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.667 ' HB3' HG21 ' A' ' 21' ' ' ILE . 12.1 p90 -168.17 138.79 2.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 12' ' ' SER . 1.4 mttp -109.88 124.01 50.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 p -76.51 -178.14 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.307 -0.871 . . . . 0.0 110.148 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 58' ' ' THR . 2.3 mm100 -159.53 150.8 19.86 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.864 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.06 146.97 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 120.915 -1.116 . . . . 0.0 111.126 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.864 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -171.04 -103.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.57 29.14 6.79 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 164.54 -114.02 0.58 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 106.294 -2.722 . . . . 0.0 106.294 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 53' ' ' GLN . 28.8 m -166.92 113.72 0.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -1.157 . . . . 0.0 111.005 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.619 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 70.0 m-20 -73.51 -166.55 0.36 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.6 ' CD1' HG12 ' A' ' 99' ' ' VAL . 86.6 m-85 -154.44 153.75 32.06 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.632 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.628 ' C ' HD22 ' A' ' 122' ' ' LEU . 22.8 m-85 -138.04 130.41 29.14 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.824 HG22 HG13 ' A' ' 64' ' ' VAL . 11.7 mt -149.34 122.68 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 119.583 -1.948 . . . . 0.0 112.098 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 21.8 ttpt -92.16 95.53 9.8 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 47' ' ' ALA . 14.6 m -101.9 140.06 21.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.64 127.0 31.47 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.611 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.98 45.11 1.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.928 0.871 . . . . 0.0 109.615 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 99.37 -122.88 7.72 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' GLY . 16.8 t70 -43.26 -101.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.939 . . . . 0.0 111.37 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.3 m120 -120.02 -4.27 10.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.6 mttt -69.47 179.17 2.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 108.624 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 30.3 m-85 -146.52 168.25 21.69 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.026 -1.046 . . . . 0.0 109.94 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.748 ' O ' HG22 ' A' ' 64' ' ' VAL . 18.9 mtp -154.87 115.43 3.9 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.695 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -73.69 137.58 44.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.986 HD11 HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -125.17 123.26 39.25 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.497 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -108.68 121.65 45.47 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.591 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.007 HG21 HG23 ' A' ' 24' ' ' ILE . 2.5 t -125.27 166.26 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.59 -1.319 . . . . 0.0 109.445 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.702 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 10.0 t80 -125.08 136.45 53.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.987 -1.071 . . . . 0.0 108.201 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.598 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.929 0.871 . . . . 0.0 109.872 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 108' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 122.251 1.025 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.728 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.7 p -139.27 162.36 27.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.715 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 18.6 tp -99.31 88.09 3.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 100' ' ' PHE . 14.7 p -71.53 -29.71 65.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 111.85 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . -168.94 -163.31 22.75 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.337 -1.411 . . . . 0.0 109.85 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 20.5 p90 166.48 135.64 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.41 -1.053 . . . . 0.0 109.854 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.4 mm-40 -95.48 95.4 8.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 115' A ASP . 6.3 p -67.51 160.15 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.092 -1.005 . . . . 0.0 110.57 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' A ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 115' ' ' VAL . 21.2 t0 43.2 28.37 0.16 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.304 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.59 ' HG3' ' CB ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -82.26 160.96 22.83 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.701 -1.249 . . . . 0.0 107.807 179.207 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.87 -170.91 1.91 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.756 -1.215 . . . . 0.0 110.888 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 18.9 mttt -68.47 -69.64 0.31 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.713 -0.617 . . . . 0.0 110.657 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -40.8 -26.91 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.347 -0.846 . . . . 0.0 110.292 -179.128 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 96' ' ' HIS . 14.8 t70 -47.43 109.88 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.027 . . . . 0.0 110.733 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.553 ' O ' ' CG2' ' A' ' 123' ' ' THR . 74.8 tt0 -84.3 136.91 33.72 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 62' ' ' ILE . 2.6 mp -67.27 -32.38 73.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.904 -1.122 . . . . 0.0 108.741 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.62 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 45.36 -167.02 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.038 0.923 . . . . 0.0 110.499 177.149 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.902 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -43.35 -21.57 0.16 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.676 0 O-C-N 121.213 -1.169 . . . . 0.0 109.079 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.413 ' O ' HG23 ' A' ' 7' ' ' ILE . 34.5 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 6' ' ' MET . 0.4 OUTLIER -154.21 77.78 5.43 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.226 -0.922 . . . . 0.0 109.598 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.85 101.17 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.573 2.182 . . . . 0.0 110.596 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.42 172.07 28.59 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 85.53 135.98 3.77 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.821 HD22 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -37.91 108.06 0.07 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.521 -0.988 . . . . 0.0 111.47 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 3.8 m -102.78 -179.1 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.871 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -51.75 -177.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -92.23 110.71 22.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.098 -1.001 . . . . 0.0 110.74 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -76.93 138.25 65.71 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 175.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' ALA . 26.5 Cg_endo -64.44 131.84 31.31 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 109.152 -1.134 . . . . 0.0 109.152 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.603 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -41.67 167.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.511 1.148 . . . . 0.0 111.493 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.654 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -147.28 -167.43 0.15 Allowed Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.654 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.6 Cg_endo -73.13 -20.73 21.26 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 N-CA-C 108.471 -1.396 . . . . 0.0 108.471 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -39.93 22.95 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.219 -0.926 . . . . 0.0 108.688 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.741 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.7 mm -62.28 -54.83 29.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 23.5 tp60 -59.69 -19.44 49.76 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -76.2 -43.78 40.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.725 -1.234 . . . . 0.0 108.801 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.011 HG23 HG21 ' A' ' 99' ' ' VAL . 5.5 mt -55.48 -52.5 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.803 HG22 HD12 ' A' ' 45' ' ' LEU . 12.3 p -67.51 -39.98 83.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 122.028 0.918 . . . . 0.0 109.717 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.717 ' N ' HG13 ' A' ' 25' ' ' VAL . 25.6 t70 -70.71 -10.74 60.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -100.25 -18.07 17.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 97' ' ' LEU . 19.8 m -116.28 1.48 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.514 -0.741 . . . . 0.0 110.397 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.641 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.56 -39.84 79.79 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.736 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 29' ' ' LYS . 33.7 Cg_endo -77.55 -35.37 1.58 Allowed 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 108.172 -1.511 . . . . 0.0 108.172 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 61.0 mt-30 -66.78 -15.32 63.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.72 HD11 HD11 ' A' ' 97' ' ' LEU . 4.6 mt -89.92 -34.27 16.11 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.555 0.693 . . . . 0.0 109.535 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.639 ' HG2' HG23 ' A' ' 39' ' ' THR . 0.7 OUTLIER -55.14 -55.19 33.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 110.41 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.18 -8.52 50.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 31' ' ' GLN . 3.3 tttp -91.23 5.38 49.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.778 -1.201 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 32' ' ' LEU . 9.7 p -131.61 -56.8 1.0 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 36' ' ' THR . 45.8 p30 134.15 20.54 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -149.65 -177.82 6.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.87 -1.144 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.639 HG23 ' HG2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -117.72 118.68 32.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' HE1' HG23 ' A' ' 115' ' ' VAL . 74.0 m-85 -90.88 178.99 5.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 108.936 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -130.5 -168.04 12.16 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -37.47 127.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.926 . . . . 0.0 109.283 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.803 HD12 HG22 ' A' ' 25' ' ' VAL . 59.2 mt -102.97 79.99 1.82 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.059 -1.026 . . . . 0.0 108.704 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 1.3 mt-10 -61.8 85.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.145 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.799 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -43.64 145.9 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.235 1.017 . . . . 0.0 109.998 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.78 -44.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HG2' ' HB3' ' A' ' 63' ' ' LYS . 2.4 pt20 -151.57 169.53 21.89 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.741 ' HB3' HG21 ' A' ' 21' ' ' ILE . 14.1 p90 -163.12 133.56 4.54 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.055 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HD2' ' HB2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -99.01 126.53 44.73 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.51 145.07 45.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.272 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.693 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -144.47 177.73 8.45 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.834 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.07 158.93 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 111.563 -178.257 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.97 -102.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.49 28.46 5.04 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.1 -110.34 0.44 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 53' ' ' GLN . 86.5 m -165.67 109.59 0.83 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.367 -1.078 . . . . 0.0 110.76 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.671 ' ND2' ' CD2' ' A' ' 100' ' ' PHE . 31.4 m120 -69.57 -176.44 1.01 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CD1' HG12 ' A' ' 99' ' ' VAL . 78.6 m-85 -149.54 151.61 34.17 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.472 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.64 ' HB3' HD22 ' A' ' 122' ' ' LEU . 8.3 m-85 -138.04 132.55 32.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.645 HG12 HG23 ' A' ' 21' ' ' ILE . 13.6 mt -150.77 115.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 116.847 -1.941 . . . . 0.0 111.683 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.628 ' HB2' HD11 ' A' ' 122' ' ' LEU . 1.4 ttmp? -81.02 103.11 10.62 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.799 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -109.39 138.5 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.942 -176.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -68.11 127.18 31.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.08 46.07 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.044 0.926 . . . . 0.0 109.125 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 78.55 -93.84 1.26 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 22.6 p-10 -56.01 -163.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.187 -1.184 . . . . 0.0 109.563 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.45 -10.84 59.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.05 159.42 33.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 109.045 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.607 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 30.3 m-85 -129.35 176.21 8.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.7 ttp -155.76 113.22 3.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 109.561 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 1.053 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER -69.83 151.72 45.4 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 28' ' ' VAL . 11.0 tp -132.8 142.66 49.1 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 111.025 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -132.41 102.77 5.87 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.011 HG21 HG23 ' A' ' 24' ' ' ILE . 2.3 t -110.35 161.41 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.346 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.81 ' HB2' HG21 ' A' ' 111' ' ' THR . 6.7 t80 -123.77 135.92 54.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.2 . . . . 0.0 108.28 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.634 ' HG2' HD11 ' A' ' 108' ' ' LEU . 1.9 tmtt? -96.77 122.71 40.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.529 ' O ' ' O ' ' A' ' 102' A LEU . 74.2 m -102.27 46.19 0.94 Allowed 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.616 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' A LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 102' ' ' SER . 0.6 OUTLIER 51.95 166.31 0.04 OUTLIER Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 121.115 -0.991 . . . . 0.0 110.559 178.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 102' A LEU . 35.0 Cg_endo -76.46 117.05 4.46 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.257 1.971 . . . . 0.0 110.378 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.28 34.03 0.77 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 105' A ASN . 25.4 mt-30 50.99 -149.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -1.181 . . . . 0.0 109.623 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' A ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 105' ' ' GLN . 7.0 m120 39.64 -153.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 110.134 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -58.66 159.62 6.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.865 . . . . 0.0 109.551 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -145.7 147.36 31.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.935 . . . . 0.0 109.874 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.634 HD11 ' HG2' ' A' ' 101' ' ' LYS . 8.0 mp 49.82 170.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.698 1.237 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.723 HG13 HG23 ' A' ' 111' ' ' THR . 14.7 p -156.91 163.39 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.71 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.64 HD11 ' O ' ' A' ' 112' ' ' GLY . 10.3 tp -98.9 83.37 2.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.81 HG21 ' HB2' ' A' ' 100' ' ' PHE . 17.2 p -69.49 -11.77 61.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.965 . . . . 0.0 111.249 -176.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.64 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 173.81 -165.96 37.98 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.83 -1.652 . . . . 0.0 110.929 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.6 p90 167.76 135.57 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.672 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -96.19 96.67 8.97 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 177.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.473 HG23 ' HE1' ' A' ' 40' ' ' TYR . 8.5 p -67.72 157.03 6.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.836 -1.165 . . . . 0.0 110.19 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' A ASP . . . . . . . . . . . . . 1.5 t0 51.56 21.15 1.21 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.1 OUTLIER -83.11 131.18 35.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.672 -1.268 . . . . 0.0 108.044 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.36 178.59 7.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.297 -0.877 . . . . 0.0 111.45 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 119' ' ' ASP . 10.2 tmtt? -61.51 -50.01 74.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.188 0.518 . . . . 0.0 110.197 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 118' ' ' LYS . 41.6 t0 -43.29 -26.43 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.179 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.459 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -69.45 93.3 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.358 -0.839 . . . . 0.0 110.321 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 123' ' ' THR . 2.3 tt0 -68.15 141.99 55.87 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.053 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -64.17 -35.65 81.48 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.364 -1.46 . . . . 0.0 110.27 -178.064 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.715 ' O ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER 49.48 -149.73 0.22 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.821 ' HA2' HD22 ' A' ' 11' ' ' LEU . . . -48.82 -99.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 104.41 -3.476 . . . . 0.0 104.41 175.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.672 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 23.5 t80 . . . . . 0 C--N 1.29 -1.979 0 O-C-N 119.237 -2.331 . . . . 0.0 108.138 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.342 0.592 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 mt -48.94 119.19 8.17 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.526 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' GLY . 36.4 Cg_endo -77.48 160.06 32.15 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.358 2.039 . . . . 0.0 110.462 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . 51.03 -179.39 0.04 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -85.72 1.29 88.14 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.13 -1.217 . . . . 0.0 110.16 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.802 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -35.1 108.0 0.06 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 122.206 1.003 . . . . 0.0 111.504 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -102.28 179.25 4.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.675 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.323 -0.861 . . . . 0.0 109.031 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -91.47 101.02 13.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.789 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -70.93 141.07 86.51 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 103.236 -2.876 . . . . 0.0 103.236 175.331 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -68.02 126.63 14.76 Favored 'Trans proline' 0 C--N 1.29 -2.535 0 N-CA-C 109.531 -0.988 . . . . 0.0 109.531 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.623 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -42.59 147.86 0.26 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.42 1.105 . . . . 0.0 111.994 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.646 HG23 HG12 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -122.3 -168.44 0.13 Allowed Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -71.56 -20.01 27.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 109.202 -1.115 . . . . 0.0 109.202 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -82.5 -43.97 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -0.999 . . . . 0.0 108.663 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.698 HG21 ' HB3' ' A' ' 50' ' ' TYR . 7.6 mm -58.81 -52.09 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.532 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -64.46 -18.22 64.56 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.381 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 28.8 tp10 -76.47 -31.24 57.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.597 -1.315 . . . . 0.0 108.525 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.015 HG23 HG21 ' A' ' 99' ' ' VAL . 5.4 mt -69.36 -50.66 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.754 HG21 HG11 ' A' ' 64' ' ' VAL . 7.3 p -62.48 -43.44 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-O 122.089 0.947 . . . . 0.0 109.358 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.733 ' N ' HG13 ' A' ' 25' ' ' VAL . 21.4 t70 -74.4 -18.92 60.59 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.21 -12.76 56.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.226 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.613 HG11 ' CG2' ' A' ' 99' ' ' VAL . 27.7 m -116.59 -8.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.476 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.9 ttpp -42.25 -49.99 11.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 110.389 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.25 -34.75 7.54 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.535 1.49 . . . . 0.0 110.006 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' HD23 ' A' ' 110' ' ' LEU . 91.0 mt-30 -78.84 0.07 28.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.206 -0.934 . . . . 0.0 108.592 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.067 ' O ' HG22 ' A' ' 36' ' ' THR . 3.2 mt -100.26 -41.23 7.16 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.444 -0.785 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 48.5 mt-10 -59.37 -44.38 92.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.5 -46.62 89.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.474 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB3' ' OH ' ' A' ' 113' ' ' TYR . 1.2 mmtp -71.11 -66.1 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 110.019 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 1.067 HG22 ' O ' ' A' ' 32' ' ' LEU . 9.4 t -70.12 -0.68 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.392 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 2.7 p-10 40.91 48.2 2.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.158 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.514 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -119.19 172.22 7.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.283 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' TYR . 5.9 t -80.91 -29.78 35.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 0.0 109.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.947 ' CZ ' HG21 ' A' ' 36' ' ' THR . 4.9 m-30 40.31 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.529 0.681 . . . . 0.0 110.256 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 168.6 -163.39 37.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.1 118.26 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.488 -1.007 . . . . 0.0 109.443 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.71 ' HB3' HG11 ' A' ' 64' ' ' VAL . 36.5 mt -100.47 86.04 3.08 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.142 . . . . 0.0 108.073 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 47' ' ' ALA . 63.4 mt-10 -69.83 83.74 0.47 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -0.763 . . . . 0.0 110.063 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.799 ' N ' HG13 ' A' ' 64' ' ' VAL . . . -41.11 145.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.148 0.975 . . . . 0.0 110.25 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -122.02 -44.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.863 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 42.2 mt-30 -149.45 170.08 19.4 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.698 ' HB3' HG21 ' A' ' 21' ' ' ILE . 17.5 p90 -164.45 138.19 5.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.196 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 35.3 mttt -108.93 125.32 51.9 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.2 p -76.4 175.74 8.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 109.785 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.902 ' O ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -150.6 154.53 37.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.358 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.84 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -128.31 141.72 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.025 -1.047 . . . . 0.0 110.303 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.49 -101.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.73 30.17 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 157.9 -110.91 0.46 Allowed Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.902 HG23 ' O ' ' A' ' 53' ' ' GLN . 29.6 m -165.17 108.22 0.84 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.364 -1.08 . . . . 0.0 110.913 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.618 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 76.0 m-20 -71.37 -170.44 0.5 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.618 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 19.6 m-85 -143.55 154.95 44.13 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.468 -0.77 . . . . 0.0 109.586 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.856 ' HB3' HD22 ' A' ' 122' ' ' LEU . 21.2 m-85 -137.21 133.5 35.22 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.774 HG22 ' CG2' ' A' ' 64' ' ' VAL . 12.9 mt -149.11 114.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 117.004 -1.878 . . . . 0.0 111.442 -177.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 19.2 ttpt -81.09 99.23 8.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.799 HG13 ' N ' ' A' ' 47' ' ' ALA . 38.2 t -109.13 144.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.37 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.4 mmm180 -69.71 132.93 46.9 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.13 44.9 1.17 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.976 0.893 . . . . 0.0 108.951 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 84.67 -92.79 1.76 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' GLY . 10.5 p-10 -60.68 -140.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.258 -1.142 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.64 -7.98 57.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.958 -1.089 . . . . 0.0 109.994 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.485 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -69.45 178.36 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 108.692 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.578 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 25.6 m-85 -142.78 179.06 7.22 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.06 -1.025 . . . . 0.0 109.285 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . 1.037 ' HE1' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.76 114.02 1.11 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.462 -179.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.907 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -71.65 140.94 49.9 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.056 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -124.84 133.99 52.9 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.511 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -121.71 113.9 20.36 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.135 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.015 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -119.89 159.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.777 -1.202 . . . . 0.0 109.684 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.717 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 4.2 t80 -121.67 130.77 53.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.592 -1.318 . . . . 0.0 108.173 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.531 ' HE2' ' HB ' ' A' ' 58' ' ' THR . 2.5 pttt -107.08 160.59 15.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 102' A LEU . 12.1 t -100.81 89.77 3.99 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.109 -0.994 . . . . 0.0 110.289 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' A LEU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 1.3 mt 52.66 167.05 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.787 -0.571 . . . . 0.0 110.576 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 102' A LEU . 33.9 Cg_endo -76.29 169.47 21.92 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.339 2.026 . . . . 0.0 110.446 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.5 -72.97 0.45 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -155.81 -179.63 8.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -1.074 . . . . 0.0 109.212 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' A ASN . . . . . . . . . . . . . 2.4 m-80 -80.68 102.29 9.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.934 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.522 ' O ' HD13 ' A' ' 108' ' ' LEU . 2.2 pp20? -98.59 -166.73 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.438 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -71.49 83.44 0.82 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.381 -0.824 . . . . 0.0 110.456 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.3 mp -63.53 -174.5 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.086 0.945 . . . . 0.0 109.467 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.717 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.1 p -147.65 161.23 7.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.808 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.629 HD13 HD11 ' A' ' 97' ' ' LEU . 18.1 tp -97.81 87.94 4.16 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -75.57 -8.76 57.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 111.87 -176.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . 174.01 -168.27 41.03 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.625 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.606 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 31.4 p90 165.84 138.0 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.717 -0.872 . . . . 0.0 109.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.625 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.1 mm-40 -97.34 97.87 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.8 HG23 ' OH ' ' A' ' 40' ' ' TYR . 7.4 p -69.35 159.06 5.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.845 -1.16 . . . . 0.0 110.282 -178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' A ASP . . . . . 0.438 ' N ' HG22 ' A' ' 115' ' ' VAL . 56.4 t0 52.24 22.25 1.92 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.78 -0.575 . . . . 0.0 110.562 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 3.2 mptp? -90.56 106.31 18.42 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.755 -1.216 . . . . 0.0 108.951 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 4.5 m120 -69.51 -172.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 110.127 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -16.46 62.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.88 -20.05 63.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.539 ' CB ' ' HG3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -90.82 110.02 21.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 110.072 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' C ' HG22 ' A' ' 123' ' ' THR . 2.1 tt0 -92.62 150.6 20.61 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.907 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 2.0 mp -68.87 -44.27 73.65 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.515 -1.366 . . . . 0.0 107.734 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER 39.2 18.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.624 -0.672 . . . . 0.0 112.485 175.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.802 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . 154.94 -65.63 0.32 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.2 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.625 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.269 0 O-C-N 121.286 -1.126 . . . . 0.0 109.251 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.3 pt -109.62 154.54 42.35 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.204 -0.935 . . . . 0.0 109.151 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.14 88.32 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.592 2.194 . . . . 0.0 110.376 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.29 136.73 3.51 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 116.09 140.95 7.08 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -35.88 128.45 0.67 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.724 -0.868 . . . . 0.0 111.096 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 m -101.25 163.91 12.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.384 0.612 . . . . 0.0 109.458 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 5.7 tt0 -48.14 176.94 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.398 -0.814 . . . . 0.0 109.308 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HB1' ' CG ' ' A' ' 49' ' ' GLN . . . -84.89 96.7 9.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.109 . . . . 0.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.68 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 20.0 mmtt -72.27 133.19 83.52 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 176.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 17' ' ' ALA . 27.5 Cg_endo -65.98 126.08 15.25 Favored 'Trans proline' 0 C--N 1.291 -2.452 0 N-CA-C 109.257 -1.093 . . . . 0.0 109.257 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.623 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -39.37 153.52 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.536 1.16 . . . . 0.0 111.815 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.63 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -136.27 -170.12 0.23 Allowed Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.3 Cg_endo -68.97 -16.53 40.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 N-CA-C 109.244 -1.099 . . . . 0.0 109.244 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.56 -46.45 14.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.068 -1.02 . . . . 0.0 108.41 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.763 HG21 ' HB3' ' A' ' 50' ' ' TYR . 10.2 mm -58.88 -53.67 44.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 22.9 tp60 -61.47 -19.17 61.73 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -76.13 -37.06 58.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.711 -1.243 . . . . 0.0 108.776 179.061 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.912 HG23 HG21 ' A' ' 99' ' ' VAL . 3.9 mt -63.22 -50.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.862 HG22 HD12 ' A' ' 45' ' ' LEU . 11.4 p -66.21 -41.62 89.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 122.183 0.992 . . . . 0.0 109.251 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.709 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.8 t70 -69.39 -16.58 63.54 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -85.9 -20.16 29.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 24' ' ' ILE . 13.1 m -118.4 6.58 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.613 -0.68 . . . . 0.0 110.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.885 ' HA ' HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -53.14 -36.85 42.16 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.687 -1.258 . . . . 0.0 110.646 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HD3' ' CG ' ' A' ' 29' ' ' LYS . 35.9 Cg_endo -79.3 -37.04 0.57 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 108.361 -1.438 . . . . 0.0 108.361 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.659 ' O ' HD23 ' A' ' 110' ' ' LEU . 1.8 mt-30 -74.17 -3.24 28.57 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.889 HD22 ' SD ' ' A' ' 95' ' ' MET . 10.0 mt -92.43 -41.12 10.49 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.417 -0.802 . . . . 0.0 109.624 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.809 ' OE2' HG22 ' A' ' 39' ' ' THR . 23.6 mt-10 -65.32 -46.27 80.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.511 -0.743 . . . . 0.0 110.972 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.7 -37.26 62.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.807 -1.183 . . . . 0.0 111.136 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -58.08 -42.65 86.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.771 -1.205 . . . . 0.0 110.063 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.823 HG21 ' OH ' ' A' ' 40' ' ' TYR . 1.3 p -86.5 -57.48 2.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.933 -1.104 . . . . 0.0 109.663 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 36' ' ' THR . 52.6 p-10 131.26 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 C-N-CA 122.937 0.495 . . . . 0.0 109.714 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 5.0 pt-20 -133.93 171.75 13.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 109.148 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.809 HG22 ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -107.14 117.76 34.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.009 -1.057 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.823 ' OH ' HG21 ' A' ' 36' ' ' THR . 58.8 m-85 -93.05 178.77 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 108.594 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -126.31 -157.57 9.6 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 43' ' ' GLY . 4.2 tttt -41.68 125.11 2.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.451 -1.029 . . . . 0.0 109.151 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.862 HD12 HG22 ' A' ' 25' ' ' VAL . 28.4 mt -97.43 77.41 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.055 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.53 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.872 -177.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.816 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -45.69 144.27 1.72 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.127 -0.983 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.5 t -125.6 -42.14 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' CG ' ' HB1' ' A' ' 14' ' ' ALA . 8.8 mt-30 -150.28 166.96 28.39 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.763 ' HB3' HG21 ' A' ' 21' ' ' ILE . 2.5 p90 -163.54 138.06 6.07 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.458 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 23.8 mttt -113.38 131.89 55.81 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.878 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -81.08 -173.72 4.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.196 -0.94 . . . . 0.0 110.86 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -164.32 156.01 16.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.765 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -125.43 141.43 45.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.949 -1.094 . . . . 0.0 110.746 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -170.2 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.275 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.29 28.93 5.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.512 ' HA2' HD21 ' A' ' 102' A LEU . . . 160.23 -104.04 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 53' ' ' GLN . 9.1 m -168.75 112.31 0.56 Allowed 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.7 -0.883 . . . . 0.0 109.766 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.606 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 32.6 m-80 -71.36 -166.63 0.19 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 28.5 m-85 -150.44 154.34 37.53 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.689 ' HB3' HD22 ' A' ' 122' ' ' LEU . 22.6 m-85 -138.99 133.76 32.15 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 177.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.813 HD12 HD23 ' A' ' 97' ' ' LEU . 11.1 mt -151.81 118.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 C-N-CA 116.719 -1.992 . . . . 0.0 111.589 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.555 ' CE ' ' HA ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -78.44 98.7 6.13 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 175.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.816 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -108.81 132.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.353 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 5.7 ttp180 -66.36 139.14 58.0 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.55 43.96 1.07 Allowed 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.922 0.868 . . . . 0.0 109.405 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 72.9 -80.63 0.68 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.0 OUTLIER -53.67 -112.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.41 -1.053 . . . . 0.0 110.394 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.402 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 5.0 m-20 -125.44 -21.4 4.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.687 -1.258 . . . . 0.0 109.876 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -68.46 177.07 2.54 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 20.0 m-85 -135.72 176.08 9.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.007 -1.058 . . . . 0.0 109.204 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.889 ' SD ' HD22 ' A' ' 32' ' ' LEU . 4.6 ttp -156.66 117.42 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.393 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.714 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.6 m170 -69.19 148.35 50.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.813 HD23 HD12 ' A' ' 62' ' ' ILE . 13.9 tp -129.04 128.58 43.88 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.725 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 41.6 tttt -114.52 107.79 15.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.912 HG21 HG23 ' A' ' 24' ' ' ILE . 1.8 t -111.38 160.66 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.215 . . . . 0.0 109.164 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.764 ' HB2' HG21 ' A' ' 111' ' ' THR . 34.7 t80 -122.94 133.11 54.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.792 -1.192 . . . . 0.0 109.003 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -106.25 137.16 44.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . 1.03 ' O ' HD23 ' A' ' 102' A LEU . 1.1 t -102.06 -149.72 0.39 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.914 0.864 . . . . 0.0 109.416 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' A LEU . . . . . 1.03 HD23 ' O ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -160.94 -59.62 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.917 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.641 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 102' A LEU . 36.5 Cg_endo -76.8 -167.81 0.51 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.148 1.899 . . . . 0.0 110.778 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.61 62.8 4.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 47.41 -155.48 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.256 -1.144 . . . . 0.0 109.31 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' A ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.91 70.3 9.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.307 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.576 ' HG2' ' N ' ' A' ' 107' ' ' ASP . 26.7 tt0 -61.31 156.19 19.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.151 -0.968 . . . . 0.0 109.461 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.576 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 0.7 OUTLIER -105.61 148.93 26.78 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.446 -0.784 . . . . 0.0 109.311 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 108' ' ' LEU . 8.1 mp -53.02 -173.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.116 0.96 . . . . 0.0 109.784 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.776 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.3 p -152.31 166.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.089 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.695 HD11 ' O ' ' A' ' 112' ' ' GLY . 12.4 tp -98.52 85.29 3.34 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 100' ' ' PHE . 3.4 p -81.18 -1.55 45.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.1 -1.0 . . . . 0.0 111.947 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.695 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 177.67 -160.19 26.6 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.193 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.677 ' HD2' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER 150.3 133.47 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.383 0.611 . . . . 0.0 109.959 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.641 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.07 95.08 7.94 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.468 ' O ' ' HD3' ' A' ' 116' ' ' LYS . 9.4 p -67.98 161.4 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.185 . . . . 0.0 111.088 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' A ASP . . . . . 0.436 ' N ' HG22 ' A' ' 115' ' ' VAL . 49.6 t0 50.11 20.76 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.912 -0.492 . . . . 0.0 110.815 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.571 ' CG ' ' OD2' ' A' ' 120' ' ' ASP . 1.6 mptt -93.61 129.44 39.88 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.64 -1.288 . . . . 0.0 108.546 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 2.9 m-80 -104.4 -156.86 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 0.0 112.285 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.555 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 3.4 tttm -54.2 -56.7 15.73 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.937 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.42 -20.98 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 0.0 111.089 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.571 ' OD2' ' CG ' ' A' ' 116' ' ' LYS . 63.2 t0 -83.9 123.02 29.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.665 -1.272 . . . . 0.0 111.724 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.558 ' O ' ' CG2' ' A' ' 123' ' ' THR . 5.1 tt0 -100.3 139.88 35.34 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 176.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.714 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.2 mp -59.55 -49.54 77.36 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.541 -1.35 . . . . 0.0 109.411 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.3 OUTLIER 43.7 -168.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.89 178.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.575 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -55.38 91.77 0.01 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 109.488 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.5 mtp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.23 130.21 94.69 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 0.0 109.532 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.76 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.412 2.075 . . . . 0.0 110.157 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . 144.44 -77.3 0.28 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 9' ' ' GLY . . . -60.32 -131.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.037 HD22 ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER 38.92 94.48 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.331 1.062 . . . . 0.0 110.945 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 79.1 p -101.52 -176.72 3.22 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.114 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -51.02 179.77 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.976 -1.078 . . . . 0.0 108.574 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -77.94 95.79 4.87 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.289 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mmtt -70.75 126.36 92.17 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.96 127.36 18.37 Favored 'Trans proline' 0 C--N 1.293 -2.345 0 N-CA-C 109.514 -0.995 . . . . 0.0 109.514 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.631 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -42.34 165.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.346 1.07 . . . . 0.0 111.431 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.653 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.46 -167.88 0.17 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -71.93 -18.03 28.23 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 N-CA-C 108.939 -1.216 . . . . 0.0 108.939 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' HD12 ' A' ' 24' ' ' ILE . 1.5 mt-10 -83.93 -45.32 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.752 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.6 mm -57.74 -54.43 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.504 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 2.0 tp-100 -61.76 -20.29 63.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 7.0 tt0 -75.74 -34.81 60.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.471 -1.393 . . . . 0.0 108.643 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.08 HG23 HG21 ' A' ' 99' ' ' VAL . 3.7 mt -66.04 -49.67 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.004 0.907 . . . . 0.0 108.815 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 HD12 ' A' ' 45' ' ' LEU . 12.5 p -69.34 -41.38 80.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-O 121.966 0.889 . . . . 0.0 109.861 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.723 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.2 t70 -72.12 -17.0 62.01 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 14.4 tppt? -89.83 -13.47 36.49 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.863 ' CG2' HD21 ' A' ' 97' ' ' LEU . 31.3 m -126.58 4.18 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.883 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 6.3 ttpt -54.66 -43.66 98.48 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 111.07 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.68 -18.75 24.99 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.383 1.389 . . . . 0.0 109.615 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -91.92 -10.89 37.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.809 HD13 HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -92.06 -33.27 14.86 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 40' ' ' TYR . 2.3 pt-20 -82.68 -20.1 36.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 109.952 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.71 -45.85 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.017 -1.052 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -67.27 -40.16 86.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.697 HG21 ' OH ' ' A' ' 40' ' ' TYR . 2.7 m -82.67 -32.44 28.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.917 . . . . 0.0 109.388 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 88.71 26.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.254 0.55 . . . . 0.0 109.725 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -107.24 -178.84 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.518 ' O ' ' O ' ' A' ' 40' ' ' TYR . 29.9 m -97.03 -25.7 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.147 -0.971 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.697 ' OH ' HG21 ' A' ' 36' ' ' THR . 14.5 m-30 37.79 -165.29 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.705 0.764 . . . . 0.0 110.976 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 176.1 -165.63 36.29 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' O ' HD23 ' A' ' 45' ' ' LEU . 14.0 mttt -42.46 134.51 3.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.796 HD12 HG22 ' A' ' 25' ' ' VAL . 34.5 mt -111.85 81.66 1.49 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.2 tt0 -64.01 86.89 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.853 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -44.71 132.83 6.29 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.291 1.043 . . . . 0.0 110.371 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.3 t -110.83 -45.32 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 63' ' ' LYS . 1.3 pt20 -149.05 173.21 13.63 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.803 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.752 ' HB3' HG21 ' A' ' 21' ' ' ILE . 26.7 p90 -165.31 141.12 5.33 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.69 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.545 ' HD3' HD23 ' A' ' 11' ' ' LEU . 9.0 mttt -117.7 135.96 53.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.366 0.603 . . . . 0.0 109.378 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.4 p -76.93 -175.59 3.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.266 -0.896 . . . . 0.0 110.064 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 58' ' ' THR . 0.5 OUTLIER -158.94 149.15 19.46 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.869 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -123.84 141.04 45.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.798 -1.189 . . . . 0.0 110.51 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.66 -103.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 30.24 4.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.94 -111.37 0.48 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 106.734 -2.547 . . . . 0.0 106.734 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 53' ' ' GLN . 16.4 m -165.26 107.31 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.345 -1.091 . . . . 0.0 110.697 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.749 ' ND2' ' CD2' ' A' ' 100' ' ' PHE . 21.4 m120 -71.89 -171.52 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 101' ' ' LYS . 22.8 m-85 -139.38 160.2 40.39 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.827 ' HB3' HD22 ' A' ' 122' ' ' LEU . 11.0 m-85 -141.8 136.57 30.79 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.611 HG13 ' C ' ' A' ' 61' ' ' TYR . 14.1 mt -151.15 119.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.675 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.507 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 26.4 ttpp -86.36 94.61 9.41 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.853 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -100.09 137.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.843 -0.536 . . . . 0.0 110.86 -176.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.666 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -67.76 123.46 20.6 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.8 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -82.02 39.33 0.56 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.605 0.717 . . . . 0.0 111.007 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.04 -127.99 9.06 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.24 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -68.39 80.02 0.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.691 -0.888 . . . . 0.0 112.261 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 10.8 m120 71.22 -8.64 0.98 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.114 -0.991 . . . . 0.0 111.712 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.8 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -69.48 -179.76 1.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.649 -1.282 . . . . 0.0 108.367 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 7.3 m-85 -150.74 155.98 40.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.972 -1.08 . . . . 0.0 109.391 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.641 ' CE ' ' CD2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -150.79 111.21 4.19 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.862 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.11 135.25 44.74 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.863 HD21 ' CG2' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -120.25 157.35 29.32 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.868 -1.145 . . . . 0.0 111.274 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.2 tttt -141.77 107.49 5.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.08 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -115.31 160.27 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.755 -1.216 . . . . 0.0 110.308 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.749 ' CD2' ' ND2' ' A' ' 59' ' ' ASN . 0.2 OUTLIER -121.1 122.46 40.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.819 ' HG2' HD11 ' A' ' 108' ' ' LEU . 1.8 tttt -89.9 44.4 1.2 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.487 1.137 . . . . 0.0 107.998 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 102' A LEU . 0.2 OUTLIER -34.73 90.17 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.304 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' A LEU . . . . . 0.601 ' CG ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -28.74 -57.73 0.25 Allowed Pre-proline 0 N--CA 1.499 2.012 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.601 ' HD3' ' CG ' ' A' ' 102' A LEU . 37.4 Cg_endo -75.5 -104.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.351 2.034 . . . . 0.0 110.299 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.26 167.07 0.28 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 105' A ASN . 0.3 OUTLIER -132.35 -164.21 1.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -1.199 . . . . 0.0 109.289 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' A ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 105' ' ' GLN . 10.1 p-10 35.15 -147.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.787 -0.571 . . . . 0.0 109.804 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 105' A ASN . 73.7 mm-40 -43.24 160.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 109.14 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.61 162.63 12.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 110.092 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.819 HD11 ' HG2' ' A' ' 101' ' ' LYS . 5.7 mp 58.45 172.54 0.06 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.353 1.073 . . . . 0.0 110.77 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.668 ' O ' HG22 ' A' ' 99' ' ' VAL . 14.3 p -153.86 161.42 2.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.099 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.584 HD11 ' HD2' ' A' ' 113' ' ' TYR . 8.1 tp -96.69 82.05 3.26 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.61 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -70.37 -9.48 56.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 111.918 -176.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.501 ' CA ' ' HB3' ' A' ' 98' ' ' LYS . . . 168.78 -168.7 41.28 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.382 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.631 ' CB ' HD21 ' A' ' 32' ' ' LEU . 22.4 p90 167.79 135.38 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.593 -0.945 . . . . 0.0 109.139 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.691 ' HG3' ' CD2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -90.53 103.9 16.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.693 HG23 ' OH ' ' A' ' 40' ' ' TYR . 8.1 p -68.25 161.69 3.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.552 -177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' A ASP . . . . . 0.488 ' N ' HG22 ' A' ' 115' ' ' VAL . 0.9 OUTLIER 42.2 43.31 2.83 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.11 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.959 -1.088 . . . . 0.0 108.404 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.97 -171.41 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 110.306 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 14.5 tttt -66.94 -40.5 87.57 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.425 0.631 . . . . 0.0 109.627 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.19 -18.56 0.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.341 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.4 OUTLIER -88.19 105.58 17.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.828 -1.17 . . . . 0.0 110.251 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.98 162.77 20.31 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.862 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 3.0 mp -85.07 13.91 5.62 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.406 -1.434 . . . . 0.0 109.484 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.037 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.5 OUTLIER 2.77 -76.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.439 0.696 . . . . 0.0 112.236 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.706 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . -139.71 15.02 3.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.681 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.602 0 O-C-N 121.603 -0.94 . . . . 0.0 108.545 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.402 ' O ' ' C ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.827 HD12 ' O ' ' A' ' 8' ' ' PRO . 1.2 pp -42.9 161.13 0.19 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.844 . . . . 0.0 109.43 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.827 ' O ' HD12 ' A' ' 7' ' ' ILE . 33.1 Cg_endo -75.56 167.03 27.36 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.444 2.096 . . . . 0.0 110.611 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . -105.36 -82.03 1.52 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 12' ' ' SER . . . 60.53 112.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.765 HD21 ' CE2' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -44.98 94.7 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 122.383 1.087 . . . . 0.0 110.917 -178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.51 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -101.93 178.68 4.54 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.966 179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.495 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -51.96 163.83 0.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.161 -0.962 . . . . 0.0 109.182 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -72.54 107.68 5.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.942 . . . . 0.0 110.865 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.03 139.5 79.71 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 175.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.93 127.39 17.65 Favored 'Trans proline' 0 C--N 1.292 -2.435 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.599 ' HB1' ' CB ' ' A' ' 47' ' ' ALA . . . -44.61 131.43 6.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.06 0.933 . . . . 0.0 112.266 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.607 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -102.52 -173.42 0.29 Allowed Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 176.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -68.42 -20.82 41.55 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 109.643 -0.945 . . . . 0.0 109.643 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 1.6 mt-10 -81.72 -41.54 21.13 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.035 -1.041 . . . . 0.0 108.929 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.82 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -62.36 -47.48 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -67.6 -16.1 64.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.2 tt0 -77.18 -29.99 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.814 -1.179 . . . . 0.0 108.315 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.935 HG23 HG21 ' A' ' 99' ' ' VAL . 3.0 mt -70.62 -50.41 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.719 HG13 ' N ' ' A' ' 26' ' ' ASP . 7.7 p -61.42 -44.33 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.984 0.897 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.719 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.6 t0 -72.11 -20.26 61.67 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -80.34 -12.86 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.814 HG21 ' CD2' ' A' ' 97' ' ' LEU . 35.2 m -116.17 -10.85 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.556 -0.715 . . . . 0.0 110.203 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.2 ttmt -39.77 -49.91 5.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.05 -1.031 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 28.9 Cg_endo -69.69 -35.52 12.71 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.587 1.525 . . . . 0.0 109.8 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 94.9 mt-30 -73.76 -4.8 36.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 40' ' ' TYR . 7.0 mt -96.89 -43.15 7.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.62 0.724 . . . . 0.0 110.03 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.7 -27.19 69.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.752 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.04 -46.79 5.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.963 -1.085 . . . . 0.0 110.916 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 70.7 mttt -67.76 -33.89 75.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.071 . . . . 0.0 110.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 2.8 m -92.98 -35.5 13.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.886 -1.134 . . . . 0.0 109.532 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 36' ' ' THR . 1.0 OUTLIER 91.3 28.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.218 0.532 . . . . 0.0 110.019 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -115.38 -175.99 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 40' ' ' TYR . 43.2 m -98.78 -20.75 16.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.913 ' OH ' HG23 ' A' ' 115' ' ' VAL . 4.1 m-85 39.22 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.974 0.892 . . . . 0.0 111.051 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.9 -152.29 11.12 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 129.77 42.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.673 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.655 ' HB2' HG22 ' A' ' 25' ' ' VAL . 35.5 mt -111.05 81.94 1.51 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.974 -1.079 . . . . 0.0 109.028 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -65.23 85.69 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.481 0.658 . . . . 0.0 110.137 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.931 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.96 125.99 4.61 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.105 0.955 . . . . 0.0 109.891 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.9 t -103.4 -44.87 9.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.642 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 3.4 mt-30 -142.78 172.79 12.21 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.82 ' HB3' HG21 ' A' ' 21' ' ' ILE . 31.7 p90 -169.75 139.82 2.03 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.877 -1.139 . . . . 0.0 110.593 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.614 ' HG3' HD13 ' A' ' 122' ' ' LEU . 7.5 mtmt -122.23 128.99 51.82 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.92 139.6 37.32 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.171 -0.956 . . . . 0.0 110.062 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.518 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 1.3 pm0 -133.23 158.52 42.68 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 55' ' ' VAL . 4.7 p -97.36 155.85 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 111.772 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.606 HG21 ' ND2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -162.28 -101.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 27.91 5.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.55 -103.37 0.23 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 106.373 -2.691 . . . . 0.0 106.373 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -160.89 122.64 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.584 -0.951 . . . . 0.0 109.891 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.606 ' ND2' HG21 ' A' ' 55' ' ' VAL . 9.7 m-20 -85.12 -164.96 1.07 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 7.9 m-85 -149.52 131.05 14.84 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.765 ' CE2' HD21 ' A' ' 11' ' ' LEU . 8.9 m-30 -115.88 134.53 54.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.759 HG22 HG13 ' A' ' 64' ' ' VAL . 17.8 mt -150.47 128.13 2.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 116.812 -1.955 . . . . 0.0 111.371 -176.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.598 ' HG3' ' NZ ' ' A' ' 116' ' ' LYS . 19.4 ttmt -95.34 90.99 6.02 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.931 HG12 ' HA ' ' A' ' 47' ' ' ALA . 31.4 m -99.6 142.06 15.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.773 -0.579 . . . . 0.0 110.956 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.33 123.15 19.97 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -86.06 46.75 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.139 0.971 . . . . 0.0 109.141 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 -152.05 19.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 92' ' ' ASN . 2.0 p-10 -59.15 126.84 29.32 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.426 -1.044 . . . . 0.0 111.044 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 68' ' ' ASP . 7.8 p-10 31.62 44.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.217 0.532 . . . . 0.0 111.304 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -127.76 171.41 11.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.489 ' CD2' ' O ' ' A' ' 93' ' ' LYS . 25.8 m-85 -156.94 156.36 32.92 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.754 -1.216 . . . . 0.0 110.495 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.741 ' O ' HG22 ' A' ' 64' ' ' VAL . 9.2 tmm? -153.97 116.52 4.39 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.296 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.905 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -76.29 143.22 41.01 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.814 ' CD2' HG21 ' A' ' 28' ' ' VAL . 1.4 tp -133.55 131.92 40.3 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.795 -1.562 . . . . 0.0 112.437 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.2 ttpt -111.7 83.38 1.77 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.935 HG21 HG23 ' A' ' 24' ' ' ILE . 1.6 t -84.47 159.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.665 -1.272 . . . . 0.0 109.206 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.724 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 58.4 t80 -125.4 131.43 52.94 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.635 -1.291 . . . . 0.0 108.35 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.549 ' HG2' ' N ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -107.55 145.34 33.31 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.549 ' N ' ' HG2' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -98.37 73.24 2.13 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.932 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' A LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 102' ' ' SER . 74.1 mt 54.7 157.29 0.06 OUTLIER Pre-proline 0 C--N 1.307 -1.25 0 O-C-N 121.567 -0.708 . . . . 0.0 110.396 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.35 179.96 5.94 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.545 2.163 . . . . 0.0 110.037 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.414 ' C ' ' HG3' ' A' ' 105' ' ' GLN . . . 139.31 -111.42 0.77 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 105' A ASN . 14.0 mt-30 -141.66 145.71 35.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -1.17 . . . . 0.0 109.691 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' A ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER 41.0 65.86 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.515 -0.741 . . . . 0.0 109.836 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -76.56 -178.91 4.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.0 109.287 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.92 77.51 1.55 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.093 -1.004 . . . . 0.0 110.084 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.617 HD12 ' N ' ' A' ' 108' ' ' LEU . 10.6 mp -60.97 -174.35 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.307 1.051 . . . . 0.0 109.453 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.75 ' CG1' HG23 ' A' ' 111' ' ' THR . 12.5 p -163.39 164.94 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.089 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.728 HD11 ' CD2' ' A' ' 113' ' ' TYR . 4.4 tp -97.49 83.52 3.27 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.75 HG23 ' CG1' ' A' ' 109' ' ' VAL . 1.4 p -85.89 -3.61 58.96 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.016 -1.052 . . . . 0.0 112.81 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 113' ' ' TYR . . . -171.31 -172.34 37.36 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.633 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.728 ' CD2' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER 155.38 132.61 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.736 -0.861 . . . . 0.0 111.3 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.636 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 6.2 mm-40 -95.37 95.95 8.8 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.913 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -65.84 160.1 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.99 -176.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' A ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 115' ' ' VAL . 2.7 t70 42.85 37.19 1.01 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.441 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.682 ' HE3' ' CE1' ' A' ' 96' ' ' HIS . 8.1 ptmm? -69.61 -163.83 0.06 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.074 -1.016 . . . . 0.0 108.935 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.452 ' O ' ' NZ ' ' A' ' 116' ' ' LYS . 14.2 m-80 -157.35 178.5 10.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.84 -1.163 . . . . 0.0 109.922 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -68.92 -9.27 50.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.814 . . . . 0.0 109.756 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.32 5.09 46.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -100.68 119.65 38.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.035 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.686 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.9 OUTLIER -96.9 138.43 34.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.905 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 1.6 mp -58.57 -55.93 28.65 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.715 -1.241 . . . . 0.0 109.196 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 121' ' ' GLU . 0.3 OUTLIER 44.69 -169.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.182 177.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.558 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -49.51 91.93 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.539 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.594 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.827 ' C ' HD13 ' A' ' 7' ' ' ILE . 15.8 mtm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.356 0.598 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.827 HD13 ' C ' ' A' ' 6' ' ' MET . 0.0 OUTLIER -127.93 131.96 24.08 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.06 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.04 -24.04 7.23 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.378 2.052 . . . . 0.0 110.493 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.12 109.11 2.09 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' OE1' ' A' ' 53' ' ' GLN . . . 176.77 -167.89 39.54 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.547 HD12 ' HD3' ' A' ' 51' ' ' LYS . 1.3 pt? -132.88 155.94 48.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -1.144 . . . . 0.0 109.524 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 t -101.33 -177.22 3.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 110.731 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -49.98 -175.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.555 -0.716 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -90.17 107.88 19.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.928 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 9.6 mmpt? -73.26 141.11 80.32 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 175.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.47 131.29 25.87 Favored 'Trans proline' 0 C--N 1.291 -2.499 0 N-CA-C 109.45 -1.019 . . . . 0.0 109.45 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -48.17 165.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.399 1.095 . . . . 0.0 111.813 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.663 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -145.92 -166.07 0.12 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.663 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.5 Cg_endo -71.85 -18.35 28.26 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 N-CA-C 108.755 -1.287 . . . . 0.0 108.755 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.42 -45.93 15.34 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.4 mm -59.85 -53.03 54.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.474 ' OE1' ' O ' ' A' ' 45' ' ' LEU . 26.9 tp60 -60.45 -19.48 56.61 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 tt0 -75.17 -43.12 54.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 108.737 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HG21 ' A' ' 99' ' ' VAL . 3.3 mt -57.29 -52.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.84 HG22 HD12 ' A' ' 45' ' ' LEU . 11.4 p -66.42 -39.76 84.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 122.024 0.916 . . . . 0.0 109.095 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.705 ' N ' HG13 ' A' ' 25' ' ' VAL . 23.3 t70 -68.44 -13.45 62.31 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -94.76 -19.96 19.91 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.257 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.825 HG21 HD11 ' A' ' 97' ' ' LEU . 27.4 m -111.66 -6.03 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.885 . . . . 0.0 111.23 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.688 ' HG3' HD11 ' A' ' 45' ' ' LEU . 1.4 ttpm? -44.46 -48.25 26.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -29.96 12.62 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.625 1.55 . . . . 0.0 110.112 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' HD23 ' A' ' 110' ' ' LEU . 94.7 mt-30 -83.77 -0.72 52.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.951 HD11 ' CD1' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.27 -37.6 8.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 1.5 tm-20 -72.08 -30.6 65.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -19.44 29.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.0 . . . . 0.0 109.886 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 7.6 44.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 109.855 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.821 HG21 ' CZ ' ' A' ' 40' ' ' TYR . 14.4 t -135.56 -32.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.939 -1.1 . . . . 0.0 110.281 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.679 ' ND2' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER 92.62 18.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.919 -0.488 . . . . 0.0 110.116 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.706 ' H ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -115.5 157.76 23.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.916 -1.115 . . . . 0.0 109.057 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.524 ' O ' ' O ' ' A' ' 40' ' ' TYR . 8.9 m -81.22 -15.43 55.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.822 ' OH ' HG23 ' A' ' 115' ' ' VAL . 12.0 m-30 39.0 -165.76 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.521 0.677 . . . . 0.0 110.14 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -176.65 -169.44 38.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' O ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -42.04 134.44 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.464 -1.021 . . . . 0.0 108.875 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.84 HD12 HG22 ' A' ' 25' ' ' VAL . 34.0 mt -112.55 83.73 1.86 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.085 -1.01 . . . . 0.0 109.859 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 3.7 mt-10 -65.33 85.5 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.481 0.658 . . . . 0.0 109.667 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.838 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -47.89 116.88 1.64 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.3 1.048 . . . . 0.0 110.579 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.788 HG21 ' NH1' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -90.67 -46.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.636 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 2.4 mt-30 -148.73 168.78 21.98 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.696 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.729 ' HB3' HG21 ' A' ' 21' ' ' ILE . 7.0 p90 -161.75 136.23 6.98 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.821 -1.152 . . . . 0.0 110.983 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HD3' HD12 ' A' ' 11' ' ' LEU . 11.5 mttt -105.41 137.0 43.94 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 p -86.97 178.63 6.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.858 . . . . 0.0 110.049 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.823 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -157.32 161.25 39.1 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.685 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -127.02 140.08 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.068 -1.02 . . . . 0.0 110.374 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -165.15 -103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HB3' ' HZ ' ' A' ' 100' ' ' PHE . . . -99.63 29.35 4.13 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.729 ' HA2' HD21 ' A' ' 102' A LEU . . . 158.65 -99.74 0.18 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 53' ' ' GLN . 18.7 m -167.38 120.4 0.94 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.644 -0.916 . . . . 0.0 110.236 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.659 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 17.5 m-20 -77.92 -164.25 0.5 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.662 ' CD1' HG12 ' A' ' 99' ' ' VAL . 75.9 m-85 -151.58 152.61 33.13 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.704 0.764 . . . . 0.0 109.023 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' A' ' 125' ' ' PHE . 19.7 m-85 -138.58 132.78 31.6 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.751 HD12 HD23 ' A' ' 97' ' ' LEU . 14.4 mt -149.11 119.0 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 C-N-CA 116.917 -1.913 . . . . 0.0 111.378 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HD2' ' HB2' ' A' ' 49' ' ' GLN . 14.2 ptpt -85.99 98.71 10.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -102.26 141.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.217 0.532 . . . . 0.0 110.746 -175.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.788 ' NH1' HG21 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -68.93 125.0 25.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -83.11 38.95 0.62 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.619 0.723 . . . . 0.0 110.839 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.87 -74.09 0.8 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.612 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 54.0 p30 -78.21 44.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.982 -1.305 . . . . 0.0 113.485 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 3.4 t-20 79.94 -41.28 0.22 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.849 -1.157 . . . . 0.0 111.246 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.872 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 33.6 mtmt -67.21 144.3 56.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.723 -1.236 . . . . 0.0 107.826 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.62 ' CE2' ' NH1' ' A' ' 65' ' ' ARG . 18.8 m-30 -104.82 172.16 6.94 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.416 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.574 ' HE1' ' CD2' ' A' ' 40' ' ' TYR . 2.4 mtp -144.01 115.68 8.19 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.723 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -69.63 148.45 49.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.951 ' CD1' HD11 ' A' ' 32' ' ' LEU . 12.9 tp -133.27 132.76 41.79 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.296 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 30.0 tttt -122.61 103.34 8.62 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.016 HG21 HG23 ' A' ' 24' ' ' ILE . 2.4 t -108.8 163.64 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.32 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.698 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.2 t80 -127.05 133.13 50.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.975 -1.078 . . . . 0.0 108.809 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.585 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 5.9 tttt -99.61 129.46 45.76 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 102' A LEU . 7.4 m -102.03 14.27 32.41 Favored 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.143 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' A LEU . . . . . 0.729 HD21 ' HA2' ' A' ' 57' ' ' GLY . 0.7 OUTLIER 18.55 64.19 0.23 Allowed Pre-proline 0 N--CA 1.499 1.995 0 CA-C-O 120.825 0.345 . . . . 0.0 111.533 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 102' A LEU . 37.5 Cg_endo -79.12 19.49 0.91 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.014 2.476 . . . . 0.0 111.317 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.2 47.08 50.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -154.64 -154.84 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.155 . . . . 0.0 109.393 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' A ASN . . . . . . . . . . . . . 10.8 t-20 -62.3 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 0.0 109.299 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.98 139.54 30.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 109.318 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -155.25 49.97 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 109.598 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 108' ' ' LEU . 6.9 mp -79.24 -174.74 4.29 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.422 1.106 . . . . 0.0 110.107 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.4 p -146.07 164.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.927 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.629 HD11 ' O ' ' A' ' 112' ' ' GLY . 11.1 tp -98.01 83.85 3.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.615 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -72.69 -10.15 59.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 111.157 -177.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.629 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 174.35 -165.96 37.7 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 37.6 p90 164.98 137.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.677 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 1.5 mm-40 -103.09 107.99 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.822 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -66.6 162.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.634 -1.291 . . . . 0.0 111.626 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' A ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 115' ' ' VAL . 22.6 t0 39.49 30.69 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.635 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -77.8 158.39 29.55 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.695 -1.253 . . . . 0.0 108.254 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -118.34 179.4 4.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.039 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -65.03 -50.07 67.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 0.0 109.271 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' LYS . 13.9 t70 -44.5 -27.16 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.493 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -76.19 88.39 3.06 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.507 -0.746 . . . . 0.0 109.385 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.08 164.82 3.74 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.723 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -90.35 50.84 1.9 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.373 -1.454 . . . . 0.0 109.674 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -48.84 -177.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.083 178.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.464 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -42.41 94.11 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.677 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.363 -1.081 . . . . 0.0 109.646 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.523 ' CB ' HD12 ' A' ' 7' ' ' ILE . 1.6 ptt? . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.256 0.55 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.523 HD12 ' CB ' ' A' ' 6' ' ' MET . 3.0 mp 52.42 92.27 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.878 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.46 -31.92 2.47 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.721 2.281 . . . . 0.0 110.237 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.13 99.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 136.29 126.54 2.56 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.93 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -41.41 128.7 3.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.598 -0.942 . . . . 0.0 111.082 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' GLU . 2.0 t -101.4 167.95 9.84 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.52 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.652 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.14 98.62 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.39 127.3 90.33 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 176.386 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.72 124.39 13.12 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -45.47 128.77 8.3 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.952 0.882 . . . . 0.0 111.667 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.611 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -101.07 -171.89 0.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 177.255 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.4 Cg_endo -69.06 -18.29 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 N-CA-C 109.369 -1.05 . . . . 0.0 109.369 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -43.3 22.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.143 -0.973 . . . . 0.0 108.504 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.827 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -63.33 -47.46 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.55 ' HG2' ' HB3' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -58.31 -23.03 55.24 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.4 tt0 -76.88 -40.61 46.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.22 -0.925 . . . . 0.0 110.286 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.01 HG23 HG21 ' A' ' 99' ' ' VAL . 3.0 mt -61.28 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.802 HG22 ' HB2' ' A' ' 45' ' ' LEU . 14.7 p -64.14 -41.65 93.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.017 0.913 . . . . 0.0 109.021 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.707 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.9 t70 -72.51 -12.56 61.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mttt -96.71 -10.12 27.57 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.039 HG21 HD21 ' A' ' 97' ' ' LEU . 4.3 m -120.76 -6.03 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 110.473 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.627 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -48.37 -45.28 67.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 0.0 110.379 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.4 Cg_endo -72.23 -28.94 14.85 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.287 1.324 . . . . 0.0 109.517 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' O ' HD23 ' A' ' 110' ' ' LEU . 74.9 mt-30 -81.79 -7.49 59.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.015 HD11 HD13 ' A' ' 97' ' ' LEU . 11.1 mt -88.1 -48.77 7.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -63.29 -25.25 68.23 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.149 0.5 . . . . 0.0 110.027 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -88.58 -28.14 20.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 110.178 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 13.8 mmtt -99.87 2.85 44.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 110.094 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.911 HG21 ' CE2' ' A' ' 40' ' ' TYR . 6.1 t -128.2 -4.48 5.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.121 -0.987 . . . . 0.0 109.874 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 40.14 45.3 1.67 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 109.834 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -138.14 161.25 37.28 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.408 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -88.16 119.11 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 110.309 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.911 ' CE2' HG21 ' A' ' 36' ' ' THR . 14.8 m-30 -114.29 -169.8 1.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -153.89 -171.84 21.35 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 43' ' ' GLY . 3.8 mttt -44.36 135.66 4.48 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.802 ' HB2' HG22 ' A' ' 25' ' ' VAL . 31.0 mt -107.66 69.77 0.75 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.897 -1.127 . . . . 0.0 109.028 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -58.15 86.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.271 -178.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.602 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -41.01 142.68 0.46 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 109.963 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 2.1 t -125.26 -40.31 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -140.43 171.32 14.3 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.827 ' HB3' HG21 ' A' ' 21' ' ' ILE . 4.3 p90 -170.18 141.45 2.09 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.73 -1.231 . . . . 0.0 110.944 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 4.7 mttp -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.1 p -82.83 -174.31 5.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.153 -0.967 . . . . 0.0 110.739 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.764 ' O ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -165.11 148.74 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.21 134.62 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 120.844 -1.16 . . . . 0.0 110.936 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -160.35 -102.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.03 29.06 4.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.433 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 159.66 -105.54 0.27 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 53' ' ' GLN . 23.3 m -168.26 118.78 0.78 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.682 -0.893 . . . . 0.0 110.327 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.632 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 43.3 m-20 -79.07 -165.64 0.79 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 32.2 m-85 -148.36 157.62 43.59 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.236 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.646 ' C ' HG13 ' A' ' 62' ' ' ILE . 18.9 m-85 -139.65 137.56 35.36 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.713 ' N ' HD22 ' A' ' 122' ' ' LEU . 10.9 mt -155.9 126.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 116.935 -1.906 . . . . 0.0 112.067 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.663 ' HZ1' ' HB3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -97.45 94.54 7.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 176.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 25' ' ' VAL . 5.3 m -102.51 143.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.519 -0.738 . . . . 0.0 111.338 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.01 125.34 26.0 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.91 46.24 1.16 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.147 0.975 . . . . 0.0 109.358 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 94.2 -105.79 3.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 67' ' ' GLY . 5.6 p-10 -58.29 -144.73 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.497 -1.002 . . . . 0.0 109.93 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -77.53 -2.11 33.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.823 -1.173 . . . . 0.0 110.252 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -69.82 168.9 14.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.651 ' CD1' ' HD2' ' A' ' 63' ' ' LYS . 35.6 m-85 -142.13 165.3 27.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.779 ' HE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -152.7 116.5 4.8 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.725 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.894 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -73.99 143.61 45.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.039 HD21 HG21 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -146.29 130.19 17.22 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.845 -1.159 . . . . 0.0 110.786 -178.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.3 pttm -115.26 130.7 56.98 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.487 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.01 HG21 HG23 ' A' ' 24' ' ' ILE . 1.6 t -117.15 167.11 10.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.717 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.9 t80 -132.23 123.57 27.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.467 -1.396 . . . . 0.0 108.445 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.942 ' HG3' HD11 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -96.22 126.38 41.4 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.328 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 102' A LEU . 13.1 p -101.16 44.3 1.02 Allowed 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.678 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' A LEU . . . . . 0.52 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 1.0 OUTLIER 54.44 164.56 0.05 OUTLIER Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.476 -0.765 . . . . 0.0 109.785 179.021 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 102' A LEU . 34.7 Cg_endo -77.67 90.42 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.512 2.141 . . . . 0.0 110.528 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.61 -76.05 0.23 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.448 ' O ' ' CB ' ' A' ' 105' A ASN . 1.5 pp0? -168.05 -174.34 2.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.618 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' A ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 10.7 t-20 73.06 -170.84 0.13 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.301 -0.875 . . . . 0.0 109.942 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -54.74 179.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.725 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 108' ' ' LEU . 1.3 t70 -111.44 124.87 53.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.489 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.942 HD11 ' HG3' ' A' ' 101' ' ' LYS . 11.0 mp 49.7 177.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.408 1.099 . . . . 0.0 109.928 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.717 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.0 p -148.78 160.93 5.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.774 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.874 HD13 HD11 ' A' ' 97' ' ' LEU . 1.9 tp -96.84 86.25 3.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -68.7 -20.71 64.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.97 -1.081 . . . . 0.0 111.087 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.506 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 178.32 -163.35 31.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.777 -1.677 . . . . 0.0 110.84 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.755 ' HD2' HD11 ' A' ' 110' ' ' LEU . 29.2 p90 167.81 135.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.687 -0.89 . . . . 0.0 108.896 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.679 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -94.55 103.36 15.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.023 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.483 ' HA ' ' HG2' ' A' ' 95' ' ' MET . 3.6 p -67.06 159.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.679 -1.263 . . . . 0.0 110.536 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.76 32.93 1.35 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.663 ' HB3' ' HZ1' ' A' ' 63' ' ' LYS . 5.0 tptt -90.53 127.06 36.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.519 -1.363 . . . . 0.0 109.248 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.517 ' O ' ' CE ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -68.9 170.57 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.51 -0.744 . . . . 0.0 110.191 -178.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -62.99 -61.13 2.6 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.428 -0.795 . . . . 0.0 109.551 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 12.7 t0 -40.28 -31.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.48 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 1.1 t70 -50.77 121.54 6.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 110.031 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.7 OUTLIER -88.66 134.93 33.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.894 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 2.5 mp -65.22 -40.95 94.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.834 -1.166 . . . . 0.0 108.442 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 54.83 -161.91 0.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.027 0.918 . . . . 0.0 111.248 176.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.93 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -47.84 -17.97 0.64 Allowed Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.679 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 O-C-N 121.17 -1.194 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.318 0.58 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -151.86 81.08 5.9 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 109.347 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.17 126.64 7.9 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.713 2.276 . . . . 0.0 110.568 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.17 -166.01 34.37 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 73.74 135.46 0.3 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -41.58 122.3 1.92 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.2 -1.176 . . . . 0.0 110.586 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.516 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -102.07 -178.63 3.76 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.357 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.533 ' O ' ' CE ' ' A' ' 15' ' ' LYS . 2.8 mm-40 -59.01 135.0 57.49 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.05 -1.031 . . . . 0.0 108.797 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.586 ' HB2' ' CG ' ' A' ' 121' ' ' GLU . . . -39.4 109.34 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.226 -0.921 . . . . 0.0 110.936 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -79.59 129.85 70.01 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 175.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.95 128.92 20.71 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.635 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -43.29 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.627 1.203 . . . . 0.0 112.285 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.659 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.59 -167.69 0.16 Allowed Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.7 Cg_endo -71.83 -18.02 28.58 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 109.263 -1.091 . . . . 0.0 109.263 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -83.28 -44.91 14.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 108.569 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 21' ' ' ILE . 4.1 mm -57.82 -54.57 29.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.509 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 9.7 tp60 -60.45 -20.86 61.35 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.536 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 tm-20 -73.67 -36.84 65.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.683 -1.26 . . . . 0.0 109.091 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.889 HG23 HG21 ' A' ' 99' ' ' VAL . 4.5 mt -65.95 -50.76 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.084 0.945 . . . . 0.0 108.967 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 45' ' ' LEU . 8.7 p -65.0 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 122.074 0.94 . . . . 0.0 109.708 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.74 ' N ' HG13 ' A' ' 25' ' ' VAL . 31.6 t70 -70.26 -18.15 63.13 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.91 -17.68 27.54 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.591 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.695 HG11 ' CG2' ' A' ' 99' ' ' VAL . 30.9 m -107.54 -9.32 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -47.07 -46.13 53.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.912 -1.117 . . . . 0.0 109.947 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.3 Cg_endo -73.73 -29.89 10.11 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.442 1.428 . . . . 0.0 109.097 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 110' ' ' LEU . 7.4 mt-30 -81.57 -2.22 49.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.053 ' CD1' HD21 ' A' ' 97' ' ' LEU . 4.6 mt -95.08 -41.39 9.14 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.542 -0.723 . . . . 0.0 109.503 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 10.5 mt-10 -75.29 -23.64 57.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.537 -0.727 . . . . 0.0 109.441 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -23.57 21.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.994 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.33 -6.43 34.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.703 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 32' ' ' LEU . 1.4 t -127.58 -30.57 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.8 OUTLIER 91.98 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.403 0.621 . . . . 0.0 109.939 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.513 ' HB2' ' CG2' ' A' ' 36' ' ' THR . 1.2 mm-40 -110.04 -176.56 3.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 0.0 109.363 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' TYR . 7.3 m -108.89 -24.45 11.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.799 ' OH ' HG23 ' A' ' 115' ' ' VAL . 20.5 m-85 34.31 -162.91 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.784 0.802 . . . . 0.0 111.088 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' HG ' ' A' ' 45' ' ' LEU . . . 175.26 -160.27 28.87 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -42.6 125.78 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -1.095 . . . . 0.0 109.275 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 25' ' ' VAL . 68.1 mt -108.62 82.58 1.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.079 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 25.5 mt-10 -64.16 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.35 -0.844 . . . . 0.0 110.094 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.88 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -42.05 149.42 0.15 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.397 1.094 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.91 -44.46 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -152.69 168.89 24.17 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 17.5 p90 -166.0 144.53 5.84 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 111.284 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.578 ' CE ' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -109.14 165.7 11.4 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.62 141.71 29.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.511 ' HG3' ' OH ' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -117.55 162.87 17.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -117.59 135.17 58.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.162 -0.961 . . . . 0.0 110.035 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -158.74 -101.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -101.01 30.17 4.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.993 ' HA2' HD23 ' A' ' 102' A LEU . . . 156.77 -115.24 0.65 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 106.411 -2.676 . . . . 0.0 106.411 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.512 ' CB ' ' HE3' ' A' ' 101' ' ' LYS . 10.3 m -160.55 125.95 3.89 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.275 -1.132 . . . . 0.0 110.343 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.544 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 61.8 m-80 -78.0 -172.37 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' A' ' 101' ' ' LYS . 18.7 m-85 -150.4 154.37 37.63 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.439 1.114 . . . . 0.0 110.004 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 17.2 m-85 -152.73 130.83 11.88 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.612 HG22 HG22 ' A' ' 64' ' ' VAL . 4.3 mt -146.39 118.53 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 117.133 -1.827 . . . . 0.0 112.073 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.692 ' N ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.31 102.29 6.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 175.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.88 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -111.65 137.85 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.739 . . . . 0.0 110.807 -175.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.2 127.41 32.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.846 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -80.45 36.71 0.38 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.557 0.694 . . . . 0.0 110.884 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.96 -75.78 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.596 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -79.85 47.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 113.165 -176.37 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 1.2 t-20 79.31 -38.75 0.2 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.93 -1.106 . . . . 0.0 111.739 177.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.846 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.8 mtmp? -66.99 144.57 56.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.581 -1.324 . . . . 0.0 107.469 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.608 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 15.3 m-30 -108.51 170.89 7.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.298 -0.877 . . . . 0.0 109.898 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -155.82 127.94 7.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.496 -0.752 . . . . 0.0 109.069 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.777 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -77.5 139.92 39.69 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.053 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -123.05 127.78 49.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 111.097 -179.043 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 4.4 ttmt -113.01 126.84 55.93 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.889 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -133.49 166.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.087 -1.008 . . . . 0.0 109.515 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.677 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 48.3 t80 -130.79 132.68 45.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -110.44 145.78 37.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.277 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.582 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -102.33 108.93 20.45 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.926 0.869 . . . . 0.0 108.782 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' A LEU . . . . . 0.993 HD23 ' HA2' ' A' ' 57' ' ' GLY . 1.3 pp -73.22 -21.99 0.48 Allowed Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 102' A LEU . 36.2 Cg_endo -81.72 113.29 2.51 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 120.929 1.086 . . . . 0.0 110.302 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.05 -130.85 9.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -129.95 -163.18 1.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.292 -1.122 . . . . 0.0 109.241 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' A ASN . . . . . . . . . . . . . 6.6 t-20 -62.91 87.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.235 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -85.08 -179.0 6.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.244 -0.91 . . . . 0.0 109.246 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 108' ' ' LEU . 47.6 m-20 -79.43 100.54 7.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.356 -0.84 . . . . 0.0 110.234 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 5.6 mp -51.1 -177.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.217 1.008 . . . . 0.0 109.186 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.828 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.4 p -137.6 162.44 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.084 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.663 HD11 ' O ' ' A' ' 112' ' ' GLY . 16.3 tp -102.28 89.07 3.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.449 HG21 ' HB2' ' A' ' 100' ' ' PHE . 11.2 p -68.5 -21.22 64.61 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.314 -0.866 . . . . 0.0 110.707 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.663 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -179.7 -161.26 26.69 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.623 -1.751 . . . . 0.0 111.029 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.674 ' CB ' HD21 ' A' ' 32' ' ' LEU . 29.1 p90 170.08 133.48 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.745 -0.856 . . . . 0.0 108.968 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.673 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.18 107.84 20.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.799 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -66.75 158.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.582 -1.324 . . . . 0.0 111.239 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.9 t70 41.84 37.87 0.88 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.714 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.529 ' CE ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -81.06 -169.77 2.4 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.543 -1.348 . . . . 0.0 107.953 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 62.6 m-80 -148.07 -176.42 5.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.648 -1.283 . . . . 0.0 110.686 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 119' ' ' ASP . 1.3 ttmm -74.74 -46.22 38.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.63 -0.669 . . . . 0.0 109.464 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.5 t70 -47.61 -24.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.142 -0.974 . . . . 0.0 108.441 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 21.6 t0 -83.22 66.12 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.672 -0.643 . . . . 0.0 109.395 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.586 ' CG ' ' HB2' ' A' ' 14' ' ' ALA . 1.8 tt0 -61.35 103.27 0.29 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.786 -1.196 . . . . 0.0 108.052 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.777 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 3.4 mp -26.39 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.585 1.184 . . . . 0.0 110.256 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER -108.0 -7.91 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.066 -177.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.15 107.43 0.2 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.673 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.661 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 pt -146.38 85.97 7.12 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.958 . . . . 0.0 109.74 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.5 -65.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.687 2.258 . . . . 0.0 110.468 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.64 137.08 3.79 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 91.04 133.5 5.71 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 123' ' ' THR . 0.5 OUTLIER -40.37 115.55 0.57 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.608 -0.936 . . . . 0.0 110.935 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -101.51 171.22 7.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' SER . 12.7 tm-20 -43.53 166.97 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.281 -0.887 . . . . 0.0 109.347 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' N ' ' CD ' ' A' ' 13' ' ' GLU . . . -71.25 103.05 2.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.609 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -73.28 132.65 81.72 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 175.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.39 127.67 18.69 Favored 'Trans proline' 0 C--N 1.293 -2.352 0 N-CA-C 109.378 -1.047 . . . . 0.0 109.378 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.729 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -47.29 132.35 12.87 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.044 0.926 . . . . 0.0 111.909 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.619 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -102.56 -172.63 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.273 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.0 Cg_endo -68.08 -17.59 45.77 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 N-CA-C 109.545 -0.983 . . . . 0.0 109.545 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -81.79 -36.62 28.23 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.09 -1.006 . . . . 0.0 108.494 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.822 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -68.84 -45.31 80.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.504 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 11.0 tp60 -66.82 -18.92 65.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.73 -30.29 59.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.835 -1.166 . . . . 0.0 108.774 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.922 ' O ' HG22 ' A' ' 28' ' ' VAL . 46.0 mt -71.61 -51.98 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.737 HG13 ' N ' ' A' ' 26' ' ' ASP . 8.4 p -60.1 -42.89 91.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.879 0.847 . . . . 0.0 109.074 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.737 ' N ' HG13 ' A' ' 25' ' ' VAL . 1.4 t70 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' GLU . 7.3 mttt -81.45 -6.85 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.041 HG21 ' CD2' ' A' ' 97' ' ' LEU . 6.4 m -127.05 -8.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.577 -0.702 . . . . 0.0 110.501 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 15.5 ttpp -41.66 -47.9 9.74 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.024 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.0 Cg_endo -72.87 -34.88 6.17 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.33 1.354 . . . . 0.0 109.655 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.502 ' O ' HD23 ' A' ' 110' ' ' LEU . 60.9 mt-30 -74.6 -5.35 42.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.922 . . . . 0.0 108.513 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.89 HD11 HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.84 -37.47 8.67 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.863 0.839 . . . . 0.0 109.048 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.1 mt-10 -54.07 -54.88 33.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.654 -0.654 . . . . 0.0 110.55 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.71 -35.78 57.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 110.491 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 1.3 mptp? -53.46 -56.73 14.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.222 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.974 HG21 ' OH ' ' A' ' 40' ' ' TYR . 10.0 t -95.37 20.67 9.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER 41.32 39.83 1.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.328 -0.858 . . . . 0.0 110.001 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.685 ' HB3' HG23 ' A' ' 36' ' ' THR . 1.6 tt0 -136.77 160.12 39.81 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -102.92 135.8 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.698 -1.251 . . . . 0.0 110.422 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.974 ' OH ' HG21 ' A' ' 36' ' ' THR . 98.5 m-85 -117.52 169.1 9.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.834 . . . . 0.0 109.296 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -125.88 -164.69 11.86 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.1 123.82 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -1.206 . . . . 0.0 108.595 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.716 ' HB3' HG21 ' A' ' 64' ' ' VAL . 39.1 mt -100.32 76.72 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.919 -1.113 . . . . 0.0 109.063 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -57.2 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.461 0.648 . . . . 0.0 109.777 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.729 ' HB1' ' CB ' ' A' ' 17' ' ' ALA . . . -42.82 133.67 3.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.117 0.96 . . . . 0.0 110.006 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.2 t -113.36 -41.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -146.55 171.26 15.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.006 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.822 ' HB3' HG21 ' A' ' 21' ' ' ILE . 1.9 p90 -167.6 141.43 3.53 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.38 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 1.1 mppp? -121.14 128.91 52.98 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.956 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.5 p -73.01 -172.07 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.967 -1.083 . . . . 0.0 109.703 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.637 ' CG ' ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -167.33 127.27 1.43 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.6 p -107.84 115.58 49.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.507 HG21 ' ND2' ' A' ' 59' ' ' ASN . 0.3 OUTLIER -136.85 -104.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.65 29.55 4.05 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 102' ' ' SER . . . 162.57 -116.73 0.73 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 11.5 m -158.61 113.49 2.55 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.218 -1.166 . . . . 0.0 110.113 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.594 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 54.8 m-20 -82.37 -173.13 4.39 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.836 0.827 . . . . 0.0 109.099 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.649 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 93.2 m-85 -137.49 152.0 49.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.637 ' CE1' ' CG ' ' A' ' 53' ' ' GLN . 4.5 m-85 -133.29 138.25 46.35 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.735 ' N ' HD22 ' A' ' 122' ' ' LEU . 13.0 mt -156.2 125.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 116.747 -1.981 . . . . 0.0 112.466 -175.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.569 ' HD2' ' NE2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -103.12 90.64 3.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 45' ' ' LEU . 5.1 m -97.47 159.69 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.355 -0.84 . . . . 0.0 110.973 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.681 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -82.38 128.93 34.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.455 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.1 45.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.005 0.907 . . . . 0.0 109.377 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 86.23 -96.82 2.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 9.8 p-10 -58.83 -146.74 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.479 -1.012 . . . . 0.0 109.759 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.72 0.84 28.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.079 -1.013 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.58 175.72 6.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.265 -0.897 . . . . 0.0 109.238 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 21.7 m-85 -150.22 169.12 22.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 108.899 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.75 ' SD ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -151.86 112.75 4.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.706 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -72.28 152.44 42.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.041 ' CD2' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -146.85 158.06 43.82 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.279 -1.368 . . . . 0.0 111.615 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 6.5 mtpt -141.3 114.03 8.37 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.965 HG11 HD23 ' A' ' 108' ' ' LEU . 2.3 t -118.8 168.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.746 -1.221 . . . . 0.0 110.358 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.633 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 1.2 t80 -130.59 122.66 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 108.708 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.835 ' CG ' HD11 ' A' ' 108' ' ' LEU . 4.9 tttt -113.73 19.88 16.35 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 122.935 1.35 . . . . 0.0 108.299 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 100' ' ' PHE . 7.0 t -103.63 -92.37 0.35 Allowed 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.792 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' A LEU . . . . . 0.499 ' HG ' ' OG ' ' A' ' 102' ' ' SER . 6.1 mt -96.4 108.99 45.43 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.586 -0.696 . . . . 0.0 109.621 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 102' ' ' SER . 36.2 Cg_endo -78.84 135.3 12.56 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.621 2.214 . . . . 0.0 110.582 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.74 -46.7 6.64 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.532 ' O ' ' CB ' ' A' ' 105' A ASN . 1.1 pt20 -170.58 162.81 8.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -1.107 . . . . 0.0 108.982 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' A ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 0.2 OUTLIER 78.61 7.21 2.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.328 -0.857 . . . . 0.0 109.568 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 105' A ASN . 4.8 mm-40 46.32 -177.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.552 -0.717 . . . . 0.0 110.56 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER 64.36 163.06 0.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.399 -0.813 . . . . 0.0 109.769 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.965 HD23 HG11 ' A' ' 99' ' ' VAL . 6.2 mp -52.08 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.314 1.054 . . . . 0.0 109.788 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.1 p -143.9 163.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.798 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.67 HD22 ' HG ' ' A' ' 32' ' ' LEU . 6.4 tp -101.7 84.38 2.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.584 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 41.4 p -67.02 -19.82 65.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -176.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 178.36 -170.24 42.24 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.442 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.3 p90 172.53 134.53 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.452 -1.029 . . . . 0.0 109.501 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.626 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 2.0 mm100 -96.85 103.25 15.15 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.683 HG23 ' OH ' ' A' ' 40' ' ' TYR . 2.2 p -66.79 154.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 122.254 1.026 . . . . 0.0 111.057 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' A ASP . . . . . . . . . . . . . 12.7 t0 47.29 33.01 2.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.952 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.525 ' HG2' ' ND1' ' A' ' 96' ' ' HIS . 5.6 tptt -77.84 162.62 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.446 -1.409 . . . . 0.0 108.461 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -107.88 160.76 15.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.93 -1.106 . . . . 0.0 109.911 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 3.0 ttpm? -55.47 -48.95 73.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -46.48 -38.44 9.22 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.335 -0.853 . . . . 0.0 109.126 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.613 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -66.27 96.31 0.34 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.325 -0.859 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.31 170.74 15.78 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.735 HD22 ' N ' ' A' ' 62' ' ' ILE . 3.4 mp -93.16 25.4 3.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.411 -1.43 . . . . 0.0 109.202 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.922 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -17.14 -59.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.596 177.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . -150.09 41.06 0.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CG ' ' OXT' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.57 0 CA-C-O 117.827 -1.083 . . . . 0.0 109.054 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.665 ' C ' HD13 ' A' ' 7' ' ' ILE . 2.1 ttp . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.306 0.574 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.665 HD13 ' C ' ' A' ' 6' ' ' MET . 0.6 OUTLIER -118.48 89.8 37.5 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.242 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.42 68.87 7.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.522 2.148 . . . . 0.0 110.507 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.29 171.19 42.11 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.552 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -133.5 6.93 4.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 123' ' ' THR . 0.2 OUTLIER -6.74 100.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.969 0.89 . . . . 0.0 112.867 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.518 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 23.0 t -102.2 169.56 8.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 42.4 tt0 -46.87 172.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.109 -0.995 . . . . 0.0 109.267 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -81.65 107.25 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.956 -1.09 . . . . 0.0 110.228 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.665 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 1.1 mmtt -77.37 139.95 64.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.22 129.23 22.3 Favored 'Trans proline' 0 C--N 1.291 -2.476 0 N-CA-C 109.584 -0.968 . . . . 0.0 109.584 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.64 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -51.63 133.7 30.45 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.373 1.083 . . . . 0.0 111.788 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.656 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -109.33 -165.19 0.07 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.656 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -72.11 -16.52 28.62 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.428 ' CG ' ' N ' ' A' ' 21' ' ' ILE . 7.5 pt-20 -81.53 -39.1 25.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.924 -1.11 . . . . 0.0 108.539 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.797 HG21 ' HB3' ' A' ' 50' ' ' TYR . 25.7 mm -67.39 -50.32 63.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.559 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -65.13 -15.04 61.97 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -77.37 -37.35 52.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.174 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 99' ' ' VAL . 4.6 mt -63.9 -50.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 26' ' ' ASP . 14.3 p -66.75 -40.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.099 0.952 . . . . 0.0 109.253 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.698 ' N ' HG13 ' A' ' 25' ' ' VAL . 18.5 t0 -72.37 -15.08 61.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -92.91 -13.56 28.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' CG2' ' A' ' 99' ' ' VAL . 31.6 m -116.86 -6.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.487 -0.758 . . . . 0.0 109.676 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.614 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -46.03 -48.55 41.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.894 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.8 Cg_endo -73.58 -29.19 11.13 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.575 1.517 . . . . 0.0 109.101 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' HD23 ' A' ' 110' ' ' LEU . 54.0 mt-30 -79.66 -4.77 53.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.057 ' O ' HG22 ' A' ' 36' ' ' THR . 2.3 mt -98.2 -41.34 7.94 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.657 0.741 . . . . 0.0 109.016 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -65.83 -22.58 66.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 110.453 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -36.45 12.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.955 -1.091 . . . . 0.0 110.206 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -53.68 10.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.043 . . . . 0.0 110.045 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 1.057 HG22 ' O ' ' A' ' 32' ' ' LEU . 10.0 t -78.76 6.6 8.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.737 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 3.5 p-10 42.93 42.95 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.715 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.548 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 7.9 tt0 -139.22 159.67 41.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.162 -0.962 . . . . 0.0 108.961 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.561 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -94.32 133.51 37.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 110.203 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.845 ' OH ' HG21 ' A' ' 36' ' ' THR . 21.1 m-85 -122.77 -168.51 1.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -144.25 -171.1 14.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.99 136.05 3.9 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.162 -1.199 . . . . 0.0 108.978 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.645 ' HB2' HG22 ' A' ' 25' ' ' VAL . 29.9 mt -107.89 85.18 2.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.044 -1.035 . . . . 0.0 108.901 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -68.64 84.47 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.697 -0.627 . . . . 0.0 109.534 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.949 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.6 129.5 5.33 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.211 1.005 . . . . 0.0 109.953 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.536 HG11 ' NZ ' ' A' ' 63' ' ' LYS . 1.5 t -105.0 -46.26 9.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.646 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 1.8 mt-30 -146.92 167.23 24.47 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.797 ' HB3' HG21 ' A' ' 21' ' ' ILE . 3.8 p90 -161.1 137.51 8.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.565 -1.335 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 1.9 mttt -103.73 122.92 46.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.503 HG22 ' HE2' ' A' ' 50' ' ' TYR . 44.1 p -70.43 -173.67 0.75 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.882 ' O ' HG23 ' A' ' 58' ' ' THR . 0.6 OUTLIER -162.18 145.84 11.95 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.885 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -127.67 139.45 51.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.741 -1.224 . . . . 0.0 110.283 179.246 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.885 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.38 -100.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.22 29.6 5.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 157.72 -115.68 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 106.449 -2.66 . . . . 0.0 106.449 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.882 HG23 ' O ' ' A' ' 53' ' ' GLN . 27.4 m -162.32 111.66 1.45 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.188 -1.184 . . . . 0.0 110.831 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.702 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 77.8 m-20 -77.92 -169.49 1.57 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.633 ' CD1' HG12 ' A' ' 99' ' ' VAL . 25.2 m-85 -149.97 159.09 44.66 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.279 -0.888 . . . . 0.0 109.891 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.609 ' HB3' HD22 ' A' ' 122' ' ' LEU . 22.9 m-85 -140.11 136.53 33.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.829 HD12 HD23 ' A' ' 97' ' ' LEU . 14.4 mt -151.29 121.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 116.775 -1.97 . . . . 0.0 111.312 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' NZ ' HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -86.92 94.77 9.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.949 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.6 m -102.01 141.66 17.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.566 -0.709 . . . . 0.0 110.943 -176.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.614 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -68.88 129.41 39.85 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.59 47.25 1.4 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.033 0.92 . . . . 0.0 108.744 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.56 -94.96 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.69 -164.74 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.333 -1.098 . . . . 0.0 109.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -64.0 -9.04 13.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 110.121 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -68.53 163.52 23.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.614 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 6.5 m-85 -133.32 176.6 8.38 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 108.707 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.682 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -157.32 108.76 2.34 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.176 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.972 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -69.58 144.49 53.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.829 HD23 HD12 ' A' ' 62' ' ' ILE . 46.3 tp -130.59 153.32 49.02 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.994 -1.066 . . . . 0.0 111.063 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.3 ttmt -139.01 111.09 7.31 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 24' ' ' ILE . 1.9 t -117.44 161.14 16.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.713 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 3.2 t80 -127.36 127.92 45.03 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.702 -1.249 . . . . 0.0 107.815 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HB3' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -103.4 141.09 36.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.266 -0.896 . . . . 0.0 108.721 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 102' A LEU . 1.1 t -101.58 104.53 15.41 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.517 -0.739 . . . . 0.0 109.153 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' A LEU . . . . . 0.656 HD12 ' N ' ' A' ' 102' A LEU . 0.2 OUTLIER -36.73 164.85 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.939 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.075 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 102' A LEU . 29.7 Cg_endo -69.63 127.02 14.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.369 2.046 . . . . 0.0 111.083 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.35 -23.94 0.76 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 105' A ASN . 0.0 OUTLIER -131.47 6.33 4.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.576 -0.955 . . . . 0.0 109.128 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' A ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 105' A ASN . 5.6 p-10 41.75 95.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.383 0.611 . . . . 0.0 110.397 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -125.21 178.72 5.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.232 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -127.61 51.55 1.92 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.3 mp 44.41 -177.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.42 1.105 . . . . 0.0 110.658 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.727 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.9 p -158.57 164.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.055 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.81 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.9 tp -97.47 83.13 3.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.6 OUTLIER -71.94 -11.57 60.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 112.082 -176.197 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.509 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . 175.28 -171.91 45.0 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.575 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.81 ' HD2' HD11 ' A' ' 110' ' ' LEU . 20.8 p90 168.39 134.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.217 -1.167 . . . . 0.0 109.137 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -94.61 102.2 14.1 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.498 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 2.3 p -68.41 164.08 2.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.868 -1.145 . . . . 0.0 110.73 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.88 25.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.86 -0.525 . . . . 0.0 110.711 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.576 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.54 161.72 13.52 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 120.66 -1.275 . . . . 0.0 108.366 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.55 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 25.0 p-10 -140.4 -155.79 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.613 -1.305 . . . . 0.0 111.389 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -65.31 -48.46 73.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.27 0.557 . . . . 0.0 110.031 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 118' ' ' LYS . 2.9 t70 -41.05 -26.59 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 109.915 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.576 ' CB ' ' CD ' ' A' ' 116' ' ' LYS . 3.1 t70 -98.26 115.0 27.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 111.376 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.7 ' O ' HG23 ' A' ' 123' ' ' THR . 3.0 tt0 -75.07 146.89 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.972 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -66.59 -12.3 57.23 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.336 -1.477 . . . . 0.0 109.417 -178.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 37.25 -156.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.44 177.486 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -83.93 49.58 4.26 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.655 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.267 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.543 ' C ' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.786 HD13 ' N ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -110.09 174.47 2.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.326 -0.859 . . . . 0.0 109.019 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 7' ' ' ILE . 36.6 Cg_endo -80.6 30.44 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.584 2.189 . . . . 0.0 110.815 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.703 ' HA2' HG12 ' A' ' 54' ' ' VAL . . . 132.69 66.83 0.08 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.82 126.06 1.37 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.109 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.614 HD22 ' C ' ' A' ' 123' ' ' THR . 1.1 mp -50.6 143.7 9.02 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.668 -0.901 . . . . 0.0 111.125 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -101.59 171.44 7.56 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.67 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.99 -179.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.384 -0.823 . . . . 0.0 109.526 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HB1' ' CD ' ' A' ' 49' ' ' GLN . . . -82.89 107.76 15.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.005 . . . . 0.0 110.003 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.669 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -83.4 128.78 62.99 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 175.692 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.87 130.78 23.9 Favored 'Trans proline' 0 C--N 1.294 -2.29 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.501 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -46.53 162.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.392 1.092 . . . . 0.0 111.552 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.642 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -143.31 -166.95 0.14 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.73 -18.28 28.74 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 N-CA-C 108.992 -1.195 . . . . 0.0 108.992 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.45 -45.57 14.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 0.0 108.567 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.816 HG21 ' HB3' ' A' ' 50' ' ' TYR . 3.6 mm -58.48 -53.16 50.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.536 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.37 -19.84 62.32 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 tm-20 -73.87 -35.73 64.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.428 -1.42 . . . . 0.0 108.505 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.94 HG23 HG21 ' A' ' 99' ' ' VAL . 5.1 mt -65.46 -51.22 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.75 0.786 . . . . 0.0 108.934 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.828 HG21 HG11 ' A' ' 64' ' ' VAL . 8.8 p -62.34 -41.99 93.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 122.054 0.931 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.714 ' N ' HG13 ' A' ' 25' ' ' VAL . 6.3 t70 -69.95 -19.86 63.35 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.0 tttt -79.35 -20.7 47.13 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.665 HG21 HD21 ' A' ' 97' ' ' LEU . 17.6 m -117.83 3.1 7.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.732 -0.605 . . . . 0.0 109.938 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 14.7 tttp -47.91 -46.85 64.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.695 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.7 Cg_endo -75.34 -27.34 9.57 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.555 1.503 . . . . 0.0 109.028 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.624 ' O ' HD23 ' A' ' 110' ' ' LEU . 2.4 mt-30 -83.01 -1.03 51.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.127 HD11 ' CD1' ' A' ' 97' ' ' LEU . 2.5 mt -100.47 -33.48 10.33 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.676 0.75 . . . . 0.0 109.269 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 38' ' ' GLU . 2.4 mm-40 -73.89 -32.1 63.42 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.572 -0.705 . . . . 0.0 110.838 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -101.44 -4.43 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.355 -1.466 . . . . 0.0 112.009 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -99.95 -11.39 20.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.488 -1.383 . . . . 0.0 110.355 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.586 ' HB ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -140.11 -28.22 0.74 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.998 -1.064 . . . . 0.0 110.889 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.7 p30 149.11 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' GLU . 26.9 tt0 -66.38 105.09 1.36 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.234 1.016 . . . . 0.0 109.904 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 39' ' ' THR . 46.9 m -158.76 14.39 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.66 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.38 -175.53 2.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.048 -1.032 . . . . 0.0 109.171 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -145.72 -108.47 0.57 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -77.76 134.66 38.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -1.183 . . . . 0.0 108.811 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 25' ' ' VAL . 14.5 mt -108.16 83.47 1.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 108.511 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 3.7 mt-10 -71.87 85.5 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.708 -0.62 . . . . 0.0 109.961 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.838 ' N ' HG13 ' A' ' 64' ' ' VAL . . . -40.47 155.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 110.05 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.4 t -134.79 -41.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.671 ' CD ' ' HB1' ' A' ' 14' ' ' ALA . 25.1 tt0 -142.41 168.97 18.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.816 ' HB3' HG21 ' A' ' 21' ' ' ILE . 9.2 p90 -167.8 137.03 2.58 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.607 -1.308 . . . . 0.0 110.727 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 30.1 mttt -112.41 135.16 53.44 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.451 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 p -87.78 175.46 7.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.088 -1.008 . . . . 0.0 109.754 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.791 ' O ' HG23 ' A' ' 58' ' ' THR . 0.8 OUTLIER -150.31 158.96 44.73 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.65 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.703 HG12 ' HA2' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -129.49 137.03 57.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.935 -1.103 . . . . 0.0 110.495 179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -164.46 -96.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' HD11 ' A' ' 102' A LEU . . . -108.03 28.76 7.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.947 ' HA2' HD21 ' A' ' 102' A LEU . . . 161.44 -107.05 0.3 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 53' ' ' GLN . 3.3 m -168.59 109.65 0.52 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.592 -0.946 . . . . 0.0 110.729 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.625 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 41.5 m-80 -70.26 -165.98 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.613 ' CD1' HG12 ' A' ' 99' ' ' VAL . 64.6 m-85 -147.7 159.54 43.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.039 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.763 ' HB3' HD22 ' A' ' 122' ' ' LEU . 47.6 m-85 -140.41 138.18 34.55 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.787 HD12 HD23 ' A' ' 97' ' ' LEU . 24.9 mt -155.95 116.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 C-N-CA 116.873 -1.931 . . . . 0.0 111.495 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.717 ' HD2' ' CE1' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -81.66 101.79 10.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.838 HG13 ' N ' ' A' ' 47' ' ' ALA . 11.5 t -113.7 139.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 112.319 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -69.36 121.29 16.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HG2' ' A' ' 95' ' ' MET . . . -82.64 43.0 0.8 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 111.83 -129.73 9.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 67' ' ' GLY . 34.9 t70 -51.4 -107.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.518 -0.989 . . . . 0.0 110.365 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.03 3.99 36.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.71 -1.244 . . . . 0.0 109.706 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 94' ' ' TYR . 13.1 tptt -68.53 157.37 36.14 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' CD ' ' A' ' 65' ' ' ARG . 2.3 m-85 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.975 -1.078 . . . . 0.0 109.595 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . 1.032 ' HE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -163.46 133.66 4.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.572 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.841 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 2.3 m-70 -69.98 161.14 30.61 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.127 ' CD1' HD11 ' A' ' 32' ' ' LEU . 2.8 tp -142.04 129.88 21.76 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.576 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ttmt -117.54 122.43 43.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.94 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -123.83 168.19 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.971 -1.081 . . . . 0.0 109.009 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.703 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 14.8 t80 -131.84 127.42 36.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.85 -1.156 . . . . 0.0 108.954 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.532 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -113.47 152.97 29.43 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -89.59 -140.83 0.14 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.81 -1.181 . . . . 0.0 109.575 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' A LEU . . . . . 0.947 HD21 ' HA2' ' A' ' 57' ' ' GLY . 13.7 mt -119.8 -87.75 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 111.412 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.767 ' CD ' ' HB2' ' A' ' 102' A LEU . 37.1 Cg_endo -74.79 3.83 5.16 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 121.401 1.401 . . . . 0.0 110.729 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 106' ' ' GLU . . . -83.65 69.81 3.29 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 105' A ASN . 1.6 mm100 -70.45 166.11 21.12 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.046 -1.267 . . . . 0.0 108.7 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' A ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' GLN . 1.5 t-20 43.59 27.61 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.362 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 104' ' ' GLY . 2.8 pt-20 -85.62 -173.34 4.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.858 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 108' ' ' LEU . 58.5 m-20 -108.86 91.42 3.63 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.588 -0.695 . . . . 0.0 109.22 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.5 mp -52.77 -172.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.21 1.005 . . . . 0.0 109.238 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.791 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.3 p -136.73 164.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.52 -177.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 31' ' ' GLN . 7.1 tp -100.09 83.66 2.73 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -67.72 -17.29 64.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 111.197 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.622 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 176.32 -164.78 34.81 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.063 -1.541 . . . . 0.0 110.355 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 29.9 p90 165.99 137.17 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.686 -0.891 . . . . 0.0 109.099 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.622 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 8.6 mm-40 -99.0 94.51 6.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.546 ' HA ' ' CB ' ' A' ' 95' ' ' MET . 1.0 OUTLIER -67.64 157.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.029 -1.669 . . . . 0.0 110.241 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' A ASP . . . . . . . . . . . . . 7.8 t0 53.93 18.6 1.69 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.743 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -87.07 116.15 24.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.687 -1.258 . . . . 0.0 108.364 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.488 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 1.3 m120 -71.72 177.92 3.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.371 -0.831 . . . . 0.0 110.554 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -64.7 -24.22 67.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.62 -0.675 . . . . 0.0 110.066 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.64 -8.78 15.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.168 -0.957 . . . . 0.0 109.605 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.449 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -95.18 116.01 28.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.234 -0.916 . . . . 0.0 110.228 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 123' ' ' THR . 8.1 tt0 -86.95 139.31 30.73 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.841 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 3.1 mp -62.88 -46.97 85.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.775 -1.203 . . . . 0.0 109.256 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.719 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 54.78 -157.55 0.21 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 107.331 178.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.541 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -77.98 66.45 3.11 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.631 ' CD1' ' O ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.72 -0.871 . . . . 0.0 109.934 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 4.9 mtt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.353 0.597 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 7' ' ' ILE . 3.0 tt 173.41 92.7 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.043 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.45 -92.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.523 2.149 . . . . 0.0 110.651 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.68 145.76 2.45 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -123.1 46.19 1.12 Allowed Glycine 0 N--CA 1.491 2.314 0 O-C-N 121.09 -1.241 . . . . 0.0 110.254 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.112 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -37.46 120.32 0.78 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.83 0.824 . . . . 0.0 110.617 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -100.97 170.96 7.93 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.457 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 1.0 OUTLIER -49.04 -179.38 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 0.0 109.836 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.494 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . . . -81.2 99.04 8.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 110.25 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 2.2 mmpt? -70.42 128.42 91.25 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.61 126.3 14.57 Favored 'Trans proline' 0 C--N 1.292 -2.414 0 N-CA-C 108.813 -1.264 . . . . 0.0 108.813 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 21' ' ' ILE . . . -37.41 162.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.495 1.14 . . . . 0.0 111.794 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.662 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -145.6 -166.17 0.12 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -72.9 -21.09 21.51 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.503 -1.384 . . . . 0.0 108.503 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.504 ' O ' HD12 ' A' ' 24' ' ' ILE . 3.4 mt-10 -81.3 -44.92 16.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -0.969 . . . . 0.0 108.811 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.702 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.4 mm -58.7 -56.18 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.476 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 2.0 tp-100 -57.5 -20.09 29.01 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.3 tt0 -75.13 -39.17 60.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.339 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.088 HG23 HG21 ' A' ' 99' ' ' VAL . 2.2 mt -63.76 -49.63 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.043 0.925 . . . . 0.0 108.77 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.72 HG13 ' N ' ' A' ' 26' ' ' ASP . 12.4 p -66.82 -40.57 86.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 122.307 1.051 . . . . 0.0 109.401 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.72 ' N ' HG13 ' A' ' 25' ' ' VAL . 19.3 t0 -75.46 -13.35 60.38 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -95.43 -10.1 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.925 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.899 HG21 ' CD2' ' A' ' 97' ' ' LEU . 27.0 m -114.59 -15.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 110.981 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 ttpt -37.95 -51.07 3.08 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.035 -1.041 . . . . 0.0 110.911 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.5 Cg_endo -70.5 -35.9 9.72 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.421 1.414 . . . . 0.0 109.413 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' HD23 ' A' ' 110' ' ' LEU . 70.6 mt-30 -71.76 -6.44 41.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.9 HD13 ' CE ' ' A' ' 95' ' ' MET . 2.6 mt -96.79 -41.97 8.21 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 13.9 mt-10 -66.84 -8.99 32.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -0.808 . . . . 0.0 109.182 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.34 -56.4 2.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -48.56 20.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 109.958 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.607 HG22 ' CZ ' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -79.39 -14.56 58.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.06 -1.025 . . . . 0.0 108.973 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 1.4 p-10 44.97 64.84 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.417 0.627 . . . . 0.0 109.907 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.574 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 9.1 mt-10 -130.77 -177.74 4.49 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.3 m -98.8 -26.69 14.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.574 ' CE1' ' OE1' ' A' ' 38' ' ' GLU . 19.6 m-85 35.45 -161.84 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.809 0.814 . . . . 0.0 110.529 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . 179.26 -169.83 41.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.65 129.7 3.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -1.093 . . . . 0.0 108.793 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.705 HD12 HG22 ' A' ' 25' ' ' VAL . 44.2 mt -109.48 82.98 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.846 -1.158 . . . . 0.0 109.301 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -63.74 84.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.522 -0.737 . . . . 0.0 109.932 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.939 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.68 123.29 3.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.145 0.974 . . . . 0.0 109.966 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.2 t -99.51 -47.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.526 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 4.7 mm100 -145.18 172.58 12.91 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.702 ' HB3' HG21 ' A' ' 21' ' ' ILE . 17.2 p90 -166.89 137.08 3.08 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.061 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.541 ' CD ' ' HB2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.13 133.75 54.88 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.915 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.6 p -76.73 -176.87 4.02 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.273 -0.892 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.704 ' O ' HG23 ' A' ' 58' ' ' THR . 1.3 mm-40 -160.32 149.22 17.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.581 -0.699 . . . . 0.0 109.323 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -120.48 141.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 110.576 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.25 -103.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' O ' HD11 ' A' ' 102' A LEU . . . -100.1 30.58 3.71 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.876 ' HA2' HD21 ' A' ' 102' A LEU . . . 154.07 -118.19 0.85 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 106.178 -2.769 . . . . 0.0 106.178 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 53' ' ' GLN . 11.4 m -154.38 116.66 4.29 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.332 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.626 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 64.8 m-20 -77.72 -166.03 0.71 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.686 ' CD1' HG12 ' A' ' 99' ' ' VAL . 85.1 m-85 -147.34 153.14 39.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.617 ' CE1' ' OXT' ' A' ' 125' ' ' PHE . 16.0 m-30 -136.94 132.32 34.25 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.807 HG22 HG13 ' A' ' 64' ' ' VAL . 13.6 mt -148.97 124.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 117.06 -1.856 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HA ' ' HZ1' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -95.78 94.66 7.8 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 176.254 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 47' ' ' ALA . 15.7 m -99.4 144.88 11.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.274 0.559 . . . . 0.0 110.642 -176.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.658 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.1 mmm-85 -69.24 125.41 26.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.919 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -86.26 46.59 1.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.072 0.939 . . . . 0.0 108.904 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 -85.23 1.39 Allowed Glycine 0 C--N 1.287 -2.167 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.39 -168.67 1.2 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.203 -1.175 . . . . 0.0 109.87 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.13 7.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.919 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -69.21 127.02 31.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 108.798 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.599 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 5.6 m-30 -97.39 -179.12 4.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.096 -1.003 . . . . 0.0 110.324 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.9 ' CE ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.0 99.93 3.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.514 -0.741 . . . . 0.0 109.569 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.93 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -71.71 146.96 47.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.899 ' CD2' HG21 ' A' ' 28' ' ' VAL . 4.7 tp -138.21 139.26 39.2 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.371 -1.331 . . . . 0.0 111.531 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 9.6 ttpp -122.92 94.28 4.22 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.088 HG21 HG23 ' A' ' 24' ' ' ILE . 2.3 t -97.25 164.58 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.736 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 7.1 t80 -119.25 138.5 52.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.661 -1.274 . . . . 0.0 108.298 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.651 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -100.65 135.76 41.59 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.778 0.799 . . . . 0.0 109.064 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.511 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -103.29 94.67 5.63 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.053 178.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' A LEU . . . . . 0.876 HD21 ' HA2' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -41.49 -49.27 9.48 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.688 -0.633 . . . . 0.0 110.537 -179.56 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 102' A LEU . 35.1 Cg_endo -77.62 106.09 2.14 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.954 1.769 . . . . 0.0 110.446 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.4 137.51 2.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 105' A ASN . 4.3 mm-40 -77.75 -111.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.38 -1.071 . . . . 0.0 109.349 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' A ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 105' ' ' GLN . 5.8 t-20 -39.38 150.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 109.769 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.34 145.1 2.54 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.711 0.767 . . . . 0.0 110.499 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -158.52 44.54 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 3.0 mp -68.54 -175.28 0.64 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 122.373 1.082 . . . . 0.0 110.381 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.736 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 11.8 p -147.89 162.19 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.627 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.681 HD22 ' HG ' ' A' ' 32' ' ' LEU . 8.0 tp -98.05 89.23 4.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 100' ' ' PHE . 4.4 p -82.12 -11.98 58.45 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.901 -1.124 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.534 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . -175.01 -168.98 36.35 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.607 ' CZ ' HG22 ' A' ' 36' ' ' THR . 27.0 p90 164.84 139.29 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.578 -0.954 . . . . 0.0 109.26 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.628 ' HG2' ' CE2' ' A' ' 125' ' ' PHE . 3.4 mm100 -102.31 97.82 8.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.523 HG21 ' OE2' ' A' ' 38' ' ' GLU . 2.0 p -66.85 164.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 110.354 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' A ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 115' ' ' VAL . 35.1 t0 43.46 24.75 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.115 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.604 ' HE3' ' CE1' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -69.45 155.35 40.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.702 -1.249 . . . . 0.0 108.284 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.497 ' N ' ' HG2' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -107.9 -174.91 2.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -70.21 -38.78 75.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.813 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.96 -8.07 20.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.984 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.555 ' CB ' ' HG2' ' A' ' 116' ' ' LYS . 5.3 t0 -75.19 91.41 2.62 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.042 -1.036 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -64.4 155.1 33.56 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.93 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -90.13 55.65 3.16 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.667 1.222 . . . . 0.0 109.575 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -46.85 -172.09 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.291 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 1.112 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -45.09 -16.08 0.07 OUTLIER Glycine 0 N--CA 1.503 3.142 0 O-C-N 121.025 -1.047 . . . . 0.0 110.548 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.628 ' CE2' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.685 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.798 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.8 tpp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 mt 48.05 71.32 1.63 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.333 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.9 82.99 2.35 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.749 2.3 . . . . 0.0 111.107 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.56 ' HA2' HG12 ' A' ' 54' ' ' VAL . . . 68.48 123.42 0.03 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.76 157.01 21.94 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.768 HD22 ' HA2' ' A' ' 124' ' ' GLY . 1.2 pt? -107.04 149.45 27.56 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.128 -1.219 . . . . 0.0 109.027 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' GLU . 42.4 m -100.52 179.8 4.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 110.829 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tt0 -49.87 -176.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.674 -0.641 . . . . 0.0 109.992 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.912 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -91.38 100.55 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -68.06 146.58 98.22 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 175.517 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.12 129.63 20.99 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 N-CA-C 108.885 -1.237 . . . . 0.0 108.885 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -37.36 159.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.282 1.039 . . . . 0.0 111.346 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.642 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -139.41 -166.52 0.12 Allowed Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 30.3 Cg_endo -73.65 -17.62 23.1 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 108.693 -1.311 . . . . 0.0 108.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -85.68 -39.95 16.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.713 HG21 ' HB3' ' A' ' 50' ' ' TYR . 6.2 mm -65.17 -53.72 37.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.55 HE22 ' HB2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -57.95 -26.0 61.69 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.297 178.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 60.6 tt0 -76.91 -41.12 44.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 109.54 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.072 HG23 HG21 ' A' ' 99' ' ' VAL . 5.8 mt -56.48 -53.65 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 122.319 1.057 . . . . 0.0 108.271 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.713 HG13 ' N ' ' A' ' 26' ' ' ASP . 11.7 p -66.05 -40.69 87.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.615 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.713 ' N ' HG13 ' A' ' 25' ' ' VAL . 1.8 t70 -70.39 -10.53 59.33 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -99.26 -20.2 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.557 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.749 HG21 HD21 ' A' ' 97' ' ' LEU . 16.1 m -110.41 -4.94 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -44.72 -47.6 28.26 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.003 -1.06 . . . . 0.0 110.133 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -32.4 9.75 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.36 1.374 . . . . 0.0 109.421 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' HD23 ' A' ' 110' ' ' LEU . 82.5 mt-30 -79.77 -1.39 38.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.884 HD11 ' CD1' ' A' ' 97' ' ' LEU . 4.2 mt -95.85 -38.48 10.27 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.572 -0.705 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 3.3 mt-10 -66.11 -43.78 86.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.424 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -84.34 -11.29 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -0.967 . . . . 0.0 110.976 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -91.84 -12.21 34.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.76 -1.213 . . . . 0.0 110.451 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 1.049 HG21 ' OH ' ' A' ' 40' ' ' TYR . 6.2 t -122.82 -31.36 3.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.847 -1.158 . . . . 0.0 110.075 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 2.3 p-10 101.83 8.82 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.349 0.595 . . . . 0.0 109.724 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.855 ' H ' HG23 ' A' ' 36' ' ' THR . 2.0 tt0 -117.03 152.92 33.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.486 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -102.29 121.26 41.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 0.0 110.689 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 1.049 ' OH ' HG21 ' A' ' 36' ' ' THR . 11.0 m-85 -110.93 -175.97 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -139.56 -156.43 6.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -38.35 132.17 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.529 -0.983 . . . . 0.0 109.763 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.706 ' HB2' HG22 ' A' ' 25' ' ' VAL . 65.8 mt -112.89 91.49 3.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.085 -1.009 . . . . 0.0 109.064 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.31 90.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.922 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -47.65 125.05 7.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.219 1.009 . . . . 0.0 110.142 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.4 t -97.63 -45.72 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.912 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 3.6 pt20 -150.91 171.33 17.43 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.713 ' HB3' HG21 ' A' ' 21' ' ' ILE . 8.9 p90 -165.42 139.73 4.8 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.858 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 61.8 mttt -109.39 123.43 49.32 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 p -73.19 -175.97 2.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.892 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -161.85 152.36 17.42 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.848 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.36 140.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 110.084 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.33 -102.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.59 30.53 3.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 157.08 -108.84 0.38 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.749 -2.54 . . . . 0.0 106.749 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 53' ' ' GLN . 26.8 m -167.82 109.2 0.59 Allowed 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.619 -0.93 . . . . 0.0 110.61 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.622 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 65.6 m-20 -69.93 -172.96 0.58 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 20.4 m-85 -144.72 145.79 31.87 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.776 ' HB3' HD22 ' A' ' 122' ' ' LEU . 1.4 m-85 -128.68 133.67 48.27 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.919 HG22 HG13 ' A' ' 64' ' ' VAL . 32.0 mt -150.99 121.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 116.423 -2.111 . . . . 0.0 112.021 -176.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.13 96.97 10.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 176.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.922 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.3 m -105.98 140.3 24.5 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 O-C-N 121.174 -0.954 . . . . 0.0 111.561 -175.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.2 mtm-85 -68.51 133.87 49.22 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -85.12 42.81 0.96 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.793 0.806 . . . . 0.0 109.175 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 73.35 -81.33 0.71 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 7.0 m-20 -55.13 -113.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -1.033 . . . . 0.0 110.496 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.05 -30.91 4.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.747 -1.22 . . . . 0.0 109.293 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.776 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 29.7 mtmt -68.73 144.58 54.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.602 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 15.7 m-30 -109.81 176.99 4.86 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.116 -0.99 . . . . 0.0 109.023 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.658 ' O ' HG22 ' A' ' 64' ' ' VAL . 20.2 ttp -144.65 119.92 10.2 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.007 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.788 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -69.17 151.13 46.72 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.884 ' CD1' HD11 ' A' ' 32' ' ' LEU . 13.3 tp -130.71 142.04 50.41 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.118 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.629 ' HE2' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -131.0 95.79 3.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.072 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -105.42 161.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.197 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.705 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.0 t80 -126.54 129.71 49.14 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.636 -1.29 . . . . 0.0 108.483 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HG2' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -98.97 115.71 29.54 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 102' A LEU . 28.8 m -102.11 47.62 0.89 Allowed 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.202 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' A LEU . . . . . 0.517 ' C ' ' O ' ' A' ' 102' ' ' SER . 0.5 OUTLIER 31.02 63.32 1.03 Allowed Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.767 -0.583 . . . . 0.0 110.287 179.31 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 102' A LEU . 36.5 Cg_endo -77.56 -167.55 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.794 2.329 . . . . 0.0 111.534 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.95 -35.24 0.06 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.2 -179.1 5.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.624 -0.927 . . . . 0.0 108.873 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' A ASN . . . . . . . . . . . . . 1.6 t-20 53.1 -146.03 0.55 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 109.737 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.458 ' O ' ' OD1' ' A' ' 107' ' ' ASP . 0.7 OUTLIER -71.88 -179.58 2.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.102 -0.999 . . . . 0.0 109.785 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' OD2' ' HG2' ' A' ' 103' ' ' PRO . 0.6 OUTLIER -151.72 140.55 20.94 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.351 -0.843 . . . . 0.0 110.146 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 108' ' ' LEU . 10.4 mp 55.6 175.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.72 1.247 . . . . 0.0 111.05 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.705 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.9 p -152.37 163.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.742 -177.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 112' ' ' GLY . 9.0 tp -100.43 83.41 2.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.604 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.9 OUTLIER -69.26 -10.51 58.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 111.735 -176.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.598 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 171.35 -165.4 38.42 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.612 -1.756 . . . . 0.0 111.157 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 30.2 p90 165.73 143.47 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.639 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.9 mm100 -105.26 103.6 13.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.629 -1.294 . . . . 0.0 107.662 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -68.61 162.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.71 -1.244 . . . . 0.0 111.162 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.1 t0 51.78 20.34 1.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.654 ' HG3' ' OD2' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -74.32 161.67 29.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.81 -1.181 . . . . 0.0 108.293 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.506 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 1.1 m120 -152.68 -167.73 2.83 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.199 -1.563 . . . . 0.0 112.752 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -36.7 -38.34 0.17 Allowed 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.196 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.43 53.27 2.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.718 ' CG ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -92.91 108.59 20.12 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.85 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.674 ' O ' HG23 ' A' ' 123' ' ' THR . 1.9 tt0 -102.29 105.49 16.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.788 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.8 OUTLIER -69.07 -28.86 66.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.364 -1.46 . . . . 0.0 107.841 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 39.9 -160.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.758 0.789 . . . . 0.0 110.55 176.146 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.768 ' HA2' HD22 ' A' ' 11' ' ' LEU . . . -69.71 -0.35 24.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.639 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.33 -1.1 . . . . 0.0 109.01 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.6 ttm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.488 HG23 ' HD2' ' A' ' 8' ' ' PRO . 10.7 mm -67.96 138.83 92.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 109.485 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HD2' HG23 ' A' ' 7' ' ' ILE . 36.2 Cg_endo -79.02 -85.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.375 2.05 . . . . 0.0 110.107 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.54 -5.54 62.48 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -77.73 -162.98 19.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.543 HD12 ' OE1' ' A' ' 53' ' ' GLN . 0.3 OUTLIER 39.98 71.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.654 1.216 . . . . 0.0 110.647 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -103.28 -176.37 3.07 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.558 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' SER . 7.5 tt0 -50.3 -179.85 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.125 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.521 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -81.1 104.92 11.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -74.83 133.44 76.22 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.47 130.2 21.8 Favored 'Trans proline' 0 C--N 1.292 -2.397 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -40.94 167.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.422 1.106 . . . . 0.0 111.786 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.639 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -149.88 -165.53 0.11 Allowed Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 30.1 Cg_endo -73.37 -19.05 22.58 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 108.581 -1.354 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.23 -45.87 13.35 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.153 -0.967 . . . . 0.0 108.572 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.688 HG21 ' HB3' ' A' ' 50' ' ' TYR . 3.2 mm -58.03 -54.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 5.0 tp-100 -58.97 -21.66 58.96 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.7 tt0 -75.14 -41.33 58.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 109.061 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.057 HG23 HG21 ' A' ' 99' ' ' VAL . 3.6 mt -60.5 -50.03 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.989 0.9 . . . . 0.0 108.791 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.733 HG22 HD12 ' A' ' 45' ' ' LEU . 11.1 p -65.03 -40.84 90.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 122.134 0.969 . . . . 0.0 108.893 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.712 ' N ' HG13 ' A' ' 25' ' ' VAL . 43.8 t0 -71.45 -13.24 61.76 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.7 mmtt -96.03 -11.26 26.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.045 HG21 HD21 ' A' ' 97' ' ' LEU . 16.9 m -121.88 -4.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 0.0 110.995 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 13.3 ttpt -47.95 -45.59 62.72 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.927 -1.108 . . . . 0.0 111.035 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.83 -36.89 4.19 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.473 1.449 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 2.8 mt-30 -71.52 -7.32 46.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.838 HD22 ' CE ' ' A' ' 95' ' ' MET . 8.8 mt -100.89 -34.86 9.62 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.612 -0.68 . . . . 0.0 109.867 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 20.2 mt-10 -52.6 -48.83 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.139 -0.976 . . . . 0.0 109.814 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' OE1' ' CA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -86.71 -44.75 11.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.322 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 5.3 mmtt -42.81 -27.0 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 67.5 p -104.48 -72.57 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.953 . . . . 0.0 110.003 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.0 p30 149.55 38.3 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -164.23 -177.99 5.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.327 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.96 125.23 53.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 110.296 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 10.8 m-85 -103.12 169.5 8.52 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -129.25 -150.99 7.23 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.811 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.99 119.81 1.62 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.486 -1.008 . . . . 0.0 109.022 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 25' ' ' VAL . 62.8 mt -99.54 86.45 3.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.964 -1.085 . . . . 0.0 108.497 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.206 0.526 . . . . 0.0 110.332 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.753 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -47.28 115.28 1.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.054 -1.029 . . . . 0.0 109.493 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.603 HG12 ' HG3' ' A' ' 49' ' ' GLN . 1.5 t -94.08 -46.34 13.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HG3' HG12 ' A' ' 48' ' ' VAL . 14.6 mt-30 -146.26 173.55 12.14 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.169 -1.013 . . . . 0.0 108.964 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.688 ' HB3' HG21 ' A' ' 21' ' ' ILE . 18.1 p90 -168.34 138.15 2.48 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.946 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -106.08 130.44 53.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.691 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 p -83.27 -174.01 5.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.38 -0.825 . . . . 0.0 110.786 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.787 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -164.69 152.1 11.51 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.675 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -125.77 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.941 -1.099 . . . . 0.0 110.594 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -165.46 -102.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.11 30.42 5.6 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 160.71 -109.27 0.39 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 53' ' ' GLN . 8.4 m -167.28 112.21 0.72 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.418 -1.048 . . . . 0.0 110.856 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.636 ' HB2' ' HB3' ' A' ' 53' ' ' GLN . 45.6 m-80 -72.38 -165.95 0.23 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CD1' HG12 ' A' ' 99' ' ' VAL . 44.7 m-85 -156.02 160.23 39.84 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.672 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 125' ' ' PHE . 26.7 m-85 -144.45 134.85 24.49 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.737 HG22 HG13 ' A' ' 64' ' ' VAL . 15.3 mt -151.41 125.26 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 116.828 -1.949 . . . . 0.0 111.405 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.701 ' CG ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -94.6 91.25 6.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.427 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 47' ' ' ALA . 34.4 m -98.77 140.43 18.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 O-C-N 121.857 -0.527 . . . . 0.0 110.317 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.649 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 ttp180 -68.12 138.3 55.61 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.702 -1.249 . . . . 0.0 107.943 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.2 46.63 1.4 Allowed 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 122.269 1.033 . . . . 0.0 108.412 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.54 -77.93 1.69 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' CD ' ' A' ' 65' ' ' ARG . 3.8 t0 -61.1 -155.77 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.274 -1.133 . . . . 0.0 109.236 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -83.22 -3.67 57.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 109.366 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.575 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -75.31 178.48 5.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.21 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.649 ' CD2' ' HA ' ' A' ' 65' ' ' ARG . 33.7 m-85 -150.76 165.89 32.11 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.038 -1.039 . . . . 0.0 109.55 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.838 ' CE ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -146.41 126.07 13.38 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 108.703 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.72 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.7 m170 -74.76 151.3 39.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.045 HD21 HG21 ' A' ' 28' ' ' VAL . 15.6 tp -138.48 133.75 33.1 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.852 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.532 ' CD ' ' OG1' ' A' ' 111' ' ' THR . 0.1 OUTLIER -115.6 124.17 50.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.174 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.057 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -129.42 166.53 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.612 -1.305 . . . . 0.0 108.698 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.691 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.8 t80 -131.06 136.0 48.06 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.844 -1.16 . . . . 0.0 109.195 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.621 ' CG ' HD11 ' A' ' 108' ' ' LEU . 6.1 tttt -102.96 108.79 20.11 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.481 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 91.4 p -102.42 87.59 3.06 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 121.419 0.628 . . . . 0.0 109.478 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' A LEU . . . . . 0.579 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -45.03 -49.15 30.39 Favored Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.413 -0.804 . . . . 0.0 109.935 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' A LEU . 35.8 Cg_endo -78.41 164.84 26.02 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.356 2.037 . . . . 0.0 110.843 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 106' ' ' GLU . . . 108.83 46.84 0.93 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 55.08 -178.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -1.159 . . . . 0.0 109.515 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' A ASN . . . . . . . . . . . . . 1.2 m-20 -69.92 86.11 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 104' ' ' GLY . 6.7 mm-40 -120.41 -176.13 3.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -0.909 . . . . 0.0 109.573 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.01 176.49 6.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.296 -0.877 . . . . 0.0 110.086 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.693 HD23 HG11 ' A' ' 99' ' ' VAL . 10.6 mp -55.92 -172.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.36 1.076 . . . . 0.0 110.89 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.795 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.3 p -145.45 164.56 11.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.499 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 97' ' ' LEU . 9.1 tp -102.35 86.88 2.9 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.532 ' OG1' ' CD ' ' A' ' 98' ' ' LYS . 2.2 p -70.38 -29.82 66.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 0.0 111.625 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.599 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -165.88 -162.85 18.14 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.865 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.756 ' CG ' HD21 ' A' ' 32' ' ' LEU . 19.1 p90 165.77 134.68 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.357 -1.084 . . . . 0.0 109.168 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.632 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.9 mm-40 -97.51 102.14 13.83 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.626 HG23 ' HE3' ' A' ' 95' ' ' MET . 0.6 OUTLIER -68.17 159.3 5.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.683 -1.26 . . . . 0.0 111.349 -177.236 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.7 t0 48.73 31.44 3.07 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.523 ' HD3' ' CB ' ' A' ' 114' ' ' GLN . 2.5 mptt -93.95 114.34 26.53 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.504 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 13.0 m-80 -69.11 -169.18 0.17 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.867 . . . . 0.0 110.062 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -44.45 40.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.454 -0.779 . . . . 0.0 109.442 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -50.9 -21.09 1.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -73.12 127.3 32.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.146 -0.971 . . . . 0.0 110.05 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 123' ' ' THR . 22.4 tt0 -93.63 136.12 34.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.72 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.5 mp -64.2 -32.12 73.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 108.664 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 43.81 -160.31 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.136 178.083 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.553 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -62.36 89.2 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.634 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -164.52 83.11 1.24 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.431 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 54' ' ' VAL . 36.2 Cg_endo -78.39 -172.37 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.597 2.198 . . . . 0.0 110.289 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.676 ' CA ' HG12 ' A' ' 54' ' ' VAL . . . 137.52 133.25 3.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.45 114.61 0.77 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.89 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.9 OUTLIER -55.61 138.26 47.36 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.949 0.88 . . . . 0.0 111.28 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.9 m -101.73 167.81 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.0 tt0 -49.28 179.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.319 -0.863 . . . . 0.0 109.458 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.527 ' CB ' ' OE1' ' A' ' 49' ' ' GLN . . . -73.3 96.21 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 0.0 110.297 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 3.1 mmpt? -69.66 131.82 89.46 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.93 124.89 13.31 Favored 'Trans proline' 0 C--N 1.291 -2.466 0 N-CA-C 109.164 -1.129 . . . . 0.0 109.164 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.721 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -47.59 123.29 5.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.902 0.858 . . . . 0.0 111.763 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.609 ' OG1' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -95.69 -172.75 0.3 Allowed Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.373 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 27.8 Cg_endo -67.82 -20.06 46.12 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 N-CA-C 109.786 -0.89 . . . . 0.0 109.786 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.58 -34.76 30.83 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.981 -1.074 . . . . 0.0 108.777 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.891 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -69.28 -46.8 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.529 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -69.57 -13.44 62.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.2 tt0 -76.56 -40.16 50.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.984 HG23 HG21 ' A' ' 99' ' ' VAL . 5.3 mt -60.76 -51.5 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.802 HG21 HG11 ' A' ' 64' ' ' VAL . 12.4 p -64.38 -42.06 94.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.981 0.895 . . . . 0.0 108.81 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.712 ' N ' HG13 ' A' ' 25' ' ' VAL . 43.3 t0 -68.84 -14.92 63.33 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -93.37 -15.16 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.198 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.747 ' O ' HD12 ' A' ' 32' ' ' LEU . 31.6 m -119.85 -0.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.872 . . . . 0.0 110.557 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 7.7 ttpp -50.82 -44.62 85.84 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.847 -1.158 . . . . 0.0 110.361 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.3 Cg_endo -73.86 -34.23 5.5 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.155 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 2.4 mt-30 -74.52 -5.52 43.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.857 HD11 HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.43 -35.84 9.43 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.519 -0.738 . . . . 0.0 109.488 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -72.37 -29.33 63.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.462 -0.774 . . . . 0.0 110.881 -179.035 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.43 -17.73 17.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.889 -1.132 . . . . 0.0 110.464 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 22.8 ttmt -78.34 -61.74 1.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.995 -1.066 . . . . 0.0 109.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.749 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -72.98 -19.33 61.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.846 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.5 OUTLIER 85.75 11.83 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.65 -0.657 . . . . 0.0 109.517 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' H ' HG23 ' A' ' 36' ' ' THR . 7.9 tt0 -109.17 138.86 44.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -76.44 125.63 29.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.124 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.659 ' OH ' HG21 ' A' ' 36' ' ' THR . 31.9 m-85 -112.77 179.76 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 108.948 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -144.68 -164.43 10.56 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.05 123.78 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -1.111 . . . . 0.0 108.836 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.65 HD12 HG22 ' A' ' 25' ' ' VAL . 46.3 mt -102.49 91.37 4.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.849 -1.157 . . . . 0.0 108.372 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -72.01 82.85 0.96 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.898 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -40.17 134.68 1.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.116 0.96 . . . . 0.0 110.005 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.683 HG12 ' HG3' ' A' ' 49' ' ' GLN . 2.0 t -118.45 -42.14 2.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.683 ' HG3' HG12 ' A' ' 48' ' ' VAL . 2.4 mt-30 -142.72 171.71 13.69 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.891 ' HB3' HG21 ' A' ' 21' ' ' ILE . 18.4 p90 -170.82 136.48 1.17 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 3.8 mttt -109.11 157.41 18.76 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.353 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.421 HG22 ' HD1' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -138.93 140.2 38.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.373 -0.829 . . . . 0.0 109.162 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.592 ' HG2' ' CE1' ' A' ' 61' ' ' TYR . 0.9 OUTLIER -138.29 174.31 10.69 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.561 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.824 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -113.4 158.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.718 -1.239 . . . . 0.0 110.933 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.67 -101.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.476 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 27.26 6.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.591 ' CA ' HD11 ' A' ' 102' A LEU . . . 153.69 -119.94 0.99 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 106.202 -2.759 . . . . 0.0 106.202 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 53' ' ' GLN . 19.1 m -151.68 109.31 3.63 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.038 -1.272 . . . . 0.0 110.542 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.721 ' ND2' HG21 ' A' ' 55' ' ' VAL . 64.4 m-80 -72.85 -171.09 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.2 m-85 -144.44 158.63 43.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.918 0.866 . . . . 0.0 108.988 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.62 ' CE2' HD21 ' A' ' 11' ' ' LEU . 2.1 m-85 -138.73 139.99 38.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.948 HD12 HD23 ' A' ' 97' ' ' LEU . 13.2 mt -154.7 123.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 116.72 -1.992 . . . . 0.0 112.06 -176.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' HE3' ' CA ' ' A' ' 118' ' ' LYS . 15.9 tttt -93.06 92.44 7.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.898 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.1 m -98.91 143.27 13.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.587 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 3.9 mtm180 -67.67 131.28 45.3 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -85.35 44.65 1.11 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.986 0.898 . . . . 0.0 109.445 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 96.69 -113.12 4.6 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.5 p30 -49.84 -104.43 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -1.031 . . . . 0.0 110.655 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -119.66 -1.9 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.945 -1.097 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.1 mptp? -68.47 -177.93 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.53 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 8.2 m-85 -146.12 166.82 25.02 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.879 -1.138 . . . . 0.0 109.727 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.646 ' O ' HG22 ' A' ' 64' ' ' VAL . 49.0 ttp -151.73 111.31 3.98 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.485 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.951 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -69.6 147.6 50.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.125 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.948 HD23 HD12 ' A' ' 62' ' ' ILE . 13.2 tp -128.52 153.02 47.61 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.246 -0.909 . . . . 0.0 110.71 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.556 ' C ' ' HG1' ' A' ' 111' ' ' THR . 2.6 tttm -143.09 102.32 3.98 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.984 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -112.95 160.39 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.762 -1.211 . . . . 0.0 109.404 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.74 ' HB2' HG21 ' A' ' 111' ' ' THR . 9.3 t80 -120.37 137.9 54.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.47 -1.394 . . . . 0.0 108.408 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -110.91 138.5 47.23 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.015 0.912 . . . . 0.0 109.317 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.46 ' N ' ' HG3' ' A' ' 101' ' ' LYS . 22.0 p -103.51 93.41 4.93 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' A LEU . . . . . 0.608 ' CD1' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -38.61 -52.7 3.45 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.757 -0.589 . . . . 0.0 110.53 -179.148 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.608 ' HD3' ' CD1' ' A' ' 102' A LEU . 36.6 Cg_endo -78.43 -173.06 1.69 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.427 2.085 . . . . 0.0 110.704 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 105' ' ' GLN . . . 87.58 125.39 2.13 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.499 ' HG3' ' N ' ' A' ' 105' A ASN . 11.6 tp60 -54.03 -104.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -1.058 . . . . 0.0 109.216 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' A ASN . . . . . 0.499 ' N ' ' HG3' ' A' ' 105' ' ' GLN . 0.9 OUTLIER -47.44 125.21 7.86 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.216 -0.928 . . . . 0.0 109.377 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -51.52 153.0 2.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 109.117 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.71 59.86 0.94 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.651 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.2 mp -60.5 -177.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.259 1.028 . . . . 0.0 109.54 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.2 p -153.7 163.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.79 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 6.7 tp -99.6 84.1 2.89 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.74 HG21 ' HB2' ' A' ' 100' ' ' PHE . 16.8 p -69.02 -15.75 63.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 111.504 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 174.68 -167.52 39.8 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 30.1 p90 170.99 137.54 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.645 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -98.04 102.66 14.47 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.532 HG23 ' OH ' ' A' ' 40' ' ' TYR . 9.9 p -67.99 158.47 5.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.131 -0.98 . . . . 0.0 111.195 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.5 t70 45.92 27.99 0.55 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 7.6 mmtm -101.01 129.76 46.9 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 120.676 -1.265 . . . . 0.0 108.48 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 6.6 m-20 -105.65 -156.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 111.054 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' CA ' ' HE3' ' A' ' 63' ' ' LYS . 1.5 ttpm? -58.73 -45.41 89.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.699 -0.626 . . . . 0.0 109.981 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.21 -22.88 0.44 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.504 ' OD1' ' CE ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -89.0 122.52 32.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 110.993 -179.346 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.698 ' O ' HG23 ' A' ' 123' ' ' THR . 0.3 OUTLIER -94.99 132.79 39.45 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.951 ' HG ' ' CE1' ' A' ' 96' ' ' HIS . 2.2 mp -60.76 -55.92 27.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.782 -1.199 . . . . 0.0 109.344 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.743 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 56.7 -163.79 0.16 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.802 -1.186 . . . . 0.0 110.031 177.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.89 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -50.52 -14.98 1.08 Allowed Glycine 0 N--CA 1.501 3.022 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.645 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 120.859 -1.377 . . . . 0.0 109.113 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 57.0 mmm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.652 HD13 ' N ' ' A' ' 7' ' ' ILE . 2.0 mm -71.37 -47.04 13.64 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.559 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 7' ' ' ILE . 36.1 Cg_endo -78.74 101.2 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.147 1.898 . . . . 0.0 110.661 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.7 -145.32 0.3 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -125.6 2.82 8.13 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 121.096 -1.238 . . . . 0.0 110.182 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.566 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER 1.47 113.89 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.916 0.865 . . . . 0.0 112.534 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -101.06 160.41 14.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 41.5 tt0 -46.76 173.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB1' ' CG ' ' A' ' 49' ' ' GLN . . . -59.85 95.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.875 -1.14 . . . . 0.0 109.871 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.608 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -69.68 130.31 90.5 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.437 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.1 Cg_endo -67.64 126.14 14.32 Favored 'Trans proline' 0 C--N 1.288 -2.608 0 N-CA-C 108.772 -1.28 . . . . 0.0 108.772 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.573 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -40.66 156.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.289 1.042 . . . . 0.0 111.468 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.648 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -135.05 -168.38 0.18 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.648 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.35 -18.11 30.22 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 N-CA-C 109.177 -1.124 . . . . 0.0 109.177 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -82.96 -47.37 11.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.046 -1.034 . . . . 0.0 108.435 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.809 HG21 ' HB3' ' A' ' 50' ' ' TYR . 6.7 mm -56.8 -54.72 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.627 HE22 ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -53.97 -26.95 28.45 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.81 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 4.2 tp10 -76.77 -35.2 57.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.083 . . . . 0.0 110.155 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.971 HG23 HG21 ' A' ' 99' ' ' VAL . 3.5 mt -66.19 -49.95 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.887 HG21 HG11 ' A' ' 64' ' ' VAL . 12.8 p -66.18 -41.3 89.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 122.279 1.038 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.702 ' N ' HG13 ' A' ' 25' ' ' VAL . 12.5 t70 -74.98 -14.17 60.59 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 30.8 ttmt -93.36 -10.96 33.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.994 HG21 HD21 ' A' ' 97' ' ' LEU . 15.5 m -117.78 -5.31 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 110.653 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 4.5 ttpm? -42.72 -48.65 13.51 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.891 -1.131 . . . . 0.0 110.661 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 29.3 Cg_endo -69.65 -33.89 16.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.294 1.329 . . . . 0.0 109.799 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' O ' HD23 ' A' ' 110' ' ' LEU . 60.1 mt-30 -74.92 -5.01 41.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.996 HD11 ' CD1' ' A' ' 97' ' ' LEU . 5.4 mt -97.67 -38.07 9.66 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.593 -0.692 . . . . 0.0 109.705 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 39' ' ' THR . 35.5 mt-10 -65.34 -26.46 68.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.503 -0.748 . . . . 0.0 109.645 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.39 -40.74 11.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HG2' ' OH ' ' A' ' 113' ' ' TYR . 12.0 tttt -75.19 -8.07 55.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 32' ' ' LEU . 9.9 p -123.03 -48.31 2.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.608 ' CB ' ' O ' ' A' ' 36' ' ' THR . 3.7 p-10 104.48 32.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.189 0.519 . . . . 0.0 109.724 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 5.1 mt-10 -130.42 145.08 51.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.265 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.6 m -75.17 -10.36 59.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.107 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.722 ' CD2' ' HE1' ' A' ' 95' ' ' MET . 25.7 m-85 36.71 -163.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.76 0.79 . . . . 0.0 110.61 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -162.97 -167.71 23.8 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.73 126.22 3.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -1.108 . . . . 0.0 108.787 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.671 ' HB2' HG22 ' A' ' 25' ' ' VAL . 41.4 mt -100.17 71.62 1.61 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 108.082 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 19.1 mt-10 -53.31 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.883 -0.51 . . . . 0.0 109.962 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -44.28 143.06 1.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.104 0.955 . . . . 0.0 109.589 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.9 -41.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.548 ' HB2' ' CD ' ' A' ' 63' ' ' LYS . 12.5 mt-30 -147.9 171.89 15.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.809 ' HB3' HG21 ' A' ' 21' ' ' ILE . 14.5 p90 -171.18 137.09 1.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.88 -1.138 . . . . 0.0 110.648 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.502 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -108.64 119.41 39.45 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 p -71.7 176.46 4.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.34 -0.85 . . . . 0.0 109.853 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.861 ' O ' HG23 ' A' ' 58' ' ' THR . 2.4 mm100 -152.34 148.25 27.28 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -129.73 137.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.942 -1.099 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -165.67 -102.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.67 28.49 5.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 1.034 ' HA2' HD11 ' A' ' 102' A LEU . . . 162.48 -121.7 1.04 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 106.856 -2.498 . . . . 0.0 106.856 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.861 HG23 ' O ' ' A' ' 53' ' ' GLN . 23.1 m -159.52 104.91 1.63 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.087 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.711 ' ND2' ' CD1' ' A' ' 100' ' ' PHE . 28.5 m120 -70.04 -178.45 1.61 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.1 m-85 -141.44 153.68 45.13 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.098 -1.001 . . . . 0.0 109.256 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 23.3 m-30 -133.76 135.53 43.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.74 HG22 HG13 ' A' ' 64' ' ' VAL . 30.5 mt -153.91 129.99 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 116.774 -1.97 . . . . 0.0 112.408 -176.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.947 ' HG2' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.22 102.79 14.17 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -109.7 139.99 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.46 -0.775 . . . . 0.0 110.825 -176.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -67.32 126.87 30.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.99 45.06 1.05 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.91 0.862 . . . . 0.0 109.646 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 85.36 -98.07 2.22 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -56.69 -157.39 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.378 -1.072 . . . . 0.0 109.612 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -71.83 -6.62 42.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 109.476 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -69.85 164.31 23.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 109.085 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.507 ' OH ' ' HD2' ' A' ' 65' ' ' ARG . 11.7 m-85 -136.77 169.87 17.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.733 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.722 ' HE1' ' CD2' ' A' ' 40' ' ' TYR . 20.8 ttm -154.93 113.31 3.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.038 -1.038 . . . . 0.0 109.659 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.923 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 m-70 -74.31 156.9 36.65 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.996 ' CD1' HD11 ' A' ' 32' ' ' LEU . 1.4 tp -148.96 139.85 22.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.698 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.1 tttt -121.63 107.25 12.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.971 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -107.24 162.08 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.729 -1.232 . . . . 0.0 109.712 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.711 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 10.5 t80 -124.15 133.03 53.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.536 -1.352 . . . . 0.0 108.681 177.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -107.02 128.01 53.97 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.838 0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.462 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -103.93 94.54 5.47 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.319 0.581 . . . . 0.0 109.865 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' A LEU . . . . . 1.034 HD11 ' HA2' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -47.2 -48.43 54.88 Favored Pre-proline 0 C--N 1.295 -1.781 0 O-C-N 121.324 -0.86 . . . . 0.0 109.732 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 102' A LEU . 36.5 Cg_endo -79.3 168.14 20.54 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.275 1.983 . . . . 0.0 110.52 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.85 145.8 5.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -76.53 -0.68 24.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -1.166 . . . . 0.0 109.851 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' A ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 106' ' ' GLU . 4.0 t-20 -166.33 111.73 0.82 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.575 -0.703 . . . . 0.0 109.528 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 105' A ASN . 1.2 pt-20 -42.98 156.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.3 OUTLIER 172.57 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.884 . . . . 0.0 109.796 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 5.4 mp -52.18 -176.05 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.087 0.946 . . . . 0.0 109.386 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 99' ' ' VAL . 13.6 p -151.98 164.76 2.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.737 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 97' ' ' LEU . 4.6 tp -101.67 83.76 2.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.577 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -72.84 -12.79 61.12 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.023 -1.048 . . . . 0.0 112.054 -176.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.688 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -176.34 -167.48 35.13 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.066 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 30.2 p90 164.66 137.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.613 -0.933 . . . . 0.0 108.975 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.663 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.8 mm-40 -100.14 97.19 8.04 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.531 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 5.3 p -67.56 163.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.987 -1.071 . . . . 0.0 111.034 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' A ASP . . . . . 0.435 ' N ' HG22 ' A' ' 115' ' ' VAL . 3.9 t0 48.92 26.64 1.38 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.045 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.555 ' HG2' ' N ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -67.73 -166.27 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.779 -1.201 . . . . 0.0 108.463 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.536 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -149.51 -177.62 5.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.749 -1.22 . . . . 0.0 110.099 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -71.69 -34.09 69.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.419 -0.801 . . . . 0.0 109.267 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.03 -14.22 59.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -72.31 103.54 3.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.824 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.1 OUTLIER -87.92 146.24 25.65 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.947 HD11 ' HG2' ' A' ' 63' ' ' LYS . 1.9 mp -66.98 -40.0 87.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.553 -1.342 . . . . 0.0 108.302 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER 40.04 22.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.007 0.908 . . . . 0.0 110.905 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 121.73 116.99 2.45 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.663 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.505 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.481 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.742 HG23 ' HD2' ' A' ' 8' ' ' PRO . 1.9 mp 62.01 143.03 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.012 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.742 ' HD2' HG23 ' A' ' 7' ' ' ILE . 34.5 Cg_endo -75.95 171.39 18.25 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.427 2.085 . . . . 0.0 110.624 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.628 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . 80.45 -173.99 54.89 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 145.6 135.0 2.76 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.571 -1.299 . . . . 0.0 110.077 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.902 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -40.55 125.42 2.18 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.408 -1.054 . . . . 0.0 110.759 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 33.6 m -101.32 171.6 7.5 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tp10 -47.8 174.79 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.912 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.23 99.62 3.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.099 -1.0 . . . . 0.0 110.006 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 9.8 mmpt? -69.16 131.19 90.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -68.11 125.35 12.91 Favored 'Trans proline' 0 C--N 1.291 -2.494 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.624 ' HB1' ' CB ' ' A' ' 47' ' ' ALA . . . -48.21 148.66 1.75 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.441 1.115 . . . . 0.0 111.466 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.629 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -128.96 -169.33 0.19 Allowed Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 27.9 Cg_endo -69.09 -17.67 40.49 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 N-CA-C 109.796 -0.886 . . . . 0.0 109.796 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.506 ' HG3' HD13 ' A' ' 21' ' ' ILE . 15.3 pt-20 -82.03 -41.79 20.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.787 -1.196 . . . . 0.0 108.758 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.667 HG21 ' HB3' ' A' ' 50' ' ' TYR . 13.0 mm -63.54 -51.58 68.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -61.47 -19.23 61.79 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.8 tp10 -75.71 -35.18 60.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.847 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.007 HG23 HG21 ' A' ' 99' ' ' VAL . 5.4 mt -64.99 -52.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.761 HG21 HG11 ' A' ' 64' ' ' VAL . 7.1 p -61.41 -42.57 94.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.722 ' N ' HG13 ' A' ' 25' ' ' VAL . 32.5 t70 -72.75 -16.44 61.65 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 11.9 tptt -89.75 -11.6 41.78 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 97' ' ' LEU . 18.3 m -116.08 -8.72 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.447 -0.783 . . . . 0.0 109.802 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 11.3 ttpp -51.95 -44.13 90.9 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.837 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.77 -29.05 13.06 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.451 1.434 . . . . 0.0 110.016 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -80.69 -11.87 59.56 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.986 HD11 HD11 ' A' ' 97' ' ' LEU . 6.4 mt -93.65 -35.25 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.503 0.668 . . . . 0.0 109.762 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 30.3 mt-10 -58.74 -46.05 88.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.77 -51.12 6.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 109.961 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -49.77 -58.32 5.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 108.497 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.749 HG21 ' OH ' ' A' ' 40' ' ' TYR . 1.4 m -68.97 -60.52 2.31 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.539 -0.726 . . . . 0.0 109.512 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 34.2 p-10 119.48 41.6 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 73.0 mm-40 -130.4 -166.73 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.888 . . . . 0.0 110.017 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 39' ' ' THR . 94.5 m -129.05 26.15 5.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.813 -0.554 . . . . 0.0 109.516 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.749 ' OH ' HG21 ' A' ' 36' ' ' THR . 11.5 m-85 -29.06 147.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.72 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -117.38 -135.52 5.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -54.65 126.29 23.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.336 -1.097 . . . . 0.0 110.078 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.633 HD12 HG22 ' A' ' 25' ' ' VAL . 28.8 mt -107.56 74.47 0.96 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -54.83 85.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.313 0.577 . . . . 0.0 110.495 -178.103 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.903 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -46.22 124.73 5.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.26 1.028 . . . . 0.0 109.754 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.486 HG12 ' HG2' ' A' ' 49' ' ' GLN . 1.9 t -101.56 -44.68 10.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.554 ' CG ' ' HB3' ' A' ' 63' ' ' LYS . 9.2 pt20 -147.23 171.34 15.53 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.667 ' HB3' HG21 ' A' ' 21' ' ' ILE . 12.1 p90 -168.17 138.79 2.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 12' ' ' SER . 1.4 mttp -109.88 124.01 50.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 p -76.51 -178.14 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.307 -0.871 . . . . 0.0 110.148 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 58' ' ' THR . 2.3 mm100 -159.53 150.8 19.86 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.864 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.06 146.97 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 120.915 -1.116 . . . . 0.0 111.126 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.864 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -171.04 -103.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.57 29.14 6.79 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 164.54 -114.02 0.58 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 106.294 -2.722 . . . . 0.0 106.294 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 53' ' ' GLN . 28.8 m -166.92 113.72 0.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -1.157 . . . . 0.0 111.005 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.619 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 70.0 m-20 -73.51 -166.55 0.36 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.6 ' CD1' HG12 ' A' ' 99' ' ' VAL . 86.6 m-85 -154.44 153.75 32.06 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.632 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.628 ' C ' HD22 ' A' ' 122' ' ' LEU . 22.8 m-85 -138.04 130.41 29.14 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.824 HG22 HG13 ' A' ' 64' ' ' VAL . 11.7 mt -149.34 122.68 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 119.583 -1.948 . . . . 0.0 112.098 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 21.8 ttpt -92.16 95.53 9.8 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 47' ' ' ALA . 14.6 m -101.9 140.06 21.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.64 127.0 31.47 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.98 45.11 1.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.928 0.871 . . . . 0.0 109.615 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 99.37 -122.88 7.72 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' GLY . 16.8 t70 -43.26 -101.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.939 . . . . 0.0 111.37 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.3 m120 -120.02 -4.27 10.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.6 mttt -69.47 179.17 2.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 108.624 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 30.3 m-85 -146.52 168.25 21.69 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.026 -1.046 . . . . 0.0 109.94 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.748 ' O ' HG22 ' A' ' 64' ' ' VAL . 18.9 mtp -154.87 115.43 3.9 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.695 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -73.69 137.58 44.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.986 HD11 HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -125.17 123.26 39.25 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.497 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -108.68 121.65 45.47 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.591 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.007 HG21 HG23 ' A' ' 24' ' ' ILE . 2.5 t -125.27 166.26 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.59 -1.319 . . . . 0.0 109.445 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.702 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 10.0 t80 -125.08 136.45 53.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.987 -1.071 . . . . 0.0 108.201 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.598 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -103.56 120.53 41.05 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.929 0.871 . . . . 0.0 109.872 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 103' ' ' PRO . 0.3 OUTLIER -102.93 80.16 1.84 Allowed 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.543 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' A LEU . . . . . 0.714 ' O ' HD12 ' A' ' 102' A LEU . 0.5 OUTLIER -30.23 91.77 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 122.032 -0.417 . . . . 0.0 110.883 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.528 ' N ' ' O ' ' A' ' 102' ' ' SER . 37.0 Cg_endo -80.81 -172.34 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.929 2.419 . . . . 0.0 110.546 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.19 -36.76 4.82 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.71 -96.93 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.508 -0.995 . . . . 0.0 108.941 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' A ASN . . . . . . . . . . . . . 23.0 t-20 -49.35 138.88 12.4 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.501 -0.749 . . . . 0.0 109.385 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 103' ' ' PRO . 12.7 mp0 -99.82 158.24 15.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 108' ' ' LEU . 8.4 p30 -154.08 57.7 0.72 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 107' ' ' ASP . 8.6 mp -49.74 178.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.251 1.025 . . . . 0.0 109.379 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.728 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.7 p -139.27 162.36 27.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.715 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 18.6 tp -99.31 88.09 3.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 100' ' ' PHE . 14.7 p -71.53 -29.71 65.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 111.85 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . -168.94 -163.31 22.75 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.337 -1.411 . . . . 0.0 109.85 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 20.5 p90 166.48 135.64 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.41 -1.053 . . . . 0.0 109.854 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.4 mm-40 -95.48 95.4 8.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 115' A ASP . 6.3 p -67.51 160.15 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.092 -1.005 . . . . 0.0 110.57 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' A ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 115' ' ' VAL . 21.2 t0 43.2 28.37 0.16 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.304 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.59 ' HG3' ' CB ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -82.26 160.96 22.83 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.701 -1.249 . . . . 0.0 107.807 179.207 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.87 -170.91 1.91 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.756 -1.215 . . . . 0.0 110.888 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 18.9 mttt -68.47 -69.64 0.31 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.713 -0.617 . . . . 0.0 110.657 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -40.8 -26.91 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.347 -0.846 . . . . 0.0 110.292 -179.128 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 96' ' ' HIS . 14.8 t70 -47.43 109.88 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.027 . . . . 0.0 110.733 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.553 ' O ' ' CG2' ' A' ' 123' ' ' THR . 74.8 tt0 -84.3 136.91 33.72 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 62' ' ' ILE . 2.6 mp -67.27 -32.38 73.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.904 -1.122 . . . . 0.0 108.741 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.62 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 45.36 -167.02 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.038 0.923 . . . . 0.0 110.499 177.149 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.902 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -43.35 -21.57 0.16 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.676 0 O-C-N 121.213 -1.169 . . . . 0.0 109.079 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.821 HD22 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 122.067 0.937 . . . . 0.0 111.47 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 3.8 m -102.78 -179.1 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.871 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -51.75 -177.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -92.23 110.71 22.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.098 -1.001 . . . . 0.0 110.74 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -76.93 138.25 65.71 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 175.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' ALA . 26.5 Cg_endo -64.44 131.84 31.31 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 109.152 -1.134 . . . . 0.0 109.152 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.603 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -41.67 167.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.511 1.148 . . . . 0.0 111.493 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.654 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -147.28 -167.43 0.15 Allowed Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.654 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.6 Cg_endo -73.13 -20.73 21.26 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 N-CA-C 108.471 -1.396 . . . . 0.0 108.471 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -39.93 22.95 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.219 -0.926 . . . . 0.0 108.688 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.741 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.7 mm -62.28 -54.83 29.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 23.5 tp60 -59.69 -19.44 49.76 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -76.2 -43.78 40.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.725 -1.234 . . . . 0.0 108.801 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.011 HG23 HG21 ' A' ' 99' ' ' VAL . 5.5 mt -55.48 -52.5 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.803 HG22 HD12 ' A' ' 45' ' ' LEU . 12.3 p -67.51 -39.98 83.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 122.028 0.918 . . . . 0.0 109.717 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.717 ' N ' HG13 ' A' ' 25' ' ' VAL . 25.6 t70 -70.71 -10.74 60.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -100.25 -18.07 17.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 97' ' ' LEU . 19.8 m -116.28 1.48 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.514 -0.741 . . . . 0.0 110.397 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.641 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.56 -39.84 79.79 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.736 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 29' ' ' LYS . 33.7 Cg_endo -77.55 -35.37 1.58 Allowed 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 108.172 -1.511 . . . . 0.0 108.172 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 26.8 mt-30 -66.78 -15.32 63.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.72 HD11 HD11 ' A' ' 97' ' ' LEU . 4.6 mt -89.92 -34.27 16.11 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.555 0.693 . . . . 0.0 109.535 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.639 ' HG2' HG23 ' A' ' 39' ' ' THR . 0.7 OUTLIER -55.14 -55.19 33.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 110.41 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.18 -8.52 50.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 31' ' ' GLN . 3.3 tttp -91.23 5.38 49.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.778 -1.201 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 32' ' ' LEU . 9.7 p -131.61 -56.8 1.0 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 36' ' ' THR . 45.8 p30 134.15 20.54 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -149.65 -177.82 6.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.87 -1.144 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.639 HG23 ' HG2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -117.72 118.68 32.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' HE1' HG23 ' A' ' 115' ' ' VAL . 74.0 m-85 -90.88 178.99 5.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 108.936 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -130.5 -168.04 12.16 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -37.47 127.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.926 . . . . 0.0 109.283 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.803 HD12 HG22 ' A' ' 25' ' ' VAL . 59.2 mt -102.97 79.99 1.82 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.059 -1.026 . . . . 0.0 108.704 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 1.3 mt-10 -61.8 85.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.145 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.799 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -43.64 145.9 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.235 1.017 . . . . 0.0 109.998 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.78 -44.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HG2' ' HB3' ' A' ' 63' ' ' LYS . 2.4 pt20 -151.57 169.53 21.89 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.741 ' HB3' HG21 ' A' ' 21' ' ' ILE . 14.1 p90 -163.12 133.56 4.54 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.055 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HD2' ' HB2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -99.01 126.53 44.73 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.51 145.07 45.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.272 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.693 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -144.47 177.73 8.45 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.834 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.07 158.93 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 111.563 -178.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.97 -102.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.49 28.46 5.04 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.1 -110.34 0.44 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 53' ' ' GLN . 86.5 m -165.67 109.59 0.83 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.367 -1.078 . . . . 0.0 110.76 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.704 HD21 HG21 ' A' ' 55' ' ' VAL . 70.2 m-80 -69.57 -176.44 1.01 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CD1' HG12 ' A' ' 99' ' ' VAL . 78.6 m-85 -149.54 151.61 34.17 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.472 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.64 ' HB3' HD22 ' A' ' 122' ' ' LEU . 8.3 m-85 -138.04 132.55 32.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.645 HG12 HG23 ' A' ' 21' ' ' ILE . 13.6 mt -150.77 115.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 116.847 -1.941 . . . . 0.0 111.683 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.628 ' HB2' HD11 ' A' ' 122' ' ' LEU . 1.4 ttmp? -81.02 103.11 10.62 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.799 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -109.39 138.5 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.942 -176.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -68.11 127.18 31.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.08 46.07 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.044 0.926 . . . . 0.0 109.125 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 78.55 -93.84 1.26 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 22.6 p-10 -56.01 -163.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.187 -1.184 . . . . 0.0 109.563 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.45 -10.84 59.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.05 159.42 33.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 109.045 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.607 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 30.3 m-85 -129.35 176.21 8.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.7 ttp -155.76 113.22 3.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 109.561 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.853 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -69.83 151.72 45.4 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 28' ' ' VAL . 11.0 tp -132.8 142.66 49.1 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 111.025 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -132.41 102.77 5.87 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.011 HG21 HG23 ' A' ' 24' ' ' ILE . 2.3 t -110.35 161.41 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.346 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.81 ' HB2' HG21 ' A' ' 111' ' ' THR . 6.7 t80 -123.77 135.92 54.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.2 . . . . 0.0 108.28 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.634 ' HG2' HD11 ' A' ' 108' ' ' LEU . 1.9 tmtt? . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.634 HD11 ' HG2' ' A' ' 101' ' ' LYS . 8.0 mp . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 122.698 1.237 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.723 HG13 HG23 ' A' ' 111' ' ' THR . 14.7 p -156.91 163.39 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.71 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.64 HD11 ' O ' ' A' ' 112' ' ' GLY . 10.3 tp -98.9 83.37 2.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.81 HG21 ' HB2' ' A' ' 100' ' ' PHE . 17.2 p -69.49 -11.77 61.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.965 . . . . 0.0 111.249 -176.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.64 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 173.81 -165.96 37.98 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.83 -1.652 . . . . 0.0 110.929 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.59 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 29.6 p90 167.76 135.57 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.672 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.6 mm-40 -96.19 96.67 8.97 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.473 HG23 ' HE1' ' A' ' 40' ' ' TYR . 8.5 p -67.72 157.03 6.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.836 -1.165 . . . . 0.0 110.19 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' A ASP . . . . . . . . . . . . . 1.5 t0 51.56 21.15 1.21 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.1 OUTLIER -83.11 131.18 35.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.672 -1.268 . . . . 0.0 108.044 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.36 178.59 7.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.297 -0.877 . . . . 0.0 111.45 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 119' ' ' ASP . 10.2 tmtt? -61.51 -50.01 74.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.188 0.518 . . . . 0.0 110.197 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 118' ' ' LYS . 41.6 t0 -43.29 -26.43 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.179 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.459 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -69.45 93.3 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.358 -0.839 . . . . 0.0 110.321 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 123' ' ' THR . 2.3 tt0 -68.15 141.99 55.87 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.853 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -64.17 -35.65 81.48 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.364 -1.46 . . . . 0.0 110.27 -178.064 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.715 ' O ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER 49.48 -149.73 0.22 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.821 ' HA2' HD22 ' A' ' 11' ' ' LEU . . . -48.82 -99.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 104.41 -3.476 . . . . 0.0 104.41 175.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.672 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 23.5 t80 . . . . . 0 C--N 1.29 -1.979 0 O-C-N 119.237 -2.331 . . . . 0.0 108.138 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.802 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 122.206 1.003 . . . . 0.0 111.504 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -102.28 179.25 4.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.675 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.323 -0.861 . . . . 0.0 109.031 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -91.47 101.02 13.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.789 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -70.93 141.07 86.51 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 103.236 -2.876 . . . . 0.0 103.236 175.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -68.02 126.63 14.76 Favored 'Trans proline' 0 C--N 1.29 -2.535 0 N-CA-C 109.531 -0.988 . . . . 0.0 109.531 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.623 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -42.59 147.86 0.26 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.42 1.105 . . . . 0.0 111.994 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.646 HG23 HG12 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -122.3 -168.44 0.13 Allowed Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -71.56 -20.01 27.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 109.202 -1.115 . . . . 0.0 109.202 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -82.5 -43.97 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -0.999 . . . . 0.0 108.663 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.698 HG21 ' HB3' ' A' ' 50' ' ' TYR . 7.6 mm -58.81 -52.09 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.558 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -64.46 -18.22 64.56 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 28.8 tp10 -76.47 -31.24 57.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.597 -1.315 . . . . 0.0 108.525 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.015 HG23 HG21 ' A' ' 99' ' ' VAL . 5.4 mt -69.36 -50.66 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.754 HG21 HG11 ' A' ' 64' ' ' VAL . 7.3 p -62.48 -43.44 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-O 122.089 0.947 . . . . 0.0 109.358 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.733 ' N ' HG13 ' A' ' 25' ' ' VAL . 21.4 t70 -74.4 -18.92 60.59 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.21 -12.76 56.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.613 HG11 ' CG2' ' A' ' 99' ' ' VAL . 27.7 m -116.59 -8.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.476 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.9 ttpp -42.25 -49.99 11.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 110.389 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.25 -34.75 7.54 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.535 1.49 . . . . 0.0 110.006 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' HD23 ' A' ' 110' ' ' LEU . 29.6 mt-30 -78.84 0.07 28.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.206 -0.934 . . . . 0.0 108.592 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.067 ' O ' HG22 ' A' ' 36' ' ' THR . 3.2 mt -100.26 -41.23 7.16 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.444 -0.785 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 48.5 mt-10 -59.37 -44.38 92.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.5 -46.62 89.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.474 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB3' ' OH ' ' A' ' 113' ' ' TYR . 1.2 mmtp -71.11 -66.1 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 110.019 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 1.067 HG22 ' O ' ' A' ' 32' ' ' LEU . 9.4 t -70.12 -0.68 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.392 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 2.7 p-10 40.91 48.2 2.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.158 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.514 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -119.19 172.22 7.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.283 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' TYR . 5.9 t -80.91 -29.78 35.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 0.0 109.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.947 ' CZ ' HG21 ' A' ' 36' ' ' THR . 4.9 m-30 40.31 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.529 0.681 . . . . 0.0 110.256 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 168.6 -163.39 37.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.1 118.26 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.488 -1.007 . . . . 0.0 109.443 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.71 ' HB3' HG11 ' A' ' 64' ' ' VAL . 36.5 mt -100.47 86.04 3.08 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.142 . . . . 0.0 108.073 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 47' ' ' ALA . 63.4 mt-10 -69.83 83.74 0.47 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -0.763 . . . . 0.0 110.063 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.799 ' N ' HG13 ' A' ' 64' ' ' VAL . . . -41.11 145.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.148 0.975 . . . . 0.0 110.25 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -122.02 -44.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.863 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 42.2 mt-30 -149.45 170.08 19.4 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.698 ' HB3' HG21 ' A' ' 21' ' ' ILE . 17.5 p90 -164.45 138.19 5.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.196 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 35.3 mttt -108.93 125.32 51.9 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.2 p -76.4 175.74 8.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 109.785 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.902 ' O ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -150.6 154.53 37.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.358 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.84 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -128.31 141.72 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.025 -1.047 . . . . 0.0 110.303 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.49 -101.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.73 30.17 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 157.9 -110.91 0.46 Allowed Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.902 HG23 ' O ' ' A' ' 53' ' ' GLN . 29.6 m -165.17 108.22 0.84 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.364 -1.08 . . . . 0.0 110.913 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.618 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 76.0 m-20 -71.37 -170.44 0.5 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.618 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 19.6 m-85 -143.55 154.95 44.13 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.468 -0.77 . . . . 0.0 109.586 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.856 ' HB3' HD22 ' A' ' 122' ' ' LEU . 21.2 m-85 -137.21 133.5 35.22 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.774 HG22 ' CG2' ' A' ' 64' ' ' VAL . 12.9 mt -149.11 114.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 117.004 -1.878 . . . . 0.0 111.442 -177.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 96' ' ' HIS . 19.2 ttpt -81.09 99.23 8.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.799 HG13 ' N ' ' A' ' 47' ' ' ALA . 38.2 t -109.13 144.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.37 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.4 mmm180 -69.71 132.93 46.9 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.13 44.9 1.17 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.976 0.893 . . . . 0.0 108.951 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 84.67 -92.79 1.76 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' GLY . 10.5 p-10 -60.68 -140.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.258 -1.142 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.64 -7.98 57.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.958 -1.089 . . . . 0.0 109.994 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.485 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -69.45 178.36 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 108.692 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.578 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 25.6 m-85 -142.78 179.06 7.22 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.06 -1.025 . . . . 0.0 109.285 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 1.037 ' HE1' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.76 114.02 1.11 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.462 -179.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.707 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.3 m170 -71.65 140.94 49.9 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.056 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -124.84 133.99 52.9 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.511 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -121.71 113.9 20.36 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.015 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -119.89 159.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.777 -1.202 . . . . 0.0 109.684 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.717 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 4.2 t80 -121.67 130.77 53.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.592 -1.318 . . . . 0.0 108.173 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.531 ' HE2' ' HB ' ' A' ' 58' ' ' THR . 2.5 pttt . . . . . 0 C--N 1.303 -1.425 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.3 mp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 122.086 0.945 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.717 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.1 p -147.65 161.23 7.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.808 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.629 HD13 HD11 ' A' ' 97' ' ' LEU . 18.1 tp -97.81 87.94 4.16 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -75.57 -8.76 57.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 111.87 -176.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . 174.01 -168.27 41.03 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.625 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.606 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 31.4 p90 165.84 138.0 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.717 -0.872 . . . . 0.0 109.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.625 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.1 mm-40 -97.34 97.87 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.8 HG23 ' OH ' ' A' ' 40' ' ' TYR . 7.4 p -69.35 159.06 5.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.845 -1.16 . . . . 0.0 110.282 -178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' A ASP . . . . . 0.438 ' N ' HG22 ' A' ' 115' ' ' VAL . 56.4 t0 52.24 22.25 1.92 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.78 -0.575 . . . . 0.0 110.562 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 3.2 mptp? -90.56 106.31 18.42 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.755 -1.216 . . . . 0.0 108.951 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 4.5 m120 -69.51 -172.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 110.127 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -16.46 62.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.88 -20.05 63.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.586 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.7 OUTLIER -90.82 110.02 21.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 110.072 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.525 ' C ' HG22 ' A' ' 123' ' ' THR . 2.1 tt0 -92.62 150.6 20.61 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 61' ' ' TYR . 2.0 mp -68.87 -44.27 73.65 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.515 -1.366 . . . . 0.0 107.734 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER 39.2 18.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.624 -0.672 . . . . 0.0 112.485 175.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.802 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . 154.94 -65.63 0.32 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.2 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.625 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.269 0 O-C-N 121.286 -1.126 . . . . 0.0 109.251 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.827 0.822 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 m -101.25 163.91 12.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.384 0.612 . . . . 0.0 109.458 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 5.7 tt0 -48.14 176.94 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.398 -0.814 . . . . 0.0 109.308 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HB1' ' CG ' ' A' ' 49' ' ' GLN . . . -84.89 96.7 9.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.109 . . . . 0.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.68 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 20.0 mmtt -72.27 133.19 83.52 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 176.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 17' ' ' ALA . 27.5 Cg_endo -65.98 126.08 15.25 Favored 'Trans proline' 0 C--N 1.291 -2.452 0 N-CA-C 109.257 -1.093 . . . . 0.0 109.257 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.623 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -39.37 153.52 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.536 1.16 . . . . 0.0 111.815 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.63 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -136.27 -170.12 0.23 Allowed Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.3 Cg_endo -68.97 -16.53 40.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 N-CA-C 109.244 -1.099 . . . . 0.0 109.244 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.56 -46.45 14.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.068 -1.02 . . . . 0.0 108.41 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.763 HG21 ' HB3' ' A' ' 50' ' ' TYR . 10.2 mm -58.88 -53.67 44.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 22.9 tp60 -61.47 -19.17 61.73 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -76.13 -37.06 58.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.711 -1.243 . . . . 0.0 108.776 179.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.912 HG23 HG21 ' A' ' 99' ' ' VAL . 3.9 mt -63.22 -50.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.862 HG22 HD12 ' A' ' 45' ' ' LEU . 11.4 p -66.21 -41.62 89.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 122.183 0.992 . . . . 0.0 109.251 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.709 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.8 t70 -69.39 -16.58 63.54 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -85.9 -20.16 29.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 24' ' ' ILE . 13.1 m -118.4 6.58 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.613 -0.68 . . . . 0.0 110.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.885 ' HA ' HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -53.14 -36.85 42.16 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.687 -1.258 . . . . 0.0 110.646 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HD3' ' CG ' ' A' ' 29' ' ' LYS . 35.9 Cg_endo -79.3 -37.04 0.57 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 108.361 -1.438 . . . . 0.0 108.361 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.659 ' O ' HD23 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -74.17 -3.24 28.57 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.889 HD22 ' SD ' ' A' ' 95' ' ' MET . 10.0 mt -92.43 -41.12 10.49 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.417 -0.802 . . . . 0.0 109.624 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.809 ' OE2' HG22 ' A' ' 39' ' ' THR . 23.6 mt-10 -65.32 -46.27 80.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.511 -0.743 . . . . 0.0 110.972 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.7 -37.26 62.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.807 -1.183 . . . . 0.0 111.136 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -58.08 -42.65 86.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.771 -1.205 . . . . 0.0 110.063 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.823 HG21 ' OH ' ' A' ' 40' ' ' TYR . 1.3 p -86.5 -57.48 2.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.933 -1.104 . . . . 0.0 109.663 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 36' ' ' THR . 52.6 p-10 131.26 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 C-N-CA 122.937 0.495 . . . . 0.0 109.714 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 5.0 pt-20 -133.93 171.75 13.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 109.148 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.809 HG22 ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -107.14 117.76 34.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.009 -1.057 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.823 ' OH ' HG21 ' A' ' 36' ' ' THR . 58.8 m-85 -93.05 178.77 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 108.594 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -126.31 -157.57 9.6 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 43' ' ' GLY . 4.2 tttt -41.68 125.11 2.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.451 -1.029 . . . . 0.0 109.151 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.862 HD12 HG22 ' A' ' 25' ' ' VAL . 28.4 mt -97.43 77.41 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.055 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.53 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.872 -177.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.816 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -45.69 144.27 1.72 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.127 -0.983 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.5 t -125.6 -42.14 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' CG ' ' HB1' ' A' ' 14' ' ' ALA . 8.8 mt-30 -150.28 166.96 28.39 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.763 ' HB3' HG21 ' A' ' 21' ' ' ILE . 2.5 p90 -163.54 138.06 6.07 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.458 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 23.8 mttt -113.38 131.89 55.81 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.878 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -81.08 -173.72 4.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.196 -0.94 . . . . 0.0 110.86 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -164.32 156.01 16.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.765 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -125.43 141.43 45.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.949 -1.094 . . . . 0.0 110.746 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -170.2 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.29 28.93 5.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.446 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 160.23 -104.04 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 53' ' ' GLN . 9.1 m -168.75 112.31 0.56 Allowed 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.7 -0.883 . . . . 0.0 109.766 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.606 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 32.6 m-80 -71.36 -166.63 0.19 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 28.5 m-85 -150.44 154.34 37.53 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.689 ' HB3' HD22 ' A' ' 122' ' ' LEU . 22.6 m-85 -138.99 133.76 32.15 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 177.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.813 HD12 HD23 ' A' ' 97' ' ' LEU . 11.1 mt -151.81 118.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 C-N-CA 116.719 -1.992 . . . . 0.0 111.589 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.555 ' CE ' ' HA ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -78.44 98.7 6.13 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 175.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.816 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -108.81 132.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.353 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 5.7 ttp180 -66.36 139.14 58.0 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.55 43.96 1.07 Allowed 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.922 0.868 . . . . 0.0 109.405 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 72.9 -80.63 0.68 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.0 OUTLIER -53.67 -112.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.41 -1.053 . . . . 0.0 110.394 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.402 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 5.0 m-20 -125.44 -21.4 4.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.687 -1.258 . . . . 0.0 109.876 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -68.46 177.07 2.54 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 20.0 m-85 -135.72 176.08 9.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.007 -1.058 . . . . 0.0 109.204 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.889 ' SD ' HD22 ' A' ' 32' ' ' LEU . 4.6 ttp -156.66 117.42 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.393 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.714 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.6 m170 -69.19 148.35 50.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.813 HD23 HD12 ' A' ' 62' ' ' ILE . 13.9 tp -129.04 128.58 43.88 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.725 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 41.6 tttt -114.52 107.79 15.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.912 HG21 HG23 ' A' ' 24' ' ' ILE . 1.8 t -111.38 160.66 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.215 . . . . 0.0 109.164 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.764 ' HB2' HG21 ' A' ' 111' ' ' THR . 34.7 t80 -122.94 133.11 54.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.792 -1.192 . . . . 0.0 109.003 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 tttp . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.232 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 108' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 122.116 0.96 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.776 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.3 p -152.31 166.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.089 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.695 HD11 ' O ' ' A' ' 112' ' ' GLY . 12.4 tp -98.52 85.29 3.34 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 100' ' ' PHE . 3.4 p -81.18 -1.55 45.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.1 -1.0 . . . . 0.0 111.947 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.695 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 177.67 -160.19 26.6 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.193 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.677 ' HD2' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER 150.3 133.47 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.383 0.611 . . . . 0.0 109.959 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.641 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.07 95.08 7.94 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.468 ' O ' ' HD3' ' A' ' 116' ' ' LYS . 9.4 p -67.98 161.4 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.185 . . . . 0.0 111.088 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' A ASP . . . . . 0.436 ' N ' HG22 ' A' ' 115' ' ' VAL . 49.6 t0 50.11 20.76 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.912 -0.492 . . . . 0.0 110.815 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.571 ' CG ' ' OD2' ' A' ' 120' ' ' ASP . 1.6 mptt -93.61 129.44 39.88 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.64 -1.288 . . . . 0.0 108.546 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 2.9 m-80 -104.4 -156.86 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 0.0 112.285 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.555 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 3.4 tttm -54.2 -56.7 15.73 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.937 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.42 -20.98 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 0.0 111.089 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.571 ' OD2' ' CG ' ' A' ' 116' ' ' LYS . 63.2 t0 -83.9 123.02 29.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.665 -1.272 . . . . 0.0 111.724 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.558 ' O ' ' CG2' ' A' ' 123' ' ' THR . 5.1 tt0 -100.3 139.88 35.34 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 176.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.714 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.2 mp -59.55 -49.54 77.36 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.541 -1.35 . . . . 0.0 109.411 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.3 OUTLIER 43.7 -168.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.89 178.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.575 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -55.38 91.77 0.01 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 109.488 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.037 HD22 ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 122.331 1.062 . . . . 0.0 110.945 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 79.1 p -101.52 -176.72 3.22 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.114 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -51.02 179.77 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.976 -1.078 . . . . 0.0 108.574 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -77.94 95.79 4.87 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.289 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mmtt -70.75 126.36 92.17 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.96 127.36 18.37 Favored 'Trans proline' 0 C--N 1.293 -2.345 0 N-CA-C 109.514 -0.995 . . . . 0.0 109.514 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.631 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -42.34 165.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.346 1.07 . . . . 0.0 111.431 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.653 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.46 -167.88 0.17 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -71.93 -18.03 28.23 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 N-CA-C 108.939 -1.216 . . . . 0.0 108.939 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' HD12 ' A' ' 24' ' ' ILE . 1.5 mt-10 -83.93 -45.32 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.752 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.6 mm -57.74 -54.43 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.504 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 13.6 tp60 -61.76 -20.29 63.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 7.0 tt0 -75.74 -34.81 60.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.471 -1.393 . . . . 0.0 108.643 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.08 HG23 HG21 ' A' ' 99' ' ' VAL . 3.7 mt -66.04 -49.67 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.004 0.907 . . . . 0.0 108.815 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 HD12 ' A' ' 45' ' ' LEU . 12.5 p -69.34 -41.38 80.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-O 121.966 0.889 . . . . 0.0 109.861 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.723 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.2 t70 -72.12 -17.0 62.01 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 14.4 tppt? -89.83 -13.47 36.49 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.863 ' CG2' HD21 ' A' ' 97' ' ' LEU . 31.3 m -126.58 4.18 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.883 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 6.3 ttpt -54.66 -43.66 98.48 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 111.07 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.68 -18.75 24.99 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.383 1.389 . . . . 0.0 109.615 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -91.92 -10.89 37.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.809 HD13 HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -92.06 -33.27 14.86 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 40' ' ' TYR . 2.3 pt-20 -82.68 -20.1 36.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 109.952 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.71 -45.85 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.017 -1.052 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -67.27 -40.16 86.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.697 HG21 ' OH ' ' A' ' 40' ' ' TYR . 2.7 m -82.67 -32.44 28.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.917 . . . . 0.0 109.388 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 88.71 26.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.254 0.55 . . . . 0.0 109.725 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -107.24 -178.84 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.518 ' O ' ' O ' ' A' ' 40' ' ' TYR . 29.9 m -97.03 -25.7 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.147 -0.971 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.697 ' OH ' HG21 ' A' ' 36' ' ' THR . 14.5 m-30 37.79 -165.29 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.705 0.764 . . . . 0.0 110.976 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 176.1 -165.63 36.29 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.444 ' O ' HD23 ' A' ' 45' ' ' LEU . 14.0 mttt -42.46 134.51 3.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.796 HD12 HG22 ' A' ' 25' ' ' VAL . 34.5 mt -111.85 81.66 1.49 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.2 tt0 -64.01 86.89 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.853 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -44.71 132.83 6.29 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.291 1.043 . . . . 0.0 110.371 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.3 t -110.83 -45.32 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 63' ' ' LYS . 1.3 pt20 -149.05 173.21 13.63 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.803 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.752 ' HB3' HG21 ' A' ' 21' ' ' ILE . 26.7 p90 -165.31 141.12 5.33 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.69 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.545 ' HD3' HD23 ' A' ' 11' ' ' LEU . 9.0 mttt -117.7 135.96 53.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.366 0.603 . . . . 0.0 109.378 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.4 p -76.93 -175.59 3.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.266 -0.896 . . . . 0.0 110.064 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 58' ' ' THR . 0.6 OUTLIER -158.94 149.15 19.46 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.869 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -123.84 141.04 45.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.798 -1.189 . . . . 0.0 110.51 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.66 -103.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 30.24 4.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.94 -111.37 0.48 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 106.734 -2.547 . . . . 0.0 106.734 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 53' ' ' GLN . 16.4 m -165.26 107.31 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.345 -1.091 . . . . 0.0 110.697 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.621 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 82.0 m-20 -71.89 -171.52 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 101' ' ' LYS . 22.8 m-85 -139.38 160.2 40.39 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.827 ' HB3' HD22 ' A' ' 122' ' ' LEU . 11.0 m-85 -141.8 136.57 30.79 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.611 HG13 ' C ' ' A' ' 61' ' ' TYR . 14.1 mt -151.15 119.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.675 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.507 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 26.4 ttpp -86.36 94.61 9.41 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.853 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -100.09 137.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.843 -0.536 . . . . 0.0 110.86 -176.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.666 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -67.76 123.46 20.6 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.8 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -82.02 39.33 0.56 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.605 0.717 . . . . 0.0 111.007 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.04 -127.99 9.06 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.24 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -68.39 80.02 0.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.691 -0.888 . . . . 0.0 112.261 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 10.8 m120 71.22 -8.64 0.98 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.114 -0.991 . . . . 0.0 111.712 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.8 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -69.48 -179.76 1.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.649 -1.282 . . . . 0.0 108.367 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 7.3 m-85 -150.74 155.98 40.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.972 -1.08 . . . . 0.0 109.391 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.641 ' CE ' ' CD2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -150.79 111.21 4.19 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.662 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.11 135.25 44.74 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.863 HD21 ' CG2' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -120.25 157.35 29.32 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.868 -1.145 . . . . 0.0 111.274 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.2 tttt -141.77 107.49 5.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.08 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -115.31 160.27 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.755 -1.216 . . . . 0.0 110.308 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.61 ' HB2' ' CG2' ' A' ' 111' ' ' THR . 0.2 OUTLIER -121.1 122.46 40.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.819 ' HG2' HD11 ' A' ' 108' ' ' LEU . 1.8 tttt . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 122.487 1.137 . . . . 0.0 107.998 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.819 HD11 ' HG2' ' A' ' 101' ' ' LYS . 5.7 mp . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 122.353 1.073 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.668 ' O ' HG22 ' A' ' 99' ' ' VAL . 14.3 p -153.86 161.42 2.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.099 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.584 HD11 ' HD2' ' A' ' 113' ' ' TYR . 8.1 tp -96.69 82.05 3.26 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.61 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -70.37 -9.48 56.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 111.918 -176.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.501 ' CA ' ' HB3' ' A' ' 98' ' ' LYS . . . 168.78 -168.7 41.28 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.382 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.631 ' CB ' HD21 ' A' ' 32' ' ' LEU . 22.4 p90 167.79 135.38 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.593 -0.945 . . . . 0.0 109.139 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.681 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -90.53 103.9 16.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.693 HG23 ' OH ' ' A' ' 40' ' ' TYR . 8.1 p -68.25 161.69 3.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.552 -177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' A ASP . . . . . 0.488 ' N ' HG22 ' A' ' 115' ' ' VAL . 0.9 OUTLIER 42.2 43.31 2.83 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.11 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.959 -1.088 . . . . 0.0 108.404 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.97 -171.41 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 110.306 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 14.5 tttt -66.94 -40.5 87.57 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.425 0.631 . . . . 0.0 109.627 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.19 -18.56 0.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.341 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.586 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.4 OUTLIER -88.19 105.58 17.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.828 -1.17 . . . . 0.0 110.251 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.98 162.77 20.31 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 61' ' ' TYR . 3.0 mp -85.07 13.91 5.62 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.406 -1.434 . . . . 0.0 109.484 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.037 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.5 OUTLIER 2.77 -76.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.439 0.696 . . . . 0.0 112.236 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.706 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . -139.71 15.02 3.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.681 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.602 0 O-C-N 121.603 -0.94 . . . . 0.0 108.545 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.765 HD21 ' CE2' ' A' ' 61' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 122.383 1.087 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.51 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -101.93 178.68 4.54 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.966 179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.495 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -51.96 163.83 0.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.161 -0.962 . . . . 0.0 109.182 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -72.54 107.68 5.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.942 . . . . 0.0 110.865 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.03 139.5 79.71 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 175.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.93 127.39 17.65 Favored 'Trans proline' 0 C--N 1.292 -2.435 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.599 ' HB1' ' CB ' ' A' ' 47' ' ' ALA . . . -44.61 131.43 6.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.06 0.933 . . . . 0.0 112.266 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.607 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -102.52 -173.42 0.29 Allowed Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 176.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -68.42 -20.82 41.55 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 109.643 -0.945 . . . . 0.0 109.643 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 1.6 mt-10 -81.72 -41.54 21.13 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.035 -1.041 . . . . 0.0 108.929 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.82 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -62.36 -47.48 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -67.6 -16.1 64.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.2 tt0 -77.18 -29.99 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.814 -1.179 . . . . 0.0 108.315 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.935 HG23 HG21 ' A' ' 99' ' ' VAL . 3.0 mt -70.62 -50.41 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.719 HG13 ' N ' ' A' ' 26' ' ' ASP . 7.7 p -61.42 -44.33 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.984 0.897 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.719 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.6 t0 -72.11 -20.26 61.67 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -80.34 -12.86 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.814 HG21 ' CD2' ' A' ' 97' ' ' LEU . 35.2 m -116.17 -10.85 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.556 -0.715 . . . . 0.0 110.203 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.2 ttmt -39.77 -49.91 5.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.05 -1.031 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 28.9 Cg_endo -69.69 -35.52 12.71 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.587 1.525 . . . . 0.0 109.8 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 27.6 mt-30 -73.76 -4.8 36.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 40' ' ' TYR . 7.0 mt -96.89 -43.15 7.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.62 0.724 . . . . 0.0 110.03 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.7 -27.19 69.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.752 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.04 -46.79 5.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.963 -1.085 . . . . 0.0 110.916 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 70.7 mttt -67.76 -33.89 75.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.071 . . . . 0.0 110.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 2.8 m -92.98 -35.5 13.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.886 -1.134 . . . . 0.0 109.532 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 36' ' ' THR . 1.0 OUTLIER 91.3 28.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.218 0.532 . . . . 0.0 110.019 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -115.38 -175.99 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 40' ' ' TYR . 43.2 m -98.78 -20.75 16.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.913 ' OH ' HG23 ' A' ' 115' ' ' VAL . 4.1 m-85 39.22 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.974 0.892 . . . . 0.0 111.051 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.9 -152.29 11.12 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 129.77 42.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.673 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.655 ' HB2' HG22 ' A' ' 25' ' ' VAL . 35.5 mt -111.05 81.94 1.51 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.974 -1.079 . . . . 0.0 109.028 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -65.23 85.69 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.481 0.658 . . . . 0.0 110.137 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.931 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.96 125.99 4.61 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.105 0.955 . . . . 0.0 109.891 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.9 t -103.4 -44.87 9.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.642 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 3.4 mt-30 -142.78 172.79 12.21 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.82 ' HB3' HG21 ' A' ' 21' ' ' ILE . 31.7 p90 -169.75 139.82 2.03 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.877 -1.139 . . . . 0.0 110.593 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.614 ' HG3' HD13 ' A' ' 122' ' ' LEU . 7.5 mtmt -122.23 128.99 51.82 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.92 139.6 37.32 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.171 -0.956 . . . . 0.0 110.062 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.518 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 1.3 pm0 -133.23 158.52 42.68 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 55' ' ' VAL . 4.7 p -97.36 155.85 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 111.772 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.606 HG21 ' ND2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -162.28 -101.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 27.91 5.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.55 -103.37 0.23 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 106.373 -2.691 . . . . 0.0 106.373 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -160.89 122.64 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.584 -0.951 . . . . 0.0 109.891 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.606 ' ND2' HG21 ' A' ' 55' ' ' VAL . 9.7 m-20 -85.12 -164.96 1.07 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 7.9 m-85 -149.52 131.05 14.84 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.765 ' CE2' HD21 ' A' ' 11' ' ' LEU . 8.9 m-30 -115.88 134.53 54.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.759 HG22 HG13 ' A' ' 64' ' ' VAL . 17.8 mt -150.47 128.13 2.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 116.812 -1.955 . . . . 0.0 111.371 -176.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.598 ' HG3' ' NZ ' ' A' ' 116' ' ' LYS . 19.4 ttmt -95.34 90.99 6.02 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.931 HG12 ' HA ' ' A' ' 47' ' ' ALA . 31.4 m -99.6 142.06 15.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.773 -0.579 . . . . 0.0 110.956 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.33 123.15 19.97 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -86.06 46.75 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.139 0.971 . . . . 0.0 109.141 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 -152.05 19.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 92' ' ' ASN . 2.0 p-10 -59.15 126.84 29.32 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.426 -1.044 . . . . 0.0 111.044 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 68' ' ' ASP . 7.8 p-10 31.62 44.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.217 0.532 . . . . 0.0 111.304 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -127.76 171.41 11.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.489 ' CD2' ' O ' ' A' ' 93' ' ' LYS . 25.8 m-85 -156.94 156.36 32.92 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.754 -1.216 . . . . 0.0 110.495 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.741 ' O ' HG22 ' A' ' 64' ' ' VAL . 9.2 tmm? -153.97 116.52 4.39 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.296 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.705 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.1 m170 -76.29 143.22 41.01 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.814 ' CD2' HG21 ' A' ' 28' ' ' VAL . 1.4 tp -133.55 131.92 40.3 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.795 -1.562 . . . . 0.0 112.437 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.2 ttpt -111.7 83.38 1.77 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.935 HG21 HG23 ' A' ' 24' ' ' ILE . 1.6 t -84.47 159.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.665 -1.272 . . . . 0.0 109.206 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.724 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 58.4 t80 -125.4 131.43 52.94 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.635 -1.291 . . . . 0.0 108.35 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.617 HD12 ' N ' ' A' ' 108' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 122.307 1.051 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.75 ' CG1' HG23 ' A' ' 111' ' ' THR . 12.5 p -163.39 164.94 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.089 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.728 HD11 ' CD2' ' A' ' 113' ' ' TYR . 4.4 tp -97.49 83.52 3.27 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.75 HG23 ' CG1' ' A' ' 109' ' ' VAL . 1.4 p -85.89 -3.61 58.96 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.016 -1.052 . . . . 0.0 112.81 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 113' ' ' TYR . . . -171.31 -172.34 37.36 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.633 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.728 ' CD2' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER 155.38 132.61 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.736 -0.861 . . . . 0.0 111.3 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.636 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 6.2 mm-40 -95.37 95.95 8.8 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.913 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -65.84 160.1 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.99 -176.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' A ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 115' ' ' VAL . 2.7 t70 42.85 37.19 1.01 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.441 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.598 ' NZ ' ' HG3' ' A' ' 63' ' ' LYS . 8.1 ptmm? -69.61 -163.83 0.06 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.074 -1.016 . . . . 0.0 108.935 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.452 ' O ' ' NZ ' ' A' ' 116' ' ' LYS . 14.2 m-80 -157.35 178.5 10.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.84 -1.163 . . . . 0.0 109.922 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -68.92 -9.27 50.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.814 . . . . 0.0 109.756 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.32 5.09 46.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -100.68 119.65 38.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.035 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.686 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.9 OUTLIER -96.9 138.43 34.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 61' ' ' TYR . 1.6 mp -58.57 -55.93 28.65 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.715 -1.241 . . . . 0.0 109.196 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 121' ' ' GLU . 0.3 OUTLIER 44.69 -169.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.182 177.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.558 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -49.51 91.93 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.539 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.594 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.547 HD12 ' HD3' ' A' ' 51' ' ' LYS . 1.3 pt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 t -101.33 -177.22 3.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 110.731 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -49.98 -175.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.555 -0.716 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -90.17 107.88 19.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.928 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 9.6 mmpt? -73.26 141.11 80.32 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 175.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.47 131.29 25.87 Favored 'Trans proline' 0 C--N 1.291 -2.499 0 N-CA-C 109.45 -1.019 . . . . 0.0 109.45 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -48.17 165.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.399 1.095 . . . . 0.0 111.813 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.663 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -145.92 -166.07 0.12 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.663 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.5 Cg_endo -71.85 -18.35 28.26 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 N-CA-C 108.755 -1.287 . . . . 0.0 108.755 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.42 -45.93 15.34 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.4 mm -59.85 -53.03 54.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.474 ' OE1' ' O ' ' A' ' 45' ' ' LEU . 26.9 tp60 -60.45 -19.48 56.61 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 tt0 -75.17 -43.12 54.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 108.737 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HG21 ' A' ' 99' ' ' VAL . 3.3 mt -57.29 -52.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.84 HG22 HD12 ' A' ' 45' ' ' LEU . 11.4 p -66.42 -39.76 84.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 122.024 0.916 . . . . 0.0 109.095 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.705 ' N ' HG13 ' A' ' 25' ' ' VAL . 23.3 t70 -68.44 -13.45 62.31 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -94.76 -19.96 19.91 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.257 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.825 HG21 HD11 ' A' ' 97' ' ' LEU . 27.4 m -111.66 -6.03 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.885 . . . . 0.0 111.23 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.688 ' HG3' HD11 ' A' ' 45' ' ' LEU . 1.4 ttpm? -44.46 -48.25 26.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -29.96 12.62 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.625 1.55 . . . . 0.0 110.112 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' HD23 ' A' ' 110' ' ' LEU . 26.3 mt-30 -83.77 -0.72 52.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.951 HD11 ' CD1' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.27 -37.6 8.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 1.5 tm-20 -72.08 -30.6 65.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -19.44 29.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.0 . . . . 0.0 109.886 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 7.6 44.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 109.855 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.821 HG21 ' CZ ' ' A' ' 40' ' ' TYR . 14.4 t -135.56 -32.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.939 -1.1 . . . . 0.0 110.281 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER 92.62 18.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.919 -0.488 . . . . 0.0 110.116 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.706 ' H ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -115.5 157.76 23.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.916 -1.115 . . . . 0.0 109.057 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.524 ' O ' ' O ' ' A' ' 40' ' ' TYR . 8.9 m -81.22 -15.43 55.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.822 ' OH ' HG23 ' A' ' 115' ' ' VAL . 12.0 m-30 39.0 -165.76 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.521 0.677 . . . . 0.0 110.14 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -176.65 -169.44 38.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' O ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -42.04 134.44 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.464 -1.021 . . . . 0.0 108.875 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.84 HD12 HG22 ' A' ' 25' ' ' VAL . 34.0 mt -112.55 83.73 1.86 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.085 -1.01 . . . . 0.0 109.859 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 3.7 mt-10 -65.33 85.5 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.481 0.658 . . . . 0.0 109.667 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.838 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -47.89 116.88 1.64 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.3 1.048 . . . . 0.0 110.579 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.788 HG21 ' NH1' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -90.67 -46.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.636 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 2.6 mt-30 -148.73 168.78 21.98 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.696 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.729 ' HB3' HG21 ' A' ' 21' ' ' ILE . 7.0 p90 -161.75 136.23 6.98 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.821 -1.152 . . . . 0.0 110.983 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HD3' HD12 ' A' ' 11' ' ' LEU . 11.5 mttt -105.41 137.0 43.94 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 p -86.97 178.63 6.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.858 . . . . 0.0 110.049 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.823 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -157.32 161.25 39.1 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.685 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -127.02 140.08 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.068 -1.02 . . . . 0.0 110.374 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -165.15 -103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HB3' ' HZ ' ' A' ' 100' ' ' PHE . . . -99.63 29.35 4.13 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 158.65 -99.74 0.18 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 53' ' ' GLN . 18.7 m -167.38 120.4 0.94 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.644 -0.916 . . . . 0.0 110.236 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.659 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 17.5 m-20 -77.92 -164.25 0.5 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.662 ' CD1' HG12 ' A' ' 99' ' ' VAL . 75.9 m-85 -151.58 152.61 33.13 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.704 0.764 . . . . 0.0 109.023 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' A' ' 125' ' ' PHE . 19.7 m-85 -138.58 132.78 31.6 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.751 HD12 HD23 ' A' ' 97' ' ' LEU . 14.4 mt -149.11 119.0 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 C-N-CA 116.917 -1.913 . . . . 0.0 111.378 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HD2' ' HB2' ' A' ' 49' ' ' GLN . 14.2 ptpt -85.99 98.71 10.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -102.26 141.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.217 0.532 . . . . 0.0 110.746 -175.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.788 ' NH1' HG21 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -68.93 125.0 25.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -83.11 38.95 0.62 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.619 0.723 . . . . 0.0 110.839 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.87 -74.09 0.8 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.612 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 54.0 p30 -78.21 44.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.982 -1.305 . . . . 0.0 113.485 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 3.4 t-20 79.94 -41.28 0.22 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.849 -1.157 . . . . 0.0 111.246 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.872 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 33.6 mtmt -67.21 144.3 56.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.723 -1.236 . . . . 0.0 107.826 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.62 ' CE2' ' NH1' ' A' ' 65' ' ' ARG . 18.8 m-30 -104.82 172.16 6.94 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.416 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.574 ' HE1' ' CD2' ' A' ' 40' ' ' TYR . 2.4 mtp -144.01 115.68 8.19 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.723 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -69.63 148.45 49.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.951 ' CD1' HD11 ' A' ' 32' ' ' LEU . 12.9 tp -133.27 132.76 41.79 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.296 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 30.0 tttt -122.61 103.34 8.62 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.016 HG21 HG23 ' A' ' 24' ' ' ILE . 2.4 t -108.8 163.64 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.32 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.698 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.2 t80 -127.05 133.13 50.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.975 -1.078 . . . . 0.0 108.809 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.585 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 5.9 tttt . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 108' ' ' LEU . 6.9 mp . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 122.422 1.106 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.4 p -146.07 164.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.927 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.629 HD11 ' O ' ' A' ' 112' ' ' GLY . 11.1 tp -98.01 83.85 3.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.615 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -72.69 -10.15 59.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 111.157 -177.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.629 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 174.35 -165.96 37.7 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.585 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 37.6 p90 164.98 137.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.677 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 1.5 mm-40 -103.09 107.99 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.822 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -66.6 162.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.634 -1.291 . . . . 0.0 111.626 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' A ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 115' ' ' VAL . 22.6 t0 39.49 30.69 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.635 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -77.8 158.39 29.55 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.695 -1.253 . . . . 0.0 108.254 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.34 179.4 4.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.039 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -65.03 -50.07 67.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 0.0 109.271 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' LYS . 13.9 t70 -44.5 -27.16 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.493 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -76.19 88.39 3.06 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.507 -0.746 . . . . 0.0 109.385 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.08 164.82 3.74 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.723 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -90.35 50.84 1.9 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.373 -1.454 . . . . 0.0 109.674 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -48.84 -177.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.083 178.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.464 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -42.41 94.11 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.677 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.363 -1.081 . . . . 0.0 109.646 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.93 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.871 0.843 . . . . 0.0 111.082 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' GLU . 2.0 t -101.4 167.95 9.84 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.52 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.652 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.14 98.62 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.39 127.3 90.33 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 176.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.72 124.39 13.12 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -45.47 128.77 8.3 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.952 0.882 . . . . 0.0 111.667 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.611 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -101.07 -171.89 0.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 177.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.4 Cg_endo -69.06 -18.29 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 N-CA-C 109.369 -1.05 . . . . 0.0 109.369 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -43.3 22.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.143 -0.973 . . . . 0.0 108.504 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.827 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -63.33 -47.46 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.674 HE21 HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -58.31 -23.03 55.24 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.4 tt0 -76.88 -40.61 46.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.22 -0.925 . . . . 0.0 110.286 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.01 HG23 HG21 ' A' ' 99' ' ' VAL . 3.0 mt -61.28 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.802 HG22 ' HB2' ' A' ' 45' ' ' LEU . 14.7 p -64.14 -41.65 93.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.017 0.913 . . . . 0.0 109.021 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.707 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.9 t70 -72.51 -12.56 61.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mttt -96.71 -10.12 27.57 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.039 HG21 HD21 ' A' ' 97' ' ' LEU . 4.3 m -120.76 -6.03 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 110.473 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.627 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -48.37 -45.28 67.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 0.0 110.379 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.4 Cg_endo -72.23 -28.94 14.85 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.287 1.324 . . . . 0.0 109.517 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' O ' HD23 ' A' ' 110' ' ' LEU . 39.1 mt-30 -81.79 -7.49 59.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.015 HD11 HD13 ' A' ' 97' ' ' LEU . 11.1 mt -88.1 -48.77 7.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -63.29 -25.25 68.23 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.149 0.5 . . . . 0.0 110.027 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -88.58 -28.14 20.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 110.178 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 13.8 mmtt -99.87 2.85 44.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 110.094 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.911 HG21 ' CE2' ' A' ' 40' ' ' TYR . 6.1 t -128.2 -4.48 5.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.121 -0.987 . . . . 0.0 109.874 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 40.14 45.3 1.67 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 109.834 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -138.14 161.25 37.28 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.408 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -88.16 119.11 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 110.309 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.911 ' CE2' HG21 ' A' ' 36' ' ' THR . 14.8 m-30 -114.29 -169.8 1.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -153.89 -171.84 21.35 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 43' ' ' GLY . 3.8 mttt -44.36 135.66 4.48 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.802 ' HB2' HG22 ' A' ' 25' ' ' VAL . 31.0 mt -107.66 69.77 0.75 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.897 -1.127 . . . . 0.0 109.028 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -58.15 86.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.271 -178.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.602 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -41.01 142.68 0.46 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 109.963 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 2.1 t -125.26 -40.31 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -140.43 171.32 14.3 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.827 ' HB3' HG21 ' A' ' 21' ' ' ILE . 4.3 p90 -170.18 141.45 2.09 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.73 -1.231 . . . . 0.0 110.944 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 4.7 mttp -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.1 p -82.83 -174.31 5.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.153 -0.967 . . . . 0.0 110.739 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.764 ' O ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -165.11 148.74 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.21 134.62 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 120.844 -1.16 . . . . 0.0 110.936 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -160.35 -102.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.03 29.06 4.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.433 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 159.66 -105.54 0.27 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 53' ' ' GLN . 23.3 m -168.26 118.78 0.78 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.682 -0.893 . . . . 0.0 110.327 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.632 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 43.3 m-20 -79.07 -165.64 0.79 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 32.2 m-85 -148.36 157.62 43.59 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.236 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.646 ' C ' HG13 ' A' ' 62' ' ' ILE . 18.9 m-85 -139.65 137.56 35.36 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.713 ' N ' HD22 ' A' ' 122' ' ' LEU . 10.9 mt -155.9 126.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 116.935 -1.906 . . . . 0.0 112.067 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.651 ' HD2' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.45 94.54 7.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 176.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 25' ' ' VAL . 5.3 m -102.51 143.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.519 -0.738 . . . . 0.0 111.338 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.01 125.34 26.0 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.91 46.24 1.16 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.147 0.975 . . . . 0.0 109.358 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 94.2 -105.79 3.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 67' ' ' GLY . 5.6 p-10 -58.29 -144.73 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.497 -1.002 . . . . 0.0 109.93 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -77.53 -2.11 33.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.823 -1.173 . . . . 0.0 110.252 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -69.82 168.9 14.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.651 ' CD1' ' HD2' ' A' ' 63' ' ' LYS . 35.6 m-85 -142.13 165.3 27.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.779 ' HE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -152.7 116.5 4.8 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.725 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.685 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -73.99 143.61 45.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.039 HD21 HG21 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -146.29 130.19 17.22 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.845 -1.159 . . . . 0.0 110.786 -178.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.3 pttm -115.26 130.7 56.98 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.487 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.01 HG21 HG23 ' A' ' 24' ' ' ILE . 1.6 t -117.15 167.11 10.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.717 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.9 t80 -132.23 123.57 27.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.467 -1.396 . . . . 0.0 108.445 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.942 ' HG3' HD11 ' A' ' 108' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.942 HD11 ' HG3' ' A' ' 101' ' ' LYS . 11.0 mp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 122.408 1.099 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.717 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.0 p -148.78 160.93 5.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.774 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.874 HD13 HD11 ' A' ' 97' ' ' LEU . 1.9 tp -96.84 86.25 3.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -68.7 -20.71 64.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.97 -1.081 . . . . 0.0 111.087 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.506 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 178.32 -163.35 31.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.777 -1.677 . . . . 0.0 110.84 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.755 ' HD2' HD11 ' A' ' 110' ' ' LEU . 29.2 p90 167.81 135.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.687 -0.89 . . . . 0.0 108.896 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.679 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -94.55 103.36 15.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.483 ' HA ' ' HG2' ' A' ' 95' ' ' MET . 3.6 p -67.06 159.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.679 -1.263 . . . . 0.0 110.536 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.76 32.93 1.35 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.491 ' CG ' ' HB2' ' A' ' 114' ' ' GLN . 5.0 tptt -90.53 127.06 36.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.519 -1.363 . . . . 0.0 109.248 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.517 ' O ' ' CE ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -68.9 170.57 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.51 -0.744 . . . . 0.0 110.191 -178.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -62.99 -61.13 2.6 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.428 -0.795 . . . . 0.0 109.551 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 12.7 t0 -40.28 -31.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.48 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 1.1 t70 -50.77 121.54 6.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 110.031 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.7 OUTLIER -88.66 134.93 33.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.719 ' C ' HG23 ' A' ' 123' ' ' THR . 2.5 mp -65.22 -40.95 94.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.834 -1.166 . . . . 0.0 108.442 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 54.83 -161.91 0.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.027 0.918 . . . . 0.0 111.248 176.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.93 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -47.84 -17.97 0.64 Allowed Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.679 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 O-C-N 121.17 -1.194 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.417 HD23 ' CG ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 122.176 0.988 . . . . 0.0 110.586 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.516 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -102.07 -178.63 3.76 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.357 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.533 ' O ' ' CE ' ' A' ' 15' ' ' LYS . 2.8 mm-40 -59.01 135.0 57.49 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.05 -1.031 . . . . 0.0 108.797 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.586 ' HB2' ' CG ' ' A' ' 121' ' ' GLU . . . -39.4 109.34 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.226 -0.921 . . . . 0.0 110.936 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -79.59 129.85 70.01 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 175.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.95 128.92 20.71 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.635 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -43.29 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.627 1.203 . . . . 0.0 112.285 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.659 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.59 -167.69 0.16 Allowed Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.7 Cg_endo -71.83 -18.02 28.58 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 109.263 -1.091 . . . . 0.0 109.263 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -83.28 -44.91 14.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 108.569 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 21' ' ' ILE . 4.1 mm -57.82 -54.57 29.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.509 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 9.7 tp60 -60.45 -20.86 61.35 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.536 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 tm-20 -73.67 -36.84 65.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.683 -1.26 . . . . 0.0 109.091 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.889 HG23 HG21 ' A' ' 99' ' ' VAL . 4.5 mt -65.95 -50.76 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.084 0.945 . . . . 0.0 108.967 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 45' ' ' LEU . 8.7 p -65.0 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 122.074 0.94 . . . . 0.0 109.708 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.74 ' N ' HG13 ' A' ' 25' ' ' VAL . 31.6 t70 -70.26 -18.15 63.13 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.91 -17.68 27.54 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.591 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.695 HG11 ' CG2' ' A' ' 99' ' ' VAL . 30.9 m -107.54 -9.32 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -47.07 -46.13 53.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.912 -1.117 . . . . 0.0 109.947 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.3 Cg_endo -73.73 -29.89 10.11 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.442 1.428 . . . . 0.0 109.097 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 110' ' ' LEU . 2.5 mt-30 -81.57 -2.22 49.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.053 ' CD1' HD21 ' A' ' 97' ' ' LEU . 4.6 mt -95.08 -41.39 9.14 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.542 -0.723 . . . . 0.0 109.503 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 10.5 mt-10 -75.29 -23.64 57.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.537 -0.727 . . . . 0.0 109.441 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -23.57 21.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.994 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.33 -6.43 34.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.703 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 32' ' ' LEU . 1.4 t -127.58 -30.57 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.8 OUTLIER 91.98 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.403 0.621 . . . . 0.0 109.939 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.513 ' HB2' ' CG2' ' A' ' 36' ' ' THR . 1.2 mm-40 -110.04 -176.56 3.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 0.0 109.363 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' TYR . 7.3 m -108.89 -24.45 11.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.799 ' OH ' HG23 ' A' ' 115' ' ' VAL . 20.5 m-85 34.31 -162.91 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.784 0.802 . . . . 0.0 111.088 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' HG ' ' A' ' 45' ' ' LEU . . . 175.26 -160.27 28.87 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -42.6 125.78 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -1.095 . . . . 0.0 109.275 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 25' ' ' VAL . 68.1 mt -108.62 82.58 1.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.079 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 25.5 mt-10 -64.16 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.35 -0.844 . . . . 0.0 110.094 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.88 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -42.05 149.42 0.15 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.397 1.094 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.91 -44.46 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -152.69 168.89 24.17 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 17.5 p90 -166.0 144.53 5.84 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 111.284 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.578 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -109.14 165.7 11.4 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.62 141.71 29.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.511 ' HG3' ' OH ' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -117.55 162.87 17.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -117.59 135.17 58.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.162 -0.961 . . . . 0.0 110.035 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -158.74 -101.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -101.01 30.17 4.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.77 -115.24 0.65 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 106.411 -2.676 . . . . 0.0 106.411 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.512 ' CB ' ' HE3' ' A' ' 101' ' ' LYS . 10.3 m -160.55 125.95 3.89 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.275 -1.132 . . . . 0.0 110.343 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.544 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 61.8 m-80 -78.0 -172.37 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' A' ' 101' ' ' LYS . 18.7 m-85 -150.4 154.37 37.63 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.439 1.114 . . . . 0.0 110.004 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 17.2 m-85 -152.73 130.83 11.88 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.612 HG22 HG22 ' A' ' 64' ' ' VAL . 4.3 mt -146.39 118.53 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 117.133 -1.827 . . . . 0.0 112.073 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.692 ' N ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.31 102.29 6.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 175.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.88 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -111.65 137.85 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.739 . . . . 0.0 110.807 -175.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.2 127.41 32.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.846 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -80.45 36.71 0.38 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.557 0.694 . . . . 0.0 110.884 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.96 -75.78 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.596 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -79.85 47.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 113.165 -176.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 1.2 t-20 79.31 -38.75 0.2 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.93 -1.106 . . . . 0.0 111.739 177.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.846 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.8 mtmp? -66.99 144.57 56.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.581 -1.324 . . . . 0.0 107.469 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.608 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 15.3 m-30 -108.51 170.89 7.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.298 -0.877 . . . . 0.0 109.898 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -155.82 127.94 7.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.496 -0.752 . . . . 0.0 109.069 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.777 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -77.5 139.92 39.69 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.053 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -123.05 127.78 49.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 111.097 -179.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 4.4 ttmt -113.01 126.84 55.93 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.889 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -133.49 166.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.087 -1.008 . . . . 0.0 109.515 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.677 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 48.3 t80 -130.79 132.68 45.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.277 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 108' ' ' LEU . 5.6 mp . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 122.217 1.008 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.828 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.4 p -137.6 162.44 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.084 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.663 HD11 ' O ' ' A' ' 112' ' ' GLY . 16.3 tp -102.28 89.07 3.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.449 HG21 ' HB2' ' A' ' 100' ' ' PHE . 11.2 p -68.5 -21.22 64.61 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.314 -0.866 . . . . 0.0 110.707 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.663 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -179.7 -161.26 26.69 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.623 -1.751 . . . . 0.0 111.029 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.674 ' CB ' HD21 ' A' ' 32' ' ' LEU . 29.1 p90 170.08 133.48 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.745 -0.856 . . . . 0.0 108.968 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.673 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.18 107.84 20.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.799 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -66.75 158.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.582 -1.324 . . . . 0.0 111.239 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.9 t70 41.84 37.87 0.88 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.714 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.529 ' HA ' ' CE ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -81.06 -169.77 2.4 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.543 -1.348 . . . . 0.0 107.953 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 62.6 m-80 -148.07 -176.42 5.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.648 -1.283 . . . . 0.0 110.686 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 119' ' ' ASP . 1.3 ttmm -74.74 -46.22 38.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.63 -0.669 . . . . 0.0 109.464 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.5 t70 -47.61 -24.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.142 -0.974 . . . . 0.0 108.441 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 21.6 t0 -83.22 66.12 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.672 -0.643 . . . . 0.0 109.395 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.586 ' CG ' ' HB2' ' A' ' 14' ' ' ALA . 1.8 tt0 -61.35 103.27 0.29 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.786 -1.196 . . . . 0.0 108.052 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.777 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 3.4 mp -26.39 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.585 1.184 . . . . 0.0 110.256 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER -108.0 -7.91 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.066 -177.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.15 107.43 0.2 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.673 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.661 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 123' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.93 0.871 . . . . 0.0 110.935 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -101.51 171.22 7.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' SER . 12.7 tm-20 -43.53 166.97 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.281 -0.887 . . . . 0.0 109.347 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' N ' ' CD ' ' A' ' 13' ' ' GLU . . . -71.25 103.05 2.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.609 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -73.28 132.65 81.72 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 175.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.39 127.67 18.69 Favored 'Trans proline' 0 C--N 1.293 -2.352 0 N-CA-C 109.378 -1.047 . . . . 0.0 109.378 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.729 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -47.29 132.35 12.87 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.044 0.926 . . . . 0.0 111.909 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.619 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -102.56 -172.63 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.0 Cg_endo -68.08 -17.59 45.77 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 N-CA-C 109.545 -0.983 . . . . 0.0 109.545 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -81.79 -36.62 28.23 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.09 -1.006 . . . . 0.0 108.494 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.822 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -68.84 -45.31 80.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.504 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 11.0 tp60 -66.82 -18.92 65.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.73 -30.29 59.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.835 -1.166 . . . . 0.0 108.774 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.922 ' O ' HG22 ' A' ' 28' ' ' VAL . 46.0 mt -71.61 -51.98 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.737 HG13 ' N ' ' A' ' 26' ' ' ASP . 8.4 p -60.1 -42.89 91.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.879 0.847 . . . . 0.0 109.074 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.737 ' N ' HG13 ' A' ' 25' ' ' VAL . 1.4 t70 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' GLU . 7.3 mttt -81.45 -6.85 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.041 HG21 ' CD2' ' A' ' 97' ' ' LEU . 6.4 m -127.05 -8.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.577 -0.702 . . . . 0.0 110.501 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 15.5 ttpp -41.66 -47.9 9.74 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.024 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.0 Cg_endo -72.87 -34.88 6.17 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.33 1.354 . . . . 0.0 109.655 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.502 ' O ' HD23 ' A' ' 110' ' ' LEU . 43.1 mt-30 -74.6 -5.35 42.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.922 . . . . 0.0 108.513 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.89 HD11 HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.84 -37.47 8.67 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.863 0.839 . . . . 0.0 109.048 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.1 mt-10 -54.07 -54.88 33.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.654 -0.654 . . . . 0.0 110.55 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.71 -35.78 57.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 110.491 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 1.3 mptp? -53.46 -56.73 14.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.222 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.974 HG21 ' OH ' ' A' ' 40' ' ' TYR . 10.0 t -95.37 20.67 9.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER 41.32 39.83 1.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.328 -0.858 . . . . 0.0 110.001 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.685 ' HB3' HG23 ' A' ' 36' ' ' THR . 1.6 tt0 -136.77 160.12 39.81 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -102.92 135.8 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.698 -1.251 . . . . 0.0 110.422 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.974 ' OH ' HG21 ' A' ' 36' ' ' THR . 98.5 m-85 -117.52 169.1 9.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.834 . . . . 0.0 109.296 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -125.88 -164.69 11.86 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.1 123.82 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -1.206 . . . . 0.0 108.595 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.716 ' HB3' HG21 ' A' ' 64' ' ' VAL . 39.1 mt -100.32 76.72 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.919 -1.113 . . . . 0.0 109.063 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -57.2 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.461 0.648 . . . . 0.0 109.777 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.729 ' HB1' ' CB ' ' A' ' 17' ' ' ALA . . . -42.82 133.67 3.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.117 0.96 . . . . 0.0 110.006 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.2 t -113.36 -41.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -146.55 171.26 15.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.006 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.822 ' HB3' HG21 ' A' ' 21' ' ' ILE . 1.9 p90 -167.6 141.43 3.53 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.38 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 1.1 mppp? -121.14 128.91 52.98 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.956 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.5 p -73.01 -172.07 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.967 -1.083 . . . . 0.0 109.703 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.637 ' CG ' ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -167.33 127.27 1.43 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.6 p -107.84 115.58 49.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.507 HG21 ' ND2' ' A' ' 59' ' ' ASN . 0.3 OUTLIER -136.85 -104.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.65 29.55 4.05 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.57 -116.73 0.73 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 11.5 m -158.61 113.49 2.55 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.218 -1.166 . . . . 0.0 110.113 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.594 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 54.8 m-20 -82.37 -173.13 4.39 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.836 0.827 . . . . 0.0 109.099 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.649 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 93.2 m-85 -137.49 152.0 49.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.637 ' CE1' ' CG ' ' A' ' 53' ' ' GLN . 4.5 m-85 -133.29 138.25 46.35 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.735 ' N ' HD22 ' A' ' 122' ' ' LEU . 13.0 mt -156.2 125.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 116.747 -1.981 . . . . 0.0 112.466 -175.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.569 ' HD2' ' NE2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -103.12 90.64 3.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 45' ' ' LEU . 5.1 m -97.47 159.69 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.355 -0.84 . . . . 0.0 110.973 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.681 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -82.38 128.93 34.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.1 45.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.005 0.907 . . . . 0.0 109.377 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 86.23 -96.82 2.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 9.8 p-10 -58.83 -146.74 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.479 -1.012 . . . . 0.0 109.759 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.72 0.84 28.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.079 -1.013 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.58 175.72 6.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.265 -0.897 . . . . 0.0 109.238 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 21.7 m-85 -150.22 169.12 22.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 108.899 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.75 ' SD ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -151.86 112.75 4.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.706 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -72.28 152.44 42.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.041 ' CD2' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -146.85 158.06 43.82 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.279 -1.368 . . . . 0.0 111.615 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 6.5 mtpt -141.3 114.03 8.37 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.965 HG11 HD23 ' A' ' 108' ' ' LEU . 2.3 t -118.8 168.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.746 -1.221 . . . . 0.0 110.358 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.633 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 1.2 t80 -130.59 122.66 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 108.708 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.835 ' CG ' HD11 ' A' ' 108' ' ' LEU . 4.9 tttt . . . . . 0 N--CA 1.504 2.266 0 CA-C-O 122.935 1.35 . . . . 0.0 108.299 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.965 HD23 HG11 ' A' ' 99' ' ' VAL . 6.2 mp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 122.314 1.054 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.1 p -143.9 163.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.798 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.67 HD22 ' HG ' ' A' ' 32' ' ' LEU . 6.4 tp -101.7 84.38 2.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.584 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 41.4 p -67.02 -19.82 65.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -176.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 178.36 -170.24 42.24 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.442 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 29.3 p90 172.53 134.53 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.452 -1.029 . . . . 0.0 109.501 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.626 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 2.0 mm100 -96.85 103.25 15.15 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.683 HG23 ' OH ' ' A' ' 40' ' ' TYR . 2.2 p -66.79 154.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 122.254 1.026 . . . . 0.0 111.057 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' A ASP . . . . . . . . . . . . . 12.7 t0 47.29 33.01 2.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.952 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.525 ' HG2' ' ND1' ' A' ' 96' ' ' HIS . 5.6 tptt -77.84 162.62 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.446 -1.409 . . . . 0.0 108.461 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.442 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -107.88 160.76 15.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.93 -1.106 . . . . 0.0 109.911 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 3.0 ttpm? -55.47 -48.95 73.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -46.48 -38.44 9.22 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.335 -0.853 . . . . 0.0 109.126 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.613 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -66.27 96.31 0.34 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.325 -0.859 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.31 170.74 15.78 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.735 HD22 ' N ' ' A' ' 62' ' ' ILE . 3.4 mp -93.16 25.4 3.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.411 -1.43 . . . . 0.0 109.202 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.922 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -17.14 -59.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.596 177.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.529 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . -150.09 41.06 0.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CG ' ' OXT' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.57 0 CA-C-O 117.827 -1.083 . . . . 0.0 109.054 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 123' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.969 0.89 . . . . 0.0 112.867 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.518 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 23.0 t -102.2 169.56 8.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 42.4 tt0 -46.87 172.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.109 -0.995 . . . . 0.0 109.267 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -81.65 107.25 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.956 -1.09 . . . . 0.0 110.228 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.665 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 1.1 mmtt -77.37 139.95 64.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.22 129.23 22.3 Favored 'Trans proline' 0 C--N 1.291 -2.476 0 N-CA-C 109.584 -0.968 . . . . 0.0 109.584 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.64 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -51.63 133.7 30.45 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.373 1.083 . . . . 0.0 111.788 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.656 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -109.33 -165.19 0.07 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.656 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -72.11 -16.52 28.62 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.428 ' CG ' ' N ' ' A' ' 21' ' ' ILE . 7.5 pt-20 -81.53 -39.1 25.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.924 -1.11 . . . . 0.0 108.539 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.797 HG21 ' HB3' ' A' ' 50' ' ' TYR . 25.7 mm -67.39 -50.32 63.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.559 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -65.13 -15.04 61.97 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -77.37 -37.35 52.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 99' ' ' VAL . 4.6 mt -63.9 -50.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 26' ' ' ASP . 14.3 p -66.75 -40.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.099 0.952 . . . . 0.0 109.253 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.698 ' N ' HG13 ' A' ' 25' ' ' VAL . 18.5 t0 -72.37 -15.08 61.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -92.91 -13.56 28.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' CG2' ' A' ' 99' ' ' VAL . 31.6 m -116.86 -6.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.487 -0.758 . . . . 0.0 109.676 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.614 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -46.03 -48.55 41.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.894 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.8 Cg_endo -73.58 -29.19 11.13 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.575 1.517 . . . . 0.0 109.101 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' HD23 ' A' ' 110' ' ' LEU . 15.9 mt-30 -79.66 -4.77 53.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.057 ' O ' HG22 ' A' ' 36' ' ' THR . 2.3 mt -98.2 -41.34 7.94 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.657 0.741 . . . . 0.0 109.016 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -65.83 -22.58 66.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 110.453 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -36.45 12.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.955 -1.091 . . . . 0.0 110.206 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -53.68 10.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.043 . . . . 0.0 110.045 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 1.057 HG22 ' O ' ' A' ' 32' ' ' LEU . 10.0 t -78.76 6.6 8.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.737 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 3.5 p-10 42.93 42.95 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.715 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.548 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 7.9 tt0 -139.22 159.67 41.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.162 -0.962 . . . . 0.0 108.961 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.561 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -94.32 133.51 37.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 110.203 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.845 ' OH ' HG21 ' A' ' 36' ' ' THR . 21.1 m-85 -122.77 -168.51 1.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -144.25 -171.1 14.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.99 136.05 3.9 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.162 -1.199 . . . . 0.0 108.978 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.645 ' HB2' HG22 ' A' ' 25' ' ' VAL . 29.9 mt -107.89 85.18 2.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.044 -1.035 . . . . 0.0 108.901 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -68.64 84.47 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.697 -0.627 . . . . 0.0 109.534 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.949 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.6 129.5 5.33 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.211 1.005 . . . . 0.0 109.953 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.536 HG11 ' NZ ' ' A' ' 63' ' ' LYS . 1.5 t -105.0 -46.26 9.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.646 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 1.8 mt-30 -146.92 167.23 24.47 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.797 ' HB3' HG21 ' A' ' 21' ' ' ILE . 3.8 p90 -161.1 137.51 8.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.565 -1.335 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 1.9 mttt -103.73 122.92 46.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.503 HG22 ' HE2' ' A' ' 50' ' ' TYR . 44.1 p -70.43 -173.67 0.75 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.882 ' O ' HG23 ' A' ' 58' ' ' THR . 0.6 OUTLIER -162.18 145.84 11.95 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.885 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -127.67 139.45 51.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.741 -1.224 . . . . 0.0 110.283 179.246 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.885 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.38 -100.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.22 29.6 5.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 157.72 -115.68 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 106.449 -2.66 . . . . 0.0 106.449 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.882 HG23 ' O ' ' A' ' 53' ' ' GLN . 27.4 m -162.32 111.66 1.45 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.188 -1.184 . . . . 0.0 110.831 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.702 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 77.8 m-20 -77.92 -169.49 1.57 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.633 ' CD1' HG12 ' A' ' 99' ' ' VAL . 25.2 m-85 -149.97 159.09 44.66 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.279 -0.888 . . . . 0.0 109.891 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.609 ' HB3' HD22 ' A' ' 122' ' ' LEU . 22.9 m-85 -140.11 136.53 33.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.829 HD12 HD23 ' A' ' 97' ' ' LEU . 14.4 mt -151.29 121.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 116.775 -1.97 . . . . 0.0 111.312 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' NZ ' HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -86.92 94.77 9.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.949 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.6 m -102.01 141.66 17.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.566 -0.709 . . . . 0.0 110.943 -176.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.614 ' HD2' ' CZ ' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -68.88 129.41 39.85 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.59 47.25 1.4 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.033 0.92 . . . . 0.0 108.744 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.56 -94.96 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.69 -164.74 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.333 -1.098 . . . . 0.0 109.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -64.0 -9.04 13.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 110.121 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -68.53 163.52 23.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.614 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 6.5 m-85 -133.32 176.6 8.38 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 108.707 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.682 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -157.32 108.76 2.34 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.176 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.765 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -69.58 144.49 53.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.829 HD23 HD12 ' A' ' 62' ' ' ILE . 46.3 tp -130.59 153.32 49.02 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.994 -1.066 . . . . 0.0 111.063 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.3 ttmt -139.01 111.09 7.31 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 24' ' ' ILE . 1.9 t -117.44 161.14 16.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.713 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 3.2 t80 -127.36 127.92 45.03 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.702 -1.249 . . . . 0.0 107.815 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HB3' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.266 -0.896 . . . . 0.0 108.721 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.3 mp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 122.42 1.105 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.727 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.9 p -158.57 164.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.055 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.81 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.9 tp -97.47 83.13 3.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.6 OUTLIER -71.94 -11.57 60.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 112.082 -176.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.509 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . 175.28 -171.91 45.0 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.575 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.81 ' HD2' HD11 ' A' ' 110' ' ' LEU . 20.8 p90 168.39 134.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.217 -1.167 . . . . 0.0 109.137 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -94.61 102.2 14.1 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.498 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 2.3 p -68.41 164.08 2.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.868 -1.145 . . . . 0.0 110.73 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.88 25.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.86 -0.525 . . . . 0.0 110.711 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.576 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.54 161.72 13.52 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 120.66 -1.275 . . . . 0.0 108.366 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.55 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 25.0 p-10 -140.4 -155.79 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.613 -1.305 . . . . 0.0 111.389 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -65.31 -48.46 73.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.27 0.557 . . . . 0.0 110.031 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 118' ' ' LYS . 2.9 t70 -41.05 -26.59 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 109.915 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.576 ' CB ' ' CD ' ' A' ' 116' ' ' LYS . 3.1 t70 -98.26 115.0 27.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 111.376 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.7 ' O ' HG23 ' A' ' 123' ' ' THR . 3.0 tt0 -75.07 146.89 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.765 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -66.59 -12.3 57.23 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.336 -1.477 . . . . 0.0 109.417 -178.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 37.25 -156.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.44 177.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -83.93 49.58 4.26 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.655 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.267 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.614 HD22 ' C ' ' A' ' 123' ' ' THR . 1.1 mp . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.955 0.883 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -101.59 171.44 7.56 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.67 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.99 -179.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.384 -0.823 . . . . 0.0 109.526 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HB1' ' CD ' ' A' ' 49' ' ' GLN . . . -82.89 107.76 15.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.005 . . . . 0.0 110.003 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.669 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -83.4 128.78 62.99 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 175.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.87 130.78 23.9 Favored 'Trans proline' 0 C--N 1.294 -2.29 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.501 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -46.53 162.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.392 1.092 . . . . 0.0 111.552 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.642 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -143.31 -166.95 0.14 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.73 -18.28 28.74 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 N-CA-C 108.992 -1.195 . . . . 0.0 108.992 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.45 -45.57 14.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 0.0 108.567 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.816 HG21 ' HB3' ' A' ' 50' ' ' TYR . 3.6 mm -58.48 -53.16 50.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.37 -19.84 62.32 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 tm-20 -73.87 -35.73 64.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.428 -1.42 . . . . 0.0 108.505 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.94 HG23 HG21 ' A' ' 99' ' ' VAL . 5.1 mt -65.46 -51.22 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.75 0.786 . . . . 0.0 108.934 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.828 HG21 HG11 ' A' ' 64' ' ' VAL . 8.8 p -62.34 -41.99 93.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 122.054 0.931 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.714 ' N ' HG13 ' A' ' 25' ' ' VAL . 6.3 t70 -69.95 -19.86 63.35 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.0 tttt -79.35 -20.7 47.13 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.665 HG21 HD21 ' A' ' 97' ' ' LEU . 17.6 m -117.83 3.1 7.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.732 -0.605 . . . . 0.0 109.938 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 14.7 tttp -47.91 -46.85 64.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.695 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.7 Cg_endo -75.34 -27.34 9.57 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.555 1.503 . . . . 0.0 109.028 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.624 ' O ' HD23 ' A' ' 110' ' ' LEU . 1.2 mt-30 -83.01 -1.03 51.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.127 HD11 ' CD1' ' A' ' 97' ' ' LEU . 2.5 mt -100.47 -33.48 10.33 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.676 0.75 . . . . 0.0 109.269 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 38' ' ' GLU . 2.4 mm-40 -73.89 -32.1 63.42 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.572 -0.705 . . . . 0.0 110.838 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -101.44 -4.43 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.355 -1.466 . . . . 0.0 112.009 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -99.95 -11.39 20.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.488 -1.383 . . . . 0.0 110.355 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.586 ' HB ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -140.11 -28.22 0.74 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.998 -1.064 . . . . 0.0 110.889 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.7 p30 149.11 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' GLU . 26.9 tt0 -66.38 105.09 1.36 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.234 1.016 . . . . 0.0 109.904 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 39' ' ' THR . 46.9 m -158.76 14.39 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.66 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.38 -175.53 2.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.048 -1.032 . . . . 0.0 109.171 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -145.72 -108.47 0.57 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -77.76 134.66 38.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -1.183 . . . . 0.0 108.811 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 25' ' ' VAL . 14.5 mt -108.16 83.47 1.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 108.511 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 3.7 mt-10 -71.87 85.5 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.708 -0.62 . . . . 0.0 109.961 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.838 ' N ' HG13 ' A' ' 64' ' ' VAL . . . -40.47 155.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 110.05 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.4 t -134.79 -41.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.671 ' CD ' ' HB1' ' A' ' 14' ' ' ALA . 25.1 tt0 -142.41 168.97 18.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.816 ' HB3' HG21 ' A' ' 21' ' ' ILE . 9.2 p90 -167.8 137.03 2.58 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.607 -1.308 . . . . 0.0 110.727 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 30.1 mttt -112.41 135.16 53.44 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.451 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 p -87.78 175.46 7.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.088 -1.008 . . . . 0.0 109.754 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.791 ' O ' HG23 ' A' ' 58' ' ' THR . 0.8 OUTLIER -150.31 158.96 44.73 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -129.49 137.03 57.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.935 -1.103 . . . . 0.0 110.495 179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -164.46 -96.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -108.03 28.76 7.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 161.44 -107.05 0.3 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 53' ' ' GLN . 3.3 m -168.59 109.65 0.52 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.592 -0.946 . . . . 0.0 110.729 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.625 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 41.5 m-80 -70.26 -165.98 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.613 ' CD1' HG12 ' A' ' 99' ' ' VAL . 64.6 m-85 -147.7 159.54 43.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.039 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.763 ' HB3' HD22 ' A' ' 122' ' ' LEU . 47.6 m-85 -140.41 138.18 34.55 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.787 HD12 HD23 ' A' ' 97' ' ' LEU . 24.9 mt -155.95 116.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 C-N-CA 116.873 -1.931 . . . . 0.0 111.495 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.518 ' HD2' ' NE2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -81.66 101.79 10.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.838 HG13 ' N ' ' A' ' 47' ' ' ALA . 11.5 t -113.7 139.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 112.319 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -69.36 121.29 16.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HG2' ' A' ' 95' ' ' MET . . . -82.64 43.0 0.8 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 111.83 -129.73 9.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 67' ' ' GLY . 34.9 t70 -51.4 -107.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.518 -0.989 . . . . 0.0 110.365 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.03 3.99 36.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.71 -1.244 . . . . 0.0 109.706 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 94' ' ' TYR . 13.1 tptt -68.53 157.37 36.14 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' CD ' ' A' ' 65' ' ' ARG . 2.3 m-85 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.975 -1.078 . . . . 0.0 109.595 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 1.032 ' HE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -163.46 133.66 4.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.572 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.655 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 5.7 m170 -69.98 161.14 30.61 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.127 ' CD1' HD11 ' A' ' 32' ' ' LEU . 2.8 tp -142.04 129.88 21.76 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.576 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ttmt -117.54 122.43 43.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.94 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -123.83 168.19 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.971 -1.081 . . . . 0.0 109.009 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.703 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 14.8 t80 -131.84 127.42 36.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.85 -1.156 . . . . 0.0 108.954 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.532 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.5 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 122.21 1.005 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.791 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.3 p -136.73 164.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.52 -177.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 31' ' ' GLN . 7.1 tp -100.09 83.66 2.73 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -67.72 -17.29 64.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 111.197 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.622 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 176.32 -164.78 34.81 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.063 -1.541 . . . . 0.0 110.355 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 29.9 p90 165.99 137.17 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.686 -0.891 . . . . 0.0 109.099 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.622 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 8.6 mm-40 -99.0 94.51 6.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.546 ' HA ' ' CB ' ' A' ' 95' ' ' MET . 1.0 OUTLIER -67.64 157.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.029 -1.669 . . . . 0.0 110.241 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' A ASP . . . . . . . . . . . . . 7.8 t0 53.93 18.6 1.69 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.743 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -87.07 116.15 24.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.687 -1.258 . . . . 0.0 108.364 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.488 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 1.3 m120 -71.72 177.92 3.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.371 -0.831 . . . . 0.0 110.554 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -64.7 -24.22 67.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.62 -0.675 . . . . 0.0 110.066 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.64 -8.78 15.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.168 -0.957 . . . . 0.0 109.605 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.537 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -95.18 116.01 28.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.234 -0.916 . . . . 0.0 110.228 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 123' ' ' THR . 8.1 tt0 -86.95 139.31 30.73 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 61' ' ' TYR . 3.1 mp -62.88 -46.97 85.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.775 -1.203 . . . . 0.0 109.256 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.719 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 54.78 -157.55 0.21 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 107.331 178.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.541 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -77.98 66.45 3.11 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.631 ' O ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.72 -0.871 . . . . 0.0 109.934 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.112 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.83 0.824 . . . . 0.0 110.617 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -100.97 170.96 7.93 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.457 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 1.0 OUTLIER -49.04 -179.38 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 0.0 109.836 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.494 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . . . -81.2 99.04 8.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 110.25 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 2.2 mmpt? -70.42 128.42 91.25 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.61 126.3 14.57 Favored 'Trans proline' 0 C--N 1.292 -2.414 0 N-CA-C 108.813 -1.264 . . . . 0.0 108.813 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 21' ' ' ILE . . . -37.41 162.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.495 1.14 . . . . 0.0 111.794 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.662 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -145.6 -166.17 0.12 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -72.9 -21.09 21.51 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.503 -1.384 . . . . 0.0 108.503 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.504 ' O ' HD12 ' A' ' 24' ' ' ILE . 3.4 mt-10 -81.3 -44.92 16.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -0.969 . . . . 0.0 108.811 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.702 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.4 mm -58.7 -56.18 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.476 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 15.2 tp60 -57.5 -20.09 29.01 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.3 tt0 -75.13 -39.17 60.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.339 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.088 HG23 HG21 ' A' ' 99' ' ' VAL . 2.2 mt -63.76 -49.63 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.043 0.925 . . . . 0.0 108.77 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.72 HG13 ' N ' ' A' ' 26' ' ' ASP . 12.4 p -66.82 -40.57 86.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 122.307 1.051 . . . . 0.0 109.401 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.72 ' N ' HG13 ' A' ' 25' ' ' VAL . 19.3 t0 -75.46 -13.35 60.38 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -95.43 -10.1 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.925 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.899 HG21 ' CD2' ' A' ' 97' ' ' LEU . 27.0 m -114.59 -15.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 110.981 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 ttpt -37.95 -51.07 3.08 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.035 -1.041 . . . . 0.0 110.911 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.5 Cg_endo -70.5 -35.9 9.72 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.421 1.414 . . . . 0.0 109.413 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' HD23 ' A' ' 110' ' ' LEU . 28.6 mt-30 -71.76 -6.44 41.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.9 HD13 ' CE ' ' A' ' 95' ' ' MET . 2.6 mt -96.79 -41.97 8.21 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 13.9 mt-10 -66.84 -8.99 32.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -0.808 . . . . 0.0 109.182 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.34 -56.4 2.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -48.56 20.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 109.958 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.607 HG22 ' CZ ' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -79.39 -14.56 58.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.06 -1.025 . . . . 0.0 108.973 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 1.4 p-10 44.97 64.84 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.417 0.627 . . . . 0.0 109.907 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.574 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 9.1 mt-10 -130.77 -177.74 4.49 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.3 m -98.8 -26.69 14.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.574 ' CE1' ' OE1' ' A' ' 38' ' ' GLU . 19.6 m-85 35.45 -161.84 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.809 0.814 . . . . 0.0 110.529 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . 179.26 -169.83 41.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.65 129.7 3.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -1.093 . . . . 0.0 108.793 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.705 HD12 HG22 ' A' ' 25' ' ' VAL . 44.2 mt -109.48 82.98 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.846 -1.158 . . . . 0.0 109.301 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -63.74 84.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.522 -0.737 . . . . 0.0 109.932 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.939 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.68 123.29 3.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.145 0.974 . . . . 0.0 109.966 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.2 t -99.51 -47.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.526 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 4.7 mm100 -145.18 172.58 12.91 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.702 ' HB3' HG21 ' A' ' 21' ' ' ILE . 17.2 p90 -166.89 137.08 3.08 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.061 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.541 ' CD ' ' HB2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.13 133.75 54.88 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.915 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.6 p -76.73 -176.87 4.02 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.273 -0.892 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.704 ' O ' HG23 ' A' ' 58' ' ' THR . 1.3 mm-40 -160.32 149.22 17.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.581 -0.699 . . . . 0.0 109.323 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -120.48 141.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 110.576 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.25 -103.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.1 30.58 3.71 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.07 -118.19 0.85 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 106.178 -2.769 . . . . 0.0 106.178 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 53' ' ' GLN . 11.4 m -154.38 116.66 4.29 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.332 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.626 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 64.8 m-20 -77.72 -166.03 0.71 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.686 ' CD1' HG12 ' A' ' 99' ' ' VAL . 85.1 m-85 -147.34 153.14 39.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.617 ' CE1' ' OXT' ' A' ' 125' ' ' PHE . 16.0 m-30 -136.94 132.32 34.25 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.807 HG22 HG13 ' A' ' 64' ' ' VAL . 13.6 mt -148.97 124.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 117.06 -1.856 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HA ' ' HZ1' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -95.78 94.66 7.8 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 176.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 47' ' ' ALA . 15.7 m -99.4 144.88 11.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.274 0.559 . . . . 0.0 110.642 -176.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.658 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.1 mmm-85 -69.24 125.41 26.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.919 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -86.26 46.59 1.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.072 0.939 . . . . 0.0 108.904 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 -85.23 1.39 Allowed Glycine 0 C--N 1.287 -2.167 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.39 -168.67 1.2 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.203 -1.175 . . . . 0.0 109.87 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.13 7.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.919 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -69.21 127.02 31.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 108.798 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.599 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 5.6 m-30 -97.39 -179.12 4.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.096 -1.003 . . . . 0.0 110.324 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.9 ' CE ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.0 99.93 3.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.514 -0.741 . . . . 0.0 109.569 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.73 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -71.71 146.96 47.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.899 ' CD2' HG21 ' A' ' 28' ' ' VAL . 4.7 tp -138.21 139.26 39.2 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.371 -1.331 . . . . 0.0 111.531 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 9.6 ttpp -122.92 94.28 4.22 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.088 HG21 HG23 ' A' ' 24' ' ' ILE . 2.3 t -97.25 164.58 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.736 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 7.1 t80 -119.25 138.5 52.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.661 -1.274 . . . . 0.0 108.298 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.651 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.778 0.799 . . . . 0.0 109.064 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 108' ' ' LEU . 3.0 mp . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 122.373 1.082 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.736 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 11.8 p -147.89 162.19 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.627 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.681 HD22 ' HG ' ' A' ' 32' ' ' LEU . 8.0 tp -98.05 89.23 4.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 100' ' ' PHE . 4.4 p -82.12 -11.98 58.45 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.901 -1.124 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.534 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . -175.01 -168.98 36.35 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.607 ' CZ ' HG22 ' A' ' 36' ' ' THR . 27.0 p90 164.84 139.29 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.578 -0.954 . . . . 0.0 109.26 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.628 ' HG2' ' CE2' ' A' ' 125' ' ' PHE . 3.4 mm100 -102.31 97.82 8.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.523 HG21 ' OE2' ' A' ' 38' ' ' GLU . 2.0 p -66.85 164.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 110.354 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' A ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 115' ' ' VAL . 35.1 t0 43.46 24.75 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.115 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.612 ' HE3' ' CD2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -69.45 155.35 40.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.702 -1.249 . . . . 0.0 108.284 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.497 ' N ' ' HG2' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -107.9 -174.91 2.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -70.21 -38.78 75.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.813 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.96 -8.07 20.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.984 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.555 ' CB ' ' HG2' ' A' ' 116' ' ' LYS . 5.3 t0 -75.19 91.41 2.62 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.042 -1.036 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -64.4 155.1 33.56 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.73 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -90.13 55.65 3.16 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.667 1.222 . . . . 0.0 109.575 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -46.85 -172.09 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.291 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 1.112 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -45.09 -16.08 0.07 OUTLIER Glycine 0 N--CA 1.503 3.142 0 O-C-N 121.025 -1.047 . . . . 0.0 110.548 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.628 ' CE2' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.685 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.798 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.768 HD22 ' HA2' ' A' ' 124' ' ' GLY . 1.2 pt? . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' GLU . 42.4 m -100.52 179.8 4.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 110.829 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tt0 -49.87 -176.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.674 -0.641 . . . . 0.0 109.992 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.912 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -91.38 100.55 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -68.06 146.58 98.22 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 175.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.12 129.63 20.99 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 N-CA-C 108.885 -1.237 . . . . 0.0 108.885 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -37.36 159.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.282 1.039 . . . . 0.0 111.346 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.642 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -139.41 -166.52 0.12 Allowed Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 30.3 Cg_endo -73.65 -17.62 23.1 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 108.693 -1.311 . . . . 0.0 108.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -85.68 -39.95 16.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.713 HG21 ' HB3' ' A' ' 50' ' ' TYR . 6.2 mm -65.17 -53.72 37.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.545 ' NE2' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -57.95 -26.0 61.69 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.297 178.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 60.6 tt0 -76.91 -41.12 44.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 109.54 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.072 HG23 HG21 ' A' ' 99' ' ' VAL . 5.8 mt -56.48 -53.65 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 122.319 1.057 . . . . 0.0 108.271 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.713 HG13 ' N ' ' A' ' 26' ' ' ASP . 11.7 p -66.05 -40.69 87.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.615 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.713 ' N ' HG13 ' A' ' 25' ' ' VAL . 1.8 t70 -70.39 -10.53 59.33 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -99.26 -20.2 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.557 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.749 HG21 HD21 ' A' ' 97' ' ' LEU . 16.1 m -110.41 -4.94 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -44.72 -47.6 28.26 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.003 -1.06 . . . . 0.0 110.133 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -32.4 9.75 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.36 1.374 . . . . 0.0 109.421 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' HD23 ' A' ' 110' ' ' LEU . 21.0 mt-30 -79.77 -1.39 38.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.884 HD11 ' CD1' ' A' ' 97' ' ' LEU . 4.2 mt -95.85 -38.48 10.27 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.572 -0.705 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 3.3 mt-10 -66.11 -43.78 86.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.424 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -84.34 -11.29 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -0.967 . . . . 0.0 110.976 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -91.84 -12.21 34.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.76 -1.213 . . . . 0.0 110.451 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 1.049 HG21 ' OH ' ' A' ' 40' ' ' TYR . 6.2 t -122.82 -31.36 3.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.847 -1.158 . . . . 0.0 110.075 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER 101.83 8.82 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.349 0.595 . . . . 0.0 109.724 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.855 ' H ' HG23 ' A' ' 36' ' ' THR . 2.0 tt0 -117.03 152.92 33.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.486 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -102.29 121.26 41.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 0.0 110.689 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 1.049 ' OH ' HG21 ' A' ' 36' ' ' THR . 11.0 m-85 -110.93 -175.97 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -139.56 -156.43 6.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -38.35 132.17 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.529 -0.983 . . . . 0.0 109.763 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.706 ' HB2' HG22 ' A' ' 25' ' ' VAL . 65.8 mt -112.89 91.49 3.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.085 -1.009 . . . . 0.0 109.064 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.31 90.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.922 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -47.65 125.05 7.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.219 1.009 . . . . 0.0 110.142 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.4 t -97.63 -45.72 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.912 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 12.8 pt20 -150.91 171.33 17.43 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.713 ' HB3' HG21 ' A' ' 21' ' ' ILE . 8.9 p90 -165.42 139.73 4.8 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.858 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 61.8 mttt -109.39 123.43 49.32 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 p -73.19 -175.97 2.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.892 ' O ' HG23 ' A' ' 58' ' ' THR . 1.1 tm0? -161.85 152.36 17.42 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.848 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.36 140.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 110.084 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.33 -102.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.59 30.53 3.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.46 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 157.08 -108.84 0.38 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.749 -2.54 . . . . 0.0 106.749 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 53' ' ' GLN . 26.8 m -167.82 109.2 0.59 Allowed 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.619 -0.93 . . . . 0.0 110.61 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.622 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 65.6 m-20 -69.93 -172.96 0.58 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 20.4 m-85 -144.72 145.79 31.87 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.776 ' HB3' HD22 ' A' ' 122' ' ' LEU . 1.4 m-85 -128.68 133.67 48.27 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.919 HG22 HG13 ' A' ' 64' ' ' VAL . 32.0 mt -150.99 121.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 116.423 -2.111 . . . . 0.0 112.021 -176.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.13 96.97 10.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 176.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.922 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.3 m -105.98 140.3 24.5 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 O-C-N 121.174 -0.954 . . . . 0.0 111.561 -175.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.2 mtm-85 -68.51 133.87 49.22 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -85.12 42.81 0.96 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.793 0.806 . . . . 0.0 109.175 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 73.35 -81.33 0.71 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 7.0 m-20 -55.13 -113.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -1.033 . . . . 0.0 110.496 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.05 -30.91 4.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.747 -1.22 . . . . 0.0 109.293 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.776 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 29.7 mtmt -68.73 144.58 54.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.602 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 15.7 m-30 -109.81 176.99 4.86 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.116 -0.99 . . . . 0.0 109.023 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.658 ' O ' HG22 ' A' ' 64' ' ' VAL . 20.2 ttp -144.65 119.92 10.2 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.007 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.788 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -69.17 151.13 46.72 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.884 ' CD1' HD11 ' A' ' 32' ' ' LEU . 13.3 tp -130.71 142.04 50.41 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.118 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.629 ' HE2' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -131.0 95.79 3.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.072 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -105.42 161.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.197 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.705 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.0 t80 -126.54 129.71 49.14 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.636 -1.29 . . . . 0.0 108.483 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HG2' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 108' ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 122.72 1.247 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.705 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.9 p -152.37 163.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.742 -177.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 112' ' ' GLY . 9.0 tp -100.43 83.41 2.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.604 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.9 OUTLIER -69.26 -10.51 58.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 111.735 -176.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.598 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 171.35 -165.4 38.42 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.612 -1.756 . . . . 0.0 111.157 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 30.2 p90 165.73 143.47 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.639 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.9 mm100 -105.26 103.6 13.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.629 -1.294 . . . . 0.0 107.662 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -68.61 162.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.71 -1.244 . . . . 0.0 111.162 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.1 t0 51.78 20.34 1.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.654 ' HG3' ' OD2' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -74.32 161.67 29.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.81 -1.181 . . . . 0.0 108.293 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.506 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 1.1 m120 -152.68 -167.73 2.83 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.199 -1.563 . . . . 0.0 112.752 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -36.7 -38.34 0.17 Allowed 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.196 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.43 53.27 2.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.718 ' CG ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -92.91 108.59 20.12 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.85 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.674 ' O ' HG23 ' A' ' 123' ' ' THR . 1.9 tt0 -102.29 105.49 16.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.788 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.8 OUTLIER -69.07 -28.86 66.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.364 -1.46 . . . . 0.0 107.841 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 39.9 -160.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.758 0.789 . . . . 0.0 110.55 176.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.768 ' HA2' HD22 ' A' ' 11' ' ' LEU . . . -69.71 -0.35 24.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.639 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.33 -1.1 . . . . 0.0 109.01 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.693 HD12 ' NE2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 122.654 1.216 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -103.28 -176.37 3.07 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.558 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' SER . 7.5 tt0 -50.3 -179.85 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.125 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' CB ' ' NE2' ' A' ' 49' ' ' GLN . . . -81.1 104.92 11.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -74.83 133.44 76.22 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.47 130.2 21.8 Favored 'Trans proline' 0 C--N 1.292 -2.397 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -40.94 167.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.422 1.106 . . . . 0.0 111.786 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.639 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -149.88 -165.53 0.11 Allowed Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 30.1 Cg_endo -73.37 -19.05 22.58 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 108.581 -1.354 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.23 -45.87 13.35 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.153 -0.967 . . . . 0.0 108.572 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.688 HG21 ' HB3' ' A' ' 50' ' ' TYR . 3.2 mm -58.03 -54.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.482 ' C ' HG12 ' A' ' 25' ' ' VAL . 34.1 tp60 -58.97 -21.66 58.96 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.7 tt0 -75.14 -41.33 58.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 109.061 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.057 HG23 HG21 ' A' ' 99' ' ' VAL . 3.6 mt -60.5 -50.03 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.989 0.9 . . . . 0.0 108.791 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.733 HG22 HD12 ' A' ' 45' ' ' LEU . 11.1 p -65.03 -40.84 90.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 122.134 0.969 . . . . 0.0 108.893 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.712 ' N ' HG13 ' A' ' 25' ' ' VAL . 43.8 t0 -71.45 -13.24 61.76 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.7 mmtt -96.03 -11.26 26.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.045 HG21 HD21 ' A' ' 97' ' ' LEU . 16.9 m -121.88 -4.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 0.0 110.995 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 13.3 ttpt -47.95 -45.59 62.72 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.927 -1.108 . . . . 0.0 111.035 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.83 -36.89 4.19 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.473 1.449 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.1 mt-30 -71.52 -7.32 46.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.838 HD22 ' CE ' ' A' ' 95' ' ' MET . 8.8 mt -100.89 -34.86 9.62 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.612 -0.68 . . . . 0.0 109.867 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 20.2 mt-10 -52.6 -48.83 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.139 -0.976 . . . . 0.0 109.814 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' CA ' ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -86.71 -44.75 11.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.322 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 5.3 mmtt -42.81 -27.0 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 67.5 p -104.48 -72.57 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.953 . . . . 0.0 110.003 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.0 p30 149.55 38.3 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -164.23 -177.99 5.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.327 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.96 125.23 53.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 110.296 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 10.8 m-85 -103.12 169.5 8.52 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -129.25 -150.99 7.23 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.811 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.99 119.81 1.62 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.486 -1.008 . . . . 0.0 109.022 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 25' ' ' VAL . 62.8 mt -99.54 86.45 3.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.964 -1.085 . . . . 0.0 108.497 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.206 0.526 . . . . 0.0 110.332 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.753 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -47.28 115.28 1.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.054 -1.029 . . . . 0.0 109.493 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.603 HG12 ' HG3' ' A' ' 49' ' ' GLN . 1.5 t -94.08 -46.34 13.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HG3' HG12 ' A' ' 48' ' ' VAL . 5.8 mt-30 -146.26 173.55 12.14 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.169 -1.013 . . . . 0.0 108.964 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.688 ' HB3' HG21 ' A' ' 21' ' ' ILE . 18.1 p90 -168.34 138.15 2.48 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.946 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -106.08 130.44 53.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 p -83.27 -174.01 5.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.38 -0.825 . . . . 0.0 110.786 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.787 ' O ' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -164.69 152.1 11.51 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.675 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -125.77 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.941 -1.099 . . . . 0.0 110.594 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -165.46 -102.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.11 30.42 5.6 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 160.71 -109.27 0.39 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 53' ' ' GLN . 8.4 m -167.28 112.21 0.72 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.418 -1.048 . . . . 0.0 110.856 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.636 ' HB2' ' HB3' ' A' ' 53' ' ' GLN . 45.6 m-80 -72.38 -165.95 0.23 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CD1' HG12 ' A' ' 99' ' ' VAL . 44.7 m-85 -156.02 160.23 39.84 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.672 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 125' ' ' PHE . 26.7 m-85 -144.45 134.85 24.49 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.737 HG22 HG13 ' A' ' 64' ' ' VAL . 15.3 mt -151.41 125.26 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 116.828 -1.949 . . . . 0.0 111.405 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.701 ' CG ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -94.6 91.25 6.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 47' ' ' ALA . 34.4 m -98.77 140.43 18.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 O-C-N 121.857 -0.527 . . . . 0.0 110.317 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.649 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 ttp180 -68.12 138.3 55.61 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.702 -1.249 . . . . 0.0 107.943 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.2 46.63 1.4 Allowed 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 122.269 1.033 . . . . 0.0 108.412 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.54 -77.93 1.69 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' CD ' ' A' ' 65' ' ' ARG . 3.8 t0 -61.1 -155.77 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.274 -1.133 . . . . 0.0 109.236 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -83.22 -3.67 57.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 109.366 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.575 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -75.31 178.48 5.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.21 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.649 ' CD2' ' HA ' ' A' ' 65' ' ' ARG . 33.7 m-85 -150.76 165.89 32.11 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.038 -1.039 . . . . 0.0 109.55 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.838 ' CE ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -146.41 126.07 13.38 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 108.703 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.72 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.7 m170 -74.76 151.3 39.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.045 HD21 HG21 ' A' ' 28' ' ' VAL . 15.6 tp -138.48 133.75 33.1 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.852 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.532 ' CD ' ' OG1' ' A' ' 111' ' ' THR . 0.1 OUTLIER -115.6 124.17 50.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.057 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -129.42 166.53 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.612 -1.305 . . . . 0.0 108.698 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.691 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.8 t80 -131.06 136.0 48.06 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.844 -1.16 . . . . 0.0 109.195 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.621 ' CG ' HD11 ' A' ' 108' ' ' LEU . 6.1 tttt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.693 HD23 HG11 ' A' ' 99' ' ' VAL . 10.6 mp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 122.36 1.076 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.795 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.3 p -145.45 164.56 11.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.499 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 97' ' ' LEU . 9.1 tp -102.35 86.88 2.9 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.532 ' OG1' ' CD ' ' A' ' 98' ' ' LYS . 2.2 p -70.38 -29.82 66.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 0.0 111.625 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.599 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -165.88 -162.85 18.14 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.865 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.756 ' CG ' HD21 ' A' ' 32' ' ' LEU . 19.1 p90 165.77 134.68 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.357 -1.084 . . . . 0.0 109.168 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.632 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.9 mm-40 -97.51 102.14 13.83 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.626 HG23 ' HE3' ' A' ' 95' ' ' MET . 0.6 OUTLIER -68.17 159.3 5.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.683 -1.26 . . . . 0.0 111.349 -177.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.7 t0 48.73 31.44 3.07 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.523 ' HD3' ' CB ' ' A' ' 114' ' ' GLN . 2.5 mptt -93.95 114.34 26.53 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.504 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 13.0 m-80 -69.11 -169.18 0.17 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.867 . . . . 0.0 110.062 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -44.45 40.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.454 -0.779 . . . . 0.0 109.442 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -50.9 -21.09 1.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -73.12 127.3 32.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.146 -0.971 . . . . 0.0 110.05 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 123' ' ' THR . 22.4 tt0 -93.63 136.12 34.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.72 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.5 mp -64.2 -32.12 73.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 108.664 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 43.81 -160.31 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.136 178.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.553 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -62.36 89.2 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.634 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.89 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.949 0.88 . . . . 0.0 111.28 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.9 m -101.73 167.81 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.0 tt0 -49.28 179.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.319 -0.863 . . . . 0.0 109.458 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.527 ' CB ' ' OE1' ' A' ' 49' ' ' GLN . . . -73.3 96.21 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 0.0 110.297 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 3.1 mmpt? -69.66 131.82 89.46 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.93 124.89 13.31 Favored 'Trans proline' 0 C--N 1.291 -2.466 0 N-CA-C 109.164 -1.129 . . . . 0.0 109.164 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.721 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -47.59 123.29 5.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.902 0.858 . . . . 0.0 111.763 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.609 ' OG1' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -95.69 -172.75 0.3 Allowed Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 27.8 Cg_endo -67.82 -20.06 46.12 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 N-CA-C 109.786 -0.89 . . . . 0.0 109.786 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.58 -34.76 30.83 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.981 -1.074 . . . . 0.0 108.777 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.891 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -69.28 -46.8 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.529 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -69.57 -13.44 62.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.2 tt0 -76.56 -40.16 50.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.984 HG23 HG21 ' A' ' 99' ' ' VAL . 5.3 mt -60.76 -51.5 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.802 HG21 HG11 ' A' ' 64' ' ' VAL . 12.4 p -64.38 -42.06 94.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.981 0.895 . . . . 0.0 108.81 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.712 ' N ' HG13 ' A' ' 25' ' ' VAL . 43.3 t0 -68.84 -14.92 63.33 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -93.37 -15.16 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.198 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.747 ' O ' HD12 ' A' ' 32' ' ' LEU . 31.6 m -119.85 -0.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.872 . . . . 0.0 110.557 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 7.7 ttpp -50.82 -44.62 85.84 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.847 -1.158 . . . . 0.0 110.361 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.3 Cg_endo -73.86 -34.23 5.5 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.155 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.8 mt-30 -74.52 -5.52 43.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.857 HD11 HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.43 -35.84 9.43 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.519 -0.738 . . . . 0.0 109.488 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -72.37 -29.33 63.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.462 -0.774 . . . . 0.0 110.881 -179.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.43 -17.73 17.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.889 -1.132 . . . . 0.0 110.464 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 22.8 ttmt -78.34 -61.74 1.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.995 -1.066 . . . . 0.0 109.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.749 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -72.98 -19.33 61.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.846 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.5 OUTLIER 85.75 11.83 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.65 -0.657 . . . . 0.0 109.517 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' H ' HG23 ' A' ' 36' ' ' THR . 7.9 tt0 -109.17 138.86 44.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -76.44 125.63 29.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.124 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.659 ' OH ' HG21 ' A' ' 36' ' ' THR . 31.9 m-85 -112.77 179.76 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 108.948 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -144.68 -164.43 10.56 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.05 123.78 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -1.111 . . . . 0.0 108.836 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.65 HD12 HG22 ' A' ' 25' ' ' VAL . 46.3 mt -102.49 91.37 4.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.849 -1.157 . . . . 0.0 108.372 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -72.01 82.85 0.96 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.898 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -40.17 134.68 1.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.116 0.96 . . . . 0.0 110.005 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.683 HG12 ' HG3' ' A' ' 49' ' ' GLN . 2.0 t -118.45 -42.14 2.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.683 ' HG3' HG12 ' A' ' 48' ' ' VAL . 2.4 mt-30 -142.72 171.71 13.69 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.891 ' HB3' HG21 ' A' ' 21' ' ' ILE . 18.4 p90 -170.82 136.48 1.17 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 3.8 mttt -109.11 157.41 18.76 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.353 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.421 HG22 ' HD1' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -138.93 140.2 38.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.373 -0.829 . . . . 0.0 109.162 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.592 ' HG2' ' CE1' ' A' ' 61' ' ' TYR . 0.9 OUTLIER -138.29 174.31 10.69 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.561 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.824 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -113.4 158.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.718 -1.239 . . . . 0.0 110.933 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.67 -101.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 27.26 6.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.69 -119.94 0.99 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 106.202 -2.759 . . . . 0.0 106.202 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 53' ' ' GLN . 19.1 m -151.68 109.31 3.63 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.038 -1.272 . . . . 0.0 110.542 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.721 ' ND2' HG21 ' A' ' 55' ' ' VAL . 64.4 m-80 -72.85 -171.09 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.2 m-85 -144.44 158.63 43.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.918 0.866 . . . . 0.0 108.988 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.62 ' CE2' HD21 ' A' ' 11' ' ' LEU . 2.1 m-85 -138.73 139.99 38.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.948 HD12 HD23 ' A' ' 97' ' ' LEU . 13.2 mt -154.7 123.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 116.72 -1.992 . . . . 0.0 112.06 -176.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.505 ' HE3' ' CA ' ' A' ' 118' ' ' LYS . 15.9 tttt -93.06 92.44 7.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.898 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.1 m -98.91 143.27 13.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.587 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 3.9 mtm180 -67.67 131.28 45.3 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -85.35 44.65 1.11 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.986 0.898 . . . . 0.0 109.445 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 96.69 -113.12 4.6 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.5 p30 -49.84 -104.43 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -1.031 . . . . 0.0 110.655 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -119.66 -1.9 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.945 -1.097 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.1 mptp? -68.47 -177.93 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.53 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 8.2 m-85 -146.12 166.82 25.02 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.879 -1.138 . . . . 0.0 109.727 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.646 ' O ' HG22 ' A' ' 64' ' ' VAL . 49.0 ttp -151.73 111.31 3.98 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.485 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.751 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -69.6 147.6 50.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.125 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.948 HD23 HD12 ' A' ' 62' ' ' ILE . 13.2 tp -128.52 153.02 47.61 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.246 -0.909 . . . . 0.0 110.71 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.556 ' C ' ' HG1' ' A' ' 111' ' ' THR . 2.6 tttm -143.09 102.32 3.98 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.984 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -112.95 160.39 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.762 -1.211 . . . . 0.0 109.404 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.74 ' HB2' HG21 ' A' ' 111' ' ' THR . 9.3 t80 -120.37 137.9 54.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.47 -1.394 . . . . 0.0 108.408 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 108' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 122.015 0.912 . . . . 0.0 109.317 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 122.259 1.028 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.2 p -153.7 163.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.79 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 6.7 tp -99.6 84.1 2.89 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.74 HG21 ' HB2' ' A' ' 100' ' ' PHE . 16.8 p -69.02 -15.75 63.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 111.504 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 174.68 -167.52 39.8 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.59 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 30.1 p90 170.99 137.54 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.645 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -98.04 102.66 14.47 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.532 HG23 ' OH ' ' A' ' 40' ' ' TYR . 9.9 p -67.99 158.47 5.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.131 -0.98 . . . . 0.0 111.195 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.5 t70 45.92 27.99 0.55 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 7.6 mmtm -101.01 129.76 46.9 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 120.676 -1.265 . . . . 0.0 108.48 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 2.4 m120 -105.65 -156.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 111.054 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' CA ' ' HE3' ' A' ' 63' ' ' LYS . 1.5 ttpm? -58.73 -45.41 89.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.699 -0.626 . . . . 0.0 109.981 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.21 -22.88 0.44 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.504 ' OD1' ' CE ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -89.0 122.52 32.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 110.993 -179.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.698 ' O ' HG23 ' A' ' 123' ' ' THR . 0.3 OUTLIER -94.99 132.79 39.45 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.751 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 2.2 mp -60.76 -55.92 27.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.782 -1.199 . . . . 0.0 109.344 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.743 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 56.7 -163.79 0.16 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.802 -1.186 . . . . 0.0 110.031 177.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.89 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -50.52 -14.98 1.08 Allowed Glycine 0 N--CA 1.501 3.022 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.645 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 120.859 -1.377 . . . . 0.0 109.113 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 121.916 0.865 . . . . 0.0 112.534 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -101.06 160.41 14.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 41.5 tt0 -46.76 173.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB1' ' CG ' ' A' ' 49' ' ' GLN . . . -59.85 95.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.875 -1.14 . . . . 0.0 109.871 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.608 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -69.68 130.31 90.5 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.1 Cg_endo -67.64 126.14 14.32 Favored 'Trans proline' 0 C--N 1.288 -2.608 0 N-CA-C 108.772 -1.28 . . . . 0.0 108.772 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.573 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -40.66 156.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.289 1.042 . . . . 0.0 111.468 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.648 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -135.05 -168.38 0.18 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.648 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.35 -18.11 30.22 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 N-CA-C 109.177 -1.124 . . . . 0.0 109.177 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -82.96 -47.37 11.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.046 -1.034 . . . . 0.0 108.435 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.809 HG21 ' HB3' ' A' ' 50' ' ' TYR . 6.7 mm -56.8 -54.72 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.573 ' NE2' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -53.97 -26.95 28.45 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.81 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 4.2 tp10 -76.77 -35.2 57.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.083 . . . . 0.0 110.155 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.971 HG23 HG21 ' A' ' 99' ' ' VAL . 3.5 mt -66.19 -49.95 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.887 HG21 HG11 ' A' ' 64' ' ' VAL . 12.8 p -66.18 -41.3 89.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 122.279 1.038 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.702 ' N ' HG13 ' A' ' 25' ' ' VAL . 12.5 t70 -74.98 -14.17 60.59 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 30.8 ttmt -93.36 -10.96 33.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.994 HG21 HD21 ' A' ' 97' ' ' LEU . 15.5 m -117.78 -5.31 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 110.653 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 4.5 ttpm? -42.72 -48.65 13.51 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.891 -1.131 . . . . 0.0 110.661 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 29.3 Cg_endo -69.65 -33.89 16.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.294 1.329 . . . . 0.0 109.799 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' O ' HD23 ' A' ' 110' ' ' LEU . 25.4 mt-30 -74.92 -5.01 41.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.996 HD11 ' CD1' ' A' ' 97' ' ' LEU . 5.4 mt -97.67 -38.07 9.66 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.593 -0.692 . . . . 0.0 109.705 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 39' ' ' THR . 35.5 mt-10 -65.34 -26.46 68.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.503 -0.748 . . . . 0.0 109.645 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.39 -40.74 11.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HG2' ' OH ' ' A' ' 113' ' ' TYR . 12.0 tttt -75.19 -8.07 55.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 32' ' ' LEU . 9.9 p -123.03 -48.31 2.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.608 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER 104.48 32.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.189 0.519 . . . . 0.0 109.724 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 5.1 mt-10 -130.42 145.08 51.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.265 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.6 m -75.17 -10.36 59.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.107 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.722 ' CD2' ' HE1' ' A' ' 95' ' ' MET . 25.7 m-85 36.71 -163.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.76 0.79 . . . . 0.0 110.61 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -162.97 -167.71 23.8 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.73 126.22 3.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -1.108 . . . . 0.0 108.787 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.671 ' HB2' HG22 ' A' ' 25' ' ' VAL . 41.4 mt -100.17 71.62 1.61 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 108.082 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 19.1 mt-10 -53.31 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.883 -0.51 . . . . 0.0 109.962 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -44.28 143.06 1.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.104 0.955 . . . . 0.0 109.589 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.9 -41.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.548 ' HB2' ' CD ' ' A' ' 63' ' ' LYS . 12.5 mt-30 -147.9 171.89 15.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.809 ' HB3' HG21 ' A' ' 21' ' ' ILE . 14.5 p90 -171.18 137.09 1.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.88 -1.138 . . . . 0.0 110.648 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.502 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -108.64 119.41 39.45 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 p -71.7 176.46 4.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.34 -0.85 . . . . 0.0 109.853 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.861 ' O ' HG23 ' A' ' 58' ' ' THR . 2.4 mm100 -152.34 148.25 27.28 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -129.73 137.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.942 -1.099 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -165.67 -102.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.67 28.49 5.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.48 -121.7 1.04 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 106.856 -2.498 . . . . 0.0 106.856 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.861 HG23 ' O ' ' A' ' 53' ' ' GLN . 23.1 m -159.52 104.91 1.63 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.087 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.625 HD21 HG21 ' A' ' 55' ' ' VAL . 48.3 m-80 -70.04 -178.45 1.61 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.1 m-85 -141.44 153.68 45.13 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.098 -1.001 . . . . 0.0 109.256 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 23.3 m-30 -133.76 135.53 43.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.74 HG22 HG13 ' A' ' 64' ' ' VAL . 30.5 mt -153.91 129.99 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 116.774 -1.97 . . . . 0.0 112.408 -176.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.947 ' HG2' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.22 102.79 14.17 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -109.7 139.99 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.46 -0.775 . . . . 0.0 110.825 -176.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -67.32 126.87 30.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.99 45.06 1.05 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.91 0.862 . . . . 0.0 109.646 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 85.36 -98.07 2.22 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -56.69 -157.39 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.378 -1.072 . . . . 0.0 109.612 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -71.83 -6.62 42.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 109.476 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -69.85 164.31 23.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 109.085 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.507 ' OH ' ' HD2' ' A' ' 65' ' ' ARG . 11.7 m-85 -136.77 169.87 17.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.733 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.722 ' HE1' ' CD2' ' A' ' 40' ' ' TYR . 20.8 ttm -154.93 113.31 3.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.038 -1.038 . . . . 0.0 109.659 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.723 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.3 m170 -74.31 156.9 36.65 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.996 ' CD1' HD11 ' A' ' 32' ' ' LEU . 1.4 tp -148.96 139.85 22.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.698 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.1 tttt -121.63 107.25 12.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.971 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -107.24 162.08 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.729 -1.232 . . . . 0.0 109.712 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.708 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 10.5 t80 -124.15 133.03 53.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.536 -1.352 . . . . 0.0 108.681 177.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.341 0 CA-C-O 121.838 0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' A' ' 108' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 122.087 0.946 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 99' ' ' VAL . 13.6 p -151.98 164.76 2.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.737 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 97' ' ' LEU . 4.6 tp -101.67 83.76 2.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.577 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -72.84 -12.79 61.12 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.023 -1.048 . . . . 0.0 112.054 -176.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.688 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -176.34 -167.48 35.13 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.066 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.602 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 30.2 p90 164.66 137.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.613 -0.933 . . . . 0.0 108.975 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.663 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.8 mm-40 -100.14 97.19 8.04 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.531 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 5.3 p -67.56 163.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.987 -1.071 . . . . 0.0 111.034 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' A ASP . . . . . 0.435 ' N ' HG22 ' A' ' 115' ' ' VAL . 3.9 t0 48.92 26.64 1.38 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.045 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.555 ' HG2' ' N ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -67.73 -166.27 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.779 -1.201 . . . . 0.0 108.463 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.536 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -149.51 -177.62 5.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.749 -1.22 . . . . 0.0 110.099 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -71.69 -34.09 69.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.419 -0.801 . . . . 0.0 109.267 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.03 -14.22 59.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.516 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 3.2 t0 -72.31 103.54 3.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.824 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.1 OUTLIER -87.92 146.24 25.65 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.947 HD11 ' HG2' ' A' ' 63' ' ' LYS . 1.9 mp -66.98 -40.0 87.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.553 -1.342 . . . . 0.0 108.302 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER 40.04 22.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.007 0.908 . . . . 0.0 110.905 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 121.73 116.99 2.45 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.663 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.505 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.902 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.92 0.866 . . . . 0.0 110.759 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 33.6 m -101.32 171.6 7.5 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tp10 -47.8 174.79 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.912 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.23 99.62 3.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.099 -1.0 . . . . 0.0 110.006 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 9.8 mmpt? -69.16 131.19 90.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -68.11 125.35 12.91 Favored 'Trans proline' 0 C--N 1.291 -2.494 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.624 ' HB1' ' CB ' ' A' ' 47' ' ' ALA . . . -48.21 148.66 1.75 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.441 1.115 . . . . 0.0 111.466 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.629 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -128.96 -169.33 0.19 Allowed Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 27.9 Cg_endo -69.09 -17.67 40.49 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 N-CA-C 109.796 -0.886 . . . . 0.0 109.796 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.506 ' HG3' HD13 ' A' ' 21' ' ' ILE . 15.3 pt-20 -82.03 -41.79 20.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.787 -1.196 . . . . 0.0 108.758 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.667 HG21 ' HB3' ' A' ' 50' ' ' TYR . 13.0 mm -63.54 -51.58 68.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.47 -19.23 61.79 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.8 tp10 -75.71 -35.18 60.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.847 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.007 HG23 HG21 ' A' ' 99' ' ' VAL . 5.4 mt -64.99 -52.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.761 HG21 HG11 ' A' ' 64' ' ' VAL . 7.1 p -61.41 -42.57 94.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.722 ' N ' HG13 ' A' ' 25' ' ' VAL . 32.5 t70 -72.75 -16.44 61.65 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 11.9 tptt -89.75 -11.6 41.78 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 97' ' ' LEU . 18.3 m -116.08 -8.72 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.447 -0.783 . . . . 0.0 109.802 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 11.3 ttpp -51.95 -44.13 90.9 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.837 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.77 -29.05 13.06 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.451 1.434 . . . . 0.0 110.016 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -80.69 -11.87 59.56 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.986 HD11 HD11 ' A' ' 97' ' ' LEU . 6.4 mt -93.65 -35.25 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.503 0.668 . . . . 0.0 109.762 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 30.3 mt-10 -58.74 -46.05 88.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.77 -51.12 6.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 109.961 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -49.77 -58.32 5.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 108.497 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.749 HG21 ' OH ' ' A' ' 40' ' ' TYR . 1.4 m -68.97 -60.52 2.31 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.539 -0.726 . . . . 0.0 109.512 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER 119.48 41.6 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 73.0 mm-40 -130.4 -166.73 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.888 . . . . 0.0 110.017 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 39' ' ' THR . 94.5 m -129.05 26.15 5.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.813 -0.554 . . . . 0.0 109.516 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.749 ' OH ' HG21 ' A' ' 36' ' ' THR . 11.5 m-85 -29.06 147.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.72 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -117.38 -135.52 5.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -54.65 126.29 23.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.336 -1.097 . . . . 0.0 110.078 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.633 HD12 HG22 ' A' ' 25' ' ' VAL . 28.8 mt -107.56 74.47 0.96 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -54.83 85.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.313 0.577 . . . . 0.0 110.495 -178.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.903 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -46.22 124.73 5.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.26 1.028 . . . . 0.0 109.754 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.486 HG12 ' HG2' ' A' ' 49' ' ' GLN . 1.9 t -101.56 -44.68 10.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.554 ' CG ' ' HB3' ' A' ' 63' ' ' LYS . 9.2 pt20 -147.23 171.34 15.53 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.667 ' HB3' HG21 ' A' ' 21' ' ' ILE . 12.1 p90 -168.17 138.79 2.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 12' ' ' SER . 1.4 mttp -109.88 124.01 50.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 p -76.51 -178.14 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.307 -0.871 . . . . 0.0 110.148 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 58' ' ' THR . 2.3 mm100 -159.53 150.8 19.86 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.864 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.06 146.97 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 120.915 -1.116 . . . . 0.0 111.126 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.864 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -171.04 -103.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.57 29.14 6.79 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 164.54 -114.02 0.58 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 106.294 -2.722 . . . . 0.0 106.294 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 53' ' ' GLN . 28.8 m -166.92 113.72 0.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -1.157 . . . . 0.0 111.005 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.619 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 70.0 m-20 -73.51 -166.55 0.36 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.6 ' CD1' HG12 ' A' ' 99' ' ' VAL . 86.6 m-85 -154.44 153.75 32.06 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.632 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.628 ' C ' HD22 ' A' ' 122' ' ' LEU . 22.8 m-85 -138.04 130.41 29.14 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.824 HG22 HG13 ' A' ' 64' ' ' VAL . 11.7 mt -149.34 122.68 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 119.583 -1.948 . . . . 0.0 112.098 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 21.8 ttpt -92.16 95.53 9.8 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 47' ' ' ALA . 14.6 m -101.9 140.06 21.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.64 127.0 31.47 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.98 45.11 1.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.928 0.871 . . . . 0.0 109.615 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 99.37 -122.88 7.72 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' GLY . 16.8 t70 -43.26 -101.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.939 . . . . 0.0 111.37 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.3 m120 -120.02 -4.27 10.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.6 mttt -69.47 179.17 2.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 108.624 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 30.3 m-85 -146.52 168.25 21.69 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.026 -1.046 . . . . 0.0 109.94 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.748 ' O ' HG22 ' A' ' 64' ' ' VAL . 18.9 mtp -154.87 115.43 3.9 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.695 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -73.69 137.58 44.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.986 HD11 HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -125.17 123.26 39.25 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.497 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -108.68 121.65 45.47 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.007 HG21 HG23 ' A' ' 24' ' ' ILE . 2.5 t -125.27 166.26 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.59 -1.319 . . . . 0.0 109.445 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.702 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 10.0 t80 -125.08 136.45 53.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.987 -1.071 . . . . 0.0 108.201 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.598 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.929 0.871 . . . . 0.0 109.872 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 108' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 122.251 1.025 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.728 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.7 p -139.27 162.36 27.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.715 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 18.6 tp -99.31 88.09 3.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 100' ' ' PHE . 14.7 p -71.53 -29.71 65.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 111.85 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . -168.94 -163.31 22.75 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.337 -1.411 . . . . 0.0 109.85 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.579 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 20.5 p90 166.48 135.64 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.41 -1.053 . . . . 0.0 109.854 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.4 mm-40 -95.48 95.4 8.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 115' A ASP . 6.3 p -67.51 160.15 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.092 -1.005 . . . . 0.0 110.57 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' A ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 115' ' ' VAL . 21.2 t0 43.2 28.37 0.16 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.304 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.59 ' HG3' ' CB ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -82.26 160.96 22.83 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.701 -1.249 . . . . 0.0 107.807 179.207 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.87 -170.91 1.91 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.756 -1.215 . . . . 0.0 110.888 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 18.9 mttt -68.47 -69.64 0.31 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.713 -0.617 . . . . 0.0 110.657 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -40.8 -26.91 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.347 -0.846 . . . . 0.0 110.292 -179.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 96' ' ' HIS . 14.8 t70 -47.43 109.88 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.027 . . . . 0.0 110.733 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.553 ' O ' ' CG2' ' A' ' 123' ' ' THR . 74.8 tt0 -84.3 136.91 33.72 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 62' ' ' ILE . 2.6 mp -67.27 -32.38 73.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.904 -1.122 . . . . 0.0 108.741 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.62 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 45.36 -167.02 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.038 0.923 . . . . 0.0 110.499 177.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.902 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -43.35 -21.57 0.16 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.676 0 O-C-N 121.213 -1.169 . . . . 0.0 109.079 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.413 ' O ' HG23 ' A' ' 7' ' ' ILE . 34.5 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 6' ' ' MET . 0.4 OUTLIER -154.21 77.78 5.43 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.226 -0.922 . . . . 0.0 109.598 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.85 101.17 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.573 2.182 . . . . 0.0 110.596 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.42 172.07 28.59 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 85.53 135.98 3.77 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.821 HD22 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -37.91 108.06 0.07 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.521 -0.988 . . . . 0.0 111.47 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 3.8 m -102.78 -179.1 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.871 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -51.75 -177.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -92.23 110.71 22.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.098 -1.001 . . . . 0.0 110.74 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -76.93 138.25 65.71 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 175.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' ALA . 26.5 Cg_endo -64.44 131.84 31.31 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 109.152 -1.134 . . . . 0.0 109.152 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.603 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -41.67 167.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.511 1.148 . . . . 0.0 111.493 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.654 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -147.28 -167.43 0.15 Allowed Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.654 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.6 Cg_endo -73.13 -20.73 21.26 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 N-CA-C 108.471 -1.396 . . . . 0.0 108.471 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -39.93 22.95 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.219 -0.926 . . . . 0.0 108.688 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.741 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.7 mm -62.28 -54.83 29.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 23.5 tp60 -59.69 -19.44 49.76 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -76.2 -43.78 40.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.725 -1.234 . . . . 0.0 108.801 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.011 HG23 HG21 ' A' ' 99' ' ' VAL . 5.5 mt -55.48 -52.5 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.803 HG22 HD12 ' A' ' 45' ' ' LEU . 12.3 p -67.51 -39.98 83.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 122.028 0.918 . . . . 0.0 109.717 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.717 ' N ' HG13 ' A' ' 25' ' ' VAL . 25.6 t70 -70.71 -10.74 60.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -100.25 -18.07 17.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 97' ' ' LEU . 19.8 m -116.28 1.48 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.514 -0.741 . . . . 0.0 110.397 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.641 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.56 -39.84 79.79 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.989 -1.069 . . . . 0.0 109.736 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 29' ' ' LYS . 33.7 Cg_endo -77.55 -35.37 1.58 Allowed 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 108.172 -1.511 . . . . 0.0 108.172 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' LYS . 26.8 mt-30 -66.78 -15.32 63.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.72 HD11 HD11 ' A' ' 97' ' ' LEU . 4.6 mt -89.92 -34.27 16.11 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.555 0.693 . . . . 0.0 109.535 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.639 ' HG2' HG23 ' A' ' 39' ' ' THR . 0.7 OUTLIER -55.14 -55.19 33.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 110.41 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.18 -8.52 50.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 31' ' ' GLN . 3.3 tttp -91.23 5.38 49.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.778 -1.201 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 32' ' ' LEU . 9.7 p -131.61 -56.8 1.0 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 36' ' ' THR . 45.8 p30 134.15 20.54 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -149.65 -177.82 6.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.87 -1.144 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.639 HG23 ' HG2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -117.72 118.68 32.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' HE1' HG23 ' A' ' 115' ' ' VAL . 74.0 m-85 -90.88 178.99 5.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 108.936 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -130.5 -168.04 12.16 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -37.47 127.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.926 . . . . 0.0 109.283 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.803 HD12 HG22 ' A' ' 25' ' ' VAL . 59.2 mt -102.97 79.99 1.82 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.059 -1.026 . . . . 0.0 108.704 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 1.3 mt-10 -61.8 85.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.145 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.799 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -43.64 145.9 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.235 1.017 . . . . 0.0 109.998 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.78 -44.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HG2' ' HB3' ' A' ' 63' ' ' LYS . 2.4 pt20 -151.57 169.53 21.89 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.741 ' HB3' HG21 ' A' ' 21' ' ' ILE . 14.1 p90 -163.12 133.56 4.54 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.055 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HD2' ' HB2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -99.01 126.53 44.73 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.51 145.07 45.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.272 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.693 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -144.47 177.73 8.45 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.834 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.07 158.93 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 111.563 -178.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.97 -102.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.49 28.46 5.04 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.1 -110.34 0.44 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 53' ' ' GLN . 86.5 m -165.67 109.59 0.83 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.367 -1.078 . . . . 0.0 110.76 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.704 HD21 HG21 ' A' ' 55' ' ' VAL . 70.2 m-80 -69.57 -176.44 1.01 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CD1' HG12 ' A' ' 99' ' ' VAL . 78.6 m-85 -149.54 151.61 34.17 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.472 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.64 ' HB3' HD22 ' A' ' 122' ' ' LEU . 8.3 m-85 -138.04 132.55 32.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.645 HG12 HG23 ' A' ' 21' ' ' ILE . 13.6 mt -150.77 115.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 116.847 -1.941 . . . . 0.0 111.683 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.628 ' HB2' HD11 ' A' ' 122' ' ' LEU . 1.4 ttmp? -81.02 103.11 10.62 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.799 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -109.39 138.5 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.942 -176.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -68.11 127.18 31.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.08 46.07 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.044 0.926 . . . . 0.0 109.125 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 78.55 -93.84 1.26 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 22.6 p-10 -56.01 -163.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.187 -1.184 . . . . 0.0 109.563 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.45 -10.84 59.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.05 159.42 33.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 109.045 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.607 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 30.3 m-85 -129.35 176.21 8.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.7 ttp -155.76 113.22 3.29 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 109.561 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.853 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -69.83 151.72 45.4 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 28' ' ' VAL . 11.0 tp -132.8 142.66 49.1 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 111.025 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -132.41 102.77 5.87 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.011 HG21 HG23 ' A' ' 24' ' ' ILE . 2.3 t -110.35 161.41 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.346 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.81 ' HB2' HG21 ' A' ' 111' ' ' THR . 6.7 t80 -123.77 135.92 54.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.2 . . . . 0.0 108.28 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.634 ' HG2' HD11 ' A' ' 108' ' ' LEU . 1.9 tmtt? -96.77 122.71 40.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.529 ' O ' ' O ' ' A' ' 102' A LEU . 74.2 m -102.27 46.19 0.94 Allowed 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.616 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 102' ' ' SER . 0.6 OUTLIER 51.95 166.31 0.04 OUTLIER Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 121.115 -0.991 . . . . 0.0 110.559 178.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 102' A LEU . 35.0 Cg_endo -76.46 117.05 4.46 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.257 1.971 . . . . 0.0 110.378 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.28 34.03 0.77 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 105' A ASN . 25.4 mt-30 50.99 -149.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -1.181 . . . . 0.0 109.623 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' A ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 105' ' ' GLN . 7.0 m120 39.64 -153.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 110.134 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -58.66 159.62 6.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.865 . . . . 0.0 109.551 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -145.7 147.36 31.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.935 . . . . 0.0 109.874 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.634 HD11 ' HG2' ' A' ' 101' ' ' LYS . 8.0 mp 49.82 170.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.698 1.237 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.723 HG13 HG23 ' A' ' 111' ' ' THR . 14.7 p -156.91 163.39 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.71 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.64 HD11 ' O ' ' A' ' 112' ' ' GLY . 10.3 tp -98.9 83.37 2.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.81 HG21 ' HB2' ' A' ' 100' ' ' PHE . 17.2 p -69.49 -11.77 61.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.965 . . . . 0.0 111.249 -176.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.64 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 173.81 -165.96 37.98 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.83 -1.652 . . . . 0.0 110.929 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.59 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 29.6 p90 167.76 135.57 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.672 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.6 mm-40 -96.19 96.67 8.97 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.473 HG23 ' HE1' ' A' ' 40' ' ' TYR . 8.5 p -67.72 157.03 6.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.836 -1.165 . . . . 0.0 110.19 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' A ASP . . . . . . . . . . . . . 1.5 t0 51.56 21.15 1.21 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.1 OUTLIER -83.11 131.18 35.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.672 -1.268 . . . . 0.0 108.044 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.36 178.59 7.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.297 -0.877 . . . . 0.0 111.45 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 119' ' ' ASP . 10.2 tmtt? -61.51 -50.01 74.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.188 0.518 . . . . 0.0 110.197 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 118' ' ' LYS . 41.6 t0 -43.29 -26.43 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.179 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.459 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -69.45 93.3 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.358 -0.839 . . . . 0.0 110.321 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 123' ' ' THR . 2.3 tt0 -68.15 141.99 55.87 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.853 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -64.17 -35.65 81.48 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.364 -1.46 . . . . 0.0 110.27 -178.064 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.715 ' O ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER 49.48 -149.73 0.22 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.821 ' HA2' HD22 ' A' ' 11' ' ' LEU . . . -48.82 -99.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 104.41 -3.476 . . . . 0.0 104.41 175.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.672 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 23.5 t80 . . . . . 0 C--N 1.29 -1.979 0 O-C-N 119.237 -2.331 . . . . 0.0 108.138 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.342 0.592 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 mt -48.94 119.19 8.17 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.526 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' GLY . 36.4 Cg_endo -77.48 160.06 32.15 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.358 2.039 . . . . 0.0 110.462 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . 51.03 -179.39 0.04 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -85.72 1.29 88.14 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.13 -1.217 . . . . 0.0 110.16 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.802 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -35.1 108.0 0.06 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 122.206 1.003 . . . . 0.0 111.504 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -102.28 179.25 4.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.675 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.323 -0.861 . . . . 0.0 109.031 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -91.47 101.02 13.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.789 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -70.93 141.07 86.51 Favored Pre-proline 0 C--N 1.294 -1.825 0 N-CA-C 103.236 -2.876 . . . . 0.0 103.236 175.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -68.02 126.63 14.76 Favored 'Trans proline' 0 C--N 1.29 -2.535 0 N-CA-C 109.531 -0.988 . . . . 0.0 109.531 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.623 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -42.59 147.86 0.26 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.42 1.105 . . . . 0.0 111.994 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.646 HG23 HG12 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -122.3 -168.44 0.13 Allowed Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -71.56 -20.01 27.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 109.202 -1.115 . . . . 0.0 109.202 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -82.5 -43.97 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -0.999 . . . . 0.0 108.663 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.698 HG21 ' HB3' ' A' ' 50' ' ' TYR . 7.6 mm -58.81 -52.09 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.558 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -64.46 -18.22 64.56 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 28.8 tp10 -76.47 -31.24 57.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.597 -1.315 . . . . 0.0 108.525 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.015 HG23 HG21 ' A' ' 99' ' ' VAL . 5.4 mt -69.36 -50.66 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.754 HG21 HG11 ' A' ' 64' ' ' VAL . 7.3 p -62.48 -43.44 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-O 122.089 0.947 . . . . 0.0 109.358 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.733 ' N ' HG13 ' A' ' 25' ' ' VAL . 21.4 t70 -74.4 -18.92 60.59 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.21 -12.76 56.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.613 HG11 ' CG2' ' A' ' 99' ' ' VAL . 27.7 m -116.59 -8.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.476 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.9 ttpp -42.25 -49.99 11.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 110.389 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.25 -34.75 7.54 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.535 1.49 . . . . 0.0 110.006 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' HD23 ' A' ' 110' ' ' LEU . 29.6 mt-30 -78.84 0.07 28.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.206 -0.934 . . . . 0.0 108.592 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.067 ' O ' HG22 ' A' ' 36' ' ' THR . 3.2 mt -100.26 -41.23 7.16 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.444 -0.785 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 48.5 mt-10 -59.37 -44.38 92.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.5 -46.62 89.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.474 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB3' ' OH ' ' A' ' 113' ' ' TYR . 1.2 mmtp -71.11 -66.1 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 110.019 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 1.067 HG22 ' O ' ' A' ' 32' ' ' LEU . 9.4 t -70.12 -0.68 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.392 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 2.7 p-10 40.91 48.2 2.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.158 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.514 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -119.19 172.22 7.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.283 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' TYR . 5.9 t -80.91 -29.78 35.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 0.0 109.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.947 ' CZ ' HG21 ' A' ' 36' ' ' THR . 4.9 m-30 40.31 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.529 0.681 . . . . 0.0 110.256 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 168.6 -163.39 37.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.1 118.26 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.488 -1.007 . . . . 0.0 109.443 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.71 ' HB3' HG11 ' A' ' 64' ' ' VAL . 36.5 mt -100.47 86.04 3.08 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.142 . . . . 0.0 108.073 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 47' ' ' ALA . 63.4 mt-10 -69.83 83.74 0.47 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -0.763 . . . . 0.0 110.063 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.799 ' N ' HG13 ' A' ' 64' ' ' VAL . . . -41.11 145.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.148 0.975 . . . . 0.0 110.25 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -122.02 -44.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.863 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 42.2 mt-30 -149.45 170.08 19.4 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.698 ' HB3' HG21 ' A' ' 21' ' ' ILE . 17.5 p90 -164.45 138.19 5.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.196 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 35.3 mttt -108.93 125.32 51.9 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.2 p -76.4 175.74 8.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 109.785 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.902 ' O ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -150.6 154.53 37.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 0.0 109.358 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.84 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -128.31 141.72 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.025 -1.047 . . . . 0.0 110.303 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -170.49 -101.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.73 30.17 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 157.9 -110.91 0.46 Allowed Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.902 HG23 ' O ' ' A' ' 53' ' ' GLN . 29.6 m -165.17 108.22 0.84 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.364 -1.08 . . . . 0.0 110.913 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.618 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 76.0 m-20 -71.37 -170.44 0.5 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.618 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 19.6 m-85 -143.55 154.95 44.13 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.468 -0.77 . . . . 0.0 109.586 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.856 ' HB3' HD22 ' A' ' 122' ' ' LEU . 21.2 m-85 -137.21 133.5 35.22 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.774 HG22 ' CG2' ' A' ' 64' ' ' VAL . 12.9 mt -149.11 114.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 117.004 -1.878 . . . . 0.0 111.442 -177.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 96' ' ' HIS . 19.2 ttpt -81.09 99.23 8.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.799 HG13 ' N ' ' A' ' 47' ' ' ALA . 38.2 t -109.13 144.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.37 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.4 mmm180 -69.71 132.93 46.9 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.13 44.9 1.17 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.976 0.893 . . . . 0.0 108.951 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 84.67 -92.79 1.76 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' GLY . 10.5 p-10 -60.68 -140.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.258 -1.142 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.64 -7.98 57.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.958 -1.089 . . . . 0.0 109.994 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.485 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -69.45 178.36 2.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 108.692 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.578 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 25.6 m-85 -142.78 179.06 7.22 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.06 -1.025 . . . . 0.0 109.285 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 1.037 ' HE1' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.76 114.02 1.11 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.462 -179.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.707 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.3 m170 -71.65 140.94 49.9 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.056 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -124.84 133.99 52.9 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.511 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -121.71 113.9 20.36 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.015 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -119.89 159.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.777 -1.202 . . . . 0.0 109.684 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.717 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 4.2 t80 -121.67 130.77 53.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.592 -1.318 . . . . 0.0 108.173 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.531 ' HE2' ' HB ' ' A' ' 58' ' ' THR . 2.5 pttt -107.08 160.59 15.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 102' A LEU . 12.1 t -100.81 89.77 3.99 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.109 -0.994 . . . . 0.0 110.289 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 1.3 mt 52.66 167.05 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.787 -0.571 . . . . 0.0 110.576 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 102' A LEU . 33.9 Cg_endo -76.29 169.47 21.92 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.339 2.026 . . . . 0.0 110.446 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.5 -72.97 0.45 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -155.81 -179.63 8.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -1.074 . . . . 0.0 109.212 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' A ASN . . . . . . . . . . . . . 2.4 m-80 -80.68 102.29 9.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.934 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.522 ' O ' HD13 ' A' ' 108' ' ' LEU . 2.2 pp20? -98.59 -166.73 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.438 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -71.49 83.44 0.82 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.381 -0.824 . . . . 0.0 110.456 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.3 mp -63.53 -174.5 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.086 0.945 . . . . 0.0 109.467 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.717 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 12.1 p -147.65 161.23 7.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.808 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.629 HD13 HD11 ' A' ' 97' ' ' LEU . 18.1 tp -97.81 87.94 4.16 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -75.57 -8.76 57.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 111.87 -176.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . 174.01 -168.27 41.03 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.625 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.606 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 31.4 p90 165.84 138.0 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.717 -0.872 . . . . 0.0 109.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.625 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.1 mm-40 -97.34 97.87 9.5 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.8 HG23 ' OH ' ' A' ' 40' ' ' TYR . 7.4 p -69.35 159.06 5.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.845 -1.16 . . . . 0.0 110.282 -178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' A ASP . . . . . 0.438 ' N ' HG22 ' A' ' 115' ' ' VAL . 56.4 t0 52.24 22.25 1.92 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.78 -0.575 . . . . 0.0 110.562 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 3.2 mptp? -90.56 106.31 18.42 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.755 -1.216 . . . . 0.0 108.951 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 4.5 m120 -69.51 -172.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 110.127 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -16.46 62.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.88 -20.05 63.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.586 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.7 OUTLIER -90.82 110.02 21.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 110.072 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' C ' HG22 ' A' ' 123' ' ' THR . 2.1 tt0 -92.62 150.6 20.61 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 61' ' ' TYR . 2.0 mp -68.87 -44.27 73.65 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.515 -1.366 . . . . 0.0 107.734 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER 39.2 18.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.624 -0.672 . . . . 0.0 112.485 175.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.802 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . 154.94 -65.63 0.32 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.2 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.625 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.269 0 O-C-N 121.286 -1.126 . . . . 0.0 109.251 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.3 pt -109.62 154.54 42.35 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.204 -0.935 . . . . 0.0 109.151 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.14 88.32 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.592 2.194 . . . . 0.0 110.376 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.29 136.73 3.51 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 116.09 140.95 7.08 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -35.88 128.45 0.67 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.724 -0.868 . . . . 0.0 111.096 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 m -101.25 163.91 12.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.384 0.612 . . . . 0.0 109.458 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 5.7 tt0 -48.14 176.94 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.398 -0.814 . . . . 0.0 109.308 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HB1' ' CG ' ' A' ' 49' ' ' GLN . . . -84.89 96.7 9.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.109 . . . . 0.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.68 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 20.0 mmtt -72.27 133.19 83.52 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 176.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 17' ' ' ALA . 27.5 Cg_endo -65.98 126.08 15.25 Favored 'Trans proline' 0 C--N 1.291 -2.452 0 N-CA-C 109.257 -1.093 . . . . 0.0 109.257 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.623 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -39.37 153.52 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.536 1.16 . . . . 0.0 111.815 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.63 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -136.27 -170.12 0.23 Allowed Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.3 Cg_endo -68.97 -16.53 40.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 N-CA-C 109.244 -1.099 . . . . 0.0 109.244 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.56 -46.45 14.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.068 -1.02 . . . . 0.0 108.41 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.763 HG21 ' HB3' ' A' ' 50' ' ' TYR . 10.2 mm -58.88 -53.67 44.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 22.9 tp60 -61.47 -19.17 61.73 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -76.13 -37.06 58.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.711 -1.243 . . . . 0.0 108.776 179.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.912 HG23 HG21 ' A' ' 99' ' ' VAL . 3.9 mt -63.22 -50.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.862 HG22 HD12 ' A' ' 45' ' ' LEU . 11.4 p -66.21 -41.62 89.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 122.183 0.992 . . . . 0.0 109.251 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.709 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.8 t70 -69.39 -16.58 63.54 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -85.9 -20.16 29.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 24' ' ' ILE . 13.1 m -118.4 6.58 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.613 -0.68 . . . . 0.0 110.603 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.885 ' HA ' HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -53.14 -36.85 42.16 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.687 -1.258 . . . . 0.0 110.646 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HD3' ' CG ' ' A' ' 29' ' ' LYS . 35.9 Cg_endo -79.3 -37.04 0.57 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 108.361 -1.438 . . . . 0.0 108.361 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.659 ' O ' HD23 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -74.17 -3.24 28.57 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.889 HD22 ' SD ' ' A' ' 95' ' ' MET . 10.0 mt -92.43 -41.12 10.49 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.417 -0.802 . . . . 0.0 109.624 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.809 ' OE2' HG22 ' A' ' 39' ' ' THR . 23.6 mt-10 -65.32 -46.27 80.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.511 -0.743 . . . . 0.0 110.972 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.7 -37.26 62.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.807 -1.183 . . . . 0.0 111.136 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -58.08 -42.65 86.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.771 -1.205 . . . . 0.0 110.063 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.823 HG21 ' OH ' ' A' ' 40' ' ' TYR . 1.3 p -86.5 -57.48 2.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.933 -1.104 . . . . 0.0 109.663 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 36' ' ' THR . 52.6 p-10 131.26 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 C-N-CA 122.937 0.495 . . . . 0.0 109.714 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 5.0 pt-20 -133.93 171.75 13.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 109.148 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.809 HG22 ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -107.14 117.76 34.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.009 -1.057 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.823 ' OH ' HG21 ' A' ' 36' ' ' THR . 58.8 m-85 -93.05 178.77 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 108.594 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -126.31 -157.57 9.6 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 43' ' ' GLY . 4.2 tttt -41.68 125.11 2.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.451 -1.029 . . . . 0.0 109.151 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.862 HD12 HG22 ' A' ' 25' ' ' VAL . 28.4 mt -97.43 77.41 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.055 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.53 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.872 -177.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.816 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -45.69 144.27 1.72 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.127 -0.983 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.5 t -125.6 -42.14 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' CG ' ' HB1' ' A' ' 14' ' ' ALA . 8.8 mt-30 -150.28 166.96 28.39 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.763 ' HB3' HG21 ' A' ' 21' ' ' ILE . 2.5 p90 -163.54 138.06 6.07 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.458 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 23.8 mttt -113.38 131.89 55.81 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.878 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -81.08 -173.72 4.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.196 -0.94 . . . . 0.0 110.86 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -164.32 156.01 16.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.765 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -125.43 141.43 45.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.949 -1.094 . . . . 0.0 110.746 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -170.2 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.29 28.93 5.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.512 ' HA2' HD21 ' A' ' 102' A LEU . . . 160.23 -104.04 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 53' ' ' GLN . 9.1 m -168.75 112.31 0.56 Allowed 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.7 -0.883 . . . . 0.0 109.766 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.606 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 32.6 m-80 -71.36 -166.63 0.19 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 28.5 m-85 -150.44 154.34 37.53 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.689 ' HB3' HD22 ' A' ' 122' ' ' LEU . 22.6 m-85 -138.99 133.76 32.15 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 177.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.813 HD12 HD23 ' A' ' 97' ' ' LEU . 11.1 mt -151.81 118.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 C-N-CA 116.719 -1.992 . . . . 0.0 111.589 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.555 ' CE ' ' HA ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -78.44 98.7 6.13 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 175.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.816 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -108.81 132.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.353 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 5.7 ttp180 -66.36 139.14 58.0 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.55 43.96 1.07 Allowed 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.922 0.868 . . . . 0.0 109.405 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 72.9 -80.63 0.68 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.0 OUTLIER -53.67 -112.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.41 -1.053 . . . . 0.0 110.394 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.402 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 5.0 m-20 -125.44 -21.4 4.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.687 -1.258 . . . . 0.0 109.876 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -68.46 177.07 2.54 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 20.0 m-85 -135.72 176.08 9.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.007 -1.058 . . . . 0.0 109.204 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.889 ' SD ' HD22 ' A' ' 32' ' ' LEU . 4.6 ttp -156.66 117.42 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.393 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.714 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.6 m170 -69.19 148.35 50.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.813 HD23 HD12 ' A' ' 62' ' ' ILE . 13.9 tp -129.04 128.58 43.88 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.725 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 41.6 tttt -114.52 107.79 15.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.912 HG21 HG23 ' A' ' 24' ' ' ILE . 1.8 t -111.38 160.66 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.215 . . . . 0.0 109.164 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.764 ' HB2' HG21 ' A' ' 111' ' ' THR . 34.7 t80 -122.94 133.11 54.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.792 -1.192 . . . . 0.0 109.003 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -106.25 137.16 44.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 1.03 ' O ' HD23 ' A' ' 102' A LEU . 1.1 t -102.06 -149.72 0.39 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.914 0.864 . . . . 0.0 109.416 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 1.03 HD23 ' O ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -160.94 -59.62 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.917 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.641 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 102' A LEU . 36.5 Cg_endo -76.8 -167.81 0.51 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.148 1.899 . . . . 0.0 110.778 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.61 62.8 4.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 47.41 -155.48 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.256 -1.144 . . . . 0.0 109.31 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' A ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.91 70.3 9.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.307 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.576 ' HG2' ' N ' ' A' ' 107' ' ' ASP . 26.7 tt0 -61.31 156.19 19.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.151 -0.968 . . . . 0.0 109.461 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.576 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 0.7 OUTLIER -105.61 148.93 26.78 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.446 -0.784 . . . . 0.0 109.311 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 108' ' ' LEU . 8.1 mp -53.02 -173.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.116 0.96 . . . . 0.0 109.784 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.776 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.3 p -152.31 166.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.089 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.695 HD11 ' O ' ' A' ' 112' ' ' GLY . 12.4 tp -98.52 85.29 3.34 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 100' ' ' PHE . 3.4 p -81.18 -1.55 45.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.1 -1.0 . . . . 0.0 111.947 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.695 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 177.67 -160.19 26.6 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.193 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.677 ' HD2' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER 150.3 133.47 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.383 0.611 . . . . 0.0 109.959 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.641 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.07 95.08 7.94 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.468 ' O ' ' HD3' ' A' ' 116' ' ' LYS . 9.4 p -67.98 161.4 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.185 . . . . 0.0 111.088 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' A ASP . . . . . 0.436 ' N ' HG22 ' A' ' 115' ' ' VAL . 49.6 t0 50.11 20.76 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.912 -0.492 . . . . 0.0 110.815 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.571 ' CG ' ' OD2' ' A' ' 120' ' ' ASP . 1.6 mptt -93.61 129.44 39.88 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.64 -1.288 . . . . 0.0 108.546 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 2.9 m-80 -104.4 -156.86 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 0.0 112.285 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.555 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 3.4 tttm -54.2 -56.7 15.73 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.937 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.42 -20.98 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 0.0 111.089 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.571 ' OD2' ' CG ' ' A' ' 116' ' ' LYS . 63.2 t0 -83.9 123.02 29.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.665 -1.272 . . . . 0.0 111.724 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.558 ' O ' ' CG2' ' A' ' 123' ' ' THR . 5.1 tt0 -100.3 139.88 35.34 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 176.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.714 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.2 mp -59.55 -49.54 77.36 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.541 -1.35 . . . . 0.0 109.411 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 124' ' ' GLY . 0.3 OUTLIER 43.7 -168.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.89 178.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.575 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -55.38 91.77 0.01 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 109.488 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.5 mtp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.23 130.21 94.69 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 0.0 109.532 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.76 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.412 2.075 . . . . 0.0 110.157 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . 144.44 -77.3 0.28 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 9' ' ' GLY . . . -60.32 -131.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.037 HD22 ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER 38.92 94.48 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.331 1.062 . . . . 0.0 110.945 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 79.1 p -101.52 -176.72 3.22 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.114 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -51.02 179.77 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.976 -1.078 . . . . 0.0 108.574 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -77.94 95.79 4.87 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.289 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mmtt -70.75 126.36 92.17 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.96 127.36 18.37 Favored 'Trans proline' 0 C--N 1.293 -2.345 0 N-CA-C 109.514 -0.995 . . . . 0.0 109.514 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.631 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -42.34 165.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.346 1.07 . . . . 0.0 111.431 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.653 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.46 -167.88 0.17 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -71.93 -18.03 28.23 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 N-CA-C 108.939 -1.216 . . . . 0.0 108.939 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' HD12 ' A' ' 24' ' ' ILE . 1.5 mt-10 -83.93 -45.32 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.752 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.6 mm -57.74 -54.43 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.504 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 13.6 tp60 -61.76 -20.29 63.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 7.0 tt0 -75.74 -34.81 60.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.471 -1.393 . . . . 0.0 108.643 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.08 HG23 HG21 ' A' ' 99' ' ' VAL . 3.7 mt -66.04 -49.67 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.004 0.907 . . . . 0.0 108.815 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 HD12 ' A' ' 45' ' ' LEU . 12.5 p -69.34 -41.38 80.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-O 121.966 0.889 . . . . 0.0 109.861 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.723 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.2 t70 -72.12 -17.0 62.01 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 14.4 tppt? -89.83 -13.47 36.49 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.863 ' CG2' HD21 ' A' ' 97' ' ' LEU . 31.3 m -126.58 4.18 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.883 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 6.3 ttpt -54.66 -43.66 98.48 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 111.07 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.68 -18.75 24.99 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.383 1.389 . . . . 0.0 109.615 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -91.92 -10.89 37.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.809 HD13 HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -92.06 -33.27 14.86 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 40' ' ' TYR . 2.3 pt-20 -82.68 -20.1 36.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 109.952 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.71 -45.85 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.017 -1.052 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -67.27 -40.16 86.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.697 HG21 ' OH ' ' A' ' 40' ' ' TYR . 2.7 m -82.67 -32.44 28.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.917 . . . . 0.0 109.388 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 88.71 26.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.254 0.55 . . . . 0.0 109.725 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -107.24 -178.84 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.518 ' O ' ' O ' ' A' ' 40' ' ' TYR . 29.9 m -97.03 -25.7 15.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.147 -0.971 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.697 ' OH ' HG21 ' A' ' 36' ' ' THR . 14.5 m-30 37.79 -165.29 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.705 0.764 . . . . 0.0 110.976 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . 176.1 -165.63 36.29 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' O ' HD23 ' A' ' 45' ' ' LEU . 14.0 mttt -42.46 134.51 3.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.796 HD12 HG22 ' A' ' 25' ' ' VAL . 34.5 mt -111.85 81.66 1.49 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.2 tt0 -64.01 86.89 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.853 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -44.71 132.83 6.29 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.291 1.043 . . . . 0.0 110.371 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.3 t -110.83 -45.32 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 63' ' ' LYS . 1.3 pt20 -149.05 173.21 13.63 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.803 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.752 ' HB3' HG21 ' A' ' 21' ' ' ILE . 26.7 p90 -165.31 141.12 5.33 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.69 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.545 ' HD3' HD23 ' A' ' 11' ' ' LEU . 9.0 mttt -117.7 135.96 53.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.366 0.603 . . . . 0.0 109.378 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.4 p -76.93 -175.59 3.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.266 -0.896 . . . . 0.0 110.064 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 58' ' ' THR . 0.6 OUTLIER -158.94 149.15 19.46 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.869 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -123.84 141.04 45.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.798 -1.189 . . . . 0.0 110.51 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.66 -103.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 30.24 4.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.94 -111.37 0.48 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 106.734 -2.547 . . . . 0.0 106.734 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 53' ' ' GLN . 16.4 m -165.26 107.31 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.345 -1.091 . . . . 0.0 110.697 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.621 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 82.0 m-20 -71.89 -171.52 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 101' ' ' LYS . 22.8 m-85 -139.38 160.2 40.39 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.827 ' HB3' HD22 ' A' ' 122' ' ' LEU . 11.0 m-85 -141.8 136.57 30.79 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.611 HG13 ' C ' ' A' ' 61' ' ' TYR . 14.1 mt -151.15 119.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.675 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.507 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 26.4 ttpp -86.36 94.61 9.41 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.853 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -100.09 137.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.843 -0.536 . . . . 0.0 110.86 -176.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.666 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -67.76 123.46 20.6 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.8 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -82.02 39.33 0.56 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.605 0.717 . . . . 0.0 111.007 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.04 -127.99 9.06 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.24 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -68.39 80.02 0.26 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.691 -0.888 . . . . 0.0 112.261 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 10.8 m120 71.22 -8.64 0.98 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.114 -0.991 . . . . 0.0 111.712 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.8 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -69.48 -179.76 1.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.649 -1.282 . . . . 0.0 108.367 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 116' ' ' LYS . 7.3 m-85 -150.74 155.98 40.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.972 -1.08 . . . . 0.0 109.391 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.641 ' CE ' ' CD2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -150.79 111.21 4.19 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.662 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.11 135.25 44.74 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.863 HD21 ' CG2' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -120.25 157.35 29.32 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.868 -1.145 . . . . 0.0 111.274 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.2 tttt -141.77 107.49 5.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.08 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -115.31 160.27 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.755 -1.216 . . . . 0.0 110.308 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.61 ' HB2' ' CG2' ' A' ' 111' ' ' THR . 0.2 OUTLIER -121.1 122.46 40.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.819 ' HG2' HD11 ' A' ' 108' ' ' LEU . 1.8 tttt -89.9 44.4 1.2 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.487 1.137 . . . . 0.0 107.998 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 102' A LEU . 0.2 OUTLIER -34.73 90.17 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.304 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.601 ' CG ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -28.74 -57.73 0.25 Allowed Pre-proline 0 N--CA 1.499 2.012 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.601 ' HD3' ' CG ' ' A' ' 102' A LEU . 37.4 Cg_endo -75.5 -104.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.351 2.034 . . . . 0.0 110.299 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.26 167.07 0.28 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 105' A ASN . 0.3 OUTLIER -132.35 -164.21 1.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -1.199 . . . . 0.0 109.289 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' A ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 105' ' ' GLN . 10.1 p-10 35.15 -147.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.787 -0.571 . . . . 0.0 109.804 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 105' A ASN . 73.7 mm-40 -43.24 160.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 109.14 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.61 162.63 12.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 110.092 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.819 HD11 ' HG2' ' A' ' 101' ' ' LYS . 5.7 mp 58.45 172.54 0.06 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.353 1.073 . . . . 0.0 110.77 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.668 ' O ' HG22 ' A' ' 99' ' ' VAL . 14.3 p -153.86 161.42 2.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.099 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.584 HD11 ' HD2' ' A' ' 113' ' ' TYR . 8.1 tp -96.69 82.05 3.26 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.61 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -70.37 -9.48 56.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 111.918 -176.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.501 ' CA ' ' HB3' ' A' ' 98' ' ' LYS . . . 168.78 -168.7 41.28 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.382 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.631 ' CB ' HD21 ' A' ' 32' ' ' LEU . 22.4 p90 167.79 135.38 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.593 -0.945 . . . . 0.0 109.139 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.681 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -90.53 103.9 16.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.693 HG23 ' OH ' ' A' ' 40' ' ' TYR . 8.1 p -68.25 161.69 3.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.552 -177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' A ASP . . . . . 0.488 ' N ' HG22 ' A' ' 115' ' ' VAL . 0.9 OUTLIER 42.2 43.31 2.83 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.11 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.959 -1.088 . . . . 0.0 108.404 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.97 -171.41 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 110.306 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 14.5 tttt -66.94 -40.5 87.57 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.425 0.631 . . . . 0.0 109.627 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.19 -18.56 0.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.341 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.586 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.4 OUTLIER -88.19 105.58 17.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.828 -1.17 . . . . 0.0 110.251 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.98 162.77 20.31 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 61' ' ' TYR . 3.0 mp -85.07 13.91 5.62 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.406 -1.434 . . . . 0.0 109.484 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.037 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.5 OUTLIER 2.77 -76.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.439 0.696 . . . . 0.0 112.236 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.706 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . -139.71 15.02 3.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.681 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.602 0 O-C-N 121.603 -0.94 . . . . 0.0 108.545 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.402 ' O ' ' C ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.827 HD12 ' O ' ' A' ' 8' ' ' PRO . 1.2 pp -42.9 161.13 0.19 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.844 . . . . 0.0 109.43 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.827 ' O ' HD12 ' A' ' 7' ' ' ILE . 33.1 Cg_endo -75.56 167.03 27.36 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.444 2.096 . . . . 0.0 110.611 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . -105.36 -82.03 1.52 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 12' ' ' SER . . . 60.53 112.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.765 HD21 ' CE2' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -44.98 94.7 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 122.383 1.087 . . . . 0.0 110.917 -178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.51 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -101.93 178.68 4.54 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.966 179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.495 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -51.96 163.83 0.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.161 -0.962 . . . . 0.0 109.182 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -72.54 107.68 5.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.942 . . . . 0.0 110.865 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.03 139.5 79.71 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 175.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.93 127.39 17.65 Favored 'Trans proline' 0 C--N 1.292 -2.435 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.599 ' HB1' ' CB ' ' A' ' 47' ' ' ALA . . . -44.61 131.43 6.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.06 0.933 . . . . 0.0 112.266 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.607 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -102.52 -173.42 0.29 Allowed Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 176.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -68.42 -20.82 41.55 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 109.643 -0.945 . . . . 0.0 109.643 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 1.6 mt-10 -81.72 -41.54 21.13 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.035 -1.041 . . . . 0.0 108.929 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.82 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -62.36 -47.48 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -67.6 -16.1 64.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.2 tt0 -77.18 -29.99 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.814 -1.179 . . . . 0.0 108.315 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.935 HG23 HG21 ' A' ' 99' ' ' VAL . 3.0 mt -70.62 -50.41 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.719 HG13 ' N ' ' A' ' 26' ' ' ASP . 7.7 p -61.42 -44.33 98.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.984 0.897 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.719 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.6 t0 -72.11 -20.26 61.67 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -80.34 -12.86 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.814 HG21 ' CD2' ' A' ' 97' ' ' LEU . 35.2 m -116.17 -10.85 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.556 -0.715 . . . . 0.0 110.203 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 16.2 ttmt -39.77 -49.91 5.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.05 -1.031 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 28.9 Cg_endo -69.69 -35.52 12.71 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.587 1.525 . . . . 0.0 109.8 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 27.6 mt-30 -73.76 -4.8 36.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 40' ' ' TYR . 7.0 mt -96.89 -43.15 7.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.62 0.724 . . . . 0.0 110.03 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.7 -27.19 69.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.752 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.04 -46.79 5.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.963 -1.085 . . . . 0.0 110.916 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 70.7 mttt -67.76 -33.89 75.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.071 . . . . 0.0 110.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.575 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 2.8 m -92.98 -35.5 13.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.886 -1.134 . . . . 0.0 109.532 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 36' ' ' THR . 1.0 OUTLIER 91.3 28.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.218 0.532 . . . . 0.0 110.019 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -115.38 -175.99 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 40' ' ' TYR . 43.2 m -98.78 -20.75 16.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.913 ' OH ' HG23 ' A' ' 115' ' ' VAL . 4.1 m-85 39.22 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.974 0.892 . . . . 0.0 111.051 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.9 -152.29 11.12 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 129.77 42.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -1.2 . . . . 0.0 108.673 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.655 ' HB2' HG22 ' A' ' 25' ' ' VAL . 35.5 mt -111.05 81.94 1.51 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.974 -1.079 . . . . 0.0 109.028 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -65.23 85.69 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.481 0.658 . . . . 0.0 110.137 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.931 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.96 125.99 4.61 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.105 0.955 . . . . 0.0 109.891 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.9 t -103.4 -44.87 9.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.642 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 3.4 mt-30 -142.78 172.79 12.21 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.82 ' HB3' HG21 ' A' ' 21' ' ' ILE . 31.7 p90 -169.75 139.82 2.03 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.877 -1.139 . . . . 0.0 110.593 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.614 ' HG3' HD13 ' A' ' 122' ' ' LEU . 7.5 mtmt -122.23 128.99 51.82 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.92 139.6 37.32 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.171 -0.956 . . . . 0.0 110.062 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.518 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 1.3 pm0 -133.23 158.52 42.68 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 55' ' ' VAL . 4.7 p -97.36 155.85 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 111.772 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.606 HG21 ' ND2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -162.28 -101.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.05 27.91 5.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.55 -103.37 0.23 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 106.373 -2.691 . . . . 0.0 106.373 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -160.89 122.64 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.584 -0.951 . . . . 0.0 109.891 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.606 ' ND2' HG21 ' A' ' 55' ' ' VAL . 9.7 m-20 -85.12 -164.96 1.07 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 7.9 m-85 -149.52 131.05 14.84 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.765 ' CE2' HD21 ' A' ' 11' ' ' LEU . 8.9 m-30 -115.88 134.53 54.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.759 HG22 HG13 ' A' ' 64' ' ' VAL . 17.8 mt -150.47 128.13 2.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 116.812 -1.955 . . . . 0.0 111.371 -176.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.598 ' HG3' ' NZ ' ' A' ' 116' ' ' LYS . 19.4 ttmt -95.34 90.99 6.02 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.931 HG12 ' HA ' ' A' ' 47' ' ' ALA . 31.4 m -99.6 142.06 15.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.773 -0.579 . . . . 0.0 110.956 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.33 123.15 19.97 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -86.06 46.75 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.139 0.971 . . . . 0.0 109.141 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 -152.05 19.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 92' ' ' ASN . 2.0 p-10 -59.15 126.84 29.32 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.426 -1.044 . . . . 0.0 111.044 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 68' ' ' ASP . 7.8 p-10 31.62 44.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.217 0.532 . . . . 0.0 111.304 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -127.76 171.41 11.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.489 ' CD2' ' O ' ' A' ' 93' ' ' LYS . 25.8 m-85 -156.94 156.36 32.92 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.754 -1.216 . . . . 0.0 110.495 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.741 ' O ' HG22 ' A' ' 64' ' ' VAL . 9.2 tmm? -153.97 116.52 4.39 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.296 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.705 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.1 m170 -76.29 143.22 41.01 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.814 ' CD2' HG21 ' A' ' 28' ' ' VAL . 1.4 tp -133.55 131.92 40.3 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.795 -1.562 . . . . 0.0 112.437 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.2 ttpt -111.7 83.38 1.77 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.935 HG21 HG23 ' A' ' 24' ' ' ILE . 1.6 t -84.47 159.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.665 -1.272 . . . . 0.0 109.206 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.724 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 58.4 t80 -125.4 131.43 52.94 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.635 -1.291 . . . . 0.0 108.35 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.549 ' HG2' ' N ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -107.55 145.34 33.31 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.549 ' N ' ' HG2' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -98.37 73.24 2.13 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.932 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 102' ' ' SER . 74.1 mt 54.7 157.29 0.06 OUTLIER Pre-proline 0 C--N 1.307 -1.25 0 O-C-N 121.567 -0.708 . . . . 0.0 110.396 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.35 179.96 5.94 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.545 2.163 . . . . 0.0 110.037 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.414 ' C ' ' HG3' ' A' ' 105' ' ' GLN . . . 139.31 -111.42 0.77 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 105' A ASN . 14.0 mt-30 -141.66 145.71 35.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -1.17 . . . . 0.0 109.691 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' A ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER 41.0 65.86 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.515 -0.741 . . . . 0.0 109.836 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -76.56 -178.91 4.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.0 109.287 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.92 77.51 1.55 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.093 -1.004 . . . . 0.0 110.084 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.617 HD12 ' N ' ' A' ' 108' ' ' LEU . 10.6 mp -60.97 -174.35 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.307 1.051 . . . . 0.0 109.453 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.75 ' CG1' HG23 ' A' ' 111' ' ' THR . 12.5 p -163.39 164.94 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.089 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.728 HD11 ' CD2' ' A' ' 113' ' ' TYR . 4.4 tp -97.49 83.52 3.27 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.75 HG23 ' CG1' ' A' ' 109' ' ' VAL . 1.4 p -85.89 -3.61 58.96 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.016 -1.052 . . . . 0.0 112.81 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 113' ' ' TYR . . . -171.31 -172.34 37.36 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.633 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.728 ' CD2' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER 155.38 132.61 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.736 -0.861 . . . . 0.0 111.3 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.636 ' NE2' ' CE1' ' A' ' 125' ' ' PHE . 6.2 mm-40 -95.37 95.95 8.8 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.913 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -65.84 160.1 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.99 -176.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' A ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 115' ' ' VAL . 2.7 t70 42.85 37.19 1.01 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.441 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.598 ' NZ ' ' HG3' ' A' ' 63' ' ' LYS . 8.1 ptmm? -69.61 -163.83 0.06 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.074 -1.016 . . . . 0.0 108.935 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.452 ' O ' ' NZ ' ' A' ' 116' ' ' LYS . 14.2 m-80 -157.35 178.5 10.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.84 -1.163 . . . . 0.0 109.922 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -68.92 -9.27 50.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.814 . . . . 0.0 109.756 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.32 5.09 46.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -100.68 119.65 38.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.035 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.686 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.9 OUTLIER -96.9 138.43 34.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 61' ' ' TYR . 1.6 mp -58.57 -55.93 28.65 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.715 -1.241 . . . . 0.0 109.196 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 121' ' ' GLU . 0.3 OUTLIER 44.69 -169.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.182 177.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.558 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -49.51 91.93 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.539 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.594 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.827 ' C ' HD13 ' A' ' 7' ' ' ILE . 15.8 mtm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.356 0.598 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.827 HD13 ' C ' ' A' ' 6' ' ' MET . 0.0 OUTLIER -127.93 131.96 24.08 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.06 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.04 -24.04 7.23 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.378 2.052 . . . . 0.0 110.493 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.12 109.11 2.09 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' OE1' ' A' ' 53' ' ' GLN . . . 176.77 -167.89 39.54 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.547 HD12 ' HD3' ' A' ' 51' ' ' LYS . 1.3 pt? -132.88 155.94 48.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -1.144 . . . . 0.0 109.524 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 1.2 t -101.33 -177.22 3.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 110.731 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -49.98 -175.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.555 -0.716 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -90.17 107.88 19.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.928 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 9.6 mmpt? -73.26 141.11 80.32 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 175.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.47 131.29 25.87 Favored 'Trans proline' 0 C--N 1.291 -2.499 0 N-CA-C 109.45 -1.019 . . . . 0.0 109.45 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -48.17 165.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.399 1.095 . . . . 0.0 111.813 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.663 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -145.92 -166.07 0.12 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.663 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.5 Cg_endo -71.85 -18.35 28.26 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 N-CA-C 108.755 -1.287 . . . . 0.0 108.755 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.42 -45.93 15.34 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.4 mm -59.85 -53.03 54.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.474 ' OE1' ' O ' ' A' ' 45' ' ' LEU . 26.9 tp60 -60.45 -19.48 56.61 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 tt0 -75.17 -43.12 54.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 108.737 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HG21 ' A' ' 99' ' ' VAL . 3.3 mt -57.29 -52.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.84 HG22 HD12 ' A' ' 45' ' ' LEU . 11.4 p -66.42 -39.76 84.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 122.024 0.916 . . . . 0.0 109.095 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.705 ' N ' HG13 ' A' ' 25' ' ' VAL . 23.3 t70 -68.44 -13.45 62.31 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -94.76 -19.96 19.91 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.257 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.825 HG21 HD11 ' A' ' 97' ' ' LEU . 27.4 m -111.66 -6.03 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.885 . . . . 0.0 111.23 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.688 ' HG3' HD11 ' A' ' 45' ' ' LEU . 1.4 ttpm? -44.46 -48.25 26.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -29.96 12.62 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.625 1.55 . . . . 0.0 110.112 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' HD23 ' A' ' 110' ' ' LEU . 26.3 mt-30 -83.77 -0.72 52.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.951 HD11 ' CD1' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.27 -37.6 8.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 1.5 tm-20 -72.08 -30.6 65.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -19.44 29.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.0 . . . . 0.0 109.886 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 7.6 44.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.187 -0.946 . . . . 0.0 109.855 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.821 HG21 ' CZ ' ' A' ' 40' ' ' TYR . 14.4 t -135.56 -32.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.939 -1.1 . . . . 0.0 110.281 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER 92.62 18.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.919 -0.488 . . . . 0.0 110.116 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.706 ' H ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -115.5 157.76 23.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.916 -1.115 . . . . 0.0 109.057 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.524 ' O ' ' O ' ' A' ' 40' ' ' TYR . 8.9 m -81.22 -15.43 55.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.822 ' OH ' HG23 ' A' ' 115' ' ' VAL . 12.0 m-30 39.0 -165.76 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.521 0.677 . . . . 0.0 110.14 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -176.65 -169.44 38.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' O ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -42.04 134.44 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.464 -1.021 . . . . 0.0 108.875 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.84 HD12 HG22 ' A' ' 25' ' ' VAL . 34.0 mt -112.55 83.73 1.86 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.085 -1.01 . . . . 0.0 109.859 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 3.7 mt-10 -65.33 85.5 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.481 0.658 . . . . 0.0 109.667 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.838 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -47.89 116.88 1.64 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.3 1.048 . . . . 0.0 110.579 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.788 HG21 ' NH1' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -90.67 -46.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.636 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 2.6 mt-30 -148.73 168.78 21.98 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.696 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.729 ' HB3' HG21 ' A' ' 21' ' ' ILE . 7.0 p90 -161.75 136.23 6.98 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.821 -1.152 . . . . 0.0 110.983 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HD3' HD12 ' A' ' 11' ' ' LEU . 11.5 mttt -105.41 137.0 43.94 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 p -86.97 178.63 6.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.858 . . . . 0.0 110.049 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.823 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -157.32 161.25 39.1 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.685 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -127.02 140.08 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.068 -1.02 . . . . 0.0 110.374 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -165.15 -103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HB3' ' HZ ' ' A' ' 100' ' ' PHE . . . -99.63 29.35 4.13 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.729 ' HA2' HD21 ' A' ' 102' A LEU . . . 158.65 -99.74 0.18 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.671 -2.572 . . . . 0.0 106.671 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 53' ' ' GLN . 18.7 m -167.38 120.4 0.94 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.644 -0.916 . . . . 0.0 110.236 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.659 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 17.5 m-20 -77.92 -164.25 0.5 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.662 ' CD1' HG12 ' A' ' 99' ' ' VAL . 75.9 m-85 -151.58 152.61 33.13 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.704 0.764 . . . . 0.0 109.023 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' A' ' 125' ' ' PHE . 19.7 m-85 -138.58 132.78 31.6 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.751 HD12 HD23 ' A' ' 97' ' ' LEU . 14.4 mt -149.11 119.0 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 C-N-CA 116.917 -1.913 . . . . 0.0 111.378 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HD2' ' HB2' ' A' ' 49' ' ' GLN . 14.2 ptpt -85.99 98.71 10.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -102.26 141.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.217 0.532 . . . . 0.0 110.746 -175.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.788 ' NH1' HG21 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -68.93 125.0 25.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -83.11 38.95 0.62 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.619 0.723 . . . . 0.0 110.839 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.87 -74.09 0.8 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.612 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 54.0 p30 -78.21 44.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.982 -1.305 . . . . 0.0 113.485 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 3.4 t-20 79.94 -41.28 0.22 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.849 -1.157 . . . . 0.0 111.246 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.872 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 33.6 mtmt -67.21 144.3 56.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.723 -1.236 . . . . 0.0 107.826 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.62 ' CE2' ' NH1' ' A' ' 65' ' ' ARG . 18.8 m-30 -104.82 172.16 6.94 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.416 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.574 ' HE1' ' CD2' ' A' ' 40' ' ' TYR . 2.4 mtp -144.01 115.68 8.19 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.723 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -69.63 148.45 49.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.951 ' CD1' HD11 ' A' ' 32' ' ' LEU . 12.9 tp -133.27 132.76 41.79 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.296 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 30.0 tttt -122.61 103.34 8.62 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.016 HG21 HG23 ' A' ' 24' ' ' ILE . 2.4 t -108.8 163.64 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.32 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.698 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.2 t80 -127.05 133.13 50.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.975 -1.078 . . . . 0.0 108.809 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.585 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 5.9 tttt -99.61 129.46 45.76 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 102' A LEU . 7.4 m -102.03 14.27 32.41 Favored 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.143 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.729 HD21 ' HA2' ' A' ' 57' ' ' GLY . 0.7 OUTLIER 18.55 64.19 0.23 Allowed Pre-proline 0 N--CA 1.499 1.995 0 CA-C-O 120.825 0.345 . . . . 0.0 111.533 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 102' A LEU . 37.5 Cg_endo -79.12 19.49 0.91 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.014 2.476 . . . . 0.0 111.317 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.2 47.08 50.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -154.64 -154.84 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.155 . . . . 0.0 109.393 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' A ASN . . . . . . . . . . . . . 10.8 t-20 -62.3 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 0.0 109.299 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.98 139.54 30.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 109.318 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -155.25 49.97 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 109.598 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 108' ' ' LEU . 6.9 mp -79.24 -174.74 4.29 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.422 1.106 . . . . 0.0 110.107 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.4 p -146.07 164.42 9.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.927 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.629 HD11 ' O ' ' A' ' 112' ' ' GLY . 11.1 tp -98.01 83.85 3.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.615 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -72.69 -10.15 59.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 111.157 -177.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.629 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 174.35 -165.96 37.7 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.585 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 37.6 p90 164.98 137.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.677 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 1.5 mm-40 -103.09 107.99 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.822 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -66.6 162.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.634 -1.291 . . . . 0.0 111.626 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' A ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 115' ' ' VAL . 22.6 t0 39.49 30.69 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.635 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -77.8 158.39 29.55 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.695 -1.253 . . . . 0.0 108.254 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.34 179.4 4.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.039 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -65.03 -50.07 67.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 0.0 109.271 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' LYS . 13.9 t70 -44.5 -27.16 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.493 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -76.19 88.39 3.06 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.507 -0.746 . . . . 0.0 109.385 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.08 164.82 3.74 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.723 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -90.35 50.84 1.9 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.373 -1.454 . . . . 0.0 109.674 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -48.84 -177.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.083 178.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.464 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -42.41 94.11 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.677 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.363 -1.081 . . . . 0.0 109.646 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.523 ' CB ' HD12 ' A' ' 7' ' ' ILE . 1.6 ptt? . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.256 0.55 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.523 HD12 ' CB ' ' A' ' 6' ' ' MET . 3.0 mp 52.42 92.27 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.878 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.46 -31.92 2.47 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.721 2.281 . . . . 0.0 110.237 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.13 99.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 136.29 126.54 2.56 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.93 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -41.41 128.7 3.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.598 -0.942 . . . . 0.0 111.082 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' GLU . 2.0 t -101.4 167.95 9.84 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.52 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.652 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.14 98.62 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.39 127.3 90.33 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 104.219 -2.512 . . . . 0.0 104.219 176.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.72 124.39 13.12 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -45.47 128.77 8.3 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.952 0.882 . . . . 0.0 111.667 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.611 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -101.07 -171.89 0.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 177.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.4 Cg_endo -69.06 -18.29 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 N-CA-C 109.369 -1.05 . . . . 0.0 109.369 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -43.3 22.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.143 -0.973 . . . . 0.0 108.504 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.827 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -63.33 -47.46 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.674 HE21 HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -58.31 -23.03 55.24 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.4 tt0 -76.88 -40.61 46.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.22 -0.925 . . . . 0.0 110.286 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.01 HG23 HG21 ' A' ' 99' ' ' VAL . 3.0 mt -61.28 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.802 HG22 ' HB2' ' A' ' 45' ' ' LEU . 14.7 p -64.14 -41.65 93.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 122.017 0.913 . . . . 0.0 109.021 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.707 ' N ' HG13 ' A' ' 25' ' ' VAL . 8.9 t70 -72.51 -12.56 61.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mttt -96.71 -10.12 27.57 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.039 HG21 HD21 ' A' ' 97' ' ' LEU . 4.3 m -120.76 -6.03 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 110.473 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.627 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -48.37 -45.28 67.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 0.0 110.379 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.4 Cg_endo -72.23 -28.94 14.85 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.287 1.324 . . . . 0.0 109.517 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' O ' HD23 ' A' ' 110' ' ' LEU . 39.1 mt-30 -81.79 -7.49 59.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.015 HD11 HD13 ' A' ' 97' ' ' LEU . 11.1 mt -88.1 -48.77 7.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -63.29 -25.25 68.23 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.149 0.5 . . . . 0.0 110.027 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -88.58 -28.14 20.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 110.178 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 13.8 mmtt -99.87 2.85 44.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 110.094 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.911 HG21 ' CE2' ' A' ' 40' ' ' TYR . 6.1 t -128.2 -4.48 5.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.121 -0.987 . . . . 0.0 109.874 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.7 OUTLIER 40.14 45.3 1.67 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 109.834 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -138.14 161.25 37.28 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.408 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -88.16 119.11 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 110.309 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.911 ' CE2' HG21 ' A' ' 36' ' ' THR . 14.8 m-30 -114.29 -169.8 1.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 45' ' ' LEU . . . -153.89 -171.84 21.35 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 43' ' ' GLY . 3.8 mttt -44.36 135.66 4.48 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.802 ' HB2' HG22 ' A' ' 25' ' ' VAL . 31.0 mt -107.66 69.77 0.75 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.897 -1.127 . . . . 0.0 109.028 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -58.15 86.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.271 -178.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.602 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -41.01 142.68 0.46 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 109.963 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 2.1 t -125.26 -40.31 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -140.43 171.32 14.3 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.827 ' HB3' HG21 ' A' ' 21' ' ' ILE . 4.3 p90 -170.18 141.45 2.09 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.73 -1.231 . . . . 0.0 110.944 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 4.7 mttp -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.1 p -82.83 -174.31 5.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.153 -0.967 . . . . 0.0 110.739 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.764 ' O ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -165.11 148.74 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -123.21 134.62 65.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 120.844 -1.16 . . . . 0.0 110.936 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -160.35 -102.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.03 29.06 4.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.433 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 159.66 -105.54 0.27 Allowed Glycine 0 N--CA 1.485 1.965 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 53' ' ' GLN . 23.3 m -168.26 118.78 0.78 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.682 -0.893 . . . . 0.0 110.327 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.632 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 43.3 m-20 -79.07 -165.64 0.79 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 32.2 m-85 -148.36 157.62 43.59 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.236 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.646 ' C ' HG13 ' A' ' 62' ' ' ILE . 18.9 m-85 -139.65 137.56 35.36 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.713 ' N ' HD22 ' A' ' 122' ' ' LEU . 10.9 mt -155.9 126.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 116.935 -1.906 . . . . 0.0 112.067 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.651 ' HD2' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.45 94.54 7.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 176.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 25' ' ' VAL . 5.3 m -102.51 143.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.519 -0.738 . . . . 0.0 111.338 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.01 125.34 26.0 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.91 46.24 1.16 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.147 0.975 . . . . 0.0 109.358 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 94.2 -105.79 3.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 67' ' ' GLY . 5.6 p-10 -58.29 -144.73 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.497 -1.002 . . . . 0.0 109.93 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -77.53 -2.11 33.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.823 -1.173 . . . . 0.0 110.252 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -69.82 168.9 14.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.651 ' CD1' ' HD2' ' A' ' 63' ' ' LYS . 35.6 m-85 -142.13 165.3 27.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.779 ' HE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -152.7 116.5 4.8 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.725 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.685 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -73.99 143.61 45.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.039 HD21 HG21 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -146.29 130.19 17.22 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.845 -1.159 . . . . 0.0 110.786 -178.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.3 pttm -115.26 130.7 56.98 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.487 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.01 HG21 HG23 ' A' ' 24' ' ' ILE . 1.6 t -117.15 167.11 10.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.717 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.9 t80 -132.23 123.57 27.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.467 -1.396 . . . . 0.0 108.445 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.942 ' HG3' HD11 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -96.22 126.38 41.4 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 102' A LEU . 13.1 p -101.16 44.3 1.02 Allowed 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.678 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.52 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 1.0 OUTLIER 54.44 164.56 0.05 OUTLIER Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.476 -0.765 . . . . 0.0 109.785 179.021 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 102' A LEU . 34.7 Cg_endo -77.67 90.42 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.512 2.141 . . . . 0.0 110.528 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.61 -76.05 0.23 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.448 ' O ' ' CB ' ' A' ' 105' A ASN . 1.5 pp0? -168.05 -174.34 2.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.618 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' A ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 10.7 t-20 73.06 -170.84 0.13 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.301 -0.875 . . . . 0.0 109.942 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -54.74 179.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.725 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 108' ' ' LEU . 1.3 t70 -111.44 124.87 53.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.489 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.942 HD11 ' HG3' ' A' ' 101' ' ' LYS . 11.0 mp 49.7 177.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.408 1.099 . . . . 0.0 109.928 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.717 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.0 p -148.78 160.93 5.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.774 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.874 HD13 HD11 ' A' ' 97' ' ' LEU . 1.9 tp -96.84 86.25 3.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -68.7 -20.71 64.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.97 -1.081 . . . . 0.0 111.087 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.506 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 178.32 -163.35 31.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.777 -1.677 . . . . 0.0 110.84 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.755 ' HD2' HD11 ' A' ' 110' ' ' LEU . 29.2 p90 167.81 135.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.687 -0.89 . . . . 0.0 108.896 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.679 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -94.55 103.36 15.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.483 ' HA ' ' HG2' ' A' ' 95' ' ' MET . 3.6 p -67.06 159.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.679 -1.263 . . . . 0.0 110.536 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.76 32.93 1.35 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.491 ' CG ' ' HB2' ' A' ' 114' ' ' GLN . 5.0 tptt -90.53 127.06 36.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.519 -1.363 . . . . 0.0 109.248 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.517 ' O ' ' CE ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -68.9 170.57 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.51 -0.744 . . . . 0.0 110.191 -178.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -62.99 -61.13 2.6 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.428 -0.795 . . . . 0.0 109.551 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 12.7 t0 -40.28 -31.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.48 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 1.1 t70 -50.77 121.54 6.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 110.031 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.7 OUTLIER -88.66 134.93 33.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.719 ' C ' HG23 ' A' ' 123' ' ' THR . 2.5 mp -65.22 -40.95 94.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.834 -1.166 . . . . 0.0 108.442 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 54.83 -161.91 0.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.027 0.918 . . . . 0.0 111.248 176.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.93 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -47.84 -17.97 0.64 Allowed Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.679 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 O-C-N 121.17 -1.194 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.318 0.58 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -151.86 81.08 5.9 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 109.347 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.17 126.64 7.9 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.713 2.276 . . . . 0.0 110.568 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.17 -166.01 34.37 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 73.74 135.46 0.3 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -41.58 122.3 1.92 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.2 -1.176 . . . . 0.0 110.586 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.516 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -102.07 -178.63 3.76 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.357 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.533 ' O ' ' CE ' ' A' ' 15' ' ' LYS . 2.8 mm-40 -59.01 135.0 57.49 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.05 -1.031 . . . . 0.0 108.797 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.586 ' HB2' ' CG ' ' A' ' 121' ' ' GLU . . . -39.4 109.34 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.226 -0.921 . . . . 0.0 110.936 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -79.59 129.85 70.01 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 175.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.95 128.92 20.71 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.635 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -43.29 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.627 1.203 . . . . 0.0 112.285 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.659 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -145.59 -167.69 0.16 Allowed Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.7 Cg_endo -71.83 -18.02 28.58 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 109.263 -1.091 . . . . 0.0 109.263 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -83.28 -44.91 14.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 108.569 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 21' ' ' ILE . 4.1 mm -57.82 -54.57 29.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.509 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 9.7 tp60 -60.45 -20.86 61.35 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.536 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 tm-20 -73.67 -36.84 65.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.683 -1.26 . . . . 0.0 109.091 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.889 HG23 HG21 ' A' ' 99' ' ' VAL . 4.5 mt -65.95 -50.76 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.084 0.945 . . . . 0.0 108.967 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 45' ' ' LEU . 8.7 p -65.0 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 122.074 0.94 . . . . 0.0 109.708 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.74 ' N ' HG13 ' A' ' 25' ' ' VAL . 31.6 t70 -70.26 -18.15 63.13 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.91 -17.68 27.54 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.591 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.695 HG11 ' CG2' ' A' ' 99' ' ' VAL . 30.9 m -107.54 -9.32 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -47.07 -46.13 53.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.912 -1.117 . . . . 0.0 109.947 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.3 Cg_endo -73.73 -29.89 10.11 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.442 1.428 . . . . 0.0 109.097 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 110' ' ' LEU . 2.5 mt-30 -81.57 -2.22 49.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.053 ' CD1' HD21 ' A' ' 97' ' ' LEU . 4.6 mt -95.08 -41.39 9.14 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.542 -0.723 . . . . 0.0 109.503 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 10.5 mt-10 -75.29 -23.64 57.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.537 -0.727 . . . . 0.0 109.441 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -23.57 21.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.994 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.33 -6.43 34.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.703 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 32' ' ' LEU . 1.4 t -127.58 -30.57 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.8 OUTLIER 91.98 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.403 0.621 . . . . 0.0 109.939 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.513 ' HB2' ' CG2' ' A' ' 36' ' ' THR . 1.2 mm-40 -110.04 -176.56 3.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 0.0 109.363 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 40' ' ' TYR . 7.3 m -108.89 -24.45 11.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.799 ' OH ' HG23 ' A' ' 115' ' ' VAL . 20.5 m-85 34.31 -162.91 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.784 0.802 . . . . 0.0 111.088 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' HG ' ' A' ' 45' ' ' LEU . . . 175.26 -160.27 28.87 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -42.6 125.78 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -1.095 . . . . 0.0 109.275 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 25' ' ' VAL . 68.1 mt -108.62 82.58 1.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.079 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 25.5 mt-10 -64.16 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.35 -0.844 . . . . 0.0 110.094 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.88 ' HA ' HG13 ' A' ' 64' ' ' VAL . . . -42.05 149.42 0.15 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.397 1.094 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.91 -44.46 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -152.69 168.89 24.17 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 17.5 p90 -166.0 144.53 5.84 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 111.284 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.578 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -109.14 165.7 11.4 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.62 141.71 29.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.511 ' HG3' ' OH ' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -117.55 162.87 17.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -117.59 135.17 58.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.162 -0.961 . . . . 0.0 110.035 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -158.74 -101.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -101.01 30.17 4.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.993 ' HA2' HD23 ' A' ' 102' A LEU . . . 156.77 -115.24 0.65 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 106.411 -2.676 . . . . 0.0 106.411 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.512 ' CB ' ' HE3' ' A' ' 101' ' ' LYS . 10.3 m -160.55 125.95 3.89 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.275 -1.132 . . . . 0.0 110.343 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.544 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 61.8 m-80 -78.0 -172.37 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' A' ' 101' ' ' LYS . 18.7 m-85 -150.4 154.37 37.63 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.439 1.114 . . . . 0.0 110.004 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 17.2 m-85 -152.73 130.83 11.88 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.612 HG22 HG22 ' A' ' 64' ' ' VAL . 4.3 mt -146.39 118.53 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 117.133 -1.827 . . . . 0.0 112.073 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.692 ' N ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.31 102.29 6.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 175.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.88 HG13 ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -111.65 137.85 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.739 . . . . 0.0 110.807 -175.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -68.2 127.41 32.8 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.846 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -80.45 36.71 0.38 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.557 0.694 . . . . 0.0 110.884 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.96 -75.78 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.596 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -79.85 47.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 113.165 -176.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' ASP . 1.2 t-20 79.31 -38.75 0.2 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.93 -1.106 . . . . 0.0 111.739 177.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.846 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.8 mtmp? -66.99 144.57 56.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.581 -1.324 . . . . 0.0 107.469 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.608 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 15.3 m-30 -108.51 170.89 7.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.298 -0.877 . . . . 0.0 109.898 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -155.82 127.94 7.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.496 -0.752 . . . . 0.0 109.069 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.777 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -77.5 139.92 39.69 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.053 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -123.05 127.78 49.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 111.097 -179.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 4.4 ttmt -113.01 126.84 55.93 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.889 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -133.49 166.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.087 -1.008 . . . . 0.0 109.515 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.677 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 48.3 t80 -130.79 132.68 45.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -110.44 145.78 37.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.277 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.582 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -102.33 108.93 20.45 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.926 0.869 . . . . 0.0 108.782 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.993 HD23 ' HA2' ' A' ' 57' ' ' GLY . 1.3 pp -73.22 -21.99 0.48 Allowed Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 102' A LEU . 36.2 Cg_endo -81.72 113.29 2.51 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 120.929 1.086 . . . . 0.0 110.302 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.05 -130.85 9.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -129.95 -163.18 1.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.292 -1.122 . . . . 0.0 109.241 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' A ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.91 87.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.235 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -85.08 -179.0 6.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.244 -0.91 . . . . 0.0 109.246 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 108' ' ' LEU . 47.6 m-20 -79.43 100.54 7.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.356 -0.84 . . . . 0.0 110.234 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 108' ' ' LEU . 5.6 mp -51.1 -177.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.217 1.008 . . . . 0.0 109.186 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.828 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.4 p -137.6 162.44 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.084 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.663 HD11 ' O ' ' A' ' 112' ' ' GLY . 16.3 tp -102.28 89.07 3.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.449 HG21 ' HB2' ' A' ' 100' ' ' PHE . 11.2 p -68.5 -21.22 64.61 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.314 -0.866 . . . . 0.0 110.707 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.663 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -179.7 -161.26 26.69 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.623 -1.751 . . . . 0.0 111.029 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.674 ' CB ' HD21 ' A' ' 32' ' ' LEU . 29.1 p90 170.08 133.48 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.745 -0.856 . . . . 0.0 108.968 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.673 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.3 mm-40 -96.18 107.84 20.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.799 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -66.75 158.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.582 -1.324 . . . . 0.0 111.239 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.9 t70 41.84 37.87 0.88 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.714 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.529 ' HA ' ' CE ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -81.06 -169.77 2.4 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.543 -1.348 . . . . 0.0 107.953 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 62.6 m-80 -148.07 -176.42 5.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.648 -1.283 . . . . 0.0 110.686 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 119' ' ' ASP . 1.3 ttmm -74.74 -46.22 38.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.63 -0.669 . . . . 0.0 109.464 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.5 t70 -47.61 -24.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.142 -0.974 . . . . 0.0 108.441 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 21.6 t0 -83.22 66.12 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.672 -0.643 . . . . 0.0 109.395 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.586 ' CG ' ' HB2' ' A' ' 14' ' ' ALA . 1.8 tt0 -61.35 103.27 0.29 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.786 -1.196 . . . . 0.0 108.052 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.777 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 3.4 mp -26.39 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.585 1.184 . . . . 0.0 110.256 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER -108.0 -7.91 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.066 -177.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.15 107.43 0.2 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.673 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.661 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 pt -146.38 85.97 7.12 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.958 . . . . 0.0 109.74 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.5 -65.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.687 2.258 . . . . 0.0 110.468 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.64 137.08 3.79 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 91.04 133.5 5.71 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 123' ' ' THR . 0.5 OUTLIER -40.37 115.55 0.57 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.608 -0.936 . . . . 0.0 110.935 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -101.51 171.22 7.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' SER . 12.7 tm-20 -43.53 166.97 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.281 -0.887 . . . . 0.0 109.347 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' N ' ' CD ' ' A' ' 13' ' ' GLU . . . -71.25 103.05 2.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.609 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -73.28 132.65 81.72 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 175.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.39 127.67 18.69 Favored 'Trans proline' 0 C--N 1.293 -2.352 0 N-CA-C 109.378 -1.047 . . . . 0.0 109.378 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.729 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -47.29 132.35 12.87 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.044 0.926 . . . . 0.0 111.909 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.619 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -102.56 -172.63 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.0 Cg_endo -68.08 -17.59 45.77 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 N-CA-C 109.545 -0.983 . . . . 0.0 109.545 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -81.79 -36.62 28.23 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.09 -1.006 . . . . 0.0 108.494 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.822 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -68.84 -45.31 80.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.504 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 11.0 tp60 -66.82 -18.92 65.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.73 -30.29 59.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.835 -1.166 . . . . 0.0 108.774 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.922 ' O ' HG22 ' A' ' 28' ' ' VAL . 46.0 mt -71.61 -51.98 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.737 HG13 ' N ' ' A' ' 26' ' ' ASP . 8.4 p -60.1 -42.89 91.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.879 0.847 . . . . 0.0 109.074 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.737 ' N ' HG13 ' A' ' 25' ' ' VAL . 1.4 t70 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' GLU . 7.3 mttt -81.45 -6.85 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.041 HG21 ' CD2' ' A' ' 97' ' ' LEU . 6.4 m -127.05 -8.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.577 -0.702 . . . . 0.0 110.501 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 15.5 ttpp -41.66 -47.9 9.74 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.024 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.0 Cg_endo -72.87 -34.88 6.17 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.33 1.354 . . . . 0.0 109.655 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.502 ' O ' HD23 ' A' ' 110' ' ' LEU . 43.1 mt-30 -74.6 -5.35 42.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.922 . . . . 0.0 108.513 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.89 HD11 HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.84 -37.47 8.67 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.863 0.839 . . . . 0.0 109.048 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.1 mt-10 -54.07 -54.88 33.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.654 -0.654 . . . . 0.0 110.55 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.71 -35.78 57.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 110.491 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 1.3 mptp? -53.46 -56.73 14.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.222 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.974 HG21 ' OH ' ' A' ' 40' ' ' TYR . 10.0 t -95.37 20.67 9.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER 41.32 39.83 1.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.328 -0.858 . . . . 0.0 110.001 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.685 ' HB3' HG23 ' A' ' 36' ' ' THR . 1.6 tt0 -136.77 160.12 39.81 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -102.92 135.8 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.698 -1.251 . . . . 0.0 110.422 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.974 ' OH ' HG21 ' A' ' 36' ' ' THR . 98.5 m-85 -117.52 169.1 9.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.834 . . . . 0.0 109.296 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -125.88 -164.69 11.86 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.1 123.82 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -1.206 . . . . 0.0 108.595 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.716 ' HB3' HG21 ' A' ' 64' ' ' VAL . 39.1 mt -100.32 76.72 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.919 -1.113 . . . . 0.0 109.063 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -57.2 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.461 0.648 . . . . 0.0 109.777 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.729 ' HB1' ' CB ' ' A' ' 17' ' ' ALA . . . -42.82 133.67 3.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.117 0.96 . . . . 0.0 110.006 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.2 t -113.36 -41.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -146.55 171.26 15.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.006 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.822 ' HB3' HG21 ' A' ' 21' ' ' ILE . 1.9 p90 -167.6 141.43 3.53 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.38 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 1.1 mppp? -121.14 128.91 52.98 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.956 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.5 p -73.01 -172.07 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.967 -1.083 . . . . 0.0 109.703 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.637 ' CG ' ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -167.33 127.27 1.43 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.6 p -107.84 115.58 49.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.507 HG21 ' ND2' ' A' ' 59' ' ' ASN . 0.3 OUTLIER -136.85 -104.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.65 29.55 4.05 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 102' ' ' SER . . . 162.57 -116.73 0.73 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 11.5 m -158.61 113.49 2.55 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.218 -1.166 . . . . 0.0 110.113 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.594 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 54.8 m-20 -82.37 -173.13 4.39 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.836 0.827 . . . . 0.0 109.099 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.649 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 93.2 m-85 -137.49 152.0 49.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.637 ' CE1' ' CG ' ' A' ' 53' ' ' GLN . 4.5 m-85 -133.29 138.25 46.35 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.735 ' N ' HD22 ' A' ' 122' ' ' LEU . 13.0 mt -156.2 125.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 116.747 -1.981 . . . . 0.0 112.466 -175.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.569 ' HD2' ' NE2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -103.12 90.64 3.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 45' ' ' LEU . 5.1 m -97.47 159.69 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.355 -0.84 . . . . 0.0 110.973 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.681 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -82.38 128.93 34.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.1 45.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.005 0.907 . . . . 0.0 109.377 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 86.23 -96.82 2.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 9.8 p-10 -58.83 -146.74 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.479 -1.012 . . . . 0.0 109.759 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.72 0.84 28.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.079 -1.013 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.58 175.72 6.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.265 -0.897 . . . . 0.0 109.238 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 21.7 m-85 -150.22 169.12 22.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 108.899 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.75 ' SD ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -151.86 112.75 4.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.706 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -72.28 152.44 42.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.041 ' CD2' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -146.85 158.06 43.82 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.279 -1.368 . . . . 0.0 111.615 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 6.5 mtpt -141.3 114.03 8.37 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.965 HG11 HD23 ' A' ' 108' ' ' LEU . 2.3 t -118.8 168.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.746 -1.221 . . . . 0.0 110.358 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.633 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 1.2 t80 -130.59 122.66 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 108.708 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.835 ' CG ' HD11 ' A' ' 108' ' ' LEU . 4.9 tttt -113.73 19.88 16.35 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 122.935 1.35 . . . . 0.0 108.299 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 100' ' ' PHE . 7.0 t -103.63 -92.37 0.35 Allowed 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.792 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.499 ' HG ' ' OG ' ' A' ' 102' ' ' SER . 6.1 mt -96.4 108.99 45.43 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.586 -0.696 . . . . 0.0 109.621 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 102' ' ' SER . 36.2 Cg_endo -78.84 135.3 12.56 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.621 2.214 . . . . 0.0 110.582 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.74 -46.7 6.64 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.532 ' O ' ' CB ' ' A' ' 105' A ASN . 1.1 pt20 -170.58 162.81 8.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -1.107 . . . . 0.0 108.982 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' A ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 20.9 t-20 78.61 7.21 2.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.328 -0.857 . . . . 0.0 109.568 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 105' A ASN . 4.8 mm-40 46.32 -177.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.552 -0.717 . . . . 0.0 110.56 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER 64.36 163.06 0.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.399 -0.813 . . . . 0.0 109.769 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.965 HD23 HG11 ' A' ' 99' ' ' VAL . 6.2 mp -52.08 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.314 1.054 . . . . 0.0 109.788 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.1 p -143.9 163.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.798 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.67 HD22 ' HG ' ' A' ' 32' ' ' LEU . 6.4 tp -101.7 84.38 2.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.584 ' CG2' ' HB2' ' A' ' 100' ' ' PHE . 41.4 p -67.02 -19.82 65.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -176.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 178.36 -170.24 42.24 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.442 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 29.3 p90 172.53 134.53 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.452 -1.029 . . . . 0.0 109.501 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.626 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 2.0 mm100 -96.85 103.25 15.15 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.683 HG23 ' OH ' ' A' ' 40' ' ' TYR . 2.2 p -66.79 154.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 122.254 1.026 . . . . 0.0 111.057 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' A ASP . . . . . . . . . . . . . 12.7 t0 47.29 33.01 2.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.952 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.525 ' HG2' ' ND1' ' A' ' 96' ' ' HIS . 5.6 tptt -77.84 162.62 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.446 -1.409 . . . . 0.0 108.461 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -107.88 160.76 15.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.93 -1.106 . . . . 0.0 109.911 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 3.0 ttpm? -55.47 -48.95 73.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -46.48 -38.44 9.22 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.335 -0.853 . . . . 0.0 109.126 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.613 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -66.27 96.31 0.34 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.325 -0.859 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.31 170.74 15.78 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.735 HD22 ' N ' ' A' ' 62' ' ' ILE . 3.4 mp -93.16 25.4 3.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.411 -1.43 . . . . 0.0 109.202 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.922 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -17.14 -59.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.596 177.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' HA2' HD13 ' A' ' 11' ' ' LEU . . . -150.09 41.06 0.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CG ' ' OXT' ' A' ' 125' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.57 0 CA-C-O 117.827 -1.083 . . . . 0.0 109.054 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.665 ' C ' HD13 ' A' ' 7' ' ' ILE . 2.1 ttp . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.306 0.574 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.665 HD13 ' C ' ' A' ' 6' ' ' MET . 0.6 OUTLIER -118.48 89.8 37.5 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.242 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.42 68.87 7.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.522 2.148 . . . . 0.0 110.507 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.29 171.19 42.11 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.552 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -133.5 6.93 4.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 123' ' ' THR . 0.2 OUTLIER -6.74 100.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.969 0.89 . . . . 0.0 112.867 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.518 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 23.0 t -102.2 169.56 8.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 42.4 tt0 -46.87 172.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.109 -0.995 . . . . 0.0 109.267 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 49' ' ' GLN . . . -81.65 107.25 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.956 -1.09 . . . . 0.0 110.228 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.665 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 1.1 mmtt -77.37 139.95 64.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.22 129.23 22.3 Favored 'Trans proline' 0 C--N 1.291 -2.476 0 N-CA-C 109.584 -0.968 . . . . 0.0 109.584 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.64 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -51.63 133.7 30.45 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.373 1.083 . . . . 0.0 111.788 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.656 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -109.33 -165.19 0.07 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.656 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.2 Cg_endo -72.11 -16.52 28.62 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.428 ' CG ' ' N ' ' A' ' 21' ' ' ILE . 7.5 pt-20 -81.53 -39.1 25.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.924 -1.11 . . . . 0.0 108.539 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.797 HG21 ' HB3' ' A' ' 50' ' ' TYR . 25.7 mm -67.39 -50.32 63.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.559 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -65.13 -15.04 61.97 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -77.37 -37.35 52.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 99' ' ' VAL . 4.6 mt -63.9 -50.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 26' ' ' ASP . 14.3 p -66.75 -40.91 87.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.099 0.952 . . . . 0.0 109.253 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.698 ' N ' HG13 ' A' ' 25' ' ' VAL . 18.5 t0 -72.37 -15.08 61.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -92.91 -13.56 28.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' CG2' ' A' ' 99' ' ' VAL . 31.6 m -116.86 -6.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.487 -0.758 . . . . 0.0 109.676 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.614 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -46.03 -48.55 41.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.894 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.8 Cg_endo -73.58 -29.19 11.13 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.575 1.517 . . . . 0.0 109.101 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' HD23 ' A' ' 110' ' ' LEU . 15.9 mt-30 -79.66 -4.77 53.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.057 ' O ' HG22 ' A' ' 36' ' ' THR . 2.3 mt -98.2 -41.34 7.94 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.657 0.741 . . . . 0.0 109.016 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -65.83 -22.58 66.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.578 -0.701 . . . . 0.0 110.453 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -36.45 12.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.955 -1.091 . . . . 0.0 110.206 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -53.68 10.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.043 . . . . 0.0 110.045 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 1.057 HG22 ' O ' ' A' ' 32' ' ' LEU . 10.0 t -78.76 6.6 8.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.737 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 3.5 p-10 42.93 42.95 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.715 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.548 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 7.9 tt0 -139.22 159.67 41.61 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.162 -0.962 . . . . 0.0 108.961 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.561 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -94.32 133.51 37.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 110.203 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.845 ' OH ' HG21 ' A' ' 36' ' ' THR . 21.1 m-85 -122.77 -168.51 1.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -144.25 -171.1 14.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.99 136.05 3.9 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.162 -1.199 . . . . 0.0 108.978 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.645 ' HB2' HG22 ' A' ' 25' ' ' VAL . 29.9 mt -107.89 85.18 2.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.044 -1.035 . . . . 0.0 108.901 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -68.64 84.47 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.697 -0.627 . . . . 0.0 109.534 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.949 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.6 129.5 5.33 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.211 1.005 . . . . 0.0 109.953 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.536 HG11 ' NZ ' ' A' ' 63' ' ' LYS . 1.5 t -105.0 -46.26 9.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.646 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 1.8 mt-30 -146.92 167.23 24.47 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.797 ' HB3' HG21 ' A' ' 21' ' ' ILE . 3.8 p90 -161.1 137.51 8.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.565 -1.335 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 1.9 mttt -103.73 122.92 46.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.503 HG22 ' HE2' ' A' ' 50' ' ' TYR . 44.1 p -70.43 -173.67 0.75 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.882 ' O ' HG23 ' A' ' 58' ' ' THR . 0.6 OUTLIER -162.18 145.84 11.95 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.885 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -127.67 139.45 51.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.741 -1.224 . . . . 0.0 110.283 179.246 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.885 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.38 -100.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.22 29.6 5.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 157.72 -115.68 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 106.449 -2.66 . . . . 0.0 106.449 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.882 HG23 ' O ' ' A' ' 53' ' ' GLN . 27.4 m -162.32 111.66 1.45 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.188 -1.184 . . . . 0.0 110.831 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.702 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 77.8 m-20 -77.92 -169.49 1.57 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.633 ' CD1' HG12 ' A' ' 99' ' ' VAL . 25.2 m-85 -149.97 159.09 44.66 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.279 -0.888 . . . . 0.0 109.891 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.609 ' HB3' HD22 ' A' ' 122' ' ' LEU . 22.9 m-85 -140.11 136.53 33.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.829 HD12 HD23 ' A' ' 97' ' ' LEU . 14.4 mt -151.29 121.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 116.775 -1.97 . . . . 0.0 111.312 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' NZ ' HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -86.92 94.77 9.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.949 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.6 m -102.01 141.66 17.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.566 -0.709 . . . . 0.0 110.943 -176.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.614 ' HD2' ' CZ ' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -68.88 129.41 39.85 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.59 47.25 1.4 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.033 0.92 . . . . 0.0 108.744 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.56 -94.96 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.69 -164.74 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.333 -1.098 . . . . 0.0 109.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -64.0 -9.04 13.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 110.121 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -68.53 163.52 23.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.614 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 6.5 m-85 -133.32 176.6 8.38 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 108.707 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.682 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -157.32 108.76 2.34 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.176 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.765 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -69.58 144.49 53.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.829 HD23 HD12 ' A' ' 62' ' ' ILE . 46.3 tp -130.59 153.32 49.02 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.994 -1.066 . . . . 0.0 111.063 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.3 ttmt -139.01 111.09 7.31 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 24' ' ' ILE . 1.9 t -117.44 161.14 16.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.713 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 3.2 t80 -127.36 127.92 45.03 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.702 -1.249 . . . . 0.0 107.815 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HB3' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -103.4 141.09 36.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.266 -0.896 . . . . 0.0 108.721 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 102' A LEU . 1.1 t -101.58 104.53 15.41 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.517 -0.739 . . . . 0.0 109.153 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.656 HD12 ' N ' ' A' ' 102' A LEU . 0.2 OUTLIER -36.73 164.85 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.939 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.075 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 102' A LEU . 29.7 Cg_endo -69.63 127.02 14.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.369 2.046 . . . . 0.0 111.083 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.35 -23.94 0.76 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 105' A ASN . 0.0 OUTLIER -131.47 6.33 4.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.576 -0.955 . . . . 0.0 109.128 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' A ASN . . . . . 0.524 ' O ' ' ND2' ' A' ' 105' A ASN . 5.6 p-10 41.75 95.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.383 0.611 . . . . 0.0 110.397 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -125.21 178.72 5.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.232 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -127.61 51.55 1.92 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.3 mp 44.41 -177.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.42 1.105 . . . . 0.0 110.658 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.727 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.9 p -158.57 164.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.055 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.81 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.9 tp -97.47 83.13 3.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.6 OUTLIER -71.94 -11.57 60.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 112.082 -176.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.509 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . 175.28 -171.91 45.0 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.575 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.81 ' HD2' HD11 ' A' ' 110' ' ' LEU . 20.8 p90 168.39 134.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.217 -1.167 . . . . 0.0 109.137 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -94.61 102.2 14.1 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.498 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 2.3 p -68.41 164.08 2.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.868 -1.145 . . . . 0.0 110.73 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' A ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.88 25.82 0.17 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.86 -0.525 . . . . 0.0 110.711 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.576 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.54 161.72 13.52 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 120.66 -1.275 . . . . 0.0 108.366 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.55 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 25.0 p-10 -140.4 -155.79 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.613 -1.305 . . . . 0.0 111.389 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -65.31 -48.46 73.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.27 0.557 . . . . 0.0 110.031 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 118' ' ' LYS . 2.9 t70 -41.05 -26.59 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 109.915 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.576 ' CB ' ' CD ' ' A' ' 116' ' ' LYS . 3.1 t70 -98.26 115.0 27.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 111.376 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.7 ' O ' HG23 ' A' ' 123' ' ' THR . 3.0 tt0 -75.07 146.89 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.765 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -66.59 -12.3 57.23 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.336 -1.477 . . . . 0.0 109.417 -178.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 37.25 -156.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.44 177.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -83.93 49.58 4.26 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.655 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.267 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.543 ' C ' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.786 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -110.09 174.47 2.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.326 -0.859 . . . . 0.0 109.019 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 7' ' ' ILE . 36.6 Cg_endo -80.6 30.44 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.584 2.189 . . . . 0.0 110.815 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.703 ' HA2' HG12 ' A' ' 54' ' ' VAL . . . 132.69 66.83 0.08 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.82 126.06 1.37 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.109 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.614 HD22 ' C ' ' A' ' 123' ' ' THR . 1.1 mp -50.6 143.7 9.02 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.668 -0.901 . . . . 0.0 111.125 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -101.59 171.44 7.56 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.67 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.99 -179.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.384 -0.823 . . . . 0.0 109.526 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HB1' ' CD ' ' A' ' 49' ' ' GLN . . . -82.89 107.76 15.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.005 . . . . 0.0 110.003 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.669 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -83.4 128.78 62.99 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 175.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.87 130.78 23.9 Favored 'Trans proline' 0 C--N 1.294 -2.29 0 N-CA-C 109.311 -1.073 . . . . 0.0 109.311 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.501 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -46.53 162.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.392 1.092 . . . . 0.0 111.552 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.642 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -143.31 -166.95 0.14 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.73 -18.28 28.74 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 N-CA-C 108.992 -1.195 . . . . 0.0 108.992 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.45 -45.57 14.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 0.0 108.567 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.816 HG21 ' HB3' ' A' ' 50' ' ' TYR . 3.6 mm -58.48 -53.16 50.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.37 -19.84 62.32 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 tm-20 -73.87 -35.73 64.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.428 -1.42 . . . . 0.0 108.505 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.94 HG23 HG21 ' A' ' 99' ' ' VAL . 5.1 mt -65.46 -51.22 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.75 0.786 . . . . 0.0 108.934 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.828 HG21 HG11 ' A' ' 64' ' ' VAL . 8.8 p -62.34 -41.99 93.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 122.054 0.931 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.714 ' N ' HG13 ' A' ' 25' ' ' VAL . 6.3 t70 -69.95 -19.86 63.35 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.0 tttt -79.35 -20.7 47.13 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.665 HG21 HD21 ' A' ' 97' ' ' LEU . 17.6 m -117.83 3.1 7.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.732 -0.605 . . . . 0.0 109.938 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 14.7 tttp -47.91 -46.85 64.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.695 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.7 Cg_endo -75.34 -27.34 9.57 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.555 1.503 . . . . 0.0 109.028 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.624 ' O ' HD23 ' A' ' 110' ' ' LEU . 1.2 mt-30 -83.01 -1.03 51.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.127 HD11 ' CD1' ' A' ' 97' ' ' LEU . 2.5 mt -100.47 -33.48 10.33 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.676 0.75 . . . . 0.0 109.269 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 38' ' ' GLU . 2.4 mm-40 -73.89 -32.1 63.42 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.572 -0.705 . . . . 0.0 110.838 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -101.44 -4.43 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.355 -1.466 . . . . 0.0 112.009 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -99.95 -11.39 20.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.488 -1.383 . . . . 0.0 110.355 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.586 ' HB ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -140.11 -28.22 0.74 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.998 -1.064 . . . . 0.0 110.889 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.7 p30 149.11 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' GLU . 26.9 tt0 -66.38 105.09 1.36 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.234 1.016 . . . . 0.0 109.904 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 39' ' ' THR . 46.9 m -158.76 14.39 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.66 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.38 -175.53 2.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.048 -1.032 . . . . 0.0 109.171 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -145.72 -108.47 0.57 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -77.76 134.66 38.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -1.183 . . . . 0.0 108.811 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 25' ' ' VAL . 14.5 mt -108.16 83.47 1.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 108.511 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 3.7 mt-10 -71.87 85.5 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.708 -0.62 . . . . 0.0 109.961 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.838 ' N ' HG13 ' A' ' 64' ' ' VAL . . . -40.47 155.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 110.05 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.4 t -134.79 -41.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.671 ' CD ' ' HB1' ' A' ' 14' ' ' ALA . 25.1 tt0 -142.41 168.97 18.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.816 ' HB3' HG21 ' A' ' 21' ' ' ILE . 9.2 p90 -167.8 137.03 2.58 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.607 -1.308 . . . . 0.0 110.727 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 30.1 mttt -112.41 135.16 53.44 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.451 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 p -87.78 175.46 7.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.088 -1.008 . . . . 0.0 109.754 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.791 ' O ' HG23 ' A' ' 58' ' ' THR . 0.8 OUTLIER -150.31 158.96 44.73 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.703 HG12 ' HA2' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -129.49 137.03 57.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.935 -1.103 . . . . 0.0 110.495 179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -164.46 -96.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' HD11 ' A' ' 102' A LEU . . . -108.03 28.76 7.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.947 ' HA2' HD21 ' A' ' 102' A LEU . . . 161.44 -107.05 0.3 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 53' ' ' GLN . 3.3 m -168.59 109.65 0.52 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.592 -0.946 . . . . 0.0 110.729 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.625 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 41.5 m-80 -70.26 -165.98 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.613 ' CD1' HG12 ' A' ' 99' ' ' VAL . 64.6 m-85 -147.7 159.54 43.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.039 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.763 ' HB3' HD22 ' A' ' 122' ' ' LEU . 47.6 m-85 -140.41 138.18 34.55 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.787 HD12 HD23 ' A' ' 97' ' ' LEU . 24.9 mt -155.95 116.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 C-N-CA 116.873 -1.931 . . . . 0.0 111.495 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.518 ' HD2' ' NE2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -81.66 101.79 10.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.838 HG13 ' N ' ' A' ' 47' ' ' ALA . 11.5 t -113.7 139.97 36.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 112.319 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -69.36 121.29 16.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HG2' ' A' ' 95' ' ' MET . . . -82.64 43.0 0.8 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 111.83 -129.73 9.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 67' ' ' GLY . 34.9 t70 -51.4 -107.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.518 -0.989 . . . . 0.0 110.365 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.03 3.99 36.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.71 -1.244 . . . . 0.0 109.706 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 94' ' ' TYR . 13.1 tptt -68.53 157.37 36.14 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' CD ' ' A' ' 65' ' ' ARG . 2.3 m-85 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.975 -1.078 . . . . 0.0 109.595 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 1.032 ' HE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -163.46 133.66 4.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.572 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.655 ' CE1' ' HG ' ' A' ' 122' ' ' LEU . 5.7 m170 -69.98 161.14 30.61 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.127 ' CD1' HD11 ' A' ' 32' ' ' LEU . 2.8 tp -142.04 129.88 21.76 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.576 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HG3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ttmt -117.54 122.43 43.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.94 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -123.83 168.19 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.971 -1.081 . . . . 0.0 109.009 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.703 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 14.8 t80 -131.84 127.42 36.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.85 -1.156 . . . . 0.0 108.954 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.532 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -113.47 152.97 29.43 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -89.59 -140.83 0.14 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.81 -1.181 . . . . 0.0 109.575 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.947 HD21 ' HA2' ' A' ' 57' ' ' GLY . 13.7 mt -119.8 -87.75 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 111.412 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.767 ' CD ' ' HB2' ' A' ' 102' A LEU . 37.1 Cg_endo -74.79 3.83 5.16 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 121.401 1.401 . . . . 0.0 110.729 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 106' ' ' GLU . . . -83.65 69.81 3.29 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 105' A ASN . 1.6 mm100 -70.45 166.11 21.12 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.046 -1.267 . . . . 0.0 108.7 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' A ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' GLN . 1.5 t-20 43.59 27.61 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.362 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 104' ' ' GLY . 2.8 pt-20 -85.62 -173.34 4.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.858 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 108' ' ' LEU . 58.5 m-20 -108.86 91.42 3.63 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.588 -0.695 . . . . 0.0 109.22 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.5 mp -52.77 -172.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.21 1.005 . . . . 0.0 109.238 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.791 ' O ' HG22 ' A' ' 99' ' ' VAL . 7.3 p -136.73 164.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.52 -177.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 31' ' ' GLN . 7.1 tp -100.09 83.66 2.73 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -67.72 -17.29 64.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 111.197 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.622 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 176.32 -164.78 34.81 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.063 -1.541 . . . . 0.0 110.355 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 29.9 p90 165.99 137.17 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.686 -0.891 . . . . 0.0 109.099 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.622 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 8.6 mm-40 -99.0 94.51 6.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.546 ' HA ' ' CB ' ' A' ' 95' ' ' MET . 1.0 OUTLIER -67.64 157.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.029 -1.669 . . . . 0.0 110.241 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' A ASP . . . . . . . . . . . . . 7.8 t0 53.93 18.6 1.69 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.743 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -87.07 116.15 24.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.687 -1.258 . . . . 0.0 108.364 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.488 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 1.3 m120 -71.72 177.92 3.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.371 -0.831 . . . . 0.0 110.554 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -64.7 -24.22 67.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.62 -0.675 . . . . 0.0 110.066 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.64 -8.78 15.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.168 -0.957 . . . . 0.0 109.605 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.537 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -95.18 116.01 28.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.234 -0.916 . . . . 0.0 110.228 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 123' ' ' THR . 8.1 tt0 -86.95 139.31 30.73 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 61' ' ' TYR . 3.1 mp -62.88 -46.97 85.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.775 -1.203 . . . . 0.0 109.256 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.719 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 54.78 -157.55 0.21 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 107.331 178.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.541 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -77.98 66.45 3.11 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.631 ' O ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.72 -0.871 . . . . 0.0 109.934 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 4.9 mtt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.353 0.597 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 7' ' ' ILE . 3.0 tt 173.41 92.7 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.043 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.45 -92.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.523 2.149 . . . . 0.0 110.651 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.68 145.76 2.45 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -123.1 46.19 1.12 Allowed Glycine 0 N--CA 1.491 2.314 0 O-C-N 121.09 -1.241 . . . . 0.0 110.254 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.112 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -37.46 120.32 0.78 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.83 0.824 . . . . 0.0 110.617 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -100.97 170.96 7.93 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.457 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 1.0 OUTLIER -49.04 -179.38 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 0.0 109.836 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.494 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . . . -81.2 99.04 8.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 110.25 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 2.2 mmpt? -70.42 128.42 91.25 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.61 126.3 14.57 Favored 'Trans proline' 0 C--N 1.292 -2.414 0 N-CA-C 108.813 -1.264 . . . . 0.0 108.813 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 21' ' ' ILE . . . -37.41 162.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.495 1.14 . . . . 0.0 111.794 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.662 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -145.6 -166.17 0.12 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 29.4 Cg_endo -72.9 -21.09 21.51 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.503 -1.384 . . . . 0.0 108.503 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.504 ' O ' HD12 ' A' ' 24' ' ' ILE . 3.4 mt-10 -81.3 -44.92 16.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -0.969 . . . . 0.0 108.811 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.702 HG21 ' HB3' ' A' ' 50' ' ' TYR . 4.4 mm -58.7 -56.18 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.476 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 15.2 tp60 -57.5 -20.09 29.01 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.3 tt0 -75.13 -39.17 60.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.339 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.088 HG23 HG21 ' A' ' 99' ' ' VAL . 2.2 mt -63.76 -49.63 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.043 0.925 . . . . 0.0 108.77 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.72 HG13 ' N ' ' A' ' 26' ' ' ASP . 12.4 p -66.82 -40.57 86.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 122.307 1.051 . . . . 0.0 109.401 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.72 ' N ' HG13 ' A' ' 25' ' ' VAL . 19.3 t0 -75.46 -13.35 60.38 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -95.43 -10.1 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.925 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.899 HG21 ' CD2' ' A' ' 97' ' ' LEU . 27.0 m -114.59 -15.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 110.981 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 ttpt -37.95 -51.07 3.08 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.035 -1.041 . . . . 0.0 110.911 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.5 Cg_endo -70.5 -35.9 9.72 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.421 1.414 . . . . 0.0 109.413 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' HD23 ' A' ' 110' ' ' LEU . 28.6 mt-30 -71.76 -6.44 41.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.9 HD13 ' CE ' ' A' ' 95' ' ' MET . 2.6 mt -96.79 -41.97 8.21 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 13.9 mt-10 -66.84 -8.99 32.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -0.808 . . . . 0.0 109.182 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.34 -56.4 2.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -48.56 20.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 109.958 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.607 HG22 ' CZ ' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -79.39 -14.56 58.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.06 -1.025 . . . . 0.0 108.973 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 1.4 p-10 44.97 64.84 1.24 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.417 0.627 . . . . 0.0 109.907 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.574 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 9.1 mt-10 -130.77 -177.74 4.49 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.3 m -98.8 -26.69 14.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.574 ' CE1' ' OE1' ' A' ' 38' ' ' GLU . 19.6 m-85 35.45 -161.84 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.809 0.814 . . . . 0.0 110.529 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . 179.26 -169.83 41.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.65 129.7 3.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -1.093 . . . . 0.0 108.793 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.705 HD12 HG22 ' A' ' 25' ' ' VAL . 44.2 mt -109.48 82.98 1.68 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.846 -1.158 . . . . 0.0 109.301 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -63.74 84.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.522 -0.737 . . . . 0.0 109.932 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.939 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -43.68 123.29 3.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.145 0.974 . . . . 0.0 109.966 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.2 t -99.51 -47.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.526 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 4.7 mm100 -145.18 172.58 12.91 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.702 ' HB3' HG21 ' A' ' 21' ' ' ILE . 17.2 p90 -166.89 137.08 3.08 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.061 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.541 ' CD ' ' HB2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -113.13 133.75 54.88 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.915 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.6 p -76.73 -176.87 4.02 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.273 -0.892 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.704 ' O ' HG23 ' A' ' 58' ' ' THR . 1.3 mm-40 -160.32 149.22 17.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.581 -0.699 . . . . 0.0 109.323 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -120.48 141.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 110.576 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.25 -103.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' O ' HD11 ' A' ' 102' A LEU . . . -100.1 30.58 3.71 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.876 ' HA2' HD21 ' A' ' 102' A LEU . . . 154.07 -118.19 0.85 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 106.178 -2.769 . . . . 0.0 106.178 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 53' ' ' GLN . 11.4 m -154.38 116.66 4.29 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.332 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.626 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 64.8 m-20 -77.72 -166.03 0.71 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.686 ' CD1' HG12 ' A' ' 99' ' ' VAL . 85.1 m-85 -147.34 153.14 39.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.617 ' CE1' ' OXT' ' A' ' 125' ' ' PHE . 16.0 m-30 -136.94 132.32 34.25 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.807 HG22 HG13 ' A' ' 64' ' ' VAL . 13.6 mt -148.97 124.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 117.06 -1.856 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HA ' ' HZ1' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -95.78 94.66 7.8 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 176.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 47' ' ' ALA . 15.7 m -99.4 144.88 11.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.274 0.559 . . . . 0.0 110.642 -176.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.658 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.1 mmm-85 -69.24 125.41 26.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.919 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -86.26 46.59 1.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.072 0.939 . . . . 0.0 108.904 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 -85.23 1.39 Allowed Glycine 0 C--N 1.287 -2.167 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.39 -168.67 1.2 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.203 -1.175 . . . . 0.0 109.87 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.13 7.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.919 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -69.21 127.02 31.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 108.798 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.599 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 5.6 m-30 -97.39 -179.12 4.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.096 -1.003 . . . . 0.0 110.324 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.9 ' CE ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.0 99.93 3.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.514 -0.741 . . . . 0.0 109.569 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.73 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -71.71 146.96 47.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.899 ' CD2' HG21 ' A' ' 28' ' ' VAL . 4.7 tp -138.21 139.26 39.2 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.371 -1.331 . . . . 0.0 111.531 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 9.6 ttpp -122.92 94.28 4.22 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.088 HG21 HG23 ' A' ' 24' ' ' ILE . 2.3 t -97.25 164.58 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.736 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 7.1 t80 -119.25 138.5 52.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.661 -1.274 . . . . 0.0 108.298 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.651 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -100.65 135.76 41.59 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.778 0.799 . . . . 0.0 109.064 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.511 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -103.29 94.67 5.63 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.053 178.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.876 HD21 ' HA2' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -41.49 -49.27 9.48 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.688 -0.633 . . . . 0.0 110.537 -179.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 102' A LEU . 35.1 Cg_endo -77.62 106.09 2.14 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.954 1.769 . . . . 0.0 110.446 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.4 137.51 2.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 105' A ASN . 4.3 mm-40 -77.75 -111.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.38 -1.071 . . . . 0.0 109.349 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' A ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 105' ' ' GLN . 5.8 t-20 -39.38 150.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 109.769 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.34 145.1 2.54 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.711 0.767 . . . . 0.0 110.499 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -158.52 44.54 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 108' ' ' LEU . 3.0 mp -68.54 -175.28 0.64 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 122.373 1.082 . . . . 0.0 110.381 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.736 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 11.8 p -147.89 162.19 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.627 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.681 HD22 ' HG ' ' A' ' 32' ' ' LEU . 8.0 tp -98.05 89.23 4.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 100' ' ' PHE . 4.4 p -82.12 -11.98 58.45 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.901 -1.124 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.534 ' C ' ' CD2' ' A' ' 113' ' ' TYR . . . -175.01 -168.98 36.35 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.607 ' CZ ' HG22 ' A' ' 36' ' ' THR . 27.0 p90 164.84 139.29 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.578 -0.954 . . . . 0.0 109.26 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.628 ' HG2' ' CE2' ' A' ' 125' ' ' PHE . 3.4 mm100 -102.31 97.82 8.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.523 HG21 ' OE2' ' A' ' 38' ' ' GLU . 2.0 p -66.85 164.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 110.354 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' A ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 115' ' ' VAL . 35.1 t0 43.46 24.75 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.115 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.612 ' HE3' ' CD2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -69.45 155.35 40.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.702 -1.249 . . . . 0.0 108.284 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.497 ' N ' ' HG2' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -107.9 -174.91 2.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -70.21 -38.78 75.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.813 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.96 -8.07 20.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 109.984 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.555 ' CB ' ' HG2' ' A' ' 116' ' ' LYS . 5.3 t0 -75.19 91.41 2.62 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.042 -1.036 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -64.4 155.1 33.56 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.73 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -90.13 55.65 3.16 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.667 1.222 . . . . 0.0 109.575 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -46.85 -172.09 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.291 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 1.112 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -45.09 -16.08 0.07 OUTLIER Glycine 0 N--CA 1.503 3.142 0 O-C-N 121.025 -1.047 . . . . 0.0 110.548 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.628 ' CE2' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.685 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.798 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.8 tpp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 mt 48.05 71.32 1.63 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.333 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.9 82.99 2.35 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.749 2.3 . . . . 0.0 111.107 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.56 ' HA2' HG12 ' A' ' 54' ' ' VAL . . . 68.48 123.42 0.03 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' C ' ' NE2' ' A' ' 53' ' ' GLN . . . -176.76 157.01 21.94 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.768 HD22 ' HA2' ' A' ' 124' ' ' GLY . 1.2 pt? -107.04 149.45 27.56 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.128 -1.219 . . . . 0.0 109.027 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' GLU . 42.4 m -100.52 179.8 4.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 110.829 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tt0 -49.87 -176.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.674 -0.641 . . . . 0.0 109.992 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.912 ' HB1' ' HB2' ' A' ' 49' ' ' GLN . . . -91.38 100.55 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -68.06 146.58 98.22 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 175.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.12 129.63 20.99 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 N-CA-C 108.885 -1.237 . . . . 0.0 108.885 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -37.36 159.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.282 1.039 . . . . 0.0 111.346 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.642 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -139.41 -166.52 0.12 Allowed Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 30.3 Cg_endo -73.65 -17.62 23.1 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 108.693 -1.311 . . . . 0.0 108.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -85.68 -39.95 16.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.713 HG21 ' HB3' ' A' ' 50' ' ' TYR . 6.2 mm -65.17 -53.72 37.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.545 ' NE2' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -57.95 -26.0 61.69 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.297 178.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 60.6 tt0 -76.91 -41.12 44.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 109.54 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.072 HG23 HG21 ' A' ' 99' ' ' VAL . 5.8 mt -56.48 -53.65 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 122.319 1.057 . . . . 0.0 108.271 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.713 HG13 ' N ' ' A' ' 26' ' ' ASP . 11.7 p -66.05 -40.69 87.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.615 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.713 ' N ' HG13 ' A' ' 25' ' ' VAL . 1.8 t70 -70.39 -10.53 59.33 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -99.26 -20.2 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.557 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.749 HG21 HD21 ' A' ' 97' ' ' LEU . 16.1 m -110.41 -4.94 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -44.72 -47.6 28.26 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.003 -1.06 . . . . 0.0 110.133 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.58 -32.4 9.75 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.36 1.374 . . . . 0.0 109.421 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' HD23 ' A' ' 110' ' ' LEU . 21.0 mt-30 -79.77 -1.39 38.47 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.884 HD11 ' CD1' ' A' ' 97' ' ' LEU . 4.2 mt -95.85 -38.48 10.27 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.572 -0.705 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 3.3 mt-10 -66.11 -43.78 86.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.424 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -84.34 -11.29 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -0.967 . . . . 0.0 110.976 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -91.84 -12.21 34.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.76 -1.213 . . . . 0.0 110.451 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 1.049 HG21 ' OH ' ' A' ' 40' ' ' TYR . 6.2 t -122.82 -31.36 3.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.847 -1.158 . . . . 0.0 110.075 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER 101.83 8.82 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.349 0.595 . . . . 0.0 109.724 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.855 ' H ' HG23 ' A' ' 36' ' ' THR . 2.0 tt0 -117.03 152.92 33.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.486 ' N ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -102.29 121.26 41.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 0.0 110.689 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 1.049 ' OH ' HG21 ' A' ' 36' ' ' THR . 11.0 m-85 -110.93 -175.97 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -139.56 -156.43 6.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -38.35 132.17 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.529 -0.983 . . . . 0.0 109.763 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.706 ' HB2' HG22 ' A' ' 25' ' ' VAL . 65.8 mt -112.89 91.49 3.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.085 -1.009 . . . . 0.0 109.064 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.31 90.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.922 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -47.65 125.05 7.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.219 1.009 . . . . 0.0 110.142 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 63' ' ' LYS . 1.4 t -97.63 -45.72 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.912 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 12.8 pt20 -150.91 171.33 17.43 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.713 ' HB3' HG21 ' A' ' 21' ' ' ILE . 8.9 p90 -165.42 139.73 4.8 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.858 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 61.8 mttt -109.39 123.43 49.32 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 p -73.19 -175.97 2.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.892 ' O ' HG23 ' A' ' 58' ' ' THR . 1.1 tm0? -161.85 152.36 17.42 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.848 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.36 140.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 110.084 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.33 -102.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.59 30.53 3.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 157.08 -108.84 0.38 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.749 -2.54 . . . . 0.0 106.749 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 53' ' ' GLN . 26.8 m -167.82 109.2 0.59 Allowed 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.619 -0.93 . . . . 0.0 110.61 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.622 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 65.6 m-20 -69.93 -172.96 0.58 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 20.4 m-85 -144.72 145.79 31.87 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.776 ' HB3' HD22 ' A' ' 122' ' ' LEU . 1.4 m-85 -128.68 133.67 48.27 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.919 HG22 HG13 ' A' ' 64' ' ' VAL . 32.0 mt -150.99 121.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 116.423 -2.111 . . . . 0.0 112.021 -176.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.13 96.97 10.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 176.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.922 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.3 m -105.98 140.3 24.5 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 O-C-N 121.174 -0.954 . . . . 0.0 111.561 -175.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.2 mtm-85 -68.51 133.87 49.22 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 93' ' ' LYS . . . -85.12 42.81 0.96 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.793 0.806 . . . . 0.0 109.175 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 73.35 -81.33 0.71 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' GLY . 7.0 m-20 -55.13 -113.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -1.033 . . . . 0.0 110.496 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.05 -30.91 4.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.747 -1.22 . . . . 0.0 109.293 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.776 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 29.7 mtmt -68.73 144.58 54.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.602 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 15.7 m-30 -109.81 176.99 4.86 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.116 -0.99 . . . . 0.0 109.023 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.658 ' O ' HG22 ' A' ' 64' ' ' VAL . 20.2 ttp -144.65 119.92 10.2 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.007 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.788 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -69.17 151.13 46.72 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.884 ' CD1' HD11 ' A' ' 32' ' ' LEU . 13.3 tp -130.71 142.04 50.41 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.118 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.629 ' HE2' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -131.0 95.79 3.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.072 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -105.42 161.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.197 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.705 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 5.0 t80 -126.54 129.71 49.14 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.636 -1.29 . . . . 0.0 108.483 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HG2' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -98.97 115.71 29.54 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 102' A LEU . 28.8 m -102.11 47.62 0.89 Allowed 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.202 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.517 ' C ' ' O ' ' A' ' 102' ' ' SER . 0.5 OUTLIER 31.02 63.32 1.03 Allowed Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.767 -0.583 . . . . 0.0 110.287 179.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 102' A LEU . 36.5 Cg_endo -77.56 -167.55 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.794 2.329 . . . . 0.0 111.534 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.95 -35.24 0.06 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.2 -179.1 5.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.624 -0.927 . . . . 0.0 108.873 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' A ASN . . . . . . . . . . . . . 1.6 t-20 53.1 -146.03 0.55 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 109.737 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.458 ' O ' ' OD1' ' A' ' 107' ' ' ASP . 0.7 OUTLIER -71.88 -179.58 2.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.102 -0.999 . . . . 0.0 109.785 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' OD2' ' HG2' ' A' ' 103' ' ' PRO . 0.6 OUTLIER -151.72 140.55 20.94 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.351 -0.843 . . . . 0.0 110.146 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 108' ' ' LEU . 10.4 mp 55.6 175.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.72 1.247 . . . . 0.0 111.05 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.705 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 13.9 p -152.37 163.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.742 -177.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 112' ' ' GLY . 9.0 tp -100.43 83.41 2.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.604 HG21 ' HB2' ' A' ' 100' ' ' PHE . 0.9 OUTLIER -69.26 -10.51 58.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 111.735 -176.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.598 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 171.35 -165.4 38.42 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.612 -1.756 . . . . 0.0 111.157 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 30.2 p90 165.73 143.47 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.639 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 3.9 mm100 -105.26 103.6 13.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.629 -1.294 . . . . 0.0 107.662 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -68.61 162.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.71 -1.244 . . . . 0.0 111.162 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.1 t0 51.78 20.34 1.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.654 ' HG3' ' OD2' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -74.32 161.67 29.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.81 -1.181 . . . . 0.0 108.293 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.506 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 1.1 m120 -152.68 -167.73 2.83 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.199 -1.563 . . . . 0.0 112.752 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -36.7 -38.34 0.17 Allowed 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.196 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.43 53.27 2.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.718 ' CG ' ' CE1' ' A' ' 96' ' ' HIS . 1.1 t0 -92.91 108.59 20.12 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.85 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.674 ' O ' HG23 ' A' ' 123' ' ' THR . 1.9 tt0 -102.29 105.49 16.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.788 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 0.8 OUTLIER -69.07 -28.86 66.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.364 -1.46 . . . . 0.0 107.841 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 39.9 -160.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.758 0.789 . . . . 0.0 110.55 176.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.768 ' HA2' HD22 ' A' ' 11' ' ' LEU . . . -69.71 -0.35 24.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.639 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.33 -1.1 . . . . 0.0 109.01 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.6 ttm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.488 HG23 ' HD2' ' A' ' 8' ' ' PRO . 10.7 mm -67.96 138.83 92.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 109.485 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HD2' HG23 ' A' ' 7' ' ' ILE . 36.2 Cg_endo -79.02 -85.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.375 2.05 . . . . 0.0 110.107 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.54 -5.54 62.48 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' NE2' ' A' ' 53' ' ' GLN . . . -77.73 -162.98 19.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.693 HD12 ' NE2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER 39.98 71.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.654 1.216 . . . . 0.0 110.647 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -103.28 -176.37 3.07 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.558 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' SER . 7.5 tt0 -50.3 -179.85 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.125 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' CB ' ' NE2' ' A' ' 49' ' ' GLN . . . -81.1 104.92 11.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -74.83 133.44 76.22 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . 28.3 Cg_endo -67.47 130.2 21.8 Favored 'Trans proline' 0 C--N 1.292 -2.397 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -40.94 167.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.422 1.106 . . . . 0.0 111.786 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.639 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -149.88 -165.53 0.11 Allowed Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 30.1 Cg_endo -73.37 -19.05 22.58 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 108.581 -1.354 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.23 -45.87 13.35 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.153 -0.967 . . . . 0.0 108.572 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.688 HG21 ' HB3' ' A' ' 50' ' ' TYR . 3.2 mm -58.03 -54.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.482 ' C ' HG12 ' A' ' 25' ' ' VAL . 34.1 tp60 -58.97 -21.66 58.96 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.7 tt0 -75.14 -41.33 58.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 109.061 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.057 HG23 HG21 ' A' ' 99' ' ' VAL . 3.6 mt -60.5 -50.03 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.989 0.9 . . . . 0.0 108.791 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.733 HG22 HD12 ' A' ' 45' ' ' LEU . 11.1 p -65.03 -40.84 90.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 122.134 0.969 . . . . 0.0 108.893 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.712 ' N ' HG13 ' A' ' 25' ' ' VAL . 43.8 t0 -71.45 -13.24 61.76 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.7 mmtt -96.03 -11.26 26.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.045 HG21 HD21 ' A' ' 97' ' ' LEU . 16.9 m -121.88 -4.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 0.0 110.995 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 13.3 ttpt -47.95 -45.59 62.72 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.927 -1.108 . . . . 0.0 111.035 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 31.9 Cg_endo -72.83 -36.89 4.19 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.473 1.449 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.1 mt-30 -71.52 -7.32 46.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.838 HD22 ' CE ' ' A' ' 95' ' ' MET . 8.8 mt -100.89 -34.86 9.62 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.612 -0.68 . . . . 0.0 109.867 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 20.2 mt-10 -52.6 -48.83 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.139 -0.976 . . . . 0.0 109.814 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' CA ' ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -86.71 -44.75 11.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.322 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 5.3 mmtt -42.81 -27.0 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 67.5 p -104.48 -72.57 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.953 . . . . 0.0 110.003 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 36' ' ' THR . 11.0 p30 149.55 38.3 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HG2' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -164.23 -177.99 5.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.327 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.96 125.23 53.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 110.296 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 10.8 m-85 -103.12 169.5 8.52 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -129.25 -150.99 7.23 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.811 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.99 119.81 1.62 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.486 -1.008 . . . . 0.0 109.022 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 25' ' ' VAL . 62.8 mt -99.54 86.45 3.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.964 -1.085 . . . . 0.0 108.497 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.206 0.526 . . . . 0.0 110.332 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.753 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -47.28 115.28 1.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.054 -1.029 . . . . 0.0 109.493 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.603 HG12 ' HG3' ' A' ' 49' ' ' GLN . 1.5 t -94.08 -46.34 13.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HG3' HG12 ' A' ' 48' ' ' VAL . 5.8 mt-30 -146.26 173.55 12.14 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.169 -1.013 . . . . 0.0 108.964 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.688 ' HB3' HG21 ' A' ' 21' ' ' ILE . 18.1 p90 -168.34 138.15 2.48 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.946 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -106.08 130.44 53.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 p -83.27 -174.01 5.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.38 -0.825 . . . . 0.0 110.786 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.787 ' O ' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -164.69 152.1 11.51 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.675 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -125.77 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.941 -1.099 . . . . 0.0 110.594 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -165.46 -102.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.11 30.42 5.6 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 160.71 -109.27 0.39 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 53' ' ' GLN . 8.4 m -167.28 112.21 0.72 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.418 -1.048 . . . . 0.0 110.856 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.636 ' HB2' ' HB3' ' A' ' 53' ' ' GLN . 45.6 m-80 -72.38 -165.95 0.23 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CD1' HG12 ' A' ' 99' ' ' VAL . 44.7 m-85 -156.02 160.23 39.84 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.672 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 125' ' ' PHE . 26.7 m-85 -144.45 134.85 24.49 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.737 HG22 HG13 ' A' ' 64' ' ' VAL . 15.3 mt -151.41 125.26 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 116.828 -1.949 . . . . 0.0 111.405 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.701 ' CG ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -94.6 91.25 6.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 47' ' ' ALA . 34.4 m -98.77 140.43 18.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 O-C-N 121.857 -0.527 . . . . 0.0 110.317 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.649 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 ttp180 -68.12 138.3 55.61 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.702 -1.249 . . . . 0.0 107.943 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.2 46.63 1.4 Allowed 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 122.269 1.033 . . . . 0.0 108.412 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.54 -77.93 1.69 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' CD ' ' A' ' 65' ' ' ARG . 3.8 t0 -61.1 -155.77 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.274 -1.133 . . . . 0.0 109.236 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -83.22 -3.67 57.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 109.366 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.575 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -75.31 178.48 5.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.21 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.649 ' CD2' ' HA ' ' A' ' 65' ' ' ARG . 33.7 m-85 -150.76 165.89 32.11 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.038 -1.039 . . . . 0.0 109.55 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.838 ' CE ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -146.41 126.07 13.38 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 108.703 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.72 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 2.7 m170 -74.76 151.3 39.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.045 HD21 HG21 ' A' ' 28' ' ' VAL . 15.6 tp -138.48 133.75 33.1 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.852 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.532 ' CD ' ' OG1' ' A' ' 111' ' ' THR . 0.1 OUTLIER -115.6 124.17 50.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.057 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -129.42 166.53 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.612 -1.305 . . . . 0.0 108.698 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.691 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 9.8 t80 -131.06 136.0 48.06 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.844 -1.16 . . . . 0.0 109.195 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.621 ' CG ' HD11 ' A' ' 108' ' ' LEU . 6.1 tttt -102.96 108.79 20.11 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.481 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 91.4 p -102.42 87.59 3.06 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 121.419 0.628 . . . . 0.0 109.478 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.579 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -45.03 -49.15 30.39 Favored Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.413 -0.804 . . . . 0.0 109.935 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' A LEU . 35.8 Cg_endo -78.41 164.84 26.02 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.356 2.037 . . . . 0.0 110.843 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 106' ' ' GLU . . . 108.83 46.84 0.93 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 55.08 -178.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -1.159 . . . . 0.0 109.515 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' A ASN . . . . . . . . . . . . . 1.2 m-20 -69.92 86.11 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 104' ' ' GLY . 6.7 mm-40 -120.41 -176.13 3.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -0.909 . . . . 0.0 109.573 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.01 176.49 6.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.296 -0.877 . . . . 0.0 110.086 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.693 HD23 HG11 ' A' ' 99' ' ' VAL . 10.6 mp -55.92 -172.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.36 1.076 . . . . 0.0 110.89 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.795 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.3 p -145.45 164.56 11.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.499 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 97' ' ' LEU . 9.1 tp -102.35 86.88 2.9 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.532 ' OG1' ' CD ' ' A' ' 98' ' ' LYS . 2.2 p -70.38 -29.82 66.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 0.0 111.625 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.599 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -165.88 -162.85 18.14 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.865 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.756 ' CG ' HD21 ' A' ' 32' ' ' LEU . 19.1 p90 165.77 134.68 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.357 -1.084 . . . . 0.0 109.168 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.632 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.9 mm-40 -97.51 102.14 13.83 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.626 HG23 ' HE3' ' A' ' 95' ' ' MET . 0.6 OUTLIER -68.17 159.3 5.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.683 -1.26 . . . . 0.0 111.349 -177.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' A ASP . . . . . . . . . . . . . 11.7 t0 48.73 31.44 3.07 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.523 ' HD3' ' CB ' ' A' ' 114' ' ' GLN . 2.5 mptt -93.95 114.34 26.53 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.504 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 13.0 m-80 -69.11 -169.18 0.17 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.867 . . . . 0.0 110.062 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -44.45 40.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.454 -0.779 . . . . 0.0 109.442 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -50.9 -21.09 1.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -73.12 127.3 32.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.146 -0.971 . . . . 0.0 110.05 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 123' ' ' THR . 22.4 tt0 -93.63 136.12 34.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.72 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 1.5 mp -64.2 -32.12 73.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 108.664 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER 43.81 -160.31 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.136 178.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.553 ' N ' ' OG1' ' A' ' 123' ' ' THR . . . -62.36 89.2 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.634 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -164.52 83.11 1.24 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.431 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 54' ' ' VAL . 36.2 Cg_endo -78.39 -172.37 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.597 2.198 . . . . 0.0 110.289 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.676 ' CA ' HG12 ' A' ' 54' ' ' VAL . . . 137.52 133.25 3.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.45 114.61 0.77 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.89 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.9 OUTLIER -55.61 138.26 47.36 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.949 0.88 . . . . 0.0 111.28 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.9 m -101.73 167.81 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.0 tt0 -49.28 179.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.319 -0.863 . . . . 0.0 109.458 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.527 ' CB ' ' OE1' ' A' ' 49' ' ' GLN . . . -73.3 96.21 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 0.0 110.297 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 50' ' ' TYR . 3.1 mmpt? -69.66 131.82 89.46 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.93 124.89 13.31 Favored 'Trans proline' 0 C--N 1.291 -2.466 0 N-CA-C 109.164 -1.129 . . . . 0.0 109.164 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.721 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -47.59 123.29 5.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.902 0.858 . . . . 0.0 111.763 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.609 ' OG1' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -95.69 -172.75 0.3 Allowed Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 27.8 Cg_endo -67.82 -20.06 46.12 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 N-CA-C 109.786 -0.89 . . . . 0.0 109.786 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.58 -34.76 30.83 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.981 -1.074 . . . . 0.0 108.777 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.891 HG21 ' HB3' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -69.28 -46.8 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.529 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -69.57 -13.44 62.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.2 tt0 -76.56 -40.16 50.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.984 HG23 HG21 ' A' ' 99' ' ' VAL . 5.3 mt -60.76 -51.5 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.802 HG21 HG11 ' A' ' 64' ' ' VAL . 12.4 p -64.38 -42.06 94.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.981 0.895 . . . . 0.0 108.81 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.712 ' N ' HG13 ' A' ' 25' ' ' VAL . 43.3 t0 -68.84 -14.92 63.33 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -93.37 -15.16 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.198 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.747 ' O ' HD12 ' A' ' 32' ' ' LEU . 31.6 m -119.85 -0.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.872 . . . . 0.0 110.557 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 7.7 ttpp -50.82 -44.62 85.84 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.847 -1.158 . . . . 0.0 110.361 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 32.3 Cg_endo -73.86 -34.23 5.5 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.155 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.8 mt-30 -74.52 -5.52 43.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.857 HD11 HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -100.43 -35.84 9.43 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.519 -0.738 . . . . 0.0 109.488 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -72.37 -29.33 63.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.462 -0.774 . . . . 0.0 110.881 -179.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.43 -17.73 17.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.889 -1.132 . . . . 0.0 110.464 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 22.8 ttmt -78.34 -61.74 1.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.995 -1.066 . . . . 0.0 109.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.749 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -72.98 -19.33 61.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.846 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.5 OUTLIER 85.75 11.83 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.65 -0.657 . . . . 0.0 109.517 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' H ' HG23 ' A' ' 36' ' ' THR . 7.9 tt0 -109.17 138.86 44.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -76.44 125.63 29.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.124 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.659 ' OH ' HG21 ' A' ' 36' ' ' THR . 31.9 m-85 -112.77 179.76 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 108.948 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -144.68 -164.43 10.56 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -43.05 123.78 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -1.111 . . . . 0.0 108.836 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.65 HD12 HG22 ' A' ' 25' ' ' VAL . 46.3 mt -102.49 91.37 4.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.849 -1.157 . . . . 0.0 108.372 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -72.01 82.85 0.96 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.898 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -40.17 134.68 1.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.116 0.96 . . . . 0.0 110.005 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.683 HG12 ' HG3' ' A' ' 49' ' ' GLN . 2.0 t -118.45 -42.14 2.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.683 ' HG3' HG12 ' A' ' 48' ' ' VAL . 2.4 mt-30 -142.72 171.71 13.69 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.891 ' HB3' HG21 ' A' ' 21' ' ' ILE . 18.4 p90 -170.82 136.48 1.17 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 61' ' ' TYR . 3.8 mttt -109.11 157.41 18.76 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.353 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.421 HG22 ' HD1' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -138.93 140.2 38.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.373 -0.829 . . . . 0.0 109.162 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.592 ' HG2' ' CE1' ' A' ' 61' ' ' TYR . 0.9 OUTLIER -138.29 174.31 10.69 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.561 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.824 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -113.4 158.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.718 -1.239 . . . . 0.0 110.933 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.67 -101.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 27.26 6.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.591 ' CA ' HD11 ' A' ' 102' A LEU . . . 153.69 -119.94 0.99 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 106.202 -2.759 . . . . 0.0 106.202 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 53' ' ' GLN . 19.1 m -151.68 109.31 3.63 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.038 -1.272 . . . . 0.0 110.542 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.721 ' ND2' HG21 ' A' ' 55' ' ' VAL . 64.4 m-80 -72.85 -171.09 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.2 m-85 -144.44 158.63 43.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.918 0.866 . . . . 0.0 108.988 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.62 ' CE2' HD21 ' A' ' 11' ' ' LEU . 2.1 m-85 -138.73 139.99 38.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.948 HD12 HD23 ' A' ' 97' ' ' LEU . 13.2 mt -154.7 123.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 116.72 -1.992 . . . . 0.0 112.06 -176.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' HE3' ' CA ' ' A' ' 118' ' ' LYS . 15.9 tttt -93.06 92.44 7.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.898 HG12 ' HA ' ' A' ' 47' ' ' ALA . 6.1 m -98.91 143.27 13.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.587 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 3.9 mtm180 -67.67 131.28 45.3 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . . . -85.35 44.65 1.11 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.986 0.898 . . . . 0.0 109.445 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 96.69 -113.12 4.6 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 67' ' ' GLY . 1.5 p30 -49.84 -104.43 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -1.031 . . . . 0.0 110.655 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -119.66 -1.9 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.945 -1.097 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.1 mptp? -68.47 -177.93 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.53 ' CD1' ' HA ' ' A' ' 65' ' ' ARG . 8.2 m-85 -146.12 166.82 25.02 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.879 -1.138 . . . . 0.0 109.727 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.646 ' O ' HG22 ' A' ' 64' ' ' VAL . 49.0 ttp -151.73 111.31 3.98 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.485 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.751 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -69.6 147.6 50.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.125 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.948 HD23 HD12 ' A' ' 62' ' ' ILE . 13.2 tp -128.52 153.02 47.61 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.246 -0.909 . . . . 0.0 110.71 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.556 ' C ' ' HG1' ' A' ' 111' ' ' THR . 2.6 tttm -143.09 102.32 3.98 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.984 HG21 HG23 ' A' ' 24' ' ' ILE . 2.1 t -112.95 160.39 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.762 -1.211 . . . . 0.0 109.404 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.74 ' HB2' HG21 ' A' ' 111' ' ' THR . 9.3 t80 -120.37 137.9 54.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.47 -1.394 . . . . 0.0 108.408 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -110.91 138.5 47.23 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.015 0.912 . . . . 0.0 109.317 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.46 ' N ' ' HG3' ' A' ' 101' ' ' LYS . 22.0 p -103.51 93.41 4.93 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.608 ' CD1' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -38.61 -52.7 3.45 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.757 -0.589 . . . . 0.0 110.53 -179.148 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.608 ' HD3' ' CD1' ' A' ' 102' A LEU . 36.6 Cg_endo -78.43 -173.06 1.69 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.427 2.085 . . . . 0.0 110.704 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 105' ' ' GLN . . . 87.58 125.39 2.13 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.499 ' HG3' ' N ' ' A' ' 105' A ASN . 11.6 tp60 -54.03 -104.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -1.058 . . . . 0.0 109.216 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' A ASN . . . . . 0.499 ' N ' ' HG3' ' A' ' 105' ' ' GLN . 0.9 OUTLIER -47.44 125.21 7.86 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.216 -0.928 . . . . 0.0 109.377 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -51.52 153.0 2.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 109.117 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.71 59.86 0.94 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.651 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 108' ' ' LEU . 7.2 mp -60.5 -177.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.259 1.028 . . . . 0.0 109.54 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 99' ' ' VAL . 12.2 p -153.7 163.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.79 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 6.7 tp -99.6 84.1 2.89 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.74 HG21 ' HB2' ' A' ' 100' ' ' PHE . 16.8 p -69.02 -15.75 63.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 111.504 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' O ' HD11 ' A' ' 110' ' ' LEU . . . 174.68 -167.52 39.8 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.59 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 30.1 p90 170.99 137.54 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.645 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -98.04 102.66 14.47 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.532 HG23 ' OH ' ' A' ' 40' ' ' TYR . 9.9 p -67.99 158.47 5.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.131 -0.98 . . . . 0.0 111.195 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' A ASP . . . . . . . . . . . . . 5.5 t70 45.92 27.99 0.55 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 7.6 mmtm -101.01 129.76 46.9 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 120.676 -1.265 . . . . 0.0 108.48 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 2.4 m120 -105.65 -156.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 111.054 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' CA ' ' HE3' ' A' ' 63' ' ' LYS . 1.5 ttpm? -58.73 -45.41 89.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.699 -0.626 . . . . 0.0 109.981 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.21 -22.88 0.44 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.504 ' OD1' ' CE ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -89.0 122.52 32.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 110.993 -179.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.698 ' O ' HG23 ' A' ' 123' ' ' THR . 0.3 OUTLIER -94.99 132.79 39.45 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.751 ' HG ' ' NE2' ' A' ' 96' ' ' HIS . 2.2 mp -60.76 -55.92 27.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.782 -1.199 . . . . 0.0 109.344 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.743 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 56.7 -163.79 0.16 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.802 -1.186 . . . . 0.0 110.031 177.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.89 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -50.52 -14.98 1.08 Allowed Glycine 0 N--CA 1.501 3.022 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.645 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 120.859 -1.377 . . . . 0.0 109.113 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 57.0 mmm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.652 ' N ' HD13 ' A' ' 7' ' ' ILE . 2.0 mm -71.37 -47.04 13.64 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.559 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 7' ' ' ILE . 36.1 Cg_endo -78.74 101.2 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.147 1.898 . . . . 0.0 110.661 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.7 -145.32 0.3 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . -125.6 2.82 8.13 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 121.096 -1.238 . . . . 0.0 110.182 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.566 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER 1.47 113.89 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.916 0.865 . . . . 0.0 112.534 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -101.06 160.41 14.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' SER . 41.5 tt0 -46.76 173.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB1' ' CG ' ' A' ' 49' ' ' GLN . . . -59.85 95.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.875 -1.14 . . . . 0.0 109.871 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.608 ' CB ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -69.68 130.31 90.5 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 17' ' ' ALA . 28.1 Cg_endo -67.64 126.14 14.32 Favored 'Trans proline' 0 C--N 1.288 -2.608 0 N-CA-C 108.772 -1.28 . . . . 0.0 108.772 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.573 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -40.66 156.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.289 1.042 . . . . 0.0 111.468 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.648 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -135.05 -168.38 0.18 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.648 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 28.5 Cg_endo -71.35 -18.11 30.22 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 N-CA-C 109.177 -1.124 . . . . 0.0 109.177 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -82.96 -47.37 11.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.046 -1.034 . . . . 0.0 108.435 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.809 HG21 ' HB3' ' A' ' 50' ' ' TYR . 6.7 mm -56.8 -54.72 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.573 ' NE2' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -53.97 -26.95 28.45 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.81 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 4.2 tp10 -76.77 -35.2 57.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.083 . . . . 0.0 110.155 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.971 HG23 HG21 ' A' ' 99' ' ' VAL . 3.5 mt -66.19 -49.95 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.887 HG21 HG11 ' A' ' 64' ' ' VAL . 12.8 p -66.18 -41.3 89.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 122.279 1.038 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.702 ' N ' HG13 ' A' ' 25' ' ' VAL . 12.5 t70 -74.98 -14.17 60.59 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 30.8 ttmt -93.36 -10.96 33.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.994 HG21 HD21 ' A' ' 97' ' ' LEU . 15.5 m -117.78 -5.31 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 110.653 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 4.5 ttpm? -42.72 -48.65 13.51 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.891 -1.131 . . . . 0.0 110.661 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 29.3 Cg_endo -69.65 -33.89 16.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.294 1.329 . . . . 0.0 109.799 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' O ' HD23 ' A' ' 110' ' ' LEU . 25.4 mt-30 -74.92 -5.01 41.42 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.996 HD11 ' CD1' ' A' ' 97' ' ' LEU . 5.4 mt -97.67 -38.07 9.66 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.593 -0.692 . . . . 0.0 109.705 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 39' ' ' THR . 35.5 mt-10 -65.34 -26.46 68.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.503 -0.748 . . . . 0.0 109.645 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.39 -40.74 11.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HG2' ' OH ' ' A' ' 113' ' ' TYR . 12.0 tttt -75.19 -8.07 55.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 32' ' ' LEU . 9.9 p -123.03 -48.31 2.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.608 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER 104.48 32.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.189 0.519 . . . . 0.0 109.724 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 5.1 mt-10 -130.42 145.08 51.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.265 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 40' ' ' TYR . 97.6 m -75.17 -10.36 59.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.107 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.722 ' CD2' ' HE1' ' A' ' 95' ' ' MET . 25.7 m-85 36.71 -163.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.76 0.79 . . . . 0.0 110.61 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . -162.97 -167.71 23.8 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.73 126.22 3.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -1.108 . . . . 0.0 108.787 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.671 ' HB2' HG22 ' A' ' 25' ' ' VAL . 41.4 mt -100.17 71.62 1.61 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 108.082 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 19.1 mt-10 -53.31 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.883 -0.51 . . . . 0.0 109.962 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -44.28 143.06 1.32 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.104 0.955 . . . . 0.0 109.589 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.9 -41.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.548 ' HB2' ' CD ' ' A' ' 63' ' ' LYS . 12.5 mt-30 -147.9 171.89 15.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.809 ' HB3' HG21 ' A' ' 21' ' ' ILE . 14.5 p90 -171.18 137.09 1.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.88 -1.138 . . . . 0.0 110.648 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.502 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -108.64 119.41 39.45 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 p -71.7 176.46 4.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.34 -0.85 . . . . 0.0 109.853 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.861 ' O ' HG23 ' A' ' 58' ' ' THR . 2.4 mm100 -152.34 148.25 27.28 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -129.73 137.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.942 -1.099 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -165.67 -102.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.67 28.49 5.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 1.034 ' HA2' HD11 ' A' ' 102' A LEU . . . 162.48 -121.7 1.04 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 106.856 -2.498 . . . . 0.0 106.856 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.861 HG23 ' O ' ' A' ' 53' ' ' GLN . 23.1 m -159.52 104.91 1.63 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.087 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.625 HD21 HG21 ' A' ' 55' ' ' VAL . 48.3 m-80 -70.04 -178.45 1.61 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 59' ' ' ASN . 21.1 m-85 -141.44 153.68 45.13 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.098 -1.001 . . . . 0.0 109.256 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CD1' ' HB2' ' A' ' 125' ' ' PHE . 23.3 m-30 -133.76 135.53 43.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.74 HG22 HG13 ' A' ' 64' ' ' VAL . 30.5 mt -153.91 129.99 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 116.774 -1.97 . . . . 0.0 112.408 -176.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.947 ' HG2' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.22 102.79 14.17 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -109.7 139.99 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.46 -0.775 . . . . 0.0 110.825 -176.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -67.32 126.87 30.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.99 45.06 1.05 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.91 0.862 . . . . 0.0 109.646 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 85.36 -98.07 2.22 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -56.69 -157.39 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.378 -1.072 . . . . 0.0 109.612 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -71.83 -6.62 42.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 109.476 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -69.85 164.31 23.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 109.085 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.507 ' OH ' ' HD2' ' A' ' 65' ' ' ARG . 11.7 m-85 -136.77 169.87 17.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.733 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.722 ' HE1' ' CD2' ' A' ' 40' ' ' TYR . 20.8 ttm -154.93 113.31 3.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.038 -1.038 . . . . 0.0 109.659 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.723 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 1.3 m170 -74.31 156.9 36.65 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.996 ' CD1' HD11 ' A' ' 32' ' ' LEU . 1.4 tp -148.96 139.85 22.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.698 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 19.1 tttt -121.63 107.25 12.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.971 HG21 HG23 ' A' ' 24' ' ' ILE . 2.2 t -107.24 162.08 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.729 -1.232 . . . . 0.0 109.712 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.708 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 10.5 t80 -124.15 133.03 53.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.536 -1.352 . . . . 0.0 108.681 177.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -107.02 128.01 53.97 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.838 0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.462 ' C ' ' HD2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -103.93 94.54 5.47 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.319 0.581 . . . . 0.0 109.865 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 1.034 HD11 ' HA2' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -47.2 -48.43 54.88 Favored Pre-proline 0 C--N 1.295 -1.781 0 O-C-N 121.324 -0.86 . . . . 0.0 109.732 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 102' A LEU . 36.5 Cg_endo -79.3 168.14 20.54 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.275 1.983 . . . . 0.0 110.52 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.85 145.8 5.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -76.53 -0.68 24.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -1.166 . . . . 0.0 109.851 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' A ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 106' ' ' GLU . 4.0 t-20 -166.33 111.73 0.82 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.575 -0.703 . . . . 0.0 109.528 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 105' A ASN . 1.2 pt-20 -42.98 156.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 108' ' ' LEU . 0.3 OUTLIER 172.57 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.884 . . . . 0.0 109.796 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' A' ' 108' ' ' LEU . 5.4 mp -52.18 -176.05 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.087 0.946 . . . . 0.0 109.386 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 99' ' ' VAL . 13.6 p -151.98 164.76 2.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.737 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 97' ' ' LEU . 4.6 tp -101.67 83.76 2.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.577 HG21 ' HB2' ' A' ' 100' ' ' PHE . 1.2 p -72.84 -12.79 61.12 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.023 -1.048 . . . . 0.0 112.054 -176.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.688 ' O ' HD11 ' A' ' 110' ' ' LEU . . . -176.34 -167.48 35.13 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.066 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.602 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 30.2 p90 164.66 137.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.613 -0.933 . . . . 0.0 108.975 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.663 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 4.8 mm-40 -100.14 97.19 8.04 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.531 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 5.3 p -67.56 163.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.987 -1.071 . . . . 0.0 111.034 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' A ASP . . . . . 0.435 ' N ' HG22 ' A' ' 115' ' ' VAL . 3.9 t0 48.92 26.64 1.38 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.045 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.555 ' HG2' ' N ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -67.73 -166.27 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.779 -1.201 . . . . 0.0 108.463 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.536 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -149.51 -177.62 5.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.749 -1.22 . . . . 0.0 110.099 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -71.69 -34.09 69.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.419 -0.801 . . . . 0.0 109.267 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.03 -14.22 59.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.516 ' O ' ' CE1' ' A' ' 96' ' ' HIS . 3.2 t0 -72.31 103.54 3.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.824 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 123' ' ' THR . 0.1 OUTLIER -87.92 146.24 25.65 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.947 HD11 ' HG2' ' A' ' 63' ' ' LYS . 1.9 mp -66.98 -40.0 87.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.553 -1.342 . . . . 0.0 108.302 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER 40.04 22.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.007 0.908 . . . . 0.0 110.905 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 121.73 116.99 2.45 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.663 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.511 0 O-C-N 121.167 -1.196 . . . . 0.0 109.505 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.481 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.742 HG23 ' HD2' ' A' ' 8' ' ' PRO . 1.9 mp 62.01 143.03 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.012 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.742 ' HD2' HG23 ' A' ' 7' ' ' ILE . 34.5 Cg_endo -75.95 171.39 18.25 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.427 2.085 . . . . 0.0 110.624 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.628 ' HA3' HG12 ' A' ' 54' ' ' VAL . . . 80.45 -173.99 54.89 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 11' ' ' LEU . . . 145.6 135.0 2.76 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.571 -1.299 . . . . 0.0 110.077 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.902 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -40.55 125.42 2.18 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.408 -1.054 . . . . 0.0 110.759 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 33.6 m -101.32 171.6 7.5 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 12' ' ' SER . 3.6 tp10 -47.8 174.79 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.912 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.23 99.62 3.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.099 -1.0 . . . . 0.0 110.006 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 9.8 mmpt? -69.16 131.19 90.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -68.11 125.35 12.91 Favored 'Trans proline' 0 C--N 1.291 -2.494 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.624 ' HB1' ' CB ' ' A' ' 47' ' ' ALA . . . -48.21 148.66 1.75 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.441 1.115 . . . . 0.0 111.466 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.629 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -128.96 -169.33 0.19 Allowed Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 27.9 Cg_endo -69.09 -17.67 40.49 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 N-CA-C 109.796 -0.886 . . . . 0.0 109.796 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.506 ' HG3' HD13 ' A' ' 21' ' ' ILE . 15.3 pt-20 -82.03 -41.79 20.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.787 -1.196 . . . . 0.0 108.758 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.667 HG21 ' HB3' ' A' ' 50' ' ' TYR . 13.0 mm -63.54 -51.58 68.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.47 -19.23 61.79 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.8 tp10 -75.71 -35.18 60.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.847 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.007 HG23 HG21 ' A' ' 99' ' ' VAL . 5.4 mt -64.99 -52.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.761 HG21 HG11 ' A' ' 64' ' ' VAL . 7.1 p -61.41 -42.57 94.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.722 ' N ' HG13 ' A' ' 25' ' ' VAL . 32.5 t70 -72.75 -16.44 61.65 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 11.9 tptt -89.75 -11.6 41.78 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 97' ' ' LEU . 18.3 m -116.08 -8.72 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.447 -0.783 . . . . 0.0 109.802 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 11.3 ttpp -51.95 -44.13 90.9 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.837 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 30.6 Cg_endo -72.77 -29.05 13.06 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.451 1.434 . . . . 0.0 110.016 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -80.69 -11.87 59.56 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.986 HD11 HD11 ' A' ' 97' ' ' LEU . 6.4 mt -93.65 -35.25 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.503 0.668 . . . . 0.0 109.762 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 39' ' ' THR . 30.3 mt-10 -58.74 -46.05 88.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.77 -51.12 6.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 109.961 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -49.77 -58.32 5.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 108.497 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.749 HG21 ' OH ' ' A' ' 40' ' ' TYR . 1.4 m -68.97 -60.52 2.31 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.539 -0.726 . . . . 0.0 109.512 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER 119.48 41.6 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 73.0 mm-40 -130.4 -166.73 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.888 . . . . 0.0 110.017 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 39' ' ' THR . 94.5 m -129.05 26.15 5.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.813 -0.554 . . . . 0.0 109.516 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.749 ' OH ' HG21 ' A' ' 36' ' ' THR . 11.5 m-85 -29.06 147.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.72 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 29' ' ' LYS . . . -117.38 -135.52 5.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -54.65 126.29 23.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.336 -1.097 . . . . 0.0 110.078 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.633 HD12 HG22 ' A' ' 25' ' ' VAL . 28.8 mt -107.56 74.47 0.96 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB3' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -54.83 85.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.313 0.577 . . . . 0.0 110.495 -178.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.903 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -46.22 124.73 5.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.26 1.028 . . . . 0.0 109.754 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.486 HG12 ' HG2' ' A' ' 49' ' ' GLN . 1.9 t -101.56 -44.68 10.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.554 ' CG ' ' HB3' ' A' ' 63' ' ' LYS . 9.2 pt20 -147.23 171.34 15.53 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.667 ' HB3' HG21 ' A' ' 21' ' ' ILE . 12.1 p90 -168.17 138.79 2.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 12' ' ' SER . 1.4 mttp -109.88 124.01 50.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 p -76.51 -178.14 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.307 -0.871 . . . . 0.0 110.148 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 58' ' ' THR . 2.3 mm100 -159.53 150.8 19.86 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.864 ' O ' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.06 146.97 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 120.915 -1.116 . . . . 0.0 111.126 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.864 HG13 ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -171.04 -103.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.57 29.14 6.79 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 58' ' ' THR . . . 164.54 -114.02 0.58 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 106.294 -2.722 . . . . 0.0 106.294 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 53' ' ' GLN . 28.8 m -166.92 113.72 0.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -1.157 . . . . 0.0 111.005 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.619 ' HB2' ' CB ' ' A' ' 53' ' ' GLN . 70.0 m-20 -73.51 -166.55 0.36 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.6 ' CD1' HG12 ' A' ' 99' ' ' VAL . 86.6 m-85 -154.44 153.75 32.06 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.632 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.628 ' C ' HD22 ' A' ' 122' ' ' LEU . 22.8 m-85 -138.04 130.41 29.14 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.824 HG22 HG13 ' A' ' 64' ' ' VAL . 11.7 mt -149.34 122.68 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 119.583 -1.948 . . . . 0.0 112.098 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 21.8 ttpt -92.16 95.53 9.8 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 47' ' ' ALA . 14.6 m -101.9 140.06 21.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -68.64 127.0 31.47 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.98 45.11 1.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.928 0.871 . . . . 0.0 109.615 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 68' ' ' ASP . . . 99.37 -122.88 7.72 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' GLY . 16.8 t70 -43.26 -101.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.939 . . . . 0.0 111.37 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.3 m120 -120.02 -4.27 10.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.577 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.6 mttt -69.47 179.17 2.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 108.624 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 30.3 m-85 -146.52 168.25 21.69 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.026 -1.046 . . . . 0.0 109.94 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.748 ' O ' HG22 ' A' ' 64' ' ' VAL . 18.9 mtp -154.87 115.43 3.9 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.695 ' NE2' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -73.69 137.58 44.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.986 HD11 HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -125.17 123.26 39.25 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.497 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -108.68 121.65 45.47 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.007 HG21 HG23 ' A' ' 24' ' ' ILE . 2.5 t -125.27 166.26 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.59 -1.319 . . . . 0.0 109.445 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.702 ' HB3' ' CG1' ' A' ' 109' ' ' VAL . 10.0 t80 -125.08 136.45 53.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.987 -1.071 . . . . 0.0 108.201 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.598 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -103.56 120.53 41.05 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.929 0.871 . . . . 0.0 109.872 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 103' ' ' PRO . 0.3 OUTLIER -102.93 80.16 1.84 Allowed 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' A LEU . . . . . 0.714 ' O ' HD12 ' A' ' 102' A LEU . 0.5 OUTLIER -30.23 91.77 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 122.032 -0.417 . . . . 0.0 110.883 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.528 ' N ' ' O ' ' A' ' 102' ' ' SER . 37.0 Cg_endo -80.81 -172.34 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.929 2.419 . . . . 0.0 110.546 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.19 -36.76 4.82 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.71 -96.93 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.508 -0.995 . . . . 0.0 108.941 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' A ASN . . . . . . . . . . . . . 23.0 t-20 -49.35 138.88 12.4 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.501 -0.749 . . . . 0.0 109.385 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 103' ' ' PRO . 12.7 mp0 -99.82 158.24 15.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 108' ' ' LEU . 8.4 p30 -154.08 57.7 0.72 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 107' ' ' ASP . 8.6 mp -49.74 178.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.251 1.025 . . . . 0.0 109.379 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.728 ' O ' HG22 ' A' ' 99' ' ' VAL . 8.7 p -139.27 162.36 27.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.715 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 18.6 tp -99.31 88.09 3.81 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 100' ' ' PHE . 14.7 p -71.53 -29.71 65.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 111.85 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 113' ' ' TYR . . . -168.94 -163.31 22.75 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.337 -1.411 . . . . 0.0 109.85 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.579 ' O ' ' CD1' ' A' ' 113' ' ' TYR . 20.5 p90 166.48 135.64 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.41 -1.053 . . . . 0.0 109.854 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.4 mm-40 -95.48 95.4 8.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 115' A ASP . 6.3 p -67.51 160.15 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.092 -1.005 . . . . 0.0 110.57 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' A ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 115' ' ' VAL . 21.2 t0 43.2 28.37 0.16 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.304 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.59 ' HG3' ' CB ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -82.26 160.96 22.83 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.701 -1.249 . . . . 0.0 107.807 179.207 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.87 -170.91 1.91 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.756 -1.215 . . . . 0.0 110.888 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 18.9 mttt -68.47 -69.64 0.31 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.713 -0.617 . . . . 0.0 110.657 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -40.8 -26.91 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.347 -0.846 . . . . 0.0 110.292 -179.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 96' ' ' HIS . 14.8 t70 -47.43 109.88 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.027 . . . . 0.0 110.733 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.553 ' O ' ' CG2' ' A' ' 123' ' ' THR . 74.8 tt0 -84.3 136.91 33.72 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 62' ' ' ILE . 2.6 mp -67.27 -32.38 73.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.904 -1.122 . . . . 0.0 108.741 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.62 HG23 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER 45.36 -167.02 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.038 0.923 . . . . 0.0 110.499 177.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.902 ' HA2' HD11 ' A' ' 11' ' ' LEU . . . -43.35 -21.57 0.16 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.636 ' CZ ' ' HG2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.676 0 O-C-N 121.213 -1.169 . . . . 0.0 109.079 -179.716 . . . . . . . . 2 2 . 1 stop_ save_